data_2mez_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mez _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.4 t80 . . . . . 0 N--CA 1.447 -0.589 0 CA-C-O 117.474 -1.251 . . . . 0.0 112.666 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -75.39 -166.19 0.5 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -174.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -16.4 -57.91 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 119.905 3.298 . . . . 0.0 119.905 166.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.2 tp -44.07 -50.84 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 118.84 2.904 . . . . 0.0 118.84 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.311 6.2 tt -84.27 -46.94 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 129.366 3.066 . . . . 0.0 110.115 175.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -52.44 -52.49 53.8 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 115.476 -2.202 . . . . 0.0 111.623 -172.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.1 p -46.33 -52.32 13.01 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.252 1.421 . . . . 0.0 109.247 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.9 -36.43 56.67 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-O 114.453 -2.689 . . . . 0.0 117.388 -172.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . 0.31 37.3 ptt85 -57.97 -43.93 86.79 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 121.201 1.819 . . . . 0.0 113.562 172.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -55.28 -34.0 63.72 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 113.575 -3.107 . . . . 0.0 111.962 164.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.65 -21.96 63.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 124.16 3.164 . . . . 0.0 109.028 178.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.8 mt -98.82 -9.87 23.74 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 125.764 1.626 . . . . 0.0 112.768 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.22 -7.33 2.59 Favored Glycine 0 N--CA 1.464 0.56 0 CA-C-N 113.014 -1.903 . . . . 0.0 117.851 174.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.5 pt -57.11 128.32 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 128.293 2.637 . . . . 0.0 111.284 -176.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.7 p -67.93 162.52 24.11 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 118.936 2.939 . . . . 0.0 118.936 -171.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -48.02 -43.97 30.5 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 117.604 -3.185 . . . . 0.0 113.951 168.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -68.69 -34.89 76.43 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 123.415 0.686 . . . . 0.0 110.002 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -71.32 -41.5 69.77 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 115.05 -2.405 . . . . 0.0 109.105 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . 0.257 29.2 tp -59.94 -46.25 90.0 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 128.081 2.552 . . . . 0.0 113.945 177.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.5 -37.77 65.7 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 110.718 -2.946 . . . . 0.0 116.492 174.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -63.78 -40.59 97.04 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.839 1.655 . . . . 0.0 113.62 165.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -63.66 1.21 0.63 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.28 1.832 . . . . 0.0 111.452 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.268 16.1 tp -145.79 4.43 0.99 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 120.377 3.473 . . . . 0.0 120.377 -170.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.26 63.7 mttt 52.18 39.01 25.98 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 130.807 3.643 . . . . 0.0 115.199 -174.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.7 m -126.66 -172.58 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 1 C-N-CA 133.38 4.672 . . . . 0.0 113.826 -176.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.1 p -101.33 152.5 20.63 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 116.599 -1.667 . . . . 0.0 114.421 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -49.09 -32.5 9.89 Favored 'General case' 0 CA--C 1.52 -0.187 0 O-C-N 126.177 2.173 . . . . 0.0 110.349 165.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -74.08 -29.63 61.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 116.599 -1.667 . . . . 0.0 109.746 -171.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mt -70.83 -47.67 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-O 126.322 2.963 . . . . 0.0 113.704 173.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.348 13.4 m -56.59 -46.72 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 2 O-C-N 113.433 -5.792 . . . . 0.0 112.148 175.149 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -56.07 -40.86 74.23 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 117.989 -2.944 . . . . 0.0 113.277 162.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.8 ttt85 -57.64 -36.59 72.05 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 115.609 -2.138 . . . . 0.0 113.174 177.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -71.51 -44.76 64.07 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 124.849 1.343 . . . . 0.0 111.066 173.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -67.7 -13.77 62.38 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 114.861 -2.495 . . . . 0.0 109.775 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.9 p -102.68 0.36 32.99 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 124.094 3.134 . . . . 0.0 111.482 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.93 6.22 87.0 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 122.268 2.303 . . . . 0.0 115.816 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -94.12 -18.83 21.38 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 119.443 1.621 . . . . 0.0 114.962 -166.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.4 tp -144.87 161.67 38.72 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 127.931 3.27 . . . . 0.0 109.04 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.258 76.2 tttt -133.65 151.94 78.05 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-O 115.627 -2.13 . . . . 0.0 112.869 171.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . 0.274 41.4 Cg_endo -63.42 168.04 11.99 Favored 'Trans proline' 0 N--CA 1.451 -0.981 1 C-N-CA 126.211 4.607 . . . . 0.0 108.807 169.636 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 81.3 p -96.34 179.22 5.11 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 127.581 2.352 . . . . 0.0 111.224 171.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.1 pt -64.66 -57.23 12.16 Favored 'Isoleucine or valine' 0 C--N 1.346 0.449 0 CA-C-O 113.434 -3.174 . . . . 0.0 114.857 -175.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 90.3 p -51.98 -29.64 21.49 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 122.975 2.625 . . . . 0.0 111.914 167.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -78.86 -53.07 7.46 Favored 'General case' 0 N--CA 1.439 -0.978 0 O-C-N 118.982 -2.324 . . . . 0.0 109.129 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -40.94 -45.57 2.59 Favored 'General case' 0 N--CA 1.448 -0.57 1 C-N-CA 131.918 4.087 . . . . 0.0 104.759 162.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -62.65 -40.0 95.65 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 118.667 -2.52 . . . . 0.0 112.253 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -79.3 -40.33 30.67 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 117.676 2.473 . . . . 0.0 117.676 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 87.5 mt -44.97 -46.13 10.94 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 114.854 -2.498 . . . . 0.0 113.965 161.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -56.03 -43.08 77.47 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 121.831 2.105 . . . . 0.0 107.353 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -85.21 -4.95 59.33 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 130.396 3.478 . . . . 0.0 118.609 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.2 tt -75.58 -31.64 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 1 O-C-N 114.395 -5.191 . . . . 0.0 116.394 -163.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.448 ' C ' ' H ' ' A' ' 76' ' ' ILE . 57.8 mt -105.56 -7.26 18.7 Favored 'General case' 0 N--CA 1.445 -0.694 2 O-C-N 115.244 -4.66 . . . . 0.0 113.0 -175.706 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.08 -20.78 0.05 OUTLIER Glycine 0 CA--C 1.526 0.765 0 O-C-N 116.486 -3.884 . . . . 0.0 112.643 -151.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.448 ' H ' ' C ' ' A' ' 74' ' ' LEU . 9.2 pt -131.05 -161.79 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-O 125.101 2.382 . . . . 0.0 116.918 -172.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.5 pttm -175.29 176.02 2.1 Favored 'General case' 0 N--CA 1.439 -0.99 0 O-C-N 117.318 -3.364 . . . . 0.0 107.08 -172.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 59.0 tp . . . . . 0 N--CA 1.445 -0.68 0 C-N-CA 129.689 3.196 . . . . 0.0 106.798 138.058 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.465 ' CD2' ' HA2' ' A' ' 58' ' ' GLY . 40.0 t80 . . . . . 0 CA--C 1.517 -0.295 0 CA-C-O 116.742 -1.599 . . . . 0.0 113.236 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -65.15 144.97 56.87 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 119.843 1.201 . . . . 0.0 112.476 -174.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -78.34 -29.12 47.45 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 119.266 3.061 . . . . 0.0 119.266 -160.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.96 -51.87 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 O-C-N 117.488 -3.257 . . . . 0.0 108.587 -170.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.2 pt -54.0 -28.66 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 117.131 -1.414 . . . . 0.0 114.312 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -60.12 -39.61 86.84 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 129.555 3.142 . . . . 0.0 111.136 173.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.5 p -90.77 -21.87 21.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 117.011 2.226 . . . . 0.0 117.011 -173.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.83 -61.27 2.75 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 131.05 3.74 . . . . 0.0 113.115 -159.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.38 -46.08 87.04 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-O 114.618 -2.611 . . . . 0.0 110.135 -169.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -63.7 -34.76 78.59 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 117.281 2.326 . . . . 0.0 117.281 169.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.97 -0.21 13.08 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 122.83 2.559 . . . . 0.0 110.659 -174.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 36.3 mt -117.43 -19.81 9.35 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 129.491 3.116 . . . . 0.0 112.527 178.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.76 -8.29 50.28 Favored Glycine 0 C--O 1.223 -0.557 0 CA-C-O 127.615 3.897 . . . . 0.0 114.463 162.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.421 HD11 ' HE3' ' A' ' 44' ' ' LYS . 35.1 pt -91.75 155.86 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 130.356 3.463 . . . . 0.0 110.459 -173.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.0 p -65.14 161.91 18.1 Favored 'General case' 0 CA--C 1.514 -0.412 0 O-C-N 119.86 -1.775 . . . . 0.0 115.065 167.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -56.42 -37.73 70.6 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 118.017 -0.992 . . . . 0.0 111.713 170.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -66.77 -31.87 72.79 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 126.004 1.722 . . . . 0.0 111.591 174.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -69.07 -39.58 79.0 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 118.644 -2.535 . . . . 0.0 112.781 170.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.0 tp -64.25 -37.92 89.21 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 118.665 -2.522 . . . . 0.0 110.216 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.79 -25.08 61.86 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.311 -0.868 . . . . 0.0 108.874 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -62.33 -36.67 82.93 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 123.603 1.668 . . . . 0.0 114.948 170.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.421 ' HE3' HD11 ' A' ' 36' ' ' ILE . 21.8 mttm -66.82 -22.85 66.0 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 117.292 -3.38 . . . . 0.0 111.807 -175.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.6 mt -133.46 -5.62 2.94 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 127.297 2.873 . . . . 0.0 108.985 -145.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.356 65.2 mmtt 51.16 -37.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 119.175 3.028 . . . . 0.0 119.175 -153.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.1 m -124.46 154.46 31.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 116.171 -1.871 . . . . 0.0 111.605 -157.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.921 ' C ' ' H ' ' A' ' 52' ' ' VAL . 84.0 p -137.87 -6.36 1.67 Allowed 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 127.966 3.291 . . . . 0.0 118.189 -135.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.544 ' N ' ' H ' ' A' ' 52' ' ' VAL . 17.7 mp0 -101.59 -32.36 10.39 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 127.651 3.094 . . . . 0.0 110.387 -162.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.452 ' H ' ' C ' ' A' ' 51' ' ' ILE . 57.0 t-20 -118.91 -42.84 2.69 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 112.446 -3.645 . . . . 0.0 113.894 -174.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.452 ' C ' ' H ' ' A' ' 50' ' ' ASN . 1.5 mt 46.12 61.75 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.354 2 C-N-CA 137.925 6.49 . . . . 0.0 112.22 -1.654 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.921 ' H ' ' C ' ' A' ' 48' ' ' SER . 27.8 t -93.66 -47.76 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 O-C-N 117.723 -3.111 . . . . 0.0 114.882 2.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -57.82 -43.22 85.6 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 120.523 3.527 . . . . 0.0 120.523 -148.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.3 ttm180 -73.44 -12.41 60.79 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 115.516 -2.183 . . . . 0.0 114.684 -157.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -52.39 -27.91 17.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 125.252 1.595 . . . . 0.0 113.765 169.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . 0.269 12.4 pt-20 -50.41 -27.45 6.41 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 123.849 3.022 . . . . 0.0 116.592 168.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.6 p -73.75 -27.81 61.36 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 119.328 3.084 . . . . 0.0 119.328 -148.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.465 ' HA2' ' CD2' ' A' ' 23' ' ' TYR . . . 78.53 19.54 73.55 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 123.106 2.684 . . . . 0.0 115.704 -172.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -122.09 4.43 9.84 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 121.314 3.82 . . . . 0.0 121.314 -162.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.6 tp -145.01 142.0 29.41 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 118.426 2.75 . . . . 0.0 118.426 -168.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.251 61.1 mttm -115.09 109.42 46.85 Favored Pre-proline 0 C--N 1.351 0.67 0 O-C-N 119.342 -2.099 . . . . 0.0 109.739 155.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -78.01 -177.84 4.17 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 124.139 3.226 . . . . 0.0 112.054 -167.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.0 p -81.58 170.86 15.35 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 165.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 11.3 tp -68.73 -46.17 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-N 112.302 -2.227 . . . . 0.0 110.59 -177.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.7 p -56.69 -34.19 67.17 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 120.892 1.678 . . . . 0.0 111.917 169.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -78.43 -50.41 11.74 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 -170.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -52.09 -40.21 60.91 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 125.62 1.825 . . . . 0.0 114.368 173.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -65.4 -46.15 81.18 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 172.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.618 ' C ' ' H ' ' A' ' 72' ' ' LYS . 35.0 mt-30 -64.33 -27.41 69.01 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 118.127 -2.858 . . . . 0.0 112.865 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 27.3 mt -90.22 -31.6 16.94 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -166.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -50.74 -31.51 16.9 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.097 149.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.618 ' H ' ' C ' ' A' ' 69' ' ' GLN . 20.0 tttm -78.46 -26.1 46.02 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 116.701 -2.0 . . . . 0.0 116.053 -161.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . 0.355 26.2 pt -57.18 -43.25 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 O-C-N 116.997 -3.564 . . . . 0.0 114.307 167.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.455 ' HG ' ' H ' ' A' ' 74' ' ' LEU . 8.7 mt -60.4 -34.76 74.39 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 -166.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.04 -5.83 7.67 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 117.269 -2.396 . . . . 0.0 113.995 -169.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.425 ' H ' ' C ' ' A' ' 74' ' ' LEU . 27.1 pt -114.89 -162.45 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 124.899 1.28 . . . . 0.0 113.059 163.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -120.38 150.25 41.07 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 114.869 -2.491 . . . . 0.0 113.671 169.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.4 mt . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 175.683 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 27.8 t80 . . . . . 0 N--CA 1.442 -0.84 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -58.34 144.71 40.57 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 128.124 2.569 . . . . 0.0 116.84 -171.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.7 tttt -116.63 -4.26 11.71 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 -157.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.1 pt -43.95 -49.3 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.747 0 C-N-CA 127.84 2.456 . . . . 0.0 116.23 -174.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.426 13.9 pt -74.23 -16.5 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 O-C-N 125.165 1.541 . . . . 0.0 115.031 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.342 19.0 tttm -66.53 -58.01 6.1 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 120.462 3.505 . . . . 0.0 120.462 -158.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 52.2 m -54.57 -40.43 68.76 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 120.469 -1.394 . . . . 0.0 109.479 174.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.98 -45.68 80.79 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 118.661 2.837 . . . . 0.0 118.661 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -47.22 -42.23 19.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.883 0.873 . . . . 0.0 112.618 164.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -73.48 -39.81 64.6 Favored 'General case' 0 N--CA 1.437 -1.109 1 CA-C-O 111.551 -4.071 . . . . 0.0 112.41 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -61.41 -41.06 96.56 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 127.554 3.034 . . . . 0.0 112.742 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 61.1 mt -58.35 -35.18 71.54 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.515 1.926 . . . . 0.0 111.512 171.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.1 2.92 5.62 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 128.375 2.893 . . . . 0.0 115.225 -173.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.5 pt -66.63 154.73 7.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 125.637 2.637 . . . . 0.0 113.966 -166.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 64.2 p -80.45 170.59 16.17 Favored 'General case' 0 N--CA 1.438 -1.038 0 O-C-N 119.151 -2.218 . . . . 0.0 113.113 -176.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -56.52 -41.66 77.09 Favored 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 117.997 -2.939 . . . . 0.0 105.138 174.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -72.53 -32.99 66.55 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 121.925 2.148 . . . . 0.0 116.625 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -64.57 -38.03 89.61 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 116.338 -3.976 . . . . 0.0 112.442 170.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.2 tp -70.3 -37.13 74.73 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 128.329 2.652 . . . . 0.0 114.489 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.3 -46.37 90.12 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.902 1.681 . . . . 0.0 112.306 169.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -63.25 -44.64 94.61 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 117.868 -1.063 . . . . 0.0 111.836 172.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -69.19 -14.49 63.01 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 125.764 1.626 . . . . 0.0 111.99 -174.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.04 1.87 10.4 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.63 1.972 . . . . 0.0 109.78 -172.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.256 0.0 OUTLIER 62.41 -35.42 0.12 Allowed 'General case' 0 N--CA 1.444 -0.767 2 C-N-CA 133.169 4.587 . . . . 0.0 114.784 -167.736 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.8 m -77.53 164.13 3.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 1 C-N-CA 133.165 4.586 . . . . 0.0 114.747 -161.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 89.3 p -79.66 159.21 26.8 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 -170.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -82.7 -12.46 57.57 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 117.557 -1.657 . . . . 0.0 110.216 -162.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -59.91 -44.34 94.33 Favored 'General case' 0 C--O 1.222 -0.391 0 O-C-N 120.663 -1.273 . . . . 0.0 109.899 166.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.5 mm -64.42 -45.52 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 C-N-CA 127.863 2.465 . . . . 0.0 108.345 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.387 1.3 m -65.11 -45.9 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -176.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -63.84 -26.76 68.76 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-O 115.308 -2.282 . . . . 0.0 116.229 172.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -59.49 -44.03 93.17 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 121.742 2.064 . . . . 0.0 109.008 176.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -82.05 -28.18 32.58 Favored 'General case' 0 CA--C 1.522 -0.112 0 O-C-N 118.421 -2.675 . . . . 0.0 110.702 -176.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -63.19 -33.75 76.16 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 119.396 -2.065 . . . . 0.0 111.159 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.2 p -126.61 22.58 6.92 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -151.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.11 21.85 62.1 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.664 165.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -97.1 26.53 4.65 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 125.9 1.68 . . . . 0.0 115.025 -164.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.2 tp -140.02 154.58 47.16 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 113.672 -1.603 . . . . 0.0 114.903 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.2 tttp -90.54 102.08 4.61 Favored Pre-proline 0 N--CA 1.443 -0.808 0 C-N-CA 125.041 1.337 . . . . 0.0 108.526 149.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -83.83 170.89 11.01 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 CA-C-O 125.041 2.017 . . . . 0.0 111.236 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.0 p -143.73 179.28 7.25 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 118.921 -2.362 . . . . 0.0 111.988 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . 0.403 60.7 mt -52.39 -61.4 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 O-C-N 127.574 3.046 . . . . 0.0 109.392 172.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 96.5 p -68.97 -31.26 69.99 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 125.329 1.643 . . . . 0.0 107.653 -173.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -77.96 -37.49 47.35 Favored 'General case' 0 N--CA 1.438 -1.073 1 O-C-N 114.581 -5.074 . . . . 0.0 109.014 -177.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.23 -45.72 90.3 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 114.466 -2.683 . . . . 0.0 107.172 169.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 39.5 tpt85 -52.61 -27.82 18.6 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 125.153 1.533 . . . . 0.0 112.496 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -93.39 -29.39 15.62 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 114.396 -2.716 . . . . 0.0 110.31 -173.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.5 tp -61.62 -53.11 60.58 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 114.927 -2.463 . . . . 0.0 115.732 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -50.9 -22.69 2.35 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 125.303 1.627 . . . . 0.0 115.175 157.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.25 76.7 tttt -87.54 -38.02 16.37 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 117.268 -3.395 . . . . 0.0 109.489 -173.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 50.5 pt -74.1 -29.91 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 34.4 tp -77.61 -25.33 49.74 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 126.54 3.066 . . . . 0.0 107.34 175.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.35 8.85 27.33 Favored Glycine 0 N--CA 1.445 -0.725 0 O-C-N 118.878 -2.389 . . . . 0.0 117.098 -168.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.2 pt -152.02 177.34 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.073 0 C-N-CA 130.018 3.327 . . . . 0.0 112.006 175.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -171.29 168.69 6.58 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 128.602 2.761 . . . . 0.0 106.892 -166.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.7 mt . . . . . 0 N--CA 1.447 -0.577 0 CA-C-N 112.407 -2.179 . . . . 0.0 115.221 179.184 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.473 ' HH ' HG12 ' A' ' 52' ' ' VAL . 49.4 t80 . . . . . 0 CA--C 1.508 -0.668 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -85.91 -162.64 0.76 Allowed 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 127.868 3.23 . . . . 0.0 111.291 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -66.4 -1.8 3.87 Favored 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 118.272 -2.767 . . . . 0.0 114.461 -168.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.0 pt -56.26 -27.67 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 O-C-N 120.13 -1.606 . . . . 0.0 115.315 160.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.348 6.7 tp -140.5 -33.15 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 O-C-N 119.998 -1.689 . . . . 0.0 109.875 -173.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -70.98 -49.28 47.0 Favored 'General case' 0 N--CA 1.445 -0.708 0 O-C-N 117.177 -3.452 . . . . 0.0 112.829 -164.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.08 -39.7 94.64 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 128.092 2.557 . . . . 0.0 106.748 175.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.72 -59.57 4.71 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 117.756 2.502 . . . . 0.0 117.756 -173.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -39.94 -45.85 1.94 Allowed 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 124.566 1.167 . . . . 0.0 109.703 169.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -58.93 -47.52 84.76 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 116.859 -3.651 . . . . 0.0 117.199 168.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -72.33 -1.71 16.46 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 122.013 2.188 . . . . 0.0 112.446 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.413 ' C ' ' H ' ' A' ' 36' ' ' ILE . 81.5 mt -101.51 -22.1 14.59 Favored 'General case' 0 N--CA 1.451 -0.413 1 O-C-N 115.161 -4.712 . . . . 0.0 107.046 -177.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.81 -12.1 0.16 Allowed Glycine 0 C--N 1.336 0.555 0 CA-C-O 125.492 2.718 . . . . 0.0 115.785 -176.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.413 ' H ' ' C ' ' A' ' 34' ' ' LEU . 31.7 pt -66.19 163.42 2.44 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 N-CA-C 119.118 3.007 . . . . 0.0 119.118 -176.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.5 p -77.17 171.75 14.34 Favored 'General case' 0 C--O 1.241 0.644 0 O-C-N 116.995 -3.566 . . . . 0.0 117.753 175.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . 0.336 2.5 mp0 -70.89 -24.43 62.48 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 120.843 -1.16 . . . . 0.0 110.03 169.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -72.89 -37.21 67.37 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 120.503 -1.373 . . . . 0.0 107.432 176.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -76.81 -32.16 57.45 Favored 'General case' 0 N--CA 1.44 -0.953 0 O-C-N 118.464 -2.648 . . . . 0.0 113.868 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.3 tp -72.54 -36.46 68.27 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 130.215 3.406 . . . . 0.0 109.716 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.54 -34.11 70.64 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 121.581 1.991 . . . . 0.0 112.873 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -60.94 -49.84 75.8 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.924 1.689 . . . . 0.0 112.304 168.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.7 mmtt -70.54 -19.25 62.91 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -173.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 94.7 mt -101.72 -9.67 20.65 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -170.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.339 7.1 mptt 61.69 -16.43 0.04 OUTLIER 'General case' 0 C--O 1.237 0.415 0 N-CA-C 117.104 2.261 . . . . 0.0 117.104 -163.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.3 m -104.51 166.1 3.23 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 CA-C-O 124.53 2.11 . . . . 0.0 112.508 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 55.3 p -74.04 166.31 23.61 Favored 'General case' 0 N--CA 1.44 -0.974 0 O-C-N 118.969 -2.332 . . . . 0.0 116.229 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -70.5 -23.48 62.67 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 118.685 -2.51 . . . . 0.0 107.689 175.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -63.1 -37.0 85.47 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.274 1.43 . . . . 0.0 110.743 171.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.5 mm -68.84 -40.4 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 125.861 3.937 . . . . 0.0 110.594 171.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.473 HG12 ' HH ' ' A' ' 23' ' ' TYR . 41.1 t -54.41 -45.32 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 113.966 -1.47 . . . . 0.0 111.262 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -59.04 -58.13 10.01 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 128.873 2.869 . . . . 0.0 106.098 169.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -53.55 -39.51 64.78 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 121.452 1.933 . . . . 0.0 110.732 -163.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -70.81 -50.81 31.57 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 118.273 -0.87 . . . . 0.0 112.826 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -51.43 -37.7 49.93 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 122.729 2.513 . . . . 0.0 112.835 170.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.4 p -83.79 4.96 26.79 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 118.44 2.756 . . . . 0.0 118.44 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.82 7.36 68.67 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 116.853 -2.082 . . . . 0.0 111.938 165.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -103.98 -15.42 15.62 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 129.152 2.981 . . . . 0.0 115.998 -167.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.3 tp -146.53 138.98 25.09 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 126.14 1.776 . . . . 0.0 115.426 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.409 ' CB ' ' CD ' ' A' ' 62' ' ' PRO . 15.6 ptpt -138.53 -164.77 0.08 OUTLIER Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-O 116.588 -1.672 . . . . 0.0 112.492 173.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 61' ' ' LYS . 88.2 Cg_endo -88.8 149.64 5.98 Favored 'Trans proline' 0 N--CA 1.44 -1.644 0 O-C-N 124.512 1.796 . . . . 0.0 112.241 177.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.0 p -144.52 -179.33 6.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.836 1.255 . . . . 0.0 113.042 -172.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.434 ' C ' ' N ' ' A' ' 66' ' ' GLN . 8.7 tp -78.69 -44.02 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 C-N-CA 125.346 1.458 . . . . 0.0 107.816 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 84.9 p -53.92 -7.67 0.14 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-N 120.389 1.45 . . . . 0.0 108.388 169.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.434 ' N ' ' C ' ' A' ' 64' ' ' ILE . 40.3 mt-30 -118.68 -37.33 3.29 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 117.722 -3.112 . . . . 0.0 115.039 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -39.38 -46.66 1.66 Allowed 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 117.565 2.431 . . . . 0.0 117.565 -162.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.5 mtm105 -71.48 -53.54 13.59 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 114.903 -2.475 . . . . 0.0 116.47 -165.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -63.18 -39.14 93.79 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 115.694 -2.098 . . . . 0.0 112.877 167.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 44.4 tp -53.85 -49.0 69.43 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 127.167 2.792 . . . . 0.0 107.131 -170.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -57.82 -51.12 70.88 Favored 'General case' 0 CA--C 1.513 -0.467 0 O-C-N 118.694 -2.504 . . . . 0.0 111.527 177.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -73.24 -29.45 62.79 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 116.579 -3.826 . . . . 0.0 115.706 -168.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 14.5 pt -66.04 -15.96 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 123.042 2.655 . . . . 0.0 112.942 161.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.372 1.3 pt? 146.24 -10.15 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.477 1 C-N-CA 133.41 4.684 . . . . 0.0 115.233 162.457 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.85 6.79 68.34 Favored Glycine 0 C--N 1.34 0.788 0 CA-C-O 113.943 -3.698 . . . . 0.0 114.014 -172.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . 0.282 1.4 pt 71.64 6.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.835 1 C-N-CA 135.196 5.398 . . . . 0.0 117.16 174.578 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -71.88 148.51 46.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 115.116 -2.373 . . . . 0.0 113.992 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . 0.259 40.1 mt . . . . . 0 N--CA 1.448 -0.553 0 C-N-CA 125.383 1.473 . . . . 0.0 113.328 168.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.444 -0.731 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -44.86 116.22 1.04 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 119.633 3.197 . . . . 0.0 119.633 -173.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -66.17 -36.73 83.86 Favored 'General case' 0 C--O 1.222 -0.375 0 N-CA-C 116.199 1.925 . . . . 0.0 116.199 -170.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.2 pt -62.08 -22.17 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 O-C-N 119.453 -2.03 . . . . 0.0 113.817 -171.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.359 2.5 mt -136.94 -53.68 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 O-C-N 117.621 -3.174 . . . . 0.0 109.646 172.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt 63.96 -96.24 0.05 Allowed 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 113.476 -3.154 . . . . 0.0 115.548 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.7 p -43.44 -31.86 0.77 Allowed 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 130.738 3.615 . . . . 0.0 111.128 -168.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.73 -26.06 31.63 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 131.105 3.762 . . . . 0.0 117.996 -154.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . 0.451 22.3 ptt180 -36.92 -50.3 0.86 Allowed 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 119.93 3.307 . . . . 0.0 119.93 -176.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . 0.25 40.9 mt-10 -72.32 -37.0 69.01 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 114.335 -2.745 . . . . 0.0 115.476 170.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -65.29 0.96 1.2 Allowed 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 126.33 1.852 . . . . 0.0 114.458 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.472 ' C ' ' H ' ' A' ' 36' ' ' ILE . 12.4 mt -72.64 -7.61 51.18 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 119.321 -2.112 . . . . 0.0 114.492 -175.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 47.98 6.75 0.03 OUTLIER Glycine 0 C--N 1.347 1.15 1 C-N-CA 131.442 4.353 . . . . 0.0 115.881 -161.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.472 ' H ' ' C ' ' A' ' 34' ' ' LEU 0.289 2.6 pt -136.32 167.73 23.75 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.509 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.677 -169.232 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 65.8 m -134.89 179.93 6.0 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 121.012 1.733 . . . . 0.0 115.249 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.42 -38.93 14.36 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 118.484 -2.635 . . . . 0.0 117.898 -159.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -75.73 -39.32 57.47 Favored 'General case' 0 N--CA 1.442 -0.844 0 O-C-N 119.404 -2.06 . . . . 0.0 109.542 -169.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -67.4 -34.95 78.33 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 160.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.6 tp -64.51 -39.42 93.75 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 121.461 1.937 . . . . 0.0 112.089 -175.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -50.81 -32.86 21.36 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.462 177.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -73.14 -50.23 23.84 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 124.148 1.928 . . . . 0.0 112.737 173.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -65.69 -4.07 5.79 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 116.511 -1.709 . . . . 0.0 110.74 -168.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.331 53.9 tp -146.93 -0.84 0.69 Allowed 'General case' 0 C--O 1.247 0.925 0 CA-C-O 123.471 1.605 . . . . 0.0 112.22 -155.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 49.58 58.38 5.48 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.384 1.074 . . . . 0.0 112.179 -175.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.7 m -143.84 166.66 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 121.503 1.956 . . . . 0.0 106.189 -173.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 96.3 p -85.55 160.72 19.59 Favored 'General case' 0 C--O 1.241 0.63 0 O-C-N 116.938 -3.601 . . . . 0.0 108.254 168.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . 0.26 5.2 mt-10 -65.93 -28.97 69.32 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 111.41 -2.632 . . . . 0.0 111.775 173.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -61.28 -36.43 80.03 Favored 'General case' 0 CA--C 1.514 -0.434 0 O-C-N 117.947 -2.97 . . . . 0.0 117.428 166.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.4 mm -59.74 -37.03 69.3 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.449 0 CA-C-N 119.35 0.977 . . . . 0.0 108.867 168.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.346 40.0 t -59.57 -44.29 92.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 O-C-N 119.403 -2.06 . . . . 0.0 110.55 -178.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.1 mttt -58.93 -37.33 76.45 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 127.904 2.482 . . . . 0.0 112.03 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -75.53 -21.56 57.85 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 130.808 3.643 . . . . 0.0 112.668 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.9 m-30 -82.35 -47.68 12.05 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 101.685 -3.45 . . . . 0.0 101.685 167.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -54.38 -25.89 27.01 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 126.668 1.987 . . . . 0.0 108.78 -166.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.9 p -105.21 -14.8 15.25 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 128.674 3.734 . . . . 0.0 114.184 -174.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.32 18.13 79.8 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 114.267 -3.519 . . . . 0.0 117.501 -167.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -74.6 -19.17 60.41 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 114.624 -2.608 . . . . 0.0 113.597 175.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . 0.31 43.1 tp -147.41 148.71 31.58 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 129.556 3.142 . . . . 0.0 112.593 177.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -106.6 147.08 34.33 Favored Pre-proline 0 N--CA 1.449 -0.522 0 N-CA-C 120.681 3.585 . . . . 0.0 120.681 168.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -60.08 153.88 55.21 Favored 'Trans proline' 0 N--CA 1.449 -1.104 1 C-N-CA 126.654 4.902 . . . . 0.0 114.306 176.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.6 p -98.91 -173.68 2.58 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 111.605 -2.543 . . . . 0.0 112.93 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.0 tt -50.57 -71.83 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 C-N-CA 130.3 3.44 . . . . 0.0 115.844 174.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.2 p -56.04 -22.85 29.74 Favored 'General case' 0 C--N 1.328 -0.368 1 O-C-N 116.126 -4.109 . . . . 0.0 111.06 172.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -83.14 -53.94 5.41 Favored 'General case' 0 N--CA 1.449 -0.493 1 CA-C-O 110.307 -4.664 . . . . 0.0 107.642 -172.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -44.77 -50.84 9.92 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 128.189 3.431 . . . . 0.0 111.138 167.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.32 -55.02 32.57 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.141 1.776 . . . . 0.0 113.82 169.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -68.39 -31.05 70.14 Favored 'General case' 0 N--CA 1.446 -0.654 1 O-C-N 115.775 -4.328 . . . . 0.0 114.478 -177.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 35.9 mt -56.33 -68.02 0.25 Allowed 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 131.042 3.737 . . . . 0.0 106.648 165.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -43.75 -29.58 0.54 Allowed 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 130.23 3.412 . . . . 0.0 110.268 176.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -74.88 -24.8 58.61 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 115.774 -2.06 . . . . 0.0 113.842 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.5 mt -80.44 -45.12 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 121.492 1.951 . . . . 0.0 107.937 162.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.538 ' C ' ' H ' ' A' ' 76' ' ' ILE . 89.3 mt -76.71 -44.1 34.79 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 123.268 1.508 . . . . 0.0 109.363 -153.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.63 -4.78 0.94 Allowed Glycine 0 C--N 1.338 0.653 0 O-C-N 120.101 -1.625 . . . . 0.0 111.891 -172.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.538 ' H ' ' C ' ' A' ' 74' ' ' LEU . 5.7 pt -102.41 170.97 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 C-N-CA 124.845 1.258 . . . . 0.0 109.119 170.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -163.96 174.61 11.22 Favored 'General case' 0 C--O 1.22 -0.46 0 O-C-N 127.661 3.1 . . . . 0.0 107.252 169.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 17.0 mt . . . . . 0 N--CA 1.445 -0.708 0 O-C-N 119.363 -2.086 . . . . 0.0 109.178 175.691 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 57.7 t80 . . . . . 0 N--CA 1.444 -0.728 0 CA-C-O 123.268 1.509 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . 0.373 1.9 p90 -60.39 78.45 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 1 C-N-CA 132.684 4.394 . . . . 0.0 116.221 170.057 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.411 ' HA ' ' HB3' ' A' ' 28' ' ' LYS . 89.4 mttt -90.59 -18.04 25.89 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 116.284 -1.817 . . . . 0.0 113.559 176.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -34.18 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 2 CA-C-N 129.096 5.407 . . . . 0.0 109.858 168.282 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.283 89.2 mt -65.04 -53.86 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 C-N-CA 129.338 3.055 . . . . 0.0 109.933 170.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 25' ' ' LYS . 38.6 tttm -53.92 -46.66 71.54 Favored 'General case' 0 CA--C 1.509 -0.597 0 O-C-N 117.062 -3.524 . . . . 0.0 116.646 -173.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.8 p -56.73 -40.25 75.38 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.925 1.69 . . . . 0.0 111.615 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.96 -50.44 28.9 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 127.704 2.402 . . . . 0.0 113.804 173.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -58.66 -22.79 57.82 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 116.062 -1.923 . . . . 0.0 108.258 177.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -71.48 -48.95 45.88 Favored 'General case' 0 N--CA 1.446 -0.66 2 CA-C-N 128.574 5.17 . . . . 0.0 108.364 173.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -62.51 -47.01 85.82 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 124.691 2.186 . . . . 0.0 106.181 -169.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.317 39.5 mt -75.45 -10.81 59.78 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 115.645 1.721 . . . . 0.0 115.645 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.11 -4.25 0.08 OUTLIER Glycine 0 C--O 1.218 -0.884 0 N-CA-C 119.849 2.7 . . . . 0.0 119.849 177.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.4 pt -50.67 129.47 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 119.936 3.309 . . . . 0.0 119.936 -175.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 94.0 p -69.81 177.05 3.25 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.929 1.291 . . . . 0.0 112.27 177.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -57.35 -43.64 83.62 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 118.346 -1.341 . . . . 0.0 114.428 164.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -61.34 -39.7 91.53 Favored 'General case' 0 N--CA 1.451 -0.401 1 O-C-N 115.993 -4.192 . . . . 0.0 111.866 -177.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -73.68 -32.71 64.09 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.4 tp -61.31 -43.15 99.35 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.125 0.97 . . . . 0.0 113.253 161.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.71 -39.66 71.36 Favored 'General case' 0 N--CA 1.442 -0.826 0 O-C-N 119.842 -1.787 . . . . 0.0 111.512 171.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -66.04 -32.44 73.92 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 117.885 2.55 . . . . 0.0 117.885 170.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.4 tptt -64.82 -14.22 58.48 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 127.675 2.39 . . . . 0.0 107.699 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.8 tp -133.09 -4.62 3.09 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 116.394 -3.941 . . . . 0.0 114.546 -156.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt 62.52 27.63 16.34 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 131.057 3.743 . . . . 0.0 114.423 178.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.82 178.17 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 C-N-CA 129.857 3.263 . . . . 0.0 111.443 -163.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.2 p -88.2 162.5 16.64 Favored 'General case' 0 N--CA 1.443 -0.803 0 O-C-N 118.508 -2.62 . . . . 0.0 115.441 176.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -63.19 -16.38 59.94 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 119.631 -1.918 . . . . 0.0 113.704 167.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -71.95 -22.45 61.46 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 171.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . 0.283 39.0 mt -72.87 -36.26 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 C-N-CA 130.7 3.6 . . . . 0.0 116.446 164.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.317 1.5 m -80.81 -49.84 17.82 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 CA-C-O 117.157 -1.401 . . . . 0.0 111.917 -176.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -37.59 -27.99 0.02 OUTLIER 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 130.2 3.4 . . . . 0.0 118.922 166.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -40.04 -55.72 2.01 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.525 1.13 . . . . 0.0 109.207 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -100.04 -32.08 11.12 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 117.894 -3.004 . . . . 0.0 112.887 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -47.9 -27.64 2.25 Favored 'General case' 0 N--CA 1.447 -0.577 1 N-CA-C 123.282 4.549 . . . . 0.0 123.282 168.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.2 m -77.69 -6.39 53.74 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.238 1.415 . . . . 0.0 113.379 -171.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.49 6.91 84.98 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 119.867 -1.158 . . . . 0.0 113.785 151.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -76.08 6.4 5.37 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 120.607 -1.525 . . . . 0.0 113.893 -174.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.402 ' CD2' HE22 ' A' ' 66' ' ' GLN . 1.2 tp -143.18 163.68 32.25 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 -164.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -98.27 126.13 40.92 Favored Pre-proline 0 N--CA 1.443 -0.813 0 O-C-N 124.36 1.037 . . . . 0.0 110.645 165.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.25 174.01 13.54 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 CA-C-N 120.924 1.366 . . . . 0.0 112.319 -174.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.8 p -135.97 -174.7 3.74 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 125.215 1.406 . . . . 0.0 113.207 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.6 -51.91 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 127.226 2.21 . . . . 0.0 112.437 177.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.2 p -62.9 -31.51 72.59 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 173.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.402 HE22 ' CD2' ' A' ' 60' ' ' LEU . 76.3 mt-30 -66.3 -63.78 1.0 Allowed 'General case' 0 C--N 1.349 0.585 0 O-C-N 116.734 -3.729 . . . . 0.0 104.539 172.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -37.3 -41.41 0.41 Allowed 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 172.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.8 ttt85 -65.03 -53.88 39.0 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 125.859 1.974 . . . . 0.0 114.977 176.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -69.5 -40.28 77.11 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 126.87 2.606 . . . . 0.0 108.175 -172.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 13.2 mt -56.25 -63.08 1.3 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 131.45 3.9 . . . . 0.0 113.697 -177.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -46.6 -30.15 2.16 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 126.896 2.622 . . . . 0.0 111.519 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -75.24 -58.29 3.37 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 118.36 -0.829 . . . . 0.0 111.985 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.7 pt -65.13 -44.8 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 119.562 1.074 . . . . 0.0 113.164 -168.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 77.9 mt -76.65 -3.55 38.43 Favored 'General case' 0 N--CA 1.452 -0.354 1 O-C-N 115.332 -4.605 . . . . 0.0 115.384 -152.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.22 8.44 8.85 Favored Glycine 0 C--O 1.223 -0.577 0 CA-C-O 116.951 -2.027 . . . . 0.0 115.481 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.0 pt -136.56 155.49 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 122.538 3.169 . . . . 0.0 108.882 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.371 23.5 pttm 163.48 142.06 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 130.637 3.575 . . . . 0.0 116.336 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.8 mt . . . . . 0 CA--C 1.518 -0.28 0 CA-C-N 122.704 2.502 . . . . 0.0 110.213 -171.314 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.309 55.3 t80 . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -74.23 77.45 1.81 Allowed 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 117.001 2.222 . . . . 0.0 117.001 -176.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -57.79 -32.52 67.61 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 129.913 3.285 . . . . 0.0 111.613 -171.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.2 pt -67.43 -37.79 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 120.191 -0.603 . . . . 0.0 109.53 -176.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.29 26.7 mm -59.17 -43.38 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 125.288 2.47 . . . . 0.0 112.651 -175.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.445 ' HZ3' ' CD ' ' A' ' 32' ' ' GLU 0.46 34.2 tttm -43.45 -75.42 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 131.072 3.749 . . . . 0.0 114.9 -156.346 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.3 m -53.96 -43.63 70.07 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 129.147 2.979 . . . . 0.0 112.729 -168.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.7 -48.26 75.32 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 118.936 2.939 . . . . 0.0 118.936 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -60.35 -37.38 80.5 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.183 0.993 . . . . 0.0 110.823 170.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.445 ' CD ' ' HZ3' ' A' ' 28' ' ' LYS . 21.6 mt-10 -69.32 -33.06 72.58 Favored 'General case' 0 N--CA 1.438 -1.042 1 O-C-N 115.531 -4.48 . . . . 0.0 113.623 178.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . 0.29 76.7 mt-30 -60.09 -26.51 66.25 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 124.534 1.146 . . . . 0.0 109.297 172.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.3 mt -78.28 -23.4 47.22 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 127.363 2.265 . . . . 0.0 113.527 -177.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.83 0.67 9.18 Favored Glycine 0 C--N 1.341 0.823 0 N-CA-C 118.052 1.981 . . . . 0.0 118.052 -174.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.2 pt -69.61 151.02 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 2 N-CA-C 123.935 4.791 . . . . 0.0 123.935 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 56.9 p -108.3 174.33 5.93 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 123.823 1.773 . . . . 0.0 114.862 -165.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -56.99 -26.44 60.17 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -55.75 -37.04 67.97 Favored 'General case' 0 C--O 1.222 -0.358 0 O-C-N 120.579 -1.326 . . . . 0.0 110.647 176.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -64.81 -40.47 95.27 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 116.879 -3.638 . . . . 0.0 113.211 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . 0.347 24.1 tp -61.74 -43.23 99.25 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 130.292 3.437 . . . . 0.0 111.026 173.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . 0.25 . . -60.91 -43.95 97.85 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 112.923 -1.944 . . . . 0.0 112.339 178.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -67.72 -34.92 77.81 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 112.421 -3.657 . . . . 0.0 111.84 167.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.6 tptt -67.18 -24.05 65.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 125.54 3.791 . . . . 0.0 115.83 -174.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.8 tp -125.17 3.93 7.87 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 128.473 2.709 . . . . 0.0 108.852 -160.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.252 79.9 mttt 44.99 66.79 0.82 Allowed 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 129.803 3.241 . . . . 0.0 111.845 -174.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.5 m -148.11 170.12 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 C-N-CA 130.674 3.59 . . . . 0.0 113.389 174.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.3 p -94.03 159.08 15.32 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 -169.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -67.62 -16.02 63.95 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 118.174 -2.829 . . . . 0.0 115.158 175.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -49.41 -47.17 48.14 Favored 'General case' 0 C--O 1.248 0.982 0 CA-C-N 121.956 2.162 . . . . 0.0 114.152 156.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 27.8 mt -77.07 -27.39 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 O-C-N 121.744 -0.598 . . . . 0.0 111.96 -175.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.5 m -79.45 -47.71 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-O 118.484 -0.77 . . . . 0.0 110.456 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -53.71 -28.11 32.03 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 121.575 1.989 . . . . 0.0 112.986 -165.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -44.38 -57.45 3.52 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 118.563 2.801 . . . . 0.0 118.563 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -95.91 -26.72 15.49 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 119.6 1.091 . . . . 0.0 110.729 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -51.19 -27.63 9.28 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 121.348 -0.845 . . . . 0.0 109.729 172.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.2 p -98.45 0.63 45.6 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 116.984 2.216 . . . . 0.0 116.984 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.76 6.84 89.14 Favored Glycine 0 CA--C 1.525 0.707 0 O-C-N 118.374 -2.704 . . . . 0.0 115.872 -172.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -96.44 -2.62 45.03 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 119.553 1.677 . . . . 0.0 114.164 -168.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 36.9 tp -145.46 130.26 18.14 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 126.592 1.957 . . . . 0.0 106.769 -174.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.6 tttt -81.71 126.88 74.58 Favored Pre-proline 0 C--O 1.221 -0.447 0 CA-C-O 114.935 -2.459 . . . . 0.0 110.726 165.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -82.64 178.05 6.43 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 124.51 3.474 . . . . 0.0 106.389 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.468 ' H ' ' HB3' ' A' ' 66' ' ' GLN . 42.6 p -96.46 167.69 11.0 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -159.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . 0.314 1.9 tt -51.27 -49.45 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 171.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.28 99.3 p -54.92 -55.33 31.82 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 120.621 1.555 . . . . 0.0 112.433 162.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.468 ' HB3' ' H ' ' A' ' 63' ' ' THR . 48.6 tt0 -71.1 -35.2 71.71 Favored 'General case' 0 CA--C 1.515 -0.371 1 CA-C-O 111.503 -4.094 . . . . 0.0 112.796 -163.533 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.77 -43.37 98.98 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 125.288 3.677 . . . . 0.0 109.112 169.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -62.17 -42.42 99.25 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 117.468 -3.27 . . . . 0.0 106.16 174.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -72.68 -30.44 64.25 Favored 'General case' 0 C--O 1.222 -0.385 1 O-C-N 116.01 -4.181 . . . . 0.0 115.34 176.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.1 mt -54.27 -76.3 0.03 OUTLIER 'General case' 0 C--O 1.243 0.719 0 C-N-CA 130.238 3.415 . . . . 0.0 109.727 -169.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -48.08 -26.75 1.97 Allowed 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 129.035 2.934 . . . . 0.0 108.944 -177.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -88.15 -40.36 13.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 113.822 -2.99 . . . . 0.0 111.424 -166.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 12.8 pt -68.83 -40.36 81.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 128.583 3.677 . . . . 0.0 109.015 173.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 74.1 mt -68.76 -26.0 65.01 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 120.323 -1.486 . . . . 0.0 110.661 -173.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.18 -18.76 0.06 OUTLIER Glycine 0 CA--C 1.528 0.863 0 CA-C-O 114.535 -3.369 . . . . 0.0 112.735 -172.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.1 pt -115.26 164.86 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 120.08 1.94 . . . . 0.0 113.328 -165.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.3 pttm -176.01 170.14 2.77 Favored 'General case' 0 CA--C 1.519 -0.226 1 C-N-CA 133.431 4.692 . . . . 0.0 111.093 177.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 57.4 mt . . . . . 0 CA--C 1.517 -0.324 0 C-N-CA 128.636 2.775 . . . . 0.0 110.615 154.098 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.0 t80 . . . . . 0 C--O 1.222 -0.383 0 CA-C-O 125.081 2.372 . . . . 0.0 104.641 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -70.66 157.8 37.34 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 117.36 -3.337 . . . . 0.0 113.196 -166.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -140.89 14.18 2.28 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 127.149 2.179 . . . . 0.0 113.259 -146.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -35.7 -57.11 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.805 1 O-C-N 114.888 -4.882 . . . . 0.0 113.886 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.7 pt -119.14 4.2 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 113.457 -1.701 . . . . 0.0 110.719 -165.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -47.95 -64.13 0.88 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.066 1.746 . . . . 0.0 114.912 -175.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.5 p -53.95 -46.58 71.63 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.283 1.833 . . . . 0.0 115.888 -174.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.58 -44.26 65.8 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 109.776 -3.375 . . . . 0.0 114.645 176.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -48.41 -44.7 35.28 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 118.551 -2.593 . . . . 0.0 112.772 169.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -72.14 -47.5 50.58 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 120.384 -1.448 . . . . 0.0 114.532 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -66.75 -25.69 66.62 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 128.641 2.776 . . . . 0.0 111.325 -167.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.5 mt -88.1 -17.05 31.87 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 127.417 2.287 . . . . 0.0 110.315 -174.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.32 11.27 58.96 Favored Glycine 0 C--O 1.243 0.674 0 CA-C-O 123.309 1.505 . . . . 0.0 113.99 177.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.9 pt -75.54 144.76 11.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 129.094 2.958 . . . . 0.0 114.202 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.5 p -93.2 166.3 12.39 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -175.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -58.71 -35.86 73.33 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.191 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -70.11 -37.37 75.35 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 115.906 -1.997 . . . . 0.0 108.132 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -66.87 -29.98 70.02 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 115.568 -2.158 . . . . 0.0 112.661 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.7 tt -78.96 -36.52 41.44 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-O 126.315 2.959 . . . . 0.0 111.836 176.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.93 -40.5 66.8 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 119.447 -2.033 . . . . 0.0 112.224 167.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -70.6 -37.07 73.85 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 118.845 -2.409 . . . . 0.0 111.007 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -66.39 -14.3 61.92 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 129.554 3.141 . . . . 0.0 110.438 -172.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.3 mt -131.01 -1.59 4.09 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 126.832 3.206 . . . . 0.0 112.781 -164.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.274 40.8 mtmt 56.39 -26.19 0.02 OUTLIER 'General case' 0 C--O 1.241 0.615 0 N-CA-C 121.094 3.739 . . . . 0.0 121.094 -162.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.9 m -83.61 172.21 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 C-N-CA 129.504 3.122 . . . . 0.0 111.378 -168.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 91.7 p -92.48 158.33 16.08 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 119.556 -1.965 . . . . 0.0 111.334 -153.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -61.56 -32.58 72.66 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 126.143 1.777 . . . . 0.0 108.031 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -65.3 -31.57 72.78 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 168.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.9 mt -67.98 -38.79 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 124.407 2.051 . . . . 0.0 112.555 172.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.297 32.6 m -80.07 -30.78 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 1 O-C-N 116.042 -4.161 . . . . 0.0 114.122 -176.777 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -53.13 -38.69 62.88 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 126.392 1.877 . . . . 0.0 109.806 155.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -71.93 -38.42 69.87 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 126.296 1.838 . . . . 0.0 106.046 -174.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -66.97 -41.46 86.82 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 121.59 1.995 . . . . 0.0 108.662 173.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.42 -14.96 62.76 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 114.464 -2.684 . . . . 0.0 111.562 -172.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.6 p -113.09 -1.68 14.36 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 123.495 2.861 . . . . 0.0 111.137 -175.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.06 28.47 73.57 Favored Glycine 0 C--N 1.343 0.922 0 O-C-N 128.665 3.728 . . . . 0.0 119.24 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -85.17 7.24 22.55 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 131.501 3.921 . . . . 0.0 113.216 -171.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.6 tt -137.17 144.2 42.8 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 127.402 2.281 . . . . 0.0 109.501 -166.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.1 tttt -83.04 126.6 72.06 Favored Pre-proline 0 C--O 1.24 0.587 0 CA-C-O 116.455 -1.736 . . . . 0.0 110.23 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -82.0 150.64 16.06 Favored 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 124.64 3.56 . . . . 0.0 112.504 -168.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.3 p -123.07 164.64 18.22 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 123.937 1.827 . . . . 0.0 113.669 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.0 pt -62.66 -50.27 80.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 O-C-N 118.715 -2.491 . . . . 0.0 113.443 174.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 99.3 p -54.67 -21.57 11.08 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 121.871 2.123 . . . . 0.0 116.649 170.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -75.33 -75.84 0.16 Allowed 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.911 177.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -12.52 -62.66 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 117.884 2.549 . . . . 0.0 117.884 150.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -56.83 -49.85 74.16 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 127.474 2.31 . . . . 0.0 107.741 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -62.49 -44.29 96.73 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 116.413 -1.756 . . . . 0.0 106.886 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 43.5 mt -63.43 -47.39 82.1 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 115.29 -2.29 . . . . 0.0 109.851 -167.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -50.98 -22.73 2.43 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 170.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.7 mttp -94.48 -52.34 4.37 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 -176.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 24.1 pt -44.24 -49.93 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 127.243 2.217 . . . . 0.0 115.471 -167.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.3 mt -77.67 -2.49 36.27 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 121.549 1.977 . . . . 0.0 109.89 -169.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.95 0.51 60.37 Favored Glycine 0 CA--C 1.522 0.478 0 O-C-N 125.535 1.772 . . . . 0.0 111.834 -169.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.6 pt -149.88 167.62 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 O-C-N 117.639 -3.271 . . . . 0.0 113.64 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.77 163.78 1.17 Allowed 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 126.885 2.074 . . . . 0.0 109.471 -177.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.9 mt . . . . . 0 N--CA 1.449 -0.502 0 CA-C-N 121.132 1.787 . . . . 0.0 109.972 -174.056 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.3 t80 . . . . . 0 N--CA 1.44 -0.929 0 CA-C-O 116.675 -1.631 . . . . 0.0 107.0 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -100.02 -173.31 2.41 Favored 'General case' 0 CA--C 1.518 -0.255 0 O-C-N 128.457 3.598 . . . . 0.0 118.054 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -59.18 -24.04 62.74 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 119.199 3.037 . . . . 0.0 119.199 -175.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.9 pt -30.42 -35.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 119.908 3.299 . . . . 0.0 119.908 145.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.1 tp -137.31 -42.94 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 121.693 2.042 . . . . 0.0 114.495 177.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.361 79.5 tttt -40.99 -58.51 1.7 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 131.07 3.748 . . . . 0.0 118.313 173.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 74.9 p -83.48 -29.7 27.78 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 113.433 -1.712 . . . . 0.0 109.087 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.12 -51.23 62.49 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.937 1.295 . . . . 0.0 110.516 -160.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -46.51 -38.07 8.79 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 126.901 2.626 . . . . 0.0 112.879 174.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -73.87 -41.34 62.33 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 129.512 3.125 . . . . 0.0 113.462 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . 0.29 43.5 mt-30 -68.66 -16.31 63.79 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.0 tp -95.99 -14.51 22.96 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 112.453 -2.158 . . . . 0.0 112.157 175.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.64 -0.63 34.13 Favored Glycine 0 CA--C 1.523 0.564 1 C-N-CA 131.037 4.16 . . . . 0.0 117.309 172.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.6 pt -69.03 155.97 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 C-N-CA 126.233 1.813 . . . . 0.0 113.78 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 93.7 p -90.63 171.84 9.09 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -176.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -59.25 -42.97 92.37 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -64.9 -41.12 95.86 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 119.242 -2.161 . . . . 0.0 109.172 -175.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -64.74 -39.41 93.59 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 119.181 -2.2 . . . . 0.0 114.066 174.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.4 tp -64.04 -38.64 91.82 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 126.768 2.027 . . . . 0.0 114.166 -173.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.12 -49.76 76.63 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-O 123.899 1.809 . . . . 0.0 107.99 173.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -64.56 -14.34 57.12 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 117.53 -3.231 . . . . 0.0 108.669 -175.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -103.54 -16.88 15.41 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 117.591 -3.193 . . . . 0.0 118.504 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 86.2 mt -135.2 15.06 3.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 120.672 -1.267 . . . . 0.0 113.723 -165.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 70.7 mttt 45.6 -27.38 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.419 1 C-N-CA 134.255 5.022 . . . . 0.0 117.931 -154.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.7 m -86.86 145.37 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 122.348 2.34 . . . . 0.0 116.419 -163.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.2 p -81.36 160.75 24.04 Favored 'General case' 0 N--CA 1.449 -0.517 1 N-CA-C 122.439 4.237 . . . . 0.0 122.439 -168.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.79 -17.24 0.33 Allowed 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 125.367 3.712 . . . . 0.0 116.962 165.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -86.68 -35.51 19.26 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 126.503 1.921 . . . . 0.0 112.055 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.9 mm -55.16 -36.76 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-O 124.197 1.951 . . . . 0.0 110.137 167.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.3 t -59.6 -65.28 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-O 115.274 -2.298 . . . . 0.0 111.007 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -44.24 -43.53 7.34 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 126.526 2.391 . . . . 0.0 114.134 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -54.34 -50.42 67.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 176.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -91.29 -40.42 11.51 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.645 1.178 . . . . 0.0 109.196 -171.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -43.58 -36.6 2.16 Favored 'General case' 0 N--CA 1.434 -1.266 0 O-C-N 118.352 -2.718 . . . . 0.0 111.567 166.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 76.1 p -90.13 -2.55 58.1 Favored 'General case' 0 C--O 1.237 0.436 1 O-C-N 116.176 -4.078 . . . . 0.0 114.371 -172.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.97 12.71 79.2 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 120.14 2.816 . . . . 0.0 120.14 -175.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -87.22 -28.42 22.39 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.624 1.97 . . . . 0.0 112.421 -168.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.1 tp -151.79 131.66 13.32 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 128.584 2.753 . . . . 0.0 111.743 -170.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -117.45 -179.62 0.67 Allowed Pre-proline 0 N--CA 1.447 -0.605 0 CA-C-O 114.935 -2.46 . . . . 0.0 108.807 165.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -46.36 150.82 1.99 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 1 C-N-CA 125.637 4.225 . . . . 0.0 116.335 -175.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.6 p -127.98 -175.11 3.39 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 128.488 2.715 . . . . 0.0 114.433 -173.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.0 tp -60.56 -54.15 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.502 1.121 . . . . 0.0 108.078 175.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 88.0 p -69.19 -16.99 63.75 Favored 'General case' 0 C--N 1.34 0.194 0 O-C-N 117.335 -3.353 . . . . 0.0 111.928 -175.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -98.76 -47.23 5.39 Favored 'General case' 0 CA--C 1.514 -0.427 0 O-C-N 116.999 -3.563 . . . . 0.0 111.145 -175.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.95 -55.67 31.57 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 125.892 1.995 . . . . 0.0 115.875 -149.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -52.24 -54.41 31.57 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 120.968 1.713 . . . . 0.0 114.092 -167.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -60.94 -40.28 92.67 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 119.417 -2.052 . . . . 0.0 114.926 167.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tt -55.23 -55.76 27.64 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 130.976 3.71 . . . . 0.0 108.331 -172.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -48.4 -48.61 36.87 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 125.077 2.37 . . . . 0.0 111.127 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -73.72 -36.33 65.19 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 119.078 -2.263 . . . . 0.0 113.035 -164.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 24.3 pt -66.48 -27.95 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 O-C-N 124.058 0.849 . . . . 0.0 112.995 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.269 1.1 pt? 164.93 -21.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 130.891 3.676 . . . . 0.0 111.228 173.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.82 29.35 59.38 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-O 123.019 1.344 . . . . 0.0 113.14 -170.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . 0.324 4.2 pt 64.46 7.7 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.706 1 C-N-CA 131.909 4.084 . . . . 0.0 113.037 165.609 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -68.44 151.6 46.6 Favored 'General case' 0 CA--C 1.515 -0.369 1 CA-C-O 111.102 -4.285 . . . . 0.0 112.333 174.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . 0.289 12.6 mt . . . . . 0 CA--C 1.517 -0.323 0 CA-C-N 125.61 3.823 . . . . 0.0 112.9 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.6 t80 . . . . . 0 N--CA 1.448 -0.56 0 CA-C-O 123.933 1.825 . . . . 0.0 114.232 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -70.6 127.53 33.01 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 -170.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -101.21 -15.57 17.28 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 125.298 1.439 . . . . 0.0 113.002 -174.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.9 pt -70.77 -25.63 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 120.571 1.532 . . . . 0.0 111.31 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.429 40.3 pt -60.36 -35.58 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 C-N-CA 127.702 2.401 . . . . 0.0 108.16 171.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.355 8.8 ttpt -44.0 -72.74 0.05 Allowed 'General case' 0 N--CA 1.454 -0.272 1 C-N-CA 132.266 4.227 . . . . 0.0 115.951 -159.548 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.9 m -72.12 -21.87 61.41 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.111 0.964 . . . . 0.0 111.948 -165.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.71 -59.95 2.56 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 128.081 2.552 . . . . 0.0 107.872 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -43.77 -35.11 1.75 Allowed 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 127.77 2.428 . . . . 0.0 108.143 169.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . 0.304 17.2 tt0 -73.45 -41.23 63.46 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 122.42 2.373 . . . . 0.0 115.402 173.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -61.51 -19.7 62.37 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 121.564 1.984 . . . . 0.0 111.973 171.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.1 tp -71.77 -34.64 69.62 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 123.503 1.621 . . . . 0.0 111.188 -173.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.57 -12.97 8.94 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-N 110.804 -2.907 . . . . 0.0 112.557 173.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.4 pt -70.79 154.54 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 O-C-N 120.383 -1.657 . . . . 0.0 110.403 -171.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 84.4 p -96.46 175.05 6.55 Favored 'General case' 0 N--CA 1.437 -1.106 0 O-C-N 118.265 -2.772 . . . . 0.0 113.473 -166.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -51.16 -40.85 59.51 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 113.437 -3.173 . . . . 0.0 113.95 161.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . 0.293 25.2 mp0 -61.16 -40.41 93.77 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 127.822 3.201 . . . . 0.0 110.002 -175.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -72.75 -34.57 67.11 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 119.706 -1.871 . . . . 0.0 113.586 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 63.1 tp -73.35 -27.68 61.64 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 122.682 1.229 . . . . 0.0 113.601 -176.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.77 -36.73 81.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 116.301 -1.809 . . . . 0.0 107.082 169.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . 0.277 87.8 mm-40 -73.29 -31.28 63.95 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 127.662 2.385 . . . . 0.0 111.266 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.7 tptt -67.3 -24.61 65.77 Favored 'General case' 0 N--CA 1.442 -0.864 0 O-C-N 117.227 -3.421 . . . . 0.0 111.736 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.9 mt -124.96 -3.14 7.67 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 128.02 2.528 . . . . 0.0 109.992 -165.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.258 27.2 mtpt 52.32 5.54 0.04 OUTLIER 'General case' 0 C--O 1.233 0.224 0 C-N-CA 130.486 3.514 . . . . 0.0 118.736 -171.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.8 m -88.51 -168.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 128.386 2.674 . . . . 0.0 108.102 -173.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 90.9 p -100.1 158.87 15.53 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.911 1.284 . . . . 0.0 112.585 -173.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -52.33 -32.58 38.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 113.12 -1.855 . . . . 0.0 110.971 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -74.21 -31.12 62.5 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 175.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 67.7 mt -74.26 -34.63 37.87 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 O-C-N 118.459 -2.651 . . . . 0.0 112.196 174.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.41 11.2 m -64.22 -59.13 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 O-C-N 118.376 -2.703 . . . . 0.0 112.79 164.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -50.03 -18.91 0.61 Allowed 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 119.801 3.259 . . . . 0.0 119.801 175.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -58.95 -32.68 69.82 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 -171.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -93.91 -44.8 7.91 Favored 'General case' 0 CA--C 1.512 -0.5 0 O-C-N 126.148 2.155 . . . . 0.0 110.035 176.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -49.26 -30.82 7.76 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 127.606 2.362 . . . . 0.0 108.787 176.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.2 p -94.81 -28.09 15.43 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 117.443 -3.286 . . . . 0.0 114.253 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.58 9.52 56.44 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 118.556 -2.59 . . . . 0.0 113.776 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -88.76 45.1 1.26 Allowed 'General case' 0 N--CA 1.447 -0.606 1 C-N-CA 131.82 4.048 . . . . 0.0 113.222 -169.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.53 135.95 54.92 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 129.036 2.935 . . . . 0.0 112.844 -159.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.317 43.3 mtpt -109.78 76.19 0.91 Allowed Pre-proline 0 N--CA 1.445 -0.697 0 CA-C-O 114.656 -2.592 . . . . 0.0 115.612 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -84.06 157.91 13.36 Favored 'Trans proline' 0 C--N 1.329 -0.492 0 C-N-CA 124.861 3.707 . . . . 0.0 113.367 -158.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.608 ' H ' ' HB2' ' A' ' 66' ' ' GLN . 58.9 p -132.16 176.35 8.46 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 128.088 2.555 . . . . 0.0 112.943 168.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 6.3 pt -48.02 -56.51 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 172.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.425 ' C ' HE21 ' A' ' 69' ' ' GLN . 90.8 p -47.34 -33.77 6.14 Favored 'General case' 0 C--N 1.342 0.244 0 O-C-N 117.468 -3.27 . . . . 0.0 115.916 166.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.608 ' HB2' ' H ' ' A' ' 63' ' ' THR . 62.4 mt-30 -75.01 -50.43 16.55 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 128.209 2.603 . . . . 0.0 112.28 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -42.62 -52.45 4.83 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 125.949 1.699 . . . . 0.0 111.458 162.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.9 mtm180 -63.82 -34.39 77.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 124.145 0.903 . . . . 0.0 111.824 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.425 HE21 ' C ' ' A' ' 65' ' ' SER . 35.5 mt-30 -80.36 -35.6 35.21 Favored 'General case' 0 CA--C 1.516 -0.351 0 O-C-N 119.695 -1.878 . . . . 0.0 112.634 -168.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.3 mt -73.69 -50.56 20.29 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 131.572 3.949 . . . . 0.0 115.264 -167.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -44.04 -34.92 1.9 Allowed 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.579 0.704 . . . . 0.0 112.215 158.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.2 mttp -98.35 10.31 41.04 Favored 'General case' 0 CA--C 1.513 -0.471 0 O-C-N 118.303 -2.748 . . . . 0.0 114.404 -165.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 20.7 pt -53.28 -50.85 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-O 125.652 2.644 . . . . 0.0 112.912 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 77.0 mt -106.43 0.67 25.01 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 118.919 -2.363 . . . . 0.0 115.901 176.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.33 0.61 11.36 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 126.617 2.055 . . . . 0.0 115.245 175.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.7 pt -116.42 -174.49 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 116.979 -3.659 . . . . 0.0 116.605 -177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -173.93 147.6 1.32 Allowed 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 113.501 -3.143 . . . . 0.0 109.432 -173.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 31.5 mt . . . . . 0 N--CA 1.446 -0.641 0 O-C-N 125.931 2.019 . . . . 0.0 110.579 164.748 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.283 58.4 t80 . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 118.375 2.731 . . . . 0.0 118.375 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -46.25 143.8 2.28 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 131.194 3.798 . . . . 0.0 118.182 -154.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -98.99 -32.87 11.07 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 117.768 2.507 . . . . 0.0 117.768 -176.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.2 pt -63.07 -33.4 60.58 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 C-N-CA 126.698 1.999 . . . . 0.0 107.59 -172.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.36 1.8 pt -60.11 -38.81 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 114.035 -1.439 . . . . 0.0 112.252 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.454 45.9 tttm -45.83 -74.6 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 118.841 2.904 . . . . 0.0 118.841 -162.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.5 m -53.47 -32.71 51.3 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 129.706 3.202 . . . . 0.0 113.706 -174.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.28 -55.86 9.27 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 114.544 -2.646 . . . . 0.0 110.775 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . 0.276 11.9 ptm180 -57.35 -40.96 79.15 Favored 'General case' 0 N--CA 1.447 -0.604 1 CA-C-N 126.302 4.137 . . . . 0.0 110.673 171.606 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -51.1 -35.78 36.9 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 114.87 -2.49 . . . . 0.0 115.448 176.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -51.54 -42.57 61.88 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 121.687 2.04 . . . . 0.0 109.736 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 50.3 mt -80.94 -25.68 37.23 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 131.538 3.935 . . . . 0.0 109.514 -176.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 55.97 5.39 0.96 Allowed Glycine 0 C--O 1.22 -0.75 0 CA-C-N 112.665 -2.061 . . . . 0.0 116.199 -170.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.5 pt -60.35 148.06 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 126.685 1.994 . . . . 0.0 108.392 -163.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 88.6 p -133.18 -177.29 4.45 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 122.728 2.513 . . . . 0.0 110.581 170.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . 0.254 65.0 mt-30 -21.61 -61.34 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 113.419 -3.181 . . . . 0.0 116.197 -163.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -58.99 -51.95 67.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 124.484 3.311 . . . . 0.0 109.365 -173.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -67.2 -29.38 69.03 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 117.435 -1.269 . . . . 0.0 110.864 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.8 tp -80.91 -23.89 38.62 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.935 1.694 . . . . 0.0 112.197 -167.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.74 -45.62 67.08 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 131.598 3.959 . . . . 0.0 111.163 153.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -77.94 -21.47 51.03 Favored 'General case' 0 CA--C 1.51 -0.561 0 O-C-N 126.773 2.546 . . . . 0.0 110.688 178.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -83.11 -12.06 57.4 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 118.304 -2.748 . . . . 0.0 105.168 -169.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 21.8 tp -125.35 -9.58 6.95 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -173.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.7 mtmt 57.31 52.89 8.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 131.196 3.798 . . . . 0.0 112.335 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.1 m -124.79 177.22 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 1 C-N-CA 134.019 4.928 . . . . 0.0 113.138 -177.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 62.1 p -82.06 159.61 23.4 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 116.81 2.152 . . . . 0.0 116.81 168.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -64.07 -14.54 55.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 169.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -80.97 -23.2 38.93 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 119.803 -1.811 . . . . 0.0 113.238 170.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.0 mt -69.45 -43.63 80.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 118.293 -0.86 . . . . 0.0 112.911 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.8 m -68.57 -25.96 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 118.44 2.755 . . . . 0.0 118.44 -178.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -42.32 -48.3 5.0 Favored 'General case' 0 N--CA 1.432 -1.374 0 C-N-CA 130.204 3.402 . . . . 0.0 116.706 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.6 mtt85 -61.72 -39.62 92.18 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 123.682 2.946 . . . . 0.0 111.13 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -82.36 -33.99 28.6 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -168.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -64.93 -49.11 71.67 Favored 'General case' 0 N--CA 1.441 -0.876 0 O-C-N 118.649 -2.532 . . . . 0.0 109.145 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.6 p -80.16 -28.66 38.76 Favored 'General case' 0 C--O 1.243 0.739 0 O-C-N 118.745 -2.472 . . . . 0.0 112.908 -167.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.2 5.48 62.17 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -171.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -93.06 54.57 2.18 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 128.737 2.815 . . . . 0.0 112.433 -174.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . 0.252 62.7 tp -144.79 130.9 19.42 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 130.837 3.655 . . . . 0.0 107.241 -167.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.5 tttt -91.4 128.67 45.99 Favored Pre-proline 0 N--CA 1.45 -0.473 0 N-CA-C 119.156 3.021 . . . . 0.0 119.156 158.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -92.46 -172.03 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 1 C-N-CA 127.167 5.245 . . . . 0.0 107.722 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.264 17.4 p -156.33 174.37 15.5 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 128.058 2.543 . . . . 0.0 111.278 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.7 pt -63.18 -44.18 99.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 126.736 2.015 . . . . 0.0 113.752 166.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.5 p -66.68 -38.38 86.68 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 121.085 1.766 . . . . 0.0 112.284 164.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 67.8 mm-40 -69.9 -27.78 65.07 Favored 'General case' 0 N--CA 1.45 -0.429 2 O-C-N 111.299 -7.125 . . . . 0.0 115.377 -171.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . 0.257 . . -55.93 -74.08 0.05 Allowed 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 123.321 2.782 . . . . 0.0 114.382 -164.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.0 mmp_? -51.02 -21.88 2.03 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 126.329 1.852 . . . . 0.0 109.867 -178.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.55 ' C ' ' H ' ' A' ' 72' ' ' LYS . 61.0 mt-30 -77.22 -36.09 55.04 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 124.615 1.197 . . . . 0.0 112.817 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 40.0 mt -79.18 -41.13 29.13 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 128.25 2.62 . . . . 0.0 104.483 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -53.84 -26.73 25.83 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 118.025 -2.922 . . . . 0.0 111.254 154.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.55 ' H ' ' C ' ' A' ' 69' ' ' GLN . 51.2 tttt -79.36 -24.88 42.39 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 125.388 3.722 . . . . 0.0 115.222 -173.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . 0.406 24.0 pt -54.52 -69.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-N 125.603 3.82 . . . . 0.0 112.291 -165.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 82.6 mt -70.48 -20.92 62.82 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 130.276 3.431 . . . . 0.0 111.781 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.71 12.68 57.36 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 130.214 3.769 . . . . 0.0 118.775 174.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.5 pt -84.1 167.65 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.08 1 C-N-CA 132.385 4.274 . . . . 0.0 112.479 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.278 5.3 ptpt -175.94 144.84 0.63 Allowed 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 128.467 2.707 . . . . 0.0 114.413 175.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 31.4 mt . . . . . 0 C--N 1.327 -0.397 0 O-C-N 125.842 1.963 . . . . 0.0 109.153 163.974 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.8 t80 . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 123.871 1.796 . . . . 0.0 113.805 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.449 ' CE2' ' HB2' ' A' ' 67' ' ' ALA . 8.7 m-85 -91.28 157.5 17.11 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 112.118 -2.31 . . . . 0.0 114.276 177.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.5 mttt -110.93 -46.44 3.34 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 -141.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.0 pt -67.6 -30.8 49.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 113.176 -3.297 . . . . 0.0 109.47 -174.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.372 20.1 pt -54.93 -49.68 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 C-N-CA 128.157 2.583 . . . . 0.0 110.12 178.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.347 74.8 mttt -29.66 -81.19 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.448 2 C-N-CA 132.418 4.287 . . . . 0.0 121.963 -174.332 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.0 p -75.82 -21.86 56.89 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 118.56 2.8 . . . . 0.0 118.56 -159.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.57 -21.83 63.02 Favored 'General case' 0 N--CA 1.439 -1.009 1 C-N-CA 133.973 4.909 . . . . 0.0 115.625 173.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . 0.282 6.6 ptm180 -44.15 -50.05 8.8 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 115.883 -2.008 . . . . 0.0 114.914 175.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -48.92 -33.24 10.42 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 126.634 1.974 . . . . 0.0 115.742 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -58.89 -25.48 63.4 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 118.605 -2.559 . . . . 0.0 112.708 -176.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.1 mp -96.32 -30.27 13.52 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.92 3.78 2.79 Favored Glycine 0 C--N 1.342 0.888 0 C-N-CA 127.943 2.687 . . . . 0.0 112.844 173.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.5 pt -66.5 154.03 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 120.344 2.072 . . . . 0.0 114.852 -173.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.0 p -71.79 161.85 30.34 Favored 'General case' 0 N--CA 1.443 -0.789 0 O-C-N 116.767 -3.708 . . . . 0.0 113.487 172.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -54.77 -46.44 74.4 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 114.604 -2.617 . . . . 0.0 108.489 173.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -61.74 -34.76 76.39 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 120.961 1.71 . . . . 0.0 111.068 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -80.43 -19.62 45.74 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 116.93 -1.908 . . . . 0.0 110.896 -175.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 66.8 tp -75.43 -46.51 32.23 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 125.856 2.741 . . . . 0.0 110.848 174.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.13 -39.31 66.36 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 118.551 -2.593 . . . . 0.0 110.953 173.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -63.86 -34.41 77.87 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 126.258 1.823 . . . . 0.0 115.918 160.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -73.97 -16.11 61.09 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 122.123 2.238 . . . . 0.0 107.693 -170.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.8 mt -123.09 -4.29 8.49 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 127.837 2.455 . . . . 0.0 112.51 -173.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.272 1.6 mptp? 43.23 56.74 4.08 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 118.652 2.834 . . . . 0.0 118.652 -167.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 31.9 m -127.7 175.77 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 1 C-N-CA 132.196 4.198 . . . . 0.0 108.583 -175.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 62.1 p -78.76 159.07 28.09 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 167.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -74.38 -13.29 60.71 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 128.229 3.455 . . . . 0.0 111.117 169.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -53.33 -50.56 64.72 Favored 'General case' 0 N--CA 1.447 -0.577 1 O-C-N 115.887 -4.258 . . . . 0.0 111.055 161.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.3 mm -59.14 -45.25 92.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 1 O-C-N 115.62 -4.425 . . . . 0.0 111.507 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.4 m -66.22 -49.29 77.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 115.173 -2.346 . . . . 0.0 106.258 -174.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.4 mtmm -50.53 -40.09 50.69 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 127.194 2.198 . . . . 0.0 113.754 173.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -60.95 -29.6 69.74 Favored 'General case' 0 C--N 1.345 0.393 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 172.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -72.46 -50.87 23.06 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 171.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -53.86 -51.92 62.08 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.984 1.714 . . . . 0.0 114.342 -173.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.5 p -74.87 -9.18 58.3 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 120.162 3.393 . . . . 0.0 120.162 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.67 16.76 80.08 Favored Glycine 0 C--O 1.243 0.713 1 CA-C-O 110.19 -5.783 . . . . 0.0 111.573 -169.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -89.83 51.84 2.17 Favored 'General case' 0 C--O 1.24 0.581 1 CA-C-N 126.839 5.32 . . . . 0.0 111.274 -172.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.9 tp -131.97 147.52 52.46 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -164.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.277 61.0 tttt -112.43 71.91 1.21 Allowed Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 113.717 -3.04 . . . . 0.0 111.743 168.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -83.6 -164.45 0.26 Allowed 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 124.552 3.501 . . . . 0.0 103.234 -166.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 p -153.57 174.39 14.51 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 130.841 3.657 . . . . 0.0 108.962 -169.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 28.9 pt -75.45 -48.15 31.9 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 CA-C-O 113.721 -3.038 . . . . 0.0 111.392 -174.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.8 p -58.91 -31.7 68.87 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 124.549 3.34 . . . . 0.0 112.826 166.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -68.47 -43.4 77.05 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 115.62 -2.134 . . . . 0.0 111.912 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.449 ' HB2' ' CE2' ' A' ' 24' ' ' TYR . . . -52.78 -44.28 66.45 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 114.44 -2.695 . . . . 0.0 111.28 165.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.2 mmp_? -56.4 -32.33 64.72 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 125.246 3.657 . . . . 0.0 110.585 170.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -82.31 -26.91 32.63 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 127.272 2.857 . . . . 0.0 111.276 -177.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.8 mt -60.54 -54.01 50.6 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 131.647 3.979 . . . . 0.0 107.463 167.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -50.6 -54.59 21.53 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 127.362 2.265 . . . . 0.0 109.013 174.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -67.54 -42.75 82.2 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 117.56 2.43 . . . . 0.0 117.56 -170.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . 0.258 9.5 pt -48.74 -63.96 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 O-C-N 116.962 -3.586 . . . . 0.0 113.852 -175.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 21.2 mt -75.88 -14.65 60.27 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 122.851 1.31 . . . . 0.0 113.228 -176.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.39 -13.65 10.55 Favored Glycine 0 CA--C 1.532 1.117 0 O-C-N 119.061 -2.274 . . . . 0.0 114.677 176.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.8 pt -92.67 162.37 2.41 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.736 0 C-N-CA 130.253 3.421 . . . . 0.0 115.238 -174.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.0 pttt -173.04 150.41 1.98 Allowed 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 129.846 3.258 . . . . 0.0 108.29 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.4 mt . . . . . 0 N--CA 1.45 -0.426 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 165.235 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.312 22.1 t80 . . . . . 0 N--CA 1.443 -0.775 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -75.59 129.08 36.61 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 125.843 1.965 . . . . 0.0 111.827 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -105.09 -21.21 13.31 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 127.831 2.452 . . . . 0.0 114.499 -175.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.8 pt -69.72 -38.1 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 1 O-C-N 115.923 -4.235 . . . . 0.0 113.794 -174.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.301 22.5 pt -67.84 -20.32 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 127.154 2.182 . . . . 0.0 115.184 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -67.09 -62.45 1.42 Allowed 'General case' 0 C--N 1.327 -0.38 1 N-CA-C 121.893 4.034 . . . . 0.0 121.893 -158.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . 0.471 76.0 p -67.1 -25.02 66.01 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 124.272 3.214 . . . . 0.0 117.154 -176.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.42 -29.3 61.41 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 117.714 2.487 . . . . 0.0 117.714 -171.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.7 ptt85 -50.59 -38.81 47.66 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 117.792 -3.068 . . . . 0.0 114.475 175.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -59.25 -29.02 67.24 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.076 1.75 . . . . 0.0 112.401 -176.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -55.98 -40.97 74.08 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 122.268 2.304 . . . . 0.0 112.663 -178.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 60.7 mt -75.45 -8.61 57.16 Favored 'General case' 0 CA--C 1.514 -0.409 0 O-C-N 127.448 2.968 . . . . 0.0 116.567 -158.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.41 -13.12 11.81 Favored Glycine 0 C--N 1.346 1.119 0 O-C-N 119.792 -1.817 . . . . 0.0 114.486 173.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.3 pt -88.24 163.42 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -164.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 96.1 p -84.18 177.62 8.14 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 118.869 -2.395 . . . . 0.0 112.406 -175.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . 0.322 27.5 tt0 -54.92 -50.14 69.56 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 120.299 1.409 . . . . 0.0 112.71 172.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -61.95 -29.57 70.32 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.333 1.853 . . . . 0.0 115.854 -176.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -78.62 -40.18 35.1 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 175.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . 0.299 5.7 tp -46.9 -44.51 19.77 Favored 'General case' 0 C--O 1.239 0.55 1 O-C-N 129.747 4.404 . . . . 0.0 110.329 165.593 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.65 -55.46 34.51 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 128.099 2.56 . . . . 0.0 112.377 173.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -63.56 -34.88 78.77 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 120.175 1.352 . . . . 0.0 112.645 174.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -63.72 -36.68 84.67 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 126.191 2.901 . . . . 0.0 108.911 -172.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.1 mp -99.29 -5.1 30.36 Favored 'General case' 0 N--CA 1.438 -1.052 1 C-N-CA 135.199 5.4 . . . . 0.0 113.44 -170.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt 55.0 57.51 5.55 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.663 1.185 . . . . 0.0 113.389 -177.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.9 m -151.6 -176.25 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 130.076 3.351 . . . . 0.0 111.445 -171.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 65.7 p -93.85 163.02 13.68 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 118.482 -2.636 . . . . 0.0 115.218 167.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -70.4 -18.13 63.03 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 119.124 0.874 . . . . 0.0 111.517 171.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -68.02 -34.67 76.94 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 114.815 -2.754 . . . . 0.0 118.32 160.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 27.8 mt -73.77 -39.57 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 O-C-N 116.766 -3.709 . . . . 0.0 109.998 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.331 11.9 m -59.01 -49.86 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 O-C-N 119.441 -2.037 . . . . 0.0 111.02 178.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -48.11 -43.51 31.07 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 129.868 3.267 . . . . 0.0 108.596 167.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -67.54 -32.43 73.2 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-N 123.184 2.72 . . . . 0.0 114.018 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -75.1 -39.49 60.61 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 129.797 3.239 . . . . 0.0 106.871 170.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 -60.1 -32.72 71.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 122.352 2.342 . . . . 0.0 108.595 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.6 p -112.15 -6.75 14.11 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -144.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.52 18.12 74.24 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-O 125.157 2.531 . . . . 0.0 114.402 -176.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -97.85 33.84 2.02 Favored 'General case' 0 N--CA 1.438 -1.025 1 O-C-N 115.423 -4.575 . . . . 0.0 113.704 -176.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.4 tp -130.65 129.73 43.02 Favored 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 130.492 3.517 . . . . 0.0 110.198 -178.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -101.65 102.7 23.73 Favored Pre-proline 0 N--CA 1.442 -0.853 0 CA-C-O 115.91 -1.995 . . . . 0.0 106.455 168.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -80.31 174.73 11.01 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 CA-C-N 120.372 1.169 . . . . 0.0 112.33 -171.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 62.1 p -139.99 174.22 10.73 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 118.8 -2.437 . . . . 0.0 110.436 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.89 -32.52 56.25 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -171.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.3 p -56.83 -53.56 56.48 Favored 'General case' 0 CA--C 1.512 -0.498 2 O-C-N 112.643 -6.286 . . . . 0.0 112.906 158.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -67.14 -36.44 81.88 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 118.431 2.752 . . . . 0.0 118.431 -170.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -31.85 -73.74 0.03 OUTLIER 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 131.434 3.893 . . . . 0.0 116.451 163.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -56.04 -36.36 67.92 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.437 -1.71 . . . . 0.0 111.856 172.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -75.47 -25.87 57.74 Favored 'General case' 0 C--O 1.246 0.88 1 CA-C-O 111.509 -4.091 . . . . 0.0 111.735 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.5 mt -69.51 -41.53 75.92 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 126.617 2.448 . . . . 0.0 107.705 -176.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -55.14 -38.06 67.74 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 117.7 2.482 . . . . 0.0 117.7 165.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -87.97 -35.0 17.88 Favored 'General case' 0 C--O 1.225 -0.225 0 O-C-N 116.845 -3.659 . . . . 0.0 114.931 -168.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.9 pt -63.71 -44.11 98.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 122.466 2.394 . . . . 0.0 107.213 -175.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.4 tp -68.94 -24.43 64.27 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 126.073 1.749 . . . . 0.0 112.699 169.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.07 -20.07 0.09 OUTLIER Glycine 0 C--N 1.337 0.636 0 N-CA-C 117.218 1.647 . . . . 0.0 117.218 -174.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.1 pt -134.25 174.27 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -168.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -147.75 166.4 27.62 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 113.784 -3.008 . . . . 0.0 108.785 -170.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.9 mt . . . . . 0 N--CA 1.446 -0.627 0 C-N-CA 127.931 2.492 . . . . 0.0 112.556 160.194 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 84.4 t80 . . . . . 0 C--O 1.236 0.374 0 N-CA-C 117.459 2.392 . . . . 0.0 117.459 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -58.65 141.74 51.6 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 118.362 -2.711 . . . . 0.0 115.541 174.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -113.08 -14.95 12.89 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 116.95 2.204 . . . . 0.0 116.95 -164.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -60.14 -48.64 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 O-C-N 124.488 1.118 . . . . 0.0 111.35 -166.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.519 6.4 pt -72.77 -23.54 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 128.046 2.538 . . . . 0.0 117.003 173.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 51.1 tttm -56.54 -67.61 0.29 Allowed 'General case' 0 C--O 1.243 0.717 0 N-CA-C 118.079 2.622 . . . . 0.0 118.079 -162.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 57.8 p -68.64 -35.82 77.79 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 121.595 1.998 . . . . 0.0 106.574 -172.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.48 -37.43 87.29 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.748 2.019 . . . . 0.0 114.468 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -54.02 -49.98 67.68 Favored 'General case' 0 N--CA 1.44 -0.938 2 O-C-N 112.401 -6.437 . . . . 0.0 112.273 166.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -63.2 -33.37 75.33 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 129.354 3.062 . . . . 0.0 111.265 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -76.47 -25.99 54.9 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 122.703 2.501 . . . . 0.0 108.59 -176.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.1 mt -76.7 -23.42 53.13 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 119.663 -1.898 . . . . 0.0 110.364 168.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.48 -14.89 6.28 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 122.327 2.33 . . . . 0.0 110.935 174.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.0 pt -71.14 155.92 7.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 O-C-N 118.392 -2.828 . . . . 0.0 113.9 -154.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . 0.309 78.8 p -74.18 175.84 7.16 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 127.84 3.213 . . . . 0.0 111.669 -177.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.77 -46.13 89.44 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 123.284 1.516 . . . . 0.0 110.292 161.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -59.07 -28.95 66.96 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 115.585 -2.15 . . . . 0.0 113.135 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -79.88 -29.17 39.92 Favored 'General case' 0 N--CA 1.446 -0.669 1 CA-C-O 111.461 -4.114 . . . . 0.0 111.47 174.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.5 tp -68.74 -34.97 76.49 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 125.205 3.638 . . . . 0.0 110.97 171.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.3 -41.53 80.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 121.382 1.901 . . . . 0.0 113.359 171.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -61.74 -42.42 98.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 127.192 2.808 . . . . 0.0 109.667 171.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -51.33 -32.35 25.03 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 127.089 3.328 . . . . 0.0 109.445 -172.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.5 mt -120.2 2.27 10.87 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 117.412 -3.305 . . . . 0.0 110.831 -153.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 77.2 mttt 47.17 -17.8 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.906 1 N-CA-C 123.725 4.713 . . . . 0.0 123.725 -159.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.3 m -94.91 156.42 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 130.15 3.38 . . . . 0.0 115.066 -172.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 84.5 p -72.39 168.09 19.15 Favored 'General case' 0 N--CA 1.441 -0.898 0 O-C-N 118.374 -2.704 . . . . 0.0 116.737 -177.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -65.91 -20.48 66.23 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 118.877 2.917 . . . . 0.0 118.877 -175.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -47.84 -34.19 8.41 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 118.234 2.679 . . . . 0.0 118.234 163.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.0 mm -80.78 -38.94 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 119.006 -1.078 . . . . 0.0 113.25 166.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.261 11.0 m -66.05 -42.77 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-O 115.496 -2.193 . . . . 0.0 115.86 -170.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -58.18 -17.96 22.48 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 127.486 2.314 . . . . 0.0 113.621 177.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -72.55 -50.75 23.48 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 130.688 3.595 . . . . 0.0 110.52 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.374 58.4 m-85 -73.13 -26.06 61.08 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 120.335 1.425 . . . . 0.0 109.173 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -69.0 -45.15 71.29 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 117.923 -2.986 . . . . 0.0 106.831 177.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.4 p -93.67 -34.93 13.07 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 -167.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.36 21.16 62.92 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-O 114.076 -3.624 . . . . 0.0 117.824 173.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -95.1 8.12 43.97 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 128.817 2.847 . . . . 0.0 114.189 -162.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.6 tp -134.38 144.0 47.96 Favored 'General case' 0 N--CA 1.447 -0.623 1 O-C-N 129.852 4.47 . . . . 0.0 114.043 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -102.09 91.8 2.71 Favored Pre-proline 0 N--CA 1.441 -0.878 0 O-C-N 118.678 -2.514 . . . . 0.0 108.749 166.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . 0.272 2.6 Cg_endo -74.9 176.65 9.59 Favored 'Trans proline' 0 N--CA 1.454 -0.81 1 C-N-CA 127.859 5.706 . . . . 0.0 107.789 -168.917 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.8 p -76.85 179.74 5.95 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.3 mp -55.04 -62.24 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 C-N-CA 128.4 2.68 . . . . 0.0 107.669 -169.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.6 p -55.05 -30.62 59.99 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 115.237 -2.316 . . . . 0.0 113.896 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -84.15 -54.48 4.79 Favored 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 127.164 2.79 . . . . 0.0 106.661 -168.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -48.49 -33.32 9.24 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 128.683 2.793 . . . . 0.0 114.761 160.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.8 mtt-85 -75.64 -34.46 60.54 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 114.329 -2.748 . . . . 0.0 113.172 166.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -70.56 -32.67 70.18 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 122.932 2.605 . . . . 0.0 115.106 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 72' ' ' LYS . 5.6 tt -41.64 -72.55 0.06 Allowed 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 130.118 3.367 . . . . 0.0 114.925 177.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -48.78 -19.43 0.37 Allowed 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 126.071 2.843 . . . . 0.0 110.26 173.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 70' ' ' LEU . 28.1 mtpt -99.91 -8.33 24.14 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 117.524 -3.235 . . . . 0.0 115.996 -163.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.5 pt -61.43 -46.78 95.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 1 N-CA-C 122.004 4.075 . . . . 0.0 122.004 -171.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 49.3 mt -74.48 -18.23 60.65 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 126.002 1.721 . . . . 0.0 110.326 -172.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.47 -0.57 17.66 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 118.752 -1.69 . . . . 0.0 116.396 -158.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 30.8 pt -142.11 175.71 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 125.906 1.682 . . . . 0.0 109.238 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.357 11.5 pttt -176.95 149.06 0.69 Allowed 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 128.668 2.787 . . . . 0.0 108.526 -174.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 N--CA 1.439 -1.008 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 176.948 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 91.8 t80 . . . . . 0 N--CA 1.449 -0.504 0 CA-C-O 121.744 0.783 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . 0.506 0.0 OUTLIER -75.74 67.66 2.21 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 119.738 3.236 . . . . 0.0 119.738 179.348 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -60.08 -22.75 63.13 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 119.797 -1.814 . . . . 0.0 113.972 -169.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.1 pt -61.96 -29.34 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-O 114.815 -2.517 . . . . 0.0 112.851 173.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.316 12.2 mm -63.92 -57.11 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 CA-C-N 122.542 2.428 . . . . 0.0 105.836 174.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -51.02 -65.03 0.63 Allowed 'General case' 0 CA--C 1.532 0.266 1 C-N-CA 134.535 5.134 . . . . 0.0 109.874 -155.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 77.4 p -57.17 -31.68 65.65 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 126.253 2.221 . . . . 0.0 113.772 -164.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.87 -58.51 3.24 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.488 1.515 . . . . 0.0 108.183 174.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 56.5 ttt180 -51.15 -36.79 42.68 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 118.631 -2.543 . . . . 0.0 114.103 -176.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -68.32 -42.22 79.69 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 123.918 3.054 . . . . 0.0 113.467 172.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -54.19 -37.84 64.96 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-O 123.898 1.809 . . . . 0.0 113.206 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.256 62.9 mt -90.44 -11.1 41.4 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 111.266 -2.697 . . . . 0.0 112.371 -161.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.36 4.77 5.38 Favored Glycine 0 C--O 1.238 0.382 0 CA-C-O 125.329 2.627 . . . . 0.0 118.327 178.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.2 pt -69.02 153.06 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 O-C-N 119.668 -2.078 . . . . 0.0 112.161 -172.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.6 p -129.9 165.97 20.96 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 117.387 2.366 . . . . 0.0 117.387 -162.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -60.39 -37.28 80.3 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 116.978 -1.487 . . . . 0.0 112.833 -176.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -52.47 -34.65 50.08 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 115.322 -2.275 . . . . 0.0 113.458 166.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -77.51 -37.76 50.39 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 122.3 2.318 . . . . 0.0 111.632 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.3 tp -73.98 -31.93 63.2 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 115.364 -2.255 . . . . 0.0 108.602 -175.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.43 -47.02 76.64 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 166.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -60.6 -42.55 96.99 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 122.802 1.287 . . . . 0.0 112.825 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -70.43 -16.99 63.0 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 118.109 -2.869 . . . . 0.0 106.491 -173.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.8 tp -110.7 5.01 20.56 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 -169.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.2 tttp 45.56 52.67 9.09 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 131.158 3.783 . . . . 0.0 110.128 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.8 m -142.45 -176.41 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 C-N-CA 130.036 3.335 . . . . 0.0 115.73 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 86.7 p -94.42 161.35 14.26 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 125.099 1.36 . . . . 0.0 112.544 167.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -73.17 -12.95 61.07 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 117.122 -3.486 . . . . 0.0 110.378 -174.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -62.29 -37.4 85.37 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 119.027 -2.296 . . . . 0.0 111.961 170.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.0 mm -68.51 -28.94 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 125.936 1.694 . . . . 0.0 110.842 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.378 3.2 m -66.29 -35.55 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 O-C-N 117.282 -3.386 . . . . 0.0 113.987 -175.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -50.18 -38.13 38.28 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 117.198 2.296 . . . . 0.0 117.198 -170.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.292 99.0 mtt180 -25.94 -87.03 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 127.927 2.491 . . . . 0.0 114.739 170.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -77.99 -25.03 47.84 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 120.425 -1.422 . . . . 0.0 111.72 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -63.24 -13.04 33.36 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 120.28 1.4 . . . . 0.0 113.967 -177.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.8 p -65.04 -20.19 66.37 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 117.81 2.522 . . . . 0.0 117.81 170.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.79 19.46 75.09 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 128.817 3.103 . . . . 0.0 114.408 174.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -92.65 12.3 23.72 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 128.385 3.05 . . . . 0.0 116.04 -174.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.5 mt -145.48 120.81 10.26 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 171.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.8 tttp -64.97 116.38 29.3 Favored Pre-proline 0 C--O 1.233 0.202 0 O-C-N 119.22 -2.175 . . . . 0.0 113.623 161.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -66.43 160.53 45.17 Favored 'Trans proline' 0 N--CA 1.448 -1.199 1 C-N-CA 128.479 6.119 . . . . 0.0 114.145 -176.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 63.9 p -108.94 -165.93 1.07 Allowed 'General case' 0 C--O 1.239 0.514 0 C-N-CA 127.246 2.218 . . . . 0.0 114.472 172.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 34.2 mt -57.88 -59.43 3.42 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.158 0 O-C-N 118.772 -2.455 . . . . 0.0 114.126 -171.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.3 p -59.75 -40.7 89.01 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 169.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -63.06 -55.21 27.49 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 116.361 1.985 . . . . 0.0 116.361 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -39.71 -47.27 2.0 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 117.196 -1.383 . . . . 0.0 113.356 160.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.1 ttt85 -67.25 -39.57 86.14 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 127.234 2.213 . . . . 0.0 107.897 -172.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -67.84 -52.23 39.12 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 116.74 -1.6 . . . . 0.0 107.174 176.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 21.6 tp -59.88 -60.32 4.02 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 127.845 3.688 . . . . 0.0 111.049 -168.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -52.63 -39.09 61.38 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 117.899 -3.001 . . . . 0.0 109.053 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -76.77 -34.73 58.0 Favored 'General case' 0 N--CA 1.446 -0.653 1 O-C-N 115.239 -4.663 . . . . 0.0 119.446 176.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 31.5 pt -67.84 -30.6 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 118.021 -1.471 . . . . 0.0 108.299 170.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 76' ' ' ILE 0.311 95.8 mt -70.97 -41.97 70.33 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 117.024 -3.547 . . . . 0.0 117.102 174.857 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.15 -8.5 0.16 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 127.307 2.384 . . . . 0.0 110.961 -167.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.479 ' H ' ' C ' ' A' ' 74' ' ' LEU . 44.8 pt -116.91 146.62 21.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 117.803 2.52 . . . . 0.0 117.803 -177.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -176.2 153.68 1.29 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 114.604 -2.617 . . . . 0.0 112.572 176.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.5 mt . . . . . 0 N--CA 1.432 -1.349 0 CA-C-O 126.485 3.04 . . . . 0.0 112.209 179.361 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.438 ' CG ' ' HA2' ' A' ' 58' ' ' GLY . 63.5 t80 . . . . . 0 N--CA 1.449 -0.483 0 CA-C-O 123.04 1.4 . . . . 0.0 108.599 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -72.73 140.93 48.11 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 126.87 3.224 . . . . 0.0 111.332 -167.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -93.96 -45.9 7.4 Favored 'General case' 0 CA--C 1.503 -0.848 1 O-C-N 114.19 -5.319 . . . . 0.0 116.456 -155.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.7 tp -65.22 -37.54 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-O 115.614 -2.136 . . . . 0.0 113.414 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.398 7.6 pt -55.05 -35.6 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 O-C-N 125.73 1.894 . . . . 0.0 109.302 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -67.54 -39.63 85.03 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 119.795 -1.816 . . . . 0.0 112.254 -174.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.9 p -62.17 -43.14 99.49 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 124.491 1.116 . . . . 0.0 108.705 -157.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.35 -74.8 0.13 Allowed 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 117.741 2.497 . . . . 0.0 117.741 -155.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -47.95 -46.36 32.13 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 -165.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -55.16 -58.6 7.01 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 124.374 3.261 . . . . 0.0 112.224 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -66.98 -23.1 65.91 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 123.519 2.872 . . . . 0.0 116.298 -172.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 99.3 mt -76.58 -1.8 29.29 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 177.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.54 -0.56 12.55 Favored Glycine 0 C--N 1.335 0.481 2 CA-C-N 107.327 -4.488 . . . . 0.0 117.064 172.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.2 pt -78.77 158.78 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 C-N-CA 130.077 3.351 . . . . 0.0 114.126 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 p -89.61 175.77 7.14 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 117.134 2.272 . . . . 0.0 117.134 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -55.73 -50.98 68.9 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 116.59 -3.819 . . . . 0.0 110.299 161.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -60.07 -47.28 86.53 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 129.27 3.028 . . . . 0.0 113.319 -170.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -64.21 -33.44 75.8 Favored 'General case' 0 N--CA 1.449 -0.51 1 CA-C-O 111.62 -4.038 . . . . 0.0 114.4 174.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 23.0 tp -85.25 -27.14 26.23 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 127.822 3.202 . . . . 0.0 109.653 -177.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.56 -24.1 67.67 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 129.28 3.032 . . . . 0.0 113.483 167.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -66.12 -55.64 15.41 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 104.089 -2.56 . . . . 0.0 104.089 169.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -62.25 -14.99 44.27 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 128.32 2.648 . . . . 0.0 113.41 -159.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 40.8 mt -131.51 -8.47 3.68 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 128.297 3.903 . . . . 0.0 109.955 -163.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.312 88.1 mttt 56.4 -5.4 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 121.709 3.966 . . . . 0.0 121.709 -158.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.3 m -131.25 153.47 39.07 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 C-N-CA 127.87 2.468 . . . . 0.0 110.907 -168.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.932 ' C ' ' H ' ' A' ' 52' ' ' VAL . 91.3 p -128.57 -11.83 4.98 Favored 'General case' 0 N--CA 1.446 -0.653 1 N-CA-C 122.196 4.147 . . . . 0.0 122.196 -169.69 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -99.59 -30.46 12.12 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 117.354 -3.342 . . . . 0.0 111.397 -158.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . 0.253 64.6 t30 -103.15 -55.49 2.4 Favored 'General case' 0 C--O 1.217 -0.618 1 N-CA-C 122.431 4.234 . . . . 0.0 122.431 177.152 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . 0.325 0.7 OUTLIER 41.23 52.03 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.491 2 O-C-N 113.689 -5.632 . . . . 0.0 118.247 14.295 . . . . . . . . 4 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.932 ' H ' ' C ' ' A' ' 48' ' ' SER . 15.7 t -105.33 -42.36 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 129.366 3.067 . . . . 0.0 107.929 23.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -69.95 -39.34 76.12 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 119.023 2.972 . . . . 0.0 119.023 -153.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -83.05 -12.59 57.02 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 120.455 1.479 . . . . 0.0 114.391 -158.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -79.7 -11.93 59.83 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -88.26 -5.95 58.06 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 118.061 -2.899 . . . . 0.0 110.693 -175.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.6 p -92.1 -7.04 49.73 Favored 'General case' 0 N--CA 1.454 -0.268 1 N-CA-C 121.936 4.05 . . . . 0.0 121.936 -142.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.438 ' HA2' ' CG ' ' A' ' 23' ' ' TYR . . . 68.47 26.13 74.49 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-O 115.109 -3.05 . . . . 0.0 110.942 177.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -130.38 -1.32 4.46 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 119.068 2.988 . . . . 0.0 119.068 -160.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.2 tp -135.31 158.87 43.27 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 -171.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -106.48 94.87 10.64 Favored Pre-proline 0 CA--C 1.513 -0.454 0 CA-C-O 115.646 -2.121 . . . . 0.0 113.259 147.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.08 151.28 34.62 Favored 'Trans proline' 0 N--CA 1.443 -1.467 0 C-N-CA 122.612 2.208 . . . . 0.0 110.61 172.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.5 p -80.17 171.72 14.72 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 127.213 2.821 . . . . 0.0 117.726 169.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . 0.315 2.1 tp -53.58 -61.17 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 130.548 3.539 . . . . 0.0 106.382 177.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 83.2 p -61.23 -23.6 65.75 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 116.308 -1.806 . . . . 0.0 112.887 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -80.77 -46.69 15.02 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 128.379 2.672 . . . . 0.0 109.233 173.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.04 93.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 130.173 3.389 . . . . 0.0 115.035 170.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -52.09 -22.41 4.12 Favored 'General case' 0 C--O 1.22 -0.476 0 C-N-CA 127.276 2.23 . . . . 0.0 113.959 175.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -66.68 -13.05 60.79 Favored 'General case' 0 N--CA 1.438 -1.025 0 C-N-CA 125.985 1.714 . . . . 0.0 111.339 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.6 tp -79.97 -49.6 11.62 Favored 'General case' 0 N--CA 1.436 -1.152 1 O-C-N 114.735 -4.978 . . . . 0.0 109.484 -175.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -50.56 -31.32 15.41 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 126.567 2.417 . . . . 0.0 108.022 172.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.1 tttp -69.17 -54.24 15.88 Favored 'General case' 0 C--O 1.24 0.579 1 C-N-CA 131.788 4.035 . . . . 0.0 106.786 -170.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 19.2 pt -79.53 -40.0 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 117.466 -3.271 . . . . 0.0 108.076 -168.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 25.4 mt -82.45 -13.46 56.7 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 128.189 2.596 . . . . 0.0 114.04 -175.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.33 4.13 42.49 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-O 114.12 -3.6 . . . . 0.0 118.228 -167.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.5 pt -171.94 135.31 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 127.854 2.462 . . . . 0.0 109.016 -161.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -65.73 131.0 45.25 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 114.173 -3.011 . . . . 0.0 115.629 170.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.5 mt . . . . . 0 N--CA 1.437 -1.102 0 CA-C-N 124.099 3.136 . . . . 0.0 111.185 -173.93 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 . . . . . 0 C--O 1.239 0.542 0 CA-C-O 119.493 -0.289 . . . . 0.0 111.614 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -90.69 -2.62 57.82 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 129.254 3.022 . . . . 0.0 114.625 -171.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.34 -13.75 37.18 Favored 'General case' 0 N--CA 1.444 -0.749 1 C-N-CA 131.968 4.107 . . . . 0.0 111.498 170.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -98.46 -0.82 42.71 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 125.273 1.429 . . . . 0.0 112.841 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.7 mt -84.91 173.01 10.92 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.989 1.716 . . . . 0.0 114.196 166.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -148.22 135.87 20.73 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -174.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.2 pp -112.65 -5.7 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 N-CA-C 119.314 3.079 . . . . 0.0 119.314 159.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.5 t -98.85 49.77 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.473 1 C-N-CA 132.866 4.466 . . . . 0.0 109.122 177.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.4 p -80.4 -12.57 59.56 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 112.452 -3.642 . . . . 0.0 113.18 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . 0.251 15.1 m-20 61.16 13.68 4.93 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 123.448 2.84 . . . . 0.0 111.292 -160.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -121.37 9.85 10.43 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 117.474 -1.251 . . . . 0.0 112.666 -176.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -75.39 -166.19 0.5 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -174.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -16.4 -57.91 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 119.905 3.298 . . . . 0.0 119.905 166.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.2 tp -44.07 -50.84 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 118.84 2.904 . . . . 0.0 118.84 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.311 6.2 tt -84.27 -46.94 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 129.366 3.066 . . . . 0.0 110.115 175.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -52.44 -52.49 53.8 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 115.476 -2.202 . . . . 0.0 111.623 -172.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.1 p -46.33 -52.32 13.01 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.252 1.421 . . . . 0.0 109.247 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.9 -36.43 56.67 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-O 114.453 -2.689 . . . . 0.0 117.388 -172.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . 0.31 37.3 ptt85 -57.97 -43.93 86.79 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 121.201 1.819 . . . . 0.0 113.562 172.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -55.28 -34.0 63.72 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 113.575 -3.107 . . . . 0.0 111.962 164.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.65 -21.96 63.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 124.16 3.164 . . . . 0.0 109.028 178.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.8 mt -98.82 -9.87 23.74 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 125.764 1.626 . . . . 0.0 112.768 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.22 -7.33 2.59 Favored Glycine 0 N--CA 1.464 0.56 0 CA-C-N 113.014 -1.903 . . . . 0.0 117.851 174.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.5 pt -57.11 128.32 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 128.293 2.637 . . . . 0.0 111.284 -176.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.7 p -67.93 162.52 24.11 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 118.936 2.939 . . . . 0.0 118.936 -171.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -48.02 -43.97 30.5 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 117.604 -3.185 . . . . 0.0 113.951 168.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -68.69 -34.89 76.43 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 123.415 0.686 . . . . 0.0 110.002 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -71.32 -41.5 69.77 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 115.05 -2.405 . . . . 0.0 109.105 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . 0.257 29.2 tp -59.94 -46.25 90.0 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 128.081 2.552 . . . . 0.0 113.945 177.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.5 -37.77 65.7 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 110.718 -2.946 . . . . 0.0 116.492 174.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -63.78 -40.59 97.04 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.839 1.655 . . . . 0.0 113.62 165.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -63.66 1.21 0.63 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.28 1.832 . . . . 0.0 111.452 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.268 16.1 tp -145.79 4.43 0.99 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 120.377 3.473 . . . . 0.0 120.377 -170.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.26 63.7 mttt 52.18 39.01 25.98 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 130.807 3.643 . . . . 0.0 115.199 -174.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.7 m -126.66 -172.58 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 1 C-N-CA 133.38 4.672 . . . . 0.0 113.826 -176.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.1 p -101.33 152.5 20.63 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 116.599 -1.667 . . . . 0.0 114.421 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -49.09 -32.5 9.89 Favored 'General case' 0 CA--C 1.52 -0.187 0 O-C-N 126.177 2.173 . . . . 0.0 110.349 165.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -74.08 -29.63 61.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 116.599 -1.667 . . . . 0.0 109.746 -171.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mt -70.83 -47.67 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-O 126.322 2.963 . . . . 0.0 113.704 173.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.348 13.4 m -56.59 -46.72 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 2 O-C-N 113.433 -5.792 . . . . 0.0 112.148 175.149 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -56.07 -40.86 74.23 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 117.989 -2.944 . . . . 0.0 113.277 162.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.8 ttt85 -57.64 -36.59 72.05 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 115.609 -2.138 . . . . 0.0 113.174 177.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -71.51 -44.76 64.07 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 124.849 1.343 . . . . 0.0 111.066 173.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -67.7 -13.77 62.38 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 114.861 -2.495 . . . . 0.0 109.775 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.9 p -102.68 0.36 32.99 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 124.094 3.134 . . . . 0.0 111.482 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.93 6.22 87.0 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 122.268 2.303 . . . . 0.0 115.816 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -94.12 -18.83 21.38 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 119.443 1.621 . . . . 0.0 114.962 -166.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.4 tp -144.87 161.67 38.72 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 127.931 3.27 . . . . 0.0 109.04 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.258 76.2 tttt -133.65 151.94 78.05 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-O 115.627 -2.13 . . . . 0.0 112.869 171.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . 0.274 41.4 Cg_endo -63.42 168.04 11.99 Favored 'Trans proline' 0 N--CA 1.451 -0.981 1 C-N-CA 126.211 4.607 . . . . 0.0 108.807 169.636 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 81.3 p -96.34 179.22 5.11 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 127.581 2.352 . . . . 0.0 111.224 171.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.1 pt -64.66 -57.23 12.16 Favored 'Isoleucine or valine' 0 C--N 1.346 0.449 0 CA-C-O 113.434 -3.174 . . . . 0.0 114.857 -175.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 90.3 p -51.98 -29.64 21.49 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 122.975 2.625 . . . . 0.0 111.914 167.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -78.86 -53.07 7.46 Favored 'General case' 0 N--CA 1.439 -0.978 0 O-C-N 118.982 -2.324 . . . . 0.0 109.129 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -40.94 -45.57 2.59 Favored 'General case' 0 N--CA 1.448 -0.57 1 C-N-CA 131.918 4.087 . . . . 0.0 104.759 162.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -62.65 -40.0 95.65 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 118.667 -2.52 . . . . 0.0 112.253 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -79.3 -40.33 30.67 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 117.676 2.473 . . . . 0.0 117.676 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 87.5 mt -44.97 -46.13 10.94 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 114.854 -2.498 . . . . 0.0 113.965 161.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -56.03 -43.08 77.47 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 121.831 2.105 . . . . 0.0 107.353 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -85.21 -4.95 59.33 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 130.396 3.478 . . . . 0.0 118.609 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.2 tt -75.58 -31.64 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 1 O-C-N 114.395 -5.191 . . . . 0.0 116.394 -163.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.448 ' C ' ' H ' ' A' ' 76' ' ' ILE . 57.8 mt -105.56 -7.26 18.7 Favored 'General case' 0 N--CA 1.445 -0.694 2 O-C-N 115.244 -4.66 . . . . 0.0 113.0 -175.706 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.43 ' HA3' ' CD2' ' A' ' 92' ' ' PHE . . . 61.08 -20.78 0.05 OUTLIER Glycine 0 CA--C 1.526 0.765 0 O-C-N 116.486 -3.884 . . . . 0.0 112.643 -151.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.448 ' H ' ' C ' ' A' ' 74' ' ' LEU . 9.2 pt -131.05 -161.79 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-O 125.101 2.382 . . . . 0.0 116.918 -172.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.5 pttm -175.29 176.02 2.1 Favored 'General case' 0 N--CA 1.439 -0.99 0 O-C-N 117.318 -3.364 . . . . 0.0 107.08 -172.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 59.0 tp 104.3 -41.26 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 129.689 3.196 . . . . 0.0 106.798 138.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.4 m -100.95 140.9 18.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 120.314 3.45 . . . . 0.0 120.314 -153.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.449 ' C ' ' H ' ' A' ' 82' ' ' LEU . 52.7 p -97.78 176.68 1.93 Allowed Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 128.111 2.564 . . . . 0.0 108.679 165.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -62.22 -11.1 20.67 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 N-CA-C 109.801 -0.884 . . . . 0.0 109.801 176.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.449 ' H ' ' C ' ' A' ' 80' ' ' THR . 1.7 mm? -108.34 -24.14 11.6 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -172.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -69.63 113.04 6.54 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 119.531 -1.98 . . . . 0.0 111.343 -172.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -96.75 -51.63 4.21 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 118.462 2.764 . . . . 0.0 118.462 -172.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -63.92 118.34 8.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 117.954 -2.966 . . . . 0.0 115.586 162.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.12 26.77 0.7 Allowed 'General case' 0 C--O 1.239 0.528 0 O-C-N 125.535 1.772 . . . . 0.0 114.571 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -66.08 107.86 2.05 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 123.333 1.54 . . . . 0.0 109.471 -164.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.5 p -159.56 143.54 14.79 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 130.002 3.321 . . . . 0.0 114.13 174.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.07 137.79 58.3 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 118.305 -2.747 . . . . 0.0 109.716 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -69.3 128.95 38.39 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 101.72 -3.437 . . . . 0.0 101.72 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -138.85 105.83 5.43 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 115.733 -2.08 . . . . 0.0 115.35 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.43 ' CD2' ' HA3' ' A' ' 75' ' ' GLY . 0.2 OUTLIER -129.43 134.83 48.04 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 127.787 3.179 . . . . 0.0 106.856 -169.304 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -38.49 143.2 0.15 Allowed 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 156.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -72.15 -40.23 68.19 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 127.421 2.951 . . . . 0.0 112.05 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.4 m -65.43 -36.9 85.32 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 172.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -56.15 -36.72 69.21 Favored Glycine 0 C--O 1.224 -0.477 0 CA-C-O 114.918 -3.157 . . . . 0.0 115.337 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 47.0 tp -96.0 -69.91 0.74 Allowed 'General case' 0 C--O 1.242 0.671 0 C-N-CA 127.247 2.219 . . . . 0.0 107.284 -176.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.6 m -88.61 -34.56 17.26 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 127.931 2.492 . . . . 0.0 111.607 -149.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 11.6 tp -81.44 -10.31 59.53 Favored 'General case' 0 N--CA 1.441 -0.883 0 O-C-N 119.76 -1.837 . . . . 0.0 113.927 161.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.98 -18.83 76.2 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-O 115.995 -2.558 . . . . 0.0 110.495 173.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -75.3 23.19 0.11 Allowed 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 123.223 3.512 . . . . 0.0 118.179 -158.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . 0.259 0.0 OUTLIER -130.82 146.69 33.59 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.416 1 C-N-CA 136.026 5.73 . . . . 0.0 112.245 -169.637 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 72.2 t -66.96 117.3 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 2 O-C-N 107.968 -9.207 . . . . 0.0 110.151 13.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -77.08 -37.15 55.01 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 116.319 -3.988 . . . . 0.0 113.503 -161.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 14.3 tt -80.18 -8.33 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 128.819 2.848 . . . . 0.0 109.767 -168.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -113.61 153.31 29.07 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 123.462 1.601 . . . . 0.0 109.363 174.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -63.54 131.05 46.86 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 129.212 3.005 . . . . 0.0 112.092 -173.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.79 -22.06 2.38 Favored Glycine 0 N--CA 1.444 -0.805 1 O-C-N 115.537 -4.477 . . . . 0.0 115.04 171.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 33.5 mttp 117.05 4.21 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 130.159 3.384 . . . . 0.0 110.363 153.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . 0.292 48.3 tttp 53.19 69.28 0.72 Allowed 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 129.396 3.079 . . . . 0.0 113.383 175.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.3 8.2 mt -86.98 166.08 15.36 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 127.502 2.321 . . . . 0.0 109.978 -178.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -65.74 -33.19 75.31 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 121.361 1.892 . . . . 0.0 114.249 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 10.7 p-80 -95.11 12.94 26.92 Favored 'General case' 0 C--O 1.233 0.207 2 O-C-N 115.241 -4.662 . . . . 0.0 110.984 -175.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 26.4 m170 . . . . . 0 N--CA 1.444 -0.754 0 C-N-CA 127.596 2.359 . . . . 0.0 113.186 -177.78 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 126.658 3.123 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -55.3 -17.82 5.34 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 111.65 -2.523 . . . . 0.0 115.182 171.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.44 11.11 9.15 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 117.839 2.533 . . . . 0.0 117.839 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -103.54 12.98 34.36 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 125.299 1.624 . . . . 0.0 114.782 169.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -108.33 173.1 6.47 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 116.958 -3.589 . . . . 0.0 111.26 159.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -167.96 135.82 2.29 Favored 'General case' 0 N--CA 1.44 -0.969 1 O-C-N 114.559 -5.088 . . . . 0.0 117.883 -167.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 24.8 pt -104.4 -8.22 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 129.403 3.081 . . . . 0.0 114.888 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.6 m -74.46 -2.22 3.57 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.535 0 CA-C-O 126.574 3.083 . . . . 0.0 109.845 175.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.6 p -51.29 -21.56 2.24 Favored 'General case' 0 N--CA 1.449 -0.5 1 O-C-N 114.389 -5.194 . . . . 0.0 113.927 157.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . 0.292 25.5 t70 -91.08 54.46 2.62 Favored 'General case' 0 CA--C 1.512 -0.495 0 O-C-N 120.124 -1.61 . . . . 0.0 108.527 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.465 ' CD2' ' HA2' ' A' ' 58' ' ' GLY . 40.0 t80 -59.3 134.16 56.75 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 112.545 -2.116 . . . . 0.0 113.236 -173.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -65.15 144.97 56.87 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 119.843 1.201 . . . . 0.0 112.476 -174.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -78.34 -29.12 47.45 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 119.266 3.061 . . . . 0.0 119.266 -160.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.96 -51.87 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 O-C-N 117.488 -3.257 . . . . 0.0 108.587 -170.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.2 pt -54.0 -28.66 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 117.131 -1.414 . . . . 0.0 114.312 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -60.12 -39.61 86.84 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 129.555 3.142 . . . . 0.0 111.136 173.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.5 p -90.77 -21.87 21.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 117.011 2.226 . . . . 0.0 117.011 -173.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.83 -61.27 2.75 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 131.05 3.74 . . . . 0.0 113.115 -159.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.38 -46.08 87.04 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-O 114.618 -2.611 . . . . 0.0 110.135 -169.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -63.7 -34.76 78.59 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 117.281 2.326 . . . . 0.0 117.281 169.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.97 -0.21 13.08 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 122.83 2.559 . . . . 0.0 110.659 -174.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 36.3 mt -117.43 -19.81 9.35 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 129.491 3.116 . . . . 0.0 112.527 178.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.76 -8.29 50.28 Favored Glycine 0 C--O 1.223 -0.557 0 CA-C-O 127.615 3.897 . . . . 0.0 114.463 162.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.421 HD11 ' HE3' ' A' ' 44' ' ' LYS . 35.1 pt -91.75 155.86 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 130.356 3.463 . . . . 0.0 110.459 -173.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.0 p -65.14 161.91 18.1 Favored 'General case' 0 CA--C 1.514 -0.412 0 O-C-N 119.86 -1.775 . . . . 0.0 115.065 167.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -56.42 -37.73 70.6 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 118.017 -0.992 . . . . 0.0 111.713 170.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -66.77 -31.87 72.79 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 126.004 1.722 . . . . 0.0 111.591 174.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -69.07 -39.58 79.0 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 118.644 -2.535 . . . . 0.0 112.781 170.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.0 tp -64.25 -37.92 89.21 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 118.665 -2.522 . . . . 0.0 110.216 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.79 -25.08 61.86 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.311 -0.868 . . . . 0.0 108.874 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -62.33 -36.67 82.93 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 123.603 1.668 . . . . 0.0 114.948 170.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.421 ' HE3' HD11 ' A' ' 36' ' ' ILE . 21.8 mttm -66.82 -22.85 66.0 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 117.292 -3.38 . . . . 0.0 111.807 -175.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.6 mt -133.46 -5.62 2.94 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 127.297 2.873 . . . . 0.0 108.985 -145.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.356 65.2 mmtt 51.16 -37.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 119.175 3.028 . . . . 0.0 119.175 -153.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.1 m -124.46 154.46 31.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 116.171 -1.871 . . . . 0.0 111.605 -157.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.921 ' C ' ' H ' ' A' ' 52' ' ' VAL . 84.0 p -137.87 -6.36 1.67 Allowed 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 127.966 3.291 . . . . 0.0 118.189 -135.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.544 ' N ' ' H ' ' A' ' 52' ' ' VAL . 17.7 mp0 -101.59 -32.36 10.39 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 127.651 3.094 . . . . 0.0 110.387 -162.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.452 ' H ' ' C ' ' A' ' 51' ' ' ILE . 57.0 t-20 -118.91 -42.84 2.69 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 112.446 -3.645 . . . . 0.0 113.894 -174.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.452 ' C ' ' H ' ' A' ' 50' ' ' ASN . 1.5 mt 46.12 61.75 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.354 2 C-N-CA 137.925 6.49 . . . . 0.0 112.22 -1.654 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.921 ' H ' ' C ' ' A' ' 48' ' ' SER . 27.8 t -93.66 -47.76 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 O-C-N 117.723 -3.111 . . . . 0.0 114.882 2.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -57.82 -43.22 85.6 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 120.523 3.527 . . . . 0.0 120.523 -148.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.3 ttm180 -73.44 -12.41 60.79 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 115.516 -2.183 . . . . 0.0 114.684 -157.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -52.39 -27.91 17.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 125.252 1.595 . . . . 0.0 113.765 169.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . 0.269 12.4 pt-20 -50.41 -27.45 6.41 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 123.849 3.022 . . . . 0.0 116.592 168.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.6 p -73.75 -27.81 61.36 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 119.328 3.084 . . . . 0.0 119.328 -148.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.465 ' HA2' ' CD2' ' A' ' 23' ' ' TYR . . . 78.53 19.54 73.55 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 123.106 2.684 . . . . 0.0 115.704 -172.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -122.09 4.43 9.84 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 121.314 3.82 . . . . 0.0 121.314 -162.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.6 tp -145.01 142.0 29.41 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 118.426 2.75 . . . . 0.0 118.426 -168.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.251 61.1 mttm -115.09 109.42 46.85 Favored Pre-proline 0 C--N 1.351 0.67 0 O-C-N 119.342 -2.099 . . . . 0.0 109.739 155.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -78.01 -177.84 4.17 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 124.139 3.226 . . . . 0.0 112.054 -167.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.0 p -81.58 170.86 15.35 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 165.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 11.3 tp -68.73 -46.17 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-N 112.302 -2.227 . . . . 0.0 110.59 -177.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.7 p -56.69 -34.19 67.17 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 120.892 1.678 . . . . 0.0 111.917 169.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -78.43 -50.41 11.74 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 -170.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -52.09 -40.21 60.91 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 125.62 1.825 . . . . 0.0 114.368 173.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -65.4 -46.15 81.18 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 172.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.618 ' C ' ' H ' ' A' ' 72' ' ' LYS . 35.0 mt-30 -64.33 -27.41 69.01 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 118.127 -2.858 . . . . 0.0 112.865 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 27.3 mt -90.22 -31.6 16.94 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -166.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -50.74 -31.51 16.9 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.097 149.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.618 ' H ' ' C ' ' A' ' 69' ' ' GLN . 20.0 tttm -78.46 -26.1 46.02 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 116.701 -2.0 . . . . 0.0 116.053 -161.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . 0.355 26.2 pt -57.18 -43.25 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 O-C-N 116.997 -3.564 . . . . 0.0 114.307 167.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.455 ' HG ' ' H ' ' A' ' 74' ' ' LEU . 8.7 mt -60.4 -34.76 74.39 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 -166.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.04 -5.83 7.67 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 117.269 -2.396 . . . . 0.0 113.995 -169.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.425 ' H ' ' C ' ' A' ' 74' ' ' LEU . 27.1 pt -114.89 -162.45 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 124.899 1.28 . . . . 0.0 113.059 163.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -120.38 150.25 41.07 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 114.869 -2.491 . . . . 0.0 113.671 169.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.4 mt -149.4 150.95 33.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 175.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.0 m -109.79 148.01 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 1 C-N-CA 132.675 4.39 . . . . 0.0 120.437 13.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.454 ' C ' ' H ' ' A' ' 82' ' ' LEU . 73.0 p -84.35 -173.48 0.43 Allowed Pre-proline 0 N--CA 1.45 -0.458 0 CA-C-N 121.035 1.743 . . . . 0.0 110.68 178.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.06 10.59 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.53 1.487 . . . . 0.0 115.093 161.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.454 ' H ' ' C ' ' A' ' 80' ' ' THR 0.266 35.4 tp -73.54 -25.05 60.21 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 119.599 -1.938 . . . . 0.0 108.795 164.211 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -153.32 -14.67 0.15 Allowed 'General case' 0 C--N 1.35 0.588 0 O-C-N 117.266 -3.396 . . . . 0.0 110.847 -176.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -151.26 126.12 9.71 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 123.733 2.97 . . . . 0.0 109.874 167.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -80.8 -9.89 59.77 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 126.147 1.779 . . . . 0.0 115.353 -172.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -143.81 161.1 39.5 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 125.87 3.941 . . . . 0.0 108.183 175.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -78.2 43.83 0.47 Allowed 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 130.348 3.459 . . . . 0.0 110.159 169.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 91.2 p -80.96 -18.39 47.17 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 128.976 2.911 . . . . 0.0 116.589 -168.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -99.53 -8.25 24.84 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 126.881 2.613 . . . . 0.0 109.582 -176.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -73.1 164.22 27.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 123.929 1.823 . . . . 0.0 113.271 169.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -164.89 177.44 7.88 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 111.421 -2.627 . . . . 0.0 112.382 -169.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.443 ' CZ ' ' HA ' ' A' ' 111' ' ' LEU 0.292 79.6 t80 -113.1 163.86 14.21 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 121.875 2.125 . . . . 0.0 109.748 172.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -162.49 148.08 12.57 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 127.183 2.193 . . . . 0.0 112.77 -176.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -69.56 -17.61 63.58 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 116.5 2.037 . . . . 0.0 116.5 -176.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.7 m -97.41 -34.67 10.94 Favored 'General case' 0 C--O 1.244 0.795 0 O-C-N 125.508 1.755 . . . . 0.0 110.203 175.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -74.34 -17.58 79.73 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 123.855 1.808 . . . . 0.0 109.215 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 57.9 tp -41.77 -43.73 3.02 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 116.934 -3.686 . . . . 0.0 113.338 165.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.18 7.91 29.76 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -171.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.5 tp -99.92 -23.37 14.95 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 118.867 2.914 . . . . 0.0 118.867 165.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 84.11 6.32 86.6 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 118.4 -2.687 . . . . 0.0 111.227 -175.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -91.82 70.96 5.67 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 117.158 -1.401 . . . . 0.0 108.516 -177.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.6 t -143.32 147.68 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 1 O-C-N 131.031 5.207 . . . . 0.0 116.52 -164.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.2 p -48.74 91.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 118.157 2.651 . . . . 0.0 118.157 164.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.1 t30 -83.34 -22.85 32.75 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 119.939 -1.726 . . . . 0.0 110.386 -173.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 15.2 pt -76.16 -31.32 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 127.954 2.501 . . . . 0.0 115.545 -171.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -95.33 139.21 31.96 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 118.706 -1.198 . . . . 0.0 109.239 174.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -89.51 141.54 28.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 125.254 2.454 . . . . 0.0 111.175 -177.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.95 -30.23 0.24 Allowed Glycine 0 C--N 1.344 0.988 0 C-N-CA 128.718 3.056 . . . . 0.0 117.439 -160.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.436 ' C ' ' H ' ' A' ' 111' ' ' LEU . 42.9 tttp -67.19 -27.3 67.15 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.1 ptpt -52.11 6.8 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 118.631 2.826 . . . . 0.0 118.631 160.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.443 ' HA ' ' CZ ' ' A' ' 92' ' ' PHE . 1.4 pt? -161.5 38.72 0.14 Allowed 'General case' 0 C--O 1.244 0.776 0 C-N-CA 126.316 1.846 . . . . 0.0 109.256 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.356 16.5 tt0 -47.89 -69.97 0.11 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 130.149 3.38 . . . . 0.0 118.242 -167.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 3.3 p-80 -119.2 18.34 13.04 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.042 1.737 . . . . 0.0 112.92 -166.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 . . . . . 0 C--O 1.252 1.209 1 C-N-CA 133.05 4.54 . . . . 0.0 109.453 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -160.37 71.61 0.45 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 123.508 1.623 . . . . 0.0 108.445 169.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -130.02 12.96 5.71 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 118.769 -2.457 . . . . 0.0 114.133 -172.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -106.88 19.01 21.08 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 127.829 2.452 . . . . 0.0 112.329 170.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.6 tp -92.06 -23.26 19.54 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.752 1.621 . . . . 0.0 112.855 -175.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -133.3 25.43 4.16 Favored 'General case' 0 N--CA 1.44 -0.959 0 O-C-N 116.666 -3.771 . . . . 0.0 112.873 -156.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.1 pt -117.65 163.38 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 113.202 -1.817 . . . . 0.0 111.697 -149.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.4 m -68.99 -177.46 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 123.787 1.756 . . . . 0.0 111.514 174.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 82.1 p -54.52 -30.17 52.8 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 131.351 3.861 . . . . 0.0 120.621 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -175.68 63.74 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 104.378 -2.453 . . . . 0.0 104.378 -161.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -56.6 113.73 1.74 Allowed 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 168.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -58.34 144.71 40.57 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 128.124 2.569 . . . . 0.0 116.84 -171.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.7 tttt -116.63 -4.26 11.71 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 -157.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.1 pt -43.95 -49.3 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.747 0 C-N-CA 127.84 2.456 . . . . 0.0 116.23 -174.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.426 13.9 pt -74.23 -16.5 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 O-C-N 125.165 1.541 . . . . 0.0 115.031 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.342 19.0 tttm -66.53 -58.01 6.1 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 120.462 3.505 . . . . 0.0 120.462 -158.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 52.2 m -54.57 -40.43 68.76 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 120.469 -1.394 . . . . 0.0 109.479 174.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.98 -45.68 80.79 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 118.661 2.837 . . . . 0.0 118.661 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -47.22 -42.23 19.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.883 0.873 . . . . 0.0 112.618 164.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -73.48 -39.81 64.6 Favored 'General case' 0 N--CA 1.437 -1.109 1 CA-C-O 111.551 -4.071 . . . . 0.0 112.41 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -61.41 -41.06 96.56 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 127.554 3.034 . . . . 0.0 112.742 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 61.1 mt -58.35 -35.18 71.54 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.515 1.926 . . . . 0.0 111.512 171.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.1 2.92 5.62 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 128.375 2.893 . . . . 0.0 115.225 -173.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.5 pt -66.63 154.73 7.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 125.637 2.637 . . . . 0.0 113.966 -166.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 64.2 p -80.45 170.59 16.17 Favored 'General case' 0 N--CA 1.438 -1.038 0 O-C-N 119.151 -2.218 . . . . 0.0 113.113 -176.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -56.52 -41.66 77.09 Favored 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 117.997 -2.939 . . . . 0.0 105.138 174.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -72.53 -32.99 66.55 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 121.925 2.148 . . . . 0.0 116.625 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -64.57 -38.03 89.61 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 116.338 -3.976 . . . . 0.0 112.442 170.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.2 tp -70.3 -37.13 74.73 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 128.329 2.652 . . . . 0.0 114.489 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.3 -46.37 90.12 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.902 1.681 . . . . 0.0 112.306 169.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -63.25 -44.64 94.61 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 117.868 -1.063 . . . . 0.0 111.836 172.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -69.19 -14.49 63.01 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 125.764 1.626 . . . . 0.0 111.99 -174.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.04 1.87 10.4 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.63 1.972 . . . . 0.0 109.78 -172.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.256 0.0 OUTLIER 62.41 -35.42 0.12 Allowed 'General case' 0 N--CA 1.444 -0.767 2 C-N-CA 133.169 4.587 . . . . 0.0 114.784 -167.736 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.8 m -77.53 164.13 3.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 1 C-N-CA 133.165 4.586 . . . . 0.0 114.747 -161.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 89.3 p -79.66 159.21 26.8 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 -170.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -82.7 -12.46 57.57 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 117.557 -1.657 . . . . 0.0 110.216 -162.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -59.91 -44.34 94.33 Favored 'General case' 0 C--O 1.222 -0.391 0 O-C-N 120.663 -1.273 . . . . 0.0 109.899 166.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.5 mm -64.42 -45.52 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 C-N-CA 127.863 2.465 . . . . 0.0 108.345 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.387 1.3 m -65.11 -45.9 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -176.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -63.84 -26.76 68.76 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-O 115.308 -2.282 . . . . 0.0 116.229 172.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -59.49 -44.03 93.17 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 121.742 2.064 . . . . 0.0 109.008 176.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -82.05 -28.18 32.58 Favored 'General case' 0 CA--C 1.522 -0.112 0 O-C-N 118.421 -2.675 . . . . 0.0 110.702 -176.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -63.19 -33.75 76.16 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 119.396 -2.065 . . . . 0.0 111.159 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.2 p -126.61 22.58 6.92 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -151.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.11 21.85 62.1 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.664 165.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -97.1 26.53 4.65 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 125.9 1.68 . . . . 0.0 115.025 -164.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.2 tp -140.02 154.58 47.16 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 113.672 -1.603 . . . . 0.0 114.903 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.2 tttp -90.54 102.08 4.61 Favored Pre-proline 0 N--CA 1.443 -0.808 0 C-N-CA 125.041 1.337 . . . . 0.0 108.526 149.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -83.83 170.89 11.01 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 CA-C-O 125.041 2.017 . . . . 0.0 111.236 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.0 p -143.73 179.28 7.25 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 118.921 -2.362 . . . . 0.0 111.988 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . 0.403 60.7 mt -52.39 -61.4 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 O-C-N 127.574 3.046 . . . . 0.0 109.392 172.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 96.5 p -68.97 -31.26 69.99 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 125.329 1.643 . . . . 0.0 107.653 -173.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -77.96 -37.49 47.35 Favored 'General case' 0 N--CA 1.438 -1.073 1 O-C-N 114.581 -5.074 . . . . 0.0 109.014 -177.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.23 -45.72 90.3 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 114.466 -2.683 . . . . 0.0 107.172 169.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 39.5 tpt85 -52.61 -27.82 18.6 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 125.153 1.533 . . . . 0.0 112.496 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -93.39 -29.39 15.62 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 114.396 -2.716 . . . . 0.0 110.31 -173.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.5 tp -61.62 -53.11 60.58 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 114.927 -2.463 . . . . 0.0 115.732 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -50.9 -22.69 2.35 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 125.303 1.627 . . . . 0.0 115.175 157.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.25 76.7 tttt -87.54 -38.02 16.37 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 117.268 -3.395 . . . . 0.0 109.489 -173.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 50.5 pt -74.1 -29.91 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 34.4 tp -77.61 -25.33 49.74 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 126.54 3.066 . . . . 0.0 107.34 175.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.35 8.85 27.33 Favored Glycine 0 N--CA 1.445 -0.725 0 O-C-N 118.878 -2.389 . . . . 0.0 117.098 -168.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.2 pt -152.02 177.34 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.073 0 C-N-CA 130.018 3.327 . . . . 0.0 112.006 175.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -171.29 168.69 6.58 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 128.602 2.761 . . . . 0.0 106.892 -166.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.7 mt -157.87 138.82 13.22 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 112.407 -2.179 . . . . 0.0 115.221 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.2 t -112.0 168.29 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 1 O-C-N 114.501 -5.125 . . . . 0.0 108.517 22.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.434 ' HB ' ' HD2' ' A' ' 81' ' ' PRO 0.497 33.8 p -91.45 -176.73 0.65 Allowed Pre-proline 0 N--CA 1.444 -0.738 0 O-C-N 126.193 2.183 . . . . 0.0 107.914 175.301 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.434 ' HD2' ' HB ' ' A' ' 80' ' ' THR 0.261 82.7 Cg_exo -49.44 -2.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 124.223 3.282 . . . . 0.0 115.353 176.407 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 47.4 tp -59.76 -35.22 74.16 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 117.661 -1.616 . . . . 0.0 112.714 162.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . 0.262 38.4 mt-10 -142.02 -13.41 0.83 Allowed 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 125.639 2.638 . . . . 0.0 114.424 174.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -150.19 141.78 23.53 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 117.323 -3.36 . . . . 0.0 113.083 -171.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -147.89 150.2 33.67 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 123.945 1.831 . . . . 0.0 109.563 -174.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -120.79 160.4 23.45 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 -173.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -83.03 167.55 17.79 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 124.376 2.036 . . . . 0.0 113.9 165.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.4 m -96.62 -16.48 20.97 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 118.708 -2.495 . . . . 0.0 116.166 -163.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -61.86 -34.82 76.68 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 125.514 1.526 . . . . 0.0 111.935 169.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -65.29 3.56 0.63 Allowed 'General case' 0 C--N 1.346 0.428 0 C-N-CA 127.158 2.183 . . . . 0.0 115.284 173.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -69.57 -34.84 74.73 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 120.919 1.691 . . . . 0.0 113.157 173.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -91.59 166.72 12.67 Favored 'General case' 0 CA--C 1.52 -0.182 0 O-C-N 125.376 1.673 . . . . 0.0 115.26 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -166.56 -36.29 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 119.034 -2.291 . . . . 0.0 110.58 169.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -103.35 -22.93 13.61 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 118.343 -2.723 . . . . 0.0 112.821 -173.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 66.4 p -126.2 -164.78 1.36 Allowed 'General case' 0 N--CA 1.439 -0.983 0 O-C-N 126.865 2.603 . . . . 0.0 110.325 176.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -151.81 166.75 30.93 Favored Glycine 0 C--N 1.339 0.719 0 O-C-N 127.14 2.775 . . . . 0.0 112.885 174.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.1 tp -76.73 4.47 9.52 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 121.144 2.472 . . . . 0.0 116.693 -171.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.29 146.64 46.87 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 128.421 2.688 . . . . 0.0 115.677 -170.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 19.0 tp -65.22 161.91 18.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 115.177 -2.344 . . . . 0.0 113.254 -171.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.467 ' C ' ' H ' ' A' ' 102' ' ' VAL . . . -81.86 9.09 57.9 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 124.066 3.121 . . . . 0.0 114.128 -174.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.324 15.8 t70 -68.54 47.71 0.06 Allowed 'General case' 0 N--CA 1.446 -0.64 2 O-C-N 116.147 -4.149 . . . . 0.0 113.736 -169.673 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.467 ' H ' ' C ' ' A' ' 100' ' ' GLY 0.266 0.1 OUTLIER -141.52 157.47 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 128.336 2.654 . . . . 0.0 114.238 -167.433 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.424 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 66.5 t -72.38 149.43 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 2 O-C-N 112.307 -6.496 . . . . 0.0 110.608 7.127 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -73.75 117.66 15.8 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 125.698 1.599 . . . . 0.0 113.399 176.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . 0.309 29.6 pt -97.11 1.56 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 118.287 2.699 . . . . 0.0 118.287 169.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -71.6 -21.4 61.86 Favored 'General case' 0 C--O 1.224 -0.265 0 O-C-N 119.664 -1.898 . . . . 0.0 107.027 165.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -68.61 -44.58 73.99 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 124.205 1.955 . . . . 0.0 112.955 163.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 158.7 149.66 5.56 Favored Glycine 0 CA--C 1.541 1.698 0 O-C-N 116.526 -3.859 . . . . 0.0 110.139 177.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -57.45 129.25 40.97 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 126.62 1.968 . . . . 0.0 110.548 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -89.62 65.96 7.08 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 118.535 -2.603 . . . . 0.0 110.164 -176.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 178.15 177.62 0.4 Allowed 'General case' 0 C--O 1.214 -0.786 0 C-N-CA 129.416 3.086 . . . . 0.0 109.014 178.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.482 13.1 tt0 -161.23 -109.44 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 119.559 1.072 . . . . 0.0 108.645 -142.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 45.0 p-80 -62.17 -18.05 59.83 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 118.685 -2.509 . . . . 0.0 117.161 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 2.5 m80 . . . . . 0 C--O 1.253 1.271 0 C-N-CA 130.6 3.56 . . . . 0.0 114.442 -176.74 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 . . . . . 0 N--CA 1.466 0.332 0 CA-C-O 118.3 -0.857 . . . . 0.0 112.894 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -83.53 -22.04 32.56 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 116.647 2.091 . . . . 0.0 116.647 -174.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.57 171.09 9.94 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 130.5 3.52 . . . . 0.0 111.751 171.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -79.93 -23.6 41.64 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 124.084 1.897 . . . . 0.0 113.787 158.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -91.62 155.97 17.96 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 176.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -138.39 134.16 33.79 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 173.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.9 pt -114.27 3.6 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 O-C-N 119.781 -1.825 . . . . 0.0 113.598 171.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.4 t -98.53 -57.62 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 O-C-N 118.88 -2.387 . . . . 0.0 108.713 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.4 p -70.09 -32.5 70.59 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-O 115.019 -2.42 . . . . 0.0 114.116 -149.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . 0.326 1.7 t0 63.79 12.17 6.49 Favored 'General case' 0 C--O 1.24 0.556 1 C-N-CA 132.116 4.166 . . . . 0.0 107.241 -171.53 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.473 ' HH ' HG12 ' A' ' 52' ' ' VAL . 49.4 t80 -101.08 53.76 0.84 Allowed 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 127.682 2.393 . . . . 0.0 115.097 169.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -85.91 -162.64 0.76 Allowed 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 127.868 3.23 . . . . 0.0 111.291 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -66.4 -1.8 3.87 Favored 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 118.272 -2.767 . . . . 0.0 114.461 -168.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.0 pt -56.26 -27.67 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 O-C-N 120.13 -1.606 . . . . 0.0 115.315 160.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.348 6.7 tp -140.5 -33.15 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 O-C-N 119.998 -1.689 . . . . 0.0 109.875 -173.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -70.98 -49.28 47.0 Favored 'General case' 0 N--CA 1.445 -0.708 0 O-C-N 117.177 -3.452 . . . . 0.0 112.829 -164.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.08 -39.7 94.64 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 128.092 2.557 . . . . 0.0 106.748 175.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.72 -59.57 4.71 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 117.756 2.502 . . . . 0.0 117.756 -173.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -39.94 -45.85 1.94 Allowed 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 124.566 1.167 . . . . 0.0 109.703 169.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -58.93 -47.52 84.76 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 116.859 -3.651 . . . . 0.0 117.199 168.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -72.33 -1.71 16.46 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 122.013 2.188 . . . . 0.0 112.446 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.413 ' C ' ' H ' ' A' ' 36' ' ' ILE . 81.5 mt -101.51 -22.1 14.59 Favored 'General case' 0 N--CA 1.451 -0.413 1 O-C-N 115.161 -4.712 . . . . 0.0 107.046 -177.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.81 -12.1 0.16 Allowed Glycine 0 C--N 1.336 0.555 0 CA-C-O 125.492 2.718 . . . . 0.0 115.785 -176.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.413 ' H ' ' C ' ' A' ' 34' ' ' LEU . 31.7 pt -66.19 163.42 2.44 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 N-CA-C 119.118 3.007 . . . . 0.0 119.118 -176.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.5 p -77.17 171.75 14.34 Favored 'General case' 0 C--O 1.241 0.644 0 O-C-N 116.995 -3.566 . . . . 0.0 117.753 175.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . 0.336 2.5 mp0 -70.89 -24.43 62.48 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 120.843 -1.16 . . . . 0.0 110.03 169.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -72.89 -37.21 67.37 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 120.503 -1.373 . . . . 0.0 107.432 176.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -76.81 -32.16 57.45 Favored 'General case' 0 N--CA 1.44 -0.953 0 O-C-N 118.464 -2.648 . . . . 0.0 113.868 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.3 tp -72.54 -36.46 68.27 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 130.215 3.406 . . . . 0.0 109.716 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.54 -34.11 70.64 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 121.581 1.991 . . . . 0.0 112.873 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -60.94 -49.84 75.8 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.924 1.689 . . . . 0.0 112.304 168.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.7 mmtt -70.54 -19.25 62.91 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -173.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 94.7 mt -101.72 -9.67 20.65 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -170.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.339 7.1 mptt 61.69 -16.43 0.04 OUTLIER 'General case' 0 C--O 1.237 0.415 0 N-CA-C 117.104 2.261 . . . . 0.0 117.104 -163.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.3 m -104.51 166.1 3.23 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 CA-C-O 124.53 2.11 . . . . 0.0 112.508 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 55.3 p -74.04 166.31 23.61 Favored 'General case' 0 N--CA 1.44 -0.974 0 O-C-N 118.969 -2.332 . . . . 0.0 116.229 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -70.5 -23.48 62.67 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 118.685 -2.51 . . . . 0.0 107.689 175.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -63.1 -37.0 85.47 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.274 1.43 . . . . 0.0 110.743 171.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.5 mm -68.84 -40.4 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 125.861 3.937 . . . . 0.0 110.594 171.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.473 HG12 ' HH ' ' A' ' 23' ' ' TYR . 41.1 t -54.41 -45.32 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 113.966 -1.47 . . . . 0.0 111.262 178.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -59.04 -58.13 10.01 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 128.873 2.869 . . . . 0.0 106.098 169.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -53.55 -39.51 64.78 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 121.452 1.933 . . . . 0.0 110.732 -163.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -70.81 -50.81 31.57 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 118.273 -0.87 . . . . 0.0 112.826 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -51.43 -37.7 49.93 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 122.729 2.513 . . . . 0.0 112.835 170.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.4 p -83.79 4.96 26.79 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 118.44 2.756 . . . . 0.0 118.44 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.82 7.36 68.67 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 116.853 -2.082 . . . . 0.0 111.938 165.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -103.98 -15.42 15.62 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 129.152 2.981 . . . . 0.0 115.998 -167.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.3 tp -146.53 138.98 25.09 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 126.14 1.776 . . . . 0.0 115.426 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.409 ' CB ' ' CD ' ' A' ' 62' ' ' PRO . 15.6 ptpt -138.53 -164.77 0.08 OUTLIER Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-O 116.588 -1.672 . . . . 0.0 112.492 173.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 61' ' ' LYS . 88.2 Cg_endo -88.8 149.64 5.98 Favored 'Trans proline' 0 N--CA 1.44 -1.644 0 O-C-N 124.512 1.796 . . . . 0.0 112.241 177.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.0 p -144.52 -179.33 6.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.836 1.255 . . . . 0.0 113.042 -172.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.434 ' C ' ' N ' ' A' ' 66' ' ' GLN . 8.7 tp -78.69 -44.02 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 C-N-CA 125.346 1.458 . . . . 0.0 107.816 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 84.9 p -53.92 -7.67 0.14 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-N 120.389 1.45 . . . . 0.0 108.388 169.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.434 ' N ' ' C ' ' A' ' 64' ' ' ILE . 40.3 mt-30 -118.68 -37.33 3.29 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 117.722 -3.112 . . . . 0.0 115.039 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -39.38 -46.66 1.66 Allowed 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 117.565 2.431 . . . . 0.0 117.565 -162.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.5 mtm105 -71.48 -53.54 13.59 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 114.903 -2.475 . . . . 0.0 116.47 -165.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.542 ' HB2' ' CD2' ' A' ' 92' ' ' PHE . 22.0 tt0 -63.18 -39.14 93.79 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 115.694 -2.098 . . . . 0.0 112.877 167.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 44.4 tp -53.85 -49.0 69.43 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 127.167 2.792 . . . . 0.0 107.131 -170.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -57.82 -51.12 70.88 Favored 'General case' 0 CA--C 1.513 -0.467 0 O-C-N 118.694 -2.504 . . . . 0.0 111.527 177.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -73.24 -29.45 62.79 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 116.579 -3.826 . . . . 0.0 115.706 -168.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 14.5 pt -66.04 -15.96 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 123.042 2.655 . . . . 0.0 112.942 161.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.372 1.3 pt? 146.24 -10.15 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.477 1 C-N-CA 133.41 4.684 . . . . 0.0 115.233 162.457 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.85 6.79 68.34 Favored Glycine 0 C--N 1.34 0.788 0 CA-C-O 113.943 -3.698 . . . . 0.0 114.014 -172.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . 0.282 1.4 pt 71.64 6.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.835 1 C-N-CA 135.196 5.398 . . . . 0.0 117.16 174.578 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -71.88 148.51 46.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 115.116 -2.373 . . . . 0.0 113.992 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . 0.259 40.1 mt -134.04 151.12 51.28 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.383 1.473 . . . . 0.0 113.328 168.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 39.6 t -105.69 134.03 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 122.488 2.404 . . . . 0.0 111.134 5.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.415 ' C ' ' H ' ' A' ' 82' ' ' LEU . 8.4 p -89.18 135.79 31.03 Favored Pre-proline 0 N--CA 1.445 -0.684 0 C-N-CA 127.554 2.341 . . . . 0.0 107.329 176.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.33 9.57 0.39 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 N-CA-C 114.831 1.05 . . . . 0.0 114.831 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.415 ' H ' ' C ' ' A' ' 80' ' ' THR . 1.0 OUTLIER -155.08 166.68 32.82 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 128.361 2.664 . . . . 0.0 108.502 175.252 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -70.36 74.8 0.53 Allowed 'General case' 0 C--O 1.241 0.613 0 C-N-CA 128.081 2.553 . . . . 0.0 112.321 174.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -66.22 125.49 25.74 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.089 2.155 . . . . 0.0 115.262 -163.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -162.2 150.28 14.6 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 129.518 3.127 . . . . 0.0 111.428 167.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -120.03 122.7 41.72 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-O 124.445 2.069 . . . . 0.0 109.035 174.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.293 12.3 pt-20 -105.72 27.8 8.11 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 126.074 2.845 . . . . 0.0 113.659 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 78.1 p -80.19 -7.4 58.94 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 112.018 -2.355 . . . . 0.0 111.627 -173.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -147.52 105.56 3.74 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 123.969 3.077 . . . . 0.0 113.269 -169.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.69 -12.54 48.04 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 118.133 2.642 . . . . 0.0 118.133 -175.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -103.15 117.37 34.38 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 125.972 2.045 . . . . 0.0 110.059 172.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.542 ' CD2' ' HB2' ' A' ' 69' ' ' GLN . 79.1 t80 -146.91 135.1 21.64 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 127.246 2.841 . . . . 0.0 107.477 169.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -160.29 141.21 12.05 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 128.562 2.745 . . . . 0.0 110.237 175.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -95.76 -12.94 24.57 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 117.987 -2.946 . . . . 0.0 116.081 174.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.7 m -37.68 -53.64 1.23 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 130.683 3.593 . . . . 0.0 116.424 -170.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -81.94 1.34 86.84 Favored Glycine 0 C--O 1.216 -1.017 0 O-C-N 117.808 -3.057 . . . . 0.0 113.298 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.8 mt -98.85 -7.99 26.45 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 118.955 -2.497 . . . . 0.0 113.791 164.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 42.3 p -127.49 -60.09 1.2 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 119.398 -0.334 . . . . 0.0 110.723 -165.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 80.0 mt -96.88 -12.57 23.33 Favored 'General case' 0 C--O 1.214 -0.768 0 C-N-CA 126.506 1.922 . . . . 0.0 113.98 -178.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.7 21.44 77.88 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 115.483 -2.843 . . . . 0.0 114.494 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.45 25.7 t70 -60.01 38.78 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 129.028 3.428 . . . . 0.0 118.325 -172.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.418 ' HA ' ' C ' ' A' ' 103' ' ' VAL . 5.0 m -140.48 168.53 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 121.699 3.962 . . . . 0.0 121.699 -171.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.418 ' C ' ' HA ' ' A' ' 102' ' ' VAL . 42.6 t -54.25 147.46 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 2 CA-C-N 127.487 4.676 . . . . 0.0 107.566 2.537 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -79.7 127.35 32.09 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 111.558 -2.564 . . . . 0.0 112.401 176.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 26.7 pt -128.86 37.46 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 O-C-N 128.559 3.662 . . . . 0.0 107.578 -167.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.5 pttt -78.34 -42.56 30.18 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 118.793 -2.442 . . . . 0.0 107.033 -176.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -78.16 -19.15 54.55 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.204 1.802 . . . . 0.0 109.612 163.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -96.07 -156.86 31.49 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 117.14 1.616 . . . . 0.0 117.14 -173.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -143.54 151.34 40.12 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 127.366 2.266 . . . . 0.0 109.912 176.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . 0.468 37.2 tttt -67.18 66.93 0.07 Allowed 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 171.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 25.1 mt -68.83 165.13 20.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 128.589 2.756 . . . . 0.0 107.313 175.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -52.51 -33.24 44.13 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 125.668 1.855 . . . . 0.0 115.141 -173.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -82.95 9.36 10.25 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 122.37 1.081 . . . . 0.0 111.236 -161.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 . . . . . 0 C--O 1.256 1.446 0 C-N-CA 124.796 1.238 . . . . 0.0 111.372 -155.108 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 . . . . . 0 N--CA 1.474 0.766 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.95 -10.15 59.17 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 -167.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.2 10.9 1.33 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 131.372 3.869 . . . . 0.0 115.599 174.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -127.11 -7.99 5.95 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 125.42 1.7 . . . . 0.0 112.283 -173.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.9 mt -91.07 -8.37 49.15 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 131.435 3.894 . . . . 0.0 116.235 -164.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -145.93 12.7 1.28 Allowed 'General case' 0 N--CA 1.442 -0.851 0 O-C-N 118.927 -2.358 . . . . 0.0 107.611 -153.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.1 pt -109.6 164.46 6.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 131.682 3.993 . . . . 0.0 117.594 174.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.4 m -57.97 154.96 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 O-C-N 119.639 -1.913 . . . . 0.0 113.488 154.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . 0.267 95.9 m -57.47 -65.72 0.58 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.857 2.063 . . . . 0.0 112.856 172.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . 0.282 26.3 t0 -70.2 41.13 0.05 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 128.75 2.82 . . . . 0.0 114.524 -178.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.75 131.44 40.83 Favored 'General case' 0 N--CA 1.444 -0.731 1 C-N-CA 132.159 4.183 . . . . 0.0 106.558 161.566 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -44.86 116.22 1.04 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 119.633 3.197 . . . . 0.0 119.633 -173.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -66.17 -36.73 83.86 Favored 'General case' 0 C--O 1.222 -0.375 0 N-CA-C 116.199 1.925 . . . . 0.0 116.199 -170.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.2 pt -62.08 -22.17 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 O-C-N 119.453 -2.03 . . . . 0.0 113.817 -171.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.359 2.5 mt -136.94 -53.68 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 O-C-N 117.621 -3.174 . . . . 0.0 109.646 172.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt 63.96 -96.24 0.05 Allowed 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 113.476 -3.154 . . . . 0.0 115.548 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.7 p -43.44 -31.86 0.77 Allowed 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 130.738 3.615 . . . . 0.0 111.128 -168.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.73 -26.06 31.63 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 131.105 3.762 . . . . 0.0 117.996 -154.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . 0.451 22.3 ptt180 -36.92 -50.3 0.86 Allowed 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 119.93 3.307 . . . . 0.0 119.93 -176.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . 0.25 40.9 mt-10 -72.32 -37.0 69.01 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 114.335 -2.745 . . . . 0.0 115.476 170.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -65.29 0.96 1.2 Allowed 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 126.33 1.852 . . . . 0.0 114.458 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.472 ' C ' ' H ' ' A' ' 36' ' ' ILE . 12.4 mt -72.64 -7.61 51.18 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 119.321 -2.112 . . . . 0.0 114.492 -175.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 47.98 6.75 0.03 OUTLIER Glycine 0 C--N 1.347 1.15 1 C-N-CA 131.442 4.353 . . . . 0.0 115.881 -161.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.472 ' H ' ' C ' ' A' ' 34' ' ' LEU 0.289 2.6 pt -136.32 167.73 23.75 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.509 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.677 -169.232 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 65.8 m -134.89 179.93 6.0 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 121.012 1.733 . . . . 0.0 115.249 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.42 -38.93 14.36 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 118.484 -2.635 . . . . 0.0 117.898 -159.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -75.73 -39.32 57.47 Favored 'General case' 0 N--CA 1.442 -0.844 0 O-C-N 119.404 -2.06 . . . . 0.0 109.542 -169.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -67.4 -34.95 78.33 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 160.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.6 tp -64.51 -39.42 93.75 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 121.461 1.937 . . . . 0.0 112.089 -175.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -50.81 -32.86 21.36 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.462 177.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -73.14 -50.23 23.84 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 124.148 1.928 . . . . 0.0 112.737 173.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -65.69 -4.07 5.79 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 116.511 -1.709 . . . . 0.0 110.74 -168.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.331 53.9 tp -146.93 -0.84 0.69 Allowed 'General case' 0 C--O 1.247 0.925 0 CA-C-O 123.471 1.605 . . . . 0.0 112.22 -155.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 49.58 58.38 5.48 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.384 1.074 . . . . 0.0 112.179 -175.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.7 m -143.84 166.66 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 121.503 1.956 . . . . 0.0 106.189 -173.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 96.3 p -85.55 160.72 19.59 Favored 'General case' 0 C--O 1.241 0.63 0 O-C-N 116.938 -3.601 . . . . 0.0 108.254 168.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . 0.26 5.2 mt-10 -65.93 -28.97 69.32 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 111.41 -2.632 . . . . 0.0 111.775 173.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -61.28 -36.43 80.03 Favored 'General case' 0 CA--C 1.514 -0.434 0 O-C-N 117.947 -2.97 . . . . 0.0 117.428 166.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.4 mm -59.74 -37.03 69.3 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.449 0 CA-C-N 119.35 0.977 . . . . 0.0 108.867 168.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.346 40.0 t -59.57 -44.29 92.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 O-C-N 119.403 -2.06 . . . . 0.0 110.55 -178.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.1 mttt -58.93 -37.33 76.45 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 127.904 2.482 . . . . 0.0 112.03 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -75.53 -21.56 57.85 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 130.808 3.643 . . . . 0.0 112.668 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.9 m-30 -82.35 -47.68 12.05 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 101.685 -3.45 . . . . 0.0 101.685 167.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -54.38 -25.89 27.01 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 126.668 1.987 . . . . 0.0 108.78 -166.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.9 p -105.21 -14.8 15.25 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 128.674 3.734 . . . . 0.0 114.184 -174.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.32 18.13 79.8 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 114.267 -3.519 . . . . 0.0 117.501 -167.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -74.6 -19.17 60.41 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 114.624 -2.608 . . . . 0.0 113.597 175.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . 0.31 43.1 tp -147.41 148.71 31.58 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 129.556 3.142 . . . . 0.0 112.593 177.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -106.6 147.08 34.33 Favored Pre-proline 0 N--CA 1.449 -0.522 0 N-CA-C 120.681 3.585 . . . . 0.0 120.681 168.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -60.08 153.88 55.21 Favored 'Trans proline' 0 N--CA 1.449 -1.104 1 C-N-CA 126.654 4.902 . . . . 0.0 114.306 176.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 58.6 p -98.91 -173.68 2.58 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 111.605 -2.543 . . . . 0.0 112.93 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.0 tt -50.57 -71.83 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 C-N-CA 130.3 3.44 . . . . 0.0 115.844 174.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.2 p -56.04 -22.85 29.74 Favored 'General case' 0 C--N 1.328 -0.368 1 O-C-N 116.126 -4.109 . . . . 0.0 111.06 172.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -83.14 -53.94 5.41 Favored 'General case' 0 N--CA 1.449 -0.493 1 CA-C-O 110.307 -4.664 . . . . 0.0 107.642 -172.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -44.77 -50.84 9.92 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 128.189 3.431 . . . . 0.0 111.138 167.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.32 -55.02 32.57 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.141 1.776 . . . . 0.0 113.82 169.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -68.39 -31.05 70.14 Favored 'General case' 0 N--CA 1.446 -0.654 1 O-C-N 115.775 -4.328 . . . . 0.0 114.478 -177.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 35.9 mt -56.33 -68.02 0.25 Allowed 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 131.042 3.737 . . . . 0.0 106.648 165.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -43.75 -29.58 0.54 Allowed 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 130.23 3.412 . . . . 0.0 110.268 176.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -74.88 -24.8 58.61 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 115.774 -2.06 . . . . 0.0 113.842 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.5 mt -80.44 -45.12 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 121.492 1.951 . . . . 0.0 107.937 162.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.538 ' C ' ' H ' ' A' ' 76' ' ' ILE . 89.3 mt -76.71 -44.1 34.79 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 123.268 1.508 . . . . 0.0 109.363 -153.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.63 -4.78 0.94 Allowed Glycine 0 C--N 1.338 0.653 0 O-C-N 120.101 -1.625 . . . . 0.0 111.891 -172.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.538 ' H ' ' C ' ' A' ' 74' ' ' LEU . 5.7 pt -102.41 170.97 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 C-N-CA 124.845 1.258 . . . . 0.0 109.119 170.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -163.96 174.61 11.22 Favored 'General case' 0 C--O 1.22 -0.46 0 O-C-N 127.661 3.1 . . . . 0.0 107.252 169.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 17.0 mt -134.31 156.85 47.73 Favored 'General case' 0 N--CA 1.445 -0.708 0 O-C-N 119.363 -2.086 . . . . 0.0 109.178 175.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 17.5 m -98.63 167.53 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 2 O-C-N 111.998 -6.688 . . . . 0.0 115.625 10.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 28.4 p -78.08 161.93 68.97 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 125.527 3.785 . . . . 0.0 105.907 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . 0.268 26.8 Cg_exo -46.23 -2.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.969 1 C-N-CA 126.435 4.757 . . . . 0.0 116.942 173.831 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 17.9 tp -84.51 -20.14 32.11 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 122.645 2.475 . . . . 0.0 113.914 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -119.19 6.88 11.23 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 126.617 3.103 . . . . 0.0 110.316 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . 0.442 0.2 OUTLIER -141.6 64.52 1.4 Allowed 'General case' 0 C--O 1.22 -0.466 1 O-C-N 115.935 -4.228 . . . . 0.0 115.734 172.118 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.55 -9.79 59.01 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 118.841 2.904 . . . . 0.0 118.841 -164.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -52.25 167.5 0.13 Allowed 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 118.42 2.748 . . . . 0.0 118.42 -169.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -71.39 108.74 4.98 Favored 'General case' 0 CA--C 1.515 -0.376 0 O-C-N 121.244 -0.91 . . . . 0.0 110.254 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.2 m -116.69 44.77 1.96 Allowed 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 127.757 3.646 . . . . 0.0 113.718 -172.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -51.86 142.23 15.76 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 118.707 -2.496 . . . . 0.0 113.673 164.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . 0.312 57.2 mtpt -68.2 139.61 56.06 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 130.619 3.567 . . . . 0.0 114.959 177.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -101.84 142.43 33.16 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 129.117 2.967 . . . . 0.0 106.241 -176.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -152.17 147.61 26.63 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 125.749 2.69 . . . . 0.0 114.66 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -81.95 -27.55 33.21 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.634 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -121.01 -65.6 1.13 Allowed 'General case' 0 C--O 1.239 0.53 0 CA-C-N 124.312 3.233 . . . . 0.0 115.165 177.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.9 p -152.66 158.32 42.22 Favored 'General case' 0 N--CA 1.446 -0.657 1 C-N-CA 133.161 4.584 . . . . 0.0 110.225 -176.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.05 127.96 45.16 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 130.161 3.743 . . . . 0.0 112.931 177.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.0 mt -90.94 146.0 24.26 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 126.854 3.216 . . . . 0.0 113.07 -158.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.9 m -136.25 142.76 44.02 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 118.748 -2.47 . . . . 0.0 113.159 -169.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.0 tp -67.06 136.62 55.5 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 131.113 3.765 . . . . 0.0 113.632 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.48 -23.47 4.09 Favored Glycine 0 N--CA 1.447 -0.601 1 CA-C-O 113.16 -4.133 . . . . 0.0 115.391 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.652 40.4 m-20 -71.89 24.82 0.05 OUTLIER 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 130.843 3.657 . . . . 0.0 116.199 -167.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -131.84 157.56 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 2 C-N-CA 133.887 4.875 . . . . 0.0 122.114 -162.732 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 85.0 t -72.72 126.67 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 2 O-C-N 111.059 -7.276 . . . . 0.0 113.776 1.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -79.29 137.63 37.43 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 116.566 -1.683 . . . . 0.0 109.8 -172.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.503 HG12 ' H ' ' A' ' 108' ' ' GLY . 0.1 OUTLIER -135.72 -178.87 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 C-N-CA 131.126 3.77 . . . . 0.0 105.352 175.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -74.96 -40.23 60.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -174.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -79.38 -27.67 41.88 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 108.942 -3.754 . . . . 0.0 113.69 171.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.503 ' H ' HG12 ' A' ' 105' ' ' ILE . . . -147.93 161.97 28.66 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 120.65 3.02 . . . . 0.0 120.65 -155.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -83.97 -11.43 56.84 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 119.688 3.218 . . . . 0.0 119.688 174.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -171.62 149.31 2.59 Favored 'General case' 0 N--CA 1.437 -1.124 0 O-C-N 126.175 2.172 . . . . 0.0 110.722 -155.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.3 mt -82.22 153.5 25.91 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 119.829 -1.794 . . . . 0.0 110.1 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -167.26 -103.96 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 130.617 3.567 . . . . 0.0 105.161 -160.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -62.82 -18.66 63.13 Favored 'General case' 0 C--N 1.331 -0.239 1 O-C-N 114.658 -5.026 . . . . 0.0 113.926 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 27.5 m80 . . . . . 0 C--O 1.252 1.203 2 C-N-CA 134.445 5.098 . . . . 0.0 115.865 -174.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -173.17 37.04 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 127.358 2.263 . . . . 0.0 114.803 177.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.31 2.8 0.53 Allowed 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 127.949 2.5 . . . . 0.0 112.583 -166.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -84.46 4.02 33.6 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 130.873 3.669 . . . . 0.0 116.353 -175.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 86.0 mt -70.45 -9.67 57.1 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 119.381 -2.074 . . . . 0.0 115.858 175.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -130.2 16.49 5.58 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 127.443 2.964 . . . . 0.0 118.24 -162.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . 0.292 15.2 pt -105.44 165.15 3.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 124.827 2.251 . . . . 0.0 113.383 -176.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.7 m -61.56 158.49 2.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 1 O-C-N 115.721 -4.362 . . . . 0.0 112.444 168.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.4 m -41.19 -65.06 0.47 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 129.44 3.096 . . . . 0.0 116.287 167.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -83.48 21.96 1.12 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.248 1.819 . . . . 0.0 112.719 -164.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -60.53 142.12 55.72 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 118.024 -2.923 . . . . 0.0 109.438 -169.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . 0.373 1.9 p90 -60.39 78.45 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 1 C-N-CA 132.684 4.394 . . . . 0.0 116.221 170.057 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.411 ' HA ' ' HB3' ' A' ' 28' ' ' LYS . 89.4 mttt -90.59 -18.04 25.89 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 116.284 -1.817 . . . . 0.0 113.559 176.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -34.18 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 2 CA-C-N 129.096 5.407 . . . . 0.0 109.858 168.282 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.283 89.2 mt -65.04 -53.86 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 C-N-CA 129.338 3.055 . . . . 0.0 109.933 170.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 25' ' ' LYS . 38.6 tttm -53.92 -46.66 71.54 Favored 'General case' 0 CA--C 1.509 -0.597 0 O-C-N 117.062 -3.524 . . . . 0.0 116.646 -173.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.8 p -56.73 -40.25 75.38 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.925 1.69 . . . . 0.0 111.615 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.96 -50.44 28.9 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 127.704 2.402 . . . . 0.0 113.804 173.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -58.66 -22.79 57.82 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 116.062 -1.923 . . . . 0.0 108.258 177.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -71.48 -48.95 45.88 Favored 'General case' 0 N--CA 1.446 -0.66 2 CA-C-N 128.574 5.17 . . . . 0.0 108.364 173.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -62.51 -47.01 85.82 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 124.691 2.186 . . . . 0.0 106.181 -169.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.317 39.5 mt -75.45 -10.81 59.78 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 115.645 1.721 . . . . 0.0 115.645 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.11 -4.25 0.08 OUTLIER Glycine 0 C--O 1.218 -0.884 0 N-CA-C 119.849 2.7 . . . . 0.0 119.849 177.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.4 pt -50.67 129.47 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 119.936 3.309 . . . . 0.0 119.936 -175.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 94.0 p -69.81 177.05 3.25 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.929 1.291 . . . . 0.0 112.27 177.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -57.35 -43.64 83.62 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 118.346 -1.341 . . . . 0.0 114.428 164.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -61.34 -39.7 91.53 Favored 'General case' 0 N--CA 1.451 -0.401 1 O-C-N 115.993 -4.192 . . . . 0.0 111.866 -177.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -73.68 -32.71 64.09 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.4 tp -61.31 -43.15 99.35 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.125 0.97 . . . . 0.0 113.253 161.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.71 -39.66 71.36 Favored 'General case' 0 N--CA 1.442 -0.826 0 O-C-N 119.842 -1.787 . . . . 0.0 111.512 171.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -66.04 -32.44 73.92 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 117.885 2.55 . . . . 0.0 117.885 170.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 19.4 tptt -64.82 -14.22 58.48 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 127.675 2.39 . . . . 0.0 107.699 179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.8 tp -133.09 -4.62 3.09 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 116.394 -3.941 . . . . 0.0 114.546 -156.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt 62.52 27.63 16.34 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 131.057 3.743 . . . . 0.0 114.423 178.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.82 178.17 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 C-N-CA 129.857 3.263 . . . . 0.0 111.443 -163.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.2 p -88.2 162.5 16.64 Favored 'General case' 0 N--CA 1.443 -0.803 0 O-C-N 118.508 -2.62 . . . . 0.0 115.441 176.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -63.19 -16.38 59.94 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 119.631 -1.918 . . . . 0.0 113.704 167.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -71.95 -22.45 61.46 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 171.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . 0.283 39.0 mt -72.87 -36.26 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 C-N-CA 130.7 3.6 . . . . 0.0 116.446 164.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.317 1.5 m -80.81 -49.84 17.82 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 CA-C-O 117.157 -1.401 . . . . 0.0 111.917 -176.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -37.59 -27.99 0.02 OUTLIER 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 130.2 3.4 . . . . 0.0 118.922 166.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -40.04 -55.72 2.01 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.525 1.13 . . . . 0.0 109.207 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -100.04 -32.08 11.12 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 117.894 -3.004 . . . . 0.0 112.887 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -47.9 -27.64 2.25 Favored 'General case' 0 N--CA 1.447 -0.577 1 N-CA-C 123.282 4.549 . . . . 0.0 123.282 168.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.2 m -77.69 -6.39 53.74 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.238 1.415 . . . . 0.0 113.379 -171.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.49 6.91 84.98 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 119.867 -1.158 . . . . 0.0 113.785 151.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -76.08 6.4 5.37 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 120.607 -1.525 . . . . 0.0 113.893 -174.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.402 ' CD2' HE22 ' A' ' 66' ' ' GLN . 1.2 tp -143.18 163.68 32.25 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 -164.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -98.27 126.13 40.92 Favored Pre-proline 0 N--CA 1.443 -0.813 0 O-C-N 124.36 1.037 . . . . 0.0 110.645 165.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.25 174.01 13.54 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 CA-C-N 120.924 1.366 . . . . 0.0 112.319 -174.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.8 p -135.97 -174.7 3.74 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 125.215 1.406 . . . . 0.0 113.207 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.6 -51.91 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 127.226 2.21 . . . . 0.0 112.437 177.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.2 p -62.9 -31.51 72.59 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 173.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.402 HE22 ' CD2' ' A' ' 60' ' ' LEU . 76.3 mt-30 -66.3 -63.78 1.0 Allowed 'General case' 0 C--N 1.349 0.585 0 O-C-N 116.734 -3.729 . . . . 0.0 104.539 172.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -37.3 -41.41 0.41 Allowed 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 172.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.8 ttt85 -65.03 -53.88 39.0 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 125.859 1.974 . . . . 0.0 114.977 176.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -69.5 -40.28 77.11 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 126.87 2.606 . . . . 0.0 108.175 -172.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 13.2 mt -56.25 -63.08 1.3 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 131.45 3.9 . . . . 0.0 113.697 -177.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -46.6 -30.15 2.16 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 126.896 2.622 . . . . 0.0 111.519 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -75.24 -58.29 3.37 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 118.36 -0.829 . . . . 0.0 111.985 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.7 pt -65.13 -44.8 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 119.562 1.074 . . . . 0.0 113.164 -168.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 77.9 mt -76.65 -3.55 38.43 Favored 'General case' 0 N--CA 1.452 -0.354 1 O-C-N 115.332 -4.605 . . . . 0.0 115.384 -152.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.22 8.44 8.85 Favored Glycine 0 C--O 1.223 -0.577 0 CA-C-O 116.951 -2.027 . . . . 0.0 115.481 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.0 pt -136.56 155.49 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 122.538 3.169 . . . . 0.0 108.882 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.371 23.5 pttm 163.48 142.06 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 130.637 3.575 . . . . 0.0 116.336 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 19.8 mt -145.24 141.95 29.08 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 122.704 2.502 . . . . 0.0 110.213 -171.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 26.9 m -92.68 170.12 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 1 O-C-N 113.739 -5.601 . . . . 0.0 107.674 10.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 78.4 p -84.94 161.79 51.76 Favored Pre-proline 0 N--CA 1.451 -0.409 0 CA-C-N 111.27 -2.696 . . . . 0.0 114.497 -165.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.31 -1.87 5.18 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 124.793 3.662 . . . . 0.0 113.843 -172.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . 0.27 26.4 tp -91.72 -28.42 17.44 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 119.783 -1.823 . . . . 0.0 113.846 166.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -86.2 -10.59 54.41 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 117.923 2.564 . . . . 0.0 117.923 174.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -144.7 150.05 36.65 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.356 1.862 . . . . 0.0 109.451 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -79.92 105.63 11.35 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 100.784 -3.784 . . . . 0.0 100.784 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -82.94 138.45 33.82 Favored 'General case' 0 N--CA 1.45 -0.475 0 O-C-N 118.948 -2.345 . . . . 0.0 110.409 -176.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.644 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 7.4 tp10 -90.51 112.64 24.37 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-O 124.016 1.865 . . . . 0.0 110.887 -159.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 85.1 p -83.82 -7.33 59.48 Favored 'General case' 0 C--O 1.221 -0.407 0 O-C-N 117.579 -3.2 . . . . 0.0 109.187 -161.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -66.43 -0.49 2.73 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 113.112 -3.328 . . . . 0.0 114.38 159.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.644 ' HE3' ' HB3' ' A' ' 87' ' ' GLU . 98.8 mttt -80.22 -23.57 40.82 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 126.79 2.557 . . . . 0.0 111.587 172.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -59.59 -22.27 61.55 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 120.997 3.703 . . . . 0.0 120.997 -164.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -98.56 158.0 15.88 Favored 'General case' 0 C--O 1.224 -0.267 1 O-C-N 113.118 -5.989 . . . . 0.0 109.634 178.214 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -44.01 -90.92 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 114.735 -2.555 . . . . 0.0 115.661 -174.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -85.79 -22.02 27.87 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 127.702 3.126 . . . . 0.0 115.135 -160.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.2 t -173.36 -176.96 1.41 Allowed 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 130.726 3.61 . . . . 0.0 109.057 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -88.66 136.36 13.63 Favored Glycine 0 C--O 1.223 -0.553 0 CA-C-O 118.178 -1.346 . . . . 0.0 113.686 176.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.6 mp -80.4 129.74 34.71 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 126.531 1.932 . . . . 0.0 112.803 -173.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.6 p -125.01 176.62 6.54 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 127.658 2.383 . . . . 0.0 113.502 172.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.459 ' C ' ' H ' ' A' ' 101' ' ' ASP . 34.6 tp -60.02 -82.43 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 118.369 -1.332 . . . . 0.0 113.958 169.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 65.75 -13.02 0.33 Allowed Glycine 0 C--O 1.216 -1.022 0 CA-C-O 114.203 -3.554 . . . . 0.0 115.971 -172.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.459 ' H ' ' C ' ' A' ' 99' ' ' LEU 0.467 0.4 OUTLIER -80.82 29.83 0.32 Allowed 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 128.408 3.063 . . . . 0.0 115.685 -166.812 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.5 m -132.41 151.98 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 125.14 1.376 . . . . 0.0 113.126 -159.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.0 p -63.15 142.1 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 2 O-C-N 110.86 -7.4 . . . . 0.0 107.992 17.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -73.13 34.4 0.07 Allowed 'General case' 0 C--O 1.216 -0.661 0 O-C-N 118.994 -2.316 . . . . 0.0 117.196 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 6.6 pt -133.56 160.63 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 O-C-N 118.286 -2.759 . . . . 0.0 106.386 169.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -98.19 -32.51 11.54 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 115.241 -2.314 . . . . 0.0 110.989 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -62.52 -35.1 78.33 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 128.215 3.447 . . . . 0.0 113.115 169.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -83.79 20.34 12.55 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 115.727 1.051 . . . . 0.0 115.727 172.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . 0.361 26.9 ttmt -151.93 7.53 0.47 Allowed 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.008 1.723 . . . . 0.0 113.961 -164.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -69.68 -43.81 71.74 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 131.29 3.836 . . . . 0.0 111.643 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.8 mp -97.55 178.76 5.08 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.212 148.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -147.62 -53.63 0.21 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.829 1.33 . . . . 0.0 113.996 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -148.54 30.81 0.82 Allowed 'General case' 0 C--O 1.238 0.477 0 CA-C-O 118.496 -0.764 . . . . 0.0 109.219 -164.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 63.1 m80 . . . . . 0 N--CA 1.439 -0.987 0 O-C-N 125.414 1.696 . . . . 0.0 109.965 -169.726 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.281 28.5 mt-10 . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 174.75 129.96 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 129.589 3.156 . . . . 0.0 115.416 143.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.9 -12.78 57.1 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 -156.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -94.68 -11.23 29.6 Favored 'General case' 0 N--CA 1.44 -0.958 0 O-C-N 117.972 -2.955 . . . . 0.0 114.615 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.8 mt -92.14 -3.19 56.0 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 114.131 -2.842 . . . . 0.0 106.233 169.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -109.46 3.56 21.48 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 123.82 3.009 . . . . 0.0 107.868 -162.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.467 HD13 ' HE2' ' A' ' 25' ' ' LYS . 45.3 pt -134.83 178.09 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 C-N-CA 128.792 2.837 . . . . 0.0 114.521 -173.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.2 m -77.61 173.55 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 O-C-N 118.718 -2.489 . . . . 0.0 113.534 152.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 m -59.94 -59.91 4.67 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 129.348 3.059 . . . . 0.0 107.236 173.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -73.33 -22.88 60.22 Favored 'General case' 0 N--CA 1.441 -0.919 0 O-C-N 120.027 -1.671 . . . . 0.0 115.356 -158.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.309 55.3 t80 -55.18 155.9 4.51 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -175.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -74.23 77.45 1.81 Allowed 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 117.001 2.222 . . . . 0.0 117.001 -176.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.467 ' HE2' HD13 ' A' ' 19' ' ' ILE . 85.1 mttt -57.79 -32.52 67.61 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 129.913 3.285 . . . . 0.0 111.613 -171.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.2 pt -67.43 -37.79 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 120.191 -0.603 . . . . 0.0 109.53 -176.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.29 26.7 mm -59.17 -43.38 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 125.288 2.47 . . . . 0.0 112.651 -175.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.445 ' HZ3' ' CD ' ' A' ' 32' ' ' GLU 0.46 34.2 tttm -43.45 -75.42 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 131.072 3.749 . . . . 0.0 114.9 -156.346 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.3 m -53.96 -43.63 70.07 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 129.147 2.979 . . . . 0.0 112.729 -168.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.7 -48.26 75.32 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 118.936 2.939 . . . . 0.0 118.936 177.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -60.35 -37.38 80.5 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.183 0.993 . . . . 0.0 110.823 170.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.445 ' CD ' ' HZ3' ' A' ' 28' ' ' LYS . 21.6 mt-10 -69.32 -33.06 72.58 Favored 'General case' 0 N--CA 1.438 -1.042 1 O-C-N 115.531 -4.48 . . . . 0.0 113.623 178.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . 0.29 76.7 mt-30 -60.09 -26.51 66.25 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 124.534 1.146 . . . . 0.0 109.297 172.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.3 mt -78.28 -23.4 47.22 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 127.363 2.265 . . . . 0.0 113.527 -177.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.83 0.67 9.18 Favored Glycine 0 C--N 1.341 0.823 0 N-CA-C 118.052 1.981 . . . . 0.0 118.052 -174.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.2 pt -69.61 151.02 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 2 N-CA-C 123.935 4.791 . . . . 0.0 123.935 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 56.9 p -108.3 174.33 5.93 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 123.823 1.773 . . . . 0.0 114.862 -165.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -56.99 -26.44 60.17 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -55.75 -37.04 67.97 Favored 'General case' 0 C--O 1.222 -0.358 0 O-C-N 120.579 -1.326 . . . . 0.0 110.647 176.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -64.81 -40.47 95.27 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 116.879 -3.638 . . . . 0.0 113.211 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . 0.347 24.1 tp -61.74 -43.23 99.25 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 130.292 3.437 . . . . 0.0 111.026 173.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . 0.25 . . -60.91 -43.95 97.85 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 112.923 -1.944 . . . . 0.0 112.339 178.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -67.72 -34.92 77.81 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 112.421 -3.657 . . . . 0.0 111.84 167.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.6 tptt -67.18 -24.05 65.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 125.54 3.791 . . . . 0.0 115.83 -174.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.8 tp -125.17 3.93 7.87 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 128.473 2.709 . . . . 0.0 108.852 -160.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.252 79.9 mttt 44.99 66.79 0.82 Allowed 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 129.803 3.241 . . . . 0.0 111.845 -174.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.5 m -148.11 170.12 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 C-N-CA 130.674 3.59 . . . . 0.0 113.389 174.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.3 p -94.03 159.08 15.32 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 -169.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -67.62 -16.02 63.95 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 118.174 -2.829 . . . . 0.0 115.158 175.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -49.41 -47.17 48.14 Favored 'General case' 0 C--O 1.248 0.982 0 CA-C-N 121.956 2.162 . . . . 0.0 114.152 156.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 27.8 mt -77.07 -27.39 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 O-C-N 121.744 -0.598 . . . . 0.0 111.96 -175.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.5 m -79.45 -47.71 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-O 118.484 -0.77 . . . . 0.0 110.456 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -53.71 -28.11 32.03 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 121.575 1.989 . . . . 0.0 112.986 -165.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -44.38 -57.45 3.52 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 118.563 2.801 . . . . 0.0 118.563 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -95.91 -26.72 15.49 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 119.6 1.091 . . . . 0.0 110.729 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -51.19 -27.63 9.28 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 121.348 -0.845 . . . . 0.0 109.729 172.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.2 p -98.45 0.63 45.6 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 116.984 2.216 . . . . 0.0 116.984 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.76 6.84 89.14 Favored Glycine 0 CA--C 1.525 0.707 0 O-C-N 118.374 -2.704 . . . . 0.0 115.872 -172.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -96.44 -2.62 45.03 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 119.553 1.677 . . . . 0.0 114.164 -168.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 36.9 tp -145.46 130.26 18.14 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 126.592 1.957 . . . . 0.0 106.769 -174.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.6 tttt -81.71 126.88 74.58 Favored Pre-proline 0 C--O 1.221 -0.447 0 CA-C-O 114.935 -2.459 . . . . 0.0 110.726 165.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -82.64 178.05 6.43 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 124.51 3.474 . . . . 0.0 106.389 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.468 ' H ' ' HB3' ' A' ' 66' ' ' GLN . 42.6 p -96.46 167.69 11.0 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -159.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . 0.314 1.9 tt -51.27 -49.45 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 171.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.28 99.3 p -54.92 -55.33 31.82 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 120.621 1.555 . . . . 0.0 112.433 162.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.468 ' HB3' ' H ' ' A' ' 63' ' ' THR . 48.6 tt0 -71.1 -35.2 71.71 Favored 'General case' 0 CA--C 1.515 -0.371 1 CA-C-O 111.503 -4.094 . . . . 0.0 112.796 -163.533 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.77 -43.37 98.98 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 125.288 3.677 . . . . 0.0 109.112 169.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -62.17 -42.42 99.25 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 117.468 -3.27 . . . . 0.0 106.16 174.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -72.68 -30.44 64.25 Favored 'General case' 0 C--O 1.222 -0.385 1 O-C-N 116.01 -4.181 . . . . 0.0 115.34 176.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.1 mt -54.27 -76.3 0.03 OUTLIER 'General case' 0 C--O 1.243 0.719 0 C-N-CA 130.238 3.415 . . . . 0.0 109.727 -169.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -48.08 -26.75 1.97 Allowed 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 129.035 2.934 . . . . 0.0 108.944 -177.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -88.15 -40.36 13.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 113.822 -2.99 . . . . 0.0 111.424 -166.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 12.8 pt -68.83 -40.36 81.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 128.583 3.677 . . . . 0.0 109.015 173.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 74.1 mt -68.76 -26.0 65.01 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 120.323 -1.486 . . . . 0.0 110.661 -173.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.18 -18.76 0.06 OUTLIER Glycine 0 CA--C 1.528 0.863 0 CA-C-O 114.535 -3.369 . . . . 0.0 112.735 -172.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.1 pt -115.26 164.86 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 120.08 1.94 . . . . 0.0 113.328 -165.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.3 pttm -176.01 170.14 2.77 Favored 'General case' 0 CA--C 1.519 -0.226 1 C-N-CA 133.431 4.692 . . . . 0.0 111.093 177.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 57.4 mt -136.64 139.95 42.43 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 128.636 2.775 . . . . 0.0 110.615 154.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 18.5 m -97.8 175.25 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 O-C-N 116.836 -3.665 . . . . 0.0 112.517 38.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.0 p -80.6 160.47 67.02 Favored Pre-proline 0 N--CA 1.441 -0.897 0 O-C-N 120.769 -1.207 . . . . 0.0 110.261 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.67 -7.5 2.25 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 N-CA-C 119.903 3.001 . . . . 0.0 119.903 162.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 75.5 mt -99.57 -6.89 26.64 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-O 115.265 -2.302 . . . . 0.0 109.614 173.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -108.3 -11.6 15.19 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 117.022 2.23 . . . . 0.0 117.022 155.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -143.77 177.57 8.42 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 120.33 1.423 . . . . 0.0 108.778 -174.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -60.65 161.43 7.79 Favored 'General case' 0 N--CA 1.449 -0.522 1 O-C-N 114.814 -4.929 . . . . 0.0 113.98 172.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -152.34 153.35 33.5 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 129.755 3.222 . . . . 0.0 111.435 165.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -122.99 139.15 54.38 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 131.154 3.782 . . . . 0.0 109.333 -157.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.8 p -85.32 -30.86 23.38 Favored 'General case' 0 N--CA 1.439 -1.013 0 O-C-N 120.461 -1.4 . . . . 0.0 112.479 175.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -79.27 92.17 5.1 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 128.163 2.585 . . . . 0.0 114.176 -175.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -144.06 0.47 1.06 Allowed 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 130.137 3.375 . . . . 0.0 112.896 -165.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -72.9 -42.05 63.98 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 114.012 -2.899 . . . . 0.0 112.598 173.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -56.56 137.29 53.81 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 127.472 2.982 . . . . 0.0 108.646 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . 0.275 14.7 t0 -82.55 -37.23 25.44 Favored 'General case' 0 C--O 1.241 0.611 0 O-C-N 120.28 -1.513 . . . . 0.0 111.546 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -131.39 -37.16 1.24 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 115.813 -2.041 . . . . 0.0 112.444 -169.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.8 t -170.31 159.6 7.28 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 127.565 2.346 . . . . 0.0 109.242 -157.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -75.64 130.7 11.33 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 128.547 2.975 . . . . 0.0 107.379 -174.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.6 mt -136.91 140.77 42.54 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 122.663 3.231 . . . . 0.0 110.42 -174.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.3 m -137.52 129.23 28.57 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 129.977 3.311 . . . . 0.0 111.015 -176.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.7 tp -157.56 -52.5 0.07 Allowed 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 116.743 2.127 . . . . 0.0 116.743 -174.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 76.69 -4.1 52.96 Favored Glycine 0 C--O 1.218 -0.855 0 C-N-CA 127.766 2.603 . . . . 0.0 110.411 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -95.45 57.52 1.95 Allowed 'General case' 0 C--N 1.344 0.36 0 CA-C-N 122.235 3.017 . . . . 0.0 112.815 -162.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.44 159.94 28.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 1 O-C-N 129.248 4.092 . . . . 0.0 114.806 -155.453 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.1 p -60.47 152.27 5.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 2 CA-C-N 131.034 6.288 . . . . 0.0 112.707 5.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -149.39 106.28 3.57 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 101.599 -3.482 . . . . 0.0 101.599 177.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 32.9 pt -89.12 -178.18 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 123.083 1.42 . . . . 0.0 111.1 176.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 40.6 tttm -73.93 -27.48 61.05 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -168.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -83.74 -27.63 28.79 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 128.183 2.593 . . . . 0.0 114.957 172.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 173.08 -174.57 45.94 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 116.323 -3.986 . . . . 0.0 118.23 -173.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -94.98 20.03 9.52 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 124.777 2.227 . . . . 0.0 109.695 -161.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -171.75 159.19 5.2 Favored 'General case' 0 C--N 1.347 0.457 0 C-N-CA 129.53 3.132 . . . . 0.0 115.393 174.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.4 mp -67.09 139.09 57.54 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 129.924 3.29 . . . . 0.0 111.861 154.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.303 13.1 mt-10 -139.86 -92.34 0.17 Allowed 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 127.973 2.509 . . . . 0.0 114.033 -165.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 16.0 p-80 -87.78 6.58 34.47 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 123.818 1.771 . . . . 0.0 115.565 171.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 37.1 m80 . . . . . 0 C--O 1.251 1.138 0 CA-C-N 111.812 -2.449 . . . . 0.0 114.864 173.072 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 . . . . . 0 N--CA 1.474 0.732 0 CA-C-O 117.06 -1.448 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -83.07 151.67 25.68 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 124.595 3.362 . . . . 0.0 112.482 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -112.82 4.76 17.14 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 119.457 3.132 . . . . 0.0 119.457 -174.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -82.39 0.73 40.61 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 119.902 3.297 . . . . 0.0 119.902 -176.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.6 mt -75.86 -31.16 59.15 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 131.68 3.992 . . . . 0.0 110.9 -172.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -128.98 9.33 5.76 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 116.979 2.215 . . . . 0.0 116.979 -146.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.0 pt -107.68 167.19 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 130.236 3.415 . . . . 0.0 111.304 -169.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.2 m -77.88 172.25 1.16 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 O-C-N 118.412 -2.68 . . . . 0.0 111.22 159.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . 0.261 85.4 m -42.97 -83.77 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.945 1 C-N-CA 133.642 4.777 . . . . 0.0 109.446 168.243 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . 0.261 25.0 t70 -91.92 43.89 1.15 Allowed 'General case' 0 C--O 1.239 0.533 0 C-N-CA 128.047 2.539 . . . . 0.0 116.314 -166.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -73.7 137.05 43.82 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 125.081 2.372 . . . . 0.0 104.641 -174.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -70.66 157.8 37.34 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 117.36 -3.337 . . . . 0.0 113.196 -166.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -140.89 14.18 2.28 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 127.149 2.179 . . . . 0.0 113.259 -146.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -35.7 -57.11 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.805 1 O-C-N 114.888 -4.882 . . . . 0.0 113.886 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.7 pt -119.14 4.2 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 113.457 -1.701 . . . . 0.0 110.719 -165.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -47.95 -64.13 0.88 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.066 1.746 . . . . 0.0 114.912 -175.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.5 p -53.95 -46.58 71.63 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.283 1.833 . . . . 0.0 115.888 -174.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.58 -44.26 65.8 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 109.776 -3.375 . . . . 0.0 114.645 176.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -48.41 -44.7 35.28 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 118.551 -2.593 . . . . 0.0 112.772 169.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -72.14 -47.5 50.58 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 120.384 -1.448 . . . . 0.0 114.532 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -66.75 -25.69 66.62 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 128.641 2.776 . . . . 0.0 111.325 -167.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.5 mt -88.1 -17.05 31.87 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 127.417 2.287 . . . . 0.0 110.315 -174.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.32 11.27 58.96 Favored Glycine 0 C--O 1.243 0.674 0 CA-C-O 123.309 1.505 . . . . 0.0 113.99 177.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.9 pt -75.54 144.76 11.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 129.094 2.958 . . . . 0.0 114.202 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.5 p -93.2 166.3 12.39 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -175.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -58.71 -35.86 73.33 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.191 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -70.11 -37.37 75.35 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 115.906 -1.997 . . . . 0.0 108.132 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -66.87 -29.98 70.02 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 115.568 -2.158 . . . . 0.0 112.661 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.7 tt -78.96 -36.52 41.44 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-O 126.315 2.959 . . . . 0.0 111.836 176.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.93 -40.5 66.8 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 119.447 -2.033 . . . . 0.0 112.224 167.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -70.6 -37.07 73.85 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 118.845 -2.409 . . . . 0.0 111.007 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -66.39 -14.3 61.92 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 129.554 3.141 . . . . 0.0 110.438 -172.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.3 mt -131.01 -1.59 4.09 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 126.832 3.206 . . . . 0.0 112.781 -164.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.274 40.8 mtmt 56.39 -26.19 0.02 OUTLIER 'General case' 0 C--O 1.241 0.615 0 N-CA-C 121.094 3.739 . . . . 0.0 121.094 -162.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.9 m -83.61 172.21 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 C-N-CA 129.504 3.122 . . . . 0.0 111.378 -168.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 91.7 p -92.48 158.33 16.08 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 119.556 -1.965 . . . . 0.0 111.334 -153.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -61.56 -32.58 72.66 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 126.143 1.777 . . . . 0.0 108.031 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -65.3 -31.57 72.78 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 168.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.9 mt -67.98 -38.79 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 124.407 2.051 . . . . 0.0 112.555 172.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.297 32.6 m -80.07 -30.78 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 1 O-C-N 116.042 -4.161 . . . . 0.0 114.122 -176.777 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -53.13 -38.69 62.88 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 126.392 1.877 . . . . 0.0 109.806 155.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -71.93 -38.42 69.87 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 126.296 1.838 . . . . 0.0 106.046 -174.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -66.97 -41.46 86.82 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 121.59 1.995 . . . . 0.0 108.662 173.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.42 -14.96 62.76 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 114.464 -2.684 . . . . 0.0 111.562 -172.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.6 p -113.09 -1.68 14.36 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 123.495 2.861 . . . . 0.0 111.137 -175.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.06 28.47 73.57 Favored Glycine 0 C--N 1.343 0.922 0 O-C-N 128.665 3.728 . . . . 0.0 119.24 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -85.17 7.24 22.55 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 131.501 3.921 . . . . 0.0 113.216 -171.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.6 tt -137.17 144.2 42.8 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 127.402 2.281 . . . . 0.0 109.501 -166.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.1 tttt -83.04 126.6 72.06 Favored Pre-proline 0 C--O 1.24 0.587 0 CA-C-O 116.455 -1.736 . . . . 0.0 110.23 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -82.0 150.64 16.06 Favored 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 124.64 3.56 . . . . 0.0 112.504 -168.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.3 p -123.07 164.64 18.22 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 123.937 1.827 . . . . 0.0 113.669 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.0 pt -62.66 -50.27 80.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 O-C-N 118.715 -2.491 . . . . 0.0 113.443 174.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 99.3 p -54.67 -21.57 11.08 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 121.871 2.123 . . . . 0.0 116.649 170.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -75.33 -75.84 0.16 Allowed 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.911 177.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -12.52 -62.66 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 117.884 2.549 . . . . 0.0 117.884 150.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -56.83 -49.85 74.16 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 127.474 2.31 . . . . 0.0 107.741 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -62.49 -44.29 96.73 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 116.413 -1.756 . . . . 0.0 106.886 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 43.5 mt -63.43 -47.39 82.1 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 115.29 -2.29 . . . . 0.0 109.851 -167.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -50.98 -22.73 2.43 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 170.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.7 mttp -94.48 -52.34 4.37 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 -176.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 24.1 pt -44.24 -49.93 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 127.243 2.217 . . . . 0.0 115.471 -167.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.3 mt -77.67 -2.49 36.27 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 121.549 1.977 . . . . 0.0 109.89 -169.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.95 0.51 60.37 Favored Glycine 0 CA--C 1.522 0.478 0 O-C-N 125.535 1.772 . . . . 0.0 111.834 -169.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.6 pt -149.88 167.62 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 O-C-N 117.639 -3.271 . . . . 0.0 113.64 -178.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.77 163.78 1.17 Allowed 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 126.885 2.074 . . . . 0.0 109.471 -177.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.9 mt -150.76 146.54 26.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 121.132 1.787 . . . . 0.0 109.972 -174.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.5 159.26 16.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 O-C-N 116.971 -3.581 . . . . 0.0 119.231 26.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . 0.259 82.7 p -99.11 171.1 6.04 Favored Pre-proline 0 C--N 1.324 -0.535 0 C-N-CA 129.205 3.002 . . . . 0.0 113.221 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -59.48 11.86 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 124.28 3.32 . . . . 0.0 112.781 171.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 39.1 tp -59.92 -33.29 71.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 121.824 2.102 . . . . 0.0 109.878 150.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -146.88 5.74 0.88 Allowed 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 120.583 1.538 . . . . 0.0 113.382 171.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -176.64 139.66 0.32 Allowed 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 119.252 -2.155 . . . . 0.0 111.235 -166.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -134.25 174.24 10.73 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 125.629 2.633 . . . . 0.0 105.663 -177.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -166.12 150.86 8.14 Favored 'General case' 0 N--CA 1.445 -0.698 0 O-C-N 119.302 -2.124 . . . . 0.0 107.763 -168.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -49.7 129.73 20.04 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 120.234 -1.541 . . . . 0.0 111.802 168.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 26.1 m -76.97 -27.28 54.71 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.315 1.846 . . . . 0.0 108.601 -166.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -71.57 -5.48 33.69 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 118.545 -2.597 . . . . 0.0 113.886 175.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -70.95 -28.94 64.84 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 123.085 1.421 . . . . 0.0 111.593 174.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -58.19 -21.22 46.61 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 129.645 3.178 . . . . 0.0 118.29 -168.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.453 ' CD2' ' HA2' ' A' ' 96' ' ' GLY . 87.3 m-85 -74.7 -177.96 3.44 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 116.991 2.219 . . . . 0.0 116.991 177.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -81.1 -31.69 34.19 Favored 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 118.589 -2.569 . . . . 0.0 116.535 174.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -138.51 -38.69 0.53 Allowed 'General case' 0 C--O 1.236 0.381 0 CA-C-N 120.404 1.456 . . . . 0.0 113.539 167.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.2 p -152.27 153.5 33.86 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.707 2.003 . . . . 0.0 108.898 -166.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.453 ' HA2' ' CD2' ' A' ' 92' ' ' PHE . . . -72.52 161.51 54.39 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -178.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 59.0 tp -92.31 -32.33 15.05 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 116.156 1.91 . . . . 0.0 116.156 -163.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.2 m -119.29 141.1 49.27 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 127.69 2.396 . . . . 0.0 113.144 -168.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 14.3 tp -92.66 127.89 38.32 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 116.727 -1.606 . . . . 0.0 110.156 174.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.72 -15.75 62.89 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-O 118.254 -1.303 . . . . 0.0 112.303 -176.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.267 16.5 t0 -91.97 27.61 2.08 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 118.428 2.751 . . . . 0.0 118.428 -148.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . 0.317 0.0 OUTLIER -139.67 157.04 26.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 131.136 3.774 . . . . 0.0 114.781 -155.003 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 6.9 m -97.89 8.56 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 2 O-C-N 109.21 -8.431 . . . . 0.0 109.761 14.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -59.91 121.9 12.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 120.559 1.527 . . . . 0.0 112.635 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 69.1 mt -100.93 134.71 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 126.649 1.979 . . . . 0.0 110.649 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -103.36 -18.02 15.02 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.461 1.105 . . . . 0.0 108.142 -161.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -67.42 -8.75 35.55 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 126.433 1.893 . . . . 0.0 109.763 153.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.83 6.92 37.29 Favored Glycine 0 C--N 1.339 0.704 0 O-C-N 117.48 -3.263 . . . . 0.0 118.4 -162.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -126.07 24.3 6.96 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-O 116.167 -1.873 . . . . 0.0 111.523 168.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 44.1 tttt -70.92 77.45 0.64 Allowed 'General case' 0 C--O 1.235 0.331 0 C-N-CA 130.989 3.716 . . . . 0.0 114.571 174.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.8 pp -172.12 179.34 2.66 Favored 'General case' 0 N--CA 1.443 -0.796 1 C-N-CA 132.073 4.149 . . . . 0.0 107.531 -169.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.294 33.0 tt0 -146.74 -104.75 0.09 Allowed 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 -176.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -86.88 -7.07 58.55 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 116.806 2.15 . . . . 0.0 116.806 -169.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 12.6 m80 . . . . . 0 C--O 1.252 1.185 0 C-N-CA 130.154 3.382 . . . . 0.0 109.929 172.773 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.287 4.6 tp10 . . . . . 0 N--CA 1.468 0.472 0 CA-C-O 124.72 2.2 . . . . 0.0 112.358 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -87.67 148.32 24.84 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 112.896 -1.956 . . . . 0.0 108.953 -163.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.44 162.79 26.68 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.96 2.104 . . . . 0.0 113.015 -172.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -80.32 -3.16 48.36 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.571 -160.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 179.57 163.87 0.99 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 127.607 2.363 . . . . 0.0 113.227 -156.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -138.05 148.17 44.81 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-O 122.367 1.08 . . . . 0.0 110.664 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 40.3 pt -123.18 -15.82 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 114.68 -2.581 . . . . 0.0 114.054 -171.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 86.6 t -80.81 -47.12 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 C-N-CA 115.824 -2.35 . . . . 0.0 111.763 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.3 m -51.09 -45.52 61.49 Favored 'General case' 0 N--CA 1.448 -0.568 1 O-C-N 115.834 -4.291 . . . . 0.0 114.38 -156.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.402 ' HA ' ' CE2' ' A' ' 24' ' ' TYR 0.403 71.3 m-20 63.76 -21.62 0.06 Allowed 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 129.366 3.067 . . . . 0.0 116.496 -163.686 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -89.32 75.24 7.75 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 116.675 -1.631 . . . . 0.0 107.0 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.402 ' CE2' ' HA ' ' A' ' 22' ' ' ASP . 9.9 m-85 -100.02 -173.31 2.41 Favored 'General case' 0 CA--C 1.518 -0.255 0 O-C-N 128.457 3.598 . . . . 0.0 118.054 176.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -59.18 -24.04 62.74 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 119.199 3.037 . . . . 0.0 119.199 -175.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.9 pt -30.42 -35.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 119.908 3.299 . . . . 0.0 119.908 145.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.1 tp -137.31 -42.94 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 121.693 2.042 . . . . 0.0 114.495 177.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.361 79.5 tttt -40.99 -58.51 1.7 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 131.07 3.748 . . . . 0.0 118.313 173.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 74.9 p -83.48 -29.7 27.78 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 113.433 -1.712 . . . . 0.0 109.087 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.12 -51.23 62.49 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.937 1.295 . . . . 0.0 110.516 -160.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -46.51 -38.07 8.79 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 126.901 2.626 . . . . 0.0 112.879 174.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -73.87 -41.34 62.33 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 129.512 3.125 . . . . 0.0 113.462 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . 0.29 43.5 mt-30 -68.66 -16.31 63.79 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.0 tp -95.99 -14.51 22.96 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 112.453 -2.158 . . . . 0.0 112.157 175.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.64 -0.63 34.13 Favored Glycine 0 CA--C 1.523 0.564 1 C-N-CA 131.037 4.16 . . . . 0.0 117.309 172.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.6 pt -69.03 155.97 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 C-N-CA 126.233 1.813 . . . . 0.0 113.78 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 93.7 p -90.63 171.84 9.09 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -176.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -59.25 -42.97 92.37 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -64.9 -41.12 95.86 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 119.242 -2.161 . . . . 0.0 109.172 -175.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -64.74 -39.41 93.59 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 119.181 -2.2 . . . . 0.0 114.066 174.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.4 tp -64.04 -38.64 91.82 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 126.768 2.027 . . . . 0.0 114.166 -173.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.12 -49.76 76.63 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-O 123.899 1.809 . . . . 0.0 107.99 173.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -64.56 -14.34 57.12 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 117.53 -3.231 . . . . 0.0 108.669 -175.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -103.54 -16.88 15.41 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 117.591 -3.193 . . . . 0.0 118.504 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 86.2 mt -135.2 15.06 3.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 120.672 -1.267 . . . . 0.0 113.723 -165.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 70.7 mttt 45.6 -27.38 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.419 1 C-N-CA 134.255 5.022 . . . . 0.0 117.931 -154.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.7 m -86.86 145.37 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 122.348 2.34 . . . . 0.0 116.419 -163.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.2 p -81.36 160.75 24.04 Favored 'General case' 0 N--CA 1.449 -0.517 1 N-CA-C 122.439 4.237 . . . . 0.0 122.439 -168.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.79 -17.24 0.33 Allowed 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 125.367 3.712 . . . . 0.0 116.962 165.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -86.68 -35.51 19.26 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 126.503 1.921 . . . . 0.0 112.055 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.9 mm -55.16 -36.76 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-O 124.197 1.951 . . . . 0.0 110.137 167.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.3 t -59.6 -65.28 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-O 115.274 -2.298 . . . . 0.0 111.007 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -44.24 -43.53 7.34 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 126.526 2.391 . . . . 0.0 114.134 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -54.34 -50.42 67.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 176.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -91.29 -40.42 11.51 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.645 1.178 . . . . 0.0 109.196 -171.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -43.58 -36.6 2.16 Favored 'General case' 0 N--CA 1.434 -1.266 0 O-C-N 118.352 -2.718 . . . . 0.0 111.567 166.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 76.1 p -90.13 -2.55 58.1 Favored 'General case' 0 C--O 1.237 0.436 1 O-C-N 116.176 -4.078 . . . . 0.0 114.371 -172.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.97 12.71 79.2 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 120.14 2.816 . . . . 0.0 120.14 -175.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -87.22 -28.42 22.39 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.624 1.97 . . . . 0.0 112.421 -168.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.1 tp -151.79 131.66 13.32 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 128.584 2.753 . . . . 0.0 111.743 -170.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -117.45 -179.62 0.67 Allowed Pre-proline 0 N--CA 1.447 -0.605 0 CA-C-O 114.935 -2.46 . . . . 0.0 108.807 165.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -46.36 150.82 1.99 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 1 C-N-CA 125.637 4.225 . . . . 0.0 116.335 -175.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.6 p -127.98 -175.11 3.39 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 128.488 2.715 . . . . 0.0 114.433 -173.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.0 tp -60.56 -54.15 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.502 1.121 . . . . 0.0 108.078 175.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 88.0 p -69.19 -16.99 63.75 Favored 'General case' 0 C--N 1.34 0.194 0 O-C-N 117.335 -3.353 . . . . 0.0 111.928 -175.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -98.76 -47.23 5.39 Favored 'General case' 0 CA--C 1.514 -0.427 0 O-C-N 116.999 -3.563 . . . . 0.0 111.145 -175.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.95 -55.67 31.57 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 125.892 1.995 . . . . 0.0 115.875 -149.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -52.24 -54.41 31.57 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 120.968 1.713 . . . . 0.0 114.092 -167.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.516 ' HB3' ' CZ ' ' A' ' 92' ' ' PHE . 15.8 tt0 -60.94 -40.28 92.67 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 119.417 -2.052 . . . . 0.0 114.926 167.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tt -55.23 -55.76 27.64 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 130.976 3.71 . . . . 0.0 108.331 -172.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -48.4 -48.61 36.87 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 125.077 2.37 . . . . 0.0 111.127 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -73.72 -36.33 65.19 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 119.078 -2.263 . . . . 0.0 113.035 -164.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 24.3 pt -66.48 -27.95 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 O-C-N 124.058 0.849 . . . . 0.0 112.995 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.269 1.1 pt? 164.93 -21.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 130.891 3.676 . . . . 0.0 111.228 173.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.82 29.35 59.38 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-O 123.019 1.344 . . . . 0.0 113.14 -170.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . 0.324 4.2 pt 64.46 7.7 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.706 1 C-N-CA 131.909 4.084 . . . . 0.0 113.037 165.609 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -68.44 151.6 46.6 Favored 'General case' 0 CA--C 1.515 -0.369 1 CA-C-O 111.102 -4.285 . . . . 0.0 112.333 174.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . 0.289 12.6 mt -135.9 140.12 43.84 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 125.61 3.823 . . . . 0.0 112.9 -176.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . 0.252 14.4 m -105.53 170.05 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 1 O-C-N 116.091 -4.131 . . . . 0.0 116.273 24.719 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . 0.309 1.6 p -89.56 99.63 1.85 Allowed Pre-proline 0 C--O 1.244 0.788 0 N-CA-C 102.876 -3.009 . . . . 0.0 102.876 158.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -46.4 -28.92 6.48 Favored 'Trans proline' 0 C--N 1.326 -0.616 1 C-N-CA 109.288 -6.675 . . . . 0.0 112.324 144.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -161.54 156.26 23.13 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 122.584 2.447 . . . . 0.0 112.937 171.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.11 116.69 8.2 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 116.085 -1.912 . . . . 0.0 111.93 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -113.31 169.74 8.73 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 126.363 2.982 . . . . 0.0 114.756 168.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -146.42 145.85 30.39 Favored 'General case' 0 C--N 1.341 0.229 0 O-C-N 117.413 -3.304 . . . . 0.0 110.957 156.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -82.18 118.42 23.07 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 173.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -76.6 13.71 0.94 Allowed 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 118.302 -2.749 . . . . 0.0 113.113 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 p -64.69 -26.13 68.24 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 129.134 2.973 . . . . 0.0 113.795 -175.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . 0.333 41.8 tt0 -174.59 105.94 0.1 Allowed 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 117.405 -3.309 . . . . 0.0 112.16 -176.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.6 tttm -66.93 -53.13 34.95 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 130.051 3.34 . . . . 0.0 119.839 173.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -74.64 116.01 14.86 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 119.289 -2.132 . . . . 0.0 112.296 -165.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.516 ' CZ ' ' HB3' ' A' ' 69' ' ' GLN . 88.4 t80 -137.61 113.4 9.68 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 116.944 2.201 . . . . 0.0 116.944 -162.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.1 t70 173.98 146.1 0.06 Allowed 'General case' 0 N--CA 1.452 -0.368 1 C-N-CA 132.879 4.471 . . . . 0.0 117.095 -175.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . 0.264 5.2 p-10 -111.12 -13.4 14.04 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 131.207 3.803 . . . . 0.0 115.911 -167.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.7 m -57.07 -40.29 76.61 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 116.905 -1.918 . . . . 0.0 115.684 -173.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -71.41 -4.53 57.17 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-O 115.417 -2.879 . . . . 0.0 112.103 -174.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.9 tp -112.37 -44.27 3.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 118.755 1.278 . . . . 0.0 113.133 177.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 41.6 p -93.38 -55.87 3.14 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 126.666 1.986 . . . . 0.0 107.953 -160.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 19.7 tp -73.52 -17.61 61.19 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.836 0.827 . . . . 0.0 109.651 159.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.44 37.05 94.2 Favored Glycine 0 C--N 1.341 0.823 0 O-C-N 119.001 -2.312 . . . . 0.0 115.018 -177.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.25 1.1 t70 -76.96 58.92 1.56 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 123.722 1.725 . . . . 0.0 111.48 -170.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.87 158.16 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 1 O-C-N 115.165 -4.71 . . . . 0.0 114.722 -178.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 25.4 t -76.05 123.97 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 1 O-C-N 110.923 -7.36 . . . . 0.0 113.014 1.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -86.52 118.26 25.83 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 112.78 -2.009 . . . . 0.0 109.53 177.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 10.0 pt -114.54 -0.45 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 O-C-N 126.445 2.34 . . . . 0.0 112.016 -174.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 31.8 tttm -103.86 -24.56 13.27 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 131.425 3.89 . . . . 0.0 117.097 -174.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -143.09 -25.03 0.61 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 129.224 3.009 . . . . 0.0 113.679 172.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -69.71 -176.77 16.97 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 117.944 -2.074 . . . . 0.0 116.212 -160.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -142.16 53.18 1.46 Allowed 'General case' 0 C--O 1.219 -0.534 0 O-C-N 119.794 -2.004 . . . . 0.0 110.229 173.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -75.23 81.06 2.35 Favored 'General case' 0 N--CA 1.439 -1.001 2 O-C-N 115.534 -4.479 . . . . 0.0 112.943 173.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.259 7.9 mt -76.73 161.12 28.75 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 119.098 -2.251 . . . . 0.0 116.266 -163.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -47.23 -38.87 12.97 Favored 'General case' 0 N--CA 1.443 -0.806 1 C-N-CA 132.531 4.333 . . . . 0.0 112.656 -173.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -94.59 -4.33 48.03 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 117.631 -3.168 . . . . 0.0 113.31 -170.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 54.3 m170 . . . . . 0 C--O 1.243 0.711 0 O-C-N 118.09 -2.881 . . . . 0.0 110.296 -174.664 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 N--CA 1.476 0.865 0 CA-C-O 124.874 2.273 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -178.96 127.14 0.1 Allowed 'General case' 0 N--CA 1.442 -0.869 1 C-N-CA 133.434 4.694 . . . . 0.0 111.378 177.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.52 -19.55 64.52 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 118.779 2.881 . . . . 0.0 118.779 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -73.1 1.13 9.69 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 118.625 2.824 . . . . 0.0 118.625 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.2 mt -113.67 8.91 17.7 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 111.375 -2.648 . . . . 0.0 117.339 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -132.76 24.19 4.31 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -160.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 40.4 pt -135.79 156.19 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 126.291 1.837 . . . . 0.0 113.588 -164.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.3 p -73.2 140.53 17.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 126.286 1.835 . . . . 0.0 107.683 175.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.8 m -64.34 -59.32 4.52 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -174.92 85.08 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 129.318 3.047 . . . . 0.0 107.101 -163.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -71.16 150.01 45.8 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 130.505 3.522 . . . . 0.0 114.232 -160.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -70.6 127.53 33.01 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 -170.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -101.21 -15.57 17.28 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 125.298 1.439 . . . . 0.0 113.002 -174.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.9 pt -70.77 -25.63 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 120.571 1.532 . . . . 0.0 111.31 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.429 40.3 pt -60.36 -35.58 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 C-N-CA 127.702 2.401 . . . . 0.0 108.16 171.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.355 8.8 ttpt -44.0 -72.74 0.05 Allowed 'General case' 0 N--CA 1.454 -0.272 1 C-N-CA 132.266 4.227 . . . . 0.0 115.951 -159.548 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.9 m -72.12 -21.87 61.41 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.111 0.964 . . . . 0.0 111.948 -165.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.71 -59.95 2.56 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 128.081 2.552 . . . . 0.0 107.872 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -43.77 -35.11 1.75 Allowed 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 127.77 2.428 . . . . 0.0 108.143 169.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . 0.304 17.2 tt0 -73.45 -41.23 63.46 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 122.42 2.373 . . . . 0.0 115.402 173.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -61.51 -19.7 62.37 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 121.564 1.984 . . . . 0.0 111.973 171.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.1 tp -71.77 -34.64 69.62 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 123.503 1.621 . . . . 0.0 111.188 -173.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.57 -12.97 8.94 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-N 110.804 -2.907 . . . . 0.0 112.557 173.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.4 pt -70.79 154.54 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 O-C-N 120.383 -1.657 . . . . 0.0 110.403 -171.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 84.4 p -96.46 175.05 6.55 Favored 'General case' 0 N--CA 1.437 -1.106 0 O-C-N 118.265 -2.772 . . . . 0.0 113.473 -166.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -51.16 -40.85 59.51 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 113.437 -3.173 . . . . 0.0 113.95 161.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . 0.293 25.2 mp0 -61.16 -40.41 93.77 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 127.822 3.201 . . . . 0.0 110.002 -175.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -72.75 -34.57 67.11 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 119.706 -1.871 . . . . 0.0 113.586 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 63.1 tp -73.35 -27.68 61.64 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 122.682 1.229 . . . . 0.0 113.601 -176.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.77 -36.73 81.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 116.301 -1.809 . . . . 0.0 107.082 169.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . 0.277 87.8 mm-40 -73.29 -31.28 63.95 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 127.662 2.385 . . . . 0.0 111.266 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.7 tptt -67.3 -24.61 65.77 Favored 'General case' 0 N--CA 1.442 -0.864 0 O-C-N 117.227 -3.421 . . . . 0.0 111.736 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.9 mt -124.96 -3.14 7.67 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 128.02 2.528 . . . . 0.0 109.992 -165.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.258 27.2 mtpt 52.32 5.54 0.04 OUTLIER 'General case' 0 C--O 1.233 0.224 0 C-N-CA 130.486 3.514 . . . . 0.0 118.736 -171.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.8 m -88.51 -168.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 128.386 2.674 . . . . 0.0 108.102 -173.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 90.9 p -100.1 158.87 15.53 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.911 1.284 . . . . 0.0 112.585 -173.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -52.33 -32.58 38.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 113.12 -1.855 . . . . 0.0 110.971 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -74.21 -31.12 62.5 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 175.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 67.7 mt -74.26 -34.63 37.87 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 O-C-N 118.459 -2.651 . . . . 0.0 112.196 174.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.41 11.2 m -64.22 -59.13 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 O-C-N 118.376 -2.703 . . . . 0.0 112.79 164.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -50.03 -18.91 0.61 Allowed 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 119.801 3.259 . . . . 0.0 119.801 175.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -58.95 -32.68 69.82 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 -171.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -93.91 -44.8 7.91 Favored 'General case' 0 CA--C 1.512 -0.5 0 O-C-N 126.148 2.155 . . . . 0.0 110.035 176.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -49.26 -30.82 7.76 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 127.606 2.362 . . . . 0.0 108.787 176.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.2 p -94.81 -28.09 15.43 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 117.443 -3.286 . . . . 0.0 114.253 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.58 9.52 56.44 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 118.556 -2.59 . . . . 0.0 113.776 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -88.76 45.1 1.26 Allowed 'General case' 0 N--CA 1.447 -0.606 1 C-N-CA 131.82 4.048 . . . . 0.0 113.222 -169.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.53 135.95 54.92 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 129.036 2.935 . . . . 0.0 112.844 -159.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.317 43.3 mtpt -109.78 76.19 0.91 Allowed Pre-proline 0 N--CA 1.445 -0.697 0 CA-C-O 114.656 -2.592 . . . . 0.0 115.612 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -84.06 157.91 13.36 Favored 'Trans proline' 0 C--N 1.329 -0.492 0 C-N-CA 124.861 3.707 . . . . 0.0 113.367 -158.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.608 ' H ' ' HB2' ' A' ' 66' ' ' GLN . 58.9 p -132.16 176.35 8.46 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 128.088 2.555 . . . . 0.0 112.943 168.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 6.3 pt -48.02 -56.51 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 172.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.425 ' C ' HE21 ' A' ' 69' ' ' GLN . 90.8 p -47.34 -33.77 6.14 Favored 'General case' 0 C--N 1.342 0.244 0 O-C-N 117.468 -3.27 . . . . 0.0 115.916 166.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.608 ' HB2' ' H ' ' A' ' 63' ' ' THR . 62.4 mt-30 -75.01 -50.43 16.55 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 128.209 2.603 . . . . 0.0 112.28 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -42.62 -52.45 4.83 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 125.949 1.699 . . . . 0.0 111.458 162.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.9 mtm180 -63.82 -34.39 77.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 124.145 0.903 . . . . 0.0 111.824 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.425 HE21 ' C ' ' A' ' 65' ' ' SER . 35.5 mt-30 -80.36 -35.6 35.21 Favored 'General case' 0 CA--C 1.516 -0.351 0 O-C-N 119.695 -1.878 . . . . 0.0 112.634 -168.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.3 mt -73.69 -50.56 20.29 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 131.572 3.949 . . . . 0.0 115.264 -167.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -44.04 -34.92 1.9 Allowed 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.579 0.704 . . . . 0.0 112.215 158.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.2 mttp -98.35 10.31 41.04 Favored 'General case' 0 CA--C 1.513 -0.471 0 O-C-N 118.303 -2.748 . . . . 0.0 114.404 -165.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 20.7 pt -53.28 -50.85 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-O 125.652 2.644 . . . . 0.0 112.912 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 77.0 mt -106.43 0.67 25.01 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 118.919 -2.363 . . . . 0.0 115.901 176.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.33 0.61 11.36 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 126.617 2.055 . . . . 0.0 115.245 175.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.7 pt -116.42 -174.49 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 116.979 -3.659 . . . . 0.0 116.605 -177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -173.93 147.6 1.32 Allowed 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 113.501 -3.143 . . . . 0.0 109.432 -173.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 31.5 mt -132.08 157.12 45.01 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 125.931 2.019 . . . . 0.0 110.579 164.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.1 153.8 10.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 2 C-N-CA 133.848 4.859 . . . . 0.0 121.537 3.884 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.0 p -88.89 175.91 3.65 Favored Pre-proline 0 N--CA 1.446 -0.672 0 O-C-N 118.399 -2.688 . . . . 0.0 109.346 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -44.51 -17.55 0.15 Allowed 'Trans proline' 0 N--CA 1.45 -1.03 0 N-CA-C 118.189 2.342 . . . . 0.0 118.189 167.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 65.5 mt -55.2 -14.17 1.59 Allowed 'General case' 0 C--O 1.219 -0.53 0 O-C-N 125.917 2.011 . . . . 0.0 115.459 163.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . 0.361 5.6 tp10 -145.8 -39.3 0.23 Allowed 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 126.188 1.795 . . . . 0.0 110.404 174.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -145.86 154.3 41.82 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 123.524 1.63 . . . . 0.0 112.462 -175.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -131.95 132.51 43.59 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 118.669 -2.519 . . . . 0.0 112.9 -176.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -50.94 107.86 0.2 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 125.295 2.474 . . . . 0.0 114.003 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.294 39.9 tt0 -132.51 61.4 1.67 Allowed 'General case' 0 C--N 1.327 -0.41 0 O-C-N 119.393 -2.067 . . . . 0.0 113.198 -165.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 73.8 m -76.96 -13.05 60.01 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.974 1.71 . . . . 0.0 112.996 -162.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -55.19 -25.58 33.61 Favored 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 118.674 -2.516 . . . . 0.0 117.406 172.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -72.75 -21.37 61.03 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 121.509 3.892 . . . . 0.0 121.509 165.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -118.64 -28.63 5.6 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 -175.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -109.49 148.9 30.4 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-O 126.43 3.014 . . . . 0.0 112.705 -175.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -69.56 -32.25 70.94 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 117.728 -3.107 . . . . 0.0 113.881 167.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -144.11 9.65 1.48 Allowed 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 116.458 2.021 . . . . 0.0 116.458 -171.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 89.0 m -107.32 137.16 45.9 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 128.307 2.643 . . . . 0.0 108.997 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.74 12.5 56.93 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 124.12 0.887 . . . . 0.0 112.787 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.64 -19.06 19.29 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 115.301 -2.285 . . . . 0.0 110.359 -164.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.2 t -154.29 137.54 15.71 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 128.603 3.69 . . . . 0.0 114.103 166.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 26.4 tp -102.67 -29.08 11.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.143 -1.39 . . . . 0.0 113.18 161.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.58 6.06 83.79 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-O 116.843 -2.087 . . . . 0.0 109.258 176.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -74.67 109.59 8.27 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 126.503 1.943 . . . . 0.0 112.309 -176.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . 0.41 6.7 m -129.42 162.13 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 1 O-C-N 129.503 4.252 . . . . 0.0 117.229 177.433 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 20.0 t -57.09 127.01 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 123.802 3.001 . . . . 0.0 115.001 -4.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -90.35 119.83 30.97 Favored 'General case' 0 C--N 1.346 0.445 0 O-C-N 121.572 -0.705 . . . . 0.0 110.866 -167.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.441 ' C ' ' H ' ' A' ' 108' ' ' GLY . 20.8 pt -116.65 3.72 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 125.928 1.691 . . . . 0.0 110.316 -174.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -75.68 -10.44 59.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 118.899 -2.376 . . . . 0.0 112.6 147.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -67.91 -23.55 65.11 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 118.526 -1.27 . . . . 0.0 110.798 152.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 105' ' ' ILE . . . 152.15 159.48 8.99 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 124.555 2.197 . . . . 0.0 117.241 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.3 tttt -83.19 43.94 0.91 Allowed 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 109.047 -3.577 . . . . 0.0 115.971 -171.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -78.88 -18.99 53.01 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 111.554 -2.566 . . . . 0.0 112.306 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 42.4 mt -101.63 150.17 23.38 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.998 2.119 . . . . 0.0 107.474 150.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.346 23.2 tt0 -164.35 -79.14 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 113.807 -2.997 . . . . 0.0 116.924 -148.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -91.31 8.54 35.55 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 118.376 2.732 . . . . 0.0 118.376 -175.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 . . . . . 0 C--O 1.256 1.406 0 C-N-CA 129.961 3.304 . . . . 0.0 111.462 -167.903 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 115.473 1.656 . . . . 0.0 115.473 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -98.15 153.58 18.35 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 116.943 -1.503 . . . . 0.0 112.05 -169.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -126.42 14.26 7.67 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 124.951 3.523 . . . . 0.0 113.067 -166.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -75.72 -32.83 60.2 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 126.791 3.186 . . . . 0.0 111.277 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.42 -9.81 53.69 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 118.613 2.819 . . . . 0.0 118.613 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -126.1 11.91 7.67 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 127.945 2.498 . . . . 0.0 110.487 -155.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.8 pp -115.89 176.01 2.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 130.354 3.462 . . . . 0.0 108.021 161.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.1 p -67.12 165.27 2.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 121.009 1.731 . . . . 0.0 115.351 -166.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 43.8 p -69.97 -62.06 1.53 Allowed 'General case' 0 C--N 1.325 -0.489 1 O-C-N 129.735 4.397 . . . . 0.0 109.774 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.0 t70 174.46 73.42 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 100.335 -3.95 . . . . 0.0 100.335 -159.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.283 58.4 t80 -59.56 137.83 57.9 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 118.375 2.731 . . . . 0.0 118.375 -166.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -46.25 143.8 2.28 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 131.194 3.798 . . . . 0.0 118.182 -154.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -98.99 -32.87 11.07 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 117.768 2.507 . . . . 0.0 117.768 -176.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.2 pt -63.07 -33.4 60.58 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 C-N-CA 126.698 1.999 . . . . 0.0 107.59 -172.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.36 1.8 pt -60.11 -38.81 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 114.035 -1.439 . . . . 0.0 112.252 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.454 45.9 tttm -45.83 -74.6 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 118.841 2.904 . . . . 0.0 118.841 -162.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.5 m -53.47 -32.71 51.3 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 129.706 3.202 . . . . 0.0 113.706 -174.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.28 -55.86 9.27 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 114.544 -2.646 . . . . 0.0 110.775 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . 0.276 11.9 ptm180 -57.35 -40.96 79.15 Favored 'General case' 0 N--CA 1.447 -0.604 1 CA-C-N 126.302 4.137 . . . . 0.0 110.673 171.606 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -51.1 -35.78 36.9 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 114.87 -2.49 . . . . 0.0 115.448 176.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -51.54 -42.57 61.88 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 121.687 2.04 . . . . 0.0 109.736 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 50.3 mt -80.94 -25.68 37.23 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 131.538 3.935 . . . . 0.0 109.514 -176.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 55.97 5.39 0.96 Allowed Glycine 0 C--O 1.22 -0.75 0 CA-C-N 112.665 -2.061 . . . . 0.0 116.199 -170.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.5 pt -60.35 148.06 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 126.685 1.994 . . . . 0.0 108.392 -163.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 88.6 p -133.18 -177.29 4.45 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 122.728 2.513 . . . . 0.0 110.581 170.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . 0.254 65.0 mt-30 -21.61 -61.34 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 113.419 -3.181 . . . . 0.0 116.197 -163.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -58.99 -51.95 67.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 124.484 3.311 . . . . 0.0 109.365 -173.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -67.2 -29.38 69.03 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 117.435 -1.269 . . . . 0.0 110.864 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.8 tp -80.91 -23.89 38.62 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.935 1.694 . . . . 0.0 112.197 -167.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.74 -45.62 67.08 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 131.598 3.959 . . . . 0.0 111.163 153.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -77.94 -21.47 51.03 Favored 'General case' 0 CA--C 1.51 -0.561 0 O-C-N 126.773 2.546 . . . . 0.0 110.688 178.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -83.11 -12.06 57.4 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 118.304 -2.748 . . . . 0.0 105.168 -169.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 21.8 tp -125.35 -9.58 6.95 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -173.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.7 mtmt 57.31 52.89 8.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 131.196 3.798 . . . . 0.0 112.335 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.1 m -124.79 177.22 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 1 C-N-CA 134.019 4.928 . . . . 0.0 113.138 -177.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 62.1 p -82.06 159.61 23.4 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 116.81 2.152 . . . . 0.0 116.81 168.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -64.07 -14.54 55.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 169.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -80.97 -23.2 38.93 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 119.803 -1.811 . . . . 0.0 113.238 170.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.0 mt -69.45 -43.63 80.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 118.293 -0.86 . . . . 0.0 112.911 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.8 m -68.57 -25.96 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 118.44 2.755 . . . . 0.0 118.44 -178.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -42.32 -48.3 5.0 Favored 'General case' 0 N--CA 1.432 -1.374 0 C-N-CA 130.204 3.402 . . . . 0.0 116.706 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.6 mtt85 -61.72 -39.62 92.18 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 123.682 2.946 . . . . 0.0 111.13 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -82.36 -33.99 28.6 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -168.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -64.93 -49.11 71.67 Favored 'General case' 0 N--CA 1.441 -0.876 0 O-C-N 118.649 -2.532 . . . . 0.0 109.145 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.6 p -80.16 -28.66 38.76 Favored 'General case' 0 C--O 1.243 0.739 0 O-C-N 118.745 -2.472 . . . . 0.0 112.908 -167.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.2 5.48 62.17 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -171.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -93.06 54.57 2.18 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 128.737 2.815 . . . . 0.0 112.433 -174.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . 0.252 62.7 tp -144.79 130.9 19.42 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 130.837 3.655 . . . . 0.0 107.241 -167.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.5 tttt -91.4 128.67 45.99 Favored Pre-proline 0 N--CA 1.45 -0.473 0 N-CA-C 119.156 3.021 . . . . 0.0 119.156 158.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -92.46 -172.03 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 1 C-N-CA 127.167 5.245 . . . . 0.0 107.722 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.264 17.4 p -156.33 174.37 15.5 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 128.058 2.543 . . . . 0.0 111.278 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.7 pt -63.18 -44.18 99.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 126.736 2.015 . . . . 0.0 113.752 166.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.5 p -66.68 -38.38 86.68 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 121.085 1.766 . . . . 0.0 112.284 164.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 67.8 mm-40 -69.9 -27.78 65.07 Favored 'General case' 0 N--CA 1.45 -0.429 2 O-C-N 111.299 -7.125 . . . . 0.0 115.377 -171.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . 0.257 . . -55.93 -74.08 0.05 Allowed 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 123.321 2.782 . . . . 0.0 114.382 -164.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.0 mmp_? -51.02 -21.88 2.03 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 126.329 1.852 . . . . 0.0 109.867 -178.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.55 ' C ' ' H ' ' A' ' 72' ' ' LYS . 61.0 mt-30 -77.22 -36.09 55.04 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 124.615 1.197 . . . . 0.0 112.817 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 40.0 mt -79.18 -41.13 29.13 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 128.25 2.62 . . . . 0.0 104.483 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -53.84 -26.73 25.83 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 118.025 -2.922 . . . . 0.0 111.254 154.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.55 ' H ' ' C ' ' A' ' 69' ' ' GLN . 51.2 tttt -79.36 -24.88 42.39 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 125.388 3.722 . . . . 0.0 115.222 -173.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . 0.406 24.0 pt -54.52 -69.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-N 125.603 3.82 . . . . 0.0 112.291 -165.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 82.6 mt -70.48 -20.92 62.82 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 130.276 3.431 . . . . 0.0 111.781 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.71 12.68 57.36 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 130.214 3.769 . . . . 0.0 118.775 174.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.5 pt -84.1 167.65 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.08 1 C-N-CA 132.385 4.274 . . . . 0.0 112.479 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.278 5.3 ptpt -175.94 144.84 0.63 Allowed 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 128.467 2.707 . . . . 0.0 114.413 175.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 31.4 mt -153.28 163.35 40.05 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 125.842 1.963 . . . . 0.0 109.153 163.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.7 m -113.92 148.5 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 1 C-N-CA 141.971 8.109 . . . . 0.0 114.935 14.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.7 p -92.82 -178.59 0.89 Allowed Pre-proline 0 N--CA 1.447 -0.582 0 C-N-CA 125.816 1.646 . . . . 0.0 112.987 -175.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -59.56 -3.4 1.92 Allowed 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 123.302 2.668 . . . . 0.0 114.849 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 60.3 mt -81.19 -0.36 40.11 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 120.436 1.471 . . . . 0.0 109.897 170.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.33 -43.2 0.25 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 128.917 2.887 . . . . 0.0 111.271 175.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -157.88 153.07 25.71 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 121.253 1.842 . . . . 0.0 111.471 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -135.64 131.07 35.31 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 118.394 -2.691 . . . . 0.0 115.073 -167.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -145.96 129.54 16.99 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 -170.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -135.1 142.79 46.31 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.996 2.118 . . . . 0.0 113.423 -168.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 86.8 p -86.57 -5.31 59.18 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 118.346 -2.721 . . . . 0.0 107.495 -170.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -55.55 -16.53 4.03 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 163.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -106.32 28.34 7.84 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 172.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -140.64 -28.55 0.7 Allowed 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.714 2.006 . . . . 0.0 111.085 -173.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -81.43 159.19 24.34 Favored 'General case' 0 N--CA 1.442 -0.851 0 O-C-N 118.095 -2.878 . . . . 0.0 105.7 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -98.97 -32.2 11.42 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 112.567 -2.106 . . . . 0.0 111.229 174.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -120.54 5.99 10.59 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 118.935 2.939 . . . . 0.0 118.935 -176.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.7 m -145.14 149.69 35.44 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 126.164 1.786 . . . . 0.0 111.991 -165.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.01 17.15 58.31 Favored Glycine 0 N--CA 1.438 -1.211 0 C-N-CA 126.316 1.912 . . . . 0.0 114.486 -168.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.2 mt -81.63 -12.67 58.62 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 -170.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.7 t -138.48 140.29 39.16 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 128.216 2.606 . . . . 0.0 112.741 175.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 26.8 tp -38.46 -36.48 0.24 Allowed 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 127.368 2.267 . . . . 0.0 114.638 159.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.62 2.08 87.55 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 126.893 2.187 . . . . 0.0 113.774 -166.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -66.77 100.3 0.69 Allowed 'General case' 0 N--CA 1.438 -1.036 1 O-C-N 115.421 -4.576 . . . . 0.0 112.84 174.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 103' ' ' VAL . 0.9 OUTLIER -129.6 150.58 34.76 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 C-N-CA 126.494 1.918 . . . . 0.0 111.508 -162.528 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.432 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 69.0 t -76.86 133.92 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 1 O-C-N 113.898 -5.501 . . . . 0.0 108.279 10.449 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -83.54 108.93 16.99 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 116.806 -1.569 . . . . 0.0 108.978 -176.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -94.45 -3.98 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 124.621 1.201 . . . . 0.0 111.223 -174.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.6 ttpp -67.26 -42.91 83.1 Favored 'General case' 0 C--O 1.249 1.041 0 O-C-N 120.262 -1.524 . . . . 0.0 109.447 170.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -70.06 -12.3 61.51 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 127.854 2.461 . . . . 0.0 112.072 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 173.18 136.01 2.1 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-O 119.133 -0.815 . . . . 0.0 113.463 171.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -152.33 132.55 13.59 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 103.259 -2.867 . . . . 0.0 103.259 174.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 45.0 pttt 178.9 -17.46 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 119.351 -2.093 . . . . 0.0 106.75 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.6 mt -74.82 -171.75 1.39 Allowed 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 118.273 -2.767 . . . . 0.0 106.121 168.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -155.07 -65.7 0.13 Allowed 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 112.912 -1.949 . . . . 0.0 114.587 -146.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -115.8 11.23 15.55 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 126.966 2.107 . . . . 0.0 110.137 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 31.1 p-80 . . . . . 0 C--O 1.257 1.466 0 C-N-CA 125.891 1.676 . . . . 0.0 113.632 -168.547 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 . . . . . 0 N--CA 1.474 0.762 0 CA-C-O 124.464 2.078 . . . . 0.0 106.031 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -82.36 135.42 35.18 Favored 'General case' 0 CA--C 1.517 -0.301 0 O-C-N 119.643 -1.911 . . . . 0.0 113.277 -163.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -96.85 -13.82 22.26 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -166.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -104.15 35.13 2.78 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 126.552 3.072 . . . . 0.0 117.078 -170.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.5 mt -94.91 -20.62 19.25 Favored 'General case' 0 CA--C 1.51 -0.564 0 O-C-N 117.076 -3.515 . . . . 0.0 112.927 -173.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -129.37 8.48 5.49 Favored 'General case' 0 C--O 1.226 -0.156 0 CA-C-N 123.956 3.071 . . . . 0.0 115.389 -168.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.4 pt -116.82 159.0 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 117.819 -3.051 . . . . 0.0 112.695 -164.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 p -79.88 151.39 4.76 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 O-C-N 120.13 -1.606 . . . . 0.0 108.522 -173.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 74.8 p -58.37 -33.0 69.11 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 119.725 -1.86 . . . . 0.0 111.197 -177.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -178.81 126.78 0.1 Allowed 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 131.518 3.927 . . . . 0.0 106.132 170.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -55.77 162.3 1.81 Allowed 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 127.389 2.93 . . . . 0.0 113.805 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.449 ' CE2' ' HB2' ' A' ' 67' ' ' ALA . 8.7 m-85 -91.28 157.5 17.11 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 112.118 -2.31 . . . . 0.0 114.276 177.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.5 mttt -110.93 -46.44 3.34 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 -141.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.0 pt -67.6 -30.8 49.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 113.176 -3.297 . . . . 0.0 109.47 -174.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.372 20.1 pt -54.93 -49.68 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 C-N-CA 128.157 2.583 . . . . 0.0 110.12 178.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.347 74.8 mttt -29.66 -81.19 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.448 2 C-N-CA 132.418 4.287 . . . . 0.0 121.963 -174.332 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.0 p -75.82 -21.86 56.89 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 118.56 2.8 . . . . 0.0 118.56 -159.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.57 -21.83 63.02 Favored 'General case' 0 N--CA 1.439 -1.009 1 C-N-CA 133.973 4.909 . . . . 0.0 115.625 173.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . 0.282 6.6 ptm180 -44.15 -50.05 8.8 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 115.883 -2.008 . . . . 0.0 114.914 175.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -48.92 -33.24 10.42 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 126.634 1.974 . . . . 0.0 115.742 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -58.89 -25.48 63.4 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 118.605 -2.559 . . . . 0.0 112.708 -176.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.1 mp -96.32 -30.27 13.52 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.92 3.78 2.79 Favored Glycine 0 C--N 1.342 0.888 0 C-N-CA 127.943 2.687 . . . . 0.0 112.844 173.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.5 pt -66.5 154.03 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 120.344 2.072 . . . . 0.0 114.852 -173.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.0 p -71.79 161.85 30.34 Favored 'General case' 0 N--CA 1.443 -0.789 0 O-C-N 116.767 -3.708 . . . . 0.0 113.487 172.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -54.77 -46.44 74.4 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 114.604 -2.617 . . . . 0.0 108.489 173.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -61.74 -34.76 76.39 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 120.961 1.71 . . . . 0.0 111.068 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -80.43 -19.62 45.74 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 116.93 -1.908 . . . . 0.0 110.896 -175.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 66.8 tp -75.43 -46.51 32.23 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 125.856 2.741 . . . . 0.0 110.848 174.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.13 -39.31 66.36 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 118.551 -2.593 . . . . 0.0 110.953 173.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -63.86 -34.41 77.87 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 126.258 1.823 . . . . 0.0 115.918 160.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -73.97 -16.11 61.09 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 122.123 2.238 . . . . 0.0 107.693 -170.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.8 mt -123.09 -4.29 8.49 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 127.837 2.455 . . . . 0.0 112.51 -173.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.272 1.6 mptp? 43.23 56.74 4.08 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 118.652 2.834 . . . . 0.0 118.652 -167.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 31.9 m -127.7 175.77 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 1 C-N-CA 132.196 4.198 . . . . 0.0 108.583 -175.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 62.1 p -78.76 159.07 28.09 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 167.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -74.38 -13.29 60.71 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 128.229 3.455 . . . . 0.0 111.117 169.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -53.33 -50.56 64.72 Favored 'General case' 0 N--CA 1.447 -0.577 1 O-C-N 115.887 -4.258 . . . . 0.0 111.055 161.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.3 mm -59.14 -45.25 92.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 1 O-C-N 115.62 -4.425 . . . . 0.0 111.507 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.4 m -66.22 -49.29 77.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 115.173 -2.346 . . . . 0.0 106.258 -174.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.4 mtmm -50.53 -40.09 50.69 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 127.194 2.198 . . . . 0.0 113.754 173.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -60.95 -29.6 69.74 Favored 'General case' 0 C--N 1.345 0.393 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 172.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -72.46 -50.87 23.06 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 171.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -53.86 -51.92 62.08 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.984 1.714 . . . . 0.0 114.342 -173.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.5 p -74.87 -9.18 58.3 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 120.162 3.393 . . . . 0.0 120.162 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.67 16.76 80.08 Favored Glycine 0 C--O 1.243 0.713 1 CA-C-O 110.19 -5.783 . . . . 0.0 111.573 -169.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -89.83 51.84 2.17 Favored 'General case' 0 C--O 1.24 0.581 1 CA-C-N 126.839 5.32 . . . . 0.0 111.274 -172.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.9 tp -131.97 147.52 52.46 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -164.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.277 61.0 tttt -112.43 71.91 1.21 Allowed Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 113.717 -3.04 . . . . 0.0 111.743 168.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -83.6 -164.45 0.26 Allowed 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 124.552 3.501 . . . . 0.0 103.234 -166.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 p -153.57 174.39 14.51 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 130.841 3.657 . . . . 0.0 108.962 -169.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 28.9 pt -75.45 -48.15 31.9 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 CA-C-O 113.721 -3.038 . . . . 0.0 111.392 -174.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.8 p -58.91 -31.7 68.87 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 124.549 3.34 . . . . 0.0 112.826 166.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -68.47 -43.4 77.05 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 115.62 -2.134 . . . . 0.0 111.912 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.449 ' HB2' ' CE2' ' A' ' 24' ' ' TYR . . . -52.78 -44.28 66.45 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 114.44 -2.695 . . . . 0.0 111.28 165.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.2 mmp_? -56.4 -32.33 64.72 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 125.246 3.657 . . . . 0.0 110.585 170.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -82.31 -26.91 32.63 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 127.272 2.857 . . . . 0.0 111.276 -177.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.8 mt -60.54 -54.01 50.6 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 131.647 3.979 . . . . 0.0 107.463 167.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -50.6 -54.59 21.53 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 127.362 2.265 . . . . 0.0 109.013 174.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -67.54 -42.75 82.2 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 117.56 2.43 . . . . 0.0 117.56 -170.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . 0.258 9.5 pt -48.74 -63.96 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 O-C-N 116.962 -3.586 . . . . 0.0 113.852 -175.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 21.2 mt -75.88 -14.65 60.27 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 122.851 1.31 . . . . 0.0 113.228 -176.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.39 -13.65 10.55 Favored Glycine 0 CA--C 1.532 1.117 0 O-C-N 119.061 -2.274 . . . . 0.0 114.677 176.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.8 pt -92.67 162.37 2.41 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.736 0 C-N-CA 130.253 3.421 . . . . 0.0 115.238 -174.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.0 pttt -173.04 150.41 1.98 Allowed 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 129.846 3.258 . . . . 0.0 108.29 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.4 mt -148.03 151.94 36.58 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 165.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.7 m -111.51 177.83 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.894 1 O-C-N 115.162 -4.711 . . . . 0.0 116.616 26.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.6 p -96.56 164.49 18.09 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 126.858 2.063 . . . . 0.0 110.366 174.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -48.44 3.2 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.769 0 CA-C-O 115.927 -1.781 . . . . 0.0 115.632 164.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . 0.33 22.8 mt -70.04 -7.3 39.95 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 125.768 3.894 . . . . 0.0 114.969 158.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -150.45 -30.53 0.2 Allowed 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 128.831 2.852 . . . . 0.0 113.847 169.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -173.74 159.97 3.59 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 118.65 2.833 . . . . 0.0 118.65 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -145.23 120.68 10.33 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 126.592 1.957 . . . . 0.0 111.886 176.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -44.18 135.0 4.61 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 119.239 3.051 . . . . 0.0 119.239 163.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -86.38 146.31 26.51 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 128.432 2.693 . . . . 0.0 115.37 -175.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.9 p -77.29 -36.89 53.82 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 112.147 -2.297 . . . . 0.0 110.62 -171.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -76.24 -4.65 43.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 120.804 1.638 . . . . 0.0 111.989 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.6 mmtm -98.86 -20.36 16.89 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 127.092 2.157 . . . . 0.0 114.552 163.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -51.99 -51.84 54.54 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 127.52 2.328 . . . . 0.0 110.74 172.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -176.35 172.8 2.21 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.633 1.973 . . . . 0.0 112.434 -171.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -86.64 -17.74 33.06 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 115.089 -2.386 . . . . 0.0 111.438 -165.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -106.03 11.57 31.4 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 130.08 3.352 . . . . 0.0 109.161 -178.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 26.0 m -122.6 159.3 28.1 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 125.655 1.847 . . . . 0.0 109.054 -167.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.54 -11.86 8.93 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 120.808 3.083 . . . . 0.0 120.808 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 44.4 mt -95.15 -23.54 17.25 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 118.52 2.785 . . . . 0.0 118.52 -158.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.1 t -151.81 142.28 22.58 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 126.843 2.057 . . . . 0.0 108.177 161.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.4 tp -94.4 -20.66 19.53 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 128.188 2.595 . . . . 0.0 117.814 163.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.04 16.19 63.5 Favored Glycine 0 C--O 1.227 -0.292 0 O-C-N 124.001 0.813 . . . . 0.0 113.603 176.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -93.89 77.15 4.19 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 127.483 2.313 . . . . 0.0 107.141 -168.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.1 m -138.65 178.84 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-O 113.875 -2.964 . . . . 0.0 115.89 -177.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.4 p -58.73 148.1 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 1 CA-C-N 128.287 5.039 . . . . 0.0 110.426 11.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -72.04 102.27 2.94 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 117.317 -1.325 . . . . 0.0 110.546 -165.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 10.7 pt -77.85 -6.92 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-O 116.671 -1.633 . . . . 0.0 111.632 -175.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -80.32 -12.9 59.55 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 118.474 -1.29 . . . . 0.0 113.129 172.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -104.6 -14.59 15.58 Favored 'General case' 0 C--O 1.223 -0.304 1 C-N-CA 132.377 4.271 . . . . 0.0 109.424 171.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.2 166.11 13.08 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-O 118.241 -1.31 . . . . 0.0 115.37 155.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -118.87 143.67 46.84 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 118.805 1.302 . . . . 0.0 110.454 165.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 46.3 pttt -163.2 -21.02 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -153.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.256 1.0 OUTLIER -91.64 -178.54 5.1 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 129.204 3.002 . . . . 0.0 112.199 151.496 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.326 23.2 tt0 -159.91 -91.67 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 118.454 -2.654 . . . . 0.0 111.809 -162.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 32.1 p-80 -96.35 5.15 51.54 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 115.614 -2.136 . . . . 0.0 111.298 -165.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.19 0 C-N-CA 129.228 3.011 . . . . 0.0 110.413 166.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 . . . . . 0 N--CA 1.47 0.534 0 CA-C-O 123.566 1.65 . . . . 0.0 110.414 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -91.68 110.51 21.85 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 113.722 -1.581 . . . . 0.0 107.878 -178.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.33 -18.19 57.66 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 117.763 -3.086 . . . . 0.0 115.013 -165.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -51.54 -20.47 1.94 Allowed 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 131.038 3.735 . . . . 0.0 110.215 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . 0.36 12.2 mt -90.25 -7.58 53.12 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 130.439 3.495 . . . . 0.0 113.741 -173.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -136.39 -7.14 1.99 Allowed 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 122.666 1.222 . . . . 0.0 111.428 -163.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 8.0 pt -107.38 155.37 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 O-C-N 120.143 -1.598 . . . . 0.0 114.193 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.1 p -80.52 154.98 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 O-C-N 119.717 -1.864 . . . . 0.0 113.082 152.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.63 -83.29 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 130.604 3.562 . . . . 0.0 105.134 -173.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -85.89 80.07 9.03 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.493 1.042 . . . . 0.0 110.224 -161.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.312 22.1 t80 -88.13 156.27 19.35 Favored 'General case' 0 N--CA 1.443 -0.775 0 O-C-N 117.476 -3.265 . . . . 0.0 116.229 -169.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -75.59 129.08 36.61 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 125.843 1.965 . . . . 0.0 111.827 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -105.09 -21.21 13.31 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 127.831 2.452 . . . . 0.0 114.499 -175.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.8 pt -69.72 -38.1 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 1 O-C-N 115.923 -4.235 . . . . 0.0 113.794 -174.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.301 22.5 pt -67.84 -20.32 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 127.154 2.182 . . . . 0.0 115.184 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -67.09 -62.45 1.42 Allowed 'General case' 0 C--N 1.327 -0.38 1 N-CA-C 121.893 4.034 . . . . 0.0 121.893 -158.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . 0.471 76.0 p -67.1 -25.02 66.01 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 124.272 3.214 . . . . 0.0 117.154 -176.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.42 -29.3 61.41 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 117.714 2.487 . . . . 0.0 117.714 -171.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.7 ptt85 -50.59 -38.81 47.66 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 117.792 -3.068 . . . . 0.0 114.475 175.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -59.25 -29.02 67.24 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.076 1.75 . . . . 0.0 112.401 -176.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -55.98 -40.97 74.08 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 122.268 2.304 . . . . 0.0 112.663 -178.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 60.7 mt -75.45 -8.61 57.16 Favored 'General case' 0 CA--C 1.514 -0.409 0 O-C-N 127.448 2.968 . . . . 0.0 116.567 -158.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.41 -13.12 11.81 Favored Glycine 0 C--N 1.346 1.119 0 O-C-N 119.792 -1.817 . . . . 0.0 114.486 173.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.3 pt -88.24 163.42 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -164.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 96.1 p -84.18 177.62 8.14 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 118.869 -2.395 . . . . 0.0 112.406 -175.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . 0.322 27.5 tt0 -54.92 -50.14 69.56 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 120.299 1.409 . . . . 0.0 112.71 172.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -61.95 -29.57 70.32 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.333 1.853 . . . . 0.0 115.854 -176.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -78.62 -40.18 35.1 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 175.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . 0.299 5.7 tp -46.9 -44.51 19.77 Favored 'General case' 0 C--O 1.239 0.55 1 O-C-N 129.747 4.404 . . . . 0.0 110.329 165.593 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.65 -55.46 34.51 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 128.099 2.56 . . . . 0.0 112.377 173.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -63.56 -34.88 78.77 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 120.175 1.352 . . . . 0.0 112.645 174.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -63.72 -36.68 84.67 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 126.191 2.901 . . . . 0.0 108.911 -172.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.1 mp -99.29 -5.1 30.36 Favored 'General case' 0 N--CA 1.438 -1.052 1 C-N-CA 135.199 5.4 . . . . 0.0 113.44 -170.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt 55.0 57.51 5.55 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.663 1.185 . . . . 0.0 113.389 -177.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.9 m -151.6 -176.25 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 130.076 3.351 . . . . 0.0 111.445 -171.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 65.7 p -93.85 163.02 13.68 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 118.482 -2.636 . . . . 0.0 115.218 167.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -70.4 -18.13 63.03 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 119.124 0.874 . . . . 0.0 111.517 171.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -68.02 -34.67 76.94 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 114.815 -2.754 . . . . 0.0 118.32 160.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 27.8 mt -73.77 -39.57 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 O-C-N 116.766 -3.709 . . . . 0.0 109.998 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.331 11.9 m -59.01 -49.86 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 O-C-N 119.441 -2.037 . . . . 0.0 111.02 178.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -48.11 -43.51 31.07 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 129.868 3.267 . . . . 0.0 108.596 167.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -67.54 -32.43 73.2 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-N 123.184 2.72 . . . . 0.0 114.018 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -75.1 -39.49 60.61 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 129.797 3.239 . . . . 0.0 106.871 170.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 -60.1 -32.72 71.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 122.352 2.342 . . . . 0.0 108.595 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.6 p -112.15 -6.75 14.11 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -144.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.52 18.12 74.24 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-O 125.157 2.531 . . . . 0.0 114.402 -176.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -97.85 33.84 2.02 Favored 'General case' 0 N--CA 1.438 -1.025 1 O-C-N 115.423 -4.575 . . . . 0.0 113.704 -176.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.4 tp -130.65 129.73 43.02 Favored 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 130.492 3.517 . . . . 0.0 110.198 -178.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -101.65 102.7 23.73 Favored Pre-proline 0 N--CA 1.442 -0.853 0 CA-C-O 115.91 -1.995 . . . . 0.0 106.455 168.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -80.31 174.73 11.01 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 CA-C-N 120.372 1.169 . . . . 0.0 112.33 -171.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 62.1 p -139.99 174.22 10.73 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 118.8 -2.437 . . . . 0.0 110.436 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.89 -32.52 56.25 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -171.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.3 p -56.83 -53.56 56.48 Favored 'General case' 0 CA--C 1.512 -0.498 2 O-C-N 112.643 -6.286 . . . . 0.0 112.906 158.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -67.14 -36.44 81.88 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 118.431 2.752 . . . . 0.0 118.431 -170.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -31.85 -73.74 0.03 OUTLIER 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 131.434 3.893 . . . . 0.0 116.451 163.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -56.04 -36.36 67.92 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.437 -1.71 . . . . 0.0 111.856 172.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -75.47 -25.87 57.74 Favored 'General case' 0 C--O 1.246 0.88 1 CA-C-O 111.509 -4.091 . . . . 0.0 111.735 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.5 mt -69.51 -41.53 75.92 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 126.617 2.448 . . . . 0.0 107.705 -176.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -55.14 -38.06 67.74 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 117.7 2.482 . . . . 0.0 117.7 165.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -87.97 -35.0 17.88 Favored 'General case' 0 C--O 1.225 -0.225 0 O-C-N 116.845 -3.659 . . . . 0.0 114.931 -168.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.9 pt -63.71 -44.11 98.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 122.466 2.394 . . . . 0.0 107.213 -175.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.4 tp -68.94 -24.43 64.27 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 126.073 1.749 . . . . 0.0 112.699 169.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.07 -20.07 0.09 OUTLIER Glycine 0 C--N 1.337 0.636 0 N-CA-C 117.218 1.647 . . . . 0.0 117.218 -174.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.1 pt -134.25 174.27 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -168.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -147.75 166.4 27.62 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 113.784 -3.008 . . . . 0.0 108.785 -170.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.9 mt -144.37 154.25 42.81 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 127.931 2.492 . . . . 0.0 112.556 160.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.41 ' CG2' ' HB3' ' A' ' 84' ' ' ASN . 25.9 m -106.1 175.91 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 130.962 3.705 . . . . 0.0 114.064 22.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 81.6 p -111.21 174.59 2.27 Favored Pre-proline 0 N--CA 1.449 -0.51 0 C-N-CA 128.743 2.817 . . . . 0.0 113.708 162.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -61.62 0.83 0.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.361 0 O-C-N 125.012 2.059 . . . . 0.0 112.265 177.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.1 mt -56.53 -23.23 38.46 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 159.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -131.3 -49.09 1.0 Allowed 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 127.562 3.039 . . . . 0.0 112.133 169.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.41 ' HB3' ' CG2' ' A' ' 79' ' ' VAL . 28.4 t-20 -146.13 152.89 40.01 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 128.096 2.558 . . . . 0.0 116.502 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -110.75 108.12 17.88 Favored 'General case' 0 C--O 1.223 -0.3 0 O-C-N 119.987 -1.696 . . . . 0.0 108.947 173.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -112.91 129.24 56.54 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 117.531 -3.231 . . . . 0.0 105.704 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.324 99.4 mt-10 -119.12 163.97 16.24 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 114.391 -2.719 . . . . 0.0 110.216 -171.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 83.9 p -42.89 -35.05 1.08 Allowed 'General case' 0 N--CA 1.449 -0.52 1 CA-C-N 126.889 4.404 . . . . 0.0 110.064 -170.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -67.49 -18.98 65.26 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 117.2 -3.437 . . . . 0.0 111.252 -175.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -111.08 -22.56 11.39 Favored 'General case' 0 N--CA 1.452 -0.367 1 O-C-N 116.234 -4.041 . . . . 0.0 115.747 164.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -83.52 -15.76 48.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 116.778 -1.582 . . . . 0.0 111.551 -175.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -144.1 108.91 4.93 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 121.955 2.161 . . . . 0.0 107.372 -171.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.49 -21.25 3.55 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 131.589 3.956 . . . . 0.0 113.257 -171.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -98.19 6.02 47.89 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.607 1.563 . . . . 0.0 113.279 -169.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.55 178.33 5.24 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 116.839 -1.553 . . . . 0.0 113.57 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.29 23.33 71.29 Favored Glycine 0 C--O 1.218 -0.864 0 O-C-N 126.752 2.532 . . . . 0.0 113.249 168.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.34 -10.94 14.58 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.115 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.7 t 169.33 162.25 0.05 Allowed 'General case' 0 N--CA 1.449 -0.49 1 C-N-CA 131.86 4.064 . . . . 0.0 114.579 -170.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 15.4 tp -84.51 6.72 22.5 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 120.224 -1.547 . . . . 0.0 111.355 165.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 33.76 52.0 0.63 Allowed Glycine 0 C--N 1.336 0.563 0 C-N-CA 129.94 3.638 . . . . 0.0 109.704 -159.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -74.83 93.95 2.7 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 117.494 -3.356 . . . . 0.0 116.353 -175.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -119.12 155.83 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 O-C-N 127.442 2.964 . . . . 0.0 112.414 -165.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.1 p -59.22 135.54 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 2 O-C-N 112.728 -6.233 . . . . 0.0 113.195 17.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.427 HD22 ' HG3' ' A' ' 107' ' ' GLU . 5.9 p30 -49.03 126.75 13.08 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.011 164.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.7 pt -63.22 -15.86 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 117.823 2.527 . . . . 0.0 117.823 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.2 tptt -70.75 -35.81 72.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 122.318 2.326 . . . . 0.0 110.589 171.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.427 ' HG3' HD22 ' A' ' 104' ' ' ASN . 6.4 mm-40 -85.27 -8.38 58.55 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 117.763 2.505 . . . . 0.0 117.763 168.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 173.64 117.29 0.45 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 119.209 2.444 . . . . 0.0 119.209 160.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -124.34 142.02 51.61 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 125.07 2.367 . . . . 0.0 108.122 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . 0.265 54.2 pttt -167.98 8.35 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.425 1 C-N-CA 132.281 4.232 . . . . 0.0 118.426 -172.006 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 mt -106.55 166.58 10.45 Favored 'General case' 0 N--CA 1.446 -0.671 1 C-N-CA 131.892 4.077 . . . . 0.0 113.085 153.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.358 15.0 tt0 -152.44 -100.29 0.05 Allowed 'General case' 0 CA--C 1.518 -0.286 1 O-C-N 115.809 -4.307 . . . . 0.0 113.27 -140.799 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -78.02 -6.77 55.59 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.09 0.956 . . . . 0.0 112.692 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 . . . . . 0 C--O 1.247 0.934 0 C-N-CA 128.131 2.572 . . . . 0.0 114.56 -175.637 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 . . . . . 0 N--CA 1.472 0.626 0 CA-C-O 122.714 1.245 . . . . 0.0 108.278 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 173.44 117.27 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 111.641 -2.527 . . . . 0.0 114.893 -162.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.0 -33.8 18.27 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 116.171 -1.871 . . . . 0.0 112.983 -161.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -61.58 -23.59 66.1 Favored 'General case' 0 C--O 1.222 -0.395 0 N-CA-C 118.043 2.609 . . . . 0.0 118.043 171.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.5 tp -85.13 12.38 7.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 116.728 -1.606 . . . . 0.0 113.102 -171.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -152.39 12.45 0.55 Allowed 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -169.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.6 pt -115.24 172.65 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 O-C-N 119.353 -2.092 . . . . 0.0 112.33 165.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.9 m -82.64 164.45 2.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 O-C-N 117.288 -3.383 . . . . 0.0 115.328 172.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 p -61.83 -47.76 83.65 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 119.265 -2.147 . . . . 0.0 110.825 174.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . 0.325 11.7 m-20 -82.34 37.62 0.51 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 119.699 1.136 . . . . 0.0 112.743 -172.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -75.52 142.15 42.89 Favored 'General case' 0 C--O 1.236 0.374 1 C-N-CA 131.744 4.018 . . . . 0.0 117.459 -175.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -58.65 141.74 51.6 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 118.362 -2.711 . . . . 0.0 115.541 174.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -113.08 -14.95 12.89 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 116.95 2.204 . . . . 0.0 116.95 -164.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -60.14 -48.64 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 O-C-N 124.488 1.118 . . . . 0.0 111.35 -166.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.519 6.4 pt -72.77 -23.54 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 128.046 2.538 . . . . 0.0 117.003 173.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 51.1 tttm -56.54 -67.61 0.29 Allowed 'General case' 0 C--O 1.243 0.717 0 N-CA-C 118.079 2.622 . . . . 0.0 118.079 -162.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 57.8 p -68.64 -35.82 77.79 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 121.595 1.998 . . . . 0.0 106.574 -172.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.48 -37.43 87.29 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.748 2.019 . . . . 0.0 114.468 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -54.02 -49.98 67.68 Favored 'General case' 0 N--CA 1.44 -0.938 2 O-C-N 112.401 -6.437 . . . . 0.0 112.273 166.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -63.2 -33.37 75.33 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 129.354 3.062 . . . . 0.0 111.265 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -76.47 -25.99 54.9 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 122.703 2.501 . . . . 0.0 108.59 -176.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.1 mt -76.7 -23.42 53.13 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 119.663 -1.898 . . . . 0.0 110.364 168.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.48 -14.89 6.28 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 122.327 2.33 . . . . 0.0 110.935 174.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.0 pt -71.14 155.92 7.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 O-C-N 118.392 -2.828 . . . . 0.0 113.9 -154.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . 0.309 78.8 p -74.18 175.84 7.16 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 127.84 3.213 . . . . 0.0 111.669 -177.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.77 -46.13 89.44 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 123.284 1.516 . . . . 0.0 110.292 161.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -59.07 -28.95 66.96 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 115.585 -2.15 . . . . 0.0 113.135 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -79.88 -29.17 39.92 Favored 'General case' 0 N--CA 1.446 -0.669 1 CA-C-O 111.461 -4.114 . . . . 0.0 111.47 174.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.5 tp -68.74 -34.97 76.49 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 125.205 3.638 . . . . 0.0 110.97 171.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.3 -41.53 80.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 121.382 1.901 . . . . 0.0 113.359 171.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -61.74 -42.42 98.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 127.192 2.808 . . . . 0.0 109.667 171.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -51.33 -32.35 25.03 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 127.089 3.328 . . . . 0.0 109.445 -172.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.5 mt -120.2 2.27 10.87 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 117.412 -3.305 . . . . 0.0 110.831 -153.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 77.2 mttt 47.17 -17.8 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.906 1 N-CA-C 123.725 4.713 . . . . 0.0 123.725 -159.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.3 m -94.91 156.42 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 130.15 3.38 . . . . 0.0 115.066 -172.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 84.5 p -72.39 168.09 19.15 Favored 'General case' 0 N--CA 1.441 -0.898 0 O-C-N 118.374 -2.704 . . . . 0.0 116.737 -177.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -65.91 -20.48 66.23 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 118.877 2.917 . . . . 0.0 118.877 -175.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -47.84 -34.19 8.41 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 118.234 2.679 . . . . 0.0 118.234 163.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.0 mm -80.78 -38.94 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 119.006 -1.078 . . . . 0.0 113.25 166.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.261 11.0 m -66.05 -42.77 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-O 115.496 -2.193 . . . . 0.0 115.86 -170.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -58.18 -17.96 22.48 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 127.486 2.314 . . . . 0.0 113.621 177.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -72.55 -50.75 23.48 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 130.688 3.595 . . . . 0.0 110.52 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.374 58.4 m-85 -73.13 -26.06 61.08 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 120.335 1.425 . . . . 0.0 109.173 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -69.0 -45.15 71.29 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 117.923 -2.986 . . . . 0.0 106.831 177.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.4 p -93.67 -34.93 13.07 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 -167.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.36 21.16 62.92 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-O 114.076 -3.624 . . . . 0.0 117.824 173.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -95.1 8.12 43.97 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 128.817 2.847 . . . . 0.0 114.189 -162.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.6 tp -134.38 144.0 47.96 Favored 'General case' 0 N--CA 1.447 -0.623 1 O-C-N 129.852 4.47 . . . . 0.0 114.043 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -102.09 91.8 2.71 Favored Pre-proline 0 N--CA 1.441 -0.878 0 O-C-N 118.678 -2.514 . . . . 0.0 108.749 166.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . 0.272 2.6 Cg_endo -74.9 176.65 9.59 Favored 'Trans proline' 0 N--CA 1.454 -0.81 1 C-N-CA 127.859 5.706 . . . . 0.0 107.789 -168.917 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.8 p -76.85 179.74 5.95 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.3 mp -55.04 -62.24 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 C-N-CA 128.4 2.68 . . . . 0.0 107.669 -169.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.6 p -55.05 -30.62 59.99 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 115.237 -2.316 . . . . 0.0 113.896 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -84.15 -54.48 4.79 Favored 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 127.164 2.79 . . . . 0.0 106.661 -168.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -48.49 -33.32 9.24 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 128.683 2.793 . . . . 0.0 114.761 160.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.8 mtt-85 -75.64 -34.46 60.54 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 114.329 -2.748 . . . . 0.0 113.172 166.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -70.56 -32.67 70.18 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 122.932 2.605 . . . . 0.0 115.106 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 72' ' ' LYS . 5.6 tt -41.64 -72.55 0.06 Allowed 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 130.118 3.367 . . . . 0.0 114.925 177.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -48.78 -19.43 0.37 Allowed 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 126.071 2.843 . . . . 0.0 110.26 173.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 70' ' ' LEU . 28.1 mtpt -99.91 -8.33 24.14 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 117.524 -3.235 . . . . 0.0 115.996 -163.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.5 pt -61.43 -46.78 95.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 1 N-CA-C 122.004 4.075 . . . . 0.0 122.004 -171.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 49.3 mt -74.48 -18.23 60.65 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 126.002 1.721 . . . . 0.0 110.326 -172.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.47 -0.57 17.66 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 118.752 -1.69 . . . . 0.0 116.396 -158.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 30.8 pt -142.11 175.71 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 125.906 1.682 . . . . 0.0 109.238 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.357 11.5 pttt -176.95 149.06 0.69 Allowed 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 128.668 2.787 . . . . 0.0 108.526 -174.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.1 mt -133.81 145.07 49.4 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 176.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.2 m -113.03 152.84 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 1 C-N-CA 133.804 4.842 . . . . 0.0 114.188 21.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . 0.292 80.3 p -93.83 175.84 2.8 Favored Pre-proline 0 C--O 1.24 0.576 0 C-N-CA 127.2 2.2 . . . . 0.0 109.362 -169.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -54.53 -1.49 0.15 Allowed 'Trans proline' 0 N--CA 1.452 -0.946 1 C-N-CA 125.612 4.208 . . . . 0.0 111.363 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 65.9 mt -57.26 -31.9 66.04 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 122.709 2.504 . . . . 0.0 111.561 160.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -124.47 -39.18 2.34 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 127.778 2.431 . . . . 0.0 111.834 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -160.84 123.46 3.21 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 111.945 -2.389 . . . . 0.0 115.442 -160.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -101.18 163.7 12.15 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 126.546 2.404 . . . . 0.0 108.226 178.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . 0.285 1.3 tt0 -154.26 148.79 26.27 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 131.431 3.893 . . . . 0.0 110.438 170.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.45 129.74 40.58 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 125.281 1.613 . . . . 0.0 114.23 175.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.9 m -73.07 -13.77 61.27 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 116.564 -1.684 . . . . 0.0 114.286 -174.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -63.8 -19.61 65.15 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 119.908 1.231 . . . . 0.0 112.592 -175.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -56.28 -21.41 23.73 Favored 'General case' 0 N--CA 1.44 -0.972 0 O-C-N 116.362 -3.961 . . . . 0.0 110.208 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -82.99 -2.32 54.91 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -171.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -135.9 148.55 48.63 Favored 'General case' 0 CA--C 1.514 -0.428 0 O-C-N 116.463 -3.898 . . . . 0.0 107.878 174.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -152.03 -68.1 0.17 Allowed 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 103.801 -2.666 . . . . 0.0 103.801 -158.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -87.29 -10.83 51.32 Favored 'General case' 0 N--CA 1.447 -0.621 1 O-C-N 114.858 -4.901 . . . . 0.0 113.503 -169.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 44.3 p -120.63 174.04 6.82 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 108.729 -3.85 . . . . 0.0 110.316 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -119.59 125.9 6.52 Favored Glycine 0 C--N 1.335 0.507 1 C-N-CA 130.787 4.042 . . . . 0.0 109.42 164.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 15.0 tp -105.28 -16.71 14.68 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 118.41 -2.817 . . . . 0.0 115.968 -171.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 43.3 p -152.28 4.54 0.39 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 118.338 2.718 . . . . 0.0 118.338 -157.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.5 tp -162.35 116.21 1.79 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 129.84 3.256 . . . . 0.0 115.079 173.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 102' ' ' VAL . . . -61.93 -20.52 60.1 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-O 114.875 -3.18 . . . . 0.0 115.581 171.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.368 1.4 t70 -74.72 47.23 0.32 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 128.607 2.763 . . . . 0.0 111.203 -168.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.406 ' H ' ' C ' ' A' ' 100' ' ' GLY . 2.1 m -132.29 145.44 34.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 O-C-N 127.53 3.019 . . . . 0.0 111.889 -166.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 33.9 m -73.97 146.16 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 O-C-N 117.837 -3.04 . . . . 0.0 104.615 25.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -62.19 98.69 0.11 Allowed 'General case' 0 C--O 1.239 0.54 0 CA-C-N 112.792 -2.004 . . . . 0.0 115.178 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 88.8 mt -75.74 100.5 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 126.109 1.764 . . . . 0.0 106.938 -178.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -69.99 -15.48 63.03 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 115.642 -2.123 . . . . 0.0 109.218 174.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -75.23 -6.87 52.0 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 127.977 2.511 . . . . 0.0 113.349 -176.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 144.54 155.13 6.34 Favored Glycine 0 C--O 1.22 -0.757 0 C-N-CA 127.086 2.279 . . . . 0.0 113.736 171.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -67.79 168.84 10.72 Favored 'General case' 0 N--CA 1.439 -1.002 0 O-C-N 124.864 0.979 . . . . 0.0 112.457 170.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -51.73 101.95 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.528 1.531 . . . . 0.0 113.833 171.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.0 pp 174.77 179.66 0.12 Allowed 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 128.855 2.862 . . . . 0.0 110.461 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.551 ' C ' ' H ' ' A' ' 114' ' ' HIS . 21.7 tt0 -156.41 -110.39 0.03 OUTLIER 'General case' 0 C--O 1.222 -0.39 0 O-C-N 120.852 -1.155 . . . . 0.0 113.353 176.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -66.24 28.17 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 116.562 -3.836 . . . . 0.0 113.901 175.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . 0.551 ' H ' ' C ' ' A' ' 112' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.047 0 C-N-CA 128.698 2.799 . . . . 0.0 113.017 -175.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 . . . . . 0 C--O 1.217 -0.638 0 CA-C-O 123.408 1.575 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -154.97 98.51 2.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 116.994 2.22 . . . . 0.0 116.994 172.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.97 -7.26 15.91 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 118.913 2.931 . . . . 0.0 118.913 176.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -117.64 16.36 14.52 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 120.502 1.501 . . . . 0.0 111.728 175.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . 0.308 43.1 tp -61.02 -50.09 74.76 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 131.275 3.83 . . . . 0.0 110.009 -175.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -112.18 12.05 20.36 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 125.094 2.378 . . . . 0.0 113.357 -153.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 6.5 pt -107.45 155.11 8.27 Favored 'Isoleucine or valine' 0 C--N 1.34 0.171 1 O-C-N 115.579 -4.45 . . . . 0.0 109.128 174.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.7 m -74.36 167.15 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 121.542 1.974 . . . . 0.0 112.392 158.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.0 m -64.64 -43.51 93.46 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -76.31 10.88 1.77 Allowed 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 115.304 -2.284 . . . . 0.0 112.406 -172.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -65.91 154.13 40.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 129.986 3.314 . . . . 0.0 109.951 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . 0.506 0.0 OUTLIER -75.74 67.66 2.21 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 119.738 3.236 . . . . 0.0 119.738 179.348 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -60.08 -22.75 63.13 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 119.797 -1.814 . . . . 0.0 113.972 -169.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.1 pt -61.96 -29.34 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-O 114.815 -2.517 . . . . 0.0 112.851 173.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.316 12.2 mm -63.92 -57.11 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 CA-C-N 122.542 2.428 . . . . 0.0 105.836 174.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -51.02 -65.03 0.63 Allowed 'General case' 0 CA--C 1.532 0.266 1 C-N-CA 134.535 5.134 . . . . 0.0 109.874 -155.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 77.4 p -57.17 -31.68 65.65 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 126.253 2.221 . . . . 0.0 113.772 -164.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.87 -58.51 3.24 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.488 1.515 . . . . 0.0 108.183 174.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 56.5 ttt180 -51.15 -36.79 42.68 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 118.631 -2.543 . . . . 0.0 114.103 -176.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -68.32 -42.22 79.69 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 123.918 3.054 . . . . 0.0 113.467 172.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -54.19 -37.84 64.96 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-O 123.898 1.809 . . . . 0.0 113.206 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.256 62.9 mt -90.44 -11.1 41.4 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 111.266 -2.697 . . . . 0.0 112.371 -161.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.36 4.77 5.38 Favored Glycine 0 C--O 1.238 0.382 0 CA-C-O 125.329 2.627 . . . . 0.0 118.327 178.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.2 pt -69.02 153.06 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 O-C-N 119.668 -2.078 . . . . 0.0 112.161 -172.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.6 p -129.9 165.97 20.96 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 117.387 2.366 . . . . 0.0 117.387 -162.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -60.39 -37.28 80.3 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 116.978 -1.487 . . . . 0.0 112.833 -176.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -52.47 -34.65 50.08 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 115.322 -2.275 . . . . 0.0 113.458 166.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -77.51 -37.76 50.39 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 122.3 2.318 . . . . 0.0 111.632 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.3 tp -73.98 -31.93 63.2 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 115.364 -2.255 . . . . 0.0 108.602 -175.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.43 -47.02 76.64 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 166.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -60.6 -42.55 96.99 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 122.802 1.287 . . . . 0.0 112.825 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -70.43 -16.99 63.0 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 118.109 -2.869 . . . . 0.0 106.491 -173.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.8 tp -110.7 5.01 20.56 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 -169.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.2 tttp 45.56 52.67 9.09 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 131.158 3.783 . . . . 0.0 110.128 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.8 m -142.45 -176.41 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 C-N-CA 130.036 3.335 . . . . 0.0 115.73 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 86.7 p -94.42 161.35 14.26 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 125.099 1.36 . . . . 0.0 112.544 167.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -73.17 -12.95 61.07 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 117.122 -3.486 . . . . 0.0 110.378 -174.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -62.29 -37.4 85.37 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 119.027 -2.296 . . . . 0.0 111.961 170.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.0 mm -68.51 -28.94 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 125.936 1.694 . . . . 0.0 110.842 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.378 3.2 m -66.29 -35.55 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 O-C-N 117.282 -3.386 . . . . 0.0 113.987 -175.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -50.18 -38.13 38.28 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 117.198 2.296 . . . . 0.0 117.198 -170.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.292 99.0 mtt180 -25.94 -87.03 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 127.927 2.491 . . . . 0.0 114.739 170.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -77.99 -25.03 47.84 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 120.425 -1.422 . . . . 0.0 111.72 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -63.24 -13.04 33.36 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 120.28 1.4 . . . . 0.0 113.967 -177.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.8 p -65.04 -20.19 66.37 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 117.81 2.522 . . . . 0.0 117.81 170.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.79 19.46 75.09 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 128.817 3.103 . . . . 0.0 114.408 174.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -92.65 12.3 23.72 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 128.385 3.05 . . . . 0.0 116.04 -174.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.5 mt -145.48 120.81 10.26 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 171.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.8 tttp -64.97 116.38 29.3 Favored Pre-proline 0 C--O 1.233 0.202 0 O-C-N 119.22 -2.175 . . . . 0.0 113.623 161.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -66.43 160.53 45.17 Favored 'Trans proline' 0 N--CA 1.448 -1.199 1 C-N-CA 128.479 6.119 . . . . 0.0 114.145 -176.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 63.9 p -108.94 -165.93 1.07 Allowed 'General case' 0 C--O 1.239 0.514 0 C-N-CA 127.246 2.218 . . . . 0.0 114.472 172.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 34.2 mt -57.88 -59.43 3.42 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.158 0 O-C-N 118.772 -2.455 . . . . 0.0 114.126 -171.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.3 p -59.75 -40.7 89.01 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 169.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -63.06 -55.21 27.49 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 116.361 1.985 . . . . 0.0 116.361 -178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -39.71 -47.27 2.0 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 117.196 -1.383 . . . . 0.0 113.356 160.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.1 ttt85 -67.25 -39.57 86.14 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 127.234 2.213 . . . . 0.0 107.897 -172.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -67.84 -52.23 39.12 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 116.74 -1.6 . . . . 0.0 107.174 176.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 21.6 tp -59.88 -60.32 4.02 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 127.845 3.688 . . . . 0.0 111.049 -168.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -52.63 -39.09 61.38 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 117.899 -3.001 . . . . 0.0 109.053 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -76.77 -34.73 58.0 Favored 'General case' 0 N--CA 1.446 -0.653 1 O-C-N 115.239 -4.663 . . . . 0.0 119.446 176.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 31.5 pt -67.84 -30.6 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 118.021 -1.471 . . . . 0.0 108.299 170.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.479 ' C ' ' H ' ' A' ' 76' ' ' ILE 0.311 95.8 mt -70.97 -41.97 70.33 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 117.024 -3.547 . . . . 0.0 117.102 174.857 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.15 -8.5 0.16 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 127.307 2.384 . . . . 0.0 110.961 -167.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.479 ' H ' ' C ' ' A' ' 74' ' ' LEU . 44.8 pt -116.91 146.62 21.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 117.803 2.52 . . . . 0.0 117.803 -177.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -176.2 153.68 1.29 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 114.604 -2.617 . . . . 0.0 112.572 176.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 13.5 mt -144.33 123.03 12.57 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 126.485 3.04 . . . . 0.0 112.209 179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.9 m -96.14 174.25 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.661 1 O-C-N 113.746 -5.596 . . . . 0.0 115.942 20.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.1 p -93.84 167.06 14.47 Favored Pre-proline 0 N--CA 1.462 0.163 0 O-C-N 120.723 -1.236 . . . . 0.0 108.849 -170.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -68.75 -8.94 24.77 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 O-C-N 115.178 -3.117 . . . . 0.0 109.451 -171.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 15.1 mt -75.55 -7.21 53.61 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 116.326 -1.797 . . . . 0.0 114.863 168.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -131.67 -4.63 3.67 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 114.336 -2.745 . . . . 0.0 111.163 172.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.0 154.21 48.42 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 124.782 3.446 . . . . 0.0 109.242 166.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -79.48 119.15 22.09 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 112.293 -2.23 . . . . 0.0 111.342 169.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.487 ' CD ' ' HZ3' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -142.64 167.86 21.08 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.01 1.324 . . . . 0.0 109.777 168.167 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.483 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 27.8 tt0 -75.47 121.35 22.2 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.331 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -81.88 -17.51 47.03 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 120.134 1.334 . . . . 0.0 111.204 -160.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -55.87 -18.52 9.02 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 129.371 3.069 . . . . 0.0 111.342 169.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.487 ' HZ3' ' CD ' ' A' ' 86' ' ' GLU . 93.3 mttt -63.78 -22.18 66.79 Favored 'General case' 0 CA--C 1.516 -0.353 0 O-C-N 117.338 -3.351 . . . . 0.0 110.319 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -53.68 -37.07 62.86 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 124.177 3.171 . . . . 0.0 110.195 170.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -76.87 151.63 35.75 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 116.374 -3.954 . . . . 0.0 109.584 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -46.76 -65.35 0.57 Allowed 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.657 1.583 . . . . 0.0 114.732 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -118.3 -29.96 5.38 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 127.432 2.293 . . . . 0.0 116.795 -172.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . 0.257 12.7 t -173.59 153.94 2.41 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 127.702 3.126 . . . . 0.0 115.089 -173.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.48 117.92 13.1 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 127.657 2.551 . . . . 0.0 110.576 166.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.2 mt -94.55 153.89 17.66 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 116.145 -1.883 . . . . 0.0 113.102 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.4 m -105.94 132.95 51.42 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 126.235 2.209 . . . . 0.0 108.846 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 62.9 tp -83.92 -19.6 34.45 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 120.846 3.647 . . . . 0.0 120.846 169.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 57.09 53.33 45.43 Favored Glycine 0 N--CA 1.45 -0.421 0 O-C-N 124.023 0.827 . . . . 0.0 113.236 172.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.296 15.7 t70 -162.84 95.64 0.89 Allowed 'General case' 0 C--O 1.237 0.418 0 CA-C-O 115.33 -2.271 . . . . 0.0 112.854 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.414 ' HB ' ' HA ' ' A' ' 103' ' ' VAL . 4.2 m -133.02 163.03 39.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 O-C-N 127.27 2.856 . . . . 0.0 111.948 -173.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.414 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 56.1 t -67.93 136.18 27.04 Favored 'Isoleucine or valine' 0 C--N 1.345 0.404 1 O-C-N 113.835 -5.541 . . . . 0.0 117.37 -5.607 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -76.41 123.2 25.63 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 127.117 2.76 . . . . 0.0 110.646 166.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.407 ' CG1' ' H ' ' A' ' 108' ' ' GLY . 0.4 OUTLIER -109.55 151.12 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-N 122.764 2.529 . . . . 0.0 110.313 170.3 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -84.01 -23.7 30.85 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 120.56 1.527 . . . . 0.0 110.999 -167.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -82.8 -27.95 30.58 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 117.211 -1.376 . . . . 0.0 108.833 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.407 ' H ' ' CG1' ' A' ' 105' ' ' ILE . . . -115.56 163.37 12.29 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 122.086 2.221 . . . . 0.0 115.815 -165.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -138.17 35.61 2.32 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 128.904 2.882 . . . . 0.0 111.401 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.3 tttp 160.05 118.84 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.355 1 C-N-CA 136.093 5.757 . . . . 0.0 109.311 -166.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.1 mt -101.15 -176.26 3.11 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 156.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -153.95 -128.31 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 114.934 -2.46 . . . . 0.0 104.608 -176.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . 0.292 0.2 OUTLIER -72.1 19.51 0.07 Allowed 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 123.566 2.894 . . . . 0.0 115.993 -173.233 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . 0.254 72.4 m80 . . . . . 0 C--O 1.25 1.082 1 C-N-CA 133.702 4.801 . . . . 0.0 111.768 -179.403 . . . . . . . . 2 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.539 ' HA ' ' OE1' ' A' ' 13' ' ' GLU . 4.5 mm-40 . . . . . 0 CA--C 1.539 0.531 0 CA-C-O 118.415 -0.802 . . . . 0.0 111.595 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -137.11 55.39 1.82 Allowed 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 128.869 3.855 . . . . 0.0 117.243 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.4 -7.08 59.52 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 113.157 -1.838 . . . . 0.0 113.612 -160.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.403 0.3 OUTLIER -134.35 10.34 3.78 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 125.811 1.944 . . . . 0.0 115.164 -172.187 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . 0.29 5.8 mt 61.27 44.25 9.98 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 128.286 2.635 . . . . 0.0 111.247 177.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -157.3 135.4 11.03 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 112.789 -2.005 . . . . 0.0 115.246 -167.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 21.2 pt -105.13 -17.73 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 113.373 -1.739 . . . . 0.0 113.641 -173.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t -56.89 139.55 16.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 164.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -151.63 -45.31 0.11 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 117.394 -1.289 . . . . 0.0 111.032 -175.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -76.15 63.5 1.85 Allowed 'General case' 0 CA--C 1.504 -0.81 0 C-N-CA 129.198 2.999 . . . . 0.0 113.713 174.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.438 ' CG ' ' HA2' ' A' ' 58' ' ' GLY . 63.5 t80 -90.9 153.56 20.1 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 130.697 3.599 . . . . 0.0 108.599 -165.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -72.73 140.93 48.11 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 126.87 3.224 . . . . 0.0 111.332 -167.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -93.96 -45.9 7.4 Favored 'General case' 0 CA--C 1.503 -0.848 1 O-C-N 114.19 -5.319 . . . . 0.0 116.456 -155.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.7 tp -65.22 -37.54 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-O 115.614 -2.136 . . . . 0.0 113.414 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.398 7.6 pt -55.05 -35.6 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 O-C-N 125.73 1.894 . . . . 0.0 109.302 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -67.54 -39.63 85.03 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 119.795 -1.816 . . . . 0.0 112.254 -174.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.9 p -62.17 -43.14 99.49 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 124.491 1.116 . . . . 0.0 108.705 -157.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.35 -74.8 0.13 Allowed 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 117.741 2.497 . . . . 0.0 117.741 -155.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -47.95 -46.36 32.13 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 -165.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -55.16 -58.6 7.01 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 124.374 3.261 . . . . 0.0 112.224 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -66.98 -23.1 65.91 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 123.519 2.872 . . . . 0.0 116.298 -172.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 99.3 mt -76.58 -1.8 29.29 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 177.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.54 -0.56 12.55 Favored Glycine 0 C--N 1.335 0.481 2 CA-C-N 107.327 -4.488 . . . . 0.0 117.064 172.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.2 pt -78.77 158.78 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 C-N-CA 130.077 3.351 . . . . 0.0 114.126 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 p -89.61 175.77 7.14 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 117.134 2.272 . . . . 0.0 117.134 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -55.73 -50.98 68.9 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 116.59 -3.819 . . . . 0.0 110.299 161.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -60.07 -47.28 86.53 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 129.27 3.028 . . . . 0.0 113.319 -170.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -64.21 -33.44 75.8 Favored 'General case' 0 N--CA 1.449 -0.51 1 CA-C-O 111.62 -4.038 . . . . 0.0 114.4 174.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 23.0 tp -85.25 -27.14 26.23 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 127.822 3.202 . . . . 0.0 109.653 -177.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.56 -24.1 67.67 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 129.28 3.032 . . . . 0.0 113.483 167.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -66.12 -55.64 15.41 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 104.089 -2.56 . . . . 0.0 104.089 169.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -62.25 -14.99 44.27 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 128.32 2.648 . . . . 0.0 113.41 -159.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 40.8 mt -131.51 -8.47 3.68 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 128.297 3.903 . . . . 0.0 109.955 -163.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.312 88.1 mttt 56.4 -5.4 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 121.709 3.966 . . . . 0.0 121.709 -158.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.3 m -131.25 153.47 39.07 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 C-N-CA 127.87 2.468 . . . . 0.0 110.907 -168.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.932 ' C ' ' H ' ' A' ' 52' ' ' VAL . 91.3 p -128.57 -11.83 4.98 Favored 'General case' 0 N--CA 1.446 -0.653 1 N-CA-C 122.196 4.147 . . . . 0.0 122.196 -169.69 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -99.59 -30.46 12.12 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 117.354 -3.342 . . . . 0.0 111.397 -158.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . 0.253 64.6 t30 -103.15 -55.49 2.4 Favored 'General case' 0 C--O 1.217 -0.618 1 N-CA-C 122.431 4.234 . . . . 0.0 122.431 177.152 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . 0.325 0.7 OUTLIER 41.23 52.03 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.491 2 O-C-N 113.689 -5.632 . . . . 0.0 118.247 14.295 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.932 ' H ' ' C ' ' A' ' 48' ' ' SER . 15.7 t -105.33 -42.36 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 129.366 3.067 . . . . 0.0 107.929 23.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -69.95 -39.34 76.12 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 119.023 2.972 . . . . 0.0 119.023 -153.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -83.05 -12.59 57.02 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 120.455 1.479 . . . . 0.0 114.391 -158.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -79.7 -11.93 59.83 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -88.26 -5.95 58.06 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 118.061 -2.899 . . . . 0.0 110.693 -175.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.6 p -92.1 -7.04 49.73 Favored 'General case' 0 N--CA 1.454 -0.268 1 N-CA-C 121.936 4.05 . . . . 0.0 121.936 -142.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.438 ' HA2' ' CG ' ' A' ' 23' ' ' TYR . . . 68.47 26.13 74.49 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-O 115.109 -3.05 . . . . 0.0 110.942 177.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -130.38 -1.32 4.46 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 119.068 2.988 . . . . 0.0 119.068 -160.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.2 tp -135.31 158.87 43.27 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 -171.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -106.48 94.87 10.64 Favored Pre-proline 0 CA--C 1.513 -0.454 0 CA-C-O 115.646 -2.121 . . . . 0.0 113.259 147.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.08 151.28 34.62 Favored 'Trans proline' 0 N--CA 1.443 -1.467 0 C-N-CA 122.612 2.208 . . . . 0.0 110.61 172.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.5 p -80.17 171.72 14.72 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 127.213 2.821 . . . . 0.0 117.726 169.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . 0.315 2.1 tp -53.58 -61.17 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 130.548 3.539 . . . . 0.0 106.382 177.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 83.2 p -61.23 -23.6 65.75 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 116.308 -1.806 . . . . 0.0 112.887 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -80.77 -46.69 15.02 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 128.379 2.672 . . . . 0.0 109.233 173.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.04 93.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 130.173 3.389 . . . . 0.0 115.035 170.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -52.09 -22.41 4.12 Favored 'General case' 0 C--O 1.22 -0.476 0 C-N-CA 127.276 2.23 . . . . 0.0 113.959 175.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -66.68 -13.05 60.79 Favored 'General case' 0 N--CA 1.438 -1.025 0 C-N-CA 125.985 1.714 . . . . 0.0 111.339 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.6 tp -79.97 -49.6 11.62 Favored 'General case' 0 N--CA 1.436 -1.152 1 O-C-N 114.735 -4.978 . . . . 0.0 109.484 -175.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -50.56 -31.32 15.41 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 126.567 2.417 . . . . 0.0 108.022 172.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.1 tttp -69.17 -54.24 15.88 Favored 'General case' 0 C--O 1.24 0.579 1 C-N-CA 131.788 4.035 . . . . 0.0 106.786 -170.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 19.2 pt -79.53 -40.0 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 117.466 -3.271 . . . . 0.0 108.076 -168.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 25.4 mt -82.45 -13.46 56.7 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 128.189 2.596 . . . . 0.0 114.04 -175.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.33 4.13 42.49 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-O 114.12 -3.6 . . . . 0.0 118.228 -167.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 6.5 pt -171.94 135.31 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 127.854 2.462 . . . . 0.0 109.016 -161.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -65.73 131.0 45.25 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 114.173 -3.011 . . . . 0.0 115.629 170.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.5 mt -138.74 145.58 40.42 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 124.099 3.136 . . . . 0.0 111.185 -173.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . 0.401 1.4 m -81.62 159.03 4.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 1 O-C-N 115.708 -4.37 . . . . 0.0 116.659 -0.978 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 67.8 p -76.18 157.6 82.89 Favored Pre-proline 0 N--CA 1.451 -0.38 0 O-C-N 121.702 -0.624 . . . . 0.0 109.517 177.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -50.71 -10.41 0.28 Allowed 'Trans proline' 0 N--CA 1.445 -1.382 0 O-C-N 124.207 1.635 . . . . 0.0 115.204 170.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 32.5 tp -71.99 -41.12 68.01 Favored 'General case' 0 C--O 1.219 -0.544 0 O-C-N 118.9 -2.375 . . . . 0.0 111.423 172.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -109.35 6.07 24.08 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 118.367 2.728 . . . . 0.0 118.367 -175.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -58.59 124.45 19.69 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 119.708 -1.87 . . . . 0.0 111.203 165.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -75.19 -15.37 60.56 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 122.618 2.463 . . . . 0.0 116.102 163.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -65.01 115.89 5.87 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 126.74 2.525 . . . . 0.0 108.62 173.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -78.33 -1.26 32.37 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 112.375 -3.678 . . . . 0.0 109.39 -177.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.4 p -105.81 15.4 26.78 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 125.587 3.812 . . . . 0.0 119.087 167.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -104.76 145.08 30.86 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 127.35 2.26 . . . . 0.0 111.56 164.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.2 pttt -161.47 169.73 21.31 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 125.12 2.39 . . . . 0.0 107.701 -175.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -72.37 138.75 47.45 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 127.149 2.18 . . . . 0.0 114.026 163.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -147.42 175.13 11.05 Favored 'General case' 0 CA--C 1.507 -0.673 0 C-N-CA 124.717 1.207 . . . . 0.0 108.173 -167.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.519 ' HB3' ' H ' ' A' ' 96' ' ' GLY . 5.1 t70 -157.61 159.35 36.96 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 114.498 -2.668 . . . . 0.0 111.739 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -50.17 -29.48 9.35 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 124.206 3.185 . . . . 0.0 114.692 156.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 53.6 m -70.0 -48.6 57.5 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 172.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.519 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -71.19 -13.45 73.23 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 117.184 -2.436 . . . . 0.0 114.498 175.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.4 tp -80.39 -28.15 37.98 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 121.02 3.711 . . . . 0.0 121.02 160.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 71.0 p -87.15 -10.71 52.04 Favored 'General case' 0 N--CA 1.447 -0.608 1 O-C-N 116.172 -4.08 . . . . 0.0 112.273 168.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.7 tp -75.08 -15.95 60.59 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 119.067 -2.27 . . . . 0.0 112.177 149.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.5 ' C ' ' H ' ' A' ' 102' ' ' VAL . . . 69.0 25.35 75.47 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-O 124.229 2.016 . . . . 0.0 114.338 -178.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -73.84 37.44 0.1 Allowed 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 117.953 2.575 . . . . 0.0 117.953 -177.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.5 ' H ' ' C ' ' A' ' 100' ' ' GLY . 9.9 p -128.81 152.46 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 1 C-N-CA 132.113 4.165 . . . . 0.0 111.597 -158.342 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.283 0.3 OUTLIER 83.78 -21.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 O-C-N 118.657 -2.527 . . . . 0.0 116.032 149.246 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -66.25 -19.9 65.95 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 117.572 -1.204 . . . . 0.0 109.48 -167.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.66 -26.63 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 122.413 2.37 . . . . 0.0 115.721 171.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -80.61 165.57 21.92 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 119.999 1.272 . . . . 0.0 108.84 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -96.07 146.59 24.52 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.0 -10.58 1.58 Allowed Glycine 0 C--N 1.337 0.632 0 N-CA-C 118.991 2.357 . . . . 0.0 118.991 -166.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -61.95 1.41 0.29 Allowed 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 120.13 1.965 . . . . 0.0 112.362 173.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -89.6 -26.84 20.58 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 118.544 -2.598 . . . . 0.0 114.257 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 23.1 tp -70.29 -31.13 68.34 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 126.372 2.987 . . . . 0.0 112.646 160.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.379 17.0 tt0 -81.13 -74.35 0.33 Allowed 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 118.16 -2.837 . . . . 0.0 116.817 -177.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -77.21 6.9 5.8 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 119.875 3.287 . . . . 0.0 119.875 -176.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 . . . . . 0 C--O 1.25 1.126 0 O-C-N 118.488 -2.633 . . . . 0.0 113.787 -172.347 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.4 t80 . . . . . 0 N--CA 1.447 -0.589 0 CA-C-O 117.474 -1.251 . . . . 0.0 112.666 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -75.39 -166.19 0.5 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -174.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -16.4 -57.91 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 119.905 3.298 . . . . 0.0 119.905 166.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 78' ' ' LEU . 9.2 tp -44.07 -50.84 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 118.84 2.904 . . . . 0.0 118.84 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.311 6.2 tt -84.27 -46.94 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 129.366 3.066 . . . . 0.0 110.115 175.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -52.44 -52.49 53.8 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 115.476 -2.202 . . . . 0.0 111.623 -172.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.1 p -46.33 -52.32 13.01 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.252 1.421 . . . . 0.0 109.247 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.9 -36.43 56.67 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-O 114.453 -2.689 . . . . 0.0 117.388 -172.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.425 ' HD2' HD22 ' A' ' 41' ' ' LEU 0.31 37.3 ptt85 -57.97 -43.93 86.79 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 121.201 1.819 . . . . 0.0 113.562 172.716 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -55.28 -34.0 63.72 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 113.575 -3.107 . . . . 0.0 111.962 164.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.65 -21.96 63.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 124.16 3.164 . . . . 0.0 109.028 178.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.8 mt -98.82 -9.87 23.74 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 125.764 1.626 . . . . 0.0 112.768 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.22 -7.33 2.59 Favored Glycine 0 N--CA 1.464 0.56 0 CA-C-N 113.014 -1.903 . . . . 0.0 117.851 174.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.5 pt -57.11 128.32 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 128.293 2.637 . . . . 0.0 111.284 -176.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.7 p -67.93 162.52 24.11 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 118.936 2.939 . . . . 0.0 118.936 -171.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -48.02 -43.97 30.5 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 117.604 -3.185 . . . . 0.0 113.951 168.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -68.69 -34.89 76.43 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 123.415 0.686 . . . . 0.0 110.002 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -71.32 -41.5 69.77 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 115.05 -2.405 . . . . 0.0 109.105 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.425 HD22 ' HD2' ' A' ' 31' ' ' ARG 0.257 29.2 tp -59.94 -46.25 90.0 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 128.081 2.552 . . . . 0.0 113.945 177.501 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 47' ' ' VAL . . . -54.5 -37.77 65.7 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 110.718 -2.946 . . . . 0.0 116.492 174.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.455 ' C ' ' H ' ' A' ' 45' ' ' LEU . 43.4 mt-30 -63.78 -40.59 97.04 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.839 1.655 . . . . 0.0 113.62 165.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -63.66 1.21 0.63 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.28 1.832 . . . . 0.0 111.452 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.455 ' H ' ' C ' ' A' ' 43' ' ' GLN 0.268 16.1 tp -145.79 4.43 0.99 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 120.377 3.473 . . . . 0.0 120.377 -170.665 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.26 63.7 mttt 52.18 39.01 25.98 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 130.807 3.643 . . . . 0.0 115.199 -174.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.425 ' O ' ' HB1' ' A' ' 42' ' ' ALA . 35.7 m -126.66 -172.58 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 1 C-N-CA 133.38 4.672 . . . . 0.0 113.826 -176.5 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.1 p -101.33 152.5 20.63 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 116.599 -1.667 . . . . 0.0 114.421 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -49.09 -32.5 9.89 Favored 'General case' 0 CA--C 1.52 -0.187 0 O-C-N 126.177 2.173 . . . . 0.0 110.349 165.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -74.08 -29.63 61.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 116.599 -1.667 . . . . 0.0 109.746 -171.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mt -70.83 -47.67 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-O 126.322 2.963 . . . . 0.0 113.704 173.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.348 13.4 m -56.59 -46.72 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 2 O-C-N 113.433 -5.792 . . . . 0.0 112.148 175.149 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -56.07 -40.86 74.23 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 117.989 -2.944 . . . . 0.0 113.277 162.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.8 ttt85 -57.64 -36.59 72.05 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 115.609 -2.138 . . . . 0.0 113.174 177.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -71.51 -44.76 64.07 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 124.849 1.343 . . . . 0.0 111.066 173.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -67.7 -13.77 62.38 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 114.861 -2.495 . . . . 0.0 109.775 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.9 p -102.68 0.36 32.99 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 124.094 3.134 . . . . 0.0 111.482 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.93 6.22 87.0 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 122.268 2.303 . . . . 0.0 115.816 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -94.12 -18.83 21.38 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 119.443 1.621 . . . . 0.0 114.962 -166.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.4 tp -144.87 161.67 38.72 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 127.931 3.27 . . . . 0.0 109.04 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.258 76.2 tttt -133.65 151.94 78.05 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-O 115.627 -2.13 . . . . 0.0 112.869 171.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . 0.274 41.4 Cg_endo -63.42 168.04 11.99 Favored 'Trans proline' 0 N--CA 1.451 -0.981 1 C-N-CA 126.211 4.607 . . . . 0.0 108.807 169.636 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 81.3 p -96.34 179.22 5.11 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 127.581 2.352 . . . . 0.0 111.224 171.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.1 pt -64.66 -57.23 12.16 Favored 'Isoleucine or valine' 0 C--N 1.346 0.449 0 CA-C-O 113.434 -3.174 . . . . 0.0 114.857 -175.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 90.3 p -51.98 -29.64 21.49 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 122.975 2.625 . . . . 0.0 111.914 167.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -78.86 -53.07 7.46 Favored 'General case' 0 N--CA 1.439 -0.978 0 O-C-N 118.982 -2.324 . . . . 0.0 109.129 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -40.94 -45.57 2.59 Favored 'General case' 0 N--CA 1.448 -0.57 1 C-N-CA 131.918 4.087 . . . . 0.0 104.759 162.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -62.65 -40.0 95.65 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 118.667 -2.52 . . . . 0.0 112.253 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -79.3 -40.33 30.67 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 117.676 2.473 . . . . 0.0 117.676 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.479 ' O ' HG22 ' A' ' 73' ' ' ILE . 87.5 mt -44.97 -46.13 10.94 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 114.854 -2.498 . . . . 0.0 113.965 161.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -56.03 -43.08 77.47 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 121.831 2.105 . . . . 0.0 107.353 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -85.21 -4.95 59.33 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 130.396 3.478 . . . . 0.0 118.609 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.579 HG23 ' HG ' ' A' ' 74' ' ' LEU . 4.2 tt -75.58 -31.64 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 1 O-C-N 114.395 -5.191 . . . . 0.0 116.394 -163.991 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.579 ' HG ' HG23 ' A' ' 73' ' ' ILE . 57.8 mt -105.56 -7.26 18.7 Favored 'General case' 0 N--CA 1.445 -0.694 2 O-C-N 115.244 -4.66 . . . . 0.0 113.0 -175.706 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.08 -20.78 0.05 OUTLIER Glycine 0 CA--C 1.526 0.765 0 O-C-N 116.486 -3.884 . . . . 0.0 112.643 -151.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.438 ' H ' ' C ' ' A' ' 74' ' ' LEU . 9.2 pt -131.05 -161.79 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-O 125.101 2.382 . . . . 0.0 116.918 -172.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.5 pttm -175.29 176.02 2.1 Favored 'General case' 0 N--CA 1.439 -0.99 0 O-C-N 117.318 -3.364 . . . . 0.0 107.08 -172.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.412 ' HA ' HD12 ' A' ' 26' ' ' ILE . 59.0 tp . . . . . 0 N--CA 1.445 -0.68 0 C-N-CA 129.689 3.196 . . . . 0.0 106.798 138.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.692 ' HD1' ' H ' ' A' ' 60' ' ' LEU . 40.0 t80 . . . . . 0 CA--C 1.517 -0.295 0 CA-C-O 116.742 -1.599 . . . . 0.0 113.236 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -65.15 144.97 56.87 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 119.843 1.201 . . . . 0.0 112.476 -174.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -78.34 -29.12 47.45 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 119.266 3.061 . . . . 0.0 119.266 -160.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.96 -51.87 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 O-C-N 117.488 -3.257 . . . . 0.0 108.587 -170.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.2 pt -54.0 -28.66 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 117.131 -1.414 . . . . 0.0 114.312 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -60.12 -39.61 86.84 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 129.555 3.142 . . . . 0.0 111.136 173.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.5 p -90.77 -21.87 21.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 117.011 2.226 . . . . 0.0 117.011 -173.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.83 -61.27 2.75 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 131.05 3.74 . . . . 0.0 113.115 -159.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.38 -46.08 87.04 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-O 114.618 -2.611 . . . . 0.0 110.135 -169.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -63.7 -34.76 78.59 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 117.281 2.326 . . . . 0.0 117.281 169.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.97 -0.21 13.08 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 122.83 2.559 . . . . 0.0 110.659 -174.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 36.3 mt -117.43 -19.81 9.35 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 129.491 3.116 . . . . 0.0 112.527 178.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.76 -8.29 50.28 Favored Glycine 0 C--O 1.223 -0.557 0 CA-C-O 127.615 3.897 . . . . 0.0 114.463 162.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.44 HD13 ' HE3' ' A' ' 44' ' ' LYS . 35.1 pt -91.75 155.86 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 130.356 3.463 . . . . 0.0 110.459 -173.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.0 p -65.14 161.91 18.1 Favored 'General case' 0 CA--C 1.514 -0.412 0 O-C-N 119.86 -1.775 . . . . 0.0 115.065 167.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -56.42 -37.73 70.6 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 118.017 -0.992 . . . . 0.0 111.713 170.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -66.77 -31.87 72.79 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 126.004 1.722 . . . . 0.0 111.591 174.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -69.07 -39.58 79.0 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 118.644 -2.535 . . . . 0.0 112.781 170.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.0 tp -64.25 -37.92 89.21 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 118.665 -2.522 . . . . 0.0 110.216 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.79 -25.08 61.86 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.311 -0.868 . . . . 0.0 108.874 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -62.33 -36.67 82.93 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 123.603 1.668 . . . . 0.0 114.948 170.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.44 ' HE3' HD13 ' A' ' 36' ' ' ILE . 21.8 mttm -66.82 -22.85 66.0 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 117.292 -3.38 . . . . 0.0 111.807 -175.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.6 mt -133.46 -5.62 2.94 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 127.297 2.873 . . . . 0.0 108.985 -145.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.356 65.2 mmtt 51.16 -37.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 119.175 3.028 . . . . 0.0 119.175 -153.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.1 m -124.46 154.46 31.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 116.171 -1.871 . . . . 0.0 111.605 -157.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.913 ' C ' ' H ' ' A' ' 52' ' ' VAL . 84.0 p -137.87 -6.36 1.67 Allowed 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 127.966 3.291 . . . . 0.0 118.189 -135.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.432 ' N ' ' H ' ' A' ' 52' ' ' VAL . 17.7 mp0 -101.59 -32.36 10.39 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 127.651 3.094 . . . . 0.0 110.387 -162.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.608 ' H ' ' C ' ' A' ' 51' ' ' ILE . 57.0 t-20 -118.91 -42.84 2.69 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 112.446 -3.645 . . . . 0.0 113.894 -174.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.608 ' C ' ' H ' ' A' ' 50' ' ' ASN . 1.5 mt 46.12 61.75 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.354 2 C-N-CA 137.925 6.49 . . . . 0.0 112.22 -1.654 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.913 ' H ' ' C ' ' A' ' 48' ' ' SER . 27.8 t -93.66 -47.76 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 O-C-N 117.723 -3.111 . . . . 0.0 114.882 2.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -57.82 -43.22 85.6 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 120.523 3.527 . . . . 0.0 120.523 -148.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.3 ttm180 -73.44 -12.41 60.79 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 115.516 -2.183 . . . . 0.0 114.684 -157.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -52.39 -27.91 17.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 125.252 1.595 . . . . 0.0 113.765 169.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . 0.269 12.4 pt-20 -50.41 -27.45 6.41 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 123.849 3.022 . . . . 0.0 116.592 168.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.6 p -73.75 -27.81 61.36 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 119.328 3.084 . . . . 0.0 119.328 -148.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.48 ' HA2' ' CD2' ' A' ' 23' ' ' TYR . . . 78.53 19.54 73.55 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 123.106 2.684 . . . . 0.0 115.704 -172.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -122.09 4.43 9.84 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 121.314 3.82 . . . . 0.0 121.314 -162.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.692 ' H ' ' HD1' ' A' ' 23' ' ' TYR . 27.6 tp -145.01 142.0 29.41 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 118.426 2.75 . . . . 0.0 118.426 -168.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.251 61.1 mttm -115.09 109.42 46.85 Favored Pre-proline 0 C--N 1.351 0.67 0 O-C-N 119.342 -2.099 . . . . 0.0 109.739 155.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -78.01 -177.84 4.17 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 124.139 3.226 . . . . 0.0 112.054 -167.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.0 p -81.58 170.86 15.35 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 165.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 11.3 tp -68.73 -46.17 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-N 112.302 -2.227 . . . . 0.0 110.59 -177.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.7 p -56.69 -34.19 67.17 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 120.892 1.678 . . . . 0.0 111.917 169.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -78.43 -50.41 11.74 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 -170.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -52.09 -40.21 60.91 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 125.62 1.825 . . . . 0.0 114.368 173.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -65.4 -46.15 81.18 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 172.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.622 ' C ' ' H ' ' A' ' 72' ' ' LYS . 35.0 mt-30 -64.33 -27.41 69.01 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 118.127 -2.858 . . . . 0.0 112.865 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 27.3 mt -90.22 -31.6 16.94 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -166.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -50.74 -31.51 16.9 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.097 149.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.622 ' H ' ' C ' ' A' ' 69' ' ' GLN . 20.0 tttm -78.46 -26.1 46.02 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 116.701 -2.0 . . . . 0.0 116.053 -161.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . 0.355 26.2 pt -57.18 -43.25 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 O-C-N 116.997 -3.564 . . . . 0.0 114.307 167.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.41 ' C ' ' H ' ' A' ' 76' ' ' ILE . 8.7 mt -60.4 -34.76 74.39 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 -166.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.04 -5.83 7.67 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 117.269 -2.396 . . . . 0.0 113.995 -169.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.41 ' H ' ' C ' ' A' ' 74' ' ' LEU . 27.1 pt -114.89 -162.45 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 124.899 1.28 . . . . 0.0 113.059 163.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -120.38 150.25 41.07 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 114.869 -2.491 . . . . 0.0 113.671 169.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.4 mt . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 175.683 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 27.8 t80 . . . . . 0 N--CA 1.442 -0.84 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -58.34 144.71 40.57 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 128.124 2.569 . . . . 0.0 116.84 -171.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.7 tttt -116.63 -4.26 11.71 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 -157.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.1 pt -43.95 -49.3 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.747 0 C-N-CA 127.84 2.456 . . . . 0.0 116.23 -174.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.426 13.9 pt -74.23 -16.5 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 O-C-N 125.165 1.541 . . . . 0.0 115.031 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.342 19.0 tttm -66.53 -58.01 6.1 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 120.462 3.505 . . . . 0.0 120.462 -158.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 52.2 m -54.57 -40.43 68.76 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 120.469 -1.394 . . . . 0.0 109.479 174.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.98 -45.68 80.79 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 118.661 2.837 . . . . 0.0 118.661 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -47.22 -42.23 19.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.883 0.873 . . . . 0.0 112.618 164.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -73.48 -39.81 64.6 Favored 'General case' 0 N--CA 1.437 -1.109 1 CA-C-O 111.551 -4.071 . . . . 0.0 112.41 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -61.41 -41.06 96.56 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 127.554 3.034 . . . . 0.0 112.742 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 61.1 mt -58.35 -35.18 71.54 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.515 1.926 . . . . 0.0 111.512 171.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.1 2.92 5.62 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 128.375 2.893 . . . . 0.0 115.225 -173.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.442 ' HB ' ' HB2' ' A' ' 40' ' ' GLN . 28.5 pt -66.63 154.73 7.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 125.637 2.637 . . . . 0.0 113.966 -166.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 64.2 p -80.45 170.59 16.17 Favored 'General case' 0 N--CA 1.438 -1.038 0 O-C-N 119.151 -2.218 . . . . 0.0 113.113 -176.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -56.52 -41.66 77.09 Favored 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 117.997 -2.939 . . . . 0.0 105.138 174.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -72.53 -32.99 66.55 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 121.925 2.148 . . . . 0.0 116.625 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.442 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . 58.0 mt-30 -64.57 -38.03 89.61 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 116.338 -3.976 . . . . 0.0 112.442 170.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.2 tp -70.3 -37.13 74.73 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 128.329 2.652 . . . . 0.0 114.489 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.3 -46.37 90.12 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.902 1.681 . . . . 0.0 112.306 169.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -63.25 -44.64 94.61 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 117.868 -1.063 . . . . 0.0 111.836 172.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -69.19 -14.49 63.01 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 125.764 1.626 . . . . 0.0 111.99 -174.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.51 HD23 HD12 ' A' ' 73' ' ' ILE . 5.2 mp -121.04 1.87 10.4 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.63 1.972 . . . . 0.0 109.78 -172.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.256 0.0 OUTLIER 62.41 -35.42 0.12 Allowed 'General case' 0 N--CA 1.444 -0.767 2 C-N-CA 133.169 4.587 . . . . 0.0 114.784 -167.736 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.8 m -77.53 164.13 3.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 1 C-N-CA 133.165 4.586 . . . . 0.0 114.747 -161.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 89.3 p -79.66 159.21 26.8 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 -170.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.442 ' HA ' HG22 ' A' ' 52' ' ' VAL . 40.7 mt-10 -82.7 -12.46 57.57 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 117.557 -1.657 . . . . 0.0 110.216 -162.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -59.91 -44.34 94.33 Favored 'General case' 0 C--O 1.222 -0.391 0 O-C-N 120.663 -1.273 . . . . 0.0 109.899 166.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.5 mm -64.42 -45.52 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 C-N-CA 127.863 2.465 . . . . 0.0 108.345 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.442 HG22 ' HA ' ' A' ' 49' ' ' GLU 0.387 1.3 m -65.11 -45.9 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -176.503 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -63.84 -26.76 68.76 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-O 115.308 -2.282 . . . . 0.0 116.229 172.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -59.49 -44.03 93.17 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 121.742 2.064 . . . . 0.0 109.008 176.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -82.05 -28.18 32.58 Favored 'General case' 0 CA--C 1.522 -0.112 0 O-C-N 118.421 -2.675 . . . . 0.0 110.702 -176.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -63.19 -33.75 76.16 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 119.396 -2.065 . . . . 0.0 111.159 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.2 p -126.61 22.58 6.92 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -151.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.11 21.85 62.1 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.664 165.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -97.1 26.53 4.65 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 125.9 1.68 . . . . 0.0 115.025 -164.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.2 tp -140.02 154.58 47.16 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 113.672 -1.603 . . . . 0.0 114.903 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.2 tttp -90.54 102.08 4.61 Favored Pre-proline 0 N--CA 1.443 -0.808 0 C-N-CA 125.041 1.337 . . . . 0.0 108.526 149.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -83.83 170.89 11.01 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 CA-C-O 125.041 2.017 . . . . 0.0 111.236 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.0 p -143.73 179.28 7.25 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 118.921 -2.362 . . . . 0.0 111.988 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . 0.403 60.7 mt -52.39 -61.4 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 O-C-N 127.574 3.046 . . . . 0.0 109.392 172.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 96.5 p -68.97 -31.26 69.99 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 125.329 1.643 . . . . 0.0 107.653 -173.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -77.96 -37.49 47.35 Favored 'General case' 0 N--CA 1.438 -1.073 1 O-C-N 114.581 -5.074 . . . . 0.0 109.014 -177.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.23 -45.72 90.3 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 114.466 -2.683 . . . . 0.0 107.172 169.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 39.5 tpt85 -52.61 -27.82 18.6 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 125.153 1.533 . . . . 0.0 112.496 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -93.39 -29.39 15.62 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 114.396 -2.716 . . . . 0.0 110.31 -173.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.5 tp -61.62 -53.11 60.58 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 114.927 -2.463 . . . . 0.0 115.732 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -50.9 -22.69 2.35 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 125.303 1.627 . . . . 0.0 115.175 157.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.25 76.7 tttt -87.54 -38.02 16.37 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 117.268 -3.395 . . . . 0.0 109.489 -173.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.51 HD12 HD23 ' A' ' 45' ' ' LEU . 50.5 pt -74.1 -29.91 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 74' ' ' LEU . 34.4 tp -77.61 -25.33 49.74 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 126.54 3.066 . . . . 0.0 107.34 175.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.35 8.85 27.33 Favored Glycine 0 N--CA 1.445 -0.725 0 O-C-N 118.878 -2.389 . . . . 0.0 117.098 -168.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.2 pt -152.02 177.34 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.073 0 C-N-CA 130.018 3.327 . . . . 0.0 112.006 175.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -171.29 168.69 6.58 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 128.602 2.761 . . . . 0.0 106.892 -166.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 78' ' ' LEU . 9.7 mt . . . . . 0 N--CA 1.447 -0.577 0 CA-C-N 112.407 -2.179 . . . . 0.0 115.221 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.4 t80 . . . . . 0 CA--C 1.508 -0.668 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -85.91 -162.64 0.76 Allowed 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 127.868 3.23 . . . . 0.0 111.291 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -66.4 -1.8 3.87 Favored 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 118.272 -2.767 . . . . 0.0 114.461 -168.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.0 pt -56.26 -27.67 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 O-C-N 120.13 -1.606 . . . . 0.0 115.315 160.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.348 6.7 tp -140.5 -33.15 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 O-C-N 119.998 -1.689 . . . . 0.0 109.875 -173.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -70.98 -49.28 47.0 Favored 'General case' 0 N--CA 1.445 -0.708 0 O-C-N 117.177 -3.452 . . . . 0.0 112.829 -164.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.08 -39.7 94.64 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 128.092 2.557 . . . . 0.0 106.748 175.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.72 -59.57 4.71 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 117.756 2.502 . . . . 0.0 117.756 -173.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -39.94 -45.85 1.94 Allowed 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 124.566 1.167 . . . . 0.0 109.703 169.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -58.93 -47.52 84.76 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 116.859 -3.651 . . . . 0.0 117.199 168.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -72.33 -1.71 16.46 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 122.013 2.188 . . . . 0.0 112.446 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.414 ' C ' ' H ' ' A' ' 36' ' ' ILE . 81.5 mt -101.51 -22.1 14.59 Favored 'General case' 0 N--CA 1.451 -0.413 1 O-C-N 115.161 -4.712 . . . . 0.0 107.046 -177.728 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.81 -12.1 0.16 Allowed Glycine 0 C--N 1.336 0.555 0 CA-C-O 125.492 2.718 . . . . 0.0 115.785 -176.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.414 ' H ' ' C ' ' A' ' 34' ' ' LEU . 31.7 pt -66.19 163.42 2.44 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 N-CA-C 119.118 3.007 . . . . 0.0 119.118 -176.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.5 p -77.17 171.75 14.34 Favored 'General case' 0 C--O 1.241 0.644 0 O-C-N 116.995 -3.566 . . . . 0.0 117.753 175.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . 0.336 2.5 mp0 -70.89 -24.43 62.48 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 120.843 -1.16 . . . . 0.0 110.03 169.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -72.89 -37.21 67.37 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 120.503 -1.373 . . . . 0.0 107.432 176.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -76.81 -32.16 57.45 Favored 'General case' 0 N--CA 1.44 -0.953 0 O-C-N 118.464 -2.648 . . . . 0.0 113.868 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.3 tp -72.54 -36.46 68.27 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 130.215 3.406 . . . . 0.0 109.716 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.54 -34.11 70.64 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 121.581 1.991 . . . . 0.0 112.873 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -60.94 -49.84 75.8 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.924 1.689 . . . . 0.0 112.304 168.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.7 mmtt -70.54 -19.25 62.91 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -173.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 94.7 mt -101.72 -9.67 20.65 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -170.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.339 7.1 mptt 61.69 -16.43 0.04 OUTLIER 'General case' 0 C--O 1.237 0.415 0 N-CA-C 117.104 2.261 . . . . 0.0 117.104 -163.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.3 m -104.51 166.1 3.23 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 CA-C-O 124.53 2.11 . . . . 0.0 112.508 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 55.3 p -74.04 166.31 23.61 Favored 'General case' 0 N--CA 1.44 -0.974 0 O-C-N 118.969 -2.332 . . . . 0.0 116.229 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -70.5 -23.48 62.67 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 118.685 -2.51 . . . . 0.0 107.689 175.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -63.1 -37.0 85.47 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.274 1.43 . . . . 0.0 110.743 171.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.5 mm -68.84 -40.4 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 125.861 3.937 . . . . 0.0 110.594 171.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.1 t -54.41 -45.32 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 113.966 -1.47 . . . . 0.0 111.262 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -59.04 -58.13 10.01 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 128.873 2.869 . . . . 0.0 106.098 169.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -53.55 -39.51 64.78 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 121.452 1.933 . . . . 0.0 110.732 -163.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -70.81 -50.81 31.57 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 118.273 -0.87 . . . . 0.0 112.826 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -51.43 -37.7 49.93 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 122.729 2.513 . . . . 0.0 112.835 170.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.4 p -83.79 4.96 26.79 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 118.44 2.756 . . . . 0.0 118.44 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.82 7.36 68.67 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 116.853 -2.082 . . . . 0.0 111.938 165.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -103.98 -15.42 15.62 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 129.152 2.981 . . . . 0.0 115.998 -167.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.3 tp -146.53 138.98 25.09 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 126.14 1.776 . . . . 0.0 115.426 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.624 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 15.6 ptpt -138.53 -164.77 0.08 OUTLIER Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-O 116.588 -1.672 . . . . 0.0 112.492 173.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.624 ' HD2' ' HB2' ' A' ' 61' ' ' LYS . 88.2 Cg_endo -88.8 149.64 5.98 Favored 'Trans proline' 0 N--CA 1.44 -1.644 0 O-C-N 124.512 1.796 . . . . 0.0 112.241 177.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.0 p -144.52 -179.33 6.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.836 1.255 . . . . 0.0 113.042 -172.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.445 ' C ' ' H ' ' A' ' 66' ' ' GLN . 8.7 tp -78.69 -44.02 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 C-N-CA 125.346 1.458 . . . . 0.0 107.816 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 84.9 p -53.92 -7.67 0.14 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-N 120.389 1.45 . . . . 0.0 108.388 169.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.445 ' H ' ' C ' ' A' ' 64' ' ' ILE . 40.3 mt-30 -118.68 -37.33 3.29 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 117.722 -3.112 . . . . 0.0 115.039 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -39.38 -46.66 1.66 Allowed 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 117.565 2.431 . . . . 0.0 117.565 -162.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.5 mtm105 -71.48 -53.54 13.59 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 114.903 -2.475 . . . . 0.0 116.47 -165.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -63.18 -39.14 93.79 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 115.694 -2.098 . . . . 0.0 112.877 167.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 44.4 tp -53.85 -49.0 69.43 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 127.167 2.792 . . . . 0.0 107.131 -170.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -57.82 -51.12 70.88 Favored 'General case' 0 CA--C 1.513 -0.467 0 O-C-N 118.694 -2.504 . . . . 0.0 111.527 177.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -73.24 -29.45 62.79 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 116.579 -3.826 . . . . 0.0 115.706 -168.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 14.5 pt -66.04 -15.96 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 123.042 2.655 . . . . 0.0 112.942 161.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.372 1.3 pt? 146.24 -10.15 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.477 1 C-N-CA 133.41 4.684 . . . . 0.0 115.233 162.457 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.85 6.79 68.34 Favored Glycine 0 C--N 1.34 0.788 0 CA-C-O 113.943 -3.698 . . . . 0.0 114.014 -172.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . 0.282 1.4 pt 71.64 6.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.835 1 C-N-CA 135.196 5.398 . . . . 0.0 117.16 174.578 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -71.88 148.51 46.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 115.116 -2.373 . . . . 0.0 113.992 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.406 HD13 HD11 ' A' ' 34' ' ' LEU 0.259 40.1 mt . . . . . 0 N--CA 1.448 -0.553 0 C-N-CA 125.383 1.473 . . . . 0.0 113.328 168.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.444 -0.731 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -44.86 116.22 1.04 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 119.633 3.197 . . . . 0.0 119.633 -173.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -66.17 -36.73 83.86 Favored 'General case' 0 C--O 1.222 -0.375 0 N-CA-C 116.199 1.925 . . . . 0.0 116.199 -170.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.2 pt -62.08 -22.17 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 O-C-N 119.453 -2.03 . . . . 0.0 113.817 -171.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.359 2.5 mt -136.94 -53.68 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 O-C-N 117.621 -3.174 . . . . 0.0 109.646 172.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt 63.96 -96.24 0.05 Allowed 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 113.476 -3.154 . . . . 0.0 115.548 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.7 p -43.44 -31.86 0.77 Allowed 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 130.738 3.615 . . . . 0.0 111.128 -168.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.73 -26.06 31.63 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 131.105 3.762 . . . . 0.0 117.996 -154.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . 0.451 22.3 ptt180 -36.92 -50.3 0.86 Allowed 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 119.93 3.307 . . . . 0.0 119.93 -176.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . 0.25 40.9 mt-10 -72.32 -37.0 69.01 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 114.335 -2.745 . . . . 0.0 115.476 170.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -65.29 0.96 1.2 Allowed 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 126.33 1.852 . . . . 0.0 114.458 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.4 mt -72.64 -7.61 51.18 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 119.321 -2.112 . . . . 0.0 114.492 -175.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 47.98 6.75 0.03 OUTLIER Glycine 0 C--N 1.347 1.15 1 C-N-CA 131.442 4.353 . . . . 0.0 115.881 -161.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.289 2.6 pt -136.32 167.73 23.75 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.509 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.677 -169.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 65.8 m -134.89 179.93 6.0 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 121.012 1.733 . . . . 0.0 115.249 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.42 -38.93 14.36 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 118.484 -2.635 . . . . 0.0 117.898 -159.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -75.73 -39.32 57.47 Favored 'General case' 0 N--CA 1.442 -0.844 0 O-C-N 119.404 -2.06 . . . . 0.0 109.542 -169.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -67.4 -34.95 78.33 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 160.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.6 tp -64.51 -39.42 93.75 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 121.461 1.937 . . . . 0.0 112.089 -175.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -50.81 -32.86 21.36 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.462 177.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -73.14 -50.23 23.84 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 124.148 1.928 . . . . 0.0 112.737 173.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -65.69 -4.07 5.79 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 116.511 -1.709 . . . . 0.0 110.74 -168.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.331 53.9 tp -146.93 -0.84 0.69 Allowed 'General case' 0 C--O 1.247 0.925 0 CA-C-O 123.471 1.605 . . . . 0.0 112.22 -155.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 49.58 58.38 5.48 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.384 1.074 . . . . 0.0 112.179 -175.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.7 m -143.84 166.66 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 121.503 1.956 . . . . 0.0 106.189 -173.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 96.3 p -85.55 160.72 19.59 Favored 'General case' 0 C--O 1.241 0.63 0 O-C-N 116.938 -3.601 . . . . 0.0 108.254 168.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . 0.26 5.2 mt-10 -65.93 -28.97 69.32 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 111.41 -2.632 . . . . 0.0 111.775 173.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -61.28 -36.43 80.03 Favored 'General case' 0 CA--C 1.514 -0.434 0 O-C-N 117.947 -2.97 . . . . 0.0 117.428 166.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.4 mm -59.74 -37.03 69.3 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.449 0 CA-C-N 119.35 0.977 . . . . 0.0 108.867 168.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.346 40.0 t -59.57 -44.29 92.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 O-C-N 119.403 -2.06 . . . . 0.0 110.55 -178.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.1 mttt -58.93 -37.33 76.45 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 127.904 2.482 . . . . 0.0 112.03 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -75.53 -21.56 57.85 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 130.808 3.643 . . . . 0.0 112.668 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.9 m-30 -82.35 -47.68 12.05 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 101.685 -3.45 . . . . 0.0 101.685 167.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -54.38 -25.89 27.01 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 126.668 1.987 . . . . 0.0 108.78 -166.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.9 p -105.21 -14.8 15.25 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 128.674 3.734 . . . . 0.0 114.184 -174.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.32 18.13 79.8 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 114.267 -3.519 . . . . 0.0 117.501 -167.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -74.6 -19.17 60.41 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 114.624 -2.608 . . . . 0.0 113.597 175.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . 0.31 43.1 tp -147.41 148.71 31.58 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 129.556 3.142 . . . . 0.0 112.593 177.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -106.6 147.08 34.33 Favored Pre-proline 0 N--CA 1.449 -0.522 0 N-CA-C 120.681 3.585 . . . . 0.0 120.681 168.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -60.08 153.88 55.21 Favored 'Trans proline' 0 N--CA 1.449 -1.104 1 C-N-CA 126.654 4.902 . . . . 0.0 114.306 176.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.469 ' H ' ' HB2' ' A' ' 66' ' ' GLN . 58.6 p -98.91 -173.68 2.58 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 111.605 -2.543 . . . . 0.0 112.93 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.464 HG23 ' H ' ' A' ' 65' ' ' SER . 16.0 tt -50.57 -71.83 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 C-N-CA 130.3 3.44 . . . . 0.0 115.844 174.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.464 ' H ' HG23 ' A' ' 64' ' ' ILE . 15.2 p -56.04 -22.85 29.74 Favored 'General case' 0 C--N 1.328 -0.368 1 O-C-N 116.126 -4.109 . . . . 0.0 111.06 172.628 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.469 ' HB2' ' H ' ' A' ' 63' ' ' THR . 71.5 mt-30 -83.14 -53.94 5.41 Favored 'General case' 0 N--CA 1.449 -0.493 1 CA-C-O 110.307 -4.664 . . . . 0.0 107.642 -172.532 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -44.77 -50.84 9.92 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 128.189 3.431 . . . . 0.0 111.138 167.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.32 -55.02 32.57 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.141 1.776 . . . . 0.0 113.82 169.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -68.39 -31.05 70.14 Favored 'General case' 0 N--CA 1.446 -0.654 1 O-C-N 115.775 -4.328 . . . . 0.0 114.478 -177.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 35.9 mt -56.33 -68.02 0.25 Allowed 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 131.042 3.737 . . . . 0.0 106.648 165.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -43.75 -29.58 0.54 Allowed 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 130.23 3.412 . . . . 0.0 110.268 176.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -74.88 -24.8 58.61 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 115.774 -2.06 . . . . 0.0 113.842 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.5 mt -80.44 -45.12 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 121.492 1.951 . . . . 0.0 107.937 162.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.492 ' C ' ' H ' ' A' ' 76' ' ' ILE . 89.3 mt -76.71 -44.1 34.79 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 123.268 1.508 . . . . 0.0 109.363 -153.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.63 -4.78 0.94 Allowed Glycine 0 C--N 1.338 0.653 0 O-C-N 120.101 -1.625 . . . . 0.0 111.891 -172.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.492 ' H ' ' C ' ' A' ' 74' ' ' LEU . 5.7 pt -102.41 170.97 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 C-N-CA 124.845 1.258 . . . . 0.0 109.119 170.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -163.96 174.61 11.22 Favored 'General case' 0 C--O 1.22 -0.46 0 O-C-N 127.661 3.1 . . . . 0.0 107.252 169.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 17.0 mt . . . . . 0 N--CA 1.445 -0.708 0 O-C-N 119.363 -2.086 . . . . 0.0 109.178 175.691 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 57.7 t80 . . . . . 0 N--CA 1.444 -0.728 0 CA-C-O 123.268 1.509 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . 0.373 1.9 p90 -60.39 78.45 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 1 C-N-CA 132.684 4.394 . . . . 0.0 116.221 170.057 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.405 ' HA ' ' HB3' ' A' ' 28' ' ' LYS . 89.4 mttt -90.59 -18.04 25.89 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 116.284 -1.817 . . . . 0.0 113.559 176.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.409 HD13 ' H ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -60.33 -34.18 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 2 CA-C-N 129.096 5.407 . . . . 0.0 109.858 168.282 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.283 89.2 mt -65.04 -53.86 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 C-N-CA 129.338 3.055 . . . . 0.0 109.933 170.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.405 ' HB3' ' HA ' ' A' ' 25' ' ' LYS . 38.6 tttm -53.92 -46.66 71.54 Favored 'General case' 0 CA--C 1.509 -0.597 0 O-C-N 117.062 -3.524 . . . . 0.0 116.646 -173.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.8 p -56.73 -40.25 75.38 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.925 1.69 . . . . 0.0 111.615 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.96 -50.44 28.9 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 127.704 2.402 . . . . 0.0 113.804 173.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -58.66 -22.79 57.82 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 116.062 -1.923 . . . . 0.0 108.258 177.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -71.48 -48.95 45.88 Favored 'General case' 0 N--CA 1.446 -0.66 2 CA-C-N 128.574 5.17 . . . . 0.0 108.364 173.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -62.51 -47.01 85.82 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 124.691 2.186 . . . . 0.0 106.181 -169.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.317 39.5 mt -75.45 -10.81 59.78 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 115.645 1.721 . . . . 0.0 115.645 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.11 -4.25 0.08 OUTLIER Glycine 0 C--O 1.218 -0.884 0 N-CA-C 119.849 2.7 . . . . 0.0 119.849 177.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.4 pt -50.67 129.47 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 119.936 3.309 . . . . 0.0 119.936 -175.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 94.0 p -69.81 177.05 3.25 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.929 1.291 . . . . 0.0 112.27 177.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -57.35 -43.64 83.62 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 118.346 -1.341 . . . . 0.0 114.428 164.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -61.34 -39.7 91.53 Favored 'General case' 0 N--CA 1.451 -0.401 1 O-C-N 115.993 -4.192 . . . . 0.0 111.866 -177.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -73.68 -32.71 64.09 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.4 tp -61.31 -43.15 99.35 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.125 0.97 . . . . 0.0 113.253 161.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.71 -39.66 71.36 Favored 'General case' 0 N--CA 1.442 -0.826 0 O-C-N 119.842 -1.787 . . . . 0.0 111.512 171.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -66.04 -32.44 73.92 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 117.885 2.55 . . . . 0.0 117.885 170.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.446 ' HE2' HG23 ' A' ' 76' ' ' ILE . 19.4 tptt -64.82 -14.22 58.48 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 127.675 2.39 . . . . 0.0 107.699 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.8 tp -133.09 -4.62 3.09 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 116.394 -3.941 . . . . 0.0 114.546 -156.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt 62.52 27.63 16.34 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 131.057 3.743 . . . . 0.0 114.423 178.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.82 178.17 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 C-N-CA 129.857 3.263 . . . . 0.0 111.443 -163.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.2 p -88.2 162.5 16.64 Favored 'General case' 0 N--CA 1.443 -0.803 0 O-C-N 118.508 -2.62 . . . . 0.0 115.441 176.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -63.19 -16.38 59.94 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 119.631 -1.918 . . . . 0.0 113.704 167.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -71.95 -22.45 61.46 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 171.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . 0.283 39.0 mt -72.87 -36.26 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 C-N-CA 130.7 3.6 . . . . 0.0 116.446 164.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.317 1.5 m -80.81 -49.84 17.82 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 CA-C-O 117.157 -1.401 . . . . 0.0 111.917 -176.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.548 ' HA ' ' HB2' ' A' ' 56' ' ' GLU . 57.6 mttp -37.59 -27.99 0.02 OUTLIER 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 130.2 3.4 . . . . 0.0 118.922 166.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -40.04 -55.72 2.01 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.525 1.13 . . . . 0.0 109.207 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -100.04 -32.08 11.12 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 117.894 -3.004 . . . . 0.0 112.887 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 53' ' ' LYS . 4.4 mm-40 -47.9 -27.64 2.25 Favored 'General case' 0 N--CA 1.447 -0.577 1 N-CA-C 123.282 4.549 . . . . 0.0 123.282 168.968 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.2 m -77.69 -6.39 53.74 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.238 1.415 . . . . 0.0 113.379 -171.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.49 6.91 84.98 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 119.867 -1.158 . . . . 0.0 113.785 151.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -76.08 6.4 5.37 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 120.607 -1.525 . . . . 0.0 113.893 -174.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tp -143.18 163.68 32.25 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 -164.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -98.27 126.13 40.92 Favored Pre-proline 0 N--CA 1.443 -0.813 0 O-C-N 124.36 1.037 . . . . 0.0 110.645 165.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.25 174.01 13.54 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 CA-C-N 120.924 1.366 . . . . 0.0 112.319 -174.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.8 p -135.97 -174.7 3.74 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 125.215 1.406 . . . . 0.0 113.207 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.6 -51.91 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 127.226 2.21 . . . . 0.0 112.437 177.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.2 p -62.9 -31.51 72.59 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 173.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -66.3 -63.78 1.0 Allowed 'General case' 0 C--N 1.349 0.585 0 O-C-N 116.734 -3.729 . . . . 0.0 104.539 172.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -37.3 -41.41 0.41 Allowed 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 172.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.8 ttt85 -65.03 -53.88 39.0 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 125.859 1.974 . . . . 0.0 114.977 176.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -69.5 -40.28 77.11 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 126.87 2.606 . . . . 0.0 108.175 -172.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 13.2 mt -56.25 -63.08 1.3 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 131.45 3.9 . . . . 0.0 113.697 -177.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -46.6 -30.15 2.16 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 126.896 2.622 . . . . 0.0 111.519 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -75.24 -58.29 3.37 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 118.36 -0.829 . . . . 0.0 111.985 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.7 pt -65.13 -44.8 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 119.562 1.074 . . . . 0.0 113.164 -168.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 77.9 mt -76.65 -3.55 38.43 Favored 'General case' 0 N--CA 1.452 -0.354 1 O-C-N 115.332 -4.605 . . . . 0.0 115.384 -152.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.22 8.44 8.85 Favored Glycine 0 C--O 1.223 -0.577 0 CA-C-O 116.951 -2.027 . . . . 0.0 115.481 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.446 HG23 ' HE2' ' A' ' 44' ' ' LYS . 28.0 pt -136.56 155.49 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 122.538 3.169 . . . . 0.0 108.882 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.371 23.5 pttm 163.48 142.06 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 130.637 3.575 . . . . 0.0 116.336 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 78' ' ' LEU . 19.8 mt . . . . . 0 CA--C 1.518 -0.28 0 CA-C-N 122.704 2.502 . . . . 0.0 110.213 -171.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.309 55.3 t80 . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -74.23 77.45 1.81 Allowed 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 117.001 2.222 . . . . 0.0 117.001 -176.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -57.79 -32.52 67.61 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 129.913 3.285 . . . . 0.0 111.613 -171.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.2 pt -67.43 -37.79 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 120.191 -0.603 . . . . 0.0 109.53 -176.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.29 26.7 mm -59.17 -43.38 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 125.288 2.47 . . . . 0.0 112.651 -175.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.46 34.2 tttm -43.45 -75.42 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 131.072 3.749 . . . . 0.0 114.9 -156.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.3 m -53.96 -43.63 70.07 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 129.147 2.979 . . . . 0.0 112.729 -168.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.43 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . . . -64.7 -48.26 75.32 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 118.936 2.939 . . . . 0.0 118.936 177.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -60.35 -37.38 80.5 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.183 0.993 . . . . 0.0 110.823 170.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -69.32 -33.06 72.58 Favored 'General case' 0 N--CA 1.438 -1.042 1 O-C-N 115.531 -4.48 . . . . 0.0 113.623 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . 0.29 76.7 mt-30 -60.09 -26.51 66.25 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 124.534 1.146 . . . . 0.0 109.297 172.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.3 mt -78.28 -23.4 47.22 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 127.363 2.265 . . . . 0.0 113.527 -177.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.83 0.67 9.18 Favored Glycine 0 C--N 1.341 0.823 0 N-CA-C 118.052 1.981 . . . . 0.0 118.052 -174.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.2 pt -69.61 151.02 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 2 N-CA-C 123.935 4.791 . . . . 0.0 123.935 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 56.9 p -108.3 174.33 5.93 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 123.823 1.773 . . . . 0.0 114.862 -165.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -56.99 -26.44 60.17 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -55.75 -37.04 67.97 Favored 'General case' 0 C--O 1.222 -0.358 0 O-C-N 120.579 -1.326 . . . . 0.0 110.647 176.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -64.81 -40.47 95.27 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 116.879 -3.638 . . . . 0.0 113.211 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . 0.347 24.1 tp -61.74 -43.23 99.25 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 130.292 3.437 . . . . 0.0 111.026 173.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . 0.25 . . -60.91 -43.95 97.85 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 112.923 -1.944 . . . . 0.0 112.339 178.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -67.72 -34.92 77.81 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 112.421 -3.657 . . . . 0.0 111.84 167.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.6 tptt -67.18 -24.05 65.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 125.54 3.791 . . . . 0.0 115.83 -174.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.8 tp -125.17 3.93 7.87 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 128.473 2.709 . . . . 0.0 108.852 -160.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.252 79.9 mttt 44.99 66.79 0.82 Allowed 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 129.803 3.241 . . . . 0.0 111.845 -174.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.5 m -148.11 170.12 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 C-N-CA 130.674 3.59 . . . . 0.0 113.389 174.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.3 p -94.03 159.08 15.32 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 -169.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -67.62 -16.02 63.95 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 118.174 -2.829 . . . . 0.0 115.158 175.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -49.41 -47.17 48.14 Favored 'General case' 0 C--O 1.248 0.982 0 CA-C-N 121.956 2.162 . . . . 0.0 114.152 156.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 27.8 mt -77.07 -27.39 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 O-C-N 121.744 -0.598 . . . . 0.0 111.96 -175.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.5 m -79.45 -47.71 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-O 118.484 -0.77 . . . . 0.0 110.456 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -53.71 -28.11 32.03 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 121.575 1.989 . . . . 0.0 112.986 -165.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -44.38 -57.45 3.52 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 118.563 2.801 . . . . 0.0 118.563 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -95.91 -26.72 15.49 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 119.6 1.091 . . . . 0.0 110.729 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -51.19 -27.63 9.28 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 121.348 -0.845 . . . . 0.0 109.729 172.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.2 p -98.45 0.63 45.6 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 116.984 2.216 . . . . 0.0 116.984 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.76 6.84 89.14 Favored Glycine 0 CA--C 1.525 0.707 0 O-C-N 118.374 -2.704 . . . . 0.0 115.872 -172.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -96.44 -2.62 45.03 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 119.553 1.677 . . . . 0.0 114.164 -168.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 36.9 tp -145.46 130.26 18.14 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 126.592 1.957 . . . . 0.0 106.769 -174.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.6 tttt -81.71 126.88 74.58 Favored Pre-proline 0 C--O 1.221 -0.447 0 CA-C-O 114.935 -2.459 . . . . 0.0 110.726 165.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -82.64 178.05 6.43 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 124.51 3.474 . . . . 0.0 106.389 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.498 ' H ' ' HB3' ' A' ' 66' ' ' GLN . 42.6 p -96.46 167.69 11.0 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -159.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . 0.314 1.9 tt -51.27 -49.45 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 171.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.28 99.3 p -54.92 -55.33 31.82 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 120.621 1.555 . . . . 0.0 112.433 162.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.498 ' HB3' ' H ' ' A' ' 63' ' ' THR . 48.6 tt0 -71.1 -35.2 71.71 Favored 'General case' 0 CA--C 1.515 -0.371 1 CA-C-O 111.503 -4.094 . . . . 0.0 112.796 -163.533 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.77 -43.37 98.98 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 125.288 3.677 . . . . 0.0 109.112 169.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -62.17 -42.42 99.25 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 117.468 -3.27 . . . . 0.0 106.16 174.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -72.68 -30.44 64.25 Favored 'General case' 0 C--O 1.222 -0.385 1 O-C-N 116.01 -4.181 . . . . 0.0 115.34 176.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 70' ' ' LEU . 6.1 mt -54.27 -76.3 0.03 OUTLIER 'General case' 0 C--O 1.243 0.719 0 C-N-CA 130.238 3.415 . . . . 0.0 109.727 -169.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -48.08 -26.75 1.97 Allowed 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 129.035 2.934 . . . . 0.0 108.944 -177.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -88.15 -40.36 13.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 113.822 -2.99 . . . . 0.0 111.424 -166.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 12.8 pt -68.83 -40.36 81.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 128.583 3.677 . . . . 0.0 109.015 173.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 74' ' ' LEU . 74.1 mt -68.76 -26.0 65.01 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 120.323 -1.486 . . . . 0.0 110.661 -173.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.18 -18.76 0.06 OUTLIER Glycine 0 CA--C 1.528 0.863 0 CA-C-O 114.535 -3.369 . . . . 0.0 112.735 -172.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.1 pt -115.26 164.86 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 120.08 1.94 . . . . 0.0 113.328 -165.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.3 pttm -176.01 170.14 2.77 Favored 'General case' 0 CA--C 1.519 -0.226 1 C-N-CA 133.431 4.692 . . . . 0.0 111.093 177.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.43 ' HG ' ' HB2' ' A' ' 30' ' ' ALA . 57.4 mt . . . . . 0 CA--C 1.517 -0.324 0 C-N-CA 128.636 2.775 . . . . 0.0 110.615 154.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.0 t80 . . . . . 0 C--O 1.222 -0.383 0 CA-C-O 125.081 2.372 . . . . 0.0 104.641 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -70.66 157.8 37.34 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 117.36 -3.337 . . . . 0.0 113.196 -166.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -140.89 14.18 2.28 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 127.149 2.179 . . . . 0.0 113.259 -146.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -35.7 -57.11 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.805 1 O-C-N 114.888 -4.882 . . . . 0.0 113.886 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.407 HD11 HD22 ' A' ' 70' ' ' LEU . 11.7 pt -119.14 4.2 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 113.457 -1.701 . . . . 0.0 110.719 -165.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -47.95 -64.13 0.88 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.066 1.746 . . . . 0.0 114.912 -175.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.5 p -53.95 -46.58 71.63 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.283 1.833 . . . . 0.0 115.888 -174.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.58 -44.26 65.8 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 109.776 -3.375 . . . . 0.0 114.645 176.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -48.41 -44.7 35.28 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 118.551 -2.593 . . . . 0.0 112.772 169.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -72.14 -47.5 50.58 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 120.384 -1.448 . . . . 0.0 114.532 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -66.75 -25.69 66.62 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 128.641 2.776 . . . . 0.0 111.325 -167.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.5 mt -88.1 -17.05 31.87 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 127.417 2.287 . . . . 0.0 110.315 -174.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.32 11.27 58.96 Favored Glycine 0 C--O 1.243 0.674 0 CA-C-O 123.309 1.505 . . . . 0.0 113.99 177.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.9 pt -75.54 144.76 11.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 129.094 2.958 . . . . 0.0 114.202 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.5 p -93.2 166.3 12.39 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -175.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -58.71 -35.86 73.33 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.191 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -70.11 -37.37 75.35 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 115.906 -1.997 . . . . 0.0 108.132 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -66.87 -29.98 70.02 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 115.568 -2.158 . . . . 0.0 112.661 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.7 tt -78.96 -36.52 41.44 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-O 126.315 2.959 . . . . 0.0 111.836 176.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.93 -40.5 66.8 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 119.447 -2.033 . . . . 0.0 112.224 167.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -70.6 -37.07 73.85 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 118.845 -2.409 . . . . 0.0 111.007 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -66.39 -14.3 61.92 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 129.554 3.141 . . . . 0.0 110.438 -172.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.3 mt -131.01 -1.59 4.09 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 126.832 3.206 . . . . 0.0 112.781 -164.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.274 40.8 mtmt 56.39 -26.19 0.02 OUTLIER 'General case' 0 C--O 1.241 0.615 0 N-CA-C 121.094 3.739 . . . . 0.0 121.094 -162.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.9 m -83.61 172.21 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 C-N-CA 129.504 3.122 . . . . 0.0 111.378 -168.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 91.7 p -92.48 158.33 16.08 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 119.556 -1.965 . . . . 0.0 111.334 -153.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.409 ' HA ' HG22 ' A' ' 52' ' ' VAL . 18.3 mt-10 -61.56 -32.58 72.66 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 126.143 1.777 . . . . 0.0 108.031 177.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -65.3 -31.57 72.78 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 168.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.9 mt -67.98 -38.79 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 124.407 2.051 . . . . 0.0 112.555 172.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.409 HG22 ' HA ' ' A' ' 49' ' ' GLU 0.297 32.6 m -80.07 -30.78 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 1 O-C-N 116.042 -4.161 . . . . 0.0 114.122 -176.777 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -53.13 -38.69 62.88 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 126.392 1.877 . . . . 0.0 109.806 155.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -71.93 -38.42 69.87 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 126.296 1.838 . . . . 0.0 106.046 -174.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -66.97 -41.46 86.82 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 121.59 1.995 . . . . 0.0 108.662 173.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.42 -14.96 62.76 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 114.464 -2.684 . . . . 0.0 111.562 -172.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.6 p -113.09 -1.68 14.36 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 123.495 2.861 . . . . 0.0 111.137 -175.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.06 28.47 73.57 Favored Glycine 0 C--N 1.343 0.922 0 O-C-N 128.665 3.728 . . . . 0.0 119.24 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -85.17 7.24 22.55 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 131.501 3.921 . . . . 0.0 113.216 -171.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.6 tt -137.17 144.2 42.8 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 127.402 2.281 . . . . 0.0 109.501 -166.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.1 tttt -83.04 126.6 72.06 Favored Pre-proline 0 C--O 1.24 0.587 0 CA-C-O 116.455 -1.736 . . . . 0.0 110.23 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -82.0 150.64 16.06 Favored 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 124.64 3.56 . . . . 0.0 112.504 -168.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.3 p -123.07 164.64 18.22 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 123.937 1.827 . . . . 0.0 113.669 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.0 pt -62.66 -50.27 80.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 O-C-N 118.715 -2.491 . . . . 0.0 113.443 174.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 99.3 p -54.67 -21.57 11.08 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 121.871 2.123 . . . . 0.0 116.649 170.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -75.33 -75.84 0.16 Allowed 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.911 177.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -12.52 -62.66 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 117.884 2.549 . . . . 0.0 117.884 150.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -56.83 -49.85 74.16 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 127.474 2.31 . . . . 0.0 107.741 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -62.49 -44.29 96.73 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 116.413 -1.756 . . . . 0.0 106.886 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.407 HD22 HD11 ' A' ' 27' ' ' ILE . 43.5 mt -63.43 -47.39 82.1 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 115.29 -2.29 . . . . 0.0 109.851 -167.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -50.98 -22.73 2.43 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 170.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.7 mttp -94.48 -52.34 4.37 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 -176.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 24.1 pt -44.24 -49.93 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 127.243 2.217 . . . . 0.0 115.471 -167.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.3 mt -77.67 -2.49 36.27 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 121.549 1.977 . . . . 0.0 109.89 -169.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.95 0.51 60.37 Favored Glycine 0 CA--C 1.522 0.478 0 O-C-N 125.535 1.772 . . . . 0.0 111.834 -169.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 76' ' ' ILE . 29.6 pt -149.88 167.62 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 O-C-N 117.639 -3.271 . . . . 0.0 113.64 -178.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.77 163.78 1.17 Allowed 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 126.885 2.074 . . . . 0.0 109.471 -177.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.9 mt . . . . . 0 N--CA 1.449 -0.502 0 CA-C-N 121.132 1.787 . . . . 0.0 109.972 -174.056 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.3 t80 . . . . . 0 N--CA 1.44 -0.929 0 CA-C-O 116.675 -1.631 . . . . 0.0 107.0 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -100.02 -173.31 2.41 Favored 'General case' 0 CA--C 1.518 -0.255 0 O-C-N 128.457 3.598 . . . . 0.0 118.054 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -59.18 -24.04 62.74 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 119.199 3.037 . . . . 0.0 119.199 -175.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.9 pt -30.42 -35.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 119.908 3.299 . . . . 0.0 119.908 145.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.1 tp -137.31 -42.94 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 121.693 2.042 . . . . 0.0 114.495 177.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.361 79.5 tttt -40.99 -58.51 1.7 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 131.07 3.748 . . . . 0.0 118.313 173.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 74.9 p -83.48 -29.7 27.78 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 113.433 -1.712 . . . . 0.0 109.087 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.12 -51.23 62.49 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.937 1.295 . . . . 0.0 110.516 -160.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -46.51 -38.07 8.79 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 126.901 2.626 . . . . 0.0 112.879 174.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -73.87 -41.34 62.33 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 129.512 3.125 . . . . 0.0 113.462 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . 0.29 43.5 mt-30 -68.66 -16.31 63.79 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.447 ' HA ' HD12 ' A' ' 34' ' ' LEU . 14.0 tp -95.99 -14.51 22.96 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 112.453 -2.158 . . . . 0.0 112.157 175.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.64 -0.63 34.13 Favored Glycine 0 CA--C 1.523 0.564 1 C-N-CA 131.037 4.16 . . . . 0.0 117.309 172.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.6 pt -69.03 155.97 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 C-N-CA 126.233 1.813 . . . . 0.0 113.78 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 93.7 p -90.63 171.84 9.09 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -176.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -59.25 -42.97 92.37 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -64.9 -41.12 95.86 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 119.242 -2.161 . . . . 0.0 109.172 -175.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -64.74 -39.41 93.59 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 119.181 -2.2 . . . . 0.0 114.066 174.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.4 tp -64.04 -38.64 91.82 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 126.768 2.027 . . . . 0.0 114.166 -173.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.12 -49.76 76.63 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-O 123.899 1.809 . . . . 0.0 107.99 173.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -64.56 -14.34 57.12 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 117.53 -3.231 . . . . 0.0 108.669 -175.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -103.54 -16.88 15.41 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 117.591 -3.193 . . . . 0.0 118.504 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 86.2 mt -135.2 15.06 3.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 120.672 -1.267 . . . . 0.0 113.723 -165.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 70.7 mttt 45.6 -27.38 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.419 1 C-N-CA 134.255 5.022 . . . . 0.0 117.931 -154.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.7 m -86.86 145.37 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 122.348 2.34 . . . . 0.0 116.419 -163.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.2 p -81.36 160.75 24.04 Favored 'General case' 0 N--CA 1.449 -0.517 1 N-CA-C 122.439 4.237 . . . . 0.0 122.439 -168.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.79 -17.24 0.33 Allowed 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 125.367 3.712 . . . . 0.0 116.962 165.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -86.68 -35.51 19.26 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 126.503 1.921 . . . . 0.0 112.055 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.9 mm -55.16 -36.76 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-O 124.197 1.951 . . . . 0.0 110.137 167.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.3 t -59.6 -65.28 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-O 115.274 -2.298 . . . . 0.0 111.007 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -44.24 -43.53 7.34 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 126.526 2.391 . . . . 0.0 114.134 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -54.34 -50.42 67.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 176.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -91.29 -40.42 11.51 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.645 1.178 . . . . 0.0 109.196 -171.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -43.58 -36.6 2.16 Favored 'General case' 0 N--CA 1.434 -1.266 0 O-C-N 118.352 -2.718 . . . . 0.0 111.567 166.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 76.1 p -90.13 -2.55 58.1 Favored 'General case' 0 C--O 1.237 0.436 1 O-C-N 116.176 -4.078 . . . . 0.0 114.371 -172.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.97 12.71 79.2 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 120.14 2.816 . . . . 0.0 120.14 -175.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -87.22 -28.42 22.39 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.624 1.97 . . . . 0.0 112.421 -168.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.1 tp -151.79 131.66 13.32 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 128.584 2.753 . . . . 0.0 111.743 -170.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -117.45 -179.62 0.67 Allowed Pre-proline 0 N--CA 1.447 -0.605 0 CA-C-O 114.935 -2.46 . . . . 0.0 108.807 165.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -46.36 150.82 1.99 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 1 C-N-CA 125.637 4.225 . . . . 0.0 116.335 -175.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.6 p -127.98 -175.11 3.39 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 128.488 2.715 . . . . 0.0 114.433 -173.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.0 tp -60.56 -54.15 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.502 1.121 . . . . 0.0 108.078 175.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 88.0 p -69.19 -16.99 63.75 Favored 'General case' 0 C--N 1.34 0.194 0 O-C-N 117.335 -3.353 . . . . 0.0 111.928 -175.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -98.76 -47.23 5.39 Favored 'General case' 0 CA--C 1.514 -0.427 0 O-C-N 116.999 -3.563 . . . . 0.0 111.145 -175.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.95 -55.67 31.57 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 125.892 1.995 . . . . 0.0 115.875 -149.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -52.24 -54.41 31.57 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 120.968 1.713 . . . . 0.0 114.092 -167.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -60.94 -40.28 92.67 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 119.417 -2.052 . . . . 0.0 114.926 167.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tt -55.23 -55.76 27.64 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 130.976 3.71 . . . . 0.0 108.331 -172.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -48.4 -48.61 36.87 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 125.077 2.37 . . . . 0.0 111.127 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -73.72 -36.33 65.19 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 119.078 -2.263 . . . . 0.0 113.035 -164.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 24.3 pt -66.48 -27.95 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 O-C-N 124.058 0.849 . . . . 0.0 112.995 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.269 1.1 pt? 164.93 -21.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 130.891 3.676 . . . . 0.0 111.228 173.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.82 29.35 59.38 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-O 123.019 1.344 . . . . 0.0 113.14 -170.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . 0.324 4.2 pt 64.46 7.7 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.706 1 C-N-CA 131.909 4.084 . . . . 0.0 113.037 165.609 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -68.44 151.6 46.6 Favored 'General case' 0 CA--C 1.515 -0.369 1 CA-C-O 111.102 -4.285 . . . . 0.0 112.333 174.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . 0.289 12.6 mt . . . . . 0 CA--C 1.517 -0.323 0 CA-C-N 125.61 3.823 . . . . 0.0 112.9 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.6 t80 . . . . . 0 N--CA 1.448 -0.56 0 CA-C-O 123.933 1.825 . . . . 0.0 114.232 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -70.6 127.53 33.01 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 -170.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -101.21 -15.57 17.28 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 125.298 1.439 . . . . 0.0 113.002 -174.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.9 pt -70.77 -25.63 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 120.571 1.532 . . . . 0.0 111.31 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.429 40.3 pt -60.36 -35.58 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 C-N-CA 127.702 2.401 . . . . 0.0 108.16 171.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.355 8.8 ttpt -44.0 -72.74 0.05 Allowed 'General case' 0 N--CA 1.454 -0.272 1 C-N-CA 132.266 4.227 . . . . 0.0 115.951 -159.548 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.9 m -72.12 -21.87 61.41 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.111 0.964 . . . . 0.0 111.948 -165.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.473 ' HB1' HD12 ' A' ' 76' ' ' ILE . . . -76.71 -59.95 2.56 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 128.081 2.552 . . . . 0.0 107.872 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -43.77 -35.11 1.75 Allowed 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 127.77 2.428 . . . . 0.0 108.143 169.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . 0.304 17.2 tt0 -73.45 -41.23 63.46 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 122.42 2.373 . . . . 0.0 115.402 173.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -61.51 -19.7 62.37 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 121.564 1.984 . . . . 0.0 111.973 171.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 34' ' ' LEU . 8.1 tp -71.77 -34.64 69.62 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 123.503 1.621 . . . . 0.0 111.188 -173.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.57 -12.97 8.94 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-N 110.804 -2.907 . . . . 0.0 112.557 173.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.4 pt -70.79 154.54 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 O-C-N 120.383 -1.657 . . . . 0.0 110.403 -171.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 84.4 p -96.46 175.05 6.55 Favored 'General case' 0 N--CA 1.437 -1.106 0 O-C-N 118.265 -2.772 . . . . 0.0 113.473 -166.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -51.16 -40.85 59.51 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 113.437 -3.173 . . . . 0.0 113.95 161.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . 0.293 25.2 mp0 -61.16 -40.41 93.77 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 127.822 3.201 . . . . 0.0 110.002 -175.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -72.75 -34.57 67.11 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 119.706 -1.871 . . . . 0.0 113.586 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 63.1 tp -73.35 -27.68 61.64 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 122.682 1.229 . . . . 0.0 113.601 -176.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.77 -36.73 81.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 116.301 -1.809 . . . . 0.0 107.082 169.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . 0.277 87.8 mm-40 -73.29 -31.28 63.95 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 127.662 2.385 . . . . 0.0 111.266 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.7 tptt -67.3 -24.61 65.77 Favored 'General case' 0 N--CA 1.442 -0.864 0 O-C-N 117.227 -3.421 . . . . 0.0 111.736 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.9 mt -124.96 -3.14 7.67 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 128.02 2.528 . . . . 0.0 109.992 -165.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.258 27.2 mtpt 52.32 5.54 0.04 OUTLIER 'General case' 0 C--O 1.233 0.224 0 C-N-CA 130.486 3.514 . . . . 0.0 118.736 -171.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.8 m -88.51 -168.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 128.386 2.674 . . . . 0.0 108.102 -173.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 90.9 p -100.1 158.87 15.53 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.911 1.284 . . . . 0.0 112.585 -173.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -52.33 -32.58 38.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 113.12 -1.855 . . . . 0.0 110.971 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -74.21 -31.12 62.5 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 175.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 67.7 mt -74.26 -34.63 37.87 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 O-C-N 118.459 -2.651 . . . . 0.0 112.196 174.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.41 11.2 m -64.22 -59.13 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 O-C-N 118.376 -2.703 . . . . 0.0 112.79 164.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -50.03 -18.91 0.61 Allowed 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 119.801 3.259 . . . . 0.0 119.801 175.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -58.95 -32.68 69.82 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 -171.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -93.91 -44.8 7.91 Favored 'General case' 0 CA--C 1.512 -0.5 0 O-C-N 126.148 2.155 . . . . 0.0 110.035 176.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -49.26 -30.82 7.76 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 127.606 2.362 . . . . 0.0 108.787 176.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.2 p -94.81 -28.09 15.43 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 117.443 -3.286 . . . . 0.0 114.253 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.58 9.52 56.44 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 118.556 -2.59 . . . . 0.0 113.776 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -88.76 45.1 1.26 Allowed 'General case' 0 N--CA 1.447 -0.606 1 C-N-CA 131.82 4.048 . . . . 0.0 113.222 -169.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.53 135.95 54.92 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 129.036 2.935 . . . . 0.0 112.844 -159.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.317 43.3 mtpt -109.78 76.19 0.91 Allowed Pre-proline 0 N--CA 1.445 -0.697 0 CA-C-O 114.656 -2.592 . . . . 0.0 115.612 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -84.06 157.91 13.36 Favored 'Trans proline' 0 C--N 1.329 -0.492 0 C-N-CA 124.861 3.707 . . . . 0.0 113.367 -158.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.669 ' H ' ' HB2' ' A' ' 66' ' ' GLN . 58.9 p -132.16 176.35 8.46 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 128.088 2.555 . . . . 0.0 112.943 168.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.413 ' H ' HG12 ' A' ' 64' ' ' ILE . 6.3 pt -48.02 -56.51 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 172.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 90.8 p -47.34 -33.77 6.14 Favored 'General case' 0 C--N 1.342 0.244 0 O-C-N 117.468 -3.27 . . . . 0.0 115.916 166.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.669 ' HB2' ' H ' ' A' ' 63' ' ' THR . 62.4 mt-30 -75.01 -50.43 16.55 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 128.209 2.603 . . . . 0.0 112.28 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -42.62 -52.45 4.83 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 125.949 1.699 . . . . 0.0 111.458 162.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.9 mtm180 -63.82 -34.39 77.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 124.145 0.903 . . . . 0.0 111.824 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -80.36 -35.6 35.21 Favored 'General case' 0 CA--C 1.516 -0.351 0 O-C-N 119.695 -1.878 . . . . 0.0 112.634 -168.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.3 mt -73.69 -50.56 20.29 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 131.572 3.949 . . . . 0.0 115.264 -167.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -44.04 -34.92 1.9 Allowed 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.579 0.704 . . . . 0.0 112.215 158.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.2 mttp -98.35 10.31 41.04 Favored 'General case' 0 CA--C 1.513 -0.471 0 O-C-N 118.303 -2.748 . . . . 0.0 114.404 -165.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 20.7 pt -53.28 -50.85 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-O 125.652 2.644 . . . . 0.0 112.912 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 77.0 mt -106.43 0.67 25.01 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 118.919 -2.363 . . . . 0.0 115.901 176.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.33 0.61 11.36 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 126.617 2.055 . . . . 0.0 115.245 175.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.473 HD12 ' HB1' ' A' ' 30' ' ' ALA . 21.7 pt -116.42 -174.49 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 116.979 -3.659 . . . . 0.0 116.605 -177.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -173.93 147.6 1.32 Allowed 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 113.501 -3.143 . . . . 0.0 109.432 -173.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 31.5 mt . . . . . 0 N--CA 1.446 -0.641 0 O-C-N 125.931 2.019 . . . . 0.0 110.579 164.748 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.283 58.4 t80 . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 118.375 2.731 . . . . 0.0 118.375 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -46.25 143.8 2.28 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 131.194 3.798 . . . . 0.0 118.182 -154.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -98.99 -32.87 11.07 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 117.768 2.507 . . . . 0.0 117.768 -176.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.2 pt -63.07 -33.4 60.58 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 C-N-CA 126.698 1.999 . . . . 0.0 107.59 -172.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.36 1.8 pt -60.11 -38.81 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 114.035 -1.439 . . . . 0.0 112.252 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.454 45.9 tttm -45.83 -74.6 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 118.841 2.904 . . . . 0.0 118.841 -162.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.5 m -53.47 -32.71 51.3 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 129.706 3.202 . . . . 0.0 113.706 -174.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.28 -55.86 9.27 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 114.544 -2.646 . . . . 0.0 110.775 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . 0.276 11.9 ptm180 -57.35 -40.96 79.15 Favored 'General case' 0 N--CA 1.447 -0.604 1 CA-C-N 126.302 4.137 . . . . 0.0 110.673 171.606 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -51.1 -35.78 36.9 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 114.87 -2.49 . . . . 0.0 115.448 176.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -51.54 -42.57 61.88 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 121.687 2.04 . . . . 0.0 109.736 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 50.3 mt -80.94 -25.68 37.23 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 131.538 3.935 . . . . 0.0 109.514 -176.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 55.97 5.39 0.96 Allowed Glycine 0 C--O 1.22 -0.75 0 CA-C-N 112.665 -2.061 . . . . 0.0 116.199 -170.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.5 pt -60.35 148.06 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 126.685 1.994 . . . . 0.0 108.392 -163.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 88.6 p -133.18 -177.29 4.45 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 122.728 2.513 . . . . 0.0 110.581 170.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . 0.254 65.0 mt-30 -21.61 -61.34 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 113.419 -3.181 . . . . 0.0 116.197 -163.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -58.99 -51.95 67.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 124.484 3.311 . . . . 0.0 109.365 -173.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -67.2 -29.38 69.03 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 117.435 -1.269 . . . . 0.0 110.864 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.8 tp -80.91 -23.89 38.62 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.935 1.694 . . . . 0.0 112.197 -167.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.74 -45.62 67.08 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 131.598 3.959 . . . . 0.0 111.163 153.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -77.94 -21.47 51.03 Favored 'General case' 0 CA--C 1.51 -0.561 0 O-C-N 126.773 2.546 . . . . 0.0 110.688 178.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -83.11 -12.06 57.4 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 118.304 -2.748 . . . . 0.0 105.168 -169.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' A' ' 45' ' ' LEU . 21.8 tp -125.35 -9.58 6.95 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -173.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.7 mtmt 57.31 52.89 8.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 131.196 3.798 . . . . 0.0 112.335 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.1 m -124.79 177.22 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 1 C-N-CA 134.019 4.928 . . . . 0.0 113.138 -177.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 62.1 p -82.06 159.61 23.4 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 116.81 2.152 . . . . 0.0 116.81 168.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -64.07 -14.54 55.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 169.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -80.97 -23.2 38.93 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 119.803 -1.811 . . . . 0.0 113.238 170.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.0 mt -69.45 -43.63 80.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 118.293 -0.86 . . . . 0.0 112.911 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.8 m -68.57 -25.96 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 118.44 2.755 . . . . 0.0 118.44 -178.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -42.32 -48.3 5.0 Favored 'General case' 0 N--CA 1.432 -1.374 0 C-N-CA 130.204 3.402 . . . . 0.0 116.706 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.6 mtt85 -61.72 -39.62 92.18 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 123.682 2.946 . . . . 0.0 111.13 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -82.36 -33.99 28.6 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -168.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -64.93 -49.11 71.67 Favored 'General case' 0 N--CA 1.441 -0.876 0 O-C-N 118.649 -2.532 . . . . 0.0 109.145 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.6 p -80.16 -28.66 38.76 Favored 'General case' 0 C--O 1.243 0.739 0 O-C-N 118.745 -2.472 . . . . 0.0 112.908 -167.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.2 5.48 62.17 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -171.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -93.06 54.57 2.18 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 128.737 2.815 . . . . 0.0 112.433 -174.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . 0.252 62.7 tp -144.79 130.9 19.42 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 130.837 3.655 . . . . 0.0 107.241 -167.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.5 tttt -91.4 128.67 45.99 Favored Pre-proline 0 N--CA 1.45 -0.473 0 N-CA-C 119.156 3.021 . . . . 0.0 119.156 158.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -92.46 -172.03 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 1 C-N-CA 127.167 5.245 . . . . 0.0 107.722 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.264 17.4 p -156.33 174.37 15.5 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 128.058 2.543 . . . . 0.0 111.278 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.7 pt -63.18 -44.18 99.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 126.736 2.015 . . . . 0.0 113.752 166.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.5 p -66.68 -38.38 86.68 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 121.085 1.766 . . . . 0.0 112.284 164.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 67.8 mm-40 -69.9 -27.78 65.07 Favored 'General case' 0 N--CA 1.45 -0.429 2 O-C-N 111.299 -7.125 . . . . 0.0 115.377 -171.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . 0.257 . . -55.93 -74.08 0.05 Allowed 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 123.321 2.782 . . . . 0.0 114.382 -164.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.0 mmp_? -51.02 -21.88 2.03 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 126.329 1.852 . . . . 0.0 109.867 -178.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.569 ' C ' ' H ' ' A' ' 72' ' ' LYS . 61.0 mt-30 -77.22 -36.09 55.04 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 124.615 1.197 . . . . 0.0 112.817 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 40.0 mt -79.18 -41.13 29.13 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 128.25 2.62 . . . . 0.0 104.483 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -53.84 -26.73 25.83 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 118.025 -2.922 . . . . 0.0 111.254 154.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.569 ' H ' ' C ' ' A' ' 69' ' ' GLN . 51.2 tttt -79.36 -24.88 42.39 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 125.388 3.722 . . . . 0.0 115.222 -173.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . 0.406 24.0 pt -54.52 -69.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-N 125.603 3.82 . . . . 0.0 112.291 -165.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 82.6 mt -70.48 -20.92 62.82 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 130.276 3.431 . . . . 0.0 111.781 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.71 12.68 57.36 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 130.214 3.769 . . . . 0.0 118.775 174.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.5 pt -84.1 167.65 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.08 1 C-N-CA 132.385 4.274 . . . . 0.0 112.479 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.278 5.3 ptpt -175.94 144.84 0.63 Allowed 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 128.467 2.707 . . . . 0.0 114.413 175.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 31.4 mt . . . . . 0 C--N 1.327 -0.397 0 O-C-N 125.842 1.963 . . . . 0.0 109.153 163.974 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.8 t80 . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 123.871 1.796 . . . . 0.0 113.805 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -91.28 157.5 17.11 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 112.118 -2.31 . . . . 0.0 114.276 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.5 mttt -110.93 -46.44 3.34 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 -141.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.0 pt -67.6 -30.8 49.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 113.176 -3.297 . . . . 0.0 109.47 -174.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.372 20.1 pt -54.93 -49.68 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 C-N-CA 128.157 2.583 . . . . 0.0 110.12 178.106 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.347 74.8 mttt -29.66 -81.19 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.448 2 C-N-CA 132.418 4.287 . . . . 0.0 121.963 -174.332 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.0 p -75.82 -21.86 56.89 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 118.56 2.8 . . . . 0.0 118.56 -159.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.57 -21.83 63.02 Favored 'General case' 0 N--CA 1.439 -1.009 1 C-N-CA 133.973 4.909 . . . . 0.0 115.625 173.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . 0.282 6.6 ptm180 -44.15 -50.05 8.8 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 115.883 -2.008 . . . . 0.0 114.914 175.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -48.92 -33.24 10.42 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 126.634 1.974 . . . . 0.0 115.742 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -58.89 -25.48 63.4 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 118.605 -2.559 . . . . 0.0 112.708 -176.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.416 ' HB3' HG12 ' A' ' 36' ' ' ILE . 10.1 mp -96.32 -30.27 13.52 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.92 3.78 2.79 Favored Glycine 0 C--N 1.342 0.888 0 C-N-CA 127.943 2.687 . . . . 0.0 112.844 173.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.416 HG12 ' HB3' ' A' ' 34' ' ' LEU . 13.5 pt -66.5 154.03 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 120.344 2.072 . . . . 0.0 114.852 -173.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.0 p -71.79 161.85 30.34 Favored 'General case' 0 N--CA 1.443 -0.789 0 O-C-N 116.767 -3.708 . . . . 0.0 113.487 172.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -54.77 -46.44 74.4 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 114.604 -2.617 . . . . 0.0 108.489 173.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -61.74 -34.76 76.39 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 120.961 1.71 . . . . 0.0 111.068 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -80.43 -19.62 45.74 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 116.93 -1.908 . . . . 0.0 110.896 -175.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 66.8 tp -75.43 -46.51 32.23 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 125.856 2.741 . . . . 0.0 110.848 174.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.13 -39.31 66.36 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 118.551 -2.593 . . . . 0.0 110.953 173.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -63.86 -34.41 77.87 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 126.258 1.823 . . . . 0.0 115.918 160.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -73.97 -16.11 61.09 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 122.123 2.238 . . . . 0.0 107.693 -170.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.8 mt -123.09 -4.29 8.49 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 127.837 2.455 . . . . 0.0 112.51 -173.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.272 1.6 mptp? 43.23 56.74 4.08 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 118.652 2.834 . . . . 0.0 118.652 -167.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 31.9 m -127.7 175.77 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 1 C-N-CA 132.196 4.198 . . . . 0.0 108.583 -175.106 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 62.1 p -78.76 159.07 28.09 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 167.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -74.38 -13.29 60.71 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 128.229 3.455 . . . . 0.0 111.117 169.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -53.33 -50.56 64.72 Favored 'General case' 0 N--CA 1.447 -0.577 1 O-C-N 115.887 -4.258 . . . . 0.0 111.055 161.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.3 mm -59.14 -45.25 92.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 1 O-C-N 115.62 -4.425 . . . . 0.0 111.507 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.4 m -66.22 -49.29 77.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 115.173 -2.346 . . . . 0.0 106.258 -174.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.4 mtmm -50.53 -40.09 50.69 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 127.194 2.198 . . . . 0.0 113.754 173.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -60.95 -29.6 69.74 Favored 'General case' 0 C--N 1.345 0.393 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 172.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -72.46 -50.87 23.06 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 171.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -53.86 -51.92 62.08 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.984 1.714 . . . . 0.0 114.342 -173.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.5 p -74.87 -9.18 58.3 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 120.162 3.393 . . . . 0.0 120.162 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.67 16.76 80.08 Favored Glycine 0 C--O 1.243 0.713 1 CA-C-O 110.19 -5.783 . . . . 0.0 111.573 -169.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -89.83 51.84 2.17 Favored 'General case' 0 C--O 1.24 0.581 1 CA-C-N 126.839 5.32 . . . . 0.0 111.274 -172.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.9 tp -131.97 147.52 52.46 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -164.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.277 61.0 tttt -112.43 71.91 1.21 Allowed Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 113.717 -3.04 . . . . 0.0 111.743 168.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -83.6 -164.45 0.26 Allowed 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 124.552 3.501 . . . . 0.0 103.234 -166.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 p -153.57 174.39 14.51 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 130.841 3.657 . . . . 0.0 108.962 -169.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 28.9 pt -75.45 -48.15 31.9 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 CA-C-O 113.721 -3.038 . . . . 0.0 111.392 -174.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.8 p -58.91 -31.7 68.87 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 124.549 3.34 . . . . 0.0 112.826 166.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -68.47 -43.4 77.05 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 115.62 -2.134 . . . . 0.0 111.912 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -52.78 -44.28 66.45 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 114.44 -2.695 . . . . 0.0 111.28 165.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.2 mmp_? -56.4 -32.33 64.72 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 125.246 3.657 . . . . 0.0 110.585 170.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -82.31 -26.91 32.63 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 127.272 2.857 . . . . 0.0 111.276 -177.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.8 mt -60.54 -54.01 50.6 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 131.647 3.979 . . . . 0.0 107.463 167.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -50.6 -54.59 21.53 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 127.362 2.265 . . . . 0.0 109.013 174.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -67.54 -42.75 82.2 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 117.56 2.43 . . . . 0.0 117.56 -170.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.418 HG13 ' H ' ' A' ' 74' ' ' LEU 0.258 9.5 pt -48.74 -63.96 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 O-C-N 116.962 -3.586 . . . . 0.0 113.852 -175.305 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.418 ' H ' HG13 ' A' ' 73' ' ' ILE . 21.2 mt -75.88 -14.65 60.27 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 122.851 1.31 . . . . 0.0 113.228 -176.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.39 -13.65 10.55 Favored Glycine 0 CA--C 1.532 1.117 0 O-C-N 119.061 -2.274 . . . . 0.0 114.677 176.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.8 pt -92.67 162.37 2.41 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.736 0 C-N-CA 130.253 3.421 . . . . 0.0 115.238 -174.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.0 pttt -173.04 150.41 1.98 Allowed 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 129.846 3.258 . . . . 0.0 108.29 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.4 mt . . . . . 0 N--CA 1.45 -0.426 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 165.235 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.312 22.1 t80 . . . . . 0 N--CA 1.443 -0.775 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -75.59 129.08 36.61 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 125.843 1.965 . . . . 0.0 111.827 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -105.09 -21.21 13.31 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 127.831 2.452 . . . . 0.0 114.499 -175.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.8 pt -69.72 -38.1 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 1 O-C-N 115.923 -4.235 . . . . 0.0 113.794 -174.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.404 ' H ' HG12 ' A' ' 27' ' ' ILE 0.301 22.5 pt -67.84 -20.32 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 127.154 2.182 . . . . 0.0 115.184 179.783 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -67.09 -62.45 1.42 Allowed 'General case' 0 C--N 1.327 -0.38 1 N-CA-C 121.893 4.034 . . . . 0.0 121.893 -158.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . 0.471 76.0 p -67.1 -25.02 66.01 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 124.272 3.214 . . . . 0.0 117.154 -176.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.42 -29.3 61.41 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 117.714 2.487 . . . . 0.0 117.714 -171.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.7 ptt85 -50.59 -38.81 47.66 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 117.792 -3.068 . . . . 0.0 114.475 175.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -59.25 -29.02 67.24 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.076 1.75 . . . . 0.0 112.401 -176.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -55.98 -40.97 74.08 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 122.268 2.304 . . . . 0.0 112.663 -178.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 60.7 mt -75.45 -8.61 57.16 Favored 'General case' 0 CA--C 1.514 -0.409 0 O-C-N 127.448 2.968 . . . . 0.0 116.567 -158.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.41 -13.12 11.81 Favored Glycine 0 C--N 1.346 1.119 0 O-C-N 119.792 -1.817 . . . . 0.0 114.486 173.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.3 pt -88.24 163.42 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -164.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 96.1 p -84.18 177.62 8.14 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 118.869 -2.395 . . . . 0.0 112.406 -175.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . 0.322 27.5 tt0 -54.92 -50.14 69.56 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 120.299 1.409 . . . . 0.0 112.71 172.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -61.95 -29.57 70.32 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.333 1.853 . . . . 0.0 115.854 -176.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -78.62 -40.18 35.1 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 175.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . 0.299 5.7 tp -46.9 -44.51 19.77 Favored 'General case' 0 C--O 1.239 0.55 1 O-C-N 129.747 4.404 . . . . 0.0 110.329 165.593 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.65 -55.46 34.51 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 128.099 2.56 . . . . 0.0 112.377 173.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -63.56 -34.88 78.77 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 120.175 1.352 . . . . 0.0 112.645 174.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -63.72 -36.68 84.67 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 126.191 2.901 . . . . 0.0 108.911 -172.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.1 mp -99.29 -5.1 30.36 Favored 'General case' 0 N--CA 1.438 -1.052 1 C-N-CA 135.199 5.4 . . . . 0.0 113.44 -170.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt 55.0 57.51 5.55 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.663 1.185 . . . . 0.0 113.389 -177.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.9 m -151.6 -176.25 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 130.076 3.351 . . . . 0.0 111.445 -171.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 65.7 p -93.85 163.02 13.68 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 118.482 -2.636 . . . . 0.0 115.218 167.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -70.4 -18.13 63.03 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 119.124 0.874 . . . . 0.0 111.517 171.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -68.02 -34.67 76.94 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 114.815 -2.754 . . . . 0.0 118.32 160.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 27.8 mt -73.77 -39.57 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 O-C-N 116.766 -3.709 . . . . 0.0 109.998 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.331 11.9 m -59.01 -49.86 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 O-C-N 119.441 -2.037 . . . . 0.0 111.02 178.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -48.11 -43.51 31.07 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 129.868 3.267 . . . . 0.0 108.596 167.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -67.54 -32.43 73.2 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-N 123.184 2.72 . . . . 0.0 114.018 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -75.1 -39.49 60.61 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 129.797 3.239 . . . . 0.0 106.871 170.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 -60.1 -32.72 71.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 122.352 2.342 . . . . 0.0 108.595 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.6 p -112.15 -6.75 14.11 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -144.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.52 18.12 74.24 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-O 125.157 2.531 . . . . 0.0 114.402 -176.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -97.85 33.84 2.02 Favored 'General case' 0 N--CA 1.438 -1.025 1 O-C-N 115.423 -4.575 . . . . 0.0 113.704 -176.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.4 tp -130.65 129.73 43.02 Favored 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 130.492 3.517 . . . . 0.0 110.198 -178.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -101.65 102.7 23.73 Favored Pre-proline 0 N--CA 1.442 -0.853 0 CA-C-O 115.91 -1.995 . . . . 0.0 106.455 168.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -80.31 174.73 11.01 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 CA-C-N 120.372 1.169 . . . . 0.0 112.33 -171.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.453 ' H ' ' HB2' ' A' ' 66' ' ' GLN . 62.1 p -139.99 174.22 10.73 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 118.8 -2.437 . . . . 0.0 110.436 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.89 -32.52 56.25 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -171.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.3 p -56.83 -53.56 56.48 Favored 'General case' 0 CA--C 1.512 -0.498 2 O-C-N 112.643 -6.286 . . . . 0.0 112.906 158.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.453 ' HB2' ' H ' ' A' ' 63' ' ' THR . 57.6 mt-30 -67.14 -36.44 81.88 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 118.431 2.752 . . . . 0.0 118.431 -170.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -31.85 -73.74 0.03 OUTLIER 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 131.434 3.893 . . . . 0.0 116.451 163.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -56.04 -36.36 67.92 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.437 -1.71 . . . . 0.0 111.856 172.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -75.47 -25.87 57.74 Favored 'General case' 0 C--O 1.246 0.88 1 CA-C-O 111.509 -4.091 . . . . 0.0 111.735 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.5 mt -69.51 -41.53 75.92 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 126.617 2.448 . . . . 0.0 107.705 -176.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -55.14 -38.06 67.74 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 117.7 2.482 . . . . 0.0 117.7 165.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -87.97 -35.0 17.88 Favored 'General case' 0 C--O 1.225 -0.225 0 O-C-N 116.845 -3.659 . . . . 0.0 114.931 -168.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.9 pt -63.71 -44.11 98.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 122.466 2.394 . . . . 0.0 107.213 -175.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.4 tp -68.94 -24.43 64.27 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 126.073 1.749 . . . . 0.0 112.699 169.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.07 -20.07 0.09 OUTLIER Glycine 0 C--N 1.337 0.636 0 N-CA-C 117.218 1.647 . . . . 0.0 117.218 -174.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.1 pt -134.25 174.27 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -168.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -147.75 166.4 27.62 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 113.784 -3.008 . . . . 0.0 108.785 -170.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.9 mt . . . . . 0 N--CA 1.446 -0.627 0 C-N-CA 127.931 2.492 . . . . 0.0 112.556 160.194 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 84.4 t80 . . . . . 0 C--O 1.236 0.374 0 N-CA-C 117.459 2.392 . . . . 0.0 117.459 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -58.65 141.74 51.6 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 118.362 -2.711 . . . . 0.0 115.541 174.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -113.08 -14.95 12.89 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 116.95 2.204 . . . . 0.0 116.95 -164.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.42 ' CD1' ' HG2' ' A' ' 71' ' ' GLU . 0.9 OUTLIER -60.14 -48.64 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 O-C-N 124.488 1.118 . . . . 0.0 111.35 -166.741 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.519 6.4 pt -72.77 -23.54 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 128.046 2.538 . . . . 0.0 117.003 173.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 51.1 tttm -56.54 -67.61 0.29 Allowed 'General case' 0 C--O 1.243 0.717 0 N-CA-C 118.079 2.622 . . . . 0.0 118.079 -162.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 57.8 p -68.64 -35.82 77.79 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 121.595 1.998 . . . . 0.0 106.574 -172.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.48 -37.43 87.29 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.748 2.019 . . . . 0.0 114.468 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -54.02 -49.98 67.68 Favored 'General case' 0 N--CA 1.44 -0.938 2 O-C-N 112.401 -6.437 . . . . 0.0 112.273 166.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -63.2 -33.37 75.33 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 129.354 3.062 . . . . 0.0 111.265 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -76.47 -25.99 54.9 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 122.703 2.501 . . . . 0.0 108.59 -176.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.414 HD11 HD11 ' A' ' 76' ' ' ILE . 97.1 mt -76.7 -23.42 53.13 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 119.663 -1.898 . . . . 0.0 110.364 168.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.48 -14.89 6.28 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 122.327 2.33 . . . . 0.0 110.935 174.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.0 pt -71.14 155.92 7.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 O-C-N 118.392 -2.828 . . . . 0.0 113.9 -154.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . 0.309 78.8 p -74.18 175.84 7.16 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 127.84 3.213 . . . . 0.0 111.669 -177.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.77 -46.13 89.44 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 123.284 1.516 . . . . 0.0 110.292 161.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -59.07 -28.95 66.96 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 115.585 -2.15 . . . . 0.0 113.135 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -79.88 -29.17 39.92 Favored 'General case' 0 N--CA 1.446 -0.669 1 CA-C-O 111.461 -4.114 . . . . 0.0 111.47 174.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.5 tp -68.74 -34.97 76.49 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 125.205 3.638 . . . . 0.0 110.97 171.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.3 -41.53 80.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 121.382 1.901 . . . . 0.0 113.359 171.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -61.74 -42.42 98.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 127.192 2.808 . . . . 0.0 109.667 171.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -51.33 -32.35 25.03 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 127.089 3.328 . . . . 0.0 109.445 -172.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.5 mt -120.2 2.27 10.87 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 117.412 -3.305 . . . . 0.0 110.831 -153.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 77.2 mttt 47.17 -17.8 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.906 1 N-CA-C 123.725 4.713 . . . . 0.0 123.725 -159.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.3 m -94.91 156.42 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 130.15 3.38 . . . . 0.0 115.066 -172.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 84.5 p -72.39 168.09 19.15 Favored 'General case' 0 N--CA 1.441 -0.898 0 O-C-N 118.374 -2.704 . . . . 0.0 116.737 -177.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.443 ' HA ' HG22 ' A' ' 52' ' ' VAL . 21.5 pt-20 -65.91 -20.48 66.23 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 118.877 2.917 . . . . 0.0 118.877 -175.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -47.84 -34.19 8.41 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 118.234 2.679 . . . . 0.0 118.234 163.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.0 mm -80.78 -38.94 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 119.006 -1.078 . . . . 0.0 113.25 166.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.443 HG22 ' HA ' ' A' ' 49' ' ' GLU 0.261 11.0 m -66.05 -42.77 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-O 115.496 -2.193 . . . . 0.0 115.86 -170.001 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -58.18 -17.96 22.48 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 127.486 2.314 . . . . 0.0 113.621 177.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -72.55 -50.75 23.48 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 130.688 3.595 . . . . 0.0 110.52 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.374 58.4 m-85 -73.13 -26.06 61.08 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 120.335 1.425 . . . . 0.0 109.173 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -69.0 -45.15 71.29 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 117.923 -2.986 . . . . 0.0 106.831 177.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.4 p -93.67 -34.93 13.07 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 -167.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.36 21.16 62.92 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-O 114.076 -3.624 . . . . 0.0 117.824 173.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -95.1 8.12 43.97 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 128.817 2.847 . . . . 0.0 114.189 -162.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.6 tp -134.38 144.0 47.96 Favored 'General case' 0 N--CA 1.447 -0.623 1 O-C-N 129.852 4.47 . . . . 0.0 114.043 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -102.09 91.8 2.71 Favored Pre-proline 0 N--CA 1.441 -0.878 0 O-C-N 118.678 -2.514 . . . . 0.0 108.749 166.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . 0.272 2.6 Cg_endo -74.9 176.65 9.59 Favored 'Trans proline' 0 N--CA 1.454 -0.81 1 C-N-CA 127.859 5.706 . . . . 0.0 107.789 -168.917 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.8 p -76.85 179.74 5.95 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 178.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.649 ' H ' HD12 ' A' ' 64' ' ' ILE . 2.3 mp -55.04 -62.24 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 C-N-CA 128.4 2.68 . . . . 0.0 107.669 -169.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.6 p -55.05 -30.62 59.99 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 115.237 -2.316 . . . . 0.0 113.896 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -84.15 -54.48 4.79 Favored 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 127.164 2.79 . . . . 0.0 106.661 -168.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -48.49 -33.32 9.24 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 128.683 2.793 . . . . 0.0 114.761 160.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.8 mtt-85 -75.64 -34.46 60.54 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 114.329 -2.748 . . . . 0.0 113.172 166.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -70.56 -32.67 70.18 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 122.932 2.605 . . . . 0.0 115.106 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.44 ' C ' ' H ' ' A' ' 72' ' ' LYS . 5.6 tt -41.64 -72.55 0.06 Allowed 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 130.118 3.367 . . . . 0.0 114.925 177.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.42 ' HG2' ' CD1' ' A' ' 26' ' ' ILE . 39.7 mt-10 -48.78 -19.43 0.37 Allowed 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 126.071 2.843 . . . . 0.0 110.26 173.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.44 ' H ' ' C ' ' A' ' 70' ' ' LEU . 28.1 mtpt -99.91 -8.33 24.14 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 117.524 -3.235 . . . . 0.0 115.996 -163.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.5 pt -61.43 -46.78 95.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 1 N-CA-C 122.004 4.075 . . . . 0.0 122.004 -171.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 49.3 mt -74.48 -18.23 60.65 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 126.002 1.721 . . . . 0.0 110.326 -172.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.47 -0.57 17.66 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 118.752 -1.69 . . . . 0.0 116.396 -158.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.414 HD11 HD11 ' A' ' 34' ' ' LEU . 30.8 pt -142.11 175.71 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 125.906 1.682 . . . . 0.0 109.238 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.357 11.5 pttt -176.95 149.06 0.69 Allowed 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 128.668 2.787 . . . . 0.0 108.526 -174.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 N--CA 1.439 -1.008 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 176.948 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 91.8 t80 . . . . . 0 N--CA 1.449 -0.504 0 CA-C-O 121.744 0.783 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . 0.506 0.0 OUTLIER -75.74 67.66 2.21 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 119.738 3.236 . . . . 0.0 119.738 179.348 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -60.08 -22.75 63.13 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 119.797 -1.814 . . . . 0.0 113.972 -169.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.1 pt -61.96 -29.34 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-O 114.815 -2.517 . . . . 0.0 112.851 173.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.316 12.2 mm -63.92 -57.11 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 CA-C-N 122.542 2.428 . . . . 0.0 105.836 174.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -51.02 -65.03 0.63 Allowed 'General case' 0 CA--C 1.532 0.266 1 C-N-CA 134.535 5.134 . . . . 0.0 109.874 -155.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 77.4 p -57.17 -31.68 65.65 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 126.253 2.221 . . . . 0.0 113.772 -164.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.87 -58.51 3.24 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.488 1.515 . . . . 0.0 108.183 174.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 56.5 ttt180 -51.15 -36.79 42.68 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 118.631 -2.543 . . . . 0.0 114.103 -176.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -68.32 -42.22 79.69 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 123.918 3.054 . . . . 0.0 113.467 172.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -54.19 -37.84 64.96 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-O 123.898 1.809 . . . . 0.0 113.206 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.256 62.9 mt -90.44 -11.1 41.4 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 111.266 -2.697 . . . . 0.0 112.371 -161.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.36 4.77 5.38 Favored Glycine 0 C--O 1.238 0.382 0 CA-C-O 125.329 2.627 . . . . 0.0 118.327 178.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.2 pt -69.02 153.06 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 O-C-N 119.668 -2.078 . . . . 0.0 112.161 -172.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.6 p -129.9 165.97 20.96 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 117.387 2.366 . . . . 0.0 117.387 -162.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -60.39 -37.28 80.3 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 116.978 -1.487 . . . . 0.0 112.833 -176.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -52.47 -34.65 50.08 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 115.322 -2.275 . . . . 0.0 113.458 166.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -77.51 -37.76 50.39 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 122.3 2.318 . . . . 0.0 111.632 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.3 tp -73.98 -31.93 63.2 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 115.364 -2.255 . . . . 0.0 108.602 -175.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.43 -47.02 76.64 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 166.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -60.6 -42.55 96.99 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 122.802 1.287 . . . . 0.0 112.825 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -70.43 -16.99 63.0 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 118.109 -2.869 . . . . 0.0 106.491 -173.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.8 tp -110.7 5.01 20.56 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 -169.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.2 tttp 45.56 52.67 9.09 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 131.158 3.783 . . . . 0.0 110.128 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.8 m -142.45 -176.41 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 C-N-CA 130.036 3.335 . . . . 0.0 115.73 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 86.7 p -94.42 161.35 14.26 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 125.099 1.36 . . . . 0.0 112.544 167.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -73.17 -12.95 61.07 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 117.122 -3.486 . . . . 0.0 110.378 -174.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -62.29 -37.4 85.37 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 119.027 -2.296 . . . . 0.0 111.961 170.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.0 mm -68.51 -28.94 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 125.936 1.694 . . . . 0.0 110.842 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.378 3.2 m -66.29 -35.55 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 O-C-N 117.282 -3.386 . . . . 0.0 113.987 -175.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -50.18 -38.13 38.28 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 117.198 2.296 . . . . 0.0 117.198 -170.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.292 99.0 mtt180 -25.94 -87.03 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 127.927 2.491 . . . . 0.0 114.739 170.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -77.99 -25.03 47.84 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 120.425 -1.422 . . . . 0.0 111.72 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -63.24 -13.04 33.36 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 120.28 1.4 . . . . 0.0 113.967 -177.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.8 p -65.04 -20.19 66.37 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 117.81 2.522 . . . . 0.0 117.81 170.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.79 19.46 75.09 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 128.817 3.103 . . . . 0.0 114.408 174.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -92.65 12.3 23.72 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 128.385 3.05 . . . . 0.0 116.04 -174.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.5 mt -145.48 120.81 10.26 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 171.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.8 tttp -64.97 116.38 29.3 Favored Pre-proline 0 C--O 1.233 0.202 0 O-C-N 119.22 -2.175 . . . . 0.0 113.623 161.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -66.43 160.53 45.17 Favored 'Trans proline' 0 N--CA 1.448 -1.199 1 C-N-CA 128.479 6.119 . . . . 0.0 114.145 -176.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.519 ' H ' ' HB2' ' A' ' 66' ' ' GLN . 63.9 p -108.94 -165.93 1.07 Allowed 'General case' 0 C--O 1.239 0.514 0 C-N-CA 127.246 2.218 . . . . 0.0 114.472 172.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 34.2 mt -57.88 -59.43 3.42 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.158 0 O-C-N 118.772 -2.455 . . . . 0.0 114.126 -171.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.3 p -59.75 -40.7 89.01 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 169.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.519 ' HB2' ' H ' ' A' ' 63' ' ' THR . 55.7 mt-30 -63.06 -55.21 27.49 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 116.361 1.985 . . . . 0.0 116.361 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -39.71 -47.27 2.0 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 117.196 -1.383 . . . . 0.0 113.356 160.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.1 ttt85 -67.25 -39.57 86.14 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 127.234 2.213 . . . . 0.0 107.897 -172.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -67.84 -52.23 39.12 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 116.74 -1.6 . . . . 0.0 107.174 176.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 21.6 tp -59.88 -60.32 4.02 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 127.845 3.688 . . . . 0.0 111.049 -168.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -52.63 -39.09 61.38 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 117.899 -3.001 . . . . 0.0 109.053 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -76.77 -34.73 58.0 Favored 'General case' 0 N--CA 1.446 -0.653 1 O-C-N 115.239 -4.663 . . . . 0.0 119.446 176.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 31.5 pt -67.84 -30.6 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 118.021 -1.471 . . . . 0.0 108.299 170.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.48 ' C ' ' H ' ' A' ' 76' ' ' ILE 0.311 95.8 mt -70.97 -41.97 70.33 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 117.024 -3.547 . . . . 0.0 117.102 174.857 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.15 -8.5 0.16 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 127.307 2.384 . . . . 0.0 110.961 -167.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.48 ' H ' ' C ' ' A' ' 74' ' ' LEU . 44.8 pt -116.91 146.62 21.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 117.803 2.52 . . . . 0.0 117.803 -177.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -176.2 153.68 1.29 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 114.604 -2.617 . . . . 0.0 112.572 176.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 78' ' ' LEU . 13.5 mt . . . . . 0 N--CA 1.432 -1.349 0 CA-C-O 126.485 3.04 . . . . 0.0 112.209 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.577 ' HD1' ' H ' ' A' ' 60' ' ' LEU . 63.5 t80 . . . . . 0 N--CA 1.449 -0.483 0 CA-C-O 123.04 1.4 . . . . 0.0 108.599 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -72.73 140.93 48.11 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 126.87 3.224 . . . . 0.0 111.332 -167.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -93.96 -45.9 7.4 Favored 'General case' 0 CA--C 1.503 -0.848 1 O-C-N 114.19 -5.319 . . . . 0.0 116.456 -155.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.7 tp -65.22 -37.54 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-O 115.614 -2.136 . . . . 0.0 113.414 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.398 7.6 pt -55.05 -35.6 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 O-C-N 125.73 1.894 . . . . 0.0 109.302 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -67.54 -39.63 85.03 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 119.795 -1.816 . . . . 0.0 112.254 -174.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.9 p -62.17 -43.14 99.49 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 124.491 1.116 . . . . 0.0 108.705 -157.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.35 -74.8 0.13 Allowed 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 117.741 2.497 . . . . 0.0 117.741 -155.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -47.95 -46.36 32.13 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 -165.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -55.16 -58.6 7.01 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 124.374 3.261 . . . . 0.0 112.224 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -66.98 -23.1 65.91 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 123.519 2.872 . . . . 0.0 116.298 -172.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 99.3 mt -76.58 -1.8 29.29 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 177.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.54 -0.56 12.55 Favored Glycine 0 C--N 1.335 0.481 2 CA-C-N 107.327 -4.488 . . . . 0.0 117.064 172.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.2 pt -78.77 158.78 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 C-N-CA 130.077 3.351 . . . . 0.0 114.126 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 p -89.61 175.77 7.14 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 117.134 2.272 . . . . 0.0 117.134 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -55.73 -50.98 68.9 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 116.59 -3.819 . . . . 0.0 110.299 161.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -60.07 -47.28 86.53 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 129.27 3.028 . . . . 0.0 113.319 -170.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -64.21 -33.44 75.8 Favored 'General case' 0 N--CA 1.449 -0.51 1 CA-C-O 111.62 -4.038 . . . . 0.0 114.4 174.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 23.0 tp -85.25 -27.14 26.23 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 127.822 3.202 . . . . 0.0 109.653 -177.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.56 -24.1 67.67 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 129.28 3.032 . . . . 0.0 113.483 167.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -66.12 -55.64 15.41 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 104.089 -2.56 . . . . 0.0 104.089 169.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -62.25 -14.99 44.27 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 128.32 2.648 . . . . 0.0 113.41 -159.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 40.8 mt -131.51 -8.47 3.68 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 128.297 3.903 . . . . 0.0 109.955 -163.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.312 88.1 mttt 56.4 -5.4 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 121.709 3.966 . . . . 0.0 121.709 -158.089 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.3 m -131.25 153.47 39.07 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 C-N-CA 127.87 2.468 . . . . 0.0 110.907 -168.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.921 ' C ' ' H ' ' A' ' 52' ' ' VAL . 91.3 p -128.57 -11.83 4.98 Favored 'General case' 0 N--CA 1.446 -0.653 1 N-CA-C 122.196 4.147 . . . . 0.0 122.196 -169.69 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -99.59 -30.46 12.12 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 117.354 -3.342 . . . . 0.0 111.397 -158.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . 0.253 64.6 t30 -103.15 -55.49 2.4 Favored 'General case' 0 C--O 1.217 -0.618 1 N-CA-C 122.431 4.234 . . . . 0.0 122.431 177.152 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . 0.325 0.7 OUTLIER 41.23 52.03 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.491 2 O-C-N 113.689 -5.632 . . . . 0.0 118.247 14.295 . . . . . . . . 4 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.921 ' H ' ' C ' ' A' ' 48' ' ' SER . 15.7 t -105.33 -42.36 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 129.366 3.067 . . . . 0.0 107.929 23.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -69.95 -39.34 76.12 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 119.023 2.972 . . . . 0.0 119.023 -153.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 54' ' ' ARG . 34.8 ttm180 -83.05 -12.59 57.02 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 120.455 1.479 . . . . 0.0 114.391 -158.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -79.7 -11.93 59.83 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -88.26 -5.95 58.06 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 118.061 -2.899 . . . . 0.0 110.693 -175.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.6 p -92.1 -7.04 49.73 Favored 'General case' 0 N--CA 1.454 -0.268 1 N-CA-C 121.936 4.05 . . . . 0.0 121.936 -142.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.48 ' HA2' ' CD2' ' A' ' 23' ' ' TYR . . . 68.47 26.13 74.49 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-O 115.109 -3.05 . . . . 0.0 110.942 177.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -130.38 -1.32 4.46 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 119.068 2.988 . . . . 0.0 119.068 -160.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.577 ' H ' ' HD1' ' A' ' 23' ' ' TYR . 4.2 tp -135.31 158.87 43.27 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 -171.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -106.48 94.87 10.64 Favored Pre-proline 0 CA--C 1.513 -0.454 0 CA-C-O 115.646 -2.121 . . . . 0.0 113.259 147.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.08 151.28 34.62 Favored 'Trans proline' 0 N--CA 1.443 -1.467 0 C-N-CA 122.612 2.208 . . . . 0.0 110.61 172.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.5 p -80.17 171.72 14.72 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 127.213 2.821 . . . . 0.0 117.726 169.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . 0.315 2.1 tp -53.58 -61.17 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 130.548 3.539 . . . . 0.0 106.382 177.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 83.2 p -61.23 -23.6 65.75 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 116.308 -1.806 . . . . 0.0 112.887 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -80.77 -46.69 15.02 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 128.379 2.672 . . . . 0.0 109.233 173.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.04 93.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 130.173 3.389 . . . . 0.0 115.035 170.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -52.09 -22.41 4.12 Favored 'General case' 0 C--O 1.22 -0.476 0 C-N-CA 127.276 2.23 . . . . 0.0 113.959 175.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -66.68 -13.05 60.79 Favored 'General case' 0 N--CA 1.438 -1.025 0 C-N-CA 125.985 1.714 . . . . 0.0 111.339 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.6 tp -79.97 -49.6 11.62 Favored 'General case' 0 N--CA 1.436 -1.152 1 O-C-N 114.735 -4.978 . . . . 0.0 109.484 -175.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -50.56 -31.32 15.41 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 126.567 2.417 . . . . 0.0 108.022 172.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.1 tttp -69.17 -54.24 15.88 Favored 'General case' 0 C--O 1.24 0.579 1 C-N-CA 131.788 4.035 . . . . 0.0 106.786 -170.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 19.2 pt -79.53 -40.0 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 117.466 -3.271 . . . . 0.0 108.076 -168.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 25.4 mt -82.45 -13.46 56.7 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 128.189 2.596 . . . . 0.0 114.04 -175.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.517 ' O ' HG23 ' A' ' 76' ' ' ILE . . . 69.33 4.13 42.49 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-O 114.12 -3.6 . . . . 0.0 118.228 -167.012 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.517 HG23 ' O ' ' A' ' 75' ' ' GLY . 6.5 pt -171.94 135.31 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 127.854 2.462 . . . . 0.0 109.016 -161.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -65.73 131.0 45.25 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 114.173 -3.011 . . . . 0.0 115.629 170.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.5 mt . . . . . 0 N--CA 1.437 -1.102 0 CA-C-N 124.099 3.136 . . . . 0.0 111.185 -173.93 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 . . . . . 0 C--O 1.239 0.542 0 CA-C-O 119.493 -0.289 . . . . 0.0 111.614 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -90.69 -2.62 57.82 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 129.254 3.022 . . . . 0.0 114.625 -171.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.34 -13.75 37.18 Favored 'General case' 0 N--CA 1.444 -0.749 1 C-N-CA 131.968 4.107 . . . . 0.0 111.498 170.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -98.46 -0.82 42.71 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 125.273 1.429 . . . . 0.0 112.841 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.7 mt -84.91 173.01 10.92 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.989 1.716 . . . . 0.0 114.196 166.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -148.22 135.87 20.73 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -174.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.2 pp -112.65 -5.7 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 N-CA-C 119.314 3.079 . . . . 0.0 119.314 159.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.5 t -98.85 49.77 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.473 1 C-N-CA 132.866 4.466 . . . . 0.0 109.122 177.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.4 p -80.4 -12.57 59.56 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 112.452 -3.642 . . . . 0.0 113.18 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . 0.251 15.1 m-20 61.16 13.68 4.93 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 123.448 2.84 . . . . 0.0 111.292 -160.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -121.37 9.85 10.43 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 117.474 -1.251 . . . . 0.0 112.666 -176.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -75.39 -166.19 0.5 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -174.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -16.4 -57.91 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 119.905 3.298 . . . . 0.0 119.905 166.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 78' ' ' LEU . 9.2 tp -44.07 -50.84 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 118.84 2.904 . . . . 0.0 118.84 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.311 6.2 tt -84.27 -46.94 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 129.366 3.066 . . . . 0.0 110.115 175.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -52.44 -52.49 53.8 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 115.476 -2.202 . . . . 0.0 111.623 -172.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.1 p -46.33 -52.32 13.01 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.252 1.421 . . . . 0.0 109.247 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.9 -36.43 56.67 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-O 114.453 -2.689 . . . . 0.0 117.388 -172.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.425 ' HD2' HD22 ' A' ' 41' ' ' LEU 0.31 37.3 ptt85 -57.97 -43.93 86.79 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 121.201 1.819 . . . . 0.0 113.562 172.716 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -55.28 -34.0 63.72 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 113.575 -3.107 . . . . 0.0 111.962 164.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.65 -21.96 63.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 124.16 3.164 . . . . 0.0 109.028 178.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.8 mt -98.82 -9.87 23.74 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 125.764 1.626 . . . . 0.0 112.768 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.22 -7.33 2.59 Favored Glycine 0 N--CA 1.464 0.56 0 CA-C-N 113.014 -1.903 . . . . 0.0 117.851 174.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.5 pt -57.11 128.32 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 128.293 2.637 . . . . 0.0 111.284 -176.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.7 p -67.93 162.52 24.11 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 118.936 2.939 . . . . 0.0 118.936 -171.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -48.02 -43.97 30.5 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 117.604 -3.185 . . . . 0.0 113.951 168.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -68.69 -34.89 76.43 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 123.415 0.686 . . . . 0.0 110.002 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -71.32 -41.5 69.77 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 115.05 -2.405 . . . . 0.0 109.105 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.425 HD22 ' HD2' ' A' ' 31' ' ' ARG 0.257 29.2 tp -59.94 -46.25 90.0 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 128.081 2.552 . . . . 0.0 113.945 177.501 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 47' ' ' VAL . . . -54.5 -37.77 65.7 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 110.718 -2.946 . . . . 0.0 116.492 174.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.455 ' C ' ' H ' ' A' ' 45' ' ' LEU . 43.4 mt-30 -63.78 -40.59 97.04 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.839 1.655 . . . . 0.0 113.62 165.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -63.66 1.21 0.63 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.28 1.832 . . . . 0.0 111.452 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.455 ' H ' ' C ' ' A' ' 43' ' ' GLN 0.268 16.1 tp -145.79 4.43 0.99 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 120.377 3.473 . . . . 0.0 120.377 -170.665 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.26 63.7 mttt 52.18 39.01 25.98 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 130.807 3.643 . . . . 0.0 115.199 -174.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.425 ' O ' ' HB1' ' A' ' 42' ' ' ALA . 35.7 m -126.66 -172.58 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 1 C-N-CA 133.38 4.672 . . . . 0.0 113.826 -176.5 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.1 p -101.33 152.5 20.63 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 116.599 -1.667 . . . . 0.0 114.421 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -49.09 -32.5 9.89 Favored 'General case' 0 CA--C 1.52 -0.187 0 O-C-N 126.177 2.173 . . . . 0.0 110.349 165.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -74.08 -29.63 61.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 116.599 -1.667 . . . . 0.0 109.746 -171.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mt -70.83 -47.67 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-O 126.322 2.963 . . . . 0.0 113.704 173.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.348 13.4 m -56.59 -46.72 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 2 O-C-N 113.433 -5.792 . . . . 0.0 112.148 175.149 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -56.07 -40.86 74.23 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 117.989 -2.944 . . . . 0.0 113.277 162.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.8 ttt85 -57.64 -36.59 72.05 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 115.609 -2.138 . . . . 0.0 113.174 177.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -71.51 -44.76 64.07 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 124.849 1.343 . . . . 0.0 111.066 173.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -67.7 -13.77 62.38 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 114.861 -2.495 . . . . 0.0 109.775 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.9 p -102.68 0.36 32.99 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 124.094 3.134 . . . . 0.0 111.482 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.93 6.22 87.0 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 122.268 2.303 . . . . 0.0 115.816 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -94.12 -18.83 21.38 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 119.443 1.621 . . . . 0.0 114.962 -166.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.4 tp -144.87 161.67 38.72 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 127.931 3.27 . . . . 0.0 109.04 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.258 76.2 tttt -133.65 151.94 78.05 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-O 115.627 -2.13 . . . . 0.0 112.869 171.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . 0.274 41.4 Cg_endo -63.42 168.04 11.99 Favored 'Trans proline' 0 N--CA 1.451 -0.981 1 C-N-CA 126.211 4.607 . . . . 0.0 108.807 169.636 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 81.3 p -96.34 179.22 5.11 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 127.581 2.352 . . . . 0.0 111.224 171.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.1 pt -64.66 -57.23 12.16 Favored 'Isoleucine or valine' 0 C--N 1.346 0.449 0 CA-C-O 113.434 -3.174 . . . . 0.0 114.857 -175.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 90.3 p -51.98 -29.64 21.49 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 122.975 2.625 . . . . 0.0 111.914 167.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -78.86 -53.07 7.46 Favored 'General case' 0 N--CA 1.439 -0.978 0 O-C-N 118.982 -2.324 . . . . 0.0 109.129 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -40.94 -45.57 2.59 Favored 'General case' 0 N--CA 1.448 -0.57 1 C-N-CA 131.918 4.087 . . . . 0.0 104.759 162.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -62.65 -40.0 95.65 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 118.667 -2.52 . . . . 0.0 112.253 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -79.3 -40.33 30.67 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 117.676 2.473 . . . . 0.0 117.676 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.479 ' O ' HG22 ' A' ' 73' ' ' ILE . 87.5 mt -44.97 -46.13 10.94 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 114.854 -2.498 . . . . 0.0 113.965 161.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -56.03 -43.08 77.47 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 121.831 2.105 . . . . 0.0 107.353 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -85.21 -4.95 59.33 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 130.396 3.478 . . . . 0.0 118.609 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.579 HG23 ' HG ' ' A' ' 74' ' ' LEU . 4.2 tt -75.58 -31.64 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 1 O-C-N 114.395 -5.191 . . . . 0.0 116.394 -163.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.579 ' HG ' HG23 ' A' ' 73' ' ' ILE . 57.8 mt -105.56 -7.26 18.7 Favored 'General case' 0 N--CA 1.445 -0.694 2 O-C-N 115.244 -4.66 . . . . 0.0 113.0 -175.706 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.08 -20.78 0.05 OUTLIER Glycine 0 CA--C 1.526 0.765 0 O-C-N 116.486 -3.884 . . . . 0.0 112.643 -151.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.438 ' H ' ' C ' ' A' ' 74' ' ' LEU . 9.2 pt -131.05 -161.79 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-O 125.101 2.382 . . . . 0.0 116.918 -172.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.5 pttm -175.29 176.02 2.1 Favored 'General case' 0 N--CA 1.439 -0.99 0 O-C-N 117.318 -3.364 . . . . 0.0 107.08 -172.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.412 ' HA ' HD12 ' A' ' 26' ' ' ILE . 59.0 tp 104.3 -41.26 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 129.689 3.196 . . . . 0.0 106.798 138.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.4 m -100.95 140.9 18.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 120.314 3.45 . . . . 0.0 120.314 -153.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.7 p -97.78 176.68 1.93 Allowed Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 128.111 2.564 . . . . 0.0 108.679 165.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -62.22 -11.1 20.67 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 N-CA-C 109.801 -0.884 . . . . 0.0 109.801 176.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -108.34 -24.14 11.6 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -172.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -69.63 113.04 6.54 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 119.531 -1.98 . . . . 0.0 111.343 -172.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -96.75 -51.63 4.21 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 118.462 2.764 . . . . 0.0 118.462 -172.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -63.92 118.34 8.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 117.954 -2.966 . . . . 0.0 115.586 162.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.12 26.77 0.7 Allowed 'General case' 0 C--O 1.239 0.528 0 O-C-N 125.535 1.772 . . . . 0.0 114.571 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -66.08 107.86 2.05 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 123.333 1.54 . . . . 0.0 109.471 -164.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.5 p -159.56 143.54 14.79 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 130.002 3.321 . . . . 0.0 114.13 174.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.07 137.79 58.3 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 118.305 -2.747 . . . . 0.0 109.716 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -69.3 128.95 38.39 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 101.72 -3.437 . . . . 0.0 101.72 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -138.85 105.83 5.43 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 115.733 -2.08 . . . . 0.0 115.35 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.43 134.83 48.04 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 127.787 3.179 . . . . 0.0 106.856 -169.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -38.49 143.2 0.15 Allowed 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 156.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -72.15 -40.23 68.19 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 127.421 2.951 . . . . 0.0 112.05 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.4 m -65.43 -36.9 85.32 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 172.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -56.15 -36.72 69.21 Favored Glycine 0 C--O 1.224 -0.477 0 CA-C-O 114.918 -3.157 . . . . 0.0 115.337 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 47.0 tp -96.0 -69.91 0.74 Allowed 'General case' 0 C--O 1.242 0.671 0 C-N-CA 127.247 2.219 . . . . 0.0 107.284 -176.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.6 m -88.61 -34.56 17.26 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 127.931 2.492 . . . . 0.0 111.607 -149.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 11.6 tp -81.44 -10.31 59.53 Favored 'General case' 0 N--CA 1.441 -0.883 0 O-C-N 119.76 -1.837 . . . . 0.0 113.927 161.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.98 -18.83 76.2 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-O 115.995 -2.558 . . . . 0.0 110.495 173.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -75.3 23.19 0.11 Allowed 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 123.223 3.512 . . . . 0.0 118.179 -158.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . 0.259 0.0 OUTLIER -130.82 146.69 33.59 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.416 1 C-N-CA 136.026 5.73 . . . . 0.0 112.245 -169.637 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 72.2 t -66.96 117.3 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 2 O-C-N 107.968 -9.207 . . . . 0.0 110.151 13.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -77.08 -37.15 55.01 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 116.319 -3.988 . . . . 0.0 113.503 -161.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 14.3 tt -80.18 -8.33 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 128.819 2.848 . . . . 0.0 109.767 -168.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -113.61 153.31 29.07 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 123.462 1.601 . . . . 0.0 109.363 174.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -63.54 131.05 46.86 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 129.212 3.005 . . . . 0.0 112.092 -173.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.79 -22.06 2.38 Favored Glycine 0 N--CA 1.444 -0.805 1 O-C-N 115.537 -4.477 . . . . 0.0 115.04 171.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 33.5 mttp 117.05 4.21 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 130.159 3.384 . . . . 0.0 110.363 153.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . 0.292 48.3 tttp 53.19 69.28 0.72 Allowed 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 129.396 3.079 . . . . 0.0 113.383 175.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.3 8.2 mt -86.98 166.08 15.36 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 127.502 2.321 . . . . 0.0 109.978 -178.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -65.74 -33.19 75.31 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 121.361 1.892 . . . . 0.0 114.249 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 10.7 p-80 -95.11 12.94 26.92 Favored 'General case' 0 C--O 1.233 0.207 2 O-C-N 115.241 -4.662 . . . . 0.0 110.984 -175.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 26.4 m170 . . . . . 0 N--CA 1.444 -0.754 0 C-N-CA 127.596 2.359 . . . . 0.0 113.186 -177.78 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 126.658 3.123 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -55.3 -17.82 5.34 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 111.65 -2.523 . . . . 0.0 115.182 171.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.44 11.11 9.15 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 117.839 2.533 . . . . 0.0 117.839 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -103.54 12.98 34.36 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 125.299 1.624 . . . . 0.0 114.782 169.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -108.33 173.1 6.47 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 116.958 -3.589 . . . . 0.0 111.26 159.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -167.96 135.82 2.29 Favored 'General case' 0 N--CA 1.44 -0.969 1 O-C-N 114.559 -5.088 . . . . 0.0 117.883 -167.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 24.8 pt -104.4 -8.22 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 129.403 3.081 . . . . 0.0 114.888 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.6 m -74.46 -2.22 3.57 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.535 0 CA-C-O 126.574 3.083 . . . . 0.0 109.845 175.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.6 p -51.29 -21.56 2.24 Favored 'General case' 0 N--CA 1.449 -0.5 1 O-C-N 114.389 -5.194 . . . . 0.0 113.927 157.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . 0.292 25.5 t70 -91.08 54.46 2.62 Favored 'General case' 0 CA--C 1.512 -0.495 0 O-C-N 120.124 -1.61 . . . . 0.0 108.527 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.692 ' HD1' ' H ' ' A' ' 60' ' ' LEU . 40.0 t80 -59.3 134.16 56.75 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 112.545 -2.116 . . . . 0.0 113.236 -173.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -65.15 144.97 56.87 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 119.843 1.201 . . . . 0.0 112.476 -174.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -78.34 -29.12 47.45 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 119.266 3.061 . . . . 0.0 119.266 -160.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.96 -51.87 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 O-C-N 117.488 -3.257 . . . . 0.0 108.587 -170.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.2 pt -54.0 -28.66 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 117.131 -1.414 . . . . 0.0 114.312 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -60.12 -39.61 86.84 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 129.555 3.142 . . . . 0.0 111.136 173.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.5 p -90.77 -21.87 21.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 117.011 2.226 . . . . 0.0 117.011 -173.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.83 -61.27 2.75 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 131.05 3.74 . . . . 0.0 113.115 -159.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.38 -46.08 87.04 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-O 114.618 -2.611 . . . . 0.0 110.135 -169.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -63.7 -34.76 78.59 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 117.281 2.326 . . . . 0.0 117.281 169.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.97 -0.21 13.08 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 122.83 2.559 . . . . 0.0 110.659 -174.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 36.3 mt -117.43 -19.81 9.35 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 129.491 3.116 . . . . 0.0 112.527 178.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.76 -8.29 50.28 Favored Glycine 0 C--O 1.223 -0.557 0 CA-C-O 127.615 3.897 . . . . 0.0 114.463 162.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.44 HD13 ' HE3' ' A' ' 44' ' ' LYS . 35.1 pt -91.75 155.86 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 130.356 3.463 . . . . 0.0 110.459 -173.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.0 p -65.14 161.91 18.1 Favored 'General case' 0 CA--C 1.514 -0.412 0 O-C-N 119.86 -1.775 . . . . 0.0 115.065 167.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -56.42 -37.73 70.6 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 118.017 -0.992 . . . . 0.0 111.713 170.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -66.77 -31.87 72.79 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 126.004 1.722 . . . . 0.0 111.591 174.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -69.07 -39.58 79.0 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 118.644 -2.535 . . . . 0.0 112.781 170.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.0 tp -64.25 -37.92 89.21 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 118.665 -2.522 . . . . 0.0 110.216 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.79 -25.08 61.86 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.311 -0.868 . . . . 0.0 108.874 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -62.33 -36.67 82.93 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 123.603 1.668 . . . . 0.0 114.948 170.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.44 ' HE3' HD13 ' A' ' 36' ' ' ILE . 21.8 mttm -66.82 -22.85 66.0 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 117.292 -3.38 . . . . 0.0 111.807 -175.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.6 mt -133.46 -5.62 2.94 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 127.297 2.873 . . . . 0.0 108.985 -145.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.356 65.2 mmtt 51.16 -37.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 119.175 3.028 . . . . 0.0 119.175 -153.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.1 m -124.46 154.46 31.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 116.171 -1.871 . . . . 0.0 111.605 -157.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.913 ' C ' ' H ' ' A' ' 52' ' ' VAL . 84.0 p -137.87 -6.36 1.67 Allowed 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 127.966 3.291 . . . . 0.0 118.189 -135.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.432 ' N ' ' H ' ' A' ' 52' ' ' VAL . 17.7 mp0 -101.59 -32.36 10.39 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 127.651 3.094 . . . . 0.0 110.387 -162.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.608 ' H ' ' C ' ' A' ' 51' ' ' ILE . 57.0 t-20 -118.91 -42.84 2.69 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 112.446 -3.645 . . . . 0.0 113.894 -174.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.608 ' C ' ' H ' ' A' ' 50' ' ' ASN . 1.5 mt 46.12 61.75 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.354 2 C-N-CA 137.925 6.49 . . . . 0.0 112.22 -1.654 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.913 ' H ' ' C ' ' A' ' 48' ' ' SER . 27.8 t -93.66 -47.76 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 O-C-N 117.723 -3.111 . . . . 0.0 114.882 2.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -57.82 -43.22 85.6 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 120.523 3.527 . . . . 0.0 120.523 -148.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.3 ttm180 -73.44 -12.41 60.79 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 115.516 -2.183 . . . . 0.0 114.684 -157.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -52.39 -27.91 17.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 125.252 1.595 . . . . 0.0 113.765 169.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . 0.269 12.4 pt-20 -50.41 -27.45 6.41 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 123.849 3.022 . . . . 0.0 116.592 168.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.6 p -73.75 -27.81 61.36 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 119.328 3.084 . . . . 0.0 119.328 -148.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.48 ' HA2' ' CD2' ' A' ' 23' ' ' TYR . . . 78.53 19.54 73.55 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 123.106 2.684 . . . . 0.0 115.704 -172.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -122.09 4.43 9.84 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 121.314 3.82 . . . . 0.0 121.314 -162.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.692 ' H ' ' HD1' ' A' ' 23' ' ' TYR . 27.6 tp -145.01 142.0 29.41 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 118.426 2.75 . . . . 0.0 118.426 -168.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.251 61.1 mttm -115.09 109.42 46.85 Favored Pre-proline 0 C--N 1.351 0.67 0 O-C-N 119.342 -2.099 . . . . 0.0 109.739 155.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -78.01 -177.84 4.17 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 124.139 3.226 . . . . 0.0 112.054 -167.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.0 p -81.58 170.86 15.35 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 165.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 11.3 tp -68.73 -46.17 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-N 112.302 -2.227 . . . . 0.0 110.59 -177.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.7 p -56.69 -34.19 67.17 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 120.892 1.678 . . . . 0.0 111.917 169.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -78.43 -50.41 11.74 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 -170.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -52.09 -40.21 60.91 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 125.62 1.825 . . . . 0.0 114.368 173.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.5 ' HE ' ' CG ' ' A' ' 101' ' ' ASP . 72.3 mtt180 -65.4 -46.15 81.18 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 172.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.622 ' C ' ' H ' ' A' ' 72' ' ' LYS . 35.0 mt-30 -64.33 -27.41 69.01 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 118.127 -2.858 . . . . 0.0 112.865 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 27.3 mt -90.22 -31.6 16.94 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -166.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -50.74 -31.51 16.9 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.097 149.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.622 ' H ' ' C ' ' A' ' 69' ' ' GLN . 20.0 tttm -78.46 -26.1 46.02 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 116.701 -2.0 . . . . 0.0 116.053 -161.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . 0.355 26.2 pt -57.18 -43.25 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 O-C-N 116.997 -3.564 . . . . 0.0 114.307 167.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.41 ' C ' ' H ' ' A' ' 76' ' ' ILE . 8.7 mt -60.4 -34.76 74.39 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 -166.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.04 -5.83 7.67 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 117.269 -2.396 . . . . 0.0 113.995 -169.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.41 ' H ' ' C ' ' A' ' 74' ' ' LEU . 27.1 pt -114.89 -162.45 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 124.899 1.28 . . . . 0.0 113.059 163.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -120.38 150.25 41.07 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 114.869 -2.491 . . . . 0.0 113.671 169.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.4 mt -149.4 150.95 33.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 175.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.0 m -109.79 148.01 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 1 C-N-CA 132.675 4.39 . . . . 0.0 120.437 13.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.0 p -84.35 -173.48 0.43 Allowed Pre-proline 0 N--CA 1.45 -0.458 0 CA-C-N 121.035 1.743 . . . . 0.0 110.68 178.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.06 10.59 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.53 1.487 . . . . 0.0 115.093 161.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . 0.266 35.4 tp -73.54 -25.05 60.21 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 119.599 -1.938 . . . . 0.0 108.795 164.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -153.32 -14.67 0.15 Allowed 'General case' 0 C--N 1.35 0.588 0 O-C-N 117.266 -3.396 . . . . 0.0 110.847 -176.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -151.26 126.12 9.71 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 123.733 2.97 . . . . 0.0 109.874 167.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -80.8 -9.89 59.77 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 126.147 1.779 . . . . 0.0 115.353 -172.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -143.81 161.1 39.5 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 125.87 3.941 . . . . 0.0 108.183 175.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -78.2 43.83 0.47 Allowed 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 130.348 3.459 . . . . 0.0 110.159 169.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 91.2 p -80.96 -18.39 47.17 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 128.976 2.911 . . . . 0.0 116.589 -168.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -99.53 -8.25 24.84 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 126.881 2.613 . . . . 0.0 109.582 -176.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -73.1 164.22 27.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 123.929 1.823 . . . . 0.0 113.271 169.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -164.89 177.44 7.88 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 111.421 -2.627 . . . . 0.0 112.382 -169.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.48 ' CZ ' ' HA ' ' A' ' 111' ' ' LEU 0.292 79.6 t80 -113.1 163.86 14.21 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 121.875 2.125 . . . . 0.0 109.748 172.825 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -162.49 148.08 12.57 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 127.183 2.193 . . . . 0.0 112.77 -176.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -69.56 -17.61 63.58 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 116.5 2.037 . . . . 0.0 116.5 -176.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.7 m -97.41 -34.67 10.94 Favored 'General case' 0 C--O 1.244 0.795 0 O-C-N 125.508 1.755 . . . . 0.0 110.203 175.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -74.34 -17.58 79.73 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 123.855 1.808 . . . . 0.0 109.215 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 57.9 tp -41.77 -43.73 3.02 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 116.934 -3.686 . . . . 0.0 113.338 165.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.18 7.91 29.76 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -171.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.5 tp -99.92 -23.37 14.95 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 118.867 2.914 . . . . 0.0 118.867 165.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 84.11 6.32 86.6 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 118.4 -2.687 . . . . 0.0 111.227 -175.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.5 ' CG ' ' HE ' ' A' ' 68' ' ' ARG . 1.7 t70 -91.82 70.96 5.67 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 117.158 -1.401 . . . . 0.0 108.516 -177.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.6 t -143.32 147.68 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 1 O-C-N 131.031 5.207 . . . . 0.0 116.52 -164.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.2 p -48.74 91.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 118.157 2.651 . . . . 0.0 118.157 164.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.1 t30 -83.34 -22.85 32.75 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 119.939 -1.726 . . . . 0.0 110.386 -173.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 15.2 pt -76.16 -31.32 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 127.954 2.501 . . . . 0.0 115.545 -171.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -95.33 139.21 31.96 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 118.706 -1.198 . . . . 0.0 109.239 174.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -89.51 141.54 28.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 125.254 2.454 . . . . 0.0 111.175 -177.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.95 -30.23 0.24 Allowed Glycine 0 C--N 1.344 0.988 0 C-N-CA 128.718 3.056 . . . . 0.0 117.439 -160.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 42.9 tttp -67.19 -27.3 67.15 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.1 ptpt -52.11 6.8 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 118.631 2.826 . . . . 0.0 118.631 160.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.48 ' HA ' ' CZ ' ' A' ' 92' ' ' PHE . 1.4 pt? -161.5 38.72 0.14 Allowed 'General case' 0 C--O 1.244 0.776 0 C-N-CA 126.316 1.846 . . . . 0.0 109.256 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.356 16.5 tt0 -47.89 -69.97 0.11 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 130.149 3.38 . . . . 0.0 118.242 -167.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 3.3 p-80 -119.2 18.34 13.04 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.042 1.737 . . . . 0.0 112.92 -166.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 . . . . . 0 C--O 1.252 1.209 1 C-N-CA 133.05 4.54 . . . . 0.0 109.453 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -160.37 71.61 0.45 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 123.508 1.623 . . . . 0.0 108.445 169.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -130.02 12.96 5.71 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 118.769 -2.457 . . . . 0.0 114.133 -172.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -106.88 19.01 21.08 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 127.829 2.452 . . . . 0.0 112.329 170.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.6 tp -92.06 -23.26 19.54 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.752 1.621 . . . . 0.0 112.855 -175.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -133.3 25.43 4.16 Favored 'General case' 0 N--CA 1.44 -0.959 0 O-C-N 116.666 -3.771 . . . . 0.0 112.873 -156.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.1 pt -117.65 163.38 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 113.202 -1.817 . . . . 0.0 111.697 -149.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.4 m -68.99 -177.46 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 123.787 1.756 . . . . 0.0 111.514 174.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 82.1 p -54.52 -30.17 52.8 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 131.351 3.861 . . . . 0.0 120.621 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -175.68 63.74 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 104.378 -2.453 . . . . 0.0 104.378 -161.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -56.6 113.73 1.74 Allowed 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 168.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -58.34 144.71 40.57 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 128.124 2.569 . . . . 0.0 116.84 -171.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.7 tttt -116.63 -4.26 11.71 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 -157.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.1 pt -43.95 -49.3 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.747 0 C-N-CA 127.84 2.456 . . . . 0.0 116.23 -174.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.426 13.9 pt -74.23 -16.5 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 O-C-N 125.165 1.541 . . . . 0.0 115.031 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.342 19.0 tttm -66.53 -58.01 6.1 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 120.462 3.505 . . . . 0.0 120.462 -158.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 52.2 m -54.57 -40.43 68.76 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 120.469 -1.394 . . . . 0.0 109.479 174.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.98 -45.68 80.79 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 118.661 2.837 . . . . 0.0 118.661 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -47.22 -42.23 19.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.883 0.873 . . . . 0.0 112.618 164.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -73.48 -39.81 64.6 Favored 'General case' 0 N--CA 1.437 -1.109 1 CA-C-O 111.551 -4.071 . . . . 0.0 112.41 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -61.41 -41.06 96.56 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 127.554 3.034 . . . . 0.0 112.742 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 61.1 mt -58.35 -35.18 71.54 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.515 1.926 . . . . 0.0 111.512 171.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.1 2.92 5.62 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 128.375 2.893 . . . . 0.0 115.225 -173.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.442 ' HB ' ' HB2' ' A' ' 40' ' ' GLN . 28.5 pt -66.63 154.73 7.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 125.637 2.637 . . . . 0.0 113.966 -166.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 64.2 p -80.45 170.59 16.17 Favored 'General case' 0 N--CA 1.438 -1.038 0 O-C-N 119.151 -2.218 . . . . 0.0 113.113 -176.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -56.52 -41.66 77.09 Favored 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 117.997 -2.939 . . . . 0.0 105.138 174.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -72.53 -32.99 66.55 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 121.925 2.148 . . . . 0.0 116.625 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.442 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . 58.0 mt-30 -64.57 -38.03 89.61 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 116.338 -3.976 . . . . 0.0 112.442 170.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.2 tp -70.3 -37.13 74.73 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 128.329 2.652 . . . . 0.0 114.489 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.3 -46.37 90.12 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.902 1.681 . . . . 0.0 112.306 169.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -63.25 -44.64 94.61 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 117.868 -1.063 . . . . 0.0 111.836 172.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -69.19 -14.49 63.01 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 125.764 1.626 . . . . 0.0 111.99 -174.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.51 HD23 HD12 ' A' ' 73' ' ' ILE . 5.2 mp -121.04 1.87 10.4 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.63 1.972 . . . . 0.0 109.78 -172.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.256 0.0 OUTLIER 62.41 -35.42 0.12 Allowed 'General case' 0 N--CA 1.444 -0.767 2 C-N-CA 133.169 4.587 . . . . 0.0 114.784 -167.736 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.8 m -77.53 164.13 3.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 1 C-N-CA 133.165 4.586 . . . . 0.0 114.747 -161.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 89.3 p -79.66 159.21 26.8 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 -170.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.442 ' HA ' HG22 ' A' ' 52' ' ' VAL . 40.7 mt-10 -82.7 -12.46 57.57 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 117.557 -1.657 . . . . 0.0 110.216 -162.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -59.91 -44.34 94.33 Favored 'General case' 0 C--O 1.222 -0.391 0 O-C-N 120.663 -1.273 . . . . 0.0 109.899 166.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.5 mm -64.42 -45.52 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 C-N-CA 127.863 2.465 . . . . 0.0 108.345 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.442 HG22 ' HA ' ' A' ' 49' ' ' GLU 0.387 1.3 m -65.11 -45.9 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -176.503 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -63.84 -26.76 68.76 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-O 115.308 -2.282 . . . . 0.0 116.229 172.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -59.49 -44.03 93.17 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 121.742 2.064 . . . . 0.0 109.008 176.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -82.05 -28.18 32.58 Favored 'General case' 0 CA--C 1.522 -0.112 0 O-C-N 118.421 -2.675 . . . . 0.0 110.702 -176.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -63.19 -33.75 76.16 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 119.396 -2.065 . . . . 0.0 111.159 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.2 p -126.61 22.58 6.92 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -151.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.11 21.85 62.1 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.664 165.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -97.1 26.53 4.65 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 125.9 1.68 . . . . 0.0 115.025 -164.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.2 tp -140.02 154.58 47.16 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 113.672 -1.603 . . . . 0.0 114.903 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.2 tttp -90.54 102.08 4.61 Favored Pre-proline 0 N--CA 1.443 -0.808 0 C-N-CA 125.041 1.337 . . . . 0.0 108.526 149.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -83.83 170.89 11.01 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 CA-C-O 125.041 2.017 . . . . 0.0 111.236 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.0 p -143.73 179.28 7.25 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 118.921 -2.362 . . . . 0.0 111.988 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . 0.403 60.7 mt -52.39 -61.4 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 O-C-N 127.574 3.046 . . . . 0.0 109.392 172.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 96.5 p -68.97 -31.26 69.99 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 125.329 1.643 . . . . 0.0 107.653 -173.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -77.96 -37.49 47.35 Favored 'General case' 0 N--CA 1.438 -1.073 1 O-C-N 114.581 -5.074 . . . . 0.0 109.014 -177.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.23 -45.72 90.3 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 114.466 -2.683 . . . . 0.0 107.172 169.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 39.5 tpt85 -52.61 -27.82 18.6 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 125.153 1.533 . . . . 0.0 112.496 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -93.39 -29.39 15.62 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 114.396 -2.716 . . . . 0.0 110.31 -173.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.5 tp -61.62 -53.11 60.58 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 114.927 -2.463 . . . . 0.0 115.732 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -50.9 -22.69 2.35 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 125.303 1.627 . . . . 0.0 115.175 157.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.25 76.7 tttt -87.54 -38.02 16.37 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 117.268 -3.395 . . . . 0.0 109.489 -173.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.51 HD12 HD23 ' A' ' 45' ' ' LEU . 50.5 pt -74.1 -29.91 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 74' ' ' LEU . 34.4 tp -77.61 -25.33 49.74 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 126.54 3.066 . . . . 0.0 107.34 175.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.35 8.85 27.33 Favored Glycine 0 N--CA 1.445 -0.725 0 O-C-N 118.878 -2.389 . . . . 0.0 117.098 -168.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.2 pt -152.02 177.34 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.073 0 C-N-CA 130.018 3.327 . . . . 0.0 112.006 175.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -171.29 168.69 6.58 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 128.602 2.761 . . . . 0.0 106.892 -166.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 78' ' ' LEU . 9.7 mt -157.87 138.82 13.22 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 112.407 -2.179 . . . . 0.0 115.221 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.2 t -112.0 168.29 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 1 O-C-N 114.501 -5.125 . . . . 0.0 108.517 22.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.503 ' HB ' ' HD2' ' A' ' 81' ' ' PRO 0.497 33.8 p -91.45 -176.73 0.65 Allowed Pre-proline 0 N--CA 1.444 -0.738 0 O-C-N 126.193 2.183 . . . . 0.0 107.914 175.301 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.503 ' HD2' ' HB ' ' A' ' 80' ' ' THR 0.261 82.7 Cg_exo -49.44 -2.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 124.223 3.282 . . . . 0.0 115.353 176.407 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 47.4 tp -59.76 -35.22 74.16 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 117.661 -1.616 . . . . 0.0 112.714 162.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . 0.262 38.4 mt-10 -142.02 -13.41 0.83 Allowed 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 125.639 2.638 . . . . 0.0 114.424 174.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -150.19 141.78 23.53 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 117.323 -3.36 . . . . 0.0 113.083 -171.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -147.89 150.2 33.67 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 123.945 1.831 . . . . 0.0 109.563 -174.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -120.79 160.4 23.45 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 -173.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -83.03 167.55 17.79 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 124.376 2.036 . . . . 0.0 113.9 165.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.4 m -96.62 -16.48 20.97 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 118.708 -2.495 . . . . 0.0 116.166 -163.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -61.86 -34.82 76.68 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 125.514 1.526 . . . . 0.0 111.935 169.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -65.29 3.56 0.63 Allowed 'General case' 0 C--N 1.346 0.428 0 C-N-CA 127.158 2.183 . . . . 0.0 115.284 173.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -69.57 -34.84 74.73 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 120.919 1.691 . . . . 0.0 113.157 173.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 97' ' ' LEU . 63.6 m-85 -91.59 166.72 12.67 Favored 'General case' 0 CA--C 1.52 -0.182 0 O-C-N 125.376 1.673 . . . . 0.0 115.26 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -166.56 -36.29 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 119.034 -2.291 . . . . 0.0 110.58 169.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -103.35 -22.93 13.61 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 118.343 -2.723 . . . . 0.0 112.821 -173.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 66.4 p -126.2 -164.78 1.36 Allowed 'General case' 0 N--CA 1.439 -0.983 0 O-C-N 126.865 2.603 . . . . 0.0 110.325 176.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -151.81 166.75 30.93 Favored Glycine 0 C--N 1.339 0.719 0 O-C-N 127.14 2.775 . . . . 0.0 112.885 174.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 92' ' ' PHE . 4.1 tp -76.73 4.47 9.52 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 121.144 2.472 . . . . 0.0 116.693 -171.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.29 146.64 46.87 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 128.421 2.688 . . . . 0.0 115.677 -170.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 19.0 tp -65.22 161.91 18.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 115.177 -2.344 . . . . 0.0 113.254 -171.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -81.86 9.09 57.9 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 124.066 3.121 . . . . 0.0 114.128 -174.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.324 15.8 t70 -68.54 47.71 0.06 Allowed 'General case' 0 N--CA 1.446 -0.64 2 O-C-N 116.147 -4.149 . . . . 0.0 113.736 -169.673 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.461 ' HB ' ' HA ' ' A' ' 103' ' ' VAL 0.266 0.1 OUTLIER -141.52 157.47 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 128.336 2.654 . . . . 0.0 114.238 -167.433 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.461 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 66.5 t -72.38 149.43 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 2 O-C-N 112.307 -6.496 . . . . 0.0 110.608 7.127 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -73.75 117.66 15.8 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 125.698 1.599 . . . . 0.0 113.399 176.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . 0.309 29.6 pt -97.11 1.56 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 118.287 2.699 . . . . 0.0 118.287 169.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -71.6 -21.4 61.86 Favored 'General case' 0 C--O 1.224 -0.265 0 O-C-N 119.664 -1.898 . . . . 0.0 107.027 165.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -68.61 -44.58 73.99 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 124.205 1.955 . . . . 0.0 112.955 163.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 158.7 149.66 5.56 Favored Glycine 0 CA--C 1.541 1.698 0 O-C-N 116.526 -3.859 . . . . 0.0 110.139 177.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -57.45 129.25 40.97 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 126.62 1.968 . . . . 0.0 110.548 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -89.62 65.96 7.08 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 118.535 -2.603 . . . . 0.0 110.164 -176.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 178.15 177.62 0.4 Allowed 'General case' 0 C--O 1.214 -0.786 0 C-N-CA 129.416 3.086 . . . . 0.0 109.014 178.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.482 13.1 tt0 -161.23 -109.44 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 119.559 1.072 . . . . 0.0 108.645 -142.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 45.0 p-80 -62.17 -18.05 59.83 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 118.685 -2.509 . . . . 0.0 117.161 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 2.5 m80 . . . . . 0 C--O 1.253 1.271 0 C-N-CA 130.6 3.56 . . . . 0.0 114.442 -176.74 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 . . . . . 0 N--CA 1.466 0.332 0 CA-C-O 118.3 -0.857 . . . . 0.0 112.894 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -83.53 -22.04 32.56 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 116.647 2.091 . . . . 0.0 116.647 -174.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.57 171.09 9.94 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 130.5 3.52 . . . . 0.0 111.751 171.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -79.93 -23.6 41.64 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 124.084 1.897 . . . . 0.0 113.787 158.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -91.62 155.97 17.96 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 176.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -138.39 134.16 33.79 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 173.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.9 pt -114.27 3.6 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 O-C-N 119.781 -1.825 . . . . 0.0 113.598 171.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.4 t -98.53 -57.62 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 O-C-N 118.88 -2.387 . . . . 0.0 108.713 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.4 p -70.09 -32.5 70.59 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-O 115.019 -2.42 . . . . 0.0 114.116 -149.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . 0.326 1.7 t0 63.79 12.17 6.49 Favored 'General case' 0 C--O 1.24 0.556 1 C-N-CA 132.116 4.166 . . . . 0.0 107.241 -171.53 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -101.08 53.76 0.84 Allowed 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 127.682 2.393 . . . . 0.0 115.097 169.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -85.91 -162.64 0.76 Allowed 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 127.868 3.23 . . . . 0.0 111.291 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -66.4 -1.8 3.87 Favored 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 118.272 -2.767 . . . . 0.0 114.461 -168.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.0 pt -56.26 -27.67 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 O-C-N 120.13 -1.606 . . . . 0.0 115.315 160.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.348 6.7 tp -140.5 -33.15 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 O-C-N 119.998 -1.689 . . . . 0.0 109.875 -173.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -70.98 -49.28 47.0 Favored 'General case' 0 N--CA 1.445 -0.708 0 O-C-N 117.177 -3.452 . . . . 0.0 112.829 -164.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.08 -39.7 94.64 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 128.092 2.557 . . . . 0.0 106.748 175.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.72 -59.57 4.71 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 117.756 2.502 . . . . 0.0 117.756 -173.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -39.94 -45.85 1.94 Allowed 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 124.566 1.167 . . . . 0.0 109.703 169.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -58.93 -47.52 84.76 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 116.859 -3.651 . . . . 0.0 117.199 168.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -72.33 -1.71 16.46 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 122.013 2.188 . . . . 0.0 112.446 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.414 ' C ' ' H ' ' A' ' 36' ' ' ILE . 81.5 mt -101.51 -22.1 14.59 Favored 'General case' 0 N--CA 1.451 -0.413 1 O-C-N 115.161 -4.712 . . . . 0.0 107.046 -177.728 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.81 -12.1 0.16 Allowed Glycine 0 C--N 1.336 0.555 0 CA-C-O 125.492 2.718 . . . . 0.0 115.785 -176.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.414 ' H ' ' C ' ' A' ' 34' ' ' LEU . 31.7 pt -66.19 163.42 2.44 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 N-CA-C 119.118 3.007 . . . . 0.0 119.118 -176.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.5 p -77.17 171.75 14.34 Favored 'General case' 0 C--O 1.241 0.644 0 O-C-N 116.995 -3.566 . . . . 0.0 117.753 175.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . 0.336 2.5 mp0 -70.89 -24.43 62.48 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 120.843 -1.16 . . . . 0.0 110.03 169.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -72.89 -37.21 67.37 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 120.503 -1.373 . . . . 0.0 107.432 176.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -76.81 -32.16 57.45 Favored 'General case' 0 N--CA 1.44 -0.953 0 O-C-N 118.464 -2.648 . . . . 0.0 113.868 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.3 tp -72.54 -36.46 68.27 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 130.215 3.406 . . . . 0.0 109.716 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.54 -34.11 70.64 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 121.581 1.991 . . . . 0.0 112.873 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -60.94 -49.84 75.8 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.924 1.689 . . . . 0.0 112.304 168.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.7 mmtt -70.54 -19.25 62.91 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -173.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 94.7 mt -101.72 -9.67 20.65 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -170.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.339 7.1 mptt 61.69 -16.43 0.04 OUTLIER 'General case' 0 C--O 1.237 0.415 0 N-CA-C 117.104 2.261 . . . . 0.0 117.104 -163.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.3 m -104.51 166.1 3.23 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 CA-C-O 124.53 2.11 . . . . 0.0 112.508 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 55.3 p -74.04 166.31 23.61 Favored 'General case' 0 N--CA 1.44 -0.974 0 O-C-N 118.969 -2.332 . . . . 0.0 116.229 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -70.5 -23.48 62.67 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 118.685 -2.51 . . . . 0.0 107.689 175.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -63.1 -37.0 85.47 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.274 1.43 . . . . 0.0 110.743 171.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.5 mm -68.84 -40.4 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 125.861 3.937 . . . . 0.0 110.594 171.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.1 t -54.41 -45.32 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 113.966 -1.47 . . . . 0.0 111.262 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -59.04 -58.13 10.01 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 128.873 2.869 . . . . 0.0 106.098 169.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -53.55 -39.51 64.78 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 121.452 1.933 . . . . 0.0 110.732 -163.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -70.81 -50.81 31.57 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 118.273 -0.87 . . . . 0.0 112.826 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -51.43 -37.7 49.93 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 122.729 2.513 . . . . 0.0 112.835 170.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.4 p -83.79 4.96 26.79 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 118.44 2.756 . . . . 0.0 118.44 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.82 7.36 68.67 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 116.853 -2.082 . . . . 0.0 111.938 165.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -103.98 -15.42 15.62 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 129.152 2.981 . . . . 0.0 115.998 -167.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.3 tp -146.53 138.98 25.09 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 126.14 1.776 . . . . 0.0 115.426 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.624 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 15.6 ptpt -138.53 -164.77 0.08 OUTLIER Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-O 116.588 -1.672 . . . . 0.0 112.492 173.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.624 ' HD2' ' HB2' ' A' ' 61' ' ' LYS . 88.2 Cg_endo -88.8 149.64 5.98 Favored 'Trans proline' 0 N--CA 1.44 -1.644 0 O-C-N 124.512 1.796 . . . . 0.0 112.241 177.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.0 p -144.52 -179.33 6.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.836 1.255 . . . . 0.0 113.042 -172.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.445 ' C ' ' H ' ' A' ' 66' ' ' GLN . 8.7 tp -78.69 -44.02 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 C-N-CA 125.346 1.458 . . . . 0.0 107.816 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 84.9 p -53.92 -7.67 0.14 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-N 120.389 1.45 . . . . 0.0 108.388 169.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.445 ' H ' ' C ' ' A' ' 64' ' ' ILE . 40.3 mt-30 -118.68 -37.33 3.29 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 117.722 -3.112 . . . . 0.0 115.039 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -39.38 -46.66 1.66 Allowed 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 117.565 2.431 . . . . 0.0 117.565 -162.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.5 mtm105 -71.48 -53.54 13.59 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 114.903 -2.475 . . . . 0.0 116.47 -165.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.649 ' HB2' ' CD2' ' A' ' 92' ' ' PHE . 22.0 tt0 -63.18 -39.14 93.79 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 115.694 -2.098 . . . . 0.0 112.877 167.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 44.4 tp -53.85 -49.0 69.43 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 127.167 2.792 . . . . 0.0 107.131 -170.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -57.82 -51.12 70.88 Favored 'General case' 0 CA--C 1.513 -0.467 0 O-C-N 118.694 -2.504 . . . . 0.0 111.527 177.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -73.24 -29.45 62.79 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 116.579 -3.826 . . . . 0.0 115.706 -168.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 14.5 pt -66.04 -15.96 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 123.042 2.655 . . . . 0.0 112.942 161.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.372 1.3 pt? 146.24 -10.15 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.477 1 C-N-CA 133.41 4.684 . . . . 0.0 115.233 162.457 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.85 6.79 68.34 Favored Glycine 0 C--N 1.34 0.788 0 CA-C-O 113.943 -3.698 . . . . 0.0 114.014 -172.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . 0.282 1.4 pt 71.64 6.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.835 1 C-N-CA 135.196 5.398 . . . . 0.0 117.16 174.578 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -71.88 148.51 46.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 115.116 -2.373 . . . . 0.0 113.992 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.406 HD13 HD11 ' A' ' 34' ' ' LEU 0.259 40.1 mt -134.04 151.12 51.28 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.383 1.473 . . . . 0.0 113.328 168.88 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 39.6 t -105.69 134.03 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 122.488 2.404 . . . . 0.0 111.134 5.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.4 p -89.18 135.79 31.03 Favored Pre-proline 0 N--CA 1.445 -0.684 0 C-N-CA 127.554 2.341 . . . . 0.0 107.329 176.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.33 9.57 0.39 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 N-CA-C 114.831 1.05 . . . . 0.0 114.831 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -155.08 166.68 32.82 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 128.361 2.664 . . . . 0.0 108.502 175.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -70.36 74.8 0.53 Allowed 'General case' 0 C--O 1.241 0.613 0 C-N-CA 128.081 2.553 . . . . 0.0 112.321 174.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -66.22 125.49 25.74 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.089 2.155 . . . . 0.0 115.262 -163.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -162.2 150.28 14.6 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 129.518 3.127 . . . . 0.0 111.428 167.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -120.03 122.7 41.72 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-O 124.445 2.069 . . . . 0.0 109.035 174.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.293 12.3 pt-20 -105.72 27.8 8.11 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 126.074 2.845 . . . . 0.0 113.659 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 78.1 p -80.19 -7.4 58.94 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 112.018 -2.355 . . . . 0.0 111.627 -173.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -147.52 105.56 3.74 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 123.969 3.077 . . . . 0.0 113.269 -169.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.69 -12.54 48.04 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 118.133 2.642 . . . . 0.0 118.133 -175.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -103.15 117.37 34.38 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 125.972 2.045 . . . . 0.0 110.059 172.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.649 ' CD2' ' HB2' ' A' ' 69' ' ' GLN . 79.1 t80 -146.91 135.1 21.64 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 127.246 2.841 . . . . 0.0 107.477 169.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -160.29 141.21 12.05 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 128.562 2.745 . . . . 0.0 110.237 175.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -95.76 -12.94 24.57 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 117.987 -2.946 . . . . 0.0 116.081 174.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.7 m -37.68 -53.64 1.23 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 130.683 3.593 . . . . 0.0 116.424 -170.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -81.94 1.34 86.84 Favored Glycine 0 C--O 1.216 -1.017 0 O-C-N 117.808 -3.057 . . . . 0.0 113.298 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.8 mt -98.85 -7.99 26.45 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 118.955 -2.497 . . . . 0.0 113.791 164.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 42.3 p -127.49 -60.09 1.2 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 119.398 -0.334 . . . . 0.0 110.723 -165.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 80.0 mt -96.88 -12.57 23.33 Favored 'General case' 0 C--O 1.214 -0.768 0 C-N-CA 126.506 1.922 . . . . 0.0 113.98 -178.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.7 21.44 77.88 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 115.483 -2.843 . . . . 0.0 114.494 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.45 25.7 t70 -60.01 38.78 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 129.028 3.428 . . . . 0.0 118.325 -172.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.569 ' HB ' ' HA ' ' A' ' 103' ' ' VAL . 5.0 m -140.48 168.53 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 121.699 3.962 . . . . 0.0 121.699 -171.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.569 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 42.6 t -54.25 147.46 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 2 CA-C-N 127.487 4.676 . . . . 0.0 107.566 2.537 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -79.7 127.35 32.09 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 111.558 -2.564 . . . . 0.0 112.401 176.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 26.7 pt -128.86 37.46 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 O-C-N 128.559 3.662 . . . . 0.0 107.578 -167.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.5 pttt -78.34 -42.56 30.18 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 118.793 -2.442 . . . . 0.0 107.033 -176.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -78.16 -19.15 54.55 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.204 1.802 . . . . 0.0 109.612 163.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -96.07 -156.86 31.49 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 117.14 1.616 . . . . 0.0 117.14 -173.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -143.54 151.34 40.12 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 127.366 2.266 . . . . 0.0 109.912 176.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . 0.468 37.2 tttt -67.18 66.93 0.07 Allowed 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 171.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 25.1 mt -68.83 165.13 20.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 128.589 2.756 . . . . 0.0 107.313 175.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -52.51 -33.24 44.13 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 125.668 1.855 . . . . 0.0 115.141 -173.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 47.4 p-80 -82.95 9.36 10.25 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 122.37 1.081 . . . . 0.0 111.236 -161.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 . . . . . 0 C--O 1.256 1.446 0 C-N-CA 124.796 1.238 . . . . 0.0 111.372 -155.108 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 . . . . . 0 N--CA 1.474 0.766 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.95 -10.15 59.17 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 -167.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.2 10.9 1.33 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 131.372 3.869 . . . . 0.0 115.599 174.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -127.11 -7.99 5.95 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 125.42 1.7 . . . . 0.0 112.283 -173.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.9 mt -91.07 -8.37 49.15 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 131.435 3.894 . . . . 0.0 116.235 -164.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -145.93 12.7 1.28 Allowed 'General case' 0 N--CA 1.442 -0.851 0 O-C-N 118.927 -2.358 . . . . 0.0 107.611 -153.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.1 pt -109.6 164.46 6.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 131.682 3.993 . . . . 0.0 117.594 174.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.4 m -57.97 154.96 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 O-C-N 119.639 -1.913 . . . . 0.0 113.488 154.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . 0.267 95.9 m -57.47 -65.72 0.58 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.857 2.063 . . . . 0.0 112.856 172.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . 0.282 26.3 t0 -70.2 41.13 0.05 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 128.75 2.82 . . . . 0.0 114.524 -178.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.75 131.44 40.83 Favored 'General case' 0 N--CA 1.444 -0.731 1 C-N-CA 132.159 4.183 . . . . 0.0 106.558 161.566 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -44.86 116.22 1.04 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 119.633 3.197 . . . . 0.0 119.633 -173.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -66.17 -36.73 83.86 Favored 'General case' 0 C--O 1.222 -0.375 0 N-CA-C 116.199 1.925 . . . . 0.0 116.199 -170.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.2 pt -62.08 -22.17 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 O-C-N 119.453 -2.03 . . . . 0.0 113.817 -171.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.359 2.5 mt -136.94 -53.68 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 O-C-N 117.621 -3.174 . . . . 0.0 109.646 172.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt 63.96 -96.24 0.05 Allowed 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 113.476 -3.154 . . . . 0.0 115.548 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.7 p -43.44 -31.86 0.77 Allowed 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 130.738 3.615 . . . . 0.0 111.128 -168.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.73 -26.06 31.63 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 131.105 3.762 . . . . 0.0 117.996 -154.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . 0.451 22.3 ptt180 -36.92 -50.3 0.86 Allowed 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 119.93 3.307 . . . . 0.0 119.93 -176.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . 0.25 40.9 mt-10 -72.32 -37.0 69.01 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 114.335 -2.745 . . . . 0.0 115.476 170.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -65.29 0.96 1.2 Allowed 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 126.33 1.852 . . . . 0.0 114.458 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.4 mt -72.64 -7.61 51.18 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 119.321 -2.112 . . . . 0.0 114.492 -175.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 47.98 6.75 0.03 OUTLIER Glycine 0 C--N 1.347 1.15 1 C-N-CA 131.442 4.353 . . . . 0.0 115.881 -161.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.289 2.6 pt -136.32 167.73 23.75 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.509 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.677 -169.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 65.8 m -134.89 179.93 6.0 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 121.012 1.733 . . . . 0.0 115.249 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.42 -38.93 14.36 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 118.484 -2.635 . . . . 0.0 117.898 -159.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -75.73 -39.32 57.47 Favored 'General case' 0 N--CA 1.442 -0.844 0 O-C-N 119.404 -2.06 . . . . 0.0 109.542 -169.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -67.4 -34.95 78.33 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 160.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.6 tp -64.51 -39.42 93.75 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 121.461 1.937 . . . . 0.0 112.089 -175.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -50.81 -32.86 21.36 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.462 177.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -73.14 -50.23 23.84 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 124.148 1.928 . . . . 0.0 112.737 173.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -65.69 -4.07 5.79 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 116.511 -1.709 . . . . 0.0 110.74 -168.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.331 53.9 tp -146.93 -0.84 0.69 Allowed 'General case' 0 C--O 1.247 0.925 0 CA-C-O 123.471 1.605 . . . . 0.0 112.22 -155.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 49.58 58.38 5.48 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.384 1.074 . . . . 0.0 112.179 -175.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.7 m -143.84 166.66 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 121.503 1.956 . . . . 0.0 106.189 -173.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 96.3 p -85.55 160.72 19.59 Favored 'General case' 0 C--O 1.241 0.63 0 O-C-N 116.938 -3.601 . . . . 0.0 108.254 168.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . 0.26 5.2 mt-10 -65.93 -28.97 69.32 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 111.41 -2.632 . . . . 0.0 111.775 173.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -61.28 -36.43 80.03 Favored 'General case' 0 CA--C 1.514 -0.434 0 O-C-N 117.947 -2.97 . . . . 0.0 117.428 166.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.4 mm -59.74 -37.03 69.3 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.449 0 CA-C-N 119.35 0.977 . . . . 0.0 108.867 168.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.346 40.0 t -59.57 -44.29 92.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 O-C-N 119.403 -2.06 . . . . 0.0 110.55 -178.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.1 mttt -58.93 -37.33 76.45 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 127.904 2.482 . . . . 0.0 112.03 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -75.53 -21.56 57.85 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 130.808 3.643 . . . . 0.0 112.668 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.9 m-30 -82.35 -47.68 12.05 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 101.685 -3.45 . . . . 0.0 101.685 167.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -54.38 -25.89 27.01 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 126.668 1.987 . . . . 0.0 108.78 -166.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.9 p -105.21 -14.8 15.25 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 128.674 3.734 . . . . 0.0 114.184 -174.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.32 18.13 79.8 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 114.267 -3.519 . . . . 0.0 117.501 -167.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -74.6 -19.17 60.41 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 114.624 -2.608 . . . . 0.0 113.597 175.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . 0.31 43.1 tp -147.41 148.71 31.58 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 129.556 3.142 . . . . 0.0 112.593 177.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -106.6 147.08 34.33 Favored Pre-proline 0 N--CA 1.449 -0.522 0 N-CA-C 120.681 3.585 . . . . 0.0 120.681 168.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -60.08 153.88 55.21 Favored 'Trans proline' 0 N--CA 1.449 -1.104 1 C-N-CA 126.654 4.902 . . . . 0.0 114.306 176.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.469 ' H ' ' HB2' ' A' ' 66' ' ' GLN . 58.6 p -98.91 -173.68 2.58 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 111.605 -2.543 . . . . 0.0 112.93 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.464 HG23 ' H ' ' A' ' 65' ' ' SER . 16.0 tt -50.57 -71.83 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 C-N-CA 130.3 3.44 . . . . 0.0 115.844 174.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.464 ' H ' HG23 ' A' ' 64' ' ' ILE . 15.2 p -56.04 -22.85 29.74 Favored 'General case' 0 C--N 1.328 -0.368 1 O-C-N 116.126 -4.109 . . . . 0.0 111.06 172.628 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.469 ' HB2' ' H ' ' A' ' 63' ' ' THR . 71.5 mt-30 -83.14 -53.94 5.41 Favored 'General case' 0 N--CA 1.449 -0.493 1 CA-C-O 110.307 -4.664 . . . . 0.0 107.642 -172.532 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -44.77 -50.84 9.92 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 128.189 3.431 . . . . 0.0 111.138 167.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.32 -55.02 32.57 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.141 1.776 . . . . 0.0 113.82 169.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -68.39 -31.05 70.14 Favored 'General case' 0 N--CA 1.446 -0.654 1 O-C-N 115.775 -4.328 . . . . 0.0 114.478 -177.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 35.9 mt -56.33 -68.02 0.25 Allowed 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 131.042 3.737 . . . . 0.0 106.648 165.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -43.75 -29.58 0.54 Allowed 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 130.23 3.412 . . . . 0.0 110.268 176.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -74.88 -24.8 58.61 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 115.774 -2.06 . . . . 0.0 113.842 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.5 mt -80.44 -45.12 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 121.492 1.951 . . . . 0.0 107.937 162.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.492 ' C ' ' H ' ' A' ' 76' ' ' ILE . 89.3 mt -76.71 -44.1 34.79 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 123.268 1.508 . . . . 0.0 109.363 -153.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.63 -4.78 0.94 Allowed Glycine 0 C--N 1.338 0.653 0 O-C-N 120.101 -1.625 . . . . 0.0 111.891 -172.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.492 ' H ' ' C ' ' A' ' 74' ' ' LEU . 5.7 pt -102.41 170.97 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 C-N-CA 124.845 1.258 . . . . 0.0 109.119 170.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -163.96 174.61 11.22 Favored 'General case' 0 C--O 1.22 -0.46 0 O-C-N 127.661 3.1 . . . . 0.0 107.252 169.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 17.0 mt -134.31 156.85 47.73 Favored 'General case' 0 N--CA 1.445 -0.708 0 O-C-N 119.363 -2.086 . . . . 0.0 109.178 175.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.525 HG21 ' HB3' ' A' ' 83' ' ' GLU . 17.5 m -98.63 167.53 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 2 O-C-N 111.998 -6.688 . . . . 0.0 115.625 10.237 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.437 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 28.4 p -78.08 161.93 68.97 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 125.527 3.785 . . . . 0.0 105.907 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' A' ' 80' ' ' THR 0.268 26.8 Cg_exo -46.23 -2.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.969 1 C-N-CA 126.435 4.757 . . . . 0.0 116.942 173.831 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 17.9 tp -84.51 -20.14 32.11 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 122.645 2.475 . . . . 0.0 113.914 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.525 ' HB3' HG21 ' A' ' 79' ' ' VAL . 13.2 tt0 -119.19 6.88 11.23 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 126.617 3.103 . . . . 0.0 110.316 176.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . 0.442 2.7 p-10 -141.6 64.52 1.4 Allowed 'General case' 0 C--O 1.22 -0.466 1 O-C-N 115.935 -4.228 . . . . 0.0 115.734 172.118 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.55 -9.79 59.01 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 118.841 2.904 . . . . 0.0 118.841 -164.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -52.25 167.5 0.13 Allowed 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 118.42 2.748 . . . . 0.0 118.42 -169.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -71.39 108.74 4.98 Favored 'General case' 0 CA--C 1.515 -0.376 0 O-C-N 121.244 -0.91 . . . . 0.0 110.254 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.2 m -116.69 44.77 1.96 Allowed 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 127.757 3.646 . . . . 0.0 113.718 -172.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -51.86 142.23 15.76 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 118.707 -2.496 . . . . 0.0 113.673 164.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . 0.312 57.2 mtpt -68.2 139.61 56.06 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 130.619 3.567 . . . . 0.0 114.959 177.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -101.84 142.43 33.16 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 129.117 2.967 . . . . 0.0 106.241 -176.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -152.17 147.61 26.63 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 125.749 2.69 . . . . 0.0 114.66 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -81.95 -27.55 33.21 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.634 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -121.01 -65.6 1.13 Allowed 'General case' 0 C--O 1.239 0.53 0 CA-C-N 124.312 3.233 . . . . 0.0 115.165 177.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.9 p -152.66 158.32 42.22 Favored 'General case' 0 N--CA 1.446 -0.657 1 C-N-CA 133.161 4.584 . . . . 0.0 110.225 -176.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.05 127.96 45.16 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 130.161 3.743 . . . . 0.0 112.931 177.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.0 mt -90.94 146.0 24.26 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 126.854 3.216 . . . . 0.0 113.07 -158.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.9 m -136.25 142.76 44.02 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 118.748 -2.47 . . . . 0.0 113.159 -169.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.0 tp -67.06 136.62 55.5 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 131.113 3.765 . . . . 0.0 113.632 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.48 -23.47 4.09 Favored Glycine 0 N--CA 1.447 -0.601 1 CA-C-O 113.16 -4.133 . . . . 0.0 115.391 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.652 40.4 m-20 -71.89 24.82 0.05 OUTLIER 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 130.843 3.657 . . . . 0.0 116.199 -167.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.527 ' HB ' ' HA ' ' A' ' 103' ' ' VAL . 0.7 OUTLIER -131.84 157.56 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 2 C-N-CA 133.887 4.875 . . . . 0.0 122.114 -162.732 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.527 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 85.0 t -72.72 126.67 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 2 O-C-N 111.059 -7.276 . . . . 0.0 113.776 1.418 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -79.29 137.63 37.43 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 116.566 -1.683 . . . . 0.0 109.8 -172.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.72 -178.87 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 C-N-CA 131.126 3.77 . . . . 0.0 105.352 175.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -74.96 -40.23 60.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -174.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -79.38 -27.67 41.88 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 108.942 -3.754 . . . . 0.0 113.69 171.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -147.93 161.97 28.66 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 120.65 3.02 . . . . 0.0 120.65 -155.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -83.97 -11.43 56.84 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 119.688 3.218 . . . . 0.0 119.688 174.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -171.62 149.31 2.59 Favored 'General case' 0 N--CA 1.437 -1.124 0 O-C-N 126.175 2.172 . . . . 0.0 110.722 -155.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.3 mt -82.22 153.5 25.91 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 119.829 -1.794 . . . . 0.0 110.1 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -167.26 -103.96 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 130.617 3.567 . . . . 0.0 105.161 -160.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -62.82 -18.66 63.13 Favored 'General case' 0 C--N 1.331 -0.239 1 O-C-N 114.658 -5.026 . . . . 0.0 113.926 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 27.5 m80 . . . . . 0 C--O 1.252 1.203 2 C-N-CA 134.445 5.098 . . . . 0.0 115.865 -174.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -173.17 37.04 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 127.358 2.263 . . . . 0.0 114.803 177.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.31 2.8 0.53 Allowed 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 127.949 2.5 . . . . 0.0 112.583 -166.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -84.46 4.02 33.6 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 130.873 3.669 . . . . 0.0 116.353 -175.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 86.0 mt -70.45 -9.67 57.1 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 119.381 -2.074 . . . . 0.0 115.858 175.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -130.2 16.49 5.58 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 127.443 2.964 . . . . 0.0 118.24 -162.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . 0.292 15.2 pt -105.44 165.15 3.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 124.827 2.251 . . . . 0.0 113.383 -176.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.7 m -61.56 158.49 2.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 1 O-C-N 115.721 -4.362 . . . . 0.0 112.444 168.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.4 m -41.19 -65.06 0.47 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 129.44 3.096 . . . . 0.0 116.287 167.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -83.48 21.96 1.12 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.248 1.819 . . . . 0.0 112.719 -164.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -60.53 142.12 55.72 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 118.024 -2.923 . . . . 0.0 109.438 -169.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . 0.373 1.9 p90 -60.39 78.45 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 1 C-N-CA 132.684 4.394 . . . . 0.0 116.221 170.057 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.405 ' HA ' ' HB3' ' A' ' 28' ' ' LYS . 89.4 mttt -90.59 -18.04 25.89 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 116.284 -1.817 . . . . 0.0 113.559 176.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.409 HD13 ' H ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -60.33 -34.18 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 2 CA-C-N 129.096 5.407 . . . . 0.0 109.858 168.282 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.283 89.2 mt -65.04 -53.86 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 C-N-CA 129.338 3.055 . . . . 0.0 109.933 170.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.405 ' HB3' ' HA ' ' A' ' 25' ' ' LYS . 38.6 tttm -53.92 -46.66 71.54 Favored 'General case' 0 CA--C 1.509 -0.597 0 O-C-N 117.062 -3.524 . . . . 0.0 116.646 -173.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.8 p -56.73 -40.25 75.38 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.925 1.69 . . . . 0.0 111.615 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.96 -50.44 28.9 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 127.704 2.402 . . . . 0.0 113.804 173.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -58.66 -22.79 57.82 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 116.062 -1.923 . . . . 0.0 108.258 177.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -71.48 -48.95 45.88 Favored 'General case' 0 N--CA 1.446 -0.66 2 CA-C-N 128.574 5.17 . . . . 0.0 108.364 173.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -62.51 -47.01 85.82 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 124.691 2.186 . . . . 0.0 106.181 -169.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.317 39.5 mt -75.45 -10.81 59.78 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 115.645 1.721 . . . . 0.0 115.645 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.11 -4.25 0.08 OUTLIER Glycine 0 C--O 1.218 -0.884 0 N-CA-C 119.849 2.7 . . . . 0.0 119.849 177.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.4 pt -50.67 129.47 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 119.936 3.309 . . . . 0.0 119.936 -175.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 94.0 p -69.81 177.05 3.25 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.929 1.291 . . . . 0.0 112.27 177.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -57.35 -43.64 83.62 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 118.346 -1.341 . . . . 0.0 114.428 164.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -61.34 -39.7 91.53 Favored 'General case' 0 N--CA 1.451 -0.401 1 O-C-N 115.993 -4.192 . . . . 0.0 111.866 -177.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -73.68 -32.71 64.09 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.4 tp -61.31 -43.15 99.35 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.125 0.97 . . . . 0.0 113.253 161.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.71 -39.66 71.36 Favored 'General case' 0 N--CA 1.442 -0.826 0 O-C-N 119.842 -1.787 . . . . 0.0 111.512 171.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -66.04 -32.44 73.92 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 117.885 2.55 . . . . 0.0 117.885 170.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.446 ' HE2' HG23 ' A' ' 76' ' ' ILE . 19.4 tptt -64.82 -14.22 58.48 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 127.675 2.39 . . . . 0.0 107.699 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.8 tp -133.09 -4.62 3.09 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 116.394 -3.941 . . . . 0.0 114.546 -156.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt 62.52 27.63 16.34 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 131.057 3.743 . . . . 0.0 114.423 178.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.82 178.17 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 C-N-CA 129.857 3.263 . . . . 0.0 111.443 -163.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.2 p -88.2 162.5 16.64 Favored 'General case' 0 N--CA 1.443 -0.803 0 O-C-N 118.508 -2.62 . . . . 0.0 115.441 176.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -63.19 -16.38 59.94 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 119.631 -1.918 . . . . 0.0 113.704 167.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -71.95 -22.45 61.46 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 171.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . 0.283 39.0 mt -72.87 -36.26 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 C-N-CA 130.7 3.6 . . . . 0.0 116.446 164.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.317 1.5 m -80.81 -49.84 17.82 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 CA-C-O 117.157 -1.401 . . . . 0.0 111.917 -176.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.548 ' HA ' ' HB2' ' A' ' 56' ' ' GLU . 57.6 mttp -37.59 -27.99 0.02 OUTLIER 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 130.2 3.4 . . . . 0.0 118.922 166.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -40.04 -55.72 2.01 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.525 1.13 . . . . 0.0 109.207 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -100.04 -32.08 11.12 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 117.894 -3.004 . . . . 0.0 112.887 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 53' ' ' LYS . 4.4 mm-40 -47.9 -27.64 2.25 Favored 'General case' 0 N--CA 1.447 -0.577 1 N-CA-C 123.282 4.549 . . . . 0.0 123.282 168.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.2 m -77.69 -6.39 53.74 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.238 1.415 . . . . 0.0 113.379 -171.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.49 6.91 84.98 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 119.867 -1.158 . . . . 0.0 113.785 151.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -76.08 6.4 5.37 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 120.607 -1.525 . . . . 0.0 113.893 -174.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tp -143.18 163.68 32.25 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 -164.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -98.27 126.13 40.92 Favored Pre-proline 0 N--CA 1.443 -0.813 0 O-C-N 124.36 1.037 . . . . 0.0 110.645 165.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.25 174.01 13.54 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 CA-C-N 120.924 1.366 . . . . 0.0 112.319 -174.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.8 p -135.97 -174.7 3.74 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 125.215 1.406 . . . . 0.0 113.207 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.6 -51.91 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 127.226 2.21 . . . . 0.0 112.437 177.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.2 p -62.9 -31.51 72.59 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 173.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -66.3 -63.78 1.0 Allowed 'General case' 0 C--N 1.349 0.585 0 O-C-N 116.734 -3.729 . . . . 0.0 104.539 172.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -37.3 -41.41 0.41 Allowed 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 172.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.8 ttt85 -65.03 -53.88 39.0 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 125.859 1.974 . . . . 0.0 114.977 176.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -69.5 -40.28 77.11 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 126.87 2.606 . . . . 0.0 108.175 -172.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 13.2 mt -56.25 -63.08 1.3 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 131.45 3.9 . . . . 0.0 113.697 -177.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -46.6 -30.15 2.16 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 126.896 2.622 . . . . 0.0 111.519 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -75.24 -58.29 3.37 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 118.36 -0.829 . . . . 0.0 111.985 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.7 pt -65.13 -44.8 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 119.562 1.074 . . . . 0.0 113.164 -168.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 77.9 mt -76.65 -3.55 38.43 Favored 'General case' 0 N--CA 1.452 -0.354 1 O-C-N 115.332 -4.605 . . . . 0.0 115.384 -152.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.22 8.44 8.85 Favored Glycine 0 C--O 1.223 -0.577 0 CA-C-O 116.951 -2.027 . . . . 0.0 115.481 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.446 HG23 ' HE2' ' A' ' 44' ' ' LYS . 28.0 pt -136.56 155.49 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 122.538 3.169 . . . . 0.0 108.882 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.371 23.5 pttm 163.48 142.06 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 130.637 3.575 . . . . 0.0 116.336 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 78' ' ' LEU . 19.8 mt -145.24 141.95 29.08 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 122.704 2.502 . . . . 0.0 110.213 -171.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 26.9 m -92.68 170.12 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 1 O-C-N 113.739 -5.601 . . . . 0.0 107.674 10.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 78.4 p -84.94 161.79 51.76 Favored Pre-proline 0 N--CA 1.451 -0.409 0 CA-C-N 111.27 -2.696 . . . . 0.0 114.497 -165.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.31 -1.87 5.18 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 124.793 3.662 . . . . 0.0 113.843 -172.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . 0.27 26.4 tp -91.72 -28.42 17.44 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 119.783 -1.823 . . . . 0.0 113.846 166.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -86.2 -10.59 54.41 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 117.923 2.564 . . . . 0.0 117.923 174.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -144.7 150.05 36.65 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.356 1.862 . . . . 0.0 109.451 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -79.92 105.63 11.35 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 100.784 -3.784 . . . . 0.0 100.784 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -82.94 138.45 33.82 Favored 'General case' 0 N--CA 1.45 -0.475 0 O-C-N 118.948 -2.345 . . . . 0.0 110.409 -176.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.547 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 7.4 tp10 -90.51 112.64 24.37 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-O 124.016 1.865 . . . . 0.0 110.887 -159.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 85.1 p -83.82 -7.33 59.48 Favored 'General case' 0 C--O 1.221 -0.407 0 O-C-N 117.579 -3.2 . . . . 0.0 109.187 -161.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -66.43 -0.49 2.73 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 113.112 -3.328 . . . . 0.0 114.38 159.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.547 ' HE3' ' HB3' ' A' ' 87' ' ' GLU . 98.8 mttt -80.22 -23.57 40.82 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 126.79 2.557 . . . . 0.0 111.587 172.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -59.59 -22.27 61.55 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 120.997 3.703 . . . . 0.0 120.997 -164.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -98.56 158.0 15.88 Favored 'General case' 0 C--O 1.224 -0.267 1 O-C-N 113.118 -5.989 . . . . 0.0 109.634 178.214 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -44.01 -90.92 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 114.735 -2.555 . . . . 0.0 115.661 -174.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -85.79 -22.02 27.87 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 127.702 3.126 . . . . 0.0 115.135 -160.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.2 t -173.36 -176.96 1.41 Allowed 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 130.726 3.61 . . . . 0.0 109.057 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -88.66 136.36 13.63 Favored Glycine 0 C--O 1.223 -0.553 0 CA-C-O 118.178 -1.346 . . . . 0.0 113.686 176.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.6 mp -80.4 129.74 34.71 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 126.531 1.932 . . . . 0.0 112.803 -173.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.6 p -125.01 176.62 6.54 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 127.658 2.383 . . . . 0.0 113.502 172.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.6 tp -60.02 -82.43 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 118.369 -1.332 . . . . 0.0 113.958 169.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 65.75 -13.02 0.33 Allowed Glycine 0 C--O 1.216 -1.022 0 CA-C-O 114.203 -3.554 . . . . 0.0 115.971 -172.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.467 0.4 OUTLIER -80.82 29.83 0.32 Allowed 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 128.408 3.063 . . . . 0.0 115.685 -166.812 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.5 m -132.41 151.98 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 125.14 1.376 . . . . 0.0 113.126 -159.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.0 p -63.15 142.1 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 2 O-C-N 110.86 -7.4 . . . . 0.0 107.992 17.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -73.13 34.4 0.07 Allowed 'General case' 0 C--O 1.216 -0.661 0 O-C-N 118.994 -2.316 . . . . 0.0 117.196 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 6.6 pt -133.56 160.63 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 O-C-N 118.286 -2.759 . . . . 0.0 106.386 169.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -98.19 -32.51 11.54 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 115.241 -2.314 . . . . 0.0 110.989 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -62.52 -35.1 78.33 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 128.215 3.447 . . . . 0.0 113.115 169.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -83.79 20.34 12.55 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 115.727 1.051 . . . . 0.0 115.727 172.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . 0.361 26.9 ttmt -151.93 7.53 0.47 Allowed 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.008 1.723 . . . . 0.0 113.961 -164.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -69.68 -43.81 71.74 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 131.29 3.836 . . . . 0.0 111.643 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.8 mp -97.55 178.76 5.08 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.212 148.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -147.62 -53.63 0.21 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.829 1.33 . . . . 0.0 113.996 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -148.54 30.81 0.82 Allowed 'General case' 0 C--O 1.238 0.477 0 CA-C-O 118.496 -0.764 . . . . 0.0 109.219 -164.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 63.1 m80 . . . . . 0 N--CA 1.439 -0.987 0 O-C-N 125.414 1.696 . . . . 0.0 109.965 -169.726 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.281 28.5 mt-10 . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 174.75 129.96 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 129.589 3.156 . . . . 0.0 115.416 143.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.9 -12.78 57.1 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 -156.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -94.68 -11.23 29.6 Favored 'General case' 0 N--CA 1.44 -0.958 0 O-C-N 117.972 -2.955 . . . . 0.0 114.615 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.8 mt -92.14 -3.19 56.0 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 114.131 -2.842 . . . . 0.0 106.233 169.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -109.46 3.56 21.48 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 123.82 3.009 . . . . 0.0 107.868 -162.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 45.3 pt -134.83 178.09 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 C-N-CA 128.792 2.837 . . . . 0.0 114.521 -173.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.2 m -77.61 173.55 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 O-C-N 118.718 -2.489 . . . . 0.0 113.534 152.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 m -59.94 -59.91 4.67 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 129.348 3.059 . . . . 0.0 107.236 173.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -73.33 -22.88 60.22 Favored 'General case' 0 N--CA 1.441 -0.919 0 O-C-N 120.027 -1.671 . . . . 0.0 115.356 -158.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.309 55.3 t80 -55.18 155.9 4.51 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -175.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -74.23 77.45 1.81 Allowed 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 117.001 2.222 . . . . 0.0 117.001 -176.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -57.79 -32.52 67.61 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 129.913 3.285 . . . . 0.0 111.613 -171.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.2 pt -67.43 -37.79 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 120.191 -0.603 . . . . 0.0 109.53 -176.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.29 26.7 mm -59.17 -43.38 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 125.288 2.47 . . . . 0.0 112.651 -175.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.46 34.2 tttm -43.45 -75.42 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 131.072 3.749 . . . . 0.0 114.9 -156.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.3 m -53.96 -43.63 70.07 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 129.147 2.979 . . . . 0.0 112.729 -168.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.43 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . . . -64.7 -48.26 75.32 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 118.936 2.939 . . . . 0.0 118.936 177.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -60.35 -37.38 80.5 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.183 0.993 . . . . 0.0 110.823 170.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -69.32 -33.06 72.58 Favored 'General case' 0 N--CA 1.438 -1.042 1 O-C-N 115.531 -4.48 . . . . 0.0 113.623 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . 0.29 76.7 mt-30 -60.09 -26.51 66.25 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 124.534 1.146 . . . . 0.0 109.297 172.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.3 mt -78.28 -23.4 47.22 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 127.363 2.265 . . . . 0.0 113.527 -177.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.83 0.67 9.18 Favored Glycine 0 C--N 1.341 0.823 0 N-CA-C 118.052 1.981 . . . . 0.0 118.052 -174.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.2 pt -69.61 151.02 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 2 N-CA-C 123.935 4.791 . . . . 0.0 123.935 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 56.9 p -108.3 174.33 5.93 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 123.823 1.773 . . . . 0.0 114.862 -165.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -56.99 -26.44 60.17 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -55.75 -37.04 67.97 Favored 'General case' 0 C--O 1.222 -0.358 0 O-C-N 120.579 -1.326 . . . . 0.0 110.647 176.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -64.81 -40.47 95.27 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 116.879 -3.638 . . . . 0.0 113.211 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . 0.347 24.1 tp -61.74 -43.23 99.25 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 130.292 3.437 . . . . 0.0 111.026 173.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . 0.25 . . -60.91 -43.95 97.85 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 112.923 -1.944 . . . . 0.0 112.339 178.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -67.72 -34.92 77.81 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 112.421 -3.657 . . . . 0.0 111.84 167.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.6 tptt -67.18 -24.05 65.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 125.54 3.791 . . . . 0.0 115.83 -174.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.8 tp -125.17 3.93 7.87 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 128.473 2.709 . . . . 0.0 108.852 -160.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.252 79.9 mttt 44.99 66.79 0.82 Allowed 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 129.803 3.241 . . . . 0.0 111.845 -174.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.5 m -148.11 170.12 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 C-N-CA 130.674 3.59 . . . . 0.0 113.389 174.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.3 p -94.03 159.08 15.32 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 -169.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -67.62 -16.02 63.95 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 118.174 -2.829 . . . . 0.0 115.158 175.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -49.41 -47.17 48.14 Favored 'General case' 0 C--O 1.248 0.982 0 CA-C-N 121.956 2.162 . . . . 0.0 114.152 156.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 27.8 mt -77.07 -27.39 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 O-C-N 121.744 -0.598 . . . . 0.0 111.96 -175.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.5 m -79.45 -47.71 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-O 118.484 -0.77 . . . . 0.0 110.456 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -53.71 -28.11 32.03 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 121.575 1.989 . . . . 0.0 112.986 -165.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -44.38 -57.45 3.52 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 118.563 2.801 . . . . 0.0 118.563 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -95.91 -26.72 15.49 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 119.6 1.091 . . . . 0.0 110.729 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -51.19 -27.63 9.28 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 121.348 -0.845 . . . . 0.0 109.729 172.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.2 p -98.45 0.63 45.6 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 116.984 2.216 . . . . 0.0 116.984 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.76 6.84 89.14 Favored Glycine 0 CA--C 1.525 0.707 0 O-C-N 118.374 -2.704 . . . . 0.0 115.872 -172.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -96.44 -2.62 45.03 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 119.553 1.677 . . . . 0.0 114.164 -168.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 36.9 tp -145.46 130.26 18.14 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 126.592 1.957 . . . . 0.0 106.769 -174.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.6 tttt -81.71 126.88 74.58 Favored Pre-proline 0 C--O 1.221 -0.447 0 CA-C-O 114.935 -2.459 . . . . 0.0 110.726 165.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -82.64 178.05 6.43 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 124.51 3.474 . . . . 0.0 106.389 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.498 ' H ' ' HB3' ' A' ' 66' ' ' GLN . 42.6 p -96.46 167.69 11.0 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -159.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . 0.314 1.9 tt -51.27 -49.45 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 171.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.28 99.3 p -54.92 -55.33 31.82 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 120.621 1.555 . . . . 0.0 112.433 162.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.498 ' HB3' ' H ' ' A' ' 63' ' ' THR . 48.6 tt0 -71.1 -35.2 71.71 Favored 'General case' 0 CA--C 1.515 -0.371 1 CA-C-O 111.503 -4.094 . . . . 0.0 112.796 -163.533 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.77 -43.37 98.98 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 125.288 3.677 . . . . 0.0 109.112 169.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -62.17 -42.42 99.25 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 117.468 -3.27 . . . . 0.0 106.16 174.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -72.68 -30.44 64.25 Favored 'General case' 0 C--O 1.222 -0.385 1 O-C-N 116.01 -4.181 . . . . 0.0 115.34 176.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 70' ' ' LEU . 6.1 mt -54.27 -76.3 0.03 OUTLIER 'General case' 0 C--O 1.243 0.719 0 C-N-CA 130.238 3.415 . . . . 0.0 109.727 -169.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -48.08 -26.75 1.97 Allowed 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 129.035 2.934 . . . . 0.0 108.944 -177.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -88.15 -40.36 13.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 113.822 -2.99 . . . . 0.0 111.424 -166.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 12.8 pt -68.83 -40.36 81.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 128.583 3.677 . . . . 0.0 109.015 173.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 74' ' ' LEU . 74.1 mt -68.76 -26.0 65.01 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 120.323 -1.486 . . . . 0.0 110.661 -173.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.18 -18.76 0.06 OUTLIER Glycine 0 CA--C 1.528 0.863 0 CA-C-O 114.535 -3.369 . . . . 0.0 112.735 -172.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.1 pt -115.26 164.86 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 120.08 1.94 . . . . 0.0 113.328 -165.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.3 pttm -176.01 170.14 2.77 Favored 'General case' 0 CA--C 1.519 -0.226 1 C-N-CA 133.431 4.692 . . . . 0.0 111.093 177.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.43 ' HG ' ' HB2' ' A' ' 30' ' ' ALA . 57.4 mt -136.64 139.95 42.43 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 128.636 2.775 . . . . 0.0 110.615 154.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.416 ' CG2' ' HB3' ' A' ' 84' ' ' ASN . 18.5 m -97.8 175.25 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 O-C-N 116.836 -3.665 . . . . 0.0 112.517 38.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.0 p -80.6 160.47 67.02 Favored Pre-proline 0 N--CA 1.441 -0.897 0 O-C-N 120.769 -1.207 . . . . 0.0 110.261 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.67 -7.5 2.25 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 N-CA-C 119.903 3.001 . . . . 0.0 119.903 162.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 75.5 mt -99.57 -6.89 26.64 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-O 115.265 -2.302 . . . . 0.0 109.614 173.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -108.3 -11.6 15.19 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 117.022 2.23 . . . . 0.0 117.022 155.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.416 ' HB3' ' CG2' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -143.77 177.57 8.42 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 120.33 1.423 . . . . 0.0 108.778 -174.483 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -60.65 161.43 7.79 Favored 'General case' 0 N--CA 1.449 -0.522 1 O-C-N 114.814 -4.929 . . . . 0.0 113.98 172.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -152.34 153.35 33.5 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 129.755 3.222 . . . . 0.0 111.435 165.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -122.99 139.15 54.38 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 131.154 3.782 . . . . 0.0 109.333 -157.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.8 p -85.32 -30.86 23.38 Favored 'General case' 0 N--CA 1.439 -1.013 0 O-C-N 120.461 -1.4 . . . . 0.0 112.479 175.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -79.27 92.17 5.1 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 128.163 2.585 . . . . 0.0 114.176 -175.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -144.06 0.47 1.06 Allowed 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 130.137 3.375 . . . . 0.0 112.896 -165.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -72.9 -42.05 63.98 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 114.012 -2.899 . . . . 0.0 112.598 173.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -56.56 137.29 53.81 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 127.472 2.982 . . . . 0.0 108.646 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . 0.275 14.7 t0 -82.55 -37.23 25.44 Favored 'General case' 0 C--O 1.241 0.611 0 O-C-N 120.28 -1.513 . . . . 0.0 111.546 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -131.39 -37.16 1.24 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 115.813 -2.041 . . . . 0.0 112.444 -169.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.8 t -170.31 159.6 7.28 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 127.565 2.346 . . . . 0.0 109.242 -157.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -75.64 130.7 11.33 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 128.547 2.975 . . . . 0.0 107.379 -174.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.6 mt -136.91 140.77 42.54 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 122.663 3.231 . . . . 0.0 110.42 -174.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.3 m -137.52 129.23 28.57 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 129.977 3.311 . . . . 0.0 111.015 -176.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.7 tp -157.56 -52.5 0.07 Allowed 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 116.743 2.127 . . . . 0.0 116.743 -174.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 76.69 -4.1 52.96 Favored Glycine 0 C--O 1.218 -0.855 0 C-N-CA 127.766 2.603 . . . . 0.0 110.411 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -95.45 57.52 1.95 Allowed 'General case' 0 C--N 1.344 0.36 0 CA-C-N 122.235 3.017 . . . . 0.0 112.815 -162.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.44 159.94 28.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 1 O-C-N 129.248 4.092 . . . . 0.0 114.806 -155.453 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.1 p -60.47 152.27 5.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 2 CA-C-N 131.034 6.288 . . . . 0.0 112.707 5.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -149.39 106.28 3.57 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 101.599 -3.482 . . . . 0.0 101.599 177.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 32.9 pt -89.12 -178.18 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 123.083 1.42 . . . . 0.0 111.1 176.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 40.6 tttm -73.93 -27.48 61.05 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -168.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -83.74 -27.63 28.79 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 128.183 2.593 . . . . 0.0 114.957 172.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 173.08 -174.57 45.94 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 116.323 -3.986 . . . . 0.0 118.23 -173.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -94.98 20.03 9.52 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 124.777 2.227 . . . . 0.0 109.695 -161.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -171.75 159.19 5.2 Favored 'General case' 0 C--N 1.347 0.457 0 C-N-CA 129.53 3.132 . . . . 0.0 115.393 174.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.4 mp -67.09 139.09 57.54 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 129.924 3.29 . . . . 0.0 111.861 154.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.303 13.1 mt-10 -139.86 -92.34 0.17 Allowed 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 127.973 2.509 . . . . 0.0 114.033 -165.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 16.0 p-80 -87.78 6.58 34.47 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 123.818 1.771 . . . . 0.0 115.565 171.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 37.1 m80 . . . . . 0 C--O 1.251 1.138 0 CA-C-N 111.812 -2.449 . . . . 0.0 114.864 173.072 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 . . . . . 0 N--CA 1.474 0.732 0 CA-C-O 117.06 -1.448 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -83.07 151.67 25.68 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 124.595 3.362 . . . . 0.0 112.482 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -112.82 4.76 17.14 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 119.457 3.132 . . . . 0.0 119.457 -174.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -82.39 0.73 40.61 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 119.902 3.297 . . . . 0.0 119.902 -176.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.6 mt -75.86 -31.16 59.15 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 131.68 3.992 . . . . 0.0 110.9 -172.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -128.98 9.33 5.76 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 116.979 2.215 . . . . 0.0 116.979 -146.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.0 pt -107.68 167.19 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 130.236 3.415 . . . . 0.0 111.304 -169.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.2 m -77.88 172.25 1.16 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 O-C-N 118.412 -2.68 . . . . 0.0 111.22 159.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . 0.261 85.4 m -42.97 -83.77 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.945 1 C-N-CA 133.642 4.777 . . . . 0.0 109.446 168.243 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . 0.261 25.0 t70 -91.92 43.89 1.15 Allowed 'General case' 0 C--O 1.239 0.533 0 C-N-CA 128.047 2.539 . . . . 0.0 116.314 -166.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -73.7 137.05 43.82 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 125.081 2.372 . . . . 0.0 104.641 -174.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -70.66 157.8 37.34 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 117.36 -3.337 . . . . 0.0 113.196 -166.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -140.89 14.18 2.28 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 127.149 2.179 . . . . 0.0 113.259 -146.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -35.7 -57.11 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.805 1 O-C-N 114.888 -4.882 . . . . 0.0 113.886 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.407 HD11 HD22 ' A' ' 70' ' ' LEU . 11.7 pt -119.14 4.2 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 113.457 -1.701 . . . . 0.0 110.719 -165.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -47.95 -64.13 0.88 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.066 1.746 . . . . 0.0 114.912 -175.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.5 p -53.95 -46.58 71.63 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.283 1.833 . . . . 0.0 115.888 -174.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.58 -44.26 65.8 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 109.776 -3.375 . . . . 0.0 114.645 176.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -48.41 -44.7 35.28 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 118.551 -2.593 . . . . 0.0 112.772 169.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -72.14 -47.5 50.58 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 120.384 -1.448 . . . . 0.0 114.532 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -66.75 -25.69 66.62 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 128.641 2.776 . . . . 0.0 111.325 -167.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.5 mt -88.1 -17.05 31.87 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 127.417 2.287 . . . . 0.0 110.315 -174.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.32 11.27 58.96 Favored Glycine 0 C--O 1.243 0.674 0 CA-C-O 123.309 1.505 . . . . 0.0 113.99 177.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.9 pt -75.54 144.76 11.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 129.094 2.958 . . . . 0.0 114.202 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.5 p -93.2 166.3 12.39 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -175.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -58.71 -35.86 73.33 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.191 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -70.11 -37.37 75.35 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 115.906 -1.997 . . . . 0.0 108.132 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -66.87 -29.98 70.02 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 115.568 -2.158 . . . . 0.0 112.661 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.7 tt -78.96 -36.52 41.44 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-O 126.315 2.959 . . . . 0.0 111.836 176.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.93 -40.5 66.8 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 119.447 -2.033 . . . . 0.0 112.224 167.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -70.6 -37.07 73.85 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 118.845 -2.409 . . . . 0.0 111.007 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -66.39 -14.3 61.92 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 129.554 3.141 . . . . 0.0 110.438 -172.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.3 mt -131.01 -1.59 4.09 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 126.832 3.206 . . . . 0.0 112.781 -164.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.274 40.8 mtmt 56.39 -26.19 0.02 OUTLIER 'General case' 0 C--O 1.241 0.615 0 N-CA-C 121.094 3.739 . . . . 0.0 121.094 -162.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.9 m -83.61 172.21 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 C-N-CA 129.504 3.122 . . . . 0.0 111.378 -168.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 91.7 p -92.48 158.33 16.08 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 119.556 -1.965 . . . . 0.0 111.334 -153.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.409 ' HA ' HG22 ' A' ' 52' ' ' VAL . 18.3 mt-10 -61.56 -32.58 72.66 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 126.143 1.777 . . . . 0.0 108.031 177.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -65.3 -31.57 72.78 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 168.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.9 mt -67.98 -38.79 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 124.407 2.051 . . . . 0.0 112.555 172.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.409 HG22 ' HA ' ' A' ' 49' ' ' GLU 0.297 32.6 m -80.07 -30.78 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 1 O-C-N 116.042 -4.161 . . . . 0.0 114.122 -176.777 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -53.13 -38.69 62.88 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 126.392 1.877 . . . . 0.0 109.806 155.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -71.93 -38.42 69.87 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 126.296 1.838 . . . . 0.0 106.046 -174.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -66.97 -41.46 86.82 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 121.59 1.995 . . . . 0.0 108.662 173.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.42 -14.96 62.76 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 114.464 -2.684 . . . . 0.0 111.562 -172.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.6 p -113.09 -1.68 14.36 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 123.495 2.861 . . . . 0.0 111.137 -175.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.06 28.47 73.57 Favored Glycine 0 C--N 1.343 0.922 0 O-C-N 128.665 3.728 . . . . 0.0 119.24 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -85.17 7.24 22.55 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 131.501 3.921 . . . . 0.0 113.216 -171.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.6 tt -137.17 144.2 42.8 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 127.402 2.281 . . . . 0.0 109.501 -166.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.1 tttt -83.04 126.6 72.06 Favored Pre-proline 0 C--O 1.24 0.587 0 CA-C-O 116.455 -1.736 . . . . 0.0 110.23 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -82.0 150.64 16.06 Favored 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 124.64 3.56 . . . . 0.0 112.504 -168.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.3 p -123.07 164.64 18.22 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 123.937 1.827 . . . . 0.0 113.669 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.0 pt -62.66 -50.27 80.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 O-C-N 118.715 -2.491 . . . . 0.0 113.443 174.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 99.3 p -54.67 -21.57 11.08 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 121.871 2.123 . . . . 0.0 116.649 170.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -75.33 -75.84 0.16 Allowed 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.911 177.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -12.52 -62.66 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 117.884 2.549 . . . . 0.0 117.884 150.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -56.83 -49.85 74.16 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 127.474 2.31 . . . . 0.0 107.741 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -62.49 -44.29 96.73 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 116.413 -1.756 . . . . 0.0 106.886 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.407 HD22 HD11 ' A' ' 27' ' ' ILE . 43.5 mt -63.43 -47.39 82.1 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 115.29 -2.29 . . . . 0.0 109.851 -167.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -50.98 -22.73 2.43 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 170.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.7 mttp -94.48 -52.34 4.37 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 -176.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 24.1 pt -44.24 -49.93 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 127.243 2.217 . . . . 0.0 115.471 -167.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.3 mt -77.67 -2.49 36.27 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 121.549 1.977 . . . . 0.0 109.89 -169.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.95 0.51 60.37 Favored Glycine 0 CA--C 1.522 0.478 0 O-C-N 125.535 1.772 . . . . 0.0 111.834 -169.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 76' ' ' ILE . 29.6 pt -149.88 167.62 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 O-C-N 117.639 -3.271 . . . . 0.0 113.64 -178.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.77 163.78 1.17 Allowed 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 126.885 2.074 . . . . 0.0 109.471 -177.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.9 mt -150.76 146.54 26.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 121.132 1.787 . . . . 0.0 109.972 -174.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.556 HG23 ' HB3' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -116.5 159.26 16.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 O-C-N 116.971 -3.581 . . . . 0.0 119.231 26.722 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . 0.259 82.7 p -99.11 171.1 6.04 Favored Pre-proline 0 C--N 1.324 -0.535 0 C-N-CA 129.205 3.002 . . . . 0.0 113.221 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -59.48 11.86 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 124.28 3.32 . . . . 0.0 112.781 171.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 39.1 tp -59.92 -33.29 71.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 121.824 2.102 . . . . 0.0 109.878 150.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -146.88 5.74 0.88 Allowed 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 120.583 1.538 . . . . 0.0 113.382 171.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.556 ' HB3' HG23 ' A' ' 79' ' ' VAL . 24.7 t-20 -176.64 139.66 0.32 Allowed 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 119.252 -2.155 . . . . 0.0 111.235 -166.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -134.25 174.24 10.73 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 125.629 2.633 . . . . 0.0 105.663 -177.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -166.12 150.86 8.14 Favored 'General case' 0 N--CA 1.445 -0.698 0 O-C-N 119.302 -2.124 . . . . 0.0 107.763 -168.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.405 ' OE1' ' HA ' ' A' ' 87' ' ' GLU . 4.8 tp10 -49.7 129.73 20.04 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 120.234 -1.541 . . . . 0.0 111.802 168.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 26.1 m -76.97 -27.28 54.71 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.315 1.846 . . . . 0.0 108.601 -166.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -71.57 -5.48 33.69 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 118.545 -2.597 . . . . 0.0 113.886 175.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -70.95 -28.94 64.84 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 123.085 1.421 . . . . 0.0 111.593 174.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -58.19 -21.22 46.61 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 129.645 3.178 . . . . 0.0 118.29 -168.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.458 ' CD2' ' HA2' ' A' ' 96' ' ' GLY . 87.3 m-85 -74.7 -177.96 3.44 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 116.991 2.219 . . . . 0.0 116.991 177.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -81.1 -31.69 34.19 Favored 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 118.589 -2.569 . . . . 0.0 116.535 174.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -138.51 -38.69 0.53 Allowed 'General case' 0 C--O 1.236 0.381 0 CA-C-N 120.404 1.456 . . . . 0.0 113.539 167.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.2 p -152.27 153.5 33.86 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.707 2.003 . . . . 0.0 108.898 -166.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.458 ' HA2' ' CD2' ' A' ' 92' ' ' PHE . . . -72.52 161.51 54.39 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -178.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 59.0 tp -92.31 -32.33 15.05 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 116.156 1.91 . . . . 0.0 116.156 -163.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.2 m -119.29 141.1 49.27 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 127.69 2.396 . . . . 0.0 113.144 -168.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 14.3 tp -92.66 127.89 38.32 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 116.727 -1.606 . . . . 0.0 110.156 174.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.72 -15.75 62.89 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-O 118.254 -1.303 . . . . 0.0 112.303 -176.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.267 16.5 t0 -91.97 27.61 2.08 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 118.428 2.751 . . . . 0.0 118.428 -148.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . 0.317 0.0 OUTLIER -139.67 157.04 26.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 131.136 3.774 . . . . 0.0 114.781 -155.003 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 6.9 m -97.89 8.56 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 2 O-C-N 109.21 -8.431 . . . . 0.0 109.761 14.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -59.91 121.9 12.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 120.559 1.527 . . . . 0.0 112.635 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 105' ' ' ILE . 69.1 mt -100.93 134.71 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 126.649 1.979 . . . . 0.0 110.649 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -103.36 -18.02 15.02 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.461 1.105 . . . . 0.0 108.142 -161.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -67.42 -8.75 35.55 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 126.433 1.893 . . . . 0.0 109.763 153.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.83 6.92 37.29 Favored Glycine 0 C--N 1.339 0.704 0 O-C-N 117.48 -3.263 . . . . 0.0 118.4 -162.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -126.07 24.3 6.96 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-O 116.167 -1.873 . . . . 0.0 111.523 168.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 44.1 tttt -70.92 77.45 0.64 Allowed 'General case' 0 C--O 1.235 0.331 0 C-N-CA 130.989 3.716 . . . . 0.0 114.571 174.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.8 pp -172.12 179.34 2.66 Favored 'General case' 0 N--CA 1.443 -0.796 1 C-N-CA 132.073 4.149 . . . . 0.0 107.531 -169.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.294 33.0 tt0 -146.74 -104.75 0.09 Allowed 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 -176.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -86.88 -7.07 58.55 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 116.806 2.15 . . . . 0.0 116.806 -169.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 12.6 m80 . . . . . 0 C--O 1.252 1.185 0 C-N-CA 130.154 3.382 . . . . 0.0 109.929 172.773 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.287 4.6 tp10 . . . . . 0 N--CA 1.468 0.472 0 CA-C-O 124.72 2.2 . . . . 0.0 112.358 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -87.67 148.32 24.84 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 112.896 -1.956 . . . . 0.0 108.953 -163.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.44 162.79 26.68 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.96 2.104 . . . . 0.0 113.015 -172.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -80.32 -3.16 48.36 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.571 -160.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 179.57 163.87 0.99 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 127.607 2.363 . . . . 0.0 113.227 -156.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -138.05 148.17 44.81 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-O 122.367 1.08 . . . . 0.0 110.664 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 40.3 pt -123.18 -15.82 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 114.68 -2.581 . . . . 0.0 114.054 -171.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 86.6 t -80.81 -47.12 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 C-N-CA 115.824 -2.35 . . . . 0.0 111.763 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.3 m -51.09 -45.52 61.49 Favored 'General case' 0 N--CA 1.448 -0.568 1 O-C-N 115.834 -4.291 . . . . 0.0 114.38 -156.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . 0.403 71.3 m-20 63.76 -21.62 0.06 Allowed 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 129.366 3.067 . . . . 0.0 116.496 -163.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -89.32 75.24 7.75 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 116.675 -1.631 . . . . 0.0 107.0 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -100.02 -173.31 2.41 Favored 'General case' 0 CA--C 1.518 -0.255 0 O-C-N 128.457 3.598 . . . . 0.0 118.054 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -59.18 -24.04 62.74 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 119.199 3.037 . . . . 0.0 119.199 -175.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.9 pt -30.42 -35.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 119.908 3.299 . . . . 0.0 119.908 145.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.1 tp -137.31 -42.94 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 121.693 2.042 . . . . 0.0 114.495 177.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.361 79.5 tttt -40.99 -58.51 1.7 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 131.07 3.748 . . . . 0.0 118.313 173.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 74.9 p -83.48 -29.7 27.78 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 113.433 -1.712 . . . . 0.0 109.087 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.12 -51.23 62.49 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.937 1.295 . . . . 0.0 110.516 -160.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -46.51 -38.07 8.79 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 126.901 2.626 . . . . 0.0 112.879 174.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -73.87 -41.34 62.33 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 129.512 3.125 . . . . 0.0 113.462 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . 0.29 43.5 mt-30 -68.66 -16.31 63.79 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.447 ' HA ' HD12 ' A' ' 34' ' ' LEU . 14.0 tp -95.99 -14.51 22.96 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 112.453 -2.158 . . . . 0.0 112.157 175.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.64 -0.63 34.13 Favored Glycine 0 CA--C 1.523 0.564 1 C-N-CA 131.037 4.16 . . . . 0.0 117.309 172.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.6 pt -69.03 155.97 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 C-N-CA 126.233 1.813 . . . . 0.0 113.78 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 93.7 p -90.63 171.84 9.09 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -176.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -59.25 -42.97 92.37 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -64.9 -41.12 95.86 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 119.242 -2.161 . . . . 0.0 109.172 -175.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -64.74 -39.41 93.59 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 119.181 -2.2 . . . . 0.0 114.066 174.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.4 tp -64.04 -38.64 91.82 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 126.768 2.027 . . . . 0.0 114.166 -173.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.12 -49.76 76.63 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-O 123.899 1.809 . . . . 0.0 107.99 173.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -64.56 -14.34 57.12 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 117.53 -3.231 . . . . 0.0 108.669 -175.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -103.54 -16.88 15.41 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 117.591 -3.193 . . . . 0.0 118.504 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 86.2 mt -135.2 15.06 3.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 120.672 -1.267 . . . . 0.0 113.723 -165.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 70.7 mttt 45.6 -27.38 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.419 1 C-N-CA 134.255 5.022 . . . . 0.0 117.931 -154.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.7 m -86.86 145.37 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 122.348 2.34 . . . . 0.0 116.419 -163.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.2 p -81.36 160.75 24.04 Favored 'General case' 0 N--CA 1.449 -0.517 1 N-CA-C 122.439 4.237 . . . . 0.0 122.439 -168.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.79 -17.24 0.33 Allowed 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 125.367 3.712 . . . . 0.0 116.962 165.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -86.68 -35.51 19.26 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 126.503 1.921 . . . . 0.0 112.055 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.9 mm -55.16 -36.76 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-O 124.197 1.951 . . . . 0.0 110.137 167.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.3 t -59.6 -65.28 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-O 115.274 -2.298 . . . . 0.0 111.007 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -44.24 -43.53 7.34 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 126.526 2.391 . . . . 0.0 114.134 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -54.34 -50.42 67.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 176.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -91.29 -40.42 11.51 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.645 1.178 . . . . 0.0 109.196 -171.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -43.58 -36.6 2.16 Favored 'General case' 0 N--CA 1.434 -1.266 0 O-C-N 118.352 -2.718 . . . . 0.0 111.567 166.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 76.1 p -90.13 -2.55 58.1 Favored 'General case' 0 C--O 1.237 0.436 1 O-C-N 116.176 -4.078 . . . . 0.0 114.371 -172.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.97 12.71 79.2 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 120.14 2.816 . . . . 0.0 120.14 -175.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -87.22 -28.42 22.39 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.624 1.97 . . . . 0.0 112.421 -168.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.1 tp -151.79 131.66 13.32 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 128.584 2.753 . . . . 0.0 111.743 -170.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -117.45 -179.62 0.67 Allowed Pre-proline 0 N--CA 1.447 -0.605 0 CA-C-O 114.935 -2.46 . . . . 0.0 108.807 165.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -46.36 150.82 1.99 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 1 C-N-CA 125.637 4.225 . . . . 0.0 116.335 -175.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.6 p -127.98 -175.11 3.39 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 128.488 2.715 . . . . 0.0 114.433 -173.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.0 tp -60.56 -54.15 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.502 1.121 . . . . 0.0 108.078 175.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 88.0 p -69.19 -16.99 63.75 Favored 'General case' 0 C--N 1.34 0.194 0 O-C-N 117.335 -3.353 . . . . 0.0 111.928 -175.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -98.76 -47.23 5.39 Favored 'General case' 0 CA--C 1.514 -0.427 0 O-C-N 116.999 -3.563 . . . . 0.0 111.145 -175.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.95 -55.67 31.57 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 125.892 1.995 . . . . 0.0 115.875 -149.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -52.24 -54.41 31.57 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 120.968 1.713 . . . . 0.0 114.092 -167.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.541 ' HB3' ' CZ ' ' A' ' 92' ' ' PHE . 15.8 tt0 -60.94 -40.28 92.67 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 119.417 -2.052 . . . . 0.0 114.926 167.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tt -55.23 -55.76 27.64 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 130.976 3.71 . . . . 0.0 108.331 -172.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -48.4 -48.61 36.87 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 125.077 2.37 . . . . 0.0 111.127 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.434 ' HE2' ' HB3' ' A' ' 89' ' ' GLU . 45.1 mttp -73.72 -36.33 65.19 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 119.078 -2.263 . . . . 0.0 113.035 -164.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 24.3 pt -66.48 -27.95 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 O-C-N 124.058 0.849 . . . . 0.0 112.995 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.269 1.1 pt? 164.93 -21.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 130.891 3.676 . . . . 0.0 111.228 173.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.82 29.35 59.38 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-O 123.019 1.344 . . . . 0.0 113.14 -170.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . 0.324 4.2 pt 64.46 7.7 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.706 1 C-N-CA 131.909 4.084 . . . . 0.0 113.037 165.609 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -68.44 151.6 46.6 Favored 'General case' 0 CA--C 1.515 -0.369 1 CA-C-O 111.102 -4.285 . . . . 0.0 112.333 174.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.415 ' CD2' ' HA ' ' A' ' 79' ' ' VAL 0.289 12.6 mt -135.9 140.12 43.84 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 125.61 3.823 . . . . 0.0 112.9 -176.076 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.415 ' HA ' ' CD2' ' A' ' 78' ' ' LEU 0.252 14.4 m -105.53 170.05 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 1 O-C-N 116.091 -4.131 . . . . 0.0 116.273 24.719 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . 0.309 1.6 p -89.56 99.63 1.85 Allowed Pre-proline 0 C--O 1.244 0.788 0 N-CA-C 102.876 -3.009 . . . . 0.0 102.876 158.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -46.4 -28.92 6.48 Favored 'Trans proline' 0 C--N 1.326 -0.616 1 C-N-CA 109.288 -6.675 . . . . 0.0 112.324 144.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -161.54 156.26 23.13 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 122.584 2.447 . . . . 0.0 112.937 171.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.11 116.69 8.2 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 116.085 -1.912 . . . . 0.0 111.93 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -113.31 169.74 8.73 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 126.363 2.982 . . . . 0.0 114.756 168.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -146.42 145.85 30.39 Favored 'General case' 0 C--N 1.341 0.229 0 O-C-N 117.413 -3.304 . . . . 0.0 110.957 156.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -82.18 118.42 23.07 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 173.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -76.6 13.71 0.94 Allowed 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 118.302 -2.749 . . . . 0.0 113.113 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 p -64.69 -26.13 68.24 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 129.134 2.973 . . . . 0.0 113.795 -175.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.434 ' HB3' ' HE2' ' A' ' 72' ' ' LYS 0.333 41.8 tt0 -174.59 105.94 0.1 Allowed 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 117.405 -3.309 . . . . 0.0 112.16 -176.679 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.6 tttm -66.93 -53.13 34.95 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 130.051 3.34 . . . . 0.0 119.839 173.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -74.64 116.01 14.86 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 119.289 -2.132 . . . . 0.0 112.296 -165.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.541 ' CZ ' ' HB3' ' A' ' 69' ' ' GLN . 88.4 t80 -137.61 113.4 9.68 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 116.944 2.201 . . . . 0.0 116.944 -162.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.1 t70 173.98 146.1 0.06 Allowed 'General case' 0 N--CA 1.452 -0.368 1 C-N-CA 132.879 4.471 . . . . 0.0 117.095 -175.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . 0.264 5.2 p-10 -111.12 -13.4 14.04 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 131.207 3.803 . . . . 0.0 115.911 -167.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.7 m -57.07 -40.29 76.61 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 116.905 -1.918 . . . . 0.0 115.684 -173.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -71.41 -4.53 57.17 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-O 115.417 -2.879 . . . . 0.0 112.103 -174.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.9 tp -112.37 -44.27 3.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 118.755 1.278 . . . . 0.0 113.133 177.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 41.6 p -93.38 -55.87 3.14 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 126.666 1.986 . . . . 0.0 107.953 -160.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 19.7 tp -73.52 -17.61 61.19 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.836 0.827 . . . . 0.0 109.651 159.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.44 37.05 94.2 Favored Glycine 0 C--N 1.341 0.823 0 O-C-N 119.001 -2.312 . . . . 0.0 115.018 -177.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.25 1.1 t70 -76.96 58.92 1.56 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 123.722 1.725 . . . . 0.0 111.48 -170.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.87 158.16 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 1 O-C-N 115.165 -4.71 . . . . 0.0 114.722 -178.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 110' ' ' LYS . 25.4 t -76.05 123.97 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 1 O-C-N 110.923 -7.36 . . . . 0.0 113.014 1.82 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.423 HD21 ' HB2' ' A' ' 107' ' ' GLU . 51.7 t-20 -86.52 118.26 25.83 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 112.78 -2.009 . . . . 0.0 109.53 177.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 10.0 pt -114.54 -0.45 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 O-C-N 126.445 2.34 . . . . 0.0 112.016 -174.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 31.8 tttm -103.86 -24.56 13.27 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 131.425 3.89 . . . . 0.0 117.097 -174.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.423 ' HB2' HD21 ' A' ' 104' ' ' ASN . 51.8 mt-10 -143.09 -25.03 0.61 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 129.224 3.009 . . . . 0.0 113.679 172.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -69.71 -176.77 16.97 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 117.944 -2.074 . . . . 0.0 116.212 -160.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -142.16 53.18 1.46 Allowed 'General case' 0 C--O 1.219 -0.534 0 O-C-N 119.794 -2.004 . . . . 0.0 110.229 173.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.424 ' HB3' HG13 ' A' ' 103' ' ' VAL . 13.0 tmtt? -75.23 81.06 2.35 Favored 'General case' 0 N--CA 1.439 -1.001 2 O-C-N 115.534 -4.479 . . . . 0.0 112.943 173.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.4 ' H ' ' CE1' ' A' ' 114' ' ' HIS 0.259 7.9 mt -76.73 161.12 28.75 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 119.098 -2.251 . . . . 0.0 116.266 -163.305 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -47.23 -38.87 12.97 Favored 'General case' 0 N--CA 1.443 -0.806 1 C-N-CA 132.531 4.333 . . . . 0.0 112.656 -173.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -94.59 -4.33 48.03 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 117.631 -3.168 . . . . 0.0 113.31 -170.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.4 ' CE1' ' H ' ' A' ' 111' ' ' LEU . 54.3 m170 . . . . . 0 C--O 1.243 0.711 0 O-C-N 118.09 -2.881 . . . . 0.0 110.296 -174.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 N--CA 1.476 0.865 0 CA-C-O 124.874 2.273 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -178.96 127.14 0.1 Allowed 'General case' 0 N--CA 1.442 -0.869 1 C-N-CA 133.434 4.694 . . . . 0.0 111.378 177.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.52 -19.55 64.52 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 118.779 2.881 . . . . 0.0 118.779 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -73.1 1.13 9.69 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 118.625 2.824 . . . . 0.0 118.625 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.2 mt -113.67 8.91 17.7 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 111.375 -2.648 . . . . 0.0 117.339 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -132.76 24.19 4.31 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -160.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 40.4 pt -135.79 156.19 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 126.291 1.837 . . . . 0.0 113.588 -164.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.3 p -73.2 140.53 17.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 126.286 1.835 . . . . 0.0 107.683 175.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.8 m -64.34 -59.32 4.52 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -174.92 85.08 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 129.318 3.047 . . . . 0.0 107.101 -163.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -71.16 150.01 45.8 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 130.505 3.522 . . . . 0.0 114.232 -160.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -70.6 127.53 33.01 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 -170.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -101.21 -15.57 17.28 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 125.298 1.439 . . . . 0.0 113.002 -174.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.9 pt -70.77 -25.63 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 120.571 1.532 . . . . 0.0 111.31 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.429 40.3 pt -60.36 -35.58 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 C-N-CA 127.702 2.401 . . . . 0.0 108.16 171.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.355 8.8 ttpt -44.0 -72.74 0.05 Allowed 'General case' 0 N--CA 1.454 -0.272 1 C-N-CA 132.266 4.227 . . . . 0.0 115.951 -159.548 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.9 m -72.12 -21.87 61.41 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.111 0.964 . . . . 0.0 111.948 -165.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.473 ' HB1' HD12 ' A' ' 76' ' ' ILE . . . -76.71 -59.95 2.56 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 128.081 2.552 . . . . 0.0 107.872 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -43.77 -35.11 1.75 Allowed 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 127.77 2.428 . . . . 0.0 108.143 169.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . 0.304 17.2 tt0 -73.45 -41.23 63.46 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 122.42 2.373 . . . . 0.0 115.402 173.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -61.51 -19.7 62.37 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 121.564 1.984 . . . . 0.0 111.973 171.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 34' ' ' LEU . 8.1 tp -71.77 -34.64 69.62 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 123.503 1.621 . . . . 0.0 111.188 -173.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.57 -12.97 8.94 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-N 110.804 -2.907 . . . . 0.0 112.557 173.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.4 pt -70.79 154.54 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 O-C-N 120.383 -1.657 . . . . 0.0 110.403 -171.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 84.4 p -96.46 175.05 6.55 Favored 'General case' 0 N--CA 1.437 -1.106 0 O-C-N 118.265 -2.772 . . . . 0.0 113.473 -166.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -51.16 -40.85 59.51 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 113.437 -3.173 . . . . 0.0 113.95 161.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . 0.293 25.2 mp0 -61.16 -40.41 93.77 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 127.822 3.201 . . . . 0.0 110.002 -175.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -72.75 -34.57 67.11 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 119.706 -1.871 . . . . 0.0 113.586 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 63.1 tp -73.35 -27.68 61.64 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 122.682 1.229 . . . . 0.0 113.601 -176.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.77 -36.73 81.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 116.301 -1.809 . . . . 0.0 107.082 169.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . 0.277 87.8 mm-40 -73.29 -31.28 63.95 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 127.662 2.385 . . . . 0.0 111.266 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.7 tptt -67.3 -24.61 65.77 Favored 'General case' 0 N--CA 1.442 -0.864 0 O-C-N 117.227 -3.421 . . . . 0.0 111.736 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.9 mt -124.96 -3.14 7.67 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 128.02 2.528 . . . . 0.0 109.992 -165.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.258 27.2 mtpt 52.32 5.54 0.04 OUTLIER 'General case' 0 C--O 1.233 0.224 0 C-N-CA 130.486 3.514 . . . . 0.0 118.736 -171.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.8 m -88.51 -168.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 128.386 2.674 . . . . 0.0 108.102 -173.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 90.9 p -100.1 158.87 15.53 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.911 1.284 . . . . 0.0 112.585 -173.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -52.33 -32.58 38.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 113.12 -1.855 . . . . 0.0 110.971 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -74.21 -31.12 62.5 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 175.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 67.7 mt -74.26 -34.63 37.87 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 O-C-N 118.459 -2.651 . . . . 0.0 112.196 174.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.41 11.2 m -64.22 -59.13 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 O-C-N 118.376 -2.703 . . . . 0.0 112.79 164.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -50.03 -18.91 0.61 Allowed 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 119.801 3.259 . . . . 0.0 119.801 175.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -58.95 -32.68 69.82 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 -171.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -93.91 -44.8 7.91 Favored 'General case' 0 CA--C 1.512 -0.5 0 O-C-N 126.148 2.155 . . . . 0.0 110.035 176.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -49.26 -30.82 7.76 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 127.606 2.362 . . . . 0.0 108.787 176.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.2 p -94.81 -28.09 15.43 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 117.443 -3.286 . . . . 0.0 114.253 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.58 9.52 56.44 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 118.556 -2.59 . . . . 0.0 113.776 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -88.76 45.1 1.26 Allowed 'General case' 0 N--CA 1.447 -0.606 1 C-N-CA 131.82 4.048 . . . . 0.0 113.222 -169.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.53 135.95 54.92 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 129.036 2.935 . . . . 0.0 112.844 -159.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.317 43.3 mtpt -109.78 76.19 0.91 Allowed Pre-proline 0 N--CA 1.445 -0.697 0 CA-C-O 114.656 -2.592 . . . . 0.0 115.612 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -84.06 157.91 13.36 Favored 'Trans proline' 0 C--N 1.329 -0.492 0 C-N-CA 124.861 3.707 . . . . 0.0 113.367 -158.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.669 ' H ' ' HB2' ' A' ' 66' ' ' GLN . 58.9 p -132.16 176.35 8.46 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 128.088 2.555 . . . . 0.0 112.943 168.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.413 ' H ' HG12 ' A' ' 64' ' ' ILE . 6.3 pt -48.02 -56.51 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 172.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 90.8 p -47.34 -33.77 6.14 Favored 'General case' 0 C--N 1.342 0.244 0 O-C-N 117.468 -3.27 . . . . 0.0 115.916 166.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.669 ' HB2' ' H ' ' A' ' 63' ' ' THR . 62.4 mt-30 -75.01 -50.43 16.55 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 128.209 2.603 . . . . 0.0 112.28 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -42.62 -52.45 4.83 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 125.949 1.699 . . . . 0.0 111.458 162.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.9 mtm180 -63.82 -34.39 77.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 124.145 0.903 . . . . 0.0 111.824 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -80.36 -35.6 35.21 Favored 'General case' 0 CA--C 1.516 -0.351 0 O-C-N 119.695 -1.878 . . . . 0.0 112.634 -168.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.3 mt -73.69 -50.56 20.29 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 131.572 3.949 . . . . 0.0 115.264 -167.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -44.04 -34.92 1.9 Allowed 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.579 0.704 . . . . 0.0 112.215 158.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.2 mttp -98.35 10.31 41.04 Favored 'General case' 0 CA--C 1.513 -0.471 0 O-C-N 118.303 -2.748 . . . . 0.0 114.404 -165.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 20.7 pt -53.28 -50.85 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-O 125.652 2.644 . . . . 0.0 112.912 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 77.0 mt -106.43 0.67 25.01 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 118.919 -2.363 . . . . 0.0 115.901 176.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.33 0.61 11.36 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 126.617 2.055 . . . . 0.0 115.245 175.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.473 HD12 ' HB1' ' A' ' 30' ' ' ALA . 21.7 pt -116.42 -174.49 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 116.979 -3.659 . . . . 0.0 116.605 -177.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -173.93 147.6 1.32 Allowed 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 113.501 -3.143 . . . . 0.0 109.432 -173.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 31.5 mt -132.08 157.12 45.01 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 125.931 2.019 . . . . 0.0 110.579 164.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.1 153.8 10.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 2 C-N-CA 133.848 4.859 . . . . 0.0 121.537 3.884 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.0 p -88.89 175.91 3.65 Favored Pre-proline 0 N--CA 1.446 -0.672 0 O-C-N 118.399 -2.688 . . . . 0.0 109.346 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -44.51 -17.55 0.15 Allowed 'Trans proline' 0 N--CA 1.45 -1.03 0 N-CA-C 118.189 2.342 . . . . 0.0 118.189 167.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 65.5 mt -55.2 -14.17 1.59 Allowed 'General case' 0 C--O 1.219 -0.53 0 O-C-N 125.917 2.011 . . . . 0.0 115.459 163.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . 0.361 5.6 tp10 -145.8 -39.3 0.23 Allowed 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 126.188 1.795 . . . . 0.0 110.404 174.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -145.86 154.3 41.82 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 123.524 1.63 . . . . 0.0 112.462 -175.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -131.95 132.51 43.59 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 118.669 -2.519 . . . . 0.0 112.9 -176.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -50.94 107.86 0.2 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 125.295 2.474 . . . . 0.0 114.003 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.294 39.9 tt0 -132.51 61.4 1.67 Allowed 'General case' 0 C--N 1.327 -0.41 0 O-C-N 119.393 -2.067 . . . . 0.0 113.198 -165.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 73.8 m -76.96 -13.05 60.01 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.974 1.71 . . . . 0.0 112.996 -162.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -55.19 -25.58 33.61 Favored 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 118.674 -2.516 . . . . 0.0 117.406 172.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -72.75 -21.37 61.03 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 121.509 3.892 . . . . 0.0 121.509 165.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -118.64 -28.63 5.6 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 -175.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -109.49 148.9 30.4 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-O 126.43 3.014 . . . . 0.0 112.705 -175.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -69.56 -32.25 70.94 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 117.728 -3.107 . . . . 0.0 113.881 167.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -144.11 9.65 1.48 Allowed 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 116.458 2.021 . . . . 0.0 116.458 -171.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 89.0 m -107.32 137.16 45.9 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 128.307 2.643 . . . . 0.0 108.997 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.74 12.5 56.93 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 124.12 0.887 . . . . 0.0 112.787 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.64 -19.06 19.29 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 115.301 -2.285 . . . . 0.0 110.359 -164.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.2 t -154.29 137.54 15.71 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 128.603 3.69 . . . . 0.0 114.103 166.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 26.4 tp -102.67 -29.08 11.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.143 -1.39 . . . . 0.0 113.18 161.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.58 6.06 83.79 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-O 116.843 -2.087 . . . . 0.0 109.258 176.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -74.67 109.59 8.27 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 126.503 1.943 . . . . 0.0 112.309 -176.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.419 ' HB ' ' HA ' ' A' ' 103' ' ' VAL 0.41 6.7 m -129.42 162.13 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 1 O-C-N 129.503 4.252 . . . . 0.0 117.229 177.433 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.419 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 20.0 t -57.09 127.01 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 123.802 3.001 . . . . 0.0 115.001 -4.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -90.35 119.83 30.97 Favored 'General case' 0 C--N 1.346 0.445 0 O-C-N 121.572 -0.705 . . . . 0.0 110.866 -167.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.479 ' C ' ' H ' ' A' ' 108' ' ' GLY . 20.8 pt -116.65 3.72 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 125.928 1.691 . . . . 0.0 110.316 -174.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -75.68 -10.44 59.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 118.899 -2.376 . . . . 0.0 112.6 147.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -67.91 -23.55 65.11 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 118.526 -1.27 . . . . 0.0 110.798 152.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 105' ' ' ILE . . . 152.15 159.48 8.99 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 124.555 2.197 . . . . 0.0 117.241 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.3 tttt -83.19 43.94 0.91 Allowed 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 109.047 -3.577 . . . . 0.0 115.971 -171.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -78.88 -18.99 53.01 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 111.554 -2.566 . . . . 0.0 112.306 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 42.4 mt -101.63 150.17 23.38 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.998 2.119 . . . . 0.0 107.474 150.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.346 23.2 tt0 -164.35 -79.14 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 113.807 -2.997 . . . . 0.0 116.924 -148.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -91.31 8.54 35.55 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 118.376 2.732 . . . . 0.0 118.376 -175.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 . . . . . 0 C--O 1.256 1.406 0 C-N-CA 129.961 3.304 . . . . 0.0 111.462 -167.903 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 115.473 1.656 . . . . 0.0 115.473 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -98.15 153.58 18.35 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 116.943 -1.503 . . . . 0.0 112.05 -169.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.436 ' HA ' ' HB2' ' A' ' 18' ' ' GLU . . . -126.42 14.26 7.67 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 124.951 3.523 . . . . 0.0 113.067 -166.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -75.72 -32.83 60.2 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 126.791 3.186 . . . . 0.0 111.277 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.42 -9.81 53.69 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 118.613 2.819 . . . . 0.0 118.613 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.436 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 73.2 mm-40 -126.1 11.91 7.67 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 127.945 2.498 . . . . 0.0 110.487 -155.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.8 pp -115.89 176.01 2.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 130.354 3.462 . . . . 0.0 108.021 161.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.419 HG22 ' H ' ' A' ' 21' ' ' THR . 2.1 p -67.12 165.27 2.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 121.009 1.731 . . . . 0.0 115.351 -166.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.419 ' H ' HG22 ' A' ' 20' ' ' VAL . 43.8 p -69.97 -62.06 1.53 Allowed 'General case' 0 C--N 1.325 -0.489 1 O-C-N 129.735 4.397 . . . . 0.0 109.774 179.363 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.0 t70 174.46 73.42 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 100.335 -3.95 . . . . 0.0 100.335 -159.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.283 58.4 t80 -59.56 137.83 57.9 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 118.375 2.731 . . . . 0.0 118.375 -166.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -46.25 143.8 2.28 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 131.194 3.798 . . . . 0.0 118.182 -154.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -98.99 -32.87 11.07 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 117.768 2.507 . . . . 0.0 117.768 -176.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.2 pt -63.07 -33.4 60.58 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 C-N-CA 126.698 1.999 . . . . 0.0 107.59 -172.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.36 1.8 pt -60.11 -38.81 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 114.035 -1.439 . . . . 0.0 112.252 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.454 45.9 tttm -45.83 -74.6 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 118.841 2.904 . . . . 0.0 118.841 -162.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.5 m -53.47 -32.71 51.3 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 129.706 3.202 . . . . 0.0 113.706 -174.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.28 -55.86 9.27 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 114.544 -2.646 . . . . 0.0 110.775 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . 0.276 11.9 ptm180 -57.35 -40.96 79.15 Favored 'General case' 0 N--CA 1.447 -0.604 1 CA-C-N 126.302 4.137 . . . . 0.0 110.673 171.606 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -51.1 -35.78 36.9 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 114.87 -2.49 . . . . 0.0 115.448 176.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -51.54 -42.57 61.88 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 121.687 2.04 . . . . 0.0 109.736 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 50.3 mt -80.94 -25.68 37.23 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 131.538 3.935 . . . . 0.0 109.514 -176.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 55.97 5.39 0.96 Allowed Glycine 0 C--O 1.22 -0.75 0 CA-C-N 112.665 -2.061 . . . . 0.0 116.199 -170.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.5 pt -60.35 148.06 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 126.685 1.994 . . . . 0.0 108.392 -163.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 88.6 p -133.18 -177.29 4.45 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 122.728 2.513 . . . . 0.0 110.581 170.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . 0.254 65.0 mt-30 -21.61 -61.34 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 113.419 -3.181 . . . . 0.0 116.197 -163.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -58.99 -51.95 67.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 124.484 3.311 . . . . 0.0 109.365 -173.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -67.2 -29.38 69.03 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 117.435 -1.269 . . . . 0.0 110.864 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.8 tp -80.91 -23.89 38.62 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.935 1.694 . . . . 0.0 112.197 -167.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.74 -45.62 67.08 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 131.598 3.959 . . . . 0.0 111.163 153.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -77.94 -21.47 51.03 Favored 'General case' 0 CA--C 1.51 -0.561 0 O-C-N 126.773 2.546 . . . . 0.0 110.688 178.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -83.11 -12.06 57.4 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 118.304 -2.748 . . . . 0.0 105.168 -169.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' A' ' 45' ' ' LEU . 21.8 tp -125.35 -9.58 6.95 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -173.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.7 mtmt 57.31 52.89 8.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 131.196 3.798 . . . . 0.0 112.335 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.1 m -124.79 177.22 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 1 C-N-CA 134.019 4.928 . . . . 0.0 113.138 -177.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 62.1 p -82.06 159.61 23.4 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 116.81 2.152 . . . . 0.0 116.81 168.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -64.07 -14.54 55.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 169.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -80.97 -23.2 38.93 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 119.803 -1.811 . . . . 0.0 113.238 170.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.0 mt -69.45 -43.63 80.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 118.293 -0.86 . . . . 0.0 112.911 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.8 m -68.57 -25.96 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 118.44 2.755 . . . . 0.0 118.44 -178.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -42.32 -48.3 5.0 Favored 'General case' 0 N--CA 1.432 -1.374 0 C-N-CA 130.204 3.402 . . . . 0.0 116.706 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.6 mtt85 -61.72 -39.62 92.18 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 123.682 2.946 . . . . 0.0 111.13 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -82.36 -33.99 28.6 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -168.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -64.93 -49.11 71.67 Favored 'General case' 0 N--CA 1.441 -0.876 0 O-C-N 118.649 -2.532 . . . . 0.0 109.145 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.6 p -80.16 -28.66 38.76 Favored 'General case' 0 C--O 1.243 0.739 0 O-C-N 118.745 -2.472 . . . . 0.0 112.908 -167.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.2 5.48 62.17 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -171.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -93.06 54.57 2.18 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 128.737 2.815 . . . . 0.0 112.433 -174.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . 0.252 62.7 tp -144.79 130.9 19.42 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 130.837 3.655 . . . . 0.0 107.241 -167.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.5 tttt -91.4 128.67 45.99 Favored Pre-proline 0 N--CA 1.45 -0.473 0 N-CA-C 119.156 3.021 . . . . 0.0 119.156 158.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -92.46 -172.03 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 1 C-N-CA 127.167 5.245 . . . . 0.0 107.722 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.264 17.4 p -156.33 174.37 15.5 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 128.058 2.543 . . . . 0.0 111.278 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.7 pt -63.18 -44.18 99.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 126.736 2.015 . . . . 0.0 113.752 166.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.5 p -66.68 -38.38 86.68 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 121.085 1.766 . . . . 0.0 112.284 164.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 67.8 mm-40 -69.9 -27.78 65.07 Favored 'General case' 0 N--CA 1.45 -0.429 2 O-C-N 111.299 -7.125 . . . . 0.0 115.377 -171.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . 0.257 . . -55.93 -74.08 0.05 Allowed 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 123.321 2.782 . . . . 0.0 114.382 -164.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.0 mmp_? -51.02 -21.88 2.03 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 126.329 1.852 . . . . 0.0 109.867 -178.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.569 ' C ' ' H ' ' A' ' 72' ' ' LYS . 61.0 mt-30 -77.22 -36.09 55.04 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 124.615 1.197 . . . . 0.0 112.817 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 40.0 mt -79.18 -41.13 29.13 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 128.25 2.62 . . . . 0.0 104.483 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -53.84 -26.73 25.83 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 118.025 -2.922 . . . . 0.0 111.254 154.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.569 ' H ' ' C ' ' A' ' 69' ' ' GLN . 51.2 tttt -79.36 -24.88 42.39 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 125.388 3.722 . . . . 0.0 115.222 -173.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . 0.406 24.0 pt -54.52 -69.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-N 125.603 3.82 . . . . 0.0 112.291 -165.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 82.6 mt -70.48 -20.92 62.82 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 130.276 3.431 . . . . 0.0 111.781 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.71 12.68 57.36 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 130.214 3.769 . . . . 0.0 118.775 174.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.5 pt -84.1 167.65 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.08 1 C-N-CA 132.385 4.274 . . . . 0.0 112.479 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.278 5.3 ptpt -175.94 144.84 0.63 Allowed 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 128.467 2.707 . . . . 0.0 114.413 175.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 31.4 mt -153.28 163.35 40.05 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 125.842 1.963 . . . . 0.0 109.153 163.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.7 m -113.92 148.5 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 1 C-N-CA 141.971 8.109 . . . . 0.0 114.935 14.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.409 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 6.7 p -92.82 -178.59 0.89 Allowed Pre-proline 0 N--CA 1.447 -0.582 0 C-N-CA 125.816 1.646 . . . . 0.0 112.987 -175.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.409 ' HD2' ' HB ' ' A' ' 80' ' ' THR . 76.6 Cg_exo -59.56 -3.4 1.92 Allowed 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 123.302 2.668 . . . . 0.0 114.849 178.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 60.3 mt -81.19 -0.36 40.11 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 120.436 1.471 . . . . 0.0 109.897 170.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.33 -43.2 0.25 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 128.917 2.887 . . . . 0.0 111.271 175.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -157.88 153.07 25.71 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 121.253 1.842 . . . . 0.0 111.471 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -135.64 131.07 35.31 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 118.394 -2.691 . . . . 0.0 115.073 -167.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -145.96 129.54 16.99 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 -170.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -135.1 142.79 46.31 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.996 2.118 . . . . 0.0 113.423 -168.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 86.8 p -86.57 -5.31 59.18 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 118.346 -2.721 . . . . 0.0 107.495 -170.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -55.55 -16.53 4.03 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 163.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -106.32 28.34 7.84 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 172.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -140.64 -28.55 0.7 Allowed 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.714 2.006 . . . . 0.0 111.085 -173.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -81.43 159.19 24.34 Favored 'General case' 0 N--CA 1.442 -0.851 0 O-C-N 118.095 -2.878 . . . . 0.0 105.7 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -98.97 -32.2 11.42 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 112.567 -2.106 . . . . 0.0 111.229 174.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -120.54 5.99 10.59 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 118.935 2.939 . . . . 0.0 118.935 -176.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.7 m -145.14 149.69 35.44 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 126.164 1.786 . . . . 0.0 111.991 -165.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.01 17.15 58.31 Favored Glycine 0 N--CA 1.438 -1.211 0 C-N-CA 126.316 1.912 . . . . 0.0 114.486 -168.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.2 mt -81.63 -12.67 58.62 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 -170.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.7 t -138.48 140.29 39.16 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 128.216 2.606 . . . . 0.0 112.741 175.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 26.8 tp -38.46 -36.48 0.24 Allowed 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 127.368 2.267 . . . . 0.0 114.638 159.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.62 2.08 87.55 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 126.893 2.187 . . . . 0.0 113.774 -166.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -66.77 100.3 0.69 Allowed 'General case' 0 N--CA 1.438 -1.036 1 O-C-N 115.421 -4.576 . . . . 0.0 112.84 174.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.502 ' HB ' ' HA ' ' A' ' 103' ' ' VAL . 0.9 OUTLIER -129.6 150.58 34.76 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 C-N-CA 126.494 1.918 . . . . 0.0 111.508 -162.528 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.502 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 69.0 t -76.86 133.92 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 1 O-C-N 113.898 -5.501 . . . . 0.0 108.279 10.449 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -83.54 108.93 16.99 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 116.806 -1.569 . . . . 0.0 108.978 -176.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.696 ' H ' HD13 ' A' ' 105' ' ' ILE . 0.2 OUTLIER -94.45 -3.98 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 124.621 1.201 . . . . 0.0 111.223 -174.824 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.6 ttpp -67.26 -42.91 83.1 Favored 'General case' 0 C--O 1.249 1.041 0 O-C-N 120.262 -1.524 . . . . 0.0 109.447 170.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -70.06 -12.3 61.51 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 127.854 2.461 . . . . 0.0 112.072 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 173.18 136.01 2.1 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-O 119.133 -0.815 . . . . 0.0 113.463 171.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -152.33 132.55 13.59 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 103.259 -2.867 . . . . 0.0 103.259 174.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 45.0 pttt 178.9 -17.46 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 119.351 -2.093 . . . . 0.0 106.75 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.6 mt -74.82 -171.75 1.39 Allowed 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 118.273 -2.767 . . . . 0.0 106.121 168.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -155.07 -65.7 0.13 Allowed 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 112.912 -1.949 . . . . 0.0 114.587 -146.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -115.8 11.23 15.55 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 126.966 2.107 . . . . 0.0 110.137 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 31.1 p-80 . . . . . 0 C--O 1.257 1.466 0 C-N-CA 125.891 1.676 . . . . 0.0 113.632 -168.547 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 . . . . . 0 N--CA 1.474 0.762 0 CA-C-O 124.464 2.078 . . . . 0.0 106.031 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -82.36 135.42 35.18 Favored 'General case' 0 CA--C 1.517 -0.301 0 O-C-N 119.643 -1.911 . . . . 0.0 113.277 -163.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -96.85 -13.82 22.26 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -166.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -104.15 35.13 2.78 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 126.552 3.072 . . . . 0.0 117.078 -170.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.5 mt -94.91 -20.62 19.25 Favored 'General case' 0 CA--C 1.51 -0.564 0 O-C-N 117.076 -3.515 . . . . 0.0 112.927 -173.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -129.37 8.48 5.49 Favored 'General case' 0 C--O 1.226 -0.156 0 CA-C-N 123.956 3.071 . . . . 0.0 115.389 -168.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.4 pt -116.82 159.0 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 117.819 -3.051 . . . . 0.0 112.695 -164.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 p -79.88 151.39 4.76 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 O-C-N 120.13 -1.606 . . . . 0.0 108.522 -173.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 74.8 p -58.37 -33.0 69.11 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 119.725 -1.86 . . . . 0.0 111.197 -177.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -178.81 126.78 0.1 Allowed 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 131.518 3.927 . . . . 0.0 106.132 170.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -55.77 162.3 1.81 Allowed 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 127.389 2.93 . . . . 0.0 113.805 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -91.28 157.5 17.11 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 112.118 -2.31 . . . . 0.0 114.276 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.5 mttt -110.93 -46.44 3.34 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 -141.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.0 pt -67.6 -30.8 49.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 113.176 -3.297 . . . . 0.0 109.47 -174.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.372 20.1 pt -54.93 -49.68 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 C-N-CA 128.157 2.583 . . . . 0.0 110.12 178.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.347 74.8 mttt -29.66 -81.19 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.448 2 C-N-CA 132.418 4.287 . . . . 0.0 121.963 -174.332 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.0 p -75.82 -21.86 56.89 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 118.56 2.8 . . . . 0.0 118.56 -159.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.57 -21.83 63.02 Favored 'General case' 0 N--CA 1.439 -1.009 1 C-N-CA 133.973 4.909 . . . . 0.0 115.625 173.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . 0.282 6.6 ptm180 -44.15 -50.05 8.8 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 115.883 -2.008 . . . . 0.0 114.914 175.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -48.92 -33.24 10.42 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 126.634 1.974 . . . . 0.0 115.742 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -58.89 -25.48 63.4 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 118.605 -2.559 . . . . 0.0 112.708 -176.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.416 ' HB3' HG12 ' A' ' 36' ' ' ILE . 10.1 mp -96.32 -30.27 13.52 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.92 3.78 2.79 Favored Glycine 0 C--N 1.342 0.888 0 C-N-CA 127.943 2.687 . . . . 0.0 112.844 173.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.416 HG12 ' HB3' ' A' ' 34' ' ' LEU . 13.5 pt -66.5 154.03 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 120.344 2.072 . . . . 0.0 114.852 -173.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.0 p -71.79 161.85 30.34 Favored 'General case' 0 N--CA 1.443 -0.789 0 O-C-N 116.767 -3.708 . . . . 0.0 113.487 172.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -54.77 -46.44 74.4 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 114.604 -2.617 . . . . 0.0 108.489 173.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -61.74 -34.76 76.39 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 120.961 1.71 . . . . 0.0 111.068 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -80.43 -19.62 45.74 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 116.93 -1.908 . . . . 0.0 110.896 -175.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 66.8 tp -75.43 -46.51 32.23 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 125.856 2.741 . . . . 0.0 110.848 174.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.13 -39.31 66.36 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 118.551 -2.593 . . . . 0.0 110.953 173.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -63.86 -34.41 77.87 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 126.258 1.823 . . . . 0.0 115.918 160.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -73.97 -16.11 61.09 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 122.123 2.238 . . . . 0.0 107.693 -170.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.8 mt -123.09 -4.29 8.49 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 127.837 2.455 . . . . 0.0 112.51 -173.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.272 1.6 mptp? 43.23 56.74 4.08 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 118.652 2.834 . . . . 0.0 118.652 -167.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 31.9 m -127.7 175.77 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 1 C-N-CA 132.196 4.198 . . . . 0.0 108.583 -175.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 62.1 p -78.76 159.07 28.09 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 167.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -74.38 -13.29 60.71 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 128.229 3.455 . . . . 0.0 111.117 169.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -53.33 -50.56 64.72 Favored 'General case' 0 N--CA 1.447 -0.577 1 O-C-N 115.887 -4.258 . . . . 0.0 111.055 161.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.3 mm -59.14 -45.25 92.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 1 O-C-N 115.62 -4.425 . . . . 0.0 111.507 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.4 m -66.22 -49.29 77.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 115.173 -2.346 . . . . 0.0 106.258 -174.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.4 mtmm -50.53 -40.09 50.69 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 127.194 2.198 . . . . 0.0 113.754 173.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -60.95 -29.6 69.74 Favored 'General case' 0 C--N 1.345 0.393 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 172.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -72.46 -50.87 23.06 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 171.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -53.86 -51.92 62.08 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.984 1.714 . . . . 0.0 114.342 -173.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.5 p -74.87 -9.18 58.3 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 120.162 3.393 . . . . 0.0 120.162 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.67 16.76 80.08 Favored Glycine 0 C--O 1.243 0.713 1 CA-C-O 110.19 -5.783 . . . . 0.0 111.573 -169.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -89.83 51.84 2.17 Favored 'General case' 0 C--O 1.24 0.581 1 CA-C-N 126.839 5.32 . . . . 0.0 111.274 -172.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.9 tp -131.97 147.52 52.46 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -164.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.277 61.0 tttt -112.43 71.91 1.21 Allowed Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 113.717 -3.04 . . . . 0.0 111.743 168.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -83.6 -164.45 0.26 Allowed 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 124.552 3.501 . . . . 0.0 103.234 -166.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 p -153.57 174.39 14.51 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 130.841 3.657 . . . . 0.0 108.962 -169.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 28.9 pt -75.45 -48.15 31.9 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 CA-C-O 113.721 -3.038 . . . . 0.0 111.392 -174.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.8 p -58.91 -31.7 68.87 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 124.549 3.34 . . . . 0.0 112.826 166.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -68.47 -43.4 77.05 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 115.62 -2.134 . . . . 0.0 111.912 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -52.78 -44.28 66.45 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 114.44 -2.695 . . . . 0.0 111.28 165.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.2 mmp_? -56.4 -32.33 64.72 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 125.246 3.657 . . . . 0.0 110.585 170.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -82.31 -26.91 32.63 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 127.272 2.857 . . . . 0.0 111.276 -177.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.8 mt -60.54 -54.01 50.6 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 131.647 3.979 . . . . 0.0 107.463 167.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -50.6 -54.59 21.53 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 127.362 2.265 . . . . 0.0 109.013 174.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -67.54 -42.75 82.2 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 117.56 2.43 . . . . 0.0 117.56 -170.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.418 HG13 ' H ' ' A' ' 74' ' ' LEU 0.258 9.5 pt -48.74 -63.96 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 O-C-N 116.962 -3.586 . . . . 0.0 113.852 -175.305 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.418 ' H ' HG13 ' A' ' 73' ' ' ILE . 21.2 mt -75.88 -14.65 60.27 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 122.851 1.31 . . . . 0.0 113.228 -176.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.39 -13.65 10.55 Favored Glycine 0 CA--C 1.532 1.117 0 O-C-N 119.061 -2.274 . . . . 0.0 114.677 176.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.8 pt -92.67 162.37 2.41 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.736 0 C-N-CA 130.253 3.421 . . . . 0.0 115.238 -174.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.0 pttt -173.04 150.41 1.98 Allowed 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 129.846 3.258 . . . . 0.0 108.29 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.429 ' HB3' ' HA ' ' A' ' 79' ' ' VAL . 26.4 mt -148.03 151.94 36.58 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 165.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.429 ' HA ' ' HB3' ' A' ' 78' ' ' LEU . 7.7 m -111.51 177.83 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.894 1 O-C-N 115.162 -4.711 . . . . 0.0 116.616 26.673 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.412 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 82.6 p -96.56 164.49 18.09 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 126.858 2.063 . . . . 0.0 110.366 174.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.412 ' HD2' ' HB ' ' A' ' 80' ' ' THR . 53.1 Cg_exo -48.44 3.2 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.769 0 CA-C-O 115.927 -1.781 . . . . 0.0 115.632 164.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . 0.33 22.8 mt -70.04 -7.3 39.95 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 125.768 3.894 . . . . 0.0 114.969 158.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -150.45 -30.53 0.2 Allowed 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 128.831 2.852 . . . . 0.0 113.847 169.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -173.74 159.97 3.59 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 118.65 2.833 . . . . 0.0 118.65 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -145.23 120.68 10.33 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 126.592 1.957 . . . . 0.0 111.886 176.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -44.18 135.0 4.61 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 119.239 3.051 . . . . 0.0 119.239 163.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -86.38 146.31 26.51 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 128.432 2.693 . . . . 0.0 115.37 -175.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.9 p -77.29 -36.89 53.82 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 112.147 -2.297 . . . . 0.0 110.62 -171.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -76.24 -4.65 43.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 120.804 1.638 . . . . 0.0 111.989 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.6 mmtm -98.86 -20.36 16.89 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 127.092 2.157 . . . . 0.0 114.552 163.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -51.99 -51.84 54.54 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 127.52 2.328 . . . . 0.0 110.74 172.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -176.35 172.8 2.21 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.633 1.973 . . . . 0.0 112.434 -171.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -86.64 -17.74 33.06 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 115.089 -2.386 . . . . 0.0 111.438 -165.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -106.03 11.57 31.4 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 130.08 3.352 . . . . 0.0 109.161 -178.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 26.0 m -122.6 159.3 28.1 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 125.655 1.847 . . . . 0.0 109.054 -167.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.54 -11.86 8.93 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 120.808 3.083 . . . . 0.0 120.808 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 44.4 mt -95.15 -23.54 17.25 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 118.52 2.785 . . . . 0.0 118.52 -158.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.1 t -151.81 142.28 22.58 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 126.843 2.057 . . . . 0.0 108.177 161.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.4 tp -94.4 -20.66 19.53 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 128.188 2.595 . . . . 0.0 117.814 163.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.04 16.19 63.5 Favored Glycine 0 C--O 1.227 -0.292 0 O-C-N 124.001 0.813 . . . . 0.0 113.603 176.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -93.89 77.15 4.19 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 127.483 2.313 . . . . 0.0 107.141 -168.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.483 ' HB ' ' HA ' ' A' ' 103' ' ' VAL . 11.1 m -138.65 178.84 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-O 113.875 -2.964 . . . . 0.0 115.89 -177.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.483 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 7.4 p -58.73 148.1 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 1 CA-C-N 128.287 5.039 . . . . 0.0 110.426 11.086 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.413 ' N ' HG22 ' A' ' 103' ' ' VAL . 21.8 t30 -72.04 102.27 2.94 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 117.317 -1.325 . . . . 0.0 110.546 -165.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 10.7 pt -77.85 -6.92 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-O 116.671 -1.633 . . . . 0.0 111.632 -175.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -80.32 -12.9 59.55 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 118.474 -1.29 . . . . 0.0 113.129 172.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -104.6 -14.59 15.58 Favored 'General case' 0 C--O 1.223 -0.304 1 C-N-CA 132.377 4.271 . . . . 0.0 109.424 171.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.2 166.11 13.08 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-O 118.241 -1.31 . . . . 0.0 115.37 155.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -118.87 143.67 46.84 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 118.805 1.302 . . . . 0.0 110.454 165.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 46.3 pttt -163.2 -21.02 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -153.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.256 1.0 OUTLIER -91.64 -178.54 5.1 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 129.204 3.002 . . . . 0.0 112.199 151.496 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.326 23.2 tt0 -159.91 -91.67 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 118.454 -2.654 . . . . 0.0 111.809 -162.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 32.1 p-80 -96.35 5.15 51.54 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 115.614 -2.136 . . . . 0.0 111.298 -165.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.19 0 C-N-CA 129.228 3.011 . . . . 0.0 110.413 166.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 . . . . . 0 N--CA 1.47 0.534 0 CA-C-O 123.566 1.65 . . . . 0.0 110.414 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -91.68 110.51 21.85 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 113.722 -1.581 . . . . 0.0 107.878 -178.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.33 -18.19 57.66 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 117.763 -3.086 . . . . 0.0 115.013 -165.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -51.54 -20.47 1.94 Allowed 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 131.038 3.735 . . . . 0.0 110.215 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . 0.36 12.2 mt -90.25 -7.58 53.12 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 130.439 3.495 . . . . 0.0 113.741 -173.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -136.39 -7.14 1.99 Allowed 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 122.666 1.222 . . . . 0.0 111.428 -163.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 8.0 pt -107.38 155.37 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 O-C-N 120.143 -1.598 . . . . 0.0 114.193 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.1 p -80.52 154.98 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 O-C-N 119.717 -1.864 . . . . 0.0 113.082 152.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.63 -83.29 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 130.604 3.562 . . . . 0.0 105.134 -173.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -85.89 80.07 9.03 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.493 1.042 . . . . 0.0 110.224 -161.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.312 22.1 t80 -88.13 156.27 19.35 Favored 'General case' 0 N--CA 1.443 -0.775 0 O-C-N 117.476 -3.265 . . . . 0.0 116.229 -169.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -75.59 129.08 36.61 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 125.843 1.965 . . . . 0.0 111.827 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -105.09 -21.21 13.31 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 127.831 2.452 . . . . 0.0 114.499 -175.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.8 pt -69.72 -38.1 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 1 O-C-N 115.923 -4.235 . . . . 0.0 113.794 -174.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.404 ' H ' HG12 ' A' ' 27' ' ' ILE 0.301 22.5 pt -67.84 -20.32 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 127.154 2.182 . . . . 0.0 115.184 179.783 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -67.09 -62.45 1.42 Allowed 'General case' 0 C--N 1.327 -0.38 1 N-CA-C 121.893 4.034 . . . . 0.0 121.893 -158.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . 0.471 76.0 p -67.1 -25.02 66.01 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 124.272 3.214 . . . . 0.0 117.154 -176.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.42 -29.3 61.41 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 117.714 2.487 . . . . 0.0 117.714 -171.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.7 ptt85 -50.59 -38.81 47.66 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 117.792 -3.068 . . . . 0.0 114.475 175.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -59.25 -29.02 67.24 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.076 1.75 . . . . 0.0 112.401 -176.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -55.98 -40.97 74.08 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 122.268 2.304 . . . . 0.0 112.663 -178.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 60.7 mt -75.45 -8.61 57.16 Favored 'General case' 0 CA--C 1.514 -0.409 0 O-C-N 127.448 2.968 . . . . 0.0 116.567 -158.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.41 -13.12 11.81 Favored Glycine 0 C--N 1.346 1.119 0 O-C-N 119.792 -1.817 . . . . 0.0 114.486 173.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.3 pt -88.24 163.42 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -164.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 96.1 p -84.18 177.62 8.14 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 118.869 -2.395 . . . . 0.0 112.406 -175.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . 0.322 27.5 tt0 -54.92 -50.14 69.56 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 120.299 1.409 . . . . 0.0 112.71 172.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -61.95 -29.57 70.32 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.333 1.853 . . . . 0.0 115.854 -176.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -78.62 -40.18 35.1 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 175.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . 0.299 5.7 tp -46.9 -44.51 19.77 Favored 'General case' 0 C--O 1.239 0.55 1 O-C-N 129.747 4.404 . . . . 0.0 110.329 165.593 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.65 -55.46 34.51 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 128.099 2.56 . . . . 0.0 112.377 173.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -63.56 -34.88 78.77 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 120.175 1.352 . . . . 0.0 112.645 174.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -63.72 -36.68 84.67 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 126.191 2.901 . . . . 0.0 108.911 -172.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.1 mp -99.29 -5.1 30.36 Favored 'General case' 0 N--CA 1.438 -1.052 1 C-N-CA 135.199 5.4 . . . . 0.0 113.44 -170.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt 55.0 57.51 5.55 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.663 1.185 . . . . 0.0 113.389 -177.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.9 m -151.6 -176.25 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 130.076 3.351 . . . . 0.0 111.445 -171.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 65.7 p -93.85 163.02 13.68 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 118.482 -2.636 . . . . 0.0 115.218 167.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -70.4 -18.13 63.03 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 119.124 0.874 . . . . 0.0 111.517 171.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -68.02 -34.67 76.94 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 114.815 -2.754 . . . . 0.0 118.32 160.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 27.8 mt -73.77 -39.57 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 O-C-N 116.766 -3.709 . . . . 0.0 109.998 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.331 11.9 m -59.01 -49.86 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 O-C-N 119.441 -2.037 . . . . 0.0 111.02 178.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -48.11 -43.51 31.07 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 129.868 3.267 . . . . 0.0 108.596 167.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -67.54 -32.43 73.2 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-N 123.184 2.72 . . . . 0.0 114.018 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -75.1 -39.49 60.61 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 129.797 3.239 . . . . 0.0 106.871 170.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 -60.1 -32.72 71.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 122.352 2.342 . . . . 0.0 108.595 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.6 p -112.15 -6.75 14.11 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -144.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.52 18.12 74.24 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-O 125.157 2.531 . . . . 0.0 114.402 -176.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -97.85 33.84 2.02 Favored 'General case' 0 N--CA 1.438 -1.025 1 O-C-N 115.423 -4.575 . . . . 0.0 113.704 -176.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.4 tp -130.65 129.73 43.02 Favored 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 130.492 3.517 . . . . 0.0 110.198 -178.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -101.65 102.7 23.73 Favored Pre-proline 0 N--CA 1.442 -0.853 0 CA-C-O 115.91 -1.995 . . . . 0.0 106.455 168.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -80.31 174.73 11.01 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 CA-C-N 120.372 1.169 . . . . 0.0 112.33 -171.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.453 ' H ' ' HB2' ' A' ' 66' ' ' GLN . 62.1 p -139.99 174.22 10.73 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 118.8 -2.437 . . . . 0.0 110.436 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.89 -32.52 56.25 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -171.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.3 p -56.83 -53.56 56.48 Favored 'General case' 0 CA--C 1.512 -0.498 2 O-C-N 112.643 -6.286 . . . . 0.0 112.906 158.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.453 ' HB2' ' H ' ' A' ' 63' ' ' THR . 57.6 mt-30 -67.14 -36.44 81.88 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 118.431 2.752 . . . . 0.0 118.431 -170.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -31.85 -73.74 0.03 OUTLIER 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 131.434 3.893 . . . . 0.0 116.451 163.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -56.04 -36.36 67.92 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.437 -1.71 . . . . 0.0 111.856 172.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -75.47 -25.87 57.74 Favored 'General case' 0 C--O 1.246 0.88 1 CA-C-O 111.509 -4.091 . . . . 0.0 111.735 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.5 mt -69.51 -41.53 75.92 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 126.617 2.448 . . . . 0.0 107.705 -176.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -55.14 -38.06 67.74 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 117.7 2.482 . . . . 0.0 117.7 165.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -87.97 -35.0 17.88 Favored 'General case' 0 C--O 1.225 -0.225 0 O-C-N 116.845 -3.659 . . . . 0.0 114.931 -168.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.9 pt -63.71 -44.11 98.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 122.466 2.394 . . . . 0.0 107.213 -175.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.4 tp -68.94 -24.43 64.27 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 126.073 1.749 . . . . 0.0 112.699 169.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.07 -20.07 0.09 OUTLIER Glycine 0 C--N 1.337 0.636 0 N-CA-C 117.218 1.647 . . . . 0.0 117.218 -174.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.1 pt -134.25 174.27 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -168.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -147.75 166.4 27.62 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 113.784 -3.008 . . . . 0.0 108.785 -170.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.9 mt -144.37 154.25 42.81 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 127.931 2.492 . . . . 0.0 112.556 160.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.408 ' CG2' ' HB3' ' A' ' 84' ' ' ASN . 25.9 m -106.1 175.91 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 130.962 3.705 . . . . 0.0 114.064 22.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 81.6 p -111.21 174.59 2.27 Favored Pre-proline 0 N--CA 1.449 -0.51 0 C-N-CA 128.743 2.817 . . . . 0.0 113.708 162.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -61.62 0.83 0.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.361 0 O-C-N 125.012 2.059 . . . . 0.0 112.265 177.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.1 mt -56.53 -23.23 38.46 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 159.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -131.3 -49.09 1.0 Allowed 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 127.562 3.039 . . . . 0.0 112.133 169.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.408 ' HB3' ' CG2' ' A' ' 79' ' ' VAL . 28.4 t-20 -146.13 152.89 40.01 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 128.096 2.558 . . . . 0.0 116.502 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -110.75 108.12 17.88 Favored 'General case' 0 C--O 1.223 -0.3 0 O-C-N 119.987 -1.696 . . . . 0.0 108.947 173.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -112.91 129.24 56.54 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 117.531 -3.231 . . . . 0.0 105.704 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.324 99.4 mt-10 -119.12 163.97 16.24 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 114.391 -2.719 . . . . 0.0 110.216 -171.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 83.9 p -42.89 -35.05 1.08 Allowed 'General case' 0 N--CA 1.449 -0.52 1 CA-C-N 126.889 4.404 . . . . 0.0 110.064 -170.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -67.49 -18.98 65.26 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 117.2 -3.437 . . . . 0.0 111.252 -175.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -111.08 -22.56 11.39 Favored 'General case' 0 N--CA 1.452 -0.367 1 O-C-N 116.234 -4.041 . . . . 0.0 115.747 164.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -83.52 -15.76 48.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 116.778 -1.582 . . . . 0.0 111.551 -175.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -144.1 108.91 4.93 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 121.955 2.161 . . . . 0.0 107.372 -171.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.49 -21.25 3.55 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 131.589 3.956 . . . . 0.0 113.257 -171.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -98.19 6.02 47.89 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.607 1.563 . . . . 0.0 113.279 -169.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.55 178.33 5.24 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 116.839 -1.553 . . . . 0.0 113.57 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.29 23.33 71.29 Favored Glycine 0 C--O 1.218 -0.864 0 O-C-N 126.752 2.532 . . . . 0.0 113.249 168.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.34 -10.94 14.58 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.115 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.7 t 169.33 162.25 0.05 Allowed 'General case' 0 N--CA 1.449 -0.49 1 C-N-CA 131.86 4.064 . . . . 0.0 114.579 -170.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 15.4 tp -84.51 6.72 22.5 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 120.224 -1.547 . . . . 0.0 111.355 165.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 33.76 52.0 0.63 Allowed Glycine 0 C--N 1.336 0.563 0 C-N-CA 129.94 3.638 . . . . 0.0 109.704 -159.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -74.83 93.95 2.7 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 117.494 -3.356 . . . . 0.0 116.353 -175.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.431 ' HB ' ' HA ' ' A' ' 103' ' ' VAL . 0.9 OUTLIER -119.12 155.83 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 O-C-N 127.442 2.964 . . . . 0.0 112.414 -165.83 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.431 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 12.1 p -59.22 135.54 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 2 O-C-N 112.728 -6.233 . . . . 0.0 113.195 17.584 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.44 HD21 ' HG3' ' A' ' 107' ' ' GLU . 5.9 p30 -49.03 126.75 13.08 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.011 164.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.7 pt -63.22 -15.86 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 117.823 2.527 . . . . 0.0 117.823 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.2 tptt -70.75 -35.81 72.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 122.318 2.326 . . . . 0.0 110.589 171.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.44 ' HG3' HD21 ' A' ' 104' ' ' ASN . 6.4 mm-40 -85.27 -8.38 58.55 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 117.763 2.505 . . . . 0.0 117.763 168.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 173.64 117.29 0.45 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 119.209 2.444 . . . . 0.0 119.209 160.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -124.34 142.02 51.61 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 125.07 2.367 . . . . 0.0 108.122 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . 0.265 54.2 pttt -167.98 8.35 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.425 1 C-N-CA 132.281 4.232 . . . . 0.0 118.426 -172.006 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 mt -106.55 166.58 10.45 Favored 'General case' 0 N--CA 1.446 -0.671 1 C-N-CA 131.892 4.077 . . . . 0.0 113.085 153.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.358 15.0 tt0 -152.44 -100.29 0.05 Allowed 'General case' 0 CA--C 1.518 -0.286 1 O-C-N 115.809 -4.307 . . . . 0.0 113.27 -140.799 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 56.0 p-80 -78.02 -6.77 55.59 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.09 0.956 . . . . 0.0 112.692 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 . . . . . 0 C--O 1.247 0.934 0 C-N-CA 128.131 2.572 . . . . 0.0 114.56 -175.637 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 . . . . . 0 N--CA 1.472 0.626 0 CA-C-O 122.714 1.245 . . . . 0.0 108.278 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 173.44 117.27 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 111.641 -2.527 . . . . 0.0 114.893 -162.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.0 -33.8 18.27 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 116.171 -1.871 . . . . 0.0 112.983 -161.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -61.58 -23.59 66.1 Favored 'General case' 0 C--O 1.222 -0.395 0 N-CA-C 118.043 2.609 . . . . 0.0 118.043 171.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.5 tp -85.13 12.38 7.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 116.728 -1.606 . . . . 0.0 113.102 -171.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -152.39 12.45 0.55 Allowed 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -169.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.6 pt -115.24 172.65 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 O-C-N 119.353 -2.092 . . . . 0.0 112.33 165.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.9 m -82.64 164.45 2.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 O-C-N 117.288 -3.383 . . . . 0.0 115.328 172.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 p -61.83 -47.76 83.65 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 119.265 -2.147 . . . . 0.0 110.825 174.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . 0.325 11.7 m-20 -82.34 37.62 0.51 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 119.699 1.136 . . . . 0.0 112.743 -172.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -75.52 142.15 42.89 Favored 'General case' 0 C--O 1.236 0.374 1 C-N-CA 131.744 4.018 . . . . 0.0 117.459 -175.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -58.65 141.74 51.6 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 118.362 -2.711 . . . . 0.0 115.541 174.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -113.08 -14.95 12.89 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 116.95 2.204 . . . . 0.0 116.95 -164.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.42 ' CD1' ' HG2' ' A' ' 71' ' ' GLU . 0.9 OUTLIER -60.14 -48.64 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 O-C-N 124.488 1.118 . . . . 0.0 111.35 -166.741 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.519 6.4 pt -72.77 -23.54 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 128.046 2.538 . . . . 0.0 117.003 173.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 51.1 tttm -56.54 -67.61 0.29 Allowed 'General case' 0 C--O 1.243 0.717 0 N-CA-C 118.079 2.622 . . . . 0.0 118.079 -162.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 57.8 p -68.64 -35.82 77.79 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 121.595 1.998 . . . . 0.0 106.574 -172.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.48 -37.43 87.29 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.748 2.019 . . . . 0.0 114.468 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -54.02 -49.98 67.68 Favored 'General case' 0 N--CA 1.44 -0.938 2 O-C-N 112.401 -6.437 . . . . 0.0 112.273 166.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -63.2 -33.37 75.33 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 129.354 3.062 . . . . 0.0 111.265 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -76.47 -25.99 54.9 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 122.703 2.501 . . . . 0.0 108.59 -176.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.414 HD11 HD11 ' A' ' 76' ' ' ILE . 97.1 mt -76.7 -23.42 53.13 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 119.663 -1.898 . . . . 0.0 110.364 168.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.48 -14.89 6.28 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 122.327 2.33 . . . . 0.0 110.935 174.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.0 pt -71.14 155.92 7.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 O-C-N 118.392 -2.828 . . . . 0.0 113.9 -154.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . 0.309 78.8 p -74.18 175.84 7.16 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 127.84 3.213 . . . . 0.0 111.669 -177.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.77 -46.13 89.44 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 123.284 1.516 . . . . 0.0 110.292 161.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -59.07 -28.95 66.96 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 115.585 -2.15 . . . . 0.0 113.135 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -79.88 -29.17 39.92 Favored 'General case' 0 N--CA 1.446 -0.669 1 CA-C-O 111.461 -4.114 . . . . 0.0 111.47 174.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.5 tp -68.74 -34.97 76.49 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 125.205 3.638 . . . . 0.0 110.97 171.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.3 -41.53 80.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 121.382 1.901 . . . . 0.0 113.359 171.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -61.74 -42.42 98.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 127.192 2.808 . . . . 0.0 109.667 171.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -51.33 -32.35 25.03 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 127.089 3.328 . . . . 0.0 109.445 -172.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.5 mt -120.2 2.27 10.87 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 117.412 -3.305 . . . . 0.0 110.831 -153.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 77.2 mttt 47.17 -17.8 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.906 1 N-CA-C 123.725 4.713 . . . . 0.0 123.725 -159.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.3 m -94.91 156.42 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 130.15 3.38 . . . . 0.0 115.066 -172.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 84.5 p -72.39 168.09 19.15 Favored 'General case' 0 N--CA 1.441 -0.898 0 O-C-N 118.374 -2.704 . . . . 0.0 116.737 -177.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.443 ' HA ' HG22 ' A' ' 52' ' ' VAL . 21.5 pt-20 -65.91 -20.48 66.23 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 118.877 2.917 . . . . 0.0 118.877 -175.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -47.84 -34.19 8.41 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 118.234 2.679 . . . . 0.0 118.234 163.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.0 mm -80.78 -38.94 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 119.006 -1.078 . . . . 0.0 113.25 166.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.443 HG22 ' HA ' ' A' ' 49' ' ' GLU 0.261 11.0 m -66.05 -42.77 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-O 115.496 -2.193 . . . . 0.0 115.86 -170.001 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -58.18 -17.96 22.48 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 127.486 2.314 . . . . 0.0 113.621 177.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -72.55 -50.75 23.48 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 130.688 3.595 . . . . 0.0 110.52 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.374 58.4 m-85 -73.13 -26.06 61.08 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 120.335 1.425 . . . . 0.0 109.173 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -69.0 -45.15 71.29 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 117.923 -2.986 . . . . 0.0 106.831 177.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.4 p -93.67 -34.93 13.07 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 -167.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.36 21.16 62.92 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-O 114.076 -3.624 . . . . 0.0 117.824 173.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -95.1 8.12 43.97 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 128.817 2.847 . . . . 0.0 114.189 -162.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.6 tp -134.38 144.0 47.96 Favored 'General case' 0 N--CA 1.447 -0.623 1 O-C-N 129.852 4.47 . . . . 0.0 114.043 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -102.09 91.8 2.71 Favored Pre-proline 0 N--CA 1.441 -0.878 0 O-C-N 118.678 -2.514 . . . . 0.0 108.749 166.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . 0.272 2.6 Cg_endo -74.9 176.65 9.59 Favored 'Trans proline' 0 N--CA 1.454 -0.81 1 C-N-CA 127.859 5.706 . . . . 0.0 107.789 -168.917 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.8 p -76.85 179.74 5.95 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 178.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.649 ' H ' HD12 ' A' ' 64' ' ' ILE . 2.3 mp -55.04 -62.24 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 C-N-CA 128.4 2.68 . . . . 0.0 107.669 -169.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.6 p -55.05 -30.62 59.99 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 115.237 -2.316 . . . . 0.0 113.896 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -84.15 -54.48 4.79 Favored 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 127.164 2.79 . . . . 0.0 106.661 -168.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -48.49 -33.32 9.24 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 128.683 2.793 . . . . 0.0 114.761 160.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.8 mtt-85 -75.64 -34.46 60.54 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 114.329 -2.748 . . . . 0.0 113.172 166.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -70.56 -32.67 70.18 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 122.932 2.605 . . . . 0.0 115.106 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.44 ' C ' ' H ' ' A' ' 72' ' ' LYS . 5.6 tt -41.64 -72.55 0.06 Allowed 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 130.118 3.367 . . . . 0.0 114.925 177.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.42 ' HG2' ' CD1' ' A' ' 26' ' ' ILE . 39.7 mt-10 -48.78 -19.43 0.37 Allowed 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 126.071 2.843 . . . . 0.0 110.26 173.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.44 ' H ' ' C ' ' A' ' 70' ' ' LEU . 28.1 mtpt -99.91 -8.33 24.14 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 117.524 -3.235 . . . . 0.0 115.996 -163.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.5 pt -61.43 -46.78 95.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 1 N-CA-C 122.004 4.075 . . . . 0.0 122.004 -171.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 49.3 mt -74.48 -18.23 60.65 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 126.002 1.721 . . . . 0.0 110.326 -172.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.47 -0.57 17.66 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 118.752 -1.69 . . . . 0.0 116.396 -158.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.414 HD11 HD11 ' A' ' 34' ' ' LEU . 30.8 pt -142.11 175.71 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 125.906 1.682 . . . . 0.0 109.238 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.357 11.5 pttt -176.95 149.06 0.69 Allowed 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 128.668 2.787 . . . . 0.0 108.526 -174.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.1 mt -133.81 145.07 49.4 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 176.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.2 m -113.03 152.84 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 1 C-N-CA 133.804 4.842 . . . . 0.0 114.188 21.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.482 ' HB ' ' HD2' ' A' ' 81' ' ' PRO 0.292 80.3 p -93.83 175.84 2.8 Favored Pre-proline 0 C--O 1.24 0.576 0 C-N-CA 127.2 2.2 . . . . 0.0 109.362 -169.113 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.482 ' HD2' ' HB ' ' A' ' 80' ' ' THR . 45.5 Cg_exo -54.53 -1.49 0.15 Allowed 'Trans proline' 0 N--CA 1.452 -0.946 1 C-N-CA 125.612 4.208 . . . . 0.0 111.363 179.607 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 65.9 mt -57.26 -31.9 66.04 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 122.709 2.504 . . . . 0.0 111.561 160.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -124.47 -39.18 2.34 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 127.778 2.431 . . . . 0.0 111.834 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -160.84 123.46 3.21 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 111.945 -2.389 . . . . 0.0 115.442 -160.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -101.18 163.7 12.15 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 126.546 2.404 . . . . 0.0 108.226 178.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . 0.285 1.3 tt0 -154.26 148.79 26.27 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 131.431 3.893 . . . . 0.0 110.438 170.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.45 129.74 40.58 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 125.281 1.613 . . . . 0.0 114.23 175.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.9 m -73.07 -13.77 61.27 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 116.564 -1.684 . . . . 0.0 114.286 -174.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -63.8 -19.61 65.15 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 119.908 1.231 . . . . 0.0 112.592 -175.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -56.28 -21.41 23.73 Favored 'General case' 0 N--CA 1.44 -0.972 0 O-C-N 116.362 -3.961 . . . . 0.0 110.208 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -82.99 -2.32 54.91 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -171.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -135.9 148.55 48.63 Favored 'General case' 0 CA--C 1.514 -0.428 0 O-C-N 116.463 -3.898 . . . . 0.0 107.878 174.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -152.03 -68.1 0.17 Allowed 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 103.801 -2.666 . . . . 0.0 103.801 -158.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -87.29 -10.83 51.32 Favored 'General case' 0 N--CA 1.447 -0.621 1 O-C-N 114.858 -4.901 . . . . 0.0 113.503 -169.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 44.3 p -120.63 174.04 6.82 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 108.729 -3.85 . . . . 0.0 110.316 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -119.59 125.9 6.52 Favored Glycine 0 C--N 1.335 0.507 1 C-N-CA 130.787 4.042 . . . . 0.0 109.42 164.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 15.0 tp -105.28 -16.71 14.68 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 118.41 -2.817 . . . . 0.0 115.968 -171.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 43.3 p -152.28 4.54 0.39 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 118.338 2.718 . . . . 0.0 118.338 -157.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.527 ' HG ' ' H ' ' A' ' 101' ' ' ASP . 22.5 tp -162.35 116.21 1.79 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 129.84 3.256 . . . . 0.0 115.079 173.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -61.93 -20.52 60.1 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-O 114.875 -3.18 . . . . 0.0 115.581 171.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.527 ' H ' ' HG ' ' A' ' 99' ' ' LEU 0.368 1.4 t70 -74.72 47.23 0.32 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 128.607 2.763 . . . . 0.0 111.203 -168.662 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.447 ' HA ' ' C ' ' A' ' 103' ' ' VAL . 2.1 m -132.29 145.44 34.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 O-C-N 127.53 3.019 . . . . 0.0 111.889 -166.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.447 ' C ' ' HA ' ' A' ' 102' ' ' VAL . 33.9 m -73.97 146.16 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 O-C-N 117.837 -3.04 . . . . 0.0 104.615 25.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -62.19 98.69 0.11 Allowed 'General case' 0 C--O 1.239 0.54 0 CA-C-N 112.792 -2.004 . . . . 0.0 115.178 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 88.8 mt -75.74 100.5 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 126.109 1.764 . . . . 0.0 106.938 -178.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -69.99 -15.48 63.03 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 115.642 -2.123 . . . . 0.0 109.218 174.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -75.23 -6.87 52.0 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 127.977 2.511 . . . . 0.0 113.349 -176.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 144.54 155.13 6.34 Favored Glycine 0 C--O 1.22 -0.757 0 C-N-CA 127.086 2.279 . . . . 0.0 113.736 171.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -67.79 168.84 10.72 Favored 'General case' 0 N--CA 1.439 -1.002 0 O-C-N 124.864 0.979 . . . . 0.0 112.457 170.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -51.73 101.95 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.528 1.531 . . . . 0.0 113.833 171.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.0 pp 174.77 179.66 0.12 Allowed 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 128.855 2.862 . . . . 0.0 110.461 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.433 ' C ' ' H ' ' A' ' 114' ' ' HIS . 21.7 tt0 -156.41 -110.39 0.03 OUTLIER 'General case' 0 C--O 1.222 -0.39 0 O-C-N 120.852 -1.155 . . . . 0.0 113.353 176.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -66.24 28.17 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 116.562 -3.836 . . . . 0.0 113.901 175.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' HIS . . . . . 0.433 ' H ' ' C ' ' A' ' 112' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.047 0 C-N-CA 128.698 2.799 . . . . 0.0 113.017 -175.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 . . . . . 0 C--O 1.217 -0.638 0 CA-C-O 123.408 1.575 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -154.97 98.51 2.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 116.994 2.22 . . . . 0.0 116.994 172.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.97 -7.26 15.91 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 118.913 2.931 . . . . 0.0 118.913 176.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -117.64 16.36 14.52 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 120.502 1.501 . . . . 0.0 111.728 175.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . 0.308 43.1 tp -61.02 -50.09 74.76 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 131.275 3.83 . . . . 0.0 110.009 -175.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -112.18 12.05 20.36 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 125.094 2.378 . . . . 0.0 113.357 -153.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 6.5 pt -107.45 155.11 8.27 Favored 'Isoleucine or valine' 0 C--N 1.34 0.171 1 O-C-N 115.579 -4.45 . . . . 0.0 109.128 174.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.7 m -74.36 167.15 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 121.542 1.974 . . . . 0.0 112.392 158.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.0 m -64.64 -43.51 93.46 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -76.31 10.88 1.77 Allowed 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 115.304 -2.284 . . . . 0.0 112.406 -172.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -65.91 154.13 40.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 129.986 3.314 . . . . 0.0 109.951 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . 0.506 0.0 OUTLIER -75.74 67.66 2.21 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 119.738 3.236 . . . . 0.0 119.738 179.348 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -60.08 -22.75 63.13 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 119.797 -1.814 . . . . 0.0 113.972 -169.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.1 pt -61.96 -29.34 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-O 114.815 -2.517 . . . . 0.0 112.851 173.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.316 12.2 mm -63.92 -57.11 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 CA-C-N 122.542 2.428 . . . . 0.0 105.836 174.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -51.02 -65.03 0.63 Allowed 'General case' 0 CA--C 1.532 0.266 1 C-N-CA 134.535 5.134 . . . . 0.0 109.874 -155.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 77.4 p -57.17 -31.68 65.65 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 126.253 2.221 . . . . 0.0 113.772 -164.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.87 -58.51 3.24 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.488 1.515 . . . . 0.0 108.183 174.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 56.5 ttt180 -51.15 -36.79 42.68 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 118.631 -2.543 . . . . 0.0 114.103 -176.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -68.32 -42.22 79.69 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 123.918 3.054 . . . . 0.0 113.467 172.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -54.19 -37.84 64.96 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-O 123.898 1.809 . . . . 0.0 113.206 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.256 62.9 mt -90.44 -11.1 41.4 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 111.266 -2.697 . . . . 0.0 112.371 -161.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.36 4.77 5.38 Favored Glycine 0 C--O 1.238 0.382 0 CA-C-O 125.329 2.627 . . . . 0.0 118.327 178.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.2 pt -69.02 153.06 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 O-C-N 119.668 -2.078 . . . . 0.0 112.161 -172.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.6 p -129.9 165.97 20.96 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 117.387 2.366 . . . . 0.0 117.387 -162.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -60.39 -37.28 80.3 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 116.978 -1.487 . . . . 0.0 112.833 -176.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -52.47 -34.65 50.08 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 115.322 -2.275 . . . . 0.0 113.458 166.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -77.51 -37.76 50.39 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 122.3 2.318 . . . . 0.0 111.632 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.3 tp -73.98 -31.93 63.2 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 115.364 -2.255 . . . . 0.0 108.602 -175.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.43 -47.02 76.64 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 166.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -60.6 -42.55 96.99 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 122.802 1.287 . . . . 0.0 112.825 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -70.43 -16.99 63.0 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 118.109 -2.869 . . . . 0.0 106.491 -173.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.8 tp -110.7 5.01 20.56 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 -169.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.2 tttp 45.56 52.67 9.09 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 131.158 3.783 . . . . 0.0 110.128 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.8 m -142.45 -176.41 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 C-N-CA 130.036 3.335 . . . . 0.0 115.73 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 86.7 p -94.42 161.35 14.26 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 125.099 1.36 . . . . 0.0 112.544 167.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -73.17 -12.95 61.07 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 117.122 -3.486 . . . . 0.0 110.378 -174.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -62.29 -37.4 85.37 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 119.027 -2.296 . . . . 0.0 111.961 170.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.0 mm -68.51 -28.94 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 125.936 1.694 . . . . 0.0 110.842 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.378 3.2 m -66.29 -35.55 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 O-C-N 117.282 -3.386 . . . . 0.0 113.987 -175.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -50.18 -38.13 38.28 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 117.198 2.296 . . . . 0.0 117.198 -170.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.292 99.0 mtt180 -25.94 -87.03 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 127.927 2.491 . . . . 0.0 114.739 170.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -77.99 -25.03 47.84 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 120.425 -1.422 . . . . 0.0 111.72 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -63.24 -13.04 33.36 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 120.28 1.4 . . . . 0.0 113.967 -177.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.8 p -65.04 -20.19 66.37 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 117.81 2.522 . . . . 0.0 117.81 170.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.79 19.46 75.09 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 128.817 3.103 . . . . 0.0 114.408 174.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -92.65 12.3 23.72 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 128.385 3.05 . . . . 0.0 116.04 -174.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.5 mt -145.48 120.81 10.26 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 171.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.8 tttp -64.97 116.38 29.3 Favored Pre-proline 0 C--O 1.233 0.202 0 O-C-N 119.22 -2.175 . . . . 0.0 113.623 161.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -66.43 160.53 45.17 Favored 'Trans proline' 0 N--CA 1.448 -1.199 1 C-N-CA 128.479 6.119 . . . . 0.0 114.145 -176.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.519 ' H ' ' HB2' ' A' ' 66' ' ' GLN . 63.9 p -108.94 -165.93 1.07 Allowed 'General case' 0 C--O 1.239 0.514 0 C-N-CA 127.246 2.218 . . . . 0.0 114.472 172.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 34.2 mt -57.88 -59.43 3.42 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.158 0 O-C-N 118.772 -2.455 . . . . 0.0 114.126 -171.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.3 p -59.75 -40.7 89.01 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 169.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.519 ' HB2' ' H ' ' A' ' 63' ' ' THR . 55.7 mt-30 -63.06 -55.21 27.49 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 116.361 1.985 . . . . 0.0 116.361 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -39.71 -47.27 2.0 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 117.196 -1.383 . . . . 0.0 113.356 160.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.1 ttt85 -67.25 -39.57 86.14 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 127.234 2.213 . . . . 0.0 107.897 -172.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -67.84 -52.23 39.12 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 116.74 -1.6 . . . . 0.0 107.174 176.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 21.6 tp -59.88 -60.32 4.02 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 127.845 3.688 . . . . 0.0 111.049 -168.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -52.63 -39.09 61.38 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 117.899 -3.001 . . . . 0.0 109.053 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -76.77 -34.73 58.0 Favored 'General case' 0 N--CA 1.446 -0.653 1 O-C-N 115.239 -4.663 . . . . 0.0 119.446 176.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 31.5 pt -67.84 -30.6 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 118.021 -1.471 . . . . 0.0 108.299 170.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.48 ' C ' ' H ' ' A' ' 76' ' ' ILE 0.311 95.8 mt -70.97 -41.97 70.33 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 117.024 -3.547 . . . . 0.0 117.102 174.857 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.15 -8.5 0.16 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 127.307 2.384 . . . . 0.0 110.961 -167.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.48 ' H ' ' C ' ' A' ' 74' ' ' LEU . 44.8 pt -116.91 146.62 21.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 117.803 2.52 . . . . 0.0 117.803 -177.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -176.2 153.68 1.29 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 114.604 -2.617 . . . . 0.0 112.572 176.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 78' ' ' LEU . 13.5 mt -144.33 123.03 12.57 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 126.485 3.04 . . . . 0.0 112.209 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.9 m -96.14 174.25 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.661 1 O-C-N 113.746 -5.596 . . . . 0.0 115.942 20.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.1 p -93.84 167.06 14.47 Favored Pre-proline 0 N--CA 1.462 0.163 0 O-C-N 120.723 -1.236 . . . . 0.0 108.849 -170.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -68.75 -8.94 24.77 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 O-C-N 115.178 -3.117 . . . . 0.0 109.451 -171.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 15.1 mt -75.55 -7.21 53.61 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 116.326 -1.797 . . . . 0.0 114.863 168.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -131.67 -4.63 3.67 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 114.336 -2.745 . . . . 0.0 111.163 172.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.0 154.21 48.42 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 124.782 3.446 . . . . 0.0 109.242 166.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -79.48 119.15 22.09 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 112.293 -2.23 . . . . 0.0 111.342 169.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.64 167.86 21.08 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.01 1.324 . . . . 0.0 109.777 168.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.506 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 27.8 tt0 -75.47 121.35 22.2 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.331 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -81.88 -17.51 47.03 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 120.134 1.334 . . . . 0.0 111.204 -160.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -55.87 -18.52 9.02 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 129.371 3.069 . . . . 0.0 111.342 169.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.506 ' HE3' ' HB3' ' A' ' 87' ' ' GLU . 93.3 mttt -63.78 -22.18 66.79 Favored 'General case' 0 CA--C 1.516 -0.353 0 O-C-N 117.338 -3.351 . . . . 0.0 110.319 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -53.68 -37.07 62.86 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 124.177 3.171 . . . . 0.0 110.195 170.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -76.87 151.63 35.75 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 116.374 -3.954 . . . . 0.0 109.584 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -46.76 -65.35 0.57 Allowed 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.657 1.583 . . . . 0.0 114.732 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -118.3 -29.96 5.38 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 127.432 2.293 . . . . 0.0 116.795 -172.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . 0.257 12.7 t -173.59 153.94 2.41 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 127.702 3.126 . . . . 0.0 115.089 -173.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.48 117.92 13.1 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 127.657 2.551 . . . . 0.0 110.576 166.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.2 mt -94.55 153.89 17.66 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 116.145 -1.883 . . . . 0.0 113.102 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.4 m -105.94 132.95 51.42 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 126.235 2.209 . . . . 0.0 108.846 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 62.9 tp -83.92 -19.6 34.45 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 120.846 3.647 . . . . 0.0 120.846 169.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 57.09 53.33 45.43 Favored Glycine 0 N--CA 1.45 -0.421 0 O-C-N 124.023 0.827 . . . . 0.0 113.236 172.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.296 15.7 t70 -162.84 95.64 0.89 Allowed 'General case' 0 C--O 1.237 0.418 0 CA-C-O 115.33 -2.271 . . . . 0.0 112.854 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.615 ' HB ' ' HA ' ' A' ' 103' ' ' VAL . 4.2 m -133.02 163.03 39.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 O-C-N 127.27 2.856 . . . . 0.0 111.948 -173.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.615 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 56.1 t -67.93 136.18 27.04 Favored 'Isoleucine or valine' 0 C--N 1.345 0.404 1 O-C-N 113.835 -5.541 . . . . 0.0 117.37 -5.607 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -76.41 123.2 25.63 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 127.117 2.76 . . . . 0.0 110.646 166.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.411 HG13 ' H ' ' A' ' 108' ' ' GLY . 0.4 OUTLIER -109.55 151.12 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-N 122.764 2.529 . . . . 0.0 110.313 170.3 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -84.01 -23.7 30.85 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 120.56 1.527 . . . . 0.0 110.999 -167.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -82.8 -27.95 30.58 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 117.211 -1.376 . . . . 0.0 108.833 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.411 ' H ' HG13 ' A' ' 105' ' ' ILE . . . -115.56 163.37 12.29 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 122.086 2.221 . . . . 0.0 115.815 -165.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -138.17 35.61 2.32 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 128.904 2.882 . . . . 0.0 111.401 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.3 tttp 160.05 118.84 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.355 1 C-N-CA 136.093 5.757 . . . . 0.0 109.311 -166.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.1 mt -101.15 -176.26 3.11 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 156.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -153.95 -128.31 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 114.934 -2.46 . . . . 0.0 104.608 -176.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . 0.292 0.2 OUTLIER -72.1 19.51 0.07 Allowed 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 123.566 2.894 . . . . 0.0 115.993 -173.233 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . 0.254 72.4 m80 . . . . . 0 C--O 1.25 1.082 1 C-N-CA 133.702 4.801 . . . . 0.0 111.768 -179.403 . . . . . . . . 2 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.546 ' HA ' ' OE1' ' A' ' 13' ' ' GLU . 4.5 mm-40 . . . . . 0 CA--C 1.539 0.531 0 CA-C-O 118.415 -0.802 . . . . 0.0 111.595 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -137.11 55.39 1.82 Allowed 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 128.869 3.855 . . . . 0.0 117.243 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.4 -7.08 59.52 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 113.157 -1.838 . . . . 0.0 113.612 -160.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.403 0.3 OUTLIER -134.35 10.34 3.78 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 125.811 1.944 . . . . 0.0 115.164 -172.187 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . 0.29 5.8 mt 61.27 44.25 9.98 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 128.286 2.635 . . . . 0.0 111.247 177.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -157.3 135.4 11.03 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 112.789 -2.005 . . . . 0.0 115.246 -167.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 21.2 pt -105.13 -17.73 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 113.373 -1.739 . . . . 0.0 113.641 -173.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t -56.89 139.55 16.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 164.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -151.63 -45.31 0.11 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 117.394 -1.289 . . . . 0.0 111.032 -175.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -76.15 63.5 1.85 Allowed 'General case' 0 CA--C 1.504 -0.81 0 C-N-CA 129.198 2.999 . . . . 0.0 113.713 174.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.577 ' HD1' ' H ' ' A' ' 60' ' ' LEU . 63.5 t80 -90.9 153.56 20.1 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 130.697 3.599 . . . . 0.0 108.599 -165.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -72.73 140.93 48.11 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 126.87 3.224 . . . . 0.0 111.332 -167.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -93.96 -45.9 7.4 Favored 'General case' 0 CA--C 1.503 -0.848 1 O-C-N 114.19 -5.319 . . . . 0.0 116.456 -155.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.7 tp -65.22 -37.54 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-O 115.614 -2.136 . . . . 0.0 113.414 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.398 7.6 pt -55.05 -35.6 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 O-C-N 125.73 1.894 . . . . 0.0 109.302 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -67.54 -39.63 85.03 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 119.795 -1.816 . . . . 0.0 112.254 -174.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.9 p -62.17 -43.14 99.49 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 124.491 1.116 . . . . 0.0 108.705 -157.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.35 -74.8 0.13 Allowed 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 117.741 2.497 . . . . 0.0 117.741 -155.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -47.95 -46.36 32.13 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 -165.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -55.16 -58.6 7.01 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 124.374 3.261 . . . . 0.0 112.224 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -66.98 -23.1 65.91 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 123.519 2.872 . . . . 0.0 116.298 -172.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 99.3 mt -76.58 -1.8 29.29 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 177.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.54 -0.56 12.55 Favored Glycine 0 C--N 1.335 0.481 2 CA-C-N 107.327 -4.488 . . . . 0.0 117.064 172.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.2 pt -78.77 158.78 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 C-N-CA 130.077 3.351 . . . . 0.0 114.126 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 p -89.61 175.77 7.14 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 117.134 2.272 . . . . 0.0 117.134 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -55.73 -50.98 68.9 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 116.59 -3.819 . . . . 0.0 110.299 161.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -60.07 -47.28 86.53 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 129.27 3.028 . . . . 0.0 113.319 -170.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -64.21 -33.44 75.8 Favored 'General case' 0 N--CA 1.449 -0.51 1 CA-C-O 111.62 -4.038 . . . . 0.0 114.4 174.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 23.0 tp -85.25 -27.14 26.23 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 127.822 3.202 . . . . 0.0 109.653 -177.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.56 -24.1 67.67 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 129.28 3.032 . . . . 0.0 113.483 167.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -66.12 -55.64 15.41 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 104.089 -2.56 . . . . 0.0 104.089 169.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -62.25 -14.99 44.27 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 128.32 2.648 . . . . 0.0 113.41 -159.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 40.8 mt -131.51 -8.47 3.68 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 128.297 3.903 . . . . 0.0 109.955 -163.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.312 88.1 mttt 56.4 -5.4 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 121.709 3.966 . . . . 0.0 121.709 -158.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.3 m -131.25 153.47 39.07 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 C-N-CA 127.87 2.468 . . . . 0.0 110.907 -168.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.921 ' C ' ' H ' ' A' ' 52' ' ' VAL . 91.3 p -128.57 -11.83 4.98 Favored 'General case' 0 N--CA 1.446 -0.653 1 N-CA-C 122.196 4.147 . . . . 0.0 122.196 -169.69 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -99.59 -30.46 12.12 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 117.354 -3.342 . . . . 0.0 111.397 -158.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . 0.253 64.6 t30 -103.15 -55.49 2.4 Favored 'General case' 0 C--O 1.217 -0.618 1 N-CA-C 122.431 4.234 . . . . 0.0 122.431 177.152 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . 0.325 0.7 OUTLIER 41.23 52.03 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.491 2 O-C-N 113.689 -5.632 . . . . 0.0 118.247 14.295 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.921 ' H ' ' C ' ' A' ' 48' ' ' SER . 15.7 t -105.33 -42.36 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 129.366 3.067 . . . . 0.0 107.929 23.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -69.95 -39.34 76.12 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 119.023 2.972 . . . . 0.0 119.023 -153.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 54' ' ' ARG . 34.8 ttm180 -83.05 -12.59 57.02 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 120.455 1.479 . . . . 0.0 114.391 -158.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -79.7 -11.93 59.83 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -88.26 -5.95 58.06 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 118.061 -2.899 . . . . 0.0 110.693 -175.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.6 p -92.1 -7.04 49.73 Favored 'General case' 0 N--CA 1.454 -0.268 1 N-CA-C 121.936 4.05 . . . . 0.0 121.936 -142.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.48 ' HA2' ' CD2' ' A' ' 23' ' ' TYR . . . 68.47 26.13 74.49 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-O 115.109 -3.05 . . . . 0.0 110.942 177.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -130.38 -1.32 4.46 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 119.068 2.988 . . . . 0.0 119.068 -160.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.577 ' H ' ' HD1' ' A' ' 23' ' ' TYR . 4.2 tp -135.31 158.87 43.27 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 -171.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -106.48 94.87 10.64 Favored Pre-proline 0 CA--C 1.513 -0.454 0 CA-C-O 115.646 -2.121 . . . . 0.0 113.259 147.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.08 151.28 34.62 Favored 'Trans proline' 0 N--CA 1.443 -1.467 0 C-N-CA 122.612 2.208 . . . . 0.0 110.61 172.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.5 p -80.17 171.72 14.72 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 127.213 2.821 . . . . 0.0 117.726 169.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . 0.315 2.1 tp -53.58 -61.17 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 130.548 3.539 . . . . 0.0 106.382 177.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 83.2 p -61.23 -23.6 65.75 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 116.308 -1.806 . . . . 0.0 112.887 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -80.77 -46.69 15.02 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 128.379 2.672 . . . . 0.0 109.233 173.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.04 93.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 130.173 3.389 . . . . 0.0 115.035 170.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -52.09 -22.41 4.12 Favored 'General case' 0 C--O 1.22 -0.476 0 C-N-CA 127.276 2.23 . . . . 0.0 113.959 175.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -66.68 -13.05 60.79 Favored 'General case' 0 N--CA 1.438 -1.025 0 C-N-CA 125.985 1.714 . . . . 0.0 111.339 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.6 tp -79.97 -49.6 11.62 Favored 'General case' 0 N--CA 1.436 -1.152 1 O-C-N 114.735 -4.978 . . . . 0.0 109.484 -175.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -50.56 -31.32 15.41 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 126.567 2.417 . . . . 0.0 108.022 172.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.1 tttp -69.17 -54.24 15.88 Favored 'General case' 0 C--O 1.24 0.579 1 C-N-CA 131.788 4.035 . . . . 0.0 106.786 -170.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 19.2 pt -79.53 -40.0 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 117.466 -3.271 . . . . 0.0 108.076 -168.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 25.4 mt -82.45 -13.46 56.7 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 128.189 2.596 . . . . 0.0 114.04 -175.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.517 ' O ' HG23 ' A' ' 76' ' ' ILE . . . 69.33 4.13 42.49 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-O 114.12 -3.6 . . . . 0.0 118.228 -167.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.517 HG23 ' O ' ' A' ' 75' ' ' GLY . 6.5 pt -171.94 135.31 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 127.854 2.462 . . . . 0.0 109.016 -161.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -65.73 131.0 45.25 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 114.173 -3.011 . . . . 0.0 115.629 170.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.5 mt -138.74 145.58 40.42 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 124.099 3.136 . . . . 0.0 111.185 -173.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . 0.401 1.4 m -81.62 159.03 4.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 1 O-C-N 115.708 -4.37 . . . . 0.0 116.659 -0.978 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 67.8 p -76.18 157.6 82.89 Favored Pre-proline 0 N--CA 1.451 -0.38 0 O-C-N 121.702 -0.624 . . . . 0.0 109.517 177.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -50.71 -10.41 0.28 Allowed 'Trans proline' 0 N--CA 1.445 -1.382 0 O-C-N 124.207 1.635 . . . . 0.0 115.204 170.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 32.5 tp -71.99 -41.12 68.01 Favored 'General case' 0 C--O 1.219 -0.544 0 O-C-N 118.9 -2.375 . . . . 0.0 111.423 172.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -109.35 6.07 24.08 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 118.367 2.728 . . . . 0.0 118.367 -175.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -58.59 124.45 19.69 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 119.708 -1.87 . . . . 0.0 111.203 165.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -75.19 -15.37 60.56 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 122.618 2.463 . . . . 0.0 116.102 163.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -65.01 115.89 5.87 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 126.74 2.525 . . . . 0.0 108.62 173.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -78.33 -1.26 32.37 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 112.375 -3.678 . . . . 0.0 109.39 -177.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.4 p -105.81 15.4 26.78 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 125.587 3.812 . . . . 0.0 119.087 167.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -104.76 145.08 30.86 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 127.35 2.26 . . . . 0.0 111.56 164.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.2 pttt -161.47 169.73 21.31 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 125.12 2.39 . . . . 0.0 107.701 -175.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -72.37 138.75 47.45 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 127.149 2.18 . . . . 0.0 114.026 163.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -147.42 175.13 11.05 Favored 'General case' 0 CA--C 1.507 -0.673 0 C-N-CA 124.717 1.207 . . . . 0.0 108.173 -167.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.515 ' HB3' ' H ' ' A' ' 96' ' ' GLY . 5.1 t70 -157.61 159.35 36.96 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 114.498 -2.668 . . . . 0.0 111.739 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -50.17 -29.48 9.35 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 124.206 3.185 . . . . 0.0 114.692 156.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 53.6 m -70.0 -48.6 57.5 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 172.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.515 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -71.19 -13.45 73.23 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 117.184 -2.436 . . . . 0.0 114.498 175.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.4 tp -80.39 -28.15 37.98 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 121.02 3.711 . . . . 0.0 121.02 160.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 71.0 p -87.15 -10.71 52.04 Favored 'General case' 0 N--CA 1.447 -0.608 1 O-C-N 116.172 -4.08 . . . . 0.0 112.273 168.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.7 tp -75.08 -15.95 60.59 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 119.067 -2.27 . . . . 0.0 112.177 149.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 69.0 25.35 75.47 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-O 124.229 2.016 . . . . 0.0 114.338 -178.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -73.84 37.44 0.1 Allowed 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 117.953 2.575 . . . . 0.0 117.953 -177.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.9 p -128.81 152.46 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 1 C-N-CA 132.113 4.165 . . . . 0.0 111.597 -158.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.283 0.3 OUTLIER 83.78 -21.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 O-C-N 118.657 -2.527 . . . . 0.0 116.032 149.246 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -66.25 -19.9 65.95 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 117.572 -1.204 . . . . 0.0 109.48 -167.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.66 -26.63 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 122.413 2.37 . . . . 0.0 115.721 171.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -80.61 165.57 21.92 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 119.999 1.272 . . . . 0.0 108.84 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -96.07 146.59 24.52 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.0 -10.58 1.58 Allowed Glycine 0 C--N 1.337 0.632 0 N-CA-C 118.991 2.357 . . . . 0.0 118.991 -166.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -61.95 1.41 0.29 Allowed 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 120.13 1.965 . . . . 0.0 112.362 173.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -89.6 -26.84 20.58 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 118.544 -2.598 . . . . 0.0 114.257 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 23.1 tp -70.29 -31.13 68.34 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 126.372 2.987 . . . . 0.0 112.646 160.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.379 17.0 tt0 -81.13 -74.35 0.33 Allowed 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 118.16 -2.837 . . . . 0.0 116.817 -177.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -77.21 6.9 5.8 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 119.875 3.287 . . . . 0.0 119.875 -176.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 . . . . . 0 C--O 1.25 1.126 0 O-C-N 118.488 -2.633 . . . . 0.0 113.787 -172.347 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.4 t80 . . . . . 0 N--CA 1.447 -0.589 0 CA-C-O 117.474 -1.251 . . . . 0.0 112.666 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -75.39 -166.19 0.5 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -174.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -16.4 -57.91 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 119.905 3.298 . . . . 0.0 119.905 166.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 78' ' ' LEU . 9.2 tp -44.07 -50.84 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 118.84 2.904 . . . . 0.0 118.84 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.311 6.2 tt -84.27 -46.94 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 129.366 3.066 . . . . 0.0 110.115 175.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -52.44 -52.49 53.8 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 115.476 -2.202 . . . . 0.0 111.623 -172.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.1 p -46.33 -52.32 13.01 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.252 1.421 . . . . 0.0 109.247 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.9 -36.43 56.67 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-O 114.453 -2.689 . . . . 0.0 117.388 -172.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.425 ' HD2' HD22 ' A' ' 41' ' ' LEU 0.31 37.3 ptt85 -57.97 -43.93 86.79 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 121.201 1.819 . . . . 0.0 113.562 172.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -55.28 -34.0 63.72 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 113.575 -3.107 . . . . 0.0 111.962 164.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.65 -21.96 63.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 124.16 3.164 . . . . 0.0 109.028 178.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.8 mt -98.82 -9.87 23.74 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 125.764 1.626 . . . . 0.0 112.768 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.22 -7.33 2.59 Favored Glycine 0 N--CA 1.464 0.56 0 CA-C-N 113.014 -1.903 . . . . 0.0 117.851 174.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.5 pt -57.11 128.32 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 128.293 2.637 . . . . 0.0 111.284 -176.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.7 p -67.93 162.52 24.11 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 118.936 2.939 . . . . 0.0 118.936 -171.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -48.02 -43.97 30.5 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 117.604 -3.185 . . . . 0.0 113.951 168.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -68.69 -34.89 76.43 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 123.415 0.686 . . . . 0.0 110.002 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -71.32 -41.5 69.77 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 115.05 -2.405 . . . . 0.0 109.105 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.425 HD22 ' HD2' ' A' ' 31' ' ' ARG 0.257 29.2 tp -59.94 -46.25 90.0 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 128.081 2.552 . . . . 0.0 113.945 177.501 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 47' ' ' VAL . . . -54.5 -37.77 65.7 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 110.718 -2.946 . . . . 0.0 116.492 174.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.455 ' C ' ' H ' ' A' ' 45' ' ' LEU . 43.4 mt-30 -63.78 -40.59 97.04 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.839 1.655 . . . . 0.0 113.62 165.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -63.66 1.21 0.63 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.28 1.832 . . . . 0.0 111.452 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.455 ' H ' ' C ' ' A' ' 43' ' ' GLN 0.268 16.1 tp -145.79 4.43 0.99 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 120.377 3.473 . . . . 0.0 120.377 -170.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.26 63.7 mttt 52.18 39.01 25.98 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 130.807 3.643 . . . . 0.0 115.199 -174.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.425 ' O ' ' HB1' ' A' ' 42' ' ' ALA . 35.7 m -126.66 -172.58 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 1 C-N-CA 133.38 4.672 . . . . 0.0 113.826 -176.5 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.1 p -101.33 152.5 20.63 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 116.599 -1.667 . . . . 0.0 114.421 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -49.09 -32.5 9.89 Favored 'General case' 0 CA--C 1.52 -0.187 0 O-C-N 126.177 2.173 . . . . 0.0 110.349 165.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -74.08 -29.63 61.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 116.599 -1.667 . . . . 0.0 109.746 -171.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mt -70.83 -47.67 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-O 126.322 2.963 . . . . 0.0 113.704 173.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.348 13.4 m -56.59 -46.72 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 2 O-C-N 113.433 -5.792 . . . . 0.0 112.148 175.149 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -56.07 -40.86 74.23 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 117.989 -2.944 . . . . 0.0 113.277 162.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.8 ttt85 -57.64 -36.59 72.05 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 115.609 -2.138 . . . . 0.0 113.174 177.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -71.51 -44.76 64.07 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 124.849 1.343 . . . . 0.0 111.066 173.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -67.7 -13.77 62.38 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 114.861 -2.495 . . . . 0.0 109.775 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.9 p -102.68 0.36 32.99 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 124.094 3.134 . . . . 0.0 111.482 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.93 6.22 87.0 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 122.268 2.303 . . . . 0.0 115.816 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -94.12 -18.83 21.38 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 119.443 1.621 . . . . 0.0 114.962 -166.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.4 tp -144.87 161.67 38.72 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 127.931 3.27 . . . . 0.0 109.04 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.258 76.2 tttt -133.65 151.94 78.05 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-O 115.627 -2.13 . . . . 0.0 112.869 171.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . 0.274 41.4 Cg_endo -63.42 168.04 11.99 Favored 'Trans proline' 0 N--CA 1.451 -0.981 1 C-N-CA 126.211 4.607 . . . . 0.0 108.807 169.636 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 81.3 p -96.34 179.22 5.11 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 127.581 2.352 . . . . 0.0 111.224 171.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.1 pt -64.66 -57.23 12.16 Favored 'Isoleucine or valine' 0 C--N 1.346 0.449 0 CA-C-O 113.434 -3.174 . . . . 0.0 114.857 -175.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 90.3 p -51.98 -29.64 21.49 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 122.975 2.625 . . . . 0.0 111.914 167.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -78.86 -53.07 7.46 Favored 'General case' 0 N--CA 1.439 -0.978 0 O-C-N 118.982 -2.324 . . . . 0.0 109.129 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -40.94 -45.57 2.59 Favored 'General case' 0 N--CA 1.448 -0.57 1 C-N-CA 131.918 4.087 . . . . 0.0 104.759 162.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -62.65 -40.0 95.65 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 118.667 -2.52 . . . . 0.0 112.253 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -79.3 -40.33 30.67 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 117.676 2.473 . . . . 0.0 117.676 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.479 ' O ' HG22 ' A' ' 73' ' ' ILE . 87.5 mt -44.97 -46.13 10.94 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 114.854 -2.498 . . . . 0.0 113.965 161.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -56.03 -43.08 77.47 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 121.831 2.105 . . . . 0.0 107.353 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -85.21 -4.95 59.33 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 130.396 3.478 . . . . 0.0 118.609 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.579 HG23 ' HG ' ' A' ' 74' ' ' LEU . 4.2 tt -75.58 -31.64 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 1 O-C-N 114.395 -5.191 . . . . 0.0 116.394 -163.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.579 ' HG ' HG23 ' A' ' 73' ' ' ILE . 57.8 mt -105.56 -7.26 18.7 Favored 'General case' 0 N--CA 1.445 -0.694 2 O-C-N 115.244 -4.66 . . . . 0.0 113.0 -175.706 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.08 -20.78 0.05 OUTLIER Glycine 0 CA--C 1.526 0.765 0 O-C-N 116.486 -3.884 . . . . 0.0 112.643 -151.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.438 ' H ' ' C ' ' A' ' 74' ' ' LEU . 9.2 pt -131.05 -161.79 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-O 125.101 2.382 . . . . 0.0 116.918 -172.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.5 pttm -175.29 176.02 2.1 Favored 'General case' 0 N--CA 1.439 -0.99 0 O-C-N 117.318 -3.364 . . . . 0.0 107.08 -172.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.412 ' HA ' HD12 ' A' ' 26' ' ' ILE . 59.0 tp . . . . . 0 N--CA 1.445 -0.68 0 C-N-CA 129.689 3.196 . . . . 0.0 106.798 138.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.692 ' HD1' ' H ' ' A' ' 60' ' ' LEU . 40.0 t80 . . . . . 0 CA--C 1.517 -0.295 0 CA-C-O 116.742 -1.599 . . . . 0.0 113.236 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -65.15 144.97 56.87 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 119.843 1.201 . . . . 0.0 112.476 -174.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -78.34 -29.12 47.45 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 119.266 3.061 . . . . 0.0 119.266 -160.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.96 -51.87 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 O-C-N 117.488 -3.257 . . . . 0.0 108.587 -170.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.2 pt -54.0 -28.66 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 117.131 -1.414 . . . . 0.0 114.312 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -60.12 -39.61 86.84 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 129.555 3.142 . . . . 0.0 111.136 173.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.5 p -90.77 -21.87 21.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 117.011 2.226 . . . . 0.0 117.011 -173.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.83 -61.27 2.75 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 131.05 3.74 . . . . 0.0 113.115 -159.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.38 -46.08 87.04 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-O 114.618 -2.611 . . . . 0.0 110.135 -169.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -63.7 -34.76 78.59 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 117.281 2.326 . . . . 0.0 117.281 169.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.97 -0.21 13.08 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 122.83 2.559 . . . . 0.0 110.659 -174.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 36.3 mt -117.43 -19.81 9.35 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 129.491 3.116 . . . . 0.0 112.527 178.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.76 -8.29 50.28 Favored Glycine 0 C--O 1.223 -0.557 0 CA-C-O 127.615 3.897 . . . . 0.0 114.463 162.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.44 HD13 ' HE3' ' A' ' 44' ' ' LYS . 35.1 pt -91.75 155.86 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 130.356 3.463 . . . . 0.0 110.459 -173.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.0 p -65.14 161.91 18.1 Favored 'General case' 0 CA--C 1.514 -0.412 0 O-C-N 119.86 -1.775 . . . . 0.0 115.065 167.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -56.42 -37.73 70.6 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 118.017 -0.992 . . . . 0.0 111.713 170.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -66.77 -31.87 72.79 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 126.004 1.722 . . . . 0.0 111.591 174.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -69.07 -39.58 79.0 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 118.644 -2.535 . . . . 0.0 112.781 170.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.0 tp -64.25 -37.92 89.21 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 118.665 -2.522 . . . . 0.0 110.216 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.79 -25.08 61.86 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.311 -0.868 . . . . 0.0 108.874 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -62.33 -36.67 82.93 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 123.603 1.668 . . . . 0.0 114.948 170.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.44 ' HE3' HD13 ' A' ' 36' ' ' ILE . 21.8 mttm -66.82 -22.85 66.0 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 117.292 -3.38 . . . . 0.0 111.807 -175.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.6 mt -133.46 -5.62 2.94 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 127.297 2.873 . . . . 0.0 108.985 -145.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.356 65.2 mmtt 51.16 -37.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 119.175 3.028 . . . . 0.0 119.175 -153.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.1 m -124.46 154.46 31.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 116.171 -1.871 . . . . 0.0 111.605 -157.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.913 ' C ' ' H ' ' A' ' 52' ' ' VAL . 84.0 p -137.87 -6.36 1.67 Allowed 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 127.966 3.291 . . . . 0.0 118.189 -135.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.432 ' N ' ' H ' ' A' ' 52' ' ' VAL . 17.7 mp0 -101.59 -32.36 10.39 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 127.651 3.094 . . . . 0.0 110.387 -162.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.608 ' H ' ' C ' ' A' ' 51' ' ' ILE . 57.0 t-20 -118.91 -42.84 2.69 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 112.446 -3.645 . . . . 0.0 113.894 -174.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.608 ' C ' ' H ' ' A' ' 50' ' ' ASN . 1.5 mt 46.12 61.75 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.354 2 C-N-CA 137.925 6.49 . . . . 0.0 112.22 -1.654 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.913 ' H ' ' C ' ' A' ' 48' ' ' SER . 27.8 t -93.66 -47.76 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 O-C-N 117.723 -3.111 . . . . 0.0 114.882 2.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -57.82 -43.22 85.6 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 120.523 3.527 . . . . 0.0 120.523 -148.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.3 ttm180 -73.44 -12.41 60.79 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 115.516 -2.183 . . . . 0.0 114.684 -157.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -52.39 -27.91 17.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 125.252 1.595 . . . . 0.0 113.765 169.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . 0.269 12.4 pt-20 -50.41 -27.45 6.41 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 123.849 3.022 . . . . 0.0 116.592 168.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.6 p -73.75 -27.81 61.36 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 119.328 3.084 . . . . 0.0 119.328 -148.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.48 ' HA2' ' CD2' ' A' ' 23' ' ' TYR . . . 78.53 19.54 73.55 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 123.106 2.684 . . . . 0.0 115.704 -172.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -122.09 4.43 9.84 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 121.314 3.82 . . . . 0.0 121.314 -162.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.692 ' H ' ' HD1' ' A' ' 23' ' ' TYR . 27.6 tp -145.01 142.0 29.41 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 118.426 2.75 . . . . 0.0 118.426 -168.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.251 61.1 mttm -115.09 109.42 46.85 Favored Pre-proline 0 C--N 1.351 0.67 0 O-C-N 119.342 -2.099 . . . . 0.0 109.739 155.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -78.01 -177.84 4.17 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 124.139 3.226 . . . . 0.0 112.054 -167.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.0 p -81.58 170.86 15.35 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 165.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 11.3 tp -68.73 -46.17 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-N 112.302 -2.227 . . . . 0.0 110.59 -177.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.7 p -56.69 -34.19 67.17 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 120.892 1.678 . . . . 0.0 111.917 169.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -78.43 -50.41 11.74 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 -170.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -52.09 -40.21 60.91 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 125.62 1.825 . . . . 0.0 114.368 173.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -65.4 -46.15 81.18 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 172.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.622 ' C ' ' H ' ' A' ' 72' ' ' LYS . 35.0 mt-30 -64.33 -27.41 69.01 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 118.127 -2.858 . . . . 0.0 112.865 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 27.3 mt -90.22 -31.6 16.94 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -166.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -50.74 -31.51 16.9 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.097 149.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.622 ' H ' ' C ' ' A' ' 69' ' ' GLN . 20.0 tttm -78.46 -26.1 46.02 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 116.701 -2.0 . . . . 0.0 116.053 -161.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . 0.355 26.2 pt -57.18 -43.25 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 O-C-N 116.997 -3.564 . . . . 0.0 114.307 167.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.41 ' C ' ' H ' ' A' ' 76' ' ' ILE . 8.7 mt -60.4 -34.76 74.39 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 -166.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.04 -5.83 7.67 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 117.269 -2.396 . . . . 0.0 113.995 -169.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.41 ' H ' ' C ' ' A' ' 74' ' ' LEU . 27.1 pt -114.89 -162.45 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 124.899 1.28 . . . . 0.0 113.059 163.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -120.38 150.25 41.07 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 114.869 -2.491 . . . . 0.0 113.671 169.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.4 mt . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 175.683 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 27.8 t80 . . . . . 0 N--CA 1.442 -0.84 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -58.34 144.71 40.57 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 128.124 2.569 . . . . 0.0 116.84 -171.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.7 tttt -116.63 -4.26 11.71 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 -157.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.1 pt -43.95 -49.3 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.747 0 C-N-CA 127.84 2.456 . . . . 0.0 116.23 -174.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.426 13.9 pt -74.23 -16.5 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 O-C-N 125.165 1.541 . . . . 0.0 115.031 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.342 19.0 tttm -66.53 -58.01 6.1 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 120.462 3.505 . . . . 0.0 120.462 -158.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 52.2 m -54.57 -40.43 68.76 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 120.469 -1.394 . . . . 0.0 109.479 174.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.98 -45.68 80.79 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 118.661 2.837 . . . . 0.0 118.661 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -47.22 -42.23 19.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.883 0.873 . . . . 0.0 112.618 164.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -73.48 -39.81 64.6 Favored 'General case' 0 N--CA 1.437 -1.109 1 CA-C-O 111.551 -4.071 . . . . 0.0 112.41 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -61.41 -41.06 96.56 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 127.554 3.034 . . . . 0.0 112.742 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 61.1 mt -58.35 -35.18 71.54 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.515 1.926 . . . . 0.0 111.512 171.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.1 2.92 5.62 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 128.375 2.893 . . . . 0.0 115.225 -173.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.442 ' HB ' ' HB2' ' A' ' 40' ' ' GLN . 28.5 pt -66.63 154.73 7.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 125.637 2.637 . . . . 0.0 113.966 -166.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 64.2 p -80.45 170.59 16.17 Favored 'General case' 0 N--CA 1.438 -1.038 0 O-C-N 119.151 -2.218 . . . . 0.0 113.113 -176.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -56.52 -41.66 77.09 Favored 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 117.997 -2.939 . . . . 0.0 105.138 174.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -72.53 -32.99 66.55 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 121.925 2.148 . . . . 0.0 116.625 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.442 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . 58.0 mt-30 -64.57 -38.03 89.61 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 116.338 -3.976 . . . . 0.0 112.442 170.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.2 tp -70.3 -37.13 74.73 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 128.329 2.652 . . . . 0.0 114.489 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.3 -46.37 90.12 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.902 1.681 . . . . 0.0 112.306 169.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -63.25 -44.64 94.61 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 117.868 -1.063 . . . . 0.0 111.836 172.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -69.19 -14.49 63.01 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 125.764 1.626 . . . . 0.0 111.99 -174.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.51 HD23 HD12 ' A' ' 73' ' ' ILE . 5.2 mp -121.04 1.87 10.4 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.63 1.972 . . . . 0.0 109.78 -172.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.256 0.0 OUTLIER 62.41 -35.42 0.12 Allowed 'General case' 0 N--CA 1.444 -0.767 2 C-N-CA 133.169 4.587 . . . . 0.0 114.784 -167.736 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.8 m -77.53 164.13 3.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 1 C-N-CA 133.165 4.586 . . . . 0.0 114.747 -161.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 89.3 p -79.66 159.21 26.8 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 -170.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.442 ' HA ' HG22 ' A' ' 52' ' ' VAL . 40.7 mt-10 -82.7 -12.46 57.57 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 117.557 -1.657 . . . . 0.0 110.216 -162.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -59.91 -44.34 94.33 Favored 'General case' 0 C--O 1.222 -0.391 0 O-C-N 120.663 -1.273 . . . . 0.0 109.899 166.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.5 mm -64.42 -45.52 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 C-N-CA 127.863 2.465 . . . . 0.0 108.345 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.442 HG22 ' HA ' ' A' ' 49' ' ' GLU 0.387 1.3 m -65.11 -45.9 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -176.503 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -63.84 -26.76 68.76 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-O 115.308 -2.282 . . . . 0.0 116.229 172.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -59.49 -44.03 93.17 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 121.742 2.064 . . . . 0.0 109.008 176.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -82.05 -28.18 32.58 Favored 'General case' 0 CA--C 1.522 -0.112 0 O-C-N 118.421 -2.675 . . . . 0.0 110.702 -176.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -63.19 -33.75 76.16 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 119.396 -2.065 . . . . 0.0 111.159 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.2 p -126.61 22.58 6.92 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -151.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.11 21.85 62.1 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.664 165.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -97.1 26.53 4.65 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 125.9 1.68 . . . . 0.0 115.025 -164.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.2 tp -140.02 154.58 47.16 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 113.672 -1.603 . . . . 0.0 114.903 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.2 tttp -90.54 102.08 4.61 Favored Pre-proline 0 N--CA 1.443 -0.808 0 C-N-CA 125.041 1.337 . . . . 0.0 108.526 149.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -83.83 170.89 11.01 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 CA-C-O 125.041 2.017 . . . . 0.0 111.236 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.0 p -143.73 179.28 7.25 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 118.921 -2.362 . . . . 0.0 111.988 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . 0.403 60.7 mt -52.39 -61.4 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 O-C-N 127.574 3.046 . . . . 0.0 109.392 172.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 96.5 p -68.97 -31.26 69.99 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 125.329 1.643 . . . . 0.0 107.653 -173.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -77.96 -37.49 47.35 Favored 'General case' 0 N--CA 1.438 -1.073 1 O-C-N 114.581 -5.074 . . . . 0.0 109.014 -177.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.23 -45.72 90.3 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 114.466 -2.683 . . . . 0.0 107.172 169.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 39.5 tpt85 -52.61 -27.82 18.6 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 125.153 1.533 . . . . 0.0 112.496 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -93.39 -29.39 15.62 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 114.396 -2.716 . . . . 0.0 110.31 -173.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.5 tp -61.62 -53.11 60.58 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 114.927 -2.463 . . . . 0.0 115.732 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -50.9 -22.69 2.35 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 125.303 1.627 . . . . 0.0 115.175 157.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.25 76.7 tttt -87.54 -38.02 16.37 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 117.268 -3.395 . . . . 0.0 109.489 -173.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.51 HD12 HD23 ' A' ' 45' ' ' LEU . 50.5 pt -74.1 -29.91 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 74' ' ' LEU . 34.4 tp -77.61 -25.33 49.74 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 126.54 3.066 . . . . 0.0 107.34 175.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.35 8.85 27.33 Favored Glycine 0 N--CA 1.445 -0.725 0 O-C-N 118.878 -2.389 . . . . 0.0 117.098 -168.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.2 pt -152.02 177.34 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.073 0 C-N-CA 130.018 3.327 . . . . 0.0 112.006 175.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -171.29 168.69 6.58 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 128.602 2.761 . . . . 0.0 106.892 -166.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 78' ' ' LEU . 9.7 mt . . . . . 0 N--CA 1.447 -0.577 0 CA-C-N 112.407 -2.179 . . . . 0.0 115.221 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.4 t80 . . . . . 0 CA--C 1.508 -0.668 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -85.91 -162.64 0.76 Allowed 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 127.868 3.23 . . . . 0.0 111.291 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -66.4 -1.8 3.87 Favored 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 118.272 -2.767 . . . . 0.0 114.461 -168.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.0 pt -56.26 -27.67 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 O-C-N 120.13 -1.606 . . . . 0.0 115.315 160.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.348 6.7 tp -140.5 -33.15 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 O-C-N 119.998 -1.689 . . . . 0.0 109.875 -173.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -70.98 -49.28 47.0 Favored 'General case' 0 N--CA 1.445 -0.708 0 O-C-N 117.177 -3.452 . . . . 0.0 112.829 -164.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.08 -39.7 94.64 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 128.092 2.557 . . . . 0.0 106.748 175.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.72 -59.57 4.71 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 117.756 2.502 . . . . 0.0 117.756 -173.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -39.94 -45.85 1.94 Allowed 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 124.566 1.167 . . . . 0.0 109.703 169.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -58.93 -47.52 84.76 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 116.859 -3.651 . . . . 0.0 117.199 168.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -72.33 -1.71 16.46 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 122.013 2.188 . . . . 0.0 112.446 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.414 ' C ' ' H ' ' A' ' 36' ' ' ILE . 81.5 mt -101.51 -22.1 14.59 Favored 'General case' 0 N--CA 1.451 -0.413 1 O-C-N 115.161 -4.712 . . . . 0.0 107.046 -177.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.81 -12.1 0.16 Allowed Glycine 0 C--N 1.336 0.555 0 CA-C-O 125.492 2.718 . . . . 0.0 115.785 -176.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.414 ' H ' ' C ' ' A' ' 34' ' ' LEU . 31.7 pt -66.19 163.42 2.44 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 N-CA-C 119.118 3.007 . . . . 0.0 119.118 -176.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.5 p -77.17 171.75 14.34 Favored 'General case' 0 C--O 1.241 0.644 0 O-C-N 116.995 -3.566 . . . . 0.0 117.753 175.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . 0.336 2.5 mp0 -70.89 -24.43 62.48 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 120.843 -1.16 . . . . 0.0 110.03 169.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -72.89 -37.21 67.37 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 120.503 -1.373 . . . . 0.0 107.432 176.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -76.81 -32.16 57.45 Favored 'General case' 0 N--CA 1.44 -0.953 0 O-C-N 118.464 -2.648 . . . . 0.0 113.868 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.3 tp -72.54 -36.46 68.27 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 130.215 3.406 . . . . 0.0 109.716 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.54 -34.11 70.64 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 121.581 1.991 . . . . 0.0 112.873 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -60.94 -49.84 75.8 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.924 1.689 . . . . 0.0 112.304 168.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.7 mmtt -70.54 -19.25 62.91 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -173.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 94.7 mt -101.72 -9.67 20.65 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -170.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.339 7.1 mptt 61.69 -16.43 0.04 OUTLIER 'General case' 0 C--O 1.237 0.415 0 N-CA-C 117.104 2.261 . . . . 0.0 117.104 -163.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.3 m -104.51 166.1 3.23 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 CA-C-O 124.53 2.11 . . . . 0.0 112.508 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 55.3 p -74.04 166.31 23.61 Favored 'General case' 0 N--CA 1.44 -0.974 0 O-C-N 118.969 -2.332 . . . . 0.0 116.229 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -70.5 -23.48 62.67 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 118.685 -2.51 . . . . 0.0 107.689 175.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -63.1 -37.0 85.47 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.274 1.43 . . . . 0.0 110.743 171.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.5 mm -68.84 -40.4 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 125.861 3.937 . . . . 0.0 110.594 171.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.1 t -54.41 -45.32 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 113.966 -1.47 . . . . 0.0 111.262 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -59.04 -58.13 10.01 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 128.873 2.869 . . . . 0.0 106.098 169.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -53.55 -39.51 64.78 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 121.452 1.933 . . . . 0.0 110.732 -163.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -70.81 -50.81 31.57 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 118.273 -0.87 . . . . 0.0 112.826 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -51.43 -37.7 49.93 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 122.729 2.513 . . . . 0.0 112.835 170.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.4 p -83.79 4.96 26.79 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 118.44 2.756 . . . . 0.0 118.44 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.82 7.36 68.67 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 116.853 -2.082 . . . . 0.0 111.938 165.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -103.98 -15.42 15.62 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 129.152 2.981 . . . . 0.0 115.998 -167.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.3 tp -146.53 138.98 25.09 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 126.14 1.776 . . . . 0.0 115.426 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.624 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 15.6 ptpt -138.53 -164.77 0.08 OUTLIER Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-O 116.588 -1.672 . . . . 0.0 112.492 173.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.624 ' HD2' ' HB2' ' A' ' 61' ' ' LYS . 88.2 Cg_endo -88.8 149.64 5.98 Favored 'Trans proline' 0 N--CA 1.44 -1.644 0 O-C-N 124.512 1.796 . . . . 0.0 112.241 177.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.0 p -144.52 -179.33 6.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.836 1.255 . . . . 0.0 113.042 -172.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.445 ' C ' ' H ' ' A' ' 66' ' ' GLN . 8.7 tp -78.69 -44.02 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 C-N-CA 125.346 1.458 . . . . 0.0 107.816 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 84.9 p -53.92 -7.67 0.14 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-N 120.389 1.45 . . . . 0.0 108.388 169.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.445 ' H ' ' C ' ' A' ' 64' ' ' ILE . 40.3 mt-30 -118.68 -37.33 3.29 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 117.722 -3.112 . . . . 0.0 115.039 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -39.38 -46.66 1.66 Allowed 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 117.565 2.431 . . . . 0.0 117.565 -162.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.5 mtm105 -71.48 -53.54 13.59 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 114.903 -2.475 . . . . 0.0 116.47 -165.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -63.18 -39.14 93.79 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 115.694 -2.098 . . . . 0.0 112.877 167.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 44.4 tp -53.85 -49.0 69.43 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 127.167 2.792 . . . . 0.0 107.131 -170.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -57.82 -51.12 70.88 Favored 'General case' 0 CA--C 1.513 -0.467 0 O-C-N 118.694 -2.504 . . . . 0.0 111.527 177.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -73.24 -29.45 62.79 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 116.579 -3.826 . . . . 0.0 115.706 -168.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 14.5 pt -66.04 -15.96 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 123.042 2.655 . . . . 0.0 112.942 161.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.372 1.3 pt? 146.24 -10.15 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.477 1 C-N-CA 133.41 4.684 . . . . 0.0 115.233 162.457 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.85 6.79 68.34 Favored Glycine 0 C--N 1.34 0.788 0 CA-C-O 113.943 -3.698 . . . . 0.0 114.014 -172.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . 0.282 1.4 pt 71.64 6.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.835 1 C-N-CA 135.196 5.398 . . . . 0.0 117.16 174.578 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -71.88 148.51 46.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 115.116 -2.373 . . . . 0.0 113.992 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.406 HD13 HD11 ' A' ' 34' ' ' LEU 0.259 40.1 mt . . . . . 0 N--CA 1.448 -0.553 0 C-N-CA 125.383 1.473 . . . . 0.0 113.328 168.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.444 -0.731 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -44.86 116.22 1.04 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 119.633 3.197 . . . . 0.0 119.633 -173.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -66.17 -36.73 83.86 Favored 'General case' 0 C--O 1.222 -0.375 0 N-CA-C 116.199 1.925 . . . . 0.0 116.199 -170.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.2 pt -62.08 -22.17 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 O-C-N 119.453 -2.03 . . . . 0.0 113.817 -171.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.359 2.5 mt -136.94 -53.68 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 O-C-N 117.621 -3.174 . . . . 0.0 109.646 172.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt 63.96 -96.24 0.05 Allowed 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 113.476 -3.154 . . . . 0.0 115.548 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.7 p -43.44 -31.86 0.77 Allowed 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 130.738 3.615 . . . . 0.0 111.128 -168.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.73 -26.06 31.63 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 131.105 3.762 . . . . 0.0 117.996 -154.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . 0.451 22.3 ptt180 -36.92 -50.3 0.86 Allowed 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 119.93 3.307 . . . . 0.0 119.93 -176.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . 0.25 40.9 mt-10 -72.32 -37.0 69.01 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 114.335 -2.745 . . . . 0.0 115.476 170.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -65.29 0.96 1.2 Allowed 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 126.33 1.852 . . . . 0.0 114.458 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.4 mt -72.64 -7.61 51.18 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 119.321 -2.112 . . . . 0.0 114.492 -175.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 47.98 6.75 0.03 OUTLIER Glycine 0 C--N 1.347 1.15 1 C-N-CA 131.442 4.353 . . . . 0.0 115.881 -161.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.289 2.6 pt -136.32 167.73 23.75 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.509 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.677 -169.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 65.8 m -134.89 179.93 6.0 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 121.012 1.733 . . . . 0.0 115.249 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.42 -38.93 14.36 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 118.484 -2.635 . . . . 0.0 117.898 -159.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -75.73 -39.32 57.47 Favored 'General case' 0 N--CA 1.442 -0.844 0 O-C-N 119.404 -2.06 . . . . 0.0 109.542 -169.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -67.4 -34.95 78.33 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 160.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.6 tp -64.51 -39.42 93.75 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 121.461 1.937 . . . . 0.0 112.089 -175.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -50.81 -32.86 21.36 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.462 177.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -73.14 -50.23 23.84 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 124.148 1.928 . . . . 0.0 112.737 173.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -65.69 -4.07 5.79 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 116.511 -1.709 . . . . 0.0 110.74 -168.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.331 53.9 tp -146.93 -0.84 0.69 Allowed 'General case' 0 C--O 1.247 0.925 0 CA-C-O 123.471 1.605 . . . . 0.0 112.22 -155.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 49.58 58.38 5.48 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.384 1.074 . . . . 0.0 112.179 -175.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.7 m -143.84 166.66 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 121.503 1.956 . . . . 0.0 106.189 -173.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 96.3 p -85.55 160.72 19.59 Favored 'General case' 0 C--O 1.241 0.63 0 O-C-N 116.938 -3.601 . . . . 0.0 108.254 168.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . 0.26 5.2 mt-10 -65.93 -28.97 69.32 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 111.41 -2.632 . . . . 0.0 111.775 173.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -61.28 -36.43 80.03 Favored 'General case' 0 CA--C 1.514 -0.434 0 O-C-N 117.947 -2.97 . . . . 0.0 117.428 166.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.4 mm -59.74 -37.03 69.3 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.449 0 CA-C-N 119.35 0.977 . . . . 0.0 108.867 168.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.346 40.0 t -59.57 -44.29 92.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 O-C-N 119.403 -2.06 . . . . 0.0 110.55 -178.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.1 mttt -58.93 -37.33 76.45 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 127.904 2.482 . . . . 0.0 112.03 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -75.53 -21.56 57.85 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 130.808 3.643 . . . . 0.0 112.668 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.9 m-30 -82.35 -47.68 12.05 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 101.685 -3.45 . . . . 0.0 101.685 167.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -54.38 -25.89 27.01 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 126.668 1.987 . . . . 0.0 108.78 -166.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.9 p -105.21 -14.8 15.25 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 128.674 3.734 . . . . 0.0 114.184 -174.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.32 18.13 79.8 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 114.267 -3.519 . . . . 0.0 117.501 -167.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -74.6 -19.17 60.41 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 114.624 -2.608 . . . . 0.0 113.597 175.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . 0.31 43.1 tp -147.41 148.71 31.58 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 129.556 3.142 . . . . 0.0 112.593 177.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -106.6 147.08 34.33 Favored Pre-proline 0 N--CA 1.449 -0.522 0 N-CA-C 120.681 3.585 . . . . 0.0 120.681 168.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -60.08 153.88 55.21 Favored 'Trans proline' 0 N--CA 1.449 -1.104 1 C-N-CA 126.654 4.902 . . . . 0.0 114.306 176.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.469 ' H ' ' HB2' ' A' ' 66' ' ' GLN . 58.6 p -98.91 -173.68 2.58 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 111.605 -2.543 . . . . 0.0 112.93 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.464 HG23 ' H ' ' A' ' 65' ' ' SER . 16.0 tt -50.57 -71.83 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 C-N-CA 130.3 3.44 . . . . 0.0 115.844 174.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.464 ' H ' HG23 ' A' ' 64' ' ' ILE . 15.2 p -56.04 -22.85 29.74 Favored 'General case' 0 C--N 1.328 -0.368 1 O-C-N 116.126 -4.109 . . . . 0.0 111.06 172.628 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.469 ' HB2' ' H ' ' A' ' 63' ' ' THR . 71.5 mt-30 -83.14 -53.94 5.41 Favored 'General case' 0 N--CA 1.449 -0.493 1 CA-C-O 110.307 -4.664 . . . . 0.0 107.642 -172.532 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -44.77 -50.84 9.92 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 128.189 3.431 . . . . 0.0 111.138 167.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.32 -55.02 32.57 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.141 1.776 . . . . 0.0 113.82 169.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -68.39 -31.05 70.14 Favored 'General case' 0 N--CA 1.446 -0.654 1 O-C-N 115.775 -4.328 . . . . 0.0 114.478 -177.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 35.9 mt -56.33 -68.02 0.25 Allowed 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 131.042 3.737 . . . . 0.0 106.648 165.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -43.75 -29.58 0.54 Allowed 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 130.23 3.412 . . . . 0.0 110.268 176.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -74.88 -24.8 58.61 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 115.774 -2.06 . . . . 0.0 113.842 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.5 mt -80.44 -45.12 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 121.492 1.951 . . . . 0.0 107.937 162.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.492 ' C ' ' H ' ' A' ' 76' ' ' ILE . 89.3 mt -76.71 -44.1 34.79 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 123.268 1.508 . . . . 0.0 109.363 -153.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.63 -4.78 0.94 Allowed Glycine 0 C--N 1.338 0.653 0 O-C-N 120.101 -1.625 . . . . 0.0 111.891 -172.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.492 ' H ' ' C ' ' A' ' 74' ' ' LEU . 5.7 pt -102.41 170.97 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 C-N-CA 124.845 1.258 . . . . 0.0 109.119 170.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -163.96 174.61 11.22 Favored 'General case' 0 C--O 1.22 -0.46 0 O-C-N 127.661 3.1 . . . . 0.0 107.252 169.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 17.0 mt . . . . . 0 N--CA 1.445 -0.708 0 O-C-N 119.363 -2.086 . . . . 0.0 109.178 175.691 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 57.7 t80 . . . . . 0 N--CA 1.444 -0.728 0 CA-C-O 123.268 1.509 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . 0.373 1.9 p90 -60.39 78.45 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 1 C-N-CA 132.684 4.394 . . . . 0.0 116.221 170.057 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.405 ' HA ' ' HB3' ' A' ' 28' ' ' LYS . 89.4 mttt -90.59 -18.04 25.89 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 116.284 -1.817 . . . . 0.0 113.559 176.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.409 HD13 ' H ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -60.33 -34.18 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 2 CA-C-N 129.096 5.407 . . . . 0.0 109.858 168.282 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.283 89.2 mt -65.04 -53.86 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 C-N-CA 129.338 3.055 . . . . 0.0 109.933 170.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.405 ' HB3' ' HA ' ' A' ' 25' ' ' LYS . 38.6 tttm -53.92 -46.66 71.54 Favored 'General case' 0 CA--C 1.509 -0.597 0 O-C-N 117.062 -3.524 . . . . 0.0 116.646 -173.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.8 p -56.73 -40.25 75.38 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.925 1.69 . . . . 0.0 111.615 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.96 -50.44 28.9 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 127.704 2.402 . . . . 0.0 113.804 173.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -58.66 -22.79 57.82 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 116.062 -1.923 . . . . 0.0 108.258 177.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -71.48 -48.95 45.88 Favored 'General case' 0 N--CA 1.446 -0.66 2 CA-C-N 128.574 5.17 . . . . 0.0 108.364 173.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -62.51 -47.01 85.82 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 124.691 2.186 . . . . 0.0 106.181 -169.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.317 39.5 mt -75.45 -10.81 59.78 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 115.645 1.721 . . . . 0.0 115.645 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.11 -4.25 0.08 OUTLIER Glycine 0 C--O 1.218 -0.884 0 N-CA-C 119.849 2.7 . . . . 0.0 119.849 177.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.4 pt -50.67 129.47 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 119.936 3.309 . . . . 0.0 119.936 -175.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 94.0 p -69.81 177.05 3.25 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.929 1.291 . . . . 0.0 112.27 177.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -57.35 -43.64 83.62 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 118.346 -1.341 . . . . 0.0 114.428 164.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -61.34 -39.7 91.53 Favored 'General case' 0 N--CA 1.451 -0.401 1 O-C-N 115.993 -4.192 . . . . 0.0 111.866 -177.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -73.68 -32.71 64.09 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.4 tp -61.31 -43.15 99.35 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.125 0.97 . . . . 0.0 113.253 161.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.71 -39.66 71.36 Favored 'General case' 0 N--CA 1.442 -0.826 0 O-C-N 119.842 -1.787 . . . . 0.0 111.512 171.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -66.04 -32.44 73.92 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 117.885 2.55 . . . . 0.0 117.885 170.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.446 ' HE2' HG23 ' A' ' 76' ' ' ILE . 19.4 tptt -64.82 -14.22 58.48 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 127.675 2.39 . . . . 0.0 107.699 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.8 tp -133.09 -4.62 3.09 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 116.394 -3.941 . . . . 0.0 114.546 -156.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt 62.52 27.63 16.34 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 131.057 3.743 . . . . 0.0 114.423 178.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.82 178.17 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 C-N-CA 129.857 3.263 . . . . 0.0 111.443 -163.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.2 p -88.2 162.5 16.64 Favored 'General case' 0 N--CA 1.443 -0.803 0 O-C-N 118.508 -2.62 . . . . 0.0 115.441 176.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -63.19 -16.38 59.94 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 119.631 -1.918 . . . . 0.0 113.704 167.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -71.95 -22.45 61.46 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 171.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . 0.283 39.0 mt -72.87 -36.26 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 C-N-CA 130.7 3.6 . . . . 0.0 116.446 164.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.317 1.5 m -80.81 -49.84 17.82 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 CA-C-O 117.157 -1.401 . . . . 0.0 111.917 -176.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.548 ' HA ' ' HB2' ' A' ' 56' ' ' GLU . 57.6 mttp -37.59 -27.99 0.02 OUTLIER 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 130.2 3.4 . . . . 0.0 118.922 166.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -40.04 -55.72 2.01 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.525 1.13 . . . . 0.0 109.207 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -100.04 -32.08 11.12 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 117.894 -3.004 . . . . 0.0 112.887 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 53' ' ' LYS . 4.4 mm-40 -47.9 -27.64 2.25 Favored 'General case' 0 N--CA 1.447 -0.577 1 N-CA-C 123.282 4.549 . . . . 0.0 123.282 168.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.2 m -77.69 -6.39 53.74 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.238 1.415 . . . . 0.0 113.379 -171.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.49 6.91 84.98 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 119.867 -1.158 . . . . 0.0 113.785 151.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -76.08 6.4 5.37 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 120.607 -1.525 . . . . 0.0 113.893 -174.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.416 ' CD2' HE22 ' A' ' 66' ' ' GLN . 1.2 tp -143.18 163.68 32.25 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 -164.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -98.27 126.13 40.92 Favored Pre-proline 0 N--CA 1.443 -0.813 0 O-C-N 124.36 1.037 . . . . 0.0 110.645 165.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.25 174.01 13.54 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 CA-C-N 120.924 1.366 . . . . 0.0 112.319 -174.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.8 p -135.97 -174.7 3.74 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 125.215 1.406 . . . . 0.0 113.207 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.6 -51.91 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 127.226 2.21 . . . . 0.0 112.437 177.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.2 p -62.9 -31.51 72.59 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 173.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.416 HE22 ' CD2' ' A' ' 60' ' ' LEU . 76.3 mt-30 -66.3 -63.78 1.0 Allowed 'General case' 0 C--N 1.349 0.585 0 O-C-N 116.734 -3.729 . . . . 0.0 104.539 172.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -37.3 -41.41 0.41 Allowed 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 172.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.8 ttt85 -65.03 -53.88 39.0 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 125.859 1.974 . . . . 0.0 114.977 176.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -69.5 -40.28 77.11 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 126.87 2.606 . . . . 0.0 108.175 -172.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 13.2 mt -56.25 -63.08 1.3 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 131.45 3.9 . . . . 0.0 113.697 -177.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -46.6 -30.15 2.16 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 126.896 2.622 . . . . 0.0 111.519 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -75.24 -58.29 3.37 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 118.36 -0.829 . . . . 0.0 111.985 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.7 pt -65.13 -44.8 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 119.562 1.074 . . . . 0.0 113.164 -168.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 77.9 mt -76.65 -3.55 38.43 Favored 'General case' 0 N--CA 1.452 -0.354 1 O-C-N 115.332 -4.605 . . . . 0.0 115.384 -152.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.22 8.44 8.85 Favored Glycine 0 C--O 1.223 -0.577 0 CA-C-O 116.951 -2.027 . . . . 0.0 115.481 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.446 HG23 ' HE2' ' A' ' 44' ' ' LYS . 28.0 pt -136.56 155.49 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 122.538 3.169 . . . . 0.0 108.882 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.371 23.5 pttm 163.48 142.06 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 130.637 3.575 . . . . 0.0 116.336 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 78' ' ' LEU . 19.8 mt . . . . . 0 CA--C 1.518 -0.28 0 CA-C-N 122.704 2.502 . . . . 0.0 110.213 -171.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.309 55.3 t80 . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -74.23 77.45 1.81 Allowed 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 117.001 2.222 . . . . 0.0 117.001 -176.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -57.79 -32.52 67.61 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 129.913 3.285 . . . . 0.0 111.613 -171.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.2 pt -67.43 -37.79 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 120.191 -0.603 . . . . 0.0 109.53 -176.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.29 26.7 mm -59.17 -43.38 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 125.288 2.47 . . . . 0.0 112.651 -175.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.46 34.2 tttm -43.45 -75.42 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 131.072 3.749 . . . . 0.0 114.9 -156.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.3 m -53.96 -43.63 70.07 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 129.147 2.979 . . . . 0.0 112.729 -168.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.43 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . . . -64.7 -48.26 75.32 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 118.936 2.939 . . . . 0.0 118.936 177.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -60.35 -37.38 80.5 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.183 0.993 . . . . 0.0 110.823 170.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -69.32 -33.06 72.58 Favored 'General case' 0 N--CA 1.438 -1.042 1 O-C-N 115.531 -4.48 . . . . 0.0 113.623 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . 0.29 76.7 mt-30 -60.09 -26.51 66.25 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 124.534 1.146 . . . . 0.0 109.297 172.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.3 mt -78.28 -23.4 47.22 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 127.363 2.265 . . . . 0.0 113.527 -177.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.83 0.67 9.18 Favored Glycine 0 C--N 1.341 0.823 0 N-CA-C 118.052 1.981 . . . . 0.0 118.052 -174.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.2 pt -69.61 151.02 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 2 N-CA-C 123.935 4.791 . . . . 0.0 123.935 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 56.9 p -108.3 174.33 5.93 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 123.823 1.773 . . . . 0.0 114.862 -165.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -56.99 -26.44 60.17 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -55.75 -37.04 67.97 Favored 'General case' 0 C--O 1.222 -0.358 0 O-C-N 120.579 -1.326 . . . . 0.0 110.647 176.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -64.81 -40.47 95.27 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 116.879 -3.638 . . . . 0.0 113.211 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . 0.347 24.1 tp -61.74 -43.23 99.25 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 130.292 3.437 . . . . 0.0 111.026 173.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . 0.25 . . -60.91 -43.95 97.85 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 112.923 -1.944 . . . . 0.0 112.339 178.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -67.72 -34.92 77.81 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 112.421 -3.657 . . . . 0.0 111.84 167.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.6 tptt -67.18 -24.05 65.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 125.54 3.791 . . . . 0.0 115.83 -174.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.8 tp -125.17 3.93 7.87 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 128.473 2.709 . . . . 0.0 108.852 -160.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.252 79.9 mttt 44.99 66.79 0.82 Allowed 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 129.803 3.241 . . . . 0.0 111.845 -174.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.5 m -148.11 170.12 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 C-N-CA 130.674 3.59 . . . . 0.0 113.389 174.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.3 p -94.03 159.08 15.32 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 -169.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -67.62 -16.02 63.95 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 118.174 -2.829 . . . . 0.0 115.158 175.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -49.41 -47.17 48.14 Favored 'General case' 0 C--O 1.248 0.982 0 CA-C-N 121.956 2.162 . . . . 0.0 114.152 156.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 27.8 mt -77.07 -27.39 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 O-C-N 121.744 -0.598 . . . . 0.0 111.96 -175.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.5 m -79.45 -47.71 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-O 118.484 -0.77 . . . . 0.0 110.456 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -53.71 -28.11 32.03 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 121.575 1.989 . . . . 0.0 112.986 -165.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -44.38 -57.45 3.52 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 118.563 2.801 . . . . 0.0 118.563 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -95.91 -26.72 15.49 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 119.6 1.091 . . . . 0.0 110.729 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -51.19 -27.63 9.28 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 121.348 -0.845 . . . . 0.0 109.729 172.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.2 p -98.45 0.63 45.6 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 116.984 2.216 . . . . 0.0 116.984 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.76 6.84 89.14 Favored Glycine 0 CA--C 1.525 0.707 0 O-C-N 118.374 -2.704 . . . . 0.0 115.872 -172.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -96.44 -2.62 45.03 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 119.553 1.677 . . . . 0.0 114.164 -168.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 36.9 tp -145.46 130.26 18.14 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 126.592 1.957 . . . . 0.0 106.769 -174.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.6 tttt -81.71 126.88 74.58 Favored Pre-proline 0 C--O 1.221 -0.447 0 CA-C-O 114.935 -2.459 . . . . 0.0 110.726 165.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -82.64 178.05 6.43 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 124.51 3.474 . . . . 0.0 106.389 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.498 ' H ' ' HB3' ' A' ' 66' ' ' GLN . 42.6 p -96.46 167.69 11.0 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -159.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . 0.314 1.9 tt -51.27 -49.45 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 171.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.28 99.3 p -54.92 -55.33 31.82 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 120.621 1.555 . . . . 0.0 112.433 162.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.498 ' HB3' ' H ' ' A' ' 63' ' ' THR . 48.6 tt0 -71.1 -35.2 71.71 Favored 'General case' 0 CA--C 1.515 -0.371 1 CA-C-O 111.503 -4.094 . . . . 0.0 112.796 -163.533 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.77 -43.37 98.98 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 125.288 3.677 . . . . 0.0 109.112 169.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -62.17 -42.42 99.25 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 117.468 -3.27 . . . . 0.0 106.16 174.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -72.68 -30.44 64.25 Favored 'General case' 0 C--O 1.222 -0.385 1 O-C-N 116.01 -4.181 . . . . 0.0 115.34 176.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 70' ' ' LEU . 6.1 mt -54.27 -76.3 0.03 OUTLIER 'General case' 0 C--O 1.243 0.719 0 C-N-CA 130.238 3.415 . . . . 0.0 109.727 -169.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -48.08 -26.75 1.97 Allowed 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 129.035 2.934 . . . . 0.0 108.944 -177.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -88.15 -40.36 13.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 113.822 -2.99 . . . . 0.0 111.424 -166.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 12.8 pt -68.83 -40.36 81.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 128.583 3.677 . . . . 0.0 109.015 173.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 74' ' ' LEU . 74.1 mt -68.76 -26.0 65.01 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 120.323 -1.486 . . . . 0.0 110.661 -173.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.18 -18.76 0.06 OUTLIER Glycine 0 CA--C 1.528 0.863 0 CA-C-O 114.535 -3.369 . . . . 0.0 112.735 -172.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.1 pt -115.26 164.86 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 120.08 1.94 . . . . 0.0 113.328 -165.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.3 pttm -176.01 170.14 2.77 Favored 'General case' 0 CA--C 1.519 -0.226 1 C-N-CA 133.431 4.692 . . . . 0.0 111.093 177.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.43 ' HG ' ' HB2' ' A' ' 30' ' ' ALA . 57.4 mt . . . . . 0 CA--C 1.517 -0.324 0 C-N-CA 128.636 2.775 . . . . 0.0 110.615 154.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.0 t80 . . . . . 0 C--O 1.222 -0.383 0 CA-C-O 125.081 2.372 . . . . 0.0 104.641 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -70.66 157.8 37.34 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 117.36 -3.337 . . . . 0.0 113.196 -166.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -140.89 14.18 2.28 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 127.149 2.179 . . . . 0.0 113.259 -146.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -35.7 -57.11 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.805 1 O-C-N 114.888 -4.882 . . . . 0.0 113.886 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.407 HD11 HD22 ' A' ' 70' ' ' LEU . 11.7 pt -119.14 4.2 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 113.457 -1.701 . . . . 0.0 110.719 -165.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -47.95 -64.13 0.88 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.066 1.746 . . . . 0.0 114.912 -175.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.5 p -53.95 -46.58 71.63 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.283 1.833 . . . . 0.0 115.888 -174.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.58 -44.26 65.8 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 109.776 -3.375 . . . . 0.0 114.645 176.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -48.41 -44.7 35.28 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 118.551 -2.593 . . . . 0.0 112.772 169.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -72.14 -47.5 50.58 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 120.384 -1.448 . . . . 0.0 114.532 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -66.75 -25.69 66.62 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 128.641 2.776 . . . . 0.0 111.325 -167.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.5 mt -88.1 -17.05 31.87 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 127.417 2.287 . . . . 0.0 110.315 -174.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.32 11.27 58.96 Favored Glycine 0 C--O 1.243 0.674 0 CA-C-O 123.309 1.505 . . . . 0.0 113.99 177.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.9 pt -75.54 144.76 11.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 129.094 2.958 . . . . 0.0 114.202 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.5 p -93.2 166.3 12.39 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -175.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -58.71 -35.86 73.33 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.191 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -70.11 -37.37 75.35 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 115.906 -1.997 . . . . 0.0 108.132 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -66.87 -29.98 70.02 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 115.568 -2.158 . . . . 0.0 112.661 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.7 tt -78.96 -36.52 41.44 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-O 126.315 2.959 . . . . 0.0 111.836 176.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.93 -40.5 66.8 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 119.447 -2.033 . . . . 0.0 112.224 167.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -70.6 -37.07 73.85 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 118.845 -2.409 . . . . 0.0 111.007 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -66.39 -14.3 61.92 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 129.554 3.141 . . . . 0.0 110.438 -172.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.3 mt -131.01 -1.59 4.09 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 126.832 3.206 . . . . 0.0 112.781 -164.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.274 40.8 mtmt 56.39 -26.19 0.02 OUTLIER 'General case' 0 C--O 1.241 0.615 0 N-CA-C 121.094 3.739 . . . . 0.0 121.094 -162.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.9 m -83.61 172.21 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 C-N-CA 129.504 3.122 . . . . 0.0 111.378 -168.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 91.7 p -92.48 158.33 16.08 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 119.556 -1.965 . . . . 0.0 111.334 -153.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.409 ' HA ' HG22 ' A' ' 52' ' ' VAL . 18.3 mt-10 -61.56 -32.58 72.66 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 126.143 1.777 . . . . 0.0 108.031 177.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -65.3 -31.57 72.78 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 168.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.9 mt -67.98 -38.79 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 124.407 2.051 . . . . 0.0 112.555 172.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.409 HG22 ' HA ' ' A' ' 49' ' ' GLU 0.297 32.6 m -80.07 -30.78 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 1 O-C-N 116.042 -4.161 . . . . 0.0 114.122 -176.777 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -53.13 -38.69 62.88 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 126.392 1.877 . . . . 0.0 109.806 155.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -71.93 -38.42 69.87 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 126.296 1.838 . . . . 0.0 106.046 -174.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -66.97 -41.46 86.82 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 121.59 1.995 . . . . 0.0 108.662 173.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.42 -14.96 62.76 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 114.464 -2.684 . . . . 0.0 111.562 -172.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.6 p -113.09 -1.68 14.36 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 123.495 2.861 . . . . 0.0 111.137 -175.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.06 28.47 73.57 Favored Glycine 0 C--N 1.343 0.922 0 O-C-N 128.665 3.728 . . . . 0.0 119.24 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -85.17 7.24 22.55 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 131.501 3.921 . . . . 0.0 113.216 -171.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.6 tt -137.17 144.2 42.8 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 127.402 2.281 . . . . 0.0 109.501 -166.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.1 tttt -83.04 126.6 72.06 Favored Pre-proline 0 C--O 1.24 0.587 0 CA-C-O 116.455 -1.736 . . . . 0.0 110.23 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -82.0 150.64 16.06 Favored 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 124.64 3.56 . . . . 0.0 112.504 -168.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.3 p -123.07 164.64 18.22 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 123.937 1.827 . . . . 0.0 113.669 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.0 pt -62.66 -50.27 80.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 O-C-N 118.715 -2.491 . . . . 0.0 113.443 174.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 99.3 p -54.67 -21.57 11.08 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 121.871 2.123 . . . . 0.0 116.649 170.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -75.33 -75.84 0.16 Allowed 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.911 177.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -12.52 -62.66 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 117.884 2.549 . . . . 0.0 117.884 150.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -56.83 -49.85 74.16 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 127.474 2.31 . . . . 0.0 107.741 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -62.49 -44.29 96.73 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 116.413 -1.756 . . . . 0.0 106.886 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.407 HD22 HD11 ' A' ' 27' ' ' ILE . 43.5 mt -63.43 -47.39 82.1 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 115.29 -2.29 . . . . 0.0 109.851 -167.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -50.98 -22.73 2.43 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 170.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.7 mttp -94.48 -52.34 4.37 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 -176.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 24.1 pt -44.24 -49.93 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 127.243 2.217 . . . . 0.0 115.471 -167.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.3 mt -77.67 -2.49 36.27 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 121.549 1.977 . . . . 0.0 109.89 -169.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.95 0.51 60.37 Favored Glycine 0 CA--C 1.522 0.478 0 O-C-N 125.535 1.772 . . . . 0.0 111.834 -169.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 76' ' ' ILE . 29.6 pt -149.88 167.62 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 O-C-N 117.639 -3.271 . . . . 0.0 113.64 -178.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.77 163.78 1.17 Allowed 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 126.885 2.074 . . . . 0.0 109.471 -177.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.9 mt . . . . . 0 N--CA 1.449 -0.502 0 CA-C-N 121.132 1.787 . . . . 0.0 109.972 -174.056 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.3 t80 . . . . . 0 N--CA 1.44 -0.929 0 CA-C-O 116.675 -1.631 . . . . 0.0 107.0 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -100.02 -173.31 2.41 Favored 'General case' 0 CA--C 1.518 -0.255 0 O-C-N 128.457 3.598 . . . . 0.0 118.054 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -59.18 -24.04 62.74 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 119.199 3.037 . . . . 0.0 119.199 -175.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.9 pt -30.42 -35.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 119.908 3.299 . . . . 0.0 119.908 145.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.1 tp -137.31 -42.94 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 121.693 2.042 . . . . 0.0 114.495 177.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.361 79.5 tttt -40.99 -58.51 1.7 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 131.07 3.748 . . . . 0.0 118.313 173.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 74.9 p -83.48 -29.7 27.78 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 113.433 -1.712 . . . . 0.0 109.087 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.12 -51.23 62.49 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.937 1.295 . . . . 0.0 110.516 -160.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -46.51 -38.07 8.79 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 126.901 2.626 . . . . 0.0 112.879 174.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -73.87 -41.34 62.33 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 129.512 3.125 . . . . 0.0 113.462 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . 0.29 43.5 mt-30 -68.66 -16.31 63.79 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.447 ' HA ' HD12 ' A' ' 34' ' ' LEU . 14.0 tp -95.99 -14.51 22.96 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 112.453 -2.158 . . . . 0.0 112.157 175.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.64 -0.63 34.13 Favored Glycine 0 CA--C 1.523 0.564 1 C-N-CA 131.037 4.16 . . . . 0.0 117.309 172.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.6 pt -69.03 155.97 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 C-N-CA 126.233 1.813 . . . . 0.0 113.78 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 93.7 p -90.63 171.84 9.09 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -176.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -59.25 -42.97 92.37 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -64.9 -41.12 95.86 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 119.242 -2.161 . . . . 0.0 109.172 -175.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -64.74 -39.41 93.59 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 119.181 -2.2 . . . . 0.0 114.066 174.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.4 tp -64.04 -38.64 91.82 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 126.768 2.027 . . . . 0.0 114.166 -173.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.12 -49.76 76.63 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-O 123.899 1.809 . . . . 0.0 107.99 173.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -64.56 -14.34 57.12 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 117.53 -3.231 . . . . 0.0 108.669 -175.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -103.54 -16.88 15.41 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 117.591 -3.193 . . . . 0.0 118.504 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 86.2 mt -135.2 15.06 3.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 120.672 -1.267 . . . . 0.0 113.723 -165.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 70.7 mttt 45.6 -27.38 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.419 1 C-N-CA 134.255 5.022 . . . . 0.0 117.931 -154.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.7 m -86.86 145.37 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 122.348 2.34 . . . . 0.0 116.419 -163.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.2 p -81.36 160.75 24.04 Favored 'General case' 0 N--CA 1.449 -0.517 1 N-CA-C 122.439 4.237 . . . . 0.0 122.439 -168.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.79 -17.24 0.33 Allowed 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 125.367 3.712 . . . . 0.0 116.962 165.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -86.68 -35.51 19.26 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 126.503 1.921 . . . . 0.0 112.055 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.9 mm -55.16 -36.76 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-O 124.197 1.951 . . . . 0.0 110.137 167.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.3 t -59.6 -65.28 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-O 115.274 -2.298 . . . . 0.0 111.007 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -44.24 -43.53 7.34 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 126.526 2.391 . . . . 0.0 114.134 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -54.34 -50.42 67.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 176.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -91.29 -40.42 11.51 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.645 1.178 . . . . 0.0 109.196 -171.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -43.58 -36.6 2.16 Favored 'General case' 0 N--CA 1.434 -1.266 0 O-C-N 118.352 -2.718 . . . . 0.0 111.567 166.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 76.1 p -90.13 -2.55 58.1 Favored 'General case' 0 C--O 1.237 0.436 1 O-C-N 116.176 -4.078 . . . . 0.0 114.371 -172.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.97 12.71 79.2 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 120.14 2.816 . . . . 0.0 120.14 -175.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -87.22 -28.42 22.39 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.624 1.97 . . . . 0.0 112.421 -168.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.1 tp -151.79 131.66 13.32 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 128.584 2.753 . . . . 0.0 111.743 -170.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -117.45 -179.62 0.67 Allowed Pre-proline 0 N--CA 1.447 -0.605 0 CA-C-O 114.935 -2.46 . . . . 0.0 108.807 165.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -46.36 150.82 1.99 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 1 C-N-CA 125.637 4.225 . . . . 0.0 116.335 -175.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.6 p -127.98 -175.11 3.39 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 128.488 2.715 . . . . 0.0 114.433 -173.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.0 tp -60.56 -54.15 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.502 1.121 . . . . 0.0 108.078 175.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 88.0 p -69.19 -16.99 63.75 Favored 'General case' 0 C--N 1.34 0.194 0 O-C-N 117.335 -3.353 . . . . 0.0 111.928 -175.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -98.76 -47.23 5.39 Favored 'General case' 0 CA--C 1.514 -0.427 0 O-C-N 116.999 -3.563 . . . . 0.0 111.145 -175.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.95 -55.67 31.57 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 125.892 1.995 . . . . 0.0 115.875 -149.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -52.24 -54.41 31.57 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 120.968 1.713 . . . . 0.0 114.092 -167.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -60.94 -40.28 92.67 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 119.417 -2.052 . . . . 0.0 114.926 167.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tt -55.23 -55.76 27.64 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 130.976 3.71 . . . . 0.0 108.331 -172.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -48.4 -48.61 36.87 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 125.077 2.37 . . . . 0.0 111.127 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -73.72 -36.33 65.19 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 119.078 -2.263 . . . . 0.0 113.035 -164.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 24.3 pt -66.48 -27.95 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 O-C-N 124.058 0.849 . . . . 0.0 112.995 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.269 1.1 pt? 164.93 -21.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 130.891 3.676 . . . . 0.0 111.228 173.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.82 29.35 59.38 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-O 123.019 1.344 . . . . 0.0 113.14 -170.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . 0.324 4.2 pt 64.46 7.7 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.706 1 C-N-CA 131.909 4.084 . . . . 0.0 113.037 165.609 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -68.44 151.6 46.6 Favored 'General case' 0 CA--C 1.515 -0.369 1 CA-C-O 111.102 -4.285 . . . . 0.0 112.333 174.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . 0.289 12.6 mt . . . . . 0 CA--C 1.517 -0.323 0 CA-C-N 125.61 3.823 . . . . 0.0 112.9 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.6 t80 . . . . . 0 N--CA 1.448 -0.56 0 CA-C-O 123.933 1.825 . . . . 0.0 114.232 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -70.6 127.53 33.01 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 -170.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -101.21 -15.57 17.28 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 125.298 1.439 . . . . 0.0 113.002 -174.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.9 pt -70.77 -25.63 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 120.571 1.532 . . . . 0.0 111.31 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.429 40.3 pt -60.36 -35.58 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 C-N-CA 127.702 2.401 . . . . 0.0 108.16 171.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.355 8.8 ttpt -44.0 -72.74 0.05 Allowed 'General case' 0 N--CA 1.454 -0.272 1 C-N-CA 132.266 4.227 . . . . 0.0 115.951 -159.548 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.9 m -72.12 -21.87 61.41 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.111 0.964 . . . . 0.0 111.948 -165.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.473 ' HB1' HD12 ' A' ' 76' ' ' ILE . . . -76.71 -59.95 2.56 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 128.081 2.552 . . . . 0.0 107.872 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -43.77 -35.11 1.75 Allowed 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 127.77 2.428 . . . . 0.0 108.143 169.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . 0.304 17.2 tt0 -73.45 -41.23 63.46 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 122.42 2.373 . . . . 0.0 115.402 173.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -61.51 -19.7 62.37 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 121.564 1.984 . . . . 0.0 111.973 171.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 34' ' ' LEU . 8.1 tp -71.77 -34.64 69.62 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 123.503 1.621 . . . . 0.0 111.188 -173.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.57 -12.97 8.94 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-N 110.804 -2.907 . . . . 0.0 112.557 173.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.4 pt -70.79 154.54 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 O-C-N 120.383 -1.657 . . . . 0.0 110.403 -171.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 84.4 p -96.46 175.05 6.55 Favored 'General case' 0 N--CA 1.437 -1.106 0 O-C-N 118.265 -2.772 . . . . 0.0 113.473 -166.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -51.16 -40.85 59.51 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 113.437 -3.173 . . . . 0.0 113.95 161.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . 0.293 25.2 mp0 -61.16 -40.41 93.77 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 127.822 3.201 . . . . 0.0 110.002 -175.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -72.75 -34.57 67.11 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 119.706 -1.871 . . . . 0.0 113.586 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 63.1 tp -73.35 -27.68 61.64 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 122.682 1.229 . . . . 0.0 113.601 -176.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.77 -36.73 81.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 116.301 -1.809 . . . . 0.0 107.082 169.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . 0.277 87.8 mm-40 -73.29 -31.28 63.95 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 127.662 2.385 . . . . 0.0 111.266 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.7 tptt -67.3 -24.61 65.77 Favored 'General case' 0 N--CA 1.442 -0.864 0 O-C-N 117.227 -3.421 . . . . 0.0 111.736 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.9 mt -124.96 -3.14 7.67 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 128.02 2.528 . . . . 0.0 109.992 -165.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.258 27.2 mtpt 52.32 5.54 0.04 OUTLIER 'General case' 0 C--O 1.233 0.224 0 C-N-CA 130.486 3.514 . . . . 0.0 118.736 -171.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.8 m -88.51 -168.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 128.386 2.674 . . . . 0.0 108.102 -173.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 90.9 p -100.1 158.87 15.53 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.911 1.284 . . . . 0.0 112.585 -173.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -52.33 -32.58 38.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 113.12 -1.855 . . . . 0.0 110.971 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -74.21 -31.12 62.5 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 175.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 67.7 mt -74.26 -34.63 37.87 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 O-C-N 118.459 -2.651 . . . . 0.0 112.196 174.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.41 11.2 m -64.22 -59.13 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 O-C-N 118.376 -2.703 . . . . 0.0 112.79 164.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -50.03 -18.91 0.61 Allowed 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 119.801 3.259 . . . . 0.0 119.801 175.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -58.95 -32.68 69.82 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 -171.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -93.91 -44.8 7.91 Favored 'General case' 0 CA--C 1.512 -0.5 0 O-C-N 126.148 2.155 . . . . 0.0 110.035 176.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -49.26 -30.82 7.76 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 127.606 2.362 . . . . 0.0 108.787 176.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.2 p -94.81 -28.09 15.43 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 117.443 -3.286 . . . . 0.0 114.253 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.58 9.52 56.44 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 118.556 -2.59 . . . . 0.0 113.776 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -88.76 45.1 1.26 Allowed 'General case' 0 N--CA 1.447 -0.606 1 C-N-CA 131.82 4.048 . . . . 0.0 113.222 -169.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.53 135.95 54.92 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 129.036 2.935 . . . . 0.0 112.844 -159.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.317 43.3 mtpt -109.78 76.19 0.91 Allowed Pre-proline 0 N--CA 1.445 -0.697 0 CA-C-O 114.656 -2.592 . . . . 0.0 115.612 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -84.06 157.91 13.36 Favored 'Trans proline' 0 C--N 1.329 -0.492 0 C-N-CA 124.861 3.707 . . . . 0.0 113.367 -158.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.669 ' H ' ' HB2' ' A' ' 66' ' ' GLN . 58.9 p -132.16 176.35 8.46 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 128.088 2.555 . . . . 0.0 112.943 168.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.413 HG12 ' H ' ' A' ' 64' ' ' ILE . 6.3 pt -48.02 -56.51 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 172.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.459 ' C ' HE21 ' A' ' 69' ' ' GLN . 90.8 p -47.34 -33.77 6.14 Favored 'General case' 0 C--N 1.342 0.244 0 O-C-N 117.468 -3.27 . . . . 0.0 115.916 166.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.669 ' HB2' ' H ' ' A' ' 63' ' ' THR . 62.4 mt-30 -75.01 -50.43 16.55 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 128.209 2.603 . . . . 0.0 112.28 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -42.62 -52.45 4.83 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 125.949 1.699 . . . . 0.0 111.458 162.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.9 mtm180 -63.82 -34.39 77.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 124.145 0.903 . . . . 0.0 111.824 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.459 HE21 ' C ' ' A' ' 65' ' ' SER . 35.5 mt-30 -80.36 -35.6 35.21 Favored 'General case' 0 CA--C 1.516 -0.351 0 O-C-N 119.695 -1.878 . . . . 0.0 112.634 -168.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.3 mt -73.69 -50.56 20.29 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 131.572 3.949 . . . . 0.0 115.264 -167.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -44.04 -34.92 1.9 Allowed 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.579 0.704 . . . . 0.0 112.215 158.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.2 mttp -98.35 10.31 41.04 Favored 'General case' 0 CA--C 1.513 -0.471 0 O-C-N 118.303 -2.748 . . . . 0.0 114.404 -165.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 20.7 pt -53.28 -50.85 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-O 125.652 2.644 . . . . 0.0 112.912 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 77.0 mt -106.43 0.67 25.01 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 118.919 -2.363 . . . . 0.0 115.901 176.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.33 0.61 11.36 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 126.617 2.055 . . . . 0.0 115.245 175.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.473 HD12 ' HB1' ' A' ' 30' ' ' ALA . 21.7 pt -116.42 -174.49 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 116.979 -3.659 . . . . 0.0 116.605 -177.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -173.93 147.6 1.32 Allowed 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 113.501 -3.143 . . . . 0.0 109.432 -173.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 31.5 mt . . . . . 0 N--CA 1.446 -0.641 0 O-C-N 125.931 2.019 . . . . 0.0 110.579 164.748 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.283 58.4 t80 . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 118.375 2.731 . . . . 0.0 118.375 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -46.25 143.8 2.28 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 131.194 3.798 . . . . 0.0 118.182 -154.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -98.99 -32.87 11.07 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 117.768 2.507 . . . . 0.0 117.768 -176.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.2 pt -63.07 -33.4 60.58 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 C-N-CA 126.698 1.999 . . . . 0.0 107.59 -172.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.36 1.8 pt -60.11 -38.81 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 114.035 -1.439 . . . . 0.0 112.252 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.454 45.9 tttm -45.83 -74.6 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 118.841 2.904 . . . . 0.0 118.841 -162.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.5 m -53.47 -32.71 51.3 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 129.706 3.202 . . . . 0.0 113.706 -174.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.28 -55.86 9.27 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 114.544 -2.646 . . . . 0.0 110.775 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . 0.276 11.9 ptm180 -57.35 -40.96 79.15 Favored 'General case' 0 N--CA 1.447 -0.604 1 CA-C-N 126.302 4.137 . . . . 0.0 110.673 171.606 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -51.1 -35.78 36.9 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 114.87 -2.49 . . . . 0.0 115.448 176.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -51.54 -42.57 61.88 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 121.687 2.04 . . . . 0.0 109.736 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 50.3 mt -80.94 -25.68 37.23 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 131.538 3.935 . . . . 0.0 109.514 -176.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 55.97 5.39 0.96 Allowed Glycine 0 C--O 1.22 -0.75 0 CA-C-N 112.665 -2.061 . . . . 0.0 116.199 -170.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.5 pt -60.35 148.06 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 126.685 1.994 . . . . 0.0 108.392 -163.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 88.6 p -133.18 -177.29 4.45 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 122.728 2.513 . . . . 0.0 110.581 170.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . 0.254 65.0 mt-30 -21.61 -61.34 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 113.419 -3.181 . . . . 0.0 116.197 -163.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -58.99 -51.95 67.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 124.484 3.311 . . . . 0.0 109.365 -173.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -67.2 -29.38 69.03 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 117.435 -1.269 . . . . 0.0 110.864 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.8 tp -80.91 -23.89 38.62 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.935 1.694 . . . . 0.0 112.197 -167.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.74 -45.62 67.08 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 131.598 3.959 . . . . 0.0 111.163 153.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -77.94 -21.47 51.03 Favored 'General case' 0 CA--C 1.51 -0.561 0 O-C-N 126.773 2.546 . . . . 0.0 110.688 178.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -83.11 -12.06 57.4 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 118.304 -2.748 . . . . 0.0 105.168 -169.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' A' ' 45' ' ' LEU . 21.8 tp -125.35 -9.58 6.95 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -173.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.7 mtmt 57.31 52.89 8.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 131.196 3.798 . . . . 0.0 112.335 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.1 m -124.79 177.22 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 1 C-N-CA 134.019 4.928 . . . . 0.0 113.138 -177.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 62.1 p -82.06 159.61 23.4 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 116.81 2.152 . . . . 0.0 116.81 168.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -64.07 -14.54 55.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 169.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -80.97 -23.2 38.93 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 119.803 -1.811 . . . . 0.0 113.238 170.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.0 mt -69.45 -43.63 80.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 118.293 -0.86 . . . . 0.0 112.911 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.8 m -68.57 -25.96 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 118.44 2.755 . . . . 0.0 118.44 -178.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -42.32 -48.3 5.0 Favored 'General case' 0 N--CA 1.432 -1.374 0 C-N-CA 130.204 3.402 . . . . 0.0 116.706 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.6 mtt85 -61.72 -39.62 92.18 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 123.682 2.946 . . . . 0.0 111.13 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -82.36 -33.99 28.6 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -168.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -64.93 -49.11 71.67 Favored 'General case' 0 N--CA 1.441 -0.876 0 O-C-N 118.649 -2.532 . . . . 0.0 109.145 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.6 p -80.16 -28.66 38.76 Favored 'General case' 0 C--O 1.243 0.739 0 O-C-N 118.745 -2.472 . . . . 0.0 112.908 -167.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.2 5.48 62.17 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -171.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -93.06 54.57 2.18 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 128.737 2.815 . . . . 0.0 112.433 -174.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . 0.252 62.7 tp -144.79 130.9 19.42 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 130.837 3.655 . . . . 0.0 107.241 -167.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.5 tttt -91.4 128.67 45.99 Favored Pre-proline 0 N--CA 1.45 -0.473 0 N-CA-C 119.156 3.021 . . . . 0.0 119.156 158.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -92.46 -172.03 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 1 C-N-CA 127.167 5.245 . . . . 0.0 107.722 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.264 17.4 p -156.33 174.37 15.5 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 128.058 2.543 . . . . 0.0 111.278 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.7 pt -63.18 -44.18 99.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 126.736 2.015 . . . . 0.0 113.752 166.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.5 p -66.68 -38.38 86.68 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 121.085 1.766 . . . . 0.0 112.284 164.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 67.8 mm-40 -69.9 -27.78 65.07 Favored 'General case' 0 N--CA 1.45 -0.429 2 O-C-N 111.299 -7.125 . . . . 0.0 115.377 -171.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . 0.257 . . -55.93 -74.08 0.05 Allowed 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 123.321 2.782 . . . . 0.0 114.382 -164.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.0 mmp_? -51.02 -21.88 2.03 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 126.329 1.852 . . . . 0.0 109.867 -178.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.569 ' C ' ' H ' ' A' ' 72' ' ' LYS . 61.0 mt-30 -77.22 -36.09 55.04 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 124.615 1.197 . . . . 0.0 112.817 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 40.0 mt -79.18 -41.13 29.13 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 128.25 2.62 . . . . 0.0 104.483 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -53.84 -26.73 25.83 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 118.025 -2.922 . . . . 0.0 111.254 154.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.569 ' H ' ' C ' ' A' ' 69' ' ' GLN . 51.2 tttt -79.36 -24.88 42.39 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 125.388 3.722 . . . . 0.0 115.222 -173.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . 0.406 24.0 pt -54.52 -69.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-N 125.603 3.82 . . . . 0.0 112.291 -165.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 82.6 mt -70.48 -20.92 62.82 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 130.276 3.431 . . . . 0.0 111.781 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.71 12.68 57.36 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 130.214 3.769 . . . . 0.0 118.775 174.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.5 pt -84.1 167.65 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.08 1 C-N-CA 132.385 4.274 . . . . 0.0 112.479 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.278 5.3 ptpt -175.94 144.84 0.63 Allowed 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 128.467 2.707 . . . . 0.0 114.413 175.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 31.4 mt . . . . . 0 C--N 1.327 -0.397 0 O-C-N 125.842 1.963 . . . . 0.0 109.153 163.974 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.8 t80 . . . . . 0 N--CA 1.449 -0.481 0 CA-C-O 123.871 1.796 . . . . 0.0 113.805 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -91.28 157.5 17.11 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 112.118 -2.31 . . . . 0.0 114.276 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.5 mttt -110.93 -46.44 3.34 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 -141.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.0 pt -67.6 -30.8 49.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 113.176 -3.297 . . . . 0.0 109.47 -174.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.372 20.1 pt -54.93 -49.68 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 C-N-CA 128.157 2.583 . . . . 0.0 110.12 178.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.347 74.8 mttt -29.66 -81.19 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.448 2 C-N-CA 132.418 4.287 . . . . 0.0 121.963 -174.332 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.0 p -75.82 -21.86 56.89 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 118.56 2.8 . . . . 0.0 118.56 -159.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.57 -21.83 63.02 Favored 'General case' 0 N--CA 1.439 -1.009 1 C-N-CA 133.973 4.909 . . . . 0.0 115.625 173.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . 0.282 6.6 ptm180 -44.15 -50.05 8.8 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 115.883 -2.008 . . . . 0.0 114.914 175.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -48.92 -33.24 10.42 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 126.634 1.974 . . . . 0.0 115.742 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -58.89 -25.48 63.4 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 118.605 -2.559 . . . . 0.0 112.708 -176.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.416 ' HB3' HG12 ' A' ' 36' ' ' ILE . 10.1 mp -96.32 -30.27 13.52 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.92 3.78 2.79 Favored Glycine 0 C--N 1.342 0.888 0 C-N-CA 127.943 2.687 . . . . 0.0 112.844 173.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.416 HG12 ' HB3' ' A' ' 34' ' ' LEU . 13.5 pt -66.5 154.03 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 120.344 2.072 . . . . 0.0 114.852 -173.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.0 p -71.79 161.85 30.34 Favored 'General case' 0 N--CA 1.443 -0.789 0 O-C-N 116.767 -3.708 . . . . 0.0 113.487 172.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -54.77 -46.44 74.4 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 114.604 -2.617 . . . . 0.0 108.489 173.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -61.74 -34.76 76.39 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 120.961 1.71 . . . . 0.0 111.068 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -80.43 -19.62 45.74 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 116.93 -1.908 . . . . 0.0 110.896 -175.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 66.8 tp -75.43 -46.51 32.23 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 125.856 2.741 . . . . 0.0 110.848 174.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.13 -39.31 66.36 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 118.551 -2.593 . . . . 0.0 110.953 173.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -63.86 -34.41 77.87 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 126.258 1.823 . . . . 0.0 115.918 160.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -73.97 -16.11 61.09 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 122.123 2.238 . . . . 0.0 107.693 -170.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.8 mt -123.09 -4.29 8.49 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 127.837 2.455 . . . . 0.0 112.51 -173.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.272 1.6 mptp? 43.23 56.74 4.08 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 118.652 2.834 . . . . 0.0 118.652 -167.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 31.9 m -127.7 175.77 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 1 C-N-CA 132.196 4.198 . . . . 0.0 108.583 -175.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 62.1 p -78.76 159.07 28.09 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 167.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -74.38 -13.29 60.71 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 128.229 3.455 . . . . 0.0 111.117 169.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -53.33 -50.56 64.72 Favored 'General case' 0 N--CA 1.447 -0.577 1 O-C-N 115.887 -4.258 . . . . 0.0 111.055 161.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.3 mm -59.14 -45.25 92.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 1 O-C-N 115.62 -4.425 . . . . 0.0 111.507 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.4 m -66.22 -49.29 77.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 115.173 -2.346 . . . . 0.0 106.258 -174.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.4 mtmm -50.53 -40.09 50.69 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 127.194 2.198 . . . . 0.0 113.754 173.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -60.95 -29.6 69.74 Favored 'General case' 0 C--N 1.345 0.393 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 172.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -72.46 -50.87 23.06 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 171.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -53.86 -51.92 62.08 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.984 1.714 . . . . 0.0 114.342 -173.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.5 p -74.87 -9.18 58.3 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 120.162 3.393 . . . . 0.0 120.162 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.67 16.76 80.08 Favored Glycine 0 C--O 1.243 0.713 1 CA-C-O 110.19 -5.783 . . . . 0.0 111.573 -169.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -89.83 51.84 2.17 Favored 'General case' 0 C--O 1.24 0.581 1 CA-C-N 126.839 5.32 . . . . 0.0 111.274 -172.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.9 tp -131.97 147.52 52.46 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -164.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.277 61.0 tttt -112.43 71.91 1.21 Allowed Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 113.717 -3.04 . . . . 0.0 111.743 168.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -83.6 -164.45 0.26 Allowed 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 124.552 3.501 . . . . 0.0 103.234 -166.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 p -153.57 174.39 14.51 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 130.841 3.657 . . . . 0.0 108.962 -169.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 28.9 pt -75.45 -48.15 31.9 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 CA-C-O 113.721 -3.038 . . . . 0.0 111.392 -174.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.8 p -58.91 -31.7 68.87 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 124.549 3.34 . . . . 0.0 112.826 166.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -68.47 -43.4 77.05 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 115.62 -2.134 . . . . 0.0 111.912 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -52.78 -44.28 66.45 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 114.44 -2.695 . . . . 0.0 111.28 165.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.2 mmp_? -56.4 -32.33 64.72 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 125.246 3.657 . . . . 0.0 110.585 170.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -82.31 -26.91 32.63 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 127.272 2.857 . . . . 0.0 111.276 -177.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.8 mt -60.54 -54.01 50.6 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 131.647 3.979 . . . . 0.0 107.463 167.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -50.6 -54.59 21.53 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 127.362 2.265 . . . . 0.0 109.013 174.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -67.54 -42.75 82.2 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 117.56 2.43 . . . . 0.0 117.56 -170.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.418 HG13 ' H ' ' A' ' 74' ' ' LEU 0.258 9.5 pt -48.74 -63.96 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 O-C-N 116.962 -3.586 . . . . 0.0 113.852 -175.305 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.418 ' H ' HG13 ' A' ' 73' ' ' ILE . 21.2 mt -75.88 -14.65 60.27 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 122.851 1.31 . . . . 0.0 113.228 -176.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.39 -13.65 10.55 Favored Glycine 0 CA--C 1.532 1.117 0 O-C-N 119.061 -2.274 . . . . 0.0 114.677 176.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.8 pt -92.67 162.37 2.41 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.736 0 C-N-CA 130.253 3.421 . . . . 0.0 115.238 -174.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.0 pttt -173.04 150.41 1.98 Allowed 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 129.846 3.258 . . . . 0.0 108.29 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.4 mt . . . . . 0 N--CA 1.45 -0.426 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 165.235 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.312 22.1 t80 . . . . . 0 N--CA 1.443 -0.775 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -75.59 129.08 36.61 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 125.843 1.965 . . . . 0.0 111.827 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -105.09 -21.21 13.31 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 127.831 2.452 . . . . 0.0 114.499 -175.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.8 pt -69.72 -38.1 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 1 O-C-N 115.923 -4.235 . . . . 0.0 113.794 -174.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.404 ' H ' HG12 ' A' ' 27' ' ' ILE 0.301 22.5 pt -67.84 -20.32 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 127.154 2.182 . . . . 0.0 115.184 179.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -67.09 -62.45 1.42 Allowed 'General case' 0 C--N 1.327 -0.38 1 N-CA-C 121.893 4.034 . . . . 0.0 121.893 -158.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . 0.471 76.0 p -67.1 -25.02 66.01 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 124.272 3.214 . . . . 0.0 117.154 -176.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.42 -29.3 61.41 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 117.714 2.487 . . . . 0.0 117.714 -171.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.7 ptt85 -50.59 -38.81 47.66 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 117.792 -3.068 . . . . 0.0 114.475 175.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -59.25 -29.02 67.24 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.076 1.75 . . . . 0.0 112.401 -176.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -55.98 -40.97 74.08 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 122.268 2.304 . . . . 0.0 112.663 -178.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 60.7 mt -75.45 -8.61 57.16 Favored 'General case' 0 CA--C 1.514 -0.409 0 O-C-N 127.448 2.968 . . . . 0.0 116.567 -158.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.41 -13.12 11.81 Favored Glycine 0 C--N 1.346 1.119 0 O-C-N 119.792 -1.817 . . . . 0.0 114.486 173.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.3 pt -88.24 163.42 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -164.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 96.1 p -84.18 177.62 8.14 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 118.869 -2.395 . . . . 0.0 112.406 -175.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . 0.322 27.5 tt0 -54.92 -50.14 69.56 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 120.299 1.409 . . . . 0.0 112.71 172.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -61.95 -29.57 70.32 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.333 1.853 . . . . 0.0 115.854 -176.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -78.62 -40.18 35.1 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 175.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . 0.299 5.7 tp -46.9 -44.51 19.77 Favored 'General case' 0 C--O 1.239 0.55 1 O-C-N 129.747 4.404 . . . . 0.0 110.329 165.593 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.65 -55.46 34.51 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 128.099 2.56 . . . . 0.0 112.377 173.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -63.56 -34.88 78.77 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 120.175 1.352 . . . . 0.0 112.645 174.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -63.72 -36.68 84.67 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 126.191 2.901 . . . . 0.0 108.911 -172.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.1 mp -99.29 -5.1 30.36 Favored 'General case' 0 N--CA 1.438 -1.052 1 C-N-CA 135.199 5.4 . . . . 0.0 113.44 -170.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt 55.0 57.51 5.55 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.663 1.185 . . . . 0.0 113.389 -177.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.9 m -151.6 -176.25 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 130.076 3.351 . . . . 0.0 111.445 -171.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 65.7 p -93.85 163.02 13.68 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 118.482 -2.636 . . . . 0.0 115.218 167.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -70.4 -18.13 63.03 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 119.124 0.874 . . . . 0.0 111.517 171.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -68.02 -34.67 76.94 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 114.815 -2.754 . . . . 0.0 118.32 160.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 27.8 mt -73.77 -39.57 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 O-C-N 116.766 -3.709 . . . . 0.0 109.998 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.331 11.9 m -59.01 -49.86 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 O-C-N 119.441 -2.037 . . . . 0.0 111.02 178.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -48.11 -43.51 31.07 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 129.868 3.267 . . . . 0.0 108.596 167.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -67.54 -32.43 73.2 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-N 123.184 2.72 . . . . 0.0 114.018 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -75.1 -39.49 60.61 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 129.797 3.239 . . . . 0.0 106.871 170.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 -60.1 -32.72 71.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 122.352 2.342 . . . . 0.0 108.595 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.6 p -112.15 -6.75 14.11 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -144.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.52 18.12 74.24 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-O 125.157 2.531 . . . . 0.0 114.402 -176.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -97.85 33.84 2.02 Favored 'General case' 0 N--CA 1.438 -1.025 1 O-C-N 115.423 -4.575 . . . . 0.0 113.704 -176.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.4 tp -130.65 129.73 43.02 Favored 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 130.492 3.517 . . . . 0.0 110.198 -178.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -101.65 102.7 23.73 Favored Pre-proline 0 N--CA 1.442 -0.853 0 CA-C-O 115.91 -1.995 . . . . 0.0 106.455 168.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -80.31 174.73 11.01 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 CA-C-N 120.372 1.169 . . . . 0.0 112.33 -171.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.453 ' H ' ' HB2' ' A' ' 66' ' ' GLN . 62.1 p -139.99 174.22 10.73 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 118.8 -2.437 . . . . 0.0 110.436 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.89 -32.52 56.25 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -171.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.3 p -56.83 -53.56 56.48 Favored 'General case' 0 CA--C 1.512 -0.498 2 O-C-N 112.643 -6.286 . . . . 0.0 112.906 158.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.453 ' HB2' ' H ' ' A' ' 63' ' ' THR . 57.6 mt-30 -67.14 -36.44 81.88 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 118.431 2.752 . . . . 0.0 118.431 -170.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -31.85 -73.74 0.03 OUTLIER 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 131.434 3.893 . . . . 0.0 116.451 163.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -56.04 -36.36 67.92 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.437 -1.71 . . . . 0.0 111.856 172.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -75.47 -25.87 57.74 Favored 'General case' 0 C--O 1.246 0.88 1 CA-C-O 111.509 -4.091 . . . . 0.0 111.735 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.5 mt -69.51 -41.53 75.92 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 126.617 2.448 . . . . 0.0 107.705 -176.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -55.14 -38.06 67.74 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 117.7 2.482 . . . . 0.0 117.7 165.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -87.97 -35.0 17.88 Favored 'General case' 0 C--O 1.225 -0.225 0 O-C-N 116.845 -3.659 . . . . 0.0 114.931 -168.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.9 pt -63.71 -44.11 98.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 122.466 2.394 . . . . 0.0 107.213 -175.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.4 tp -68.94 -24.43 64.27 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 126.073 1.749 . . . . 0.0 112.699 169.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.07 -20.07 0.09 OUTLIER Glycine 0 C--N 1.337 0.636 0 N-CA-C 117.218 1.647 . . . . 0.0 117.218 -174.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.1 pt -134.25 174.27 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -168.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -147.75 166.4 27.62 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 113.784 -3.008 . . . . 0.0 108.785 -170.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.9 mt . . . . . 0 N--CA 1.446 -0.627 0 C-N-CA 127.931 2.492 . . . . 0.0 112.556 160.194 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 84.4 t80 . . . . . 0 C--O 1.236 0.374 0 N-CA-C 117.459 2.392 . . . . 0.0 117.459 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -58.65 141.74 51.6 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 118.362 -2.711 . . . . 0.0 115.541 174.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -113.08 -14.95 12.89 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 116.95 2.204 . . . . 0.0 116.95 -164.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.42 ' CD1' ' HG2' ' A' ' 71' ' ' GLU . 0.9 OUTLIER -60.14 -48.64 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 O-C-N 124.488 1.118 . . . . 0.0 111.35 -166.741 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.519 6.4 pt -72.77 -23.54 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 128.046 2.538 . . . . 0.0 117.003 173.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 51.1 tttm -56.54 -67.61 0.29 Allowed 'General case' 0 C--O 1.243 0.717 0 N-CA-C 118.079 2.622 . . . . 0.0 118.079 -162.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 57.8 p -68.64 -35.82 77.79 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 121.595 1.998 . . . . 0.0 106.574 -172.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.48 -37.43 87.29 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.748 2.019 . . . . 0.0 114.468 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -54.02 -49.98 67.68 Favored 'General case' 0 N--CA 1.44 -0.938 2 O-C-N 112.401 -6.437 . . . . 0.0 112.273 166.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -63.2 -33.37 75.33 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 129.354 3.062 . . . . 0.0 111.265 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -76.47 -25.99 54.9 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 122.703 2.501 . . . . 0.0 108.59 -176.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.414 HD11 HD11 ' A' ' 76' ' ' ILE . 97.1 mt -76.7 -23.42 53.13 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 119.663 -1.898 . . . . 0.0 110.364 168.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.48 -14.89 6.28 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 122.327 2.33 . . . . 0.0 110.935 174.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.0 pt -71.14 155.92 7.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 O-C-N 118.392 -2.828 . . . . 0.0 113.9 -154.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . 0.309 78.8 p -74.18 175.84 7.16 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 127.84 3.213 . . . . 0.0 111.669 -177.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.77 -46.13 89.44 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 123.284 1.516 . . . . 0.0 110.292 161.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -59.07 -28.95 66.96 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 115.585 -2.15 . . . . 0.0 113.135 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -79.88 -29.17 39.92 Favored 'General case' 0 N--CA 1.446 -0.669 1 CA-C-O 111.461 -4.114 . . . . 0.0 111.47 174.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.5 tp -68.74 -34.97 76.49 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 125.205 3.638 . . . . 0.0 110.97 171.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.3 -41.53 80.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 121.382 1.901 . . . . 0.0 113.359 171.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -61.74 -42.42 98.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 127.192 2.808 . . . . 0.0 109.667 171.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -51.33 -32.35 25.03 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 127.089 3.328 . . . . 0.0 109.445 -172.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.5 mt -120.2 2.27 10.87 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 117.412 -3.305 . . . . 0.0 110.831 -153.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 77.2 mttt 47.17 -17.8 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.906 1 N-CA-C 123.725 4.713 . . . . 0.0 123.725 -159.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.3 m -94.91 156.42 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 130.15 3.38 . . . . 0.0 115.066 -172.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 84.5 p -72.39 168.09 19.15 Favored 'General case' 0 N--CA 1.441 -0.898 0 O-C-N 118.374 -2.704 . . . . 0.0 116.737 -177.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.443 ' HA ' HG22 ' A' ' 52' ' ' VAL . 21.5 pt-20 -65.91 -20.48 66.23 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 118.877 2.917 . . . . 0.0 118.877 -175.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -47.84 -34.19 8.41 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 118.234 2.679 . . . . 0.0 118.234 163.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.0 mm -80.78 -38.94 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 119.006 -1.078 . . . . 0.0 113.25 166.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.443 HG22 ' HA ' ' A' ' 49' ' ' GLU 0.261 11.0 m -66.05 -42.77 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-O 115.496 -2.193 . . . . 0.0 115.86 -170.001 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -58.18 -17.96 22.48 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 127.486 2.314 . . . . 0.0 113.621 177.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -72.55 -50.75 23.48 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 130.688 3.595 . . . . 0.0 110.52 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.374 58.4 m-85 -73.13 -26.06 61.08 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 120.335 1.425 . . . . 0.0 109.173 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -69.0 -45.15 71.29 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 117.923 -2.986 . . . . 0.0 106.831 177.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.4 p -93.67 -34.93 13.07 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 -167.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.36 21.16 62.92 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-O 114.076 -3.624 . . . . 0.0 117.824 173.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -95.1 8.12 43.97 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 128.817 2.847 . . . . 0.0 114.189 -162.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.6 tp -134.38 144.0 47.96 Favored 'General case' 0 N--CA 1.447 -0.623 1 O-C-N 129.852 4.47 . . . . 0.0 114.043 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -102.09 91.8 2.71 Favored Pre-proline 0 N--CA 1.441 -0.878 0 O-C-N 118.678 -2.514 . . . . 0.0 108.749 166.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . 0.272 2.6 Cg_endo -74.9 176.65 9.59 Favored 'Trans proline' 0 N--CA 1.454 -0.81 1 C-N-CA 127.859 5.706 . . . . 0.0 107.789 -168.917 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.8 p -76.85 179.74 5.95 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 178.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.649 HD12 ' H ' ' A' ' 64' ' ' ILE . 2.3 mp -55.04 -62.24 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 C-N-CA 128.4 2.68 . . . . 0.0 107.669 -169.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.6 p -55.05 -30.62 59.99 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 115.237 -2.316 . . . . 0.0 113.896 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -84.15 -54.48 4.79 Favored 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 127.164 2.79 . . . . 0.0 106.661 -168.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -48.49 -33.32 9.24 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 128.683 2.793 . . . . 0.0 114.761 160.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.8 mtt-85 -75.64 -34.46 60.54 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 114.329 -2.748 . . . . 0.0 113.172 166.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -70.56 -32.67 70.18 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 122.932 2.605 . . . . 0.0 115.106 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.44 ' C ' ' H ' ' A' ' 72' ' ' LYS . 5.6 tt -41.64 -72.55 0.06 Allowed 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 130.118 3.367 . . . . 0.0 114.925 177.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.42 ' HG2' ' CD1' ' A' ' 26' ' ' ILE . 39.7 mt-10 -48.78 -19.43 0.37 Allowed 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 126.071 2.843 . . . . 0.0 110.26 173.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.44 ' H ' ' C ' ' A' ' 70' ' ' LEU . 28.1 mtpt -99.91 -8.33 24.14 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 117.524 -3.235 . . . . 0.0 115.996 -163.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.5 pt -61.43 -46.78 95.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 1 N-CA-C 122.004 4.075 . . . . 0.0 122.004 -171.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 49.3 mt -74.48 -18.23 60.65 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 126.002 1.721 . . . . 0.0 110.326 -172.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.47 -0.57 17.66 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 118.752 -1.69 . . . . 0.0 116.396 -158.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.414 HD11 HD11 ' A' ' 34' ' ' LEU . 30.8 pt -142.11 175.71 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 125.906 1.682 . . . . 0.0 109.238 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.357 11.5 pttt -176.95 149.06 0.69 Allowed 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 128.668 2.787 . . . . 0.0 108.526 -174.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 N--CA 1.439 -1.008 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 176.948 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 91.8 t80 . . . . . 0 N--CA 1.449 -0.504 0 CA-C-O 121.744 0.783 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . 0.506 0.0 OUTLIER -75.74 67.66 2.21 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 119.738 3.236 . . . . 0.0 119.738 179.348 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -60.08 -22.75 63.13 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 119.797 -1.814 . . . . 0.0 113.972 -169.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.1 pt -61.96 -29.34 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-O 114.815 -2.517 . . . . 0.0 112.851 173.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.316 12.2 mm -63.92 -57.11 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 CA-C-N 122.542 2.428 . . . . 0.0 105.836 174.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -51.02 -65.03 0.63 Allowed 'General case' 0 CA--C 1.532 0.266 1 C-N-CA 134.535 5.134 . . . . 0.0 109.874 -155.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 77.4 p -57.17 -31.68 65.65 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 126.253 2.221 . . . . 0.0 113.772 -164.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.87 -58.51 3.24 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.488 1.515 . . . . 0.0 108.183 174.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 56.5 ttt180 -51.15 -36.79 42.68 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 118.631 -2.543 . . . . 0.0 114.103 -176.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -68.32 -42.22 79.69 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 123.918 3.054 . . . . 0.0 113.467 172.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -54.19 -37.84 64.96 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-O 123.898 1.809 . . . . 0.0 113.206 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.256 62.9 mt -90.44 -11.1 41.4 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 111.266 -2.697 . . . . 0.0 112.371 -161.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.36 4.77 5.38 Favored Glycine 0 C--O 1.238 0.382 0 CA-C-O 125.329 2.627 . . . . 0.0 118.327 178.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.2 pt -69.02 153.06 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 O-C-N 119.668 -2.078 . . . . 0.0 112.161 -172.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.6 p -129.9 165.97 20.96 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 117.387 2.366 . . . . 0.0 117.387 -162.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -60.39 -37.28 80.3 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 116.978 -1.487 . . . . 0.0 112.833 -176.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -52.47 -34.65 50.08 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 115.322 -2.275 . . . . 0.0 113.458 166.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -77.51 -37.76 50.39 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 122.3 2.318 . . . . 0.0 111.632 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.3 tp -73.98 -31.93 63.2 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 115.364 -2.255 . . . . 0.0 108.602 -175.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.43 -47.02 76.64 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 166.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -60.6 -42.55 96.99 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 122.802 1.287 . . . . 0.0 112.825 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -70.43 -16.99 63.0 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 118.109 -2.869 . . . . 0.0 106.491 -173.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.8 tp -110.7 5.01 20.56 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 -169.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.2 tttp 45.56 52.67 9.09 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 131.158 3.783 . . . . 0.0 110.128 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.8 m -142.45 -176.41 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 C-N-CA 130.036 3.335 . . . . 0.0 115.73 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 86.7 p -94.42 161.35 14.26 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 125.099 1.36 . . . . 0.0 112.544 167.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -73.17 -12.95 61.07 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 117.122 -3.486 . . . . 0.0 110.378 -174.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -62.29 -37.4 85.37 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 119.027 -2.296 . . . . 0.0 111.961 170.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.0 mm -68.51 -28.94 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 125.936 1.694 . . . . 0.0 110.842 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.378 3.2 m -66.29 -35.55 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 O-C-N 117.282 -3.386 . . . . 0.0 113.987 -175.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -50.18 -38.13 38.28 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 117.198 2.296 . . . . 0.0 117.198 -170.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.292 99.0 mtt180 -25.94 -87.03 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 127.927 2.491 . . . . 0.0 114.739 170.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -77.99 -25.03 47.84 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 120.425 -1.422 . . . . 0.0 111.72 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -63.24 -13.04 33.36 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 120.28 1.4 . . . . 0.0 113.967 -177.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.8 p -65.04 -20.19 66.37 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 117.81 2.522 . . . . 0.0 117.81 170.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.79 19.46 75.09 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 128.817 3.103 . . . . 0.0 114.408 174.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -92.65 12.3 23.72 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 128.385 3.05 . . . . 0.0 116.04 -174.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.5 mt -145.48 120.81 10.26 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 171.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.8 tttp -64.97 116.38 29.3 Favored Pre-proline 0 C--O 1.233 0.202 0 O-C-N 119.22 -2.175 . . . . 0.0 113.623 161.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -66.43 160.53 45.17 Favored 'Trans proline' 0 N--CA 1.448 -1.199 1 C-N-CA 128.479 6.119 . . . . 0.0 114.145 -176.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.519 ' H ' ' HB2' ' A' ' 66' ' ' GLN . 63.9 p -108.94 -165.93 1.07 Allowed 'General case' 0 C--O 1.239 0.514 0 C-N-CA 127.246 2.218 . . . . 0.0 114.472 172.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 34.2 mt -57.88 -59.43 3.42 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.158 0 O-C-N 118.772 -2.455 . . . . 0.0 114.126 -171.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.3 p -59.75 -40.7 89.01 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 169.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.519 ' HB2' ' H ' ' A' ' 63' ' ' THR . 55.7 mt-30 -63.06 -55.21 27.49 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 116.361 1.985 . . . . 0.0 116.361 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -39.71 -47.27 2.0 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 117.196 -1.383 . . . . 0.0 113.356 160.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.1 ttt85 -67.25 -39.57 86.14 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 127.234 2.213 . . . . 0.0 107.897 -172.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -67.84 -52.23 39.12 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 116.74 -1.6 . . . . 0.0 107.174 176.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 21.6 tp -59.88 -60.32 4.02 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 127.845 3.688 . . . . 0.0 111.049 -168.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -52.63 -39.09 61.38 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 117.899 -3.001 . . . . 0.0 109.053 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -76.77 -34.73 58.0 Favored 'General case' 0 N--CA 1.446 -0.653 1 O-C-N 115.239 -4.663 . . . . 0.0 119.446 176.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 31.5 pt -67.84 -30.6 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 118.021 -1.471 . . . . 0.0 108.299 170.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.48 ' C ' ' H ' ' A' ' 76' ' ' ILE 0.311 95.8 mt -70.97 -41.97 70.33 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 117.024 -3.547 . . . . 0.0 117.102 174.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.15 -8.5 0.16 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 127.307 2.384 . . . . 0.0 110.961 -167.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.48 ' H ' ' C ' ' A' ' 74' ' ' LEU . 44.8 pt -116.91 146.62 21.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 117.803 2.52 . . . . 0.0 117.803 -177.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -176.2 153.68 1.29 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 114.604 -2.617 . . . . 0.0 112.572 176.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 78' ' ' LEU . 13.5 mt . . . . . 0 N--CA 1.432 -1.349 0 CA-C-O 126.485 3.04 . . . . 0.0 112.209 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.577 ' HD1' ' H ' ' A' ' 60' ' ' LEU . 63.5 t80 . . . . . 0 N--CA 1.449 -0.483 0 CA-C-O 123.04 1.4 . . . . 0.0 108.599 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -72.73 140.93 48.11 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 126.87 3.224 . . . . 0.0 111.332 -167.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -93.96 -45.9 7.4 Favored 'General case' 0 CA--C 1.503 -0.848 1 O-C-N 114.19 -5.319 . . . . 0.0 116.456 -155.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.7 tp -65.22 -37.54 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-O 115.614 -2.136 . . . . 0.0 113.414 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.398 7.6 pt -55.05 -35.6 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 O-C-N 125.73 1.894 . . . . 0.0 109.302 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -67.54 -39.63 85.03 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 119.795 -1.816 . . . . 0.0 112.254 -174.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.9 p -62.17 -43.14 99.49 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 124.491 1.116 . . . . 0.0 108.705 -157.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.35 -74.8 0.13 Allowed 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 117.741 2.497 . . . . 0.0 117.741 -155.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -47.95 -46.36 32.13 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 -165.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -55.16 -58.6 7.01 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 124.374 3.261 . . . . 0.0 112.224 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -66.98 -23.1 65.91 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 123.519 2.872 . . . . 0.0 116.298 -172.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 99.3 mt -76.58 -1.8 29.29 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 177.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.54 -0.56 12.55 Favored Glycine 0 C--N 1.335 0.481 2 CA-C-N 107.327 -4.488 . . . . 0.0 117.064 172.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.2 pt -78.77 158.78 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 C-N-CA 130.077 3.351 . . . . 0.0 114.126 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 p -89.61 175.77 7.14 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 117.134 2.272 . . . . 0.0 117.134 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -55.73 -50.98 68.9 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 116.59 -3.819 . . . . 0.0 110.299 161.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -60.07 -47.28 86.53 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 129.27 3.028 . . . . 0.0 113.319 -170.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -64.21 -33.44 75.8 Favored 'General case' 0 N--CA 1.449 -0.51 1 CA-C-O 111.62 -4.038 . . . . 0.0 114.4 174.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 23.0 tp -85.25 -27.14 26.23 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 127.822 3.202 . . . . 0.0 109.653 -177.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.56 -24.1 67.67 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 129.28 3.032 . . . . 0.0 113.483 167.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -66.12 -55.64 15.41 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 104.089 -2.56 . . . . 0.0 104.089 169.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -62.25 -14.99 44.27 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 128.32 2.648 . . . . 0.0 113.41 -159.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 40.8 mt -131.51 -8.47 3.68 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 128.297 3.903 . . . . 0.0 109.955 -163.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.312 88.1 mttt 56.4 -5.4 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 121.709 3.966 . . . . 0.0 121.709 -158.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.3 m -131.25 153.47 39.07 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 C-N-CA 127.87 2.468 . . . . 0.0 110.907 -168.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.921 ' C ' ' H ' ' A' ' 52' ' ' VAL . 91.3 p -128.57 -11.83 4.98 Favored 'General case' 0 N--CA 1.446 -0.653 1 N-CA-C 122.196 4.147 . . . . 0.0 122.196 -169.69 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -99.59 -30.46 12.12 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 117.354 -3.342 . . . . 0.0 111.397 -158.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . 0.253 64.6 t30 -103.15 -55.49 2.4 Favored 'General case' 0 C--O 1.217 -0.618 1 N-CA-C 122.431 4.234 . . . . 0.0 122.431 177.152 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . 0.325 0.7 OUTLIER 41.23 52.03 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.491 2 O-C-N 113.689 -5.632 . . . . 0.0 118.247 14.295 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.921 ' H ' ' C ' ' A' ' 48' ' ' SER . 15.7 t -105.33 -42.36 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 129.366 3.067 . . . . 0.0 107.929 23.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -69.95 -39.34 76.12 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 119.023 2.972 . . . . 0.0 119.023 -153.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 54' ' ' ARG . 34.8 ttm180 -83.05 -12.59 57.02 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 120.455 1.479 . . . . 0.0 114.391 -158.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -79.7 -11.93 59.83 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -88.26 -5.95 58.06 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 118.061 -2.899 . . . . 0.0 110.693 -175.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.6 p -92.1 -7.04 49.73 Favored 'General case' 0 N--CA 1.454 -0.268 1 N-CA-C 121.936 4.05 . . . . 0.0 121.936 -142.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.48 ' HA2' ' CD2' ' A' ' 23' ' ' TYR . . . 68.47 26.13 74.49 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-O 115.109 -3.05 . . . . 0.0 110.942 177.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -130.38 -1.32 4.46 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 119.068 2.988 . . . . 0.0 119.068 -160.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.577 ' H ' ' HD1' ' A' ' 23' ' ' TYR . 4.2 tp -135.31 158.87 43.27 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 -171.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -106.48 94.87 10.64 Favored Pre-proline 0 CA--C 1.513 -0.454 0 CA-C-O 115.646 -2.121 . . . . 0.0 113.259 147.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.08 151.28 34.62 Favored 'Trans proline' 0 N--CA 1.443 -1.467 0 C-N-CA 122.612 2.208 . . . . 0.0 110.61 172.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.5 p -80.17 171.72 14.72 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 127.213 2.821 . . . . 0.0 117.726 169.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . 0.315 2.1 tp -53.58 -61.17 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 130.548 3.539 . . . . 0.0 106.382 177.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 83.2 p -61.23 -23.6 65.75 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 116.308 -1.806 . . . . 0.0 112.887 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -80.77 -46.69 15.02 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 128.379 2.672 . . . . 0.0 109.233 173.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.04 93.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 130.173 3.389 . . . . 0.0 115.035 170.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -52.09 -22.41 4.12 Favored 'General case' 0 C--O 1.22 -0.476 0 C-N-CA 127.276 2.23 . . . . 0.0 113.959 175.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -66.68 -13.05 60.79 Favored 'General case' 0 N--CA 1.438 -1.025 0 C-N-CA 125.985 1.714 . . . . 0.0 111.339 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.6 tp -79.97 -49.6 11.62 Favored 'General case' 0 N--CA 1.436 -1.152 1 O-C-N 114.735 -4.978 . . . . 0.0 109.484 -175.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -50.56 -31.32 15.41 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 126.567 2.417 . . . . 0.0 108.022 172.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.1 tttp -69.17 -54.24 15.88 Favored 'General case' 0 C--O 1.24 0.579 1 C-N-CA 131.788 4.035 . . . . 0.0 106.786 -170.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 19.2 pt -79.53 -40.0 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 117.466 -3.271 . . . . 0.0 108.076 -168.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 25.4 mt -82.45 -13.46 56.7 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 128.189 2.596 . . . . 0.0 114.04 -175.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.517 ' O ' HG23 ' A' ' 76' ' ' ILE . . . 69.33 4.13 42.49 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-O 114.12 -3.6 . . . . 0.0 118.228 -167.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.517 HG23 ' O ' ' A' ' 75' ' ' GLY . 6.5 pt -171.94 135.31 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 127.854 2.462 . . . . 0.0 109.016 -161.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -65.73 131.0 45.25 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 114.173 -3.011 . . . . 0.0 115.629 170.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.5 mt . . . . . 0 N--CA 1.437 -1.102 0 CA-C-N 124.099 3.136 . . . . 0.0 111.185 -173.93 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 . . . . . 0 C--O 1.239 0.542 0 CA-C-O 119.493 -0.289 . . . . 0.0 111.614 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -90.69 -2.62 57.82 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 129.254 3.022 . . . . 0.0 114.625 -171.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.34 -13.75 37.18 Favored 'General case' 0 N--CA 1.444 -0.749 1 C-N-CA 131.968 4.107 . . . . 0.0 111.498 170.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -98.46 -0.82 42.71 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 125.273 1.429 . . . . 0.0 112.841 177.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.7 mt -84.91 173.01 10.92 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 125.989 1.716 . . . . 0.0 114.196 166.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -148.22 135.87 20.73 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -174.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 1.2 pp -112.65 -5.7 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 0 N-CA-C 119.314 3.079 . . . . 0.0 119.314 159.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.5 t -98.85 49.77 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.473 1 C-N-CA 132.866 4.466 . . . . 0.0 109.122 177.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.4 p -80.4 -12.57 59.56 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 112.452 -3.642 . . . . 0.0 113.18 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . 0.251 15.1 m-20 61.16 13.68 4.93 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 123.448 2.84 . . . . 0.0 111.292 -160.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -121.37 9.85 10.43 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 117.474 -1.251 . . . . 0.0 112.666 -176.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -75.39 -166.19 0.5 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 116.687 2.106 . . . . 0.0 116.687 -174.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -16.4 -57.91 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 119.905 3.298 . . . . 0.0 119.905 166.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.412 HD12 ' HA ' ' A' ' 78' ' ' LEU . 9.2 tp -44.07 -50.84 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 118.84 2.904 . . . . 0.0 118.84 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.311 6.2 tt -84.27 -46.94 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 129.366 3.066 . . . . 0.0 110.115 175.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -52.44 -52.49 53.8 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 115.476 -2.202 . . . . 0.0 111.623 -172.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.1 p -46.33 -52.32 13.01 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.252 1.421 . . . . 0.0 109.247 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.9 -36.43 56.67 Favored 'General case' 0 C--N 1.346 0.444 0 CA-C-O 114.453 -2.689 . . . . 0.0 117.388 -172.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.425 ' HD2' HD22 ' A' ' 41' ' ' LEU 0.31 37.3 ptt85 -57.97 -43.93 86.79 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 121.201 1.819 . . . . 0.0 113.562 172.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -55.28 -34.0 63.72 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 113.575 -3.107 . . . . 0.0 111.962 164.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.65 -21.96 63.5 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 124.16 3.164 . . . . 0.0 109.028 178.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.8 mt -98.82 -9.87 23.74 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 125.764 1.626 . . . . 0.0 112.768 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.22 -7.33 2.59 Favored Glycine 0 N--CA 1.464 0.56 0 CA-C-N 113.014 -1.903 . . . . 0.0 117.851 174.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.5 pt -57.11 128.32 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 128.293 2.637 . . . . 0.0 111.284 -176.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 59.7 p -67.93 162.52 24.11 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 118.936 2.939 . . . . 0.0 118.936 -171.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -48.02 -43.97 30.5 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 117.604 -3.185 . . . . 0.0 113.951 168.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -68.69 -34.89 76.43 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 123.415 0.686 . . . . 0.0 110.002 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -71.32 -41.5 69.77 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-O 115.05 -2.405 . . . . 0.0 109.105 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.425 HD22 ' HD2' ' A' ' 31' ' ' ARG 0.257 29.2 tp -59.94 -46.25 90.0 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 128.081 2.552 . . . . 0.0 113.945 177.501 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 47' ' ' VAL . . . -54.5 -37.77 65.7 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 110.718 -2.946 . . . . 0.0 116.492 174.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.455 ' C ' ' H ' ' A' ' 45' ' ' LEU . 43.4 mt-30 -63.78 -40.59 97.04 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 125.839 1.655 . . . . 0.0 113.62 165.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -63.66 1.21 0.63 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.28 1.832 . . . . 0.0 111.452 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.455 ' H ' ' C ' ' A' ' 43' ' ' GLN 0.268 16.1 tp -145.79 4.43 0.99 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 120.377 3.473 . . . . 0.0 120.377 -170.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.26 63.7 mttt 52.18 39.01 25.98 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 130.807 3.643 . . . . 0.0 115.199 -174.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.425 ' O ' ' HB1' ' A' ' 42' ' ' ALA . 35.7 m -126.66 -172.58 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 1 C-N-CA 133.38 4.672 . . . . 0.0 113.826 -176.5 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.1 p -101.33 152.5 20.63 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 116.599 -1.667 . . . . 0.0 114.421 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -49.09 -32.5 9.89 Favored 'General case' 0 CA--C 1.52 -0.187 0 O-C-N 126.177 2.173 . . . . 0.0 110.349 165.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -74.08 -29.63 61.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 116.599 -1.667 . . . . 0.0 109.746 -171.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mt -70.83 -47.67 61.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 CA-C-O 126.322 2.963 . . . . 0.0 113.704 173.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.348 13.4 m -56.59 -46.72 82.72 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 2 O-C-N 113.433 -5.792 . . . . 0.0 112.148 175.149 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 49.9 mtmt -56.07 -40.86 74.23 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 117.989 -2.944 . . . . 0.0 113.277 162.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.8 ttt85 -57.64 -36.59 72.05 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 115.609 -2.138 . . . . 0.0 113.174 177.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -71.51 -44.76 64.07 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 124.849 1.343 . . . . 0.0 111.066 173.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -67.7 -13.77 62.38 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 114.861 -2.495 . . . . 0.0 109.775 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.9 p -102.68 0.36 32.99 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 124.094 3.134 . . . . 0.0 111.482 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 83.93 6.22 87.0 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 122.268 2.303 . . . . 0.0 115.816 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -94.12 -18.83 21.38 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 119.443 1.621 . . . . 0.0 114.962 -166.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.4 tp -144.87 161.67 38.72 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 127.931 3.27 . . . . 0.0 109.04 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.258 76.2 tttt -133.65 151.94 78.05 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-O 115.627 -2.13 . . . . 0.0 112.869 171.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . 0.274 41.4 Cg_endo -63.42 168.04 11.99 Favored 'Trans proline' 0 N--CA 1.451 -0.981 1 C-N-CA 126.211 4.607 . . . . 0.0 108.807 169.636 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 81.3 p -96.34 179.22 5.11 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 127.581 2.352 . . . . 0.0 111.224 171.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.1 pt -64.66 -57.23 12.16 Favored 'Isoleucine or valine' 0 C--N 1.346 0.449 0 CA-C-O 113.434 -3.174 . . . . 0.0 114.857 -175.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 90.3 p -51.98 -29.64 21.49 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 122.975 2.625 . . . . 0.0 111.914 167.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -78.86 -53.07 7.46 Favored 'General case' 0 N--CA 1.439 -0.978 0 O-C-N 118.982 -2.324 . . . . 0.0 109.129 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -40.94 -45.57 2.59 Favored 'General case' 0 N--CA 1.448 -0.57 1 C-N-CA 131.918 4.087 . . . . 0.0 104.759 162.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -62.65 -40.0 95.65 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 118.667 -2.52 . . . . 0.0 112.253 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -79.3 -40.33 30.67 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 117.676 2.473 . . . . 0.0 117.676 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.479 ' O ' HG22 ' A' ' 73' ' ' ILE . 87.5 mt -44.97 -46.13 10.94 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 114.854 -2.498 . . . . 0.0 113.965 161.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -56.03 -43.08 77.47 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-N 121.831 2.105 . . . . 0.0 107.353 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -85.21 -4.95 59.33 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 130.396 3.478 . . . . 0.0 118.609 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.579 HG23 ' HG ' ' A' ' 74' ' ' LEU . 4.2 tt -75.58 -31.64 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 1 O-C-N 114.395 -5.191 . . . . 0.0 116.394 -163.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.579 ' HG ' HG23 ' A' ' 73' ' ' ILE . 57.8 mt -105.56 -7.26 18.7 Favored 'General case' 0 N--CA 1.445 -0.694 2 O-C-N 115.244 -4.66 . . . . 0.0 113.0 -175.706 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.08 -20.78 0.05 OUTLIER Glycine 0 CA--C 1.526 0.765 0 O-C-N 116.486 -3.884 . . . . 0.0 112.643 -151.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.438 ' H ' ' C ' ' A' ' 74' ' ' LEU . 9.2 pt -131.05 -161.79 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-O 125.101 2.382 . . . . 0.0 116.918 -172.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.5 pttm -175.29 176.02 2.1 Favored 'General case' 0 N--CA 1.439 -0.99 0 O-C-N 117.318 -3.364 . . . . 0.0 107.08 -172.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.412 ' HA ' HD12 ' A' ' 26' ' ' ILE . 59.0 tp 104.3 -41.26 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 129.689 3.196 . . . . 0.0 106.798 138.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 33.4 m -100.95 140.9 18.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 120.314 3.45 . . . . 0.0 120.314 -153.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.7 p -97.78 176.68 1.93 Allowed Pre-proline 0 N--CA 1.449 -0.482 0 C-N-CA 128.111 2.564 . . . . 0.0 108.679 165.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -62.22 -11.1 20.67 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 N-CA-C 109.801 -0.884 . . . . 0.0 109.801 176.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -108.34 -24.14 11.6 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -172.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -69.63 113.04 6.54 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 119.531 -1.98 . . . . 0.0 111.343 -172.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -96.75 -51.63 4.21 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 118.462 2.764 . . . . 0.0 118.462 -172.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -63.92 118.34 8.29 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 117.954 -2.966 . . . . 0.0 115.586 162.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.12 26.77 0.7 Allowed 'General case' 0 C--O 1.239 0.528 0 O-C-N 125.535 1.772 . . . . 0.0 114.571 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -66.08 107.86 2.05 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-O 123.333 1.54 . . . . 0.0 109.471 -164.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.5 p -159.56 143.54 14.79 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 130.002 3.321 . . . . 0.0 114.13 174.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.07 137.79 58.3 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 118.305 -2.747 . . . . 0.0 109.716 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -69.3 128.95 38.39 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 101.72 -3.437 . . . . 0.0 101.72 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -138.85 105.83 5.43 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-O 115.733 -2.08 . . . . 0.0 115.35 -177.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.43 134.83 48.04 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 127.787 3.179 . . . . 0.0 106.856 -169.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -38.49 143.2 0.15 Allowed 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 156.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -72.15 -40.23 68.19 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 127.421 2.951 . . . . 0.0 112.05 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.4 m -65.43 -36.9 85.32 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 172.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -56.15 -36.72 69.21 Favored Glycine 0 C--O 1.224 -0.477 0 CA-C-O 114.918 -3.157 . . . . 0.0 115.337 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 47.0 tp -96.0 -69.91 0.74 Allowed 'General case' 0 C--O 1.242 0.671 0 C-N-CA 127.247 2.219 . . . . 0.0 107.284 -176.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.6 m -88.61 -34.56 17.26 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 127.931 2.492 . . . . 0.0 111.607 -149.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 11.6 tp -81.44 -10.31 59.53 Favored 'General case' 0 N--CA 1.441 -0.883 0 O-C-N 119.76 -1.837 . . . . 0.0 113.927 161.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -77.98 -18.83 76.2 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-O 115.995 -2.558 . . . . 0.0 110.495 173.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -75.3 23.19 0.11 Allowed 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 123.223 3.512 . . . . 0.0 118.179 -158.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . 0.259 0.0 OUTLIER -130.82 146.69 33.59 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.416 1 C-N-CA 136.026 5.73 . . . . 0.0 112.245 -169.637 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 72.2 t -66.96 117.3 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 2 O-C-N 107.968 -9.207 . . . . 0.0 110.151 13.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -77.08 -37.15 55.01 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 116.319 -3.988 . . . . 0.0 113.503 -161.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 14.3 tt -80.18 -8.33 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 128.819 2.848 . . . . 0.0 109.767 -168.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -113.61 153.31 29.07 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 123.462 1.601 . . . . 0.0 109.363 174.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -63.54 131.05 46.86 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 129.212 3.005 . . . . 0.0 112.092 -173.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 76.79 -22.06 2.38 Favored Glycine 0 N--CA 1.444 -0.805 1 O-C-N 115.537 -4.477 . . . . 0.0 115.04 171.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 33.5 mttp 117.05 4.21 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 130.159 3.384 . . . . 0.0 110.363 153.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . 0.292 48.3 tttp 53.19 69.28 0.72 Allowed 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 129.396 3.079 . . . . 0.0 113.383 175.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.3 8.2 mt -86.98 166.08 15.36 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 127.502 2.321 . . . . 0.0 109.978 -178.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -65.74 -33.19 75.31 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 121.361 1.892 . . . . 0.0 114.249 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 10.7 p-80 -95.11 12.94 26.92 Favored 'General case' 0 C--O 1.233 0.207 2 O-C-N 115.241 -4.662 . . . . 0.0 110.984 -175.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 26.4 m170 . . . . . 0 N--CA 1.444 -0.754 0 C-N-CA 127.596 2.359 . . . . 0.0 113.186 -177.78 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 126.658 3.123 . . . . 0.0 109.106 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -55.3 -17.82 5.34 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 111.65 -2.523 . . . . 0.0 115.182 171.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.44 11.11 9.15 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 117.839 2.533 . . . . 0.0 117.839 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -103.54 12.98 34.36 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 125.299 1.624 . . . . 0.0 114.782 169.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -108.33 173.1 6.47 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 116.958 -3.589 . . . . 0.0 111.26 159.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -167.96 135.82 2.29 Favored 'General case' 0 N--CA 1.44 -0.969 1 O-C-N 114.559 -5.088 . . . . 0.0 117.883 -167.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 24.8 pt -104.4 -8.22 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 129.403 3.081 . . . . 0.0 114.888 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.6 m -74.46 -2.22 3.57 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.535 0 CA-C-O 126.574 3.083 . . . . 0.0 109.845 175.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.6 p -51.29 -21.56 2.24 Favored 'General case' 0 N--CA 1.449 -0.5 1 O-C-N 114.389 -5.194 . . . . 0.0 113.927 157.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . 0.292 25.5 t70 -91.08 54.46 2.62 Favored 'General case' 0 CA--C 1.512 -0.495 0 O-C-N 120.124 -1.61 . . . . 0.0 108.527 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.692 ' HD1' ' H ' ' A' ' 60' ' ' LEU . 40.0 t80 -59.3 134.16 56.75 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 112.545 -2.116 . . . . 0.0 113.236 -173.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -65.15 144.97 56.87 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 119.843 1.201 . . . . 0.0 112.476 -174.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -78.34 -29.12 47.45 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 119.266 3.061 . . . . 0.0 119.266 -160.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.96 -51.87 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 O-C-N 117.488 -3.257 . . . . 0.0 108.587 -170.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.2 pt -54.0 -28.66 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 117.131 -1.414 . . . . 0.0 114.312 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -60.12 -39.61 86.84 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 129.555 3.142 . . . . 0.0 111.136 173.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.5 p -90.77 -21.87 21.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 117.011 2.226 . . . . 0.0 117.011 -173.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.83 -61.27 2.75 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 131.05 3.74 . . . . 0.0 113.115 -159.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.38 -46.08 87.04 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-O 114.618 -2.611 . . . . 0.0 110.135 -169.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 68.5 mt-10 -63.7 -34.76 78.59 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 117.281 2.326 . . . . 0.0 117.281 169.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.97 -0.21 13.08 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 122.83 2.559 . . . . 0.0 110.659 -174.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 36.3 mt -117.43 -19.81 9.35 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 129.491 3.116 . . . . 0.0 112.527 178.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.76 -8.29 50.28 Favored Glycine 0 C--O 1.223 -0.557 0 CA-C-O 127.615 3.897 . . . . 0.0 114.463 162.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.44 HD13 ' HE3' ' A' ' 44' ' ' LYS . 35.1 pt -91.75 155.86 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 130.356 3.463 . . . . 0.0 110.459 -173.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.0 p -65.14 161.91 18.1 Favored 'General case' 0 CA--C 1.514 -0.412 0 O-C-N 119.86 -1.775 . . . . 0.0 115.065 167.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -56.42 -37.73 70.6 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 118.017 -0.992 . . . . 0.0 111.713 170.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -66.77 -31.87 72.79 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 126.004 1.722 . . . . 0.0 111.591 174.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -69.07 -39.58 79.0 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 118.644 -2.535 . . . . 0.0 112.781 170.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.0 tp -64.25 -37.92 89.21 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 118.665 -2.522 . . . . 0.0 110.216 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.79 -25.08 61.86 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 121.311 -0.868 . . . . 0.0 108.874 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -62.33 -36.67 82.93 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 123.603 1.668 . . . . 0.0 114.948 170.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.44 ' HE3' HD13 ' A' ' 36' ' ' ILE . 21.8 mttm -66.82 -22.85 66.0 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 117.292 -3.38 . . . . 0.0 111.807 -175.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.6 mt -133.46 -5.62 2.94 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 127.297 2.873 . . . . 0.0 108.985 -145.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.356 65.2 mmtt 51.16 -37.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 119.175 3.028 . . . . 0.0 119.175 -153.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.1 m -124.46 154.46 31.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 116.171 -1.871 . . . . 0.0 111.605 -157.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.913 ' C ' ' H ' ' A' ' 52' ' ' VAL . 84.0 p -137.87 -6.36 1.67 Allowed 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 127.966 3.291 . . . . 0.0 118.189 -135.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.432 ' N ' ' H ' ' A' ' 52' ' ' VAL . 17.7 mp0 -101.59 -32.36 10.39 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 127.651 3.094 . . . . 0.0 110.387 -162.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.608 ' H ' ' C ' ' A' ' 51' ' ' ILE . 57.0 t-20 -118.91 -42.84 2.69 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 112.446 -3.645 . . . . 0.0 113.894 -174.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.608 ' C ' ' H ' ' A' ' 50' ' ' ASN . 1.5 mt 46.12 61.75 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.354 2 C-N-CA 137.925 6.49 . . . . 0.0 112.22 -1.654 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.913 ' H ' ' C ' ' A' ' 48' ' ' SER . 27.8 t -93.66 -47.76 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 O-C-N 117.723 -3.111 . . . . 0.0 114.882 2.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -57.82 -43.22 85.6 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 120.523 3.527 . . . . 0.0 120.523 -148.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.3 ttm180 -73.44 -12.41 60.79 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 115.516 -2.183 . . . . 0.0 114.684 -157.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -52.39 -27.91 17.59 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 125.252 1.595 . . . . 0.0 113.765 169.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . 0.269 12.4 pt-20 -50.41 -27.45 6.41 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 123.849 3.022 . . . . 0.0 116.592 168.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.6 p -73.75 -27.81 61.36 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 119.328 3.084 . . . . 0.0 119.328 -148.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.48 ' HA2' ' CD2' ' A' ' 23' ' ' TYR . . . 78.53 19.54 73.55 Favored Glycine 0 CA--C 1.525 0.703 0 CA-C-N 123.106 2.684 . . . . 0.0 115.704 -172.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -122.09 4.43 9.84 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 121.314 3.82 . . . . 0.0 121.314 -162.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.692 ' H ' ' HD1' ' A' ' 23' ' ' TYR . 27.6 tp -145.01 142.0 29.41 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 118.426 2.75 . . . . 0.0 118.426 -168.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.251 61.1 mttm -115.09 109.42 46.85 Favored Pre-proline 0 C--N 1.351 0.67 0 O-C-N 119.342 -2.099 . . . . 0.0 109.739 155.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -78.01 -177.84 4.17 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 124.139 3.226 . . . . 0.0 112.054 -167.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.0 p -81.58 170.86 15.35 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 165.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 11.3 tp -68.73 -46.17 80.01 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-N 112.302 -2.227 . . . . 0.0 110.59 -177.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.7 p -56.69 -34.19 67.17 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 120.892 1.678 . . . . 0.0 111.917 169.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 56.7 mm-40 -78.43 -50.41 11.74 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 -170.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -52.09 -40.21 60.91 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 125.62 1.825 . . . . 0.0 114.368 173.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.5 ' HE ' ' CG ' ' A' ' 101' ' ' ASP . 72.3 mtt180 -65.4 -46.15 81.18 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 172.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.622 ' C ' ' H ' ' A' ' 72' ' ' LYS . 35.0 mt-30 -64.33 -27.41 69.01 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 118.127 -2.858 . . . . 0.0 112.865 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 27.3 mt -90.22 -31.6 16.94 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -166.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -50.74 -31.51 16.9 Favored 'General case' 0 CA--C 1.516 -0.327 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.097 149.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.622 ' H ' ' C ' ' A' ' 69' ' ' GLN . 20.0 tttm -78.46 -26.1 46.02 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 116.701 -2.0 . . . . 0.0 116.053 -161.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . 0.355 26.2 pt -57.18 -43.25 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 O-C-N 116.997 -3.564 . . . . 0.0 114.307 167.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.41 ' C ' ' H ' ' A' ' 76' ' ' ILE . 8.7 mt -60.4 -34.76 74.39 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 -166.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.04 -5.83 7.67 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 117.269 -2.396 . . . . 0.0 113.995 -169.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.41 ' H ' ' C ' ' A' ' 74' ' ' LEU . 27.1 pt -114.89 -162.45 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 124.899 1.28 . . . . 0.0 113.059 163.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -120.38 150.25 41.07 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 114.869 -2.491 . . . . 0.0 113.671 169.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.4 mt -149.4 150.95 33.23 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 117.46 2.393 . . . . 0.0 117.46 175.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.0 m -109.79 148.01 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 1 C-N-CA 132.675 4.39 . . . . 0.0 120.437 13.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.0 p -84.35 -173.48 0.43 Allowed Pre-proline 0 N--CA 1.45 -0.458 0 CA-C-N 121.035 1.743 . . . . 0.0 110.68 178.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.06 10.59 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.53 1.487 . . . . 0.0 115.093 161.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . 0.266 35.4 tp -73.54 -25.05 60.21 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 119.599 -1.938 . . . . 0.0 108.795 164.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -153.32 -14.67 0.15 Allowed 'General case' 0 C--N 1.35 0.588 0 O-C-N 117.266 -3.396 . . . . 0.0 110.847 -176.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -151.26 126.12 9.71 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 123.733 2.97 . . . . 0.0 109.874 167.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -80.8 -9.89 59.77 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 126.147 1.779 . . . . 0.0 115.353 -172.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -143.81 161.1 39.5 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 125.87 3.941 . . . . 0.0 108.183 175.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -78.2 43.83 0.47 Allowed 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 130.348 3.459 . . . . 0.0 110.159 169.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 91.2 p -80.96 -18.39 47.17 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 128.976 2.911 . . . . 0.0 116.589 -168.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -99.53 -8.25 24.84 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 126.881 2.613 . . . . 0.0 109.582 -176.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 82.6 mttt -73.1 164.22 27.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 123.929 1.823 . . . . 0.0 113.271 169.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -164.89 177.44 7.88 Favored 'General case' 0 C--N 1.345 0.375 0 CA-C-N 111.421 -2.627 . . . . 0.0 112.382 -169.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.48 ' CZ ' ' HA ' ' A' ' 111' ' ' LEU 0.292 79.6 t80 -113.1 163.86 14.21 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 121.875 2.125 . . . . 0.0 109.748 172.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -162.49 148.08 12.57 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 127.183 2.193 . . . . 0.0 112.77 -176.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -69.56 -17.61 63.58 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 116.5 2.037 . . . . 0.0 116.5 -176.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.7 m -97.41 -34.67 10.94 Favored 'General case' 0 C--O 1.244 0.795 0 O-C-N 125.508 1.755 . . . . 0.0 110.203 175.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -74.34 -17.58 79.73 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 123.855 1.808 . . . . 0.0 109.215 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 57.9 tp -41.77 -43.73 3.02 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 116.934 -3.686 . . . . 0.0 113.338 165.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.18 7.91 29.76 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -171.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.5 tp -99.92 -23.37 14.95 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 118.867 2.914 . . . . 0.0 118.867 165.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 84.11 6.32 86.6 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 118.4 -2.687 . . . . 0.0 111.227 -175.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.5 ' CG ' ' HE ' ' A' ' 68' ' ' ARG . 1.7 t70 -91.82 70.96 5.67 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-O 117.158 -1.401 . . . . 0.0 108.516 -177.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.6 t -143.32 147.68 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 1 O-C-N 131.031 5.207 . . . . 0.0 116.52 -164.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 7.2 p -48.74 91.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 118.157 2.651 . . . . 0.0 118.157 164.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.1 t30 -83.34 -22.85 32.75 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 119.939 -1.726 . . . . 0.0 110.386 -173.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 15.2 pt -76.16 -31.32 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 127.954 2.501 . . . . 0.0 115.545 -171.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -95.33 139.21 31.96 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 118.706 -1.198 . . . . 0.0 109.239 174.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -89.51 141.54 28.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 125.254 2.454 . . . . 0.0 111.175 -177.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.95 -30.23 0.24 Allowed Glycine 0 C--N 1.344 0.988 0 C-N-CA 128.718 3.056 . . . . 0.0 117.439 -160.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 42.9 tttp -67.19 -27.3 67.15 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 3.1 ptpt -52.11 6.8 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 118.631 2.826 . . . . 0.0 118.631 160.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.48 ' HA ' ' CZ ' ' A' ' 92' ' ' PHE . 1.4 pt? -161.5 38.72 0.14 Allowed 'General case' 0 C--O 1.244 0.776 0 C-N-CA 126.316 1.846 . . . . 0.0 109.256 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.356 16.5 tt0 -47.89 -69.97 0.11 Allowed 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 130.149 3.38 . . . . 0.0 118.242 -167.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 3.3 p-80 -119.2 18.34 13.04 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.042 1.737 . . . . 0.0 112.92 -166.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 . . . . . 0 C--O 1.252 1.209 1 C-N-CA 133.05 4.54 . . . . 0.0 109.453 174.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -160.37 71.61 0.45 Allowed 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 123.508 1.623 . . . . 0.0 108.445 169.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -130.02 12.96 5.71 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 118.769 -2.457 . . . . 0.0 114.133 -172.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -106.88 19.01 21.08 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 127.829 2.452 . . . . 0.0 112.329 170.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 52.6 tp -92.06 -23.26 19.54 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.752 1.621 . . . . 0.0 112.855 -175.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -133.3 25.43 4.16 Favored 'General case' 0 N--CA 1.44 -0.959 0 O-C-N 116.666 -3.771 . . . . 0.0 112.873 -156.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 4.1 pt -117.65 163.38 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 113.202 -1.817 . . . . 0.0 111.697 -149.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.4 m -68.99 -177.46 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 123.787 1.756 . . . . 0.0 111.514 174.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 82.1 p -54.52 -30.17 52.8 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 131.351 3.861 . . . . 0.0 120.621 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -175.68 63.74 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 104.378 -2.453 . . . . 0.0 104.378 -161.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -56.6 113.73 1.74 Allowed 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 168.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -58.34 144.71 40.57 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 128.124 2.569 . . . . 0.0 116.84 -171.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.7 tttt -116.63 -4.26 11.71 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 -157.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.1 pt -43.95 -49.3 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.747 0 C-N-CA 127.84 2.456 . . . . 0.0 116.23 -174.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.426 13.9 pt -74.23 -16.5 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 O-C-N 125.165 1.541 . . . . 0.0 115.031 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.342 19.0 tttm -66.53 -58.01 6.1 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 120.462 3.505 . . . . 0.0 120.462 -158.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 52.2 m -54.57 -40.43 68.76 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 120.469 -1.394 . . . . 0.0 109.479 174.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.98 -45.68 80.79 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 118.661 2.837 . . . . 0.0 118.661 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 30.1 ttp180 -47.22 -42.23 19.84 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.883 0.873 . . . . 0.0 112.618 164.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -73.48 -39.81 64.6 Favored 'General case' 0 N--CA 1.437 -1.109 1 CA-C-O 111.551 -4.071 . . . . 0.0 112.41 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -61.41 -41.06 96.56 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 127.554 3.034 . . . . 0.0 112.742 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 61.1 mt -58.35 -35.18 71.54 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.515 1.926 . . . . 0.0 111.512 171.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.1 2.92 5.62 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 128.375 2.893 . . . . 0.0 115.225 -173.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.442 ' HB ' ' HB2' ' A' ' 40' ' ' GLN . 28.5 pt -66.63 154.73 7.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 125.637 2.637 . . . . 0.0 113.966 -166.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 64.2 p -80.45 170.59 16.17 Favored 'General case' 0 N--CA 1.438 -1.038 0 O-C-N 119.151 -2.218 . . . . 0.0 113.113 -176.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -56.52 -41.66 77.09 Favored 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 117.997 -2.939 . . . . 0.0 105.138 174.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -72.53 -32.99 66.55 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 121.925 2.148 . . . . 0.0 116.625 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.442 ' HB2' ' HB ' ' A' ' 36' ' ' ILE . 58.0 mt-30 -64.57 -38.03 89.61 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 116.338 -3.976 . . . . 0.0 112.442 170.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.2 tp -70.3 -37.13 74.73 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 128.329 2.652 . . . . 0.0 114.489 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.3 -46.37 90.12 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.902 1.681 . . . . 0.0 112.306 169.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -63.25 -44.64 94.61 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 117.868 -1.063 . . . . 0.0 111.836 172.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -69.19 -14.49 63.01 Favored 'General case' 0 CA--C 1.514 -0.41 0 C-N-CA 125.764 1.626 . . . . 0.0 111.99 -174.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.51 HD23 HD12 ' A' ' 73' ' ' ILE . 5.2 mp -121.04 1.87 10.4 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 126.63 1.972 . . . . 0.0 109.78 -172.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.256 0.0 OUTLIER 62.41 -35.42 0.12 Allowed 'General case' 0 N--CA 1.444 -0.767 2 C-N-CA 133.169 4.587 . . . . 0.0 114.784 -167.736 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.8 m -77.53 164.13 3.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 1 C-N-CA 133.165 4.586 . . . . 0.0 114.747 -161.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 89.3 p -79.66 159.21 26.8 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 -170.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.442 ' HA ' HG22 ' A' ' 52' ' ' VAL . 40.7 mt-10 -82.7 -12.46 57.57 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 117.557 -1.657 . . . . 0.0 110.216 -162.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -59.91 -44.34 94.33 Favored 'General case' 0 C--O 1.222 -0.391 0 O-C-N 120.663 -1.273 . . . . 0.0 109.899 166.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.5 mm -64.42 -45.52 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 C-N-CA 127.863 2.465 . . . . 0.0 108.345 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.442 HG22 ' HA ' ' A' ' 49' ' ' GLU 0.387 1.3 m -65.11 -45.9 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -176.503 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -63.84 -26.76 68.76 Favored 'General case' 0 C--O 1.215 -0.721 0 CA-C-O 115.308 -2.282 . . . . 0.0 116.229 172.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -59.49 -44.03 93.17 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 121.742 2.064 . . . . 0.0 109.008 176.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -82.05 -28.18 32.58 Favored 'General case' 0 CA--C 1.522 -0.112 0 O-C-N 118.421 -2.675 . . . . 0.0 110.702 -176.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -63.19 -33.75 76.16 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 119.396 -2.065 . . . . 0.0 111.159 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.2 p -126.61 22.58 6.92 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -151.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.11 21.85 62.1 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.664 165.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -97.1 26.53 4.65 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 125.9 1.68 . . . . 0.0 115.025 -164.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.2 tp -140.02 154.58 47.16 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 113.672 -1.603 . . . . 0.0 114.903 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 28.2 tttp -90.54 102.08 4.61 Favored Pre-proline 0 N--CA 1.443 -0.808 0 C-N-CA 125.041 1.337 . . . . 0.0 108.526 149.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -83.83 170.89 11.01 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 CA-C-O 125.041 2.017 . . . . 0.0 111.236 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.0 p -143.73 179.28 7.25 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 118.921 -2.362 . . . . 0.0 111.988 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . 0.403 60.7 mt -52.39 -61.4 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 O-C-N 127.574 3.046 . . . . 0.0 109.392 172.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 96.5 p -68.97 -31.26 69.99 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 125.329 1.643 . . . . 0.0 107.653 -173.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -77.96 -37.49 47.35 Favored 'General case' 0 N--CA 1.438 -1.073 1 O-C-N 114.581 -5.074 . . . . 0.0 109.014 -177.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.23 -45.72 90.3 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 114.466 -2.683 . . . . 0.0 107.172 169.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 39.5 tpt85 -52.61 -27.82 18.6 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 125.153 1.533 . . . . 0.0 112.496 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -93.39 -29.39 15.62 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 114.396 -2.716 . . . . 0.0 110.31 -173.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 19.5 tp -61.62 -53.11 60.58 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-O 114.927 -2.463 . . . . 0.0 115.732 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -50.9 -22.69 2.35 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 125.303 1.627 . . . . 0.0 115.175 157.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.25 76.7 tttt -87.54 -38.02 16.37 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 117.268 -3.395 . . . . 0.0 109.489 -173.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.51 HD12 HD23 ' A' ' 45' ' ' LEU . 50.5 pt -74.1 -29.91 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 74' ' ' LEU . 34.4 tp -77.61 -25.33 49.74 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-O 126.54 3.066 . . . . 0.0 107.34 175.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.35 8.85 27.33 Favored Glycine 0 N--CA 1.445 -0.725 0 O-C-N 118.878 -2.389 . . . . 0.0 117.098 -168.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.2 pt -152.02 177.34 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.073 0 C-N-CA 130.018 3.327 . . . . 0.0 112.006 175.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -171.29 168.69 6.58 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 128.602 2.761 . . . . 0.0 106.892 -166.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 78' ' ' LEU . 9.7 mt -157.87 138.82 13.22 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 112.407 -2.179 . . . . 0.0 115.221 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.2 t -112.0 168.29 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 1 O-C-N 114.501 -5.125 . . . . 0.0 108.517 22.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.503 ' HB ' ' HD2' ' A' ' 81' ' ' PRO 0.497 33.8 p -91.45 -176.73 0.65 Allowed Pre-proline 0 N--CA 1.444 -0.738 0 O-C-N 126.193 2.183 . . . . 0.0 107.914 175.301 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.503 ' HD2' ' HB ' ' A' ' 80' ' ' THR 0.261 82.7 Cg_exo -49.44 -2.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 124.223 3.282 . . . . 0.0 115.353 176.407 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 47.4 tp -59.76 -35.22 74.16 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 117.661 -1.616 . . . . 0.0 112.714 162.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . 0.262 38.4 mt-10 -142.02 -13.41 0.83 Allowed 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 125.639 2.638 . . . . 0.0 114.424 174.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -150.19 141.78 23.53 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 117.323 -3.36 . . . . 0.0 113.083 -171.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -147.89 150.2 33.67 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 123.945 1.831 . . . . 0.0 109.563 -174.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -120.79 160.4 23.45 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 -173.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -83.03 167.55 17.79 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 124.376 2.036 . . . . 0.0 113.9 165.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.4 m -96.62 -16.48 20.97 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 118.708 -2.495 . . . . 0.0 116.166 -163.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -61.86 -34.82 76.68 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 125.514 1.526 . . . . 0.0 111.935 169.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.4 mtpt -65.29 3.56 0.63 Allowed 'General case' 0 C--N 1.346 0.428 0 C-N-CA 127.158 2.183 . . . . 0.0 115.284 173.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -69.57 -34.84 74.73 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 120.919 1.691 . . . . 0.0 113.157 173.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.462 ' CZ ' ' HB2' ' A' ' 97' ' ' LEU . 63.6 m-85 -91.59 166.72 12.67 Favored 'General case' 0 CA--C 1.52 -0.182 0 O-C-N 125.376 1.673 . . . . 0.0 115.26 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -166.56 -36.29 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 119.034 -2.291 . . . . 0.0 110.58 169.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -103.35 -22.93 13.61 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 118.343 -2.723 . . . . 0.0 112.821 -173.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 66.4 p -126.2 -164.78 1.36 Allowed 'General case' 0 N--CA 1.439 -0.983 0 O-C-N 126.865 2.603 . . . . 0.0 110.325 176.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -151.81 166.75 30.93 Favored Glycine 0 C--N 1.339 0.719 0 O-C-N 127.14 2.775 . . . . 0.0 112.885 174.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 92' ' ' PHE . 4.1 tp -76.73 4.47 9.52 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 121.144 2.472 . . . . 0.0 116.693 -171.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.29 146.64 46.87 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 128.421 2.688 . . . . 0.0 115.677 -170.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 19.0 tp -65.22 161.91 18.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 115.177 -2.344 . . . . 0.0 113.254 -171.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -81.86 9.09 57.9 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 124.066 3.121 . . . . 0.0 114.128 -174.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.324 15.8 t70 -68.54 47.71 0.06 Allowed 'General case' 0 N--CA 1.446 -0.64 2 O-C-N 116.147 -4.149 . . . . 0.0 113.736 -169.673 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.461 ' HB ' ' HA ' ' A' ' 103' ' ' VAL 0.266 0.1 OUTLIER -141.52 157.47 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 128.336 2.654 . . . . 0.0 114.238 -167.433 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.461 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 66.5 t -72.38 149.43 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 2 O-C-N 112.307 -6.496 . . . . 0.0 110.608 7.127 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -73.75 117.66 15.8 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 125.698 1.599 . . . . 0.0 113.399 176.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . 0.309 29.6 pt -97.11 1.56 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 118.287 2.699 . . . . 0.0 118.287 169.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -71.6 -21.4 61.86 Favored 'General case' 0 C--O 1.224 -0.265 0 O-C-N 119.664 -1.898 . . . . 0.0 107.027 165.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -68.61 -44.58 73.99 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 124.205 1.955 . . . . 0.0 112.955 163.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 158.7 149.66 5.56 Favored Glycine 0 CA--C 1.541 1.698 0 O-C-N 116.526 -3.859 . . . . 0.0 110.139 177.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -57.45 129.25 40.97 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 126.62 1.968 . . . . 0.0 110.548 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -89.62 65.96 7.08 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 118.535 -2.603 . . . . 0.0 110.164 -176.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 178.15 177.62 0.4 Allowed 'General case' 0 C--O 1.214 -0.786 0 C-N-CA 129.416 3.086 . . . . 0.0 109.014 178.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.482 13.1 tt0 -161.23 -109.44 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 119.559 1.072 . . . . 0.0 108.645 -142.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 45.0 p-80 -62.17 -18.05 59.83 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 118.685 -2.509 . . . . 0.0 117.161 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 2.5 m80 . . . . . 0 C--O 1.253 1.271 0 C-N-CA 130.6 3.56 . . . . 0.0 114.442 -176.74 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 . . . . . 0 N--CA 1.466 0.332 0 CA-C-O 118.3 -0.857 . . . . 0.0 112.894 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -83.53 -22.04 32.56 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 116.647 2.091 . . . . 0.0 116.647 -174.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.57 171.09 9.94 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 130.5 3.52 . . . . 0.0 111.751 171.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -79.93 -23.6 41.64 Favored 'General case' 0 CA--C 1.508 -0.673 0 CA-C-O 124.084 1.897 . . . . 0.0 113.787 158.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -91.62 155.97 17.96 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 117.671 2.471 . . . . 0.0 117.671 176.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -138.39 134.16 33.79 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 173.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 36.9 pt -114.27 3.6 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 O-C-N 119.781 -1.825 . . . . 0.0 113.598 171.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.4 t -98.53 -57.62 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 O-C-N 118.88 -2.387 . . . . 0.0 108.713 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.4 p -70.09 -32.5 70.59 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-O 115.019 -2.42 . . . . 0.0 114.116 -149.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . 0.326 1.7 t0 63.79 12.17 6.49 Favored 'General case' 0 C--O 1.24 0.556 1 C-N-CA 132.116 4.166 . . . . 0.0 107.241 -171.53 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -101.08 53.76 0.84 Allowed 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 127.682 2.393 . . . . 0.0 115.097 169.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -85.91 -162.64 0.76 Allowed 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 127.868 3.23 . . . . 0.0 111.291 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -66.4 -1.8 3.87 Favored 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 118.272 -2.767 . . . . 0.0 114.461 -168.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.0 pt -56.26 -27.67 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 O-C-N 120.13 -1.606 . . . . 0.0 115.315 160.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.348 6.7 tp -140.5 -33.15 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 O-C-N 119.998 -1.689 . . . . 0.0 109.875 -173.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -70.98 -49.28 47.0 Favored 'General case' 0 N--CA 1.445 -0.708 0 O-C-N 117.177 -3.452 . . . . 0.0 112.829 -164.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.08 -39.7 94.64 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 128.092 2.557 . . . . 0.0 106.748 175.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.72 -59.57 4.71 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 117.756 2.502 . . . . 0.0 117.756 -173.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -39.94 -45.85 1.94 Allowed 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 124.566 1.167 . . . . 0.0 109.703 169.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -58.93 -47.52 84.76 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 116.859 -3.651 . . . . 0.0 117.199 168.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -72.33 -1.71 16.46 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 122.013 2.188 . . . . 0.0 112.446 -178.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.414 ' C ' ' H ' ' A' ' 36' ' ' ILE . 81.5 mt -101.51 -22.1 14.59 Favored 'General case' 0 N--CA 1.451 -0.413 1 O-C-N 115.161 -4.712 . . . . 0.0 107.046 -177.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.81 -12.1 0.16 Allowed Glycine 0 C--N 1.336 0.555 0 CA-C-O 125.492 2.718 . . . . 0.0 115.785 -176.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.414 ' H ' ' C ' ' A' ' 34' ' ' LEU . 31.7 pt -66.19 163.42 2.44 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 N-CA-C 119.118 3.007 . . . . 0.0 119.118 -176.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.5 p -77.17 171.75 14.34 Favored 'General case' 0 C--O 1.241 0.644 0 O-C-N 116.995 -3.566 . . . . 0.0 117.753 175.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . 0.336 2.5 mp0 -70.89 -24.43 62.48 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 120.843 -1.16 . . . . 0.0 110.03 169.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -72.89 -37.21 67.37 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 120.503 -1.373 . . . . 0.0 107.432 176.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -76.81 -32.16 57.45 Favored 'General case' 0 N--CA 1.44 -0.953 0 O-C-N 118.464 -2.648 . . . . 0.0 113.868 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.3 tp -72.54 -36.46 68.27 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 130.215 3.406 . . . . 0.0 109.716 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.54 -34.11 70.64 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 121.581 1.991 . . . . 0.0 112.873 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -60.94 -49.84 75.8 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.924 1.689 . . . . 0.0 112.304 168.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.7 mmtt -70.54 -19.25 62.91 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -173.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 94.7 mt -101.72 -9.67 20.65 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -170.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.339 7.1 mptt 61.69 -16.43 0.04 OUTLIER 'General case' 0 C--O 1.237 0.415 0 N-CA-C 117.104 2.261 . . . . 0.0 117.104 -163.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.3 m -104.51 166.1 3.23 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 CA-C-O 124.53 2.11 . . . . 0.0 112.508 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 55.3 p -74.04 166.31 23.61 Favored 'General case' 0 N--CA 1.44 -0.974 0 O-C-N 118.969 -2.332 . . . . 0.0 116.229 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -70.5 -23.48 62.67 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 118.685 -2.51 . . . . 0.0 107.689 175.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -63.1 -37.0 85.47 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.274 1.43 . . . . 0.0 110.743 171.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.5 mm -68.84 -40.4 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 125.861 3.937 . . . . 0.0 110.594 171.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.1 t -54.41 -45.32 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 113.966 -1.47 . . . . 0.0 111.262 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -59.04 -58.13 10.01 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 128.873 2.869 . . . . 0.0 106.098 169.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -53.55 -39.51 64.78 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 121.452 1.933 . . . . 0.0 110.732 -163.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -70.81 -50.81 31.57 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 118.273 -0.87 . . . . 0.0 112.826 176.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -51.43 -37.7 49.93 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 122.729 2.513 . . . . 0.0 112.835 170.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.4 p -83.79 4.96 26.79 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 118.44 2.756 . . . . 0.0 118.44 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.82 7.36 68.67 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 116.853 -2.082 . . . . 0.0 111.938 165.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -103.98 -15.42 15.62 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 129.152 2.981 . . . . 0.0 115.998 -167.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.3 tp -146.53 138.98 25.09 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 126.14 1.776 . . . . 0.0 115.426 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.624 ' HB2' ' HD2' ' A' ' 62' ' ' PRO . 15.6 ptpt -138.53 -164.77 0.08 OUTLIER Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-O 116.588 -1.672 . . . . 0.0 112.492 173.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.624 ' HD2' ' HB2' ' A' ' 61' ' ' LYS . 88.2 Cg_endo -88.8 149.64 5.98 Favored 'Trans proline' 0 N--CA 1.44 -1.644 0 O-C-N 124.512 1.796 . . . . 0.0 112.241 177.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 23.0 p -144.52 -179.33 6.49 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.836 1.255 . . . . 0.0 113.042 -172.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.445 ' C ' ' H ' ' A' ' 66' ' ' GLN . 8.7 tp -78.69 -44.02 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 C-N-CA 125.346 1.458 . . . . 0.0 107.816 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 84.9 p -53.92 -7.67 0.14 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-N 120.389 1.45 . . . . 0.0 108.388 169.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.445 ' H ' ' C ' ' A' ' 64' ' ' ILE . 40.3 mt-30 -118.68 -37.33 3.29 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 117.722 -3.112 . . . . 0.0 115.039 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -39.38 -46.66 1.66 Allowed 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 117.565 2.431 . . . . 0.0 117.565 -162.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 33.5 mtm105 -71.48 -53.54 13.59 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 114.903 -2.475 . . . . 0.0 116.47 -165.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.649 ' HB2' ' CD2' ' A' ' 92' ' ' PHE . 22.0 tt0 -63.18 -39.14 93.79 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 115.694 -2.098 . . . . 0.0 112.877 167.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 44.4 tp -53.85 -49.0 69.43 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 127.167 2.792 . . . . 0.0 107.131 -170.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -57.82 -51.12 70.88 Favored 'General case' 0 CA--C 1.513 -0.467 0 O-C-N 118.694 -2.504 . . . . 0.0 111.527 177.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -73.24 -29.45 62.79 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 116.579 -3.826 . . . . 0.0 115.706 -168.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 14.5 pt -66.04 -15.96 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-N 123.042 2.655 . . . . 0.0 112.942 161.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.372 1.3 pt? 146.24 -10.15 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.477 1 C-N-CA 133.41 4.684 . . . . 0.0 115.233 162.457 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.85 6.79 68.34 Favored Glycine 0 C--N 1.34 0.788 0 CA-C-O 113.943 -3.698 . . . . 0.0 114.014 -172.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . 0.282 1.4 pt 71.64 6.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.835 1 C-N-CA 135.196 5.398 . . . . 0.0 117.16 174.578 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -71.88 148.51 46.04 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 115.116 -2.373 . . . . 0.0 113.992 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.406 HD13 HD11 ' A' ' 34' ' ' LEU 0.259 40.1 mt -134.04 151.12 51.28 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.383 1.473 . . . . 0.0 113.328 168.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 39.6 t -105.69 134.03 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-N 122.488 2.404 . . . . 0.0 111.134 5.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.4 p -89.18 135.79 31.03 Favored Pre-proline 0 N--CA 1.445 -0.684 0 C-N-CA 127.554 2.341 . . . . 0.0 107.329 176.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.33 9.57 0.39 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 N-CA-C 114.831 1.05 . . . . 0.0 114.831 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -155.08 166.68 32.82 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 128.361 2.664 . . . . 0.0 108.502 175.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -70.36 74.8 0.53 Allowed 'General case' 0 C--O 1.241 0.613 0 C-N-CA 128.081 2.553 . . . . 0.0 112.321 174.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -66.22 125.49 25.74 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.089 2.155 . . . . 0.0 115.262 -163.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -162.2 150.28 14.6 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 129.518 3.127 . . . . 0.0 111.428 167.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -120.03 122.7 41.72 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-O 124.445 2.069 . . . . 0.0 109.035 174.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.293 12.3 pt-20 -105.72 27.8 8.11 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 126.074 2.845 . . . . 0.0 113.659 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 78.1 p -80.19 -7.4 58.94 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 112.018 -2.355 . . . . 0.0 111.627 -173.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -147.52 105.56 3.74 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 123.969 3.077 . . . . 0.0 113.269 -169.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.69 -12.54 48.04 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 118.133 2.642 . . . . 0.0 118.133 -175.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -103.15 117.37 34.38 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 125.972 2.045 . . . . 0.0 110.059 172.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.649 ' CD2' ' HB2' ' A' ' 69' ' ' GLN . 79.1 t80 -146.91 135.1 21.64 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 127.246 2.841 . . . . 0.0 107.477 169.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -160.29 141.21 12.05 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 128.562 2.745 . . . . 0.0 110.237 175.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -95.76 -12.94 24.57 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 117.987 -2.946 . . . . 0.0 116.081 174.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.7 m -37.68 -53.64 1.23 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 130.683 3.593 . . . . 0.0 116.424 -170.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -81.94 1.34 86.84 Favored Glycine 0 C--O 1.216 -1.017 0 O-C-N 117.808 -3.057 . . . . 0.0 113.298 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 53.8 mt -98.85 -7.99 26.45 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 118.955 -2.497 . . . . 0.0 113.791 164.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 42.3 p -127.49 -60.09 1.2 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 119.398 -0.334 . . . . 0.0 110.723 -165.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 80.0 mt -96.88 -12.57 23.33 Favored 'General case' 0 C--O 1.214 -0.768 0 C-N-CA 126.506 1.922 . . . . 0.0 113.98 -178.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 70.7 21.44 77.88 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 115.483 -2.843 . . . . 0.0 114.494 172.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.45 25.7 t70 -60.01 38.78 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 129.028 3.428 . . . . 0.0 118.325 -172.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.569 ' HB ' ' HA ' ' A' ' 103' ' ' VAL . 5.0 m -140.48 168.53 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 121.699 3.962 . . . . 0.0 121.699 -171.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.569 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 42.6 t -54.25 147.46 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 2 CA-C-N 127.487 4.676 . . . . 0.0 107.566 2.537 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -79.7 127.35 32.09 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 111.558 -2.564 . . . . 0.0 112.401 176.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 26.7 pt -128.86 37.46 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 O-C-N 128.559 3.662 . . . . 0.0 107.578 -167.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.5 pttt -78.34 -42.56 30.18 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 118.793 -2.442 . . . . 0.0 107.033 -176.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -78.16 -19.15 54.55 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 126.204 1.802 . . . . 0.0 109.612 163.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -96.07 -156.86 31.49 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 117.14 1.616 . . . . 0.0 117.14 -173.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -143.54 151.34 40.12 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 127.366 2.266 . . . . 0.0 109.912 176.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . 0.468 37.2 tttt -67.18 66.93 0.07 Allowed 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 171.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 25.1 mt -68.83 165.13 20.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 128.589 2.756 . . . . 0.0 107.313 175.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -52.51 -33.24 44.13 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 125.668 1.855 . . . . 0.0 115.141 -173.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -82.95 9.36 10.25 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 122.37 1.081 . . . . 0.0 111.236 -161.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 . . . . . 0 C--O 1.256 1.446 0 C-N-CA 124.796 1.238 . . . . 0.0 111.372 -155.108 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 . . . . . 0 N--CA 1.474 0.766 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.95 -10.15 59.17 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 -167.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.2 10.9 1.33 Allowed 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 131.372 3.869 . . . . 0.0 115.599 174.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -127.11 -7.99 5.95 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 125.42 1.7 . . . . 0.0 112.283 -173.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.9 mt -91.07 -8.37 49.15 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 131.435 3.894 . . . . 0.0 116.235 -164.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -145.93 12.7 1.28 Allowed 'General case' 0 N--CA 1.442 -0.851 0 O-C-N 118.927 -2.358 . . . . 0.0 107.611 -153.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 7.1 pt -109.6 164.46 6.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 131.682 3.993 . . . . 0.0 117.594 174.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.4 m -57.97 154.96 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 O-C-N 119.639 -1.913 . . . . 0.0 113.488 154.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . 0.267 95.9 m -57.47 -65.72 0.58 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.857 2.063 . . . . 0.0 112.856 172.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . 0.282 26.3 t0 -70.2 41.13 0.05 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 128.75 2.82 . . . . 0.0 114.524 -178.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.75 131.44 40.83 Favored 'General case' 0 N--CA 1.444 -0.731 1 C-N-CA 132.159 4.183 . . . . 0.0 106.558 161.566 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -44.86 116.22 1.04 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 119.633 3.197 . . . . 0.0 119.633 -173.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -66.17 -36.73 83.86 Favored 'General case' 0 C--O 1.222 -0.375 0 N-CA-C 116.199 1.925 . . . . 0.0 116.199 -170.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.2 pt -62.08 -22.17 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 O-C-N 119.453 -2.03 . . . . 0.0 113.817 -171.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.359 2.5 mt -136.94 -53.68 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 O-C-N 117.621 -3.174 . . . . 0.0 109.646 172.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt 63.96 -96.24 0.05 Allowed 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 113.476 -3.154 . . . . 0.0 115.548 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.7 p -43.44 -31.86 0.77 Allowed 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 130.738 3.615 . . . . 0.0 111.128 -168.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -54.73 -26.06 31.63 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 131.105 3.762 . . . . 0.0 117.996 -154.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . 0.451 22.3 ptt180 -36.92 -50.3 0.86 Allowed 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 119.93 3.307 . . . . 0.0 119.93 -176.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . 0.25 40.9 mt-10 -72.32 -37.0 69.01 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 114.335 -2.745 . . . . 0.0 115.476 170.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -65.29 0.96 1.2 Allowed 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 126.33 1.852 . . . . 0.0 114.458 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 12.4 mt -72.64 -7.61 51.18 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 119.321 -2.112 . . . . 0.0 114.492 -175.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 47.98 6.75 0.03 OUTLIER Glycine 0 C--N 1.347 1.15 1 C-N-CA 131.442 4.353 . . . . 0.0 115.881 -161.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.289 2.6 pt -136.32 167.73 23.75 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.509 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.677 -169.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 65.8 m -134.89 179.93 6.0 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 121.012 1.733 . . . . 0.0 115.249 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.42 -38.93 14.36 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 118.484 -2.635 . . . . 0.0 117.898 -159.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -75.73 -39.32 57.47 Favored 'General case' 0 N--CA 1.442 -0.844 0 O-C-N 119.404 -2.06 . . . . 0.0 109.542 -169.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -67.4 -34.95 78.33 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 160.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 37.6 tp -64.51 -39.42 93.75 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 121.461 1.937 . . . . 0.0 112.089 -175.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -50.81 -32.86 21.36 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.462 177.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -73.14 -50.23 23.84 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 124.148 1.928 . . . . 0.0 112.737 173.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -65.69 -4.07 5.79 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 116.511 -1.709 . . . . 0.0 110.74 -168.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.331 53.9 tp -146.93 -0.84 0.69 Allowed 'General case' 0 C--O 1.247 0.925 0 CA-C-O 123.471 1.605 . . . . 0.0 112.22 -155.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 49.58 58.38 5.48 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.384 1.074 . . . . 0.0 112.179 -175.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.7 m -143.84 166.66 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-N 121.503 1.956 . . . . 0.0 106.189 -173.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 96.3 p -85.55 160.72 19.59 Favored 'General case' 0 C--O 1.241 0.63 0 O-C-N 116.938 -3.601 . . . . 0.0 108.254 168.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . 0.26 5.2 mt-10 -65.93 -28.97 69.32 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 111.41 -2.632 . . . . 0.0 111.775 173.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -61.28 -36.43 80.03 Favored 'General case' 0 CA--C 1.514 -0.434 0 O-C-N 117.947 -2.97 . . . . 0.0 117.428 166.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.4 mm -59.74 -37.03 69.3 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.449 0 CA-C-N 119.35 0.977 . . . . 0.0 108.867 168.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.346 40.0 t -59.57 -44.29 92.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 O-C-N 119.403 -2.06 . . . . 0.0 110.55 -178.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.1 mttt -58.93 -37.33 76.45 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 127.904 2.482 . . . . 0.0 112.03 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -75.53 -21.56 57.85 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 130.808 3.643 . . . . 0.0 112.668 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 7.9 m-30 -82.35 -47.68 12.05 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 101.685 -3.45 . . . . 0.0 101.685 167.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -54.38 -25.89 27.01 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 126.668 1.987 . . . . 0.0 108.78 -166.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.9 p -105.21 -14.8 15.25 Favored 'General case' 0 N--CA 1.449 -0.525 0 O-C-N 128.674 3.734 . . . . 0.0 114.184 -174.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.32 18.13 79.8 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 114.267 -3.519 . . . . 0.0 117.501 -167.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -74.6 -19.17 60.41 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 114.624 -2.608 . . . . 0.0 113.597 175.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . 0.31 43.1 tp -147.41 148.71 31.58 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 129.556 3.142 . . . . 0.0 112.593 177.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -106.6 147.08 34.33 Favored Pre-proline 0 N--CA 1.449 -0.522 0 N-CA-C 120.681 3.585 . . . . 0.0 120.681 168.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -60.08 153.88 55.21 Favored 'Trans proline' 0 N--CA 1.449 -1.104 1 C-N-CA 126.654 4.902 . . . . 0.0 114.306 176.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.469 ' H ' ' HB2' ' A' ' 66' ' ' GLN . 58.6 p -98.91 -173.68 2.58 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 111.605 -2.543 . . . . 0.0 112.93 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.464 HG23 ' H ' ' A' ' 65' ' ' SER . 16.0 tt -50.57 -71.83 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 C-N-CA 130.3 3.44 . . . . 0.0 115.844 174.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.464 ' H ' HG23 ' A' ' 64' ' ' ILE . 15.2 p -56.04 -22.85 29.74 Favored 'General case' 0 C--N 1.328 -0.368 1 O-C-N 116.126 -4.109 . . . . 0.0 111.06 172.628 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.469 ' HB2' ' H ' ' A' ' 63' ' ' THR . 71.5 mt-30 -83.14 -53.94 5.41 Favored 'General case' 0 N--CA 1.449 -0.493 1 CA-C-O 110.307 -4.664 . . . . 0.0 107.642 -172.532 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -44.77 -50.84 9.92 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 128.189 3.431 . . . . 0.0 111.138 167.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.32 -55.02 32.57 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 126.141 1.776 . . . . 0.0 113.82 169.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -68.39 -31.05 70.14 Favored 'General case' 0 N--CA 1.446 -0.654 1 O-C-N 115.775 -4.328 . . . . 0.0 114.478 -177.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 35.9 mt -56.33 -68.02 0.25 Allowed 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 131.042 3.737 . . . . 0.0 106.648 165.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -43.75 -29.58 0.54 Allowed 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 130.23 3.412 . . . . 0.0 110.268 176.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -74.88 -24.8 58.61 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-O 115.774 -2.06 . . . . 0.0 113.842 -175.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.5 mt -80.44 -45.12 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 121.492 1.951 . . . . 0.0 107.937 162.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.492 ' C ' ' H ' ' A' ' 76' ' ' ILE . 89.3 mt -76.71 -44.1 34.79 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 123.268 1.508 . . . . 0.0 109.363 -153.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.63 -4.78 0.94 Allowed Glycine 0 C--N 1.338 0.653 0 O-C-N 120.101 -1.625 . . . . 0.0 111.891 -172.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.492 ' H ' ' C ' ' A' ' 74' ' ' LEU . 5.7 pt -102.41 170.97 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 C-N-CA 124.845 1.258 . . . . 0.0 109.119 170.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.3 pttp -163.96 174.61 11.22 Favored 'General case' 0 C--O 1.22 -0.46 0 O-C-N 127.661 3.1 . . . . 0.0 107.252 169.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 17.0 mt -134.31 156.85 47.73 Favored 'General case' 0 N--CA 1.445 -0.708 0 O-C-N 119.363 -2.086 . . . . 0.0 109.178 175.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.525 HG21 ' HB3' ' A' ' 83' ' ' GLU . 17.5 m -98.63 167.53 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 2 O-C-N 111.998 -6.688 . . . . 0.0 115.625 10.237 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.437 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 28.4 p -78.08 161.93 68.97 Favored Pre-proline 0 N--CA 1.451 -0.41 0 CA-C-N 125.527 3.785 . . . . 0.0 105.907 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' A' ' 80' ' ' THR 0.268 26.8 Cg_exo -46.23 -2.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.969 1 C-N-CA 126.435 4.757 . . . . 0.0 116.942 173.831 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 17.9 tp -84.51 -20.14 32.11 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 122.645 2.475 . . . . 0.0 113.914 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.525 ' HB3' HG21 ' A' ' 79' ' ' VAL . 13.2 tt0 -119.19 6.88 11.23 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 126.617 3.103 . . . . 0.0 110.316 176.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . 0.442 0.2 OUTLIER -141.6 64.52 1.4 Allowed 'General case' 0 C--O 1.22 -0.466 1 O-C-N 115.935 -4.228 . . . . 0.0 115.734 172.118 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -72.55 -9.79 59.01 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 118.841 2.904 . . . . 0.0 118.841 -164.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -52.25 167.5 0.13 Allowed 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 118.42 2.748 . . . . 0.0 118.42 -169.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -71.39 108.74 4.98 Favored 'General case' 0 CA--C 1.515 -0.376 0 O-C-N 121.244 -0.91 . . . . 0.0 110.254 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.2 m -116.69 44.77 1.96 Allowed 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 127.757 3.646 . . . . 0.0 113.718 -172.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -51.86 142.23 15.76 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 118.707 -2.496 . . . . 0.0 113.673 164.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . 0.312 57.2 mtpt -68.2 139.61 56.06 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 130.619 3.567 . . . . 0.0 114.959 177.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -101.84 142.43 33.16 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 129.117 2.967 . . . . 0.0 106.241 -176.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -152.17 147.61 26.63 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 125.749 2.69 . . . . 0.0 114.66 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -81.95 -27.55 33.21 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.634 -178.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -121.01 -65.6 1.13 Allowed 'General case' 0 C--O 1.239 0.53 0 CA-C-N 124.312 3.233 . . . . 0.0 115.165 177.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.9 p -152.66 158.32 42.22 Favored 'General case' 0 N--CA 1.446 -0.657 1 C-N-CA 133.161 4.584 . . . . 0.0 110.225 -176.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.05 127.96 45.16 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 130.161 3.743 . . . . 0.0 112.931 177.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 51.0 mt -90.94 146.0 24.26 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 126.854 3.216 . . . . 0.0 113.07 -158.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.9 m -136.25 142.76 44.02 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 118.748 -2.47 . . . . 0.0 113.159 -169.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.0 tp -67.06 136.62 55.5 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 131.113 3.765 . . . . 0.0 113.632 177.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.48 -23.47 4.09 Favored Glycine 0 N--CA 1.447 -0.601 1 CA-C-O 113.16 -4.133 . . . . 0.0 115.391 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.652 40.4 m-20 -71.89 24.82 0.05 OUTLIER 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 130.843 3.657 . . . . 0.0 116.199 -167.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.527 ' HB ' ' HA ' ' A' ' 103' ' ' VAL . 0.7 OUTLIER -131.84 157.56 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 2 C-N-CA 133.887 4.875 . . . . 0.0 122.114 -162.732 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.527 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 85.0 t -72.72 126.67 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 2 O-C-N 111.059 -7.276 . . . . 0.0 113.776 1.418 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -79.29 137.63 37.43 Favored 'General case' 0 C--N 1.334 -0.088 0 CA-C-O 116.566 -1.683 . . . . 0.0 109.8 -172.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.72 -178.87 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 C-N-CA 131.126 3.77 . . . . 0.0 105.352 175.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -74.96 -40.23 60.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 -174.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -79.38 -27.67 41.88 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 108.942 -3.754 . . . . 0.0 113.69 171.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -147.93 161.97 28.66 Favored Glycine 0 CA--C 1.521 0.461 0 N-CA-C 120.65 3.02 . . . . 0.0 120.65 -155.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -83.97 -11.43 56.84 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 119.688 3.218 . . . . 0.0 119.688 174.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -171.62 149.31 2.59 Favored 'General case' 0 N--CA 1.437 -1.124 0 O-C-N 126.175 2.172 . . . . 0.0 110.722 -155.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.3 mt -82.22 153.5 25.91 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 119.829 -1.794 . . . . 0.0 110.1 -177.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -167.26 -103.96 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 130.617 3.567 . . . . 0.0 105.161 -160.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -62.82 -18.66 63.13 Favored 'General case' 0 C--N 1.331 -0.239 1 O-C-N 114.658 -5.026 . . . . 0.0 113.926 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 27.5 m80 . . . . . 0 C--O 1.252 1.203 2 C-N-CA 134.445 5.098 . . . . 0.0 115.865 -174.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -173.17 37.04 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 127.358 2.263 . . . . 0.0 114.803 177.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.31 2.8 0.53 Allowed 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 127.949 2.5 . . . . 0.0 112.583 -166.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -84.46 4.02 33.6 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 130.873 3.669 . . . . 0.0 116.353 -175.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 86.0 mt -70.45 -9.67 57.1 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 119.381 -2.074 . . . . 0.0 115.858 175.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -130.2 16.49 5.58 Favored 'General case' 0 C--O 1.239 0.536 0 O-C-N 127.443 2.964 . . . . 0.0 118.24 -162.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . 0.292 15.2 pt -105.44 165.15 3.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 124.827 2.251 . . . . 0.0 113.383 -176.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.7 m -61.56 158.49 2.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 1 O-C-N 115.721 -4.362 . . . . 0.0 112.444 168.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.4 m -41.19 -65.06 0.47 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 129.44 3.096 . . . . 0.0 116.287 167.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -83.48 21.96 1.12 Allowed 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.248 1.819 . . . . 0.0 112.719 -164.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -60.53 142.12 55.72 Favored 'General case' 0 N--CA 1.444 -0.728 0 O-C-N 118.024 -2.923 . . . . 0.0 109.438 -169.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . 0.373 1.9 p90 -60.39 78.45 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 1 C-N-CA 132.684 4.394 . . . . 0.0 116.221 170.057 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.405 ' HA ' ' HB3' ' A' ' 28' ' ' LYS . 89.4 mttt -90.59 -18.04 25.89 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 116.284 -1.817 . . . . 0.0 113.559 176.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.409 HD13 ' H ' ' A' ' 26' ' ' ILE . 0.2 OUTLIER -60.33 -34.18 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.916 2 CA-C-N 129.096 5.407 . . . . 0.0 109.858 168.282 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.283 89.2 mt -65.04 -53.86 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 C-N-CA 129.338 3.055 . . . . 0.0 109.933 170.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.405 ' HB3' ' HA ' ' A' ' 25' ' ' LYS . 38.6 tttm -53.92 -46.66 71.54 Favored 'General case' 0 CA--C 1.509 -0.597 0 O-C-N 117.062 -3.524 . . . . 0.0 116.646 -173.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 51.8 p -56.73 -40.25 75.38 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.925 1.69 . . . . 0.0 111.615 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.96 -50.44 28.9 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 127.704 2.402 . . . . 0.0 113.804 173.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -58.66 -22.79 57.82 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 116.062 -1.923 . . . . 0.0 108.258 177.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -71.48 -48.95 45.88 Favored 'General case' 0 N--CA 1.446 -0.66 2 CA-C-N 128.574 5.17 . . . . 0.0 108.364 173.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -62.51 -47.01 85.82 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-O 124.691 2.186 . . . . 0.0 106.181 -169.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.317 39.5 mt -75.45 -10.81 59.78 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 115.645 1.721 . . . . 0.0 115.645 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.11 -4.25 0.08 OUTLIER Glycine 0 C--O 1.218 -0.884 0 N-CA-C 119.849 2.7 . . . . 0.0 119.849 177.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.4 pt -50.67 129.47 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 119.936 3.309 . . . . 0.0 119.936 -175.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 94.0 p -69.81 177.05 3.25 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.929 1.291 . . . . 0.0 112.27 177.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -57.35 -43.64 83.62 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 118.346 -1.341 . . . . 0.0 114.428 164.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -61.34 -39.7 91.53 Favored 'General case' 0 N--CA 1.451 -0.401 1 O-C-N 115.993 -4.192 . . . . 0.0 111.866 -177.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -73.68 -32.71 64.09 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 54.4 tp -61.31 -43.15 99.35 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.125 0.97 . . . . 0.0 113.253 161.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.71 -39.66 71.36 Favored 'General case' 0 N--CA 1.442 -0.826 0 O-C-N 119.842 -1.787 . . . . 0.0 111.512 171.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -66.04 -32.44 73.92 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 117.885 2.55 . . . . 0.0 117.885 170.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.446 ' HE2' HG23 ' A' ' 76' ' ' ILE . 19.4 tptt -64.82 -14.22 58.48 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 127.675 2.39 . . . . 0.0 107.699 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.8 tp -133.09 -4.62 3.09 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 116.394 -3.941 . . . . 0.0 114.546 -156.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt 62.52 27.63 16.34 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 131.057 3.743 . . . . 0.0 114.423 178.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.82 178.17 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 C-N-CA 129.857 3.263 . . . . 0.0 111.443 -163.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.2 p -88.2 162.5 16.64 Favored 'General case' 0 N--CA 1.443 -0.803 0 O-C-N 118.508 -2.62 . . . . 0.0 115.441 176.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -63.19 -16.38 59.94 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 119.631 -1.918 . . . . 0.0 113.704 167.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -71.95 -22.45 61.46 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 171.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . 0.283 39.0 mt -72.87 -36.26 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 C-N-CA 130.7 3.6 . . . . 0.0 116.446 164.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.317 1.5 m -80.81 -49.84 17.82 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 CA-C-O 117.157 -1.401 . . . . 0.0 111.917 -176.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.548 ' HA ' ' HB2' ' A' ' 56' ' ' GLU . 57.6 mttp -37.59 -27.99 0.02 OUTLIER 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 130.2 3.4 . . . . 0.0 118.922 166.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -40.04 -55.72 2.01 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.525 1.13 . . . . 0.0 109.207 176.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -100.04 -32.08 11.12 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 117.894 -3.004 . . . . 0.0 112.887 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 53' ' ' LYS . 4.4 mm-40 -47.9 -27.64 2.25 Favored 'General case' 0 N--CA 1.447 -0.577 1 N-CA-C 123.282 4.549 . . . . 0.0 123.282 168.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.2 m -77.69 -6.39 53.74 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.238 1.415 . . . . 0.0 113.379 -171.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.49 6.91 84.98 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 119.867 -1.158 . . . . 0.0 113.785 151.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -76.08 6.4 5.37 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 120.607 -1.525 . . . . 0.0 113.893 -174.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.416 ' CD2' HE22 ' A' ' 66' ' ' GLN . 1.2 tp -143.18 163.68 32.25 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 116.34 1.978 . . . . 0.0 116.34 -164.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -98.27 126.13 40.92 Favored Pre-proline 0 N--CA 1.443 -0.813 0 O-C-N 124.36 1.037 . . . . 0.0 110.645 165.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.25 174.01 13.54 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 CA-C-N 120.924 1.366 . . . . 0.0 112.319 -174.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 69.8 p -135.97 -174.7 3.74 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 125.215 1.406 . . . . 0.0 113.207 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.6 -51.91 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 127.226 2.21 . . . . 0.0 112.437 177.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.2 p -62.9 -31.51 72.59 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 173.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.416 HE22 ' CD2' ' A' ' 60' ' ' LEU . 76.3 mt-30 -66.3 -63.78 1.0 Allowed 'General case' 0 C--N 1.349 0.585 0 O-C-N 116.734 -3.729 . . . . 0.0 104.539 172.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -37.3 -41.41 0.41 Allowed 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 172.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 35.8 ttt85 -65.03 -53.88 39.0 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 125.859 1.974 . . . . 0.0 114.977 176.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -69.5 -40.28 77.11 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 126.87 2.606 . . . . 0.0 108.175 -172.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 13.2 mt -56.25 -63.08 1.3 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 131.45 3.9 . . . . 0.0 113.697 -177.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -46.6 -30.15 2.16 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 126.896 2.622 . . . . 0.0 111.519 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -75.24 -58.29 3.37 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 118.36 -0.829 . . . . 0.0 111.985 -176.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.7 pt -65.13 -44.8 95.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 119.562 1.074 . . . . 0.0 113.164 -168.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 77.9 mt -76.65 -3.55 38.43 Favored 'General case' 0 N--CA 1.452 -0.354 1 O-C-N 115.332 -4.605 . . . . 0.0 115.384 -152.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.22 8.44 8.85 Favored Glycine 0 C--O 1.223 -0.577 0 CA-C-O 116.951 -2.027 . . . . 0.0 115.481 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.446 HG23 ' HE2' ' A' ' 44' ' ' LYS . 28.0 pt -136.56 155.49 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 CA-C-N 122.538 3.169 . . . . 0.0 108.882 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.371 23.5 pttm 163.48 142.06 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 130.637 3.575 . . . . 0.0 116.336 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 78' ' ' LEU . 19.8 mt -145.24 141.95 29.08 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 122.704 2.502 . . . . 0.0 110.213 -171.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 26.9 m -92.68 170.12 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 1 O-C-N 113.739 -5.601 . . . . 0.0 107.674 10.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 78.4 p -84.94 161.79 51.76 Favored Pre-proline 0 N--CA 1.451 -0.409 0 CA-C-N 111.27 -2.696 . . . . 0.0 114.497 -165.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.31 -1.87 5.18 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 124.793 3.662 . . . . 0.0 113.843 -172.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . 0.27 26.4 tp -91.72 -28.42 17.44 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 119.783 -1.823 . . . . 0.0 113.846 166.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -86.2 -10.59 54.41 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 117.923 2.564 . . . . 0.0 117.923 174.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -144.7 150.05 36.65 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 126.356 1.862 . . . . 0.0 109.451 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -79.92 105.63 11.35 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 100.784 -3.784 . . . . 0.0 100.784 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -82.94 138.45 33.82 Favored 'General case' 0 N--CA 1.45 -0.475 0 O-C-N 118.948 -2.345 . . . . 0.0 110.409 -176.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.547 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 7.4 tp10 -90.51 112.64 24.37 Favored 'General case' 0 C--O 1.216 -0.682 0 CA-C-O 124.016 1.865 . . . . 0.0 110.887 -159.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 85.1 p -83.82 -7.33 59.48 Favored 'General case' 0 C--O 1.221 -0.407 0 O-C-N 117.579 -3.2 . . . . 0.0 109.187 -161.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -66.43 -0.49 2.73 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 113.112 -3.328 . . . . 0.0 114.38 159.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.547 ' HE3' ' HB3' ' A' ' 87' ' ' GLU . 98.8 mttt -80.22 -23.57 40.82 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 126.79 2.557 . . . . 0.0 111.587 172.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -59.59 -22.27 61.55 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 120.997 3.703 . . . . 0.0 120.997 -164.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -98.56 158.0 15.88 Favored 'General case' 0 C--O 1.224 -0.267 1 O-C-N 113.118 -5.989 . . . . 0.0 109.634 178.214 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -44.01 -90.92 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 114.735 -2.555 . . . . 0.0 115.661 -174.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -85.79 -22.02 27.87 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 127.702 3.126 . . . . 0.0 115.135 -160.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 11.2 t -173.36 -176.96 1.41 Allowed 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 130.726 3.61 . . . . 0.0 109.057 -176.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -88.66 136.36 13.63 Favored Glycine 0 C--O 1.223 -0.553 0 CA-C-O 118.178 -1.346 . . . . 0.0 113.686 176.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.6 mp -80.4 129.74 34.71 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 126.531 1.932 . . . . 0.0 112.803 -173.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.6 p -125.01 176.62 6.54 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 127.658 2.383 . . . . 0.0 113.502 172.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.6 tp -60.02 -82.43 0.02 OUTLIER 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 118.369 -1.332 . . . . 0.0 113.958 169.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 65.75 -13.02 0.33 Allowed Glycine 0 C--O 1.216 -1.022 0 CA-C-O 114.203 -3.554 . . . . 0.0 115.971 -172.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.467 0.4 OUTLIER -80.82 29.83 0.32 Allowed 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 128.408 3.063 . . . . 0.0 115.685 -166.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 16.5 m -132.41 151.98 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 125.14 1.376 . . . . 0.0 113.126 -159.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 4.0 p -63.15 142.1 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 2 O-C-N 110.86 -7.4 . . . . 0.0 107.992 17.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -73.13 34.4 0.07 Allowed 'General case' 0 C--O 1.216 -0.661 0 O-C-N 118.994 -2.316 . . . . 0.0 117.196 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 6.6 pt -133.56 160.63 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 O-C-N 118.286 -2.759 . . . . 0.0 106.386 169.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -98.19 -32.51 11.54 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 115.241 -2.314 . . . . 0.0 110.989 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -62.52 -35.1 78.33 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 128.215 3.447 . . . . 0.0 113.115 169.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -83.79 20.34 12.55 Favored Glycine 0 CA--C 1.528 0.894 0 N-CA-C 115.727 1.051 . . . . 0.0 115.727 172.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . 0.361 26.9 ttmt -151.93 7.53 0.47 Allowed 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.008 1.723 . . . . 0.0 113.961 -164.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -69.68 -43.81 71.74 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 131.29 3.836 . . . . 0.0 111.643 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.8 mp -97.55 178.76 5.08 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.212 148.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -147.62 -53.63 0.21 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.829 1.33 . . . . 0.0 113.996 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -148.54 30.81 0.82 Allowed 'General case' 0 C--O 1.238 0.477 0 CA-C-O 118.496 -0.764 . . . . 0.0 109.219 -164.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 63.1 m80 . . . . . 0 N--CA 1.439 -0.987 0 O-C-N 125.414 1.696 . . . . 0.0 109.965 -169.726 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.281 28.5 mt-10 . . . . . 0 N--CA 1.481 1.1 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 174.75 129.96 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 129.589 3.156 . . . . 0.0 115.416 143.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.9 -12.78 57.1 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 -156.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -94.68 -11.23 29.6 Favored 'General case' 0 N--CA 1.44 -0.958 0 O-C-N 117.972 -2.955 . . . . 0.0 114.615 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.8 mt -92.14 -3.19 56.0 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 114.131 -2.842 . . . . 0.0 106.233 169.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -109.46 3.56 21.48 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 123.82 3.009 . . . . 0.0 107.868 -162.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 45.3 pt -134.83 178.09 5.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 C-N-CA 128.792 2.837 . . . . 0.0 114.521 -173.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.2 m -77.61 173.55 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 O-C-N 118.718 -2.489 . . . . 0.0 113.534 152.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 m -59.94 -59.91 4.67 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 129.348 3.059 . . . . 0.0 107.236 173.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -73.33 -22.88 60.22 Favored 'General case' 0 N--CA 1.441 -0.919 0 O-C-N 120.027 -1.671 . . . . 0.0 115.356 -158.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.309 55.3 t80 -55.18 155.9 4.51 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 116.086 1.884 . . . . 0.0 116.086 -175.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -74.23 77.45 1.81 Allowed 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 117.001 2.222 . . . . 0.0 117.001 -176.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -57.79 -32.52 67.61 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 129.913 3.285 . . . . 0.0 111.613 -171.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.2 pt -67.43 -37.79 79.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 120.191 -0.603 . . . . 0.0 109.53 -176.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.29 26.7 mm -59.17 -43.38 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 125.288 2.47 . . . . 0.0 112.651 -175.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.46 34.2 tttm -43.45 -75.42 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 131.072 3.749 . . . . 0.0 114.9 -156.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.3 m -53.96 -43.63 70.07 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 129.147 2.979 . . . . 0.0 112.729 -168.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.43 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . . . -64.7 -48.26 75.32 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 118.936 2.939 . . . . 0.0 118.936 177.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 51.3 ttp180 -60.35 -37.38 80.5 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.183 0.993 . . . . 0.0 110.823 170.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -69.32 -33.06 72.58 Favored 'General case' 0 N--CA 1.438 -1.042 1 O-C-N 115.531 -4.48 . . . . 0.0 113.623 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . 0.29 76.7 mt-30 -60.09 -26.51 66.25 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 124.534 1.146 . . . . 0.0 109.297 172.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.3 mt -78.28 -23.4 47.22 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 127.363 2.265 . . . . 0.0 113.527 -177.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.83 0.67 9.18 Favored Glycine 0 C--N 1.341 0.823 0 N-CA-C 118.052 1.981 . . . . 0.0 118.052 -174.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.2 pt -69.61 151.02 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 2 N-CA-C 123.935 4.791 . . . . 0.0 123.935 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 56.9 p -108.3 174.33 5.93 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 123.823 1.773 . . . . 0.0 114.862 -165.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -56.99 -26.44 60.17 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -55.75 -37.04 67.97 Favored 'General case' 0 C--O 1.222 -0.358 0 O-C-N 120.579 -1.326 . . . . 0.0 110.647 176.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -64.81 -40.47 95.27 Favored 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 116.879 -3.638 . . . . 0.0 113.211 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . 0.347 24.1 tp -61.74 -43.23 99.25 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 130.292 3.437 . . . . 0.0 111.026 173.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . 0.25 . . -60.91 -43.95 97.85 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 112.923 -1.944 . . . . 0.0 112.339 178.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -67.72 -34.92 77.81 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 112.421 -3.657 . . . . 0.0 111.84 167.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.6 tptt -67.18 -24.05 65.83 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 125.54 3.791 . . . . 0.0 115.83 -174.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.8 tp -125.17 3.93 7.87 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 128.473 2.709 . . . . 0.0 108.852 -160.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.252 79.9 mttt 44.99 66.79 0.82 Allowed 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 129.803 3.241 . . . . 0.0 111.845 -174.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.5 m -148.11 170.12 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 C-N-CA 130.674 3.59 . . . . 0.0 113.389 174.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 25.3 p -94.03 159.08 15.32 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 -169.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -67.62 -16.02 63.95 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 118.174 -2.829 . . . . 0.0 115.158 175.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -49.41 -47.17 48.14 Favored 'General case' 0 C--O 1.248 0.982 0 CA-C-N 121.956 2.162 . . . . 0.0 114.152 156.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 27.8 mt -77.07 -27.39 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 O-C-N 121.744 -0.598 . . . . 0.0 111.96 -175.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.5 m -79.45 -47.71 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-O 118.484 -0.77 . . . . 0.0 110.456 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -53.71 -28.11 32.03 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 121.575 1.989 . . . . 0.0 112.986 -165.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -44.38 -57.45 3.52 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 118.563 2.801 . . . . 0.0 118.563 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -95.91 -26.72 15.49 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 119.6 1.091 . . . . 0.0 110.729 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -51.19 -27.63 9.28 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 121.348 -0.845 . . . . 0.0 109.729 172.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.2 p -98.45 0.63 45.6 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 116.984 2.216 . . . . 0.0 116.984 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.76 6.84 89.14 Favored Glycine 0 CA--C 1.525 0.707 0 O-C-N 118.374 -2.704 . . . . 0.0 115.872 -172.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -96.44 -2.62 45.03 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 119.553 1.677 . . . . 0.0 114.164 -168.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 36.9 tp -145.46 130.26 18.14 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 126.592 1.957 . . . . 0.0 106.769 -174.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.6 tttt -81.71 126.88 74.58 Favored Pre-proline 0 C--O 1.221 -0.447 0 CA-C-O 114.935 -2.459 . . . . 0.0 110.726 165.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -82.64 178.05 6.43 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 124.51 3.474 . . . . 0.0 106.389 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.498 ' H ' ' HB3' ' A' ' 66' ' ' GLN . 42.6 p -96.46 167.69 11.0 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -159.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . 0.314 1.9 tt -51.27 -49.45 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 171.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.28 99.3 p -54.92 -55.33 31.82 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 120.621 1.555 . . . . 0.0 112.433 162.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.498 ' HB3' ' H ' ' A' ' 63' ' ' THR . 48.6 tt0 -71.1 -35.2 71.71 Favored 'General case' 0 CA--C 1.515 -0.371 1 CA-C-O 111.503 -4.094 . . . . 0.0 112.796 -163.533 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.77 -43.37 98.98 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 125.288 3.677 . . . . 0.0 109.112 169.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -62.17 -42.42 99.25 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 117.468 -3.27 . . . . 0.0 106.16 174.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -72.68 -30.44 64.25 Favored 'General case' 0 C--O 1.222 -0.385 1 O-C-N 116.01 -4.181 . . . . 0.0 115.34 176.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 70' ' ' LEU . 6.1 mt -54.27 -76.3 0.03 OUTLIER 'General case' 0 C--O 1.243 0.719 0 C-N-CA 130.238 3.415 . . . . 0.0 109.727 -169.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -48.08 -26.75 1.97 Allowed 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 129.035 2.934 . . . . 0.0 108.944 -177.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -88.15 -40.36 13.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 113.822 -2.99 . . . . 0.0 111.424 -166.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 12.8 pt -68.83 -40.36 81.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 128.583 3.677 . . . . 0.0 109.015 173.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 74' ' ' LEU . 74.1 mt -68.76 -26.0 65.01 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 120.323 -1.486 . . . . 0.0 110.661 -173.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.18 -18.76 0.06 OUTLIER Glycine 0 CA--C 1.528 0.863 0 CA-C-O 114.535 -3.369 . . . . 0.0 112.735 -172.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.1 pt -115.26 164.86 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 120.08 1.94 . . . . 0.0 113.328 -165.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.3 pttm -176.01 170.14 2.77 Favored 'General case' 0 CA--C 1.519 -0.226 1 C-N-CA 133.431 4.692 . . . . 0.0 111.093 177.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.43 ' HG ' ' HB2' ' A' ' 30' ' ' ALA . 57.4 mt -136.64 139.95 42.43 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 128.636 2.775 . . . . 0.0 110.615 154.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.416 ' CG2' ' HB3' ' A' ' 84' ' ' ASN . 18.5 m -97.8 175.25 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 O-C-N 116.836 -3.665 . . . . 0.0 112.517 38.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.0 p -80.6 160.47 67.02 Favored Pre-proline 0 N--CA 1.441 -0.897 0 O-C-N 120.769 -1.207 . . . . 0.0 110.261 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.67 -7.5 2.25 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 N-CA-C 119.903 3.001 . . . . 0.0 119.903 162.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 75.5 mt -99.57 -6.89 26.64 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-O 115.265 -2.302 . . . . 0.0 109.614 173.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -108.3 -11.6 15.19 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 117.022 2.23 . . . . 0.0 117.022 155.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.416 ' HB3' ' CG2' ' A' ' 79' ' ' VAL . 0.0 OUTLIER -143.77 177.57 8.42 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 120.33 1.423 . . . . 0.0 108.778 -174.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -60.65 161.43 7.79 Favored 'General case' 0 N--CA 1.449 -0.522 1 O-C-N 114.814 -4.929 . . . . 0.0 113.98 172.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -152.34 153.35 33.5 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 129.755 3.222 . . . . 0.0 111.435 165.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -122.99 139.15 54.38 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 131.154 3.782 . . . . 0.0 109.333 -157.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.8 p -85.32 -30.86 23.38 Favored 'General case' 0 N--CA 1.439 -1.013 0 O-C-N 120.461 -1.4 . . . . 0.0 112.479 175.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -79.27 92.17 5.1 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 128.163 2.585 . . . . 0.0 114.176 -175.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -144.06 0.47 1.06 Allowed 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 130.137 3.375 . . . . 0.0 112.896 -165.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -72.9 -42.05 63.98 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 114.012 -2.899 . . . . 0.0 112.598 173.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -56.56 137.29 53.81 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 127.472 2.982 . . . . 0.0 108.646 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . 0.275 14.7 t0 -82.55 -37.23 25.44 Favored 'General case' 0 C--O 1.241 0.611 0 O-C-N 120.28 -1.513 . . . . 0.0 111.546 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -131.39 -37.16 1.24 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 115.813 -2.041 . . . . 0.0 112.444 -169.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.8 t -170.31 159.6 7.28 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 127.565 2.346 . . . . 0.0 109.242 -157.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -75.64 130.7 11.33 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 128.547 2.975 . . . . 0.0 107.379 -174.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 8.6 mt -136.91 140.77 42.54 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 122.663 3.231 . . . . 0.0 110.42 -174.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.3 m -137.52 129.23 28.57 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 129.977 3.311 . . . . 0.0 111.015 -176.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.7 tp -157.56 -52.5 0.07 Allowed 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 116.743 2.127 . . . . 0.0 116.743 -174.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 76.69 -4.1 52.96 Favored Glycine 0 C--O 1.218 -0.855 0 C-N-CA 127.766 2.603 . . . . 0.0 110.411 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -95.45 57.52 1.95 Allowed 'General case' 0 C--N 1.344 0.36 0 CA-C-N 122.235 3.017 . . . . 0.0 112.815 -162.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.44 159.94 28.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 1 O-C-N 129.248 4.092 . . . . 0.0 114.806 -155.453 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 12.1 p -60.47 152.27 5.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 2 CA-C-N 131.034 6.288 . . . . 0.0 112.707 5.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -149.39 106.28 3.57 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 101.599 -3.482 . . . . 0.0 101.599 177.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 32.9 pt -89.12 -178.18 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 CA-C-O 123.083 1.42 . . . . 0.0 111.1 176.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 40.6 tttm -73.93 -27.48 61.05 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -168.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -83.74 -27.63 28.79 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 128.183 2.593 . . . . 0.0 114.957 172.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 173.08 -174.57 45.94 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 116.323 -3.986 . . . . 0.0 118.23 -173.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -94.98 20.03 9.52 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-O 124.777 2.227 . . . . 0.0 109.695 -161.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -171.75 159.19 5.2 Favored 'General case' 0 C--N 1.347 0.457 0 C-N-CA 129.53 3.132 . . . . 0.0 115.393 174.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.4 mp -67.09 139.09 57.54 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 129.924 3.29 . . . . 0.0 111.861 154.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.303 13.1 mt-10 -139.86 -92.34 0.17 Allowed 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 127.973 2.509 . . . . 0.0 114.033 -165.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 16.0 p-80 -87.78 6.58 34.47 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 123.818 1.771 . . . . 0.0 115.565 171.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 37.1 m80 . . . . . 0 C--O 1.251 1.138 0 CA-C-N 111.812 -2.449 . . . . 0.0 114.864 173.072 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 . . . . . 0 N--CA 1.474 0.732 0 CA-C-O 117.06 -1.448 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -83.07 151.67 25.68 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 124.595 3.362 . . . . 0.0 112.482 -178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -112.82 4.76 17.14 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 119.457 3.132 . . . . 0.0 119.457 -174.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -82.39 0.73 40.61 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 119.902 3.297 . . . . 0.0 119.902 -176.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.6 mt -75.86 -31.16 59.15 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 131.68 3.992 . . . . 0.0 110.9 -172.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -128.98 9.33 5.76 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 116.979 2.215 . . . . 0.0 116.979 -146.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.0 pt -107.68 167.19 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 130.236 3.415 . . . . 0.0 111.304 -169.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.2 m -77.88 172.25 1.16 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 O-C-N 118.412 -2.68 . . . . 0.0 111.22 159.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . 0.261 85.4 m -42.97 -83.77 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.945 1 C-N-CA 133.642 4.777 . . . . 0.0 109.446 168.243 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . 0.261 25.0 t70 -91.92 43.89 1.15 Allowed 'General case' 0 C--O 1.239 0.533 0 C-N-CA 128.047 2.539 . . . . 0.0 116.314 -166.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -73.7 137.05 43.82 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 125.081 2.372 . . . . 0.0 104.641 -174.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -70.66 157.8 37.34 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 117.36 -3.337 . . . . 0.0 113.196 -166.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.5 mttp -140.89 14.18 2.28 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 127.149 2.179 . . . . 0.0 113.259 -146.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -35.7 -57.11 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.805 1 O-C-N 114.888 -4.882 . . . . 0.0 113.886 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.407 HD11 HD22 ' A' ' 70' ' ' LEU . 11.7 pt -119.14 4.2 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 113.457 -1.701 . . . . 0.0 110.719 -165.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -47.95 -64.13 0.88 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.066 1.746 . . . . 0.0 114.912 -175.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.5 p -53.95 -46.58 71.63 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.283 1.833 . . . . 0.0 115.888 -174.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.58 -44.26 65.8 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 109.776 -3.375 . . . . 0.0 114.645 176.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -48.41 -44.7 35.28 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 118.551 -2.593 . . . . 0.0 112.772 169.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -72.14 -47.5 50.58 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 120.384 -1.448 . . . . 0.0 114.532 177.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -66.75 -25.69 66.62 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 128.641 2.776 . . . . 0.0 111.325 -167.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.5 mt -88.1 -17.05 31.87 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 127.417 2.287 . . . . 0.0 110.315 -174.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.32 11.27 58.96 Favored Glycine 0 C--O 1.243 0.674 0 CA-C-O 123.309 1.505 . . . . 0.0 113.99 177.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.9 pt -75.54 144.76 11.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 129.094 2.958 . . . . 0.0 114.202 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.5 p -93.2 166.3 12.39 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -175.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -58.71 -35.86 73.33 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.194 -1.366 . . . . 0.0 113.191 173.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -70.11 -37.37 75.35 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 115.906 -1.997 . . . . 0.0 108.132 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -66.87 -29.98 70.02 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 115.568 -2.158 . . . . 0.0 112.661 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.7 tt -78.96 -36.52 41.44 Favored 'General case' 0 C--N 1.344 0.356 0 CA-C-O 126.315 2.959 . . . . 0.0 111.836 176.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.93 -40.5 66.8 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 119.447 -2.033 . . . . 0.0 112.224 167.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -70.6 -37.07 73.85 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 118.845 -2.409 . . . . 0.0 111.007 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -66.39 -14.3 61.92 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 129.554 3.141 . . . . 0.0 110.438 -172.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 67.3 mt -131.01 -1.59 4.09 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 126.832 3.206 . . . . 0.0 112.781 -164.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.274 40.8 mtmt 56.39 -26.19 0.02 OUTLIER 'General case' 0 C--O 1.241 0.615 0 N-CA-C 121.094 3.739 . . . . 0.0 121.094 -162.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.9 m -83.61 172.21 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.607 0 C-N-CA 129.504 3.122 . . . . 0.0 111.378 -168.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 91.7 p -92.48 158.33 16.08 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 119.556 -1.965 . . . . 0.0 111.334 -153.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.409 ' HA ' HG22 ' A' ' 52' ' ' VAL . 18.3 mt-10 -61.56 -32.58 72.66 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 126.143 1.777 . . . . 0.0 108.031 177.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -65.3 -31.57 72.78 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 168.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 25.9 mt -67.98 -38.79 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-O 124.407 2.051 . . . . 0.0 112.555 172.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.409 HG22 ' HA ' ' A' ' 49' ' ' GLU 0.297 32.6 m -80.07 -30.78 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 1 O-C-N 116.042 -4.161 . . . . 0.0 114.122 -176.777 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -53.13 -38.69 62.88 Favored 'General case' 0 C--O 1.219 -0.536 0 C-N-CA 126.392 1.877 . . . . 0.0 109.806 155.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -71.93 -38.42 69.87 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 126.296 1.838 . . . . 0.0 106.046 -174.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.1 m-30 -66.97 -41.46 86.82 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 121.59 1.995 . . . . 0.0 108.662 173.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.42 -14.96 62.76 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 114.464 -2.684 . . . . 0.0 111.562 -172.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.6 p -113.09 -1.68 14.36 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 123.495 2.861 . . . . 0.0 111.137 -175.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 65.06 28.47 73.57 Favored Glycine 0 C--N 1.343 0.922 0 O-C-N 128.665 3.728 . . . . 0.0 119.24 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -85.17 7.24 22.55 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 131.501 3.921 . . . . 0.0 113.216 -171.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.6 tt -137.17 144.2 42.8 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 127.402 2.281 . . . . 0.0 109.501 -166.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.1 tttt -83.04 126.6 72.06 Favored Pre-proline 0 C--O 1.24 0.587 0 CA-C-O 116.455 -1.736 . . . . 0.0 110.23 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -82.0 150.64 16.06 Favored 'Trans proline' 0 N--CA 1.443 -1.465 0 C-N-CA 124.64 3.56 . . . . 0.0 112.504 -168.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.3 p -123.07 164.64 18.22 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 123.937 1.827 . . . . 0.0 113.669 174.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.0 pt -62.66 -50.27 80.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 O-C-N 118.715 -2.491 . . . . 0.0 113.443 174.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 99.3 p -54.67 -21.57 11.08 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 121.871 2.123 . . . . 0.0 116.649 170.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -75.33 -75.84 0.16 Allowed 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.911 177.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -12.52 -62.66 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 117.884 2.549 . . . . 0.0 117.884 150.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -56.83 -49.85 74.16 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 127.474 2.31 . . . . 0.0 107.741 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -62.49 -44.29 96.73 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 116.413 -1.756 . . . . 0.0 106.886 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.407 HD22 HD11 ' A' ' 27' ' ' ILE . 43.5 mt -63.43 -47.39 82.1 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 115.29 -2.29 . . . . 0.0 109.851 -167.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -50.98 -22.73 2.43 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 170.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.7 mttp -94.48 -52.34 4.37 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 -176.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 24.1 pt -44.24 -49.93 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 127.243 2.217 . . . . 0.0 115.471 -167.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.3 mt -77.67 -2.49 36.27 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 121.549 1.977 . . . . 0.0 109.89 -169.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.95 0.51 60.37 Favored Glycine 0 CA--C 1.522 0.478 0 O-C-N 125.535 1.772 . . . . 0.0 111.834 -169.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 76' ' ' ILE . 29.6 pt -149.88 167.62 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 O-C-N 117.639 -3.271 . . . . 0.0 113.64 -178.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.77 163.78 1.17 Allowed 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 126.885 2.074 . . . . 0.0 109.471 -177.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.9 mt -150.76 146.54 26.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 121.132 1.787 . . . . 0.0 109.972 -174.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.556 HG23 ' HB3' ' A' ' 84' ' ' ASN . 0.0 OUTLIER -116.5 159.26 16.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 O-C-N 116.971 -3.581 . . . . 0.0 119.231 26.722 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . 0.259 82.7 p -99.11 171.1 6.04 Favored Pre-proline 0 C--N 1.324 -0.535 0 C-N-CA 129.205 3.002 . . . . 0.0 113.221 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -59.48 11.86 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 124.28 3.32 . . . . 0.0 112.781 171.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 39.1 tp -59.92 -33.29 71.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 121.824 2.102 . . . . 0.0 109.878 150.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -146.88 5.74 0.88 Allowed 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 120.583 1.538 . . . . 0.0 113.382 171.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.556 ' HB3' HG23 ' A' ' 79' ' ' VAL . 24.7 t-20 -176.64 139.66 0.32 Allowed 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 119.252 -2.155 . . . . 0.0 111.235 -166.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -134.25 174.24 10.73 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 125.629 2.633 . . . . 0.0 105.663 -177.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -166.12 150.86 8.14 Favored 'General case' 0 N--CA 1.445 -0.698 0 O-C-N 119.302 -2.124 . . . . 0.0 107.763 -168.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.405 ' OE1' ' HA ' ' A' ' 87' ' ' GLU . 4.8 tp10 -49.7 129.73 20.04 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 120.234 -1.541 . . . . 0.0 111.802 168.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 26.1 m -76.97 -27.28 54.71 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.315 1.846 . . . . 0.0 108.601 -166.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -71.57 -5.48 33.69 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 118.545 -2.597 . . . . 0.0 113.886 175.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -70.95 -28.94 64.84 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 123.085 1.421 . . . . 0.0 111.593 174.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -58.19 -21.22 46.61 Favored 'General case' 0 CA--C 1.508 -0.653 0 C-N-CA 129.645 3.178 . . . . 0.0 118.29 -168.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.458 ' CD2' ' HA2' ' A' ' 96' ' ' GLY . 87.3 m-85 -74.7 -177.96 3.44 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 116.991 2.219 . . . . 0.0 116.991 177.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -81.1 -31.69 34.19 Favored 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 118.589 -2.569 . . . . 0.0 116.535 174.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -138.51 -38.69 0.53 Allowed 'General case' 0 C--O 1.236 0.381 0 CA-C-N 120.404 1.456 . . . . 0.0 113.539 167.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.2 p -152.27 153.5 33.86 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.707 2.003 . . . . 0.0 108.898 -166.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.458 ' HA2' ' CD2' ' A' ' 92' ' ' PHE . . . -72.52 161.51 54.39 Favored Glycine 0 C--N 1.34 0.777 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -178.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 59.0 tp -92.31 -32.33 15.05 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 116.156 1.91 . . . . 0.0 116.156 -163.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.2 m -119.29 141.1 49.27 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 127.69 2.396 . . . . 0.0 113.144 -168.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 14.3 tp -92.66 127.89 38.32 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 116.727 -1.606 . . . . 0.0 110.156 174.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.72 -15.75 62.89 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-O 118.254 -1.303 . . . . 0.0 112.303 -176.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.267 16.5 t0 -91.97 27.61 2.08 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 118.428 2.751 . . . . 0.0 118.428 -148.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . 0.317 0.0 OUTLIER -139.67 157.04 26.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 131.136 3.774 . . . . 0.0 114.781 -155.003 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 6.9 m -97.89 8.56 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 2 O-C-N 109.21 -8.431 . . . . 0.0 109.761 14.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -59.91 121.9 12.92 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 120.559 1.527 . . . . 0.0 112.635 178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 105' ' ' ILE . 69.1 mt -100.93 134.71 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 126.649 1.979 . . . . 0.0 110.649 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -103.36 -18.02 15.02 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.461 1.105 . . . . 0.0 108.142 -161.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -67.42 -8.75 35.55 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 126.433 1.893 . . . . 0.0 109.763 153.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.83 6.92 37.29 Favored Glycine 0 C--N 1.339 0.704 0 O-C-N 117.48 -3.263 . . . . 0.0 118.4 -162.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -126.07 24.3 6.96 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-O 116.167 -1.873 . . . . 0.0 111.523 168.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 44.1 tttt -70.92 77.45 0.64 Allowed 'General case' 0 C--O 1.235 0.331 0 C-N-CA 130.989 3.716 . . . . 0.0 114.571 174.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.8 pp -172.12 179.34 2.66 Favored 'General case' 0 N--CA 1.443 -0.796 1 C-N-CA 132.073 4.149 . . . . 0.0 107.531 -169.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.294 33.0 tt0 -146.74 -104.75 0.09 Allowed 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 -176.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -86.88 -7.07 58.55 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 116.806 2.15 . . . . 0.0 116.806 -169.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 12.6 m80 . . . . . 0 C--O 1.252 1.185 0 C-N-CA 130.154 3.382 . . . . 0.0 109.929 172.773 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . 0.287 4.6 tp10 . . . . . 0 N--CA 1.468 0.472 0 CA-C-O 124.72 2.2 . . . . 0.0 112.358 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -87.67 148.32 24.84 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 112.896 -1.956 . . . . 0.0 108.953 -163.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.44 162.79 26.68 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 126.96 2.104 . . . . 0.0 113.015 -172.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -80.32 -3.16 48.36 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.571 -160.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 179.57 163.87 0.99 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 127.607 2.363 . . . . 0.0 113.227 -156.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -138.05 148.17 44.81 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-O 122.367 1.08 . . . . 0.0 110.664 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 40.3 pt -123.18 -15.82 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 114.68 -2.581 . . . . 0.0 114.054 -171.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 86.6 t -80.81 -47.12 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 C-N-CA 115.824 -2.35 . . . . 0.0 111.763 178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.3 m -51.09 -45.52 61.49 Favored 'General case' 0 N--CA 1.448 -0.568 1 O-C-N 115.834 -4.291 . . . . 0.0 114.38 -156.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . 0.403 71.3 m-20 63.76 -21.62 0.06 Allowed 'General case' 0 N--CA 1.442 -0.851 0 C-N-CA 129.366 3.067 . . . . 0.0 116.496 -163.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -89.32 75.24 7.75 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 116.675 -1.631 . . . . 0.0 107.0 -179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -100.02 -173.31 2.41 Favored 'General case' 0 CA--C 1.518 -0.255 0 O-C-N 128.457 3.598 . . . . 0.0 118.054 176.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -59.18 -24.04 62.74 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 119.199 3.037 . . . . 0.0 119.199 -175.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.9 pt -30.42 -35.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.788 0 N-CA-C 119.908 3.299 . . . . 0.0 119.908 145.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.1 tp -137.31 -42.94 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 121.693 2.042 . . . . 0.0 114.495 177.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.361 79.5 tttt -40.99 -58.51 1.7 Allowed 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 131.07 3.748 . . . . 0.0 118.313 173.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 74.9 p -83.48 -29.7 27.78 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 113.433 -1.712 . . . . 0.0 109.087 178.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.12 -51.23 62.49 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.937 1.295 . . . . 0.0 110.516 -160.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -46.51 -38.07 8.79 Favored 'General case' 0 C--O 1.239 0.504 0 O-C-N 126.901 2.626 . . . . 0.0 112.879 174.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -73.87 -41.34 62.33 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 129.512 3.125 . . . . 0.0 113.462 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . 0.29 43.5 mt-30 -68.66 -16.31 63.79 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.447 ' HA ' HD12 ' A' ' 34' ' ' LEU . 14.0 tp -95.99 -14.51 22.96 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 112.453 -2.158 . . . . 0.0 112.157 175.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.64 -0.63 34.13 Favored Glycine 0 CA--C 1.523 0.564 1 C-N-CA 131.037 4.16 . . . . 0.0 117.309 172.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.6 pt -69.03 155.97 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 C-N-CA 126.233 1.813 . . . . 0.0 113.78 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 93.7 p -90.63 171.84 9.09 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 116.597 2.073 . . . . 0.0 116.597 -176.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -59.25 -42.97 92.37 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -64.9 -41.12 95.86 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 119.242 -2.161 . . . . 0.0 109.172 -175.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -64.74 -39.41 93.59 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 119.181 -2.2 . . . . 0.0 114.066 174.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.4 tp -64.04 -38.64 91.82 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 126.768 2.027 . . . . 0.0 114.166 -173.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.12 -49.76 76.63 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-O 123.899 1.809 . . . . 0.0 107.99 173.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -64.56 -14.34 57.12 Favored 'General case' 0 N--CA 1.441 -0.882 0 O-C-N 117.53 -3.231 . . . . 0.0 108.669 -175.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.7 tttp -103.54 -16.88 15.41 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 117.591 -3.193 . . . . 0.0 118.504 -177.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 86.2 mt -135.2 15.06 3.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 120.672 -1.267 . . . . 0.0 113.723 -165.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 70.7 mttt 45.6 -27.38 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.419 1 C-N-CA 134.255 5.022 . . . . 0.0 117.931 -154.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.7 m -86.86 145.37 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 122.348 2.34 . . . . 0.0 116.419 -163.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.2 p -81.36 160.75 24.04 Favored 'General case' 0 N--CA 1.449 -0.517 1 N-CA-C 122.439 4.237 . . . . 0.0 122.439 -168.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.79 -17.24 0.33 Allowed 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 125.367 3.712 . . . . 0.0 116.962 165.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -86.68 -35.51 19.26 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 126.503 1.921 . . . . 0.0 112.055 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.9 mm -55.16 -36.76 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-O 124.197 1.951 . . . . 0.0 110.137 167.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.3 t -59.6 -65.28 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-O 115.274 -2.298 . . . . 0.0 111.007 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -44.24 -43.53 7.34 Favored 'General case' 0 CA--C 1.509 -0.618 0 O-C-N 126.526 2.391 . . . . 0.0 114.134 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -54.34 -50.42 67.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 176.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -91.29 -40.42 11.51 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.645 1.178 . . . . 0.0 109.196 -171.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -43.58 -36.6 2.16 Favored 'General case' 0 N--CA 1.434 -1.266 0 O-C-N 118.352 -2.718 . . . . 0.0 111.567 166.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 76.1 p -90.13 -2.55 58.1 Favored 'General case' 0 C--O 1.237 0.436 1 O-C-N 116.176 -4.078 . . . . 0.0 114.371 -172.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.97 12.71 79.2 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 120.14 2.816 . . . . 0.0 120.14 -175.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -87.22 -28.42 22.39 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.624 1.97 . . . . 0.0 112.421 -168.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.1 tp -151.79 131.66 13.32 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 128.584 2.753 . . . . 0.0 111.743 -170.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -117.45 -179.62 0.67 Allowed Pre-proline 0 N--CA 1.447 -0.605 0 CA-C-O 114.935 -2.46 . . . . 0.0 108.807 165.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -46.36 150.82 1.99 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 1 C-N-CA 125.637 4.225 . . . . 0.0 116.335 -175.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.6 p -127.98 -175.11 3.39 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 128.488 2.715 . . . . 0.0 114.433 -173.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.0 tp -60.56 -54.15 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 124.502 1.121 . . . . 0.0 108.078 175.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 88.0 p -69.19 -16.99 63.75 Favored 'General case' 0 C--N 1.34 0.194 0 O-C-N 117.335 -3.353 . . . . 0.0 111.928 -175.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -98.76 -47.23 5.39 Favored 'General case' 0 CA--C 1.514 -0.427 0 O-C-N 116.999 -3.563 . . . . 0.0 111.145 -175.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.95 -55.67 31.57 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 125.892 1.995 . . . . 0.0 115.875 -149.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.2 mtp180 -52.24 -54.41 31.57 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 120.968 1.713 . . . . 0.0 114.092 -167.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.541 ' HB3' ' CZ ' ' A' ' 92' ' ' PHE . 15.8 tt0 -60.94 -40.28 92.67 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 119.417 -2.052 . . . . 0.0 114.926 167.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tt -55.23 -55.76 27.64 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 130.976 3.71 . . . . 0.0 108.331 -172.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -48.4 -48.61 36.87 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-O 125.077 2.37 . . . . 0.0 111.127 175.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.434 ' HE2' ' HB3' ' A' ' 89' ' ' GLU . 45.1 mttp -73.72 -36.33 65.19 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 119.078 -2.263 . . . . 0.0 113.035 -164.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 24.3 pt -66.48 -27.95 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 O-C-N 124.058 0.849 . . . . 0.0 112.995 -178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . 0.269 1.1 pt? 164.93 -21.0 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 130.891 3.676 . . . . 0.0 111.228 173.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 75.82 29.35 59.38 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-O 123.019 1.344 . . . . 0.0 113.14 -170.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . 0.324 4.2 pt 64.46 7.7 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.706 1 C-N-CA 131.909 4.084 . . . . 0.0 113.037 165.609 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -68.44 151.6 46.6 Favored 'General case' 0 CA--C 1.515 -0.369 1 CA-C-O 111.102 -4.285 . . . . 0.0 112.333 174.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.415 ' CD2' ' HA ' ' A' ' 79' ' ' VAL 0.289 12.6 mt -135.9 140.12 43.84 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 125.61 3.823 . . . . 0.0 112.9 -176.076 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.415 ' HA ' ' CD2' ' A' ' 78' ' ' LEU 0.252 14.4 m -105.53 170.05 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 1 O-C-N 116.091 -4.131 . . . . 0.0 116.273 24.719 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . 0.309 1.6 p -89.56 99.63 1.85 Allowed Pre-proline 0 C--O 1.244 0.788 0 N-CA-C 102.876 -3.009 . . . . 0.0 102.876 158.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -46.4 -28.92 6.48 Favored 'Trans proline' 0 C--N 1.326 -0.616 1 C-N-CA 109.288 -6.675 . . . . 0.0 112.324 144.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -161.54 156.26 23.13 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 122.584 2.447 . . . . 0.0 112.937 171.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -67.11 116.69 8.2 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 116.085 -1.912 . . . . 0.0 111.93 177.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -113.31 169.74 8.73 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 126.363 2.982 . . . . 0.0 114.756 168.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -146.42 145.85 30.39 Favored 'General case' 0 C--N 1.341 0.229 0 O-C-N 117.413 -3.304 . . . . 0.0 110.957 156.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -82.18 118.42 23.07 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 173.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -76.6 13.71 0.94 Allowed 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 118.302 -2.749 . . . . 0.0 113.113 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 p -64.69 -26.13 68.24 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 129.134 2.973 . . . . 0.0 113.795 -175.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.434 ' HB3' ' HE2' ' A' ' 72' ' ' LYS 0.333 41.8 tt0 -174.59 105.94 0.1 Allowed 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 117.405 -3.309 . . . . 0.0 112.16 -176.679 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 29.6 tttm -66.93 -53.13 34.95 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 130.051 3.34 . . . . 0.0 119.839 173.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -74.64 116.01 14.86 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 119.289 -2.132 . . . . 0.0 112.296 -165.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.541 ' CZ ' ' HB3' ' A' ' 69' ' ' GLN . 88.4 t80 -137.61 113.4 9.68 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 116.944 2.201 . . . . 0.0 116.944 -162.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.1 t70 173.98 146.1 0.06 Allowed 'General case' 0 N--CA 1.452 -0.368 1 C-N-CA 132.879 4.471 . . . . 0.0 117.095 -175.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . 0.264 5.2 p-10 -111.12 -13.4 14.04 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 131.207 3.803 . . . . 0.0 115.911 -167.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.7 m -57.07 -40.29 76.61 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 116.905 -1.918 . . . . 0.0 115.684 -173.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -71.41 -4.53 57.17 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-O 115.417 -2.879 . . . . 0.0 112.103 -174.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.9 tp -112.37 -44.27 3.4 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 118.755 1.278 . . . . 0.0 113.133 177.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 41.6 p -93.38 -55.87 3.14 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 126.666 1.986 . . . . 0.0 107.953 -160.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 19.7 tp -73.52 -17.61 61.19 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.836 0.827 . . . . 0.0 109.651 159.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.44 37.05 94.2 Favored Glycine 0 C--N 1.341 0.823 0 O-C-N 119.001 -2.312 . . . . 0.0 115.018 -177.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.25 1.1 t70 -76.96 58.92 1.56 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 123.722 1.725 . . . . 0.0 111.48 -170.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.87 158.16 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 1 O-C-N 115.165 -4.71 . . . . 0.0 114.722 -178.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.424 HG13 ' HB3' ' A' ' 110' ' ' LYS . 25.4 t -76.05 123.97 33.25 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.306 1 O-C-N 110.923 -7.36 . . . . 0.0 113.014 1.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.423 HD21 ' HB2' ' A' ' 107' ' ' GLU . 51.7 t-20 -86.52 118.26 25.83 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 112.78 -2.009 . . . . 0.0 109.53 177.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 10.0 pt -114.54 -0.45 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 O-C-N 126.445 2.34 . . . . 0.0 112.016 -174.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 31.8 tttm -103.86 -24.56 13.27 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 131.425 3.89 . . . . 0.0 117.097 -174.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.423 ' HB2' HD21 ' A' ' 104' ' ' ASN . 51.8 mt-10 -143.09 -25.03 0.61 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 129.224 3.009 . . . . 0.0 113.679 172.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -69.71 -176.77 16.97 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 117.944 -2.074 . . . . 0.0 116.212 -160.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -142.16 53.18 1.46 Allowed 'General case' 0 C--O 1.219 -0.534 0 O-C-N 119.794 -2.004 . . . . 0.0 110.229 173.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.424 ' HB3' HG13 ' A' ' 103' ' ' VAL . 13.0 tmtt? -75.23 81.06 2.35 Favored 'General case' 0 N--CA 1.439 -1.001 2 O-C-N 115.534 -4.479 . . . . 0.0 112.943 173.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.4 ' H ' ' CE1' ' A' ' 114' ' ' HIS 0.259 7.9 mt -76.73 161.12 28.75 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 119.098 -2.251 . . . . 0.0 116.266 -163.305 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -47.23 -38.87 12.97 Favored 'General case' 0 N--CA 1.443 -0.806 1 C-N-CA 132.531 4.333 . . . . 0.0 112.656 -173.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -94.59 -4.33 48.03 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 117.631 -3.168 . . . . 0.0 113.31 -170.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.4 ' CE1' ' H ' ' A' ' 111' ' ' LEU . 54.3 m170 . . . . . 0 C--O 1.243 0.711 0 O-C-N 118.09 -2.881 . . . . 0.0 110.296 -174.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 . . . . . 0 N--CA 1.476 0.865 0 CA-C-O 124.874 2.273 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -178.96 127.14 0.1 Allowed 'General case' 0 N--CA 1.442 -0.869 1 C-N-CA 133.434 4.694 . . . . 0.0 111.378 177.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.52 -19.55 64.52 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 118.779 2.881 . . . . 0.0 118.779 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -73.1 1.13 9.69 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 118.625 2.824 . . . . 0.0 118.625 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.2 mt -113.67 8.91 17.7 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 111.375 -2.648 . . . . 0.0 117.339 -179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -132.76 24.19 4.31 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -160.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 40.4 pt -135.79 156.19 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 126.291 1.837 . . . . 0.0 113.588 -164.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.3 p -73.2 140.53 17.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 126.286 1.835 . . . . 0.0 107.683 175.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.8 m -64.34 -59.32 4.52 Favored 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -174.92 85.08 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 129.318 3.047 . . . . 0.0 107.101 -163.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -71.16 150.01 45.8 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 130.505 3.522 . . . . 0.0 114.232 -160.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -70.6 127.53 33.01 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 -170.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -101.21 -15.57 17.28 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 125.298 1.439 . . . . 0.0 113.002 -174.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.9 pt -70.77 -25.63 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-N 120.571 1.532 . . . . 0.0 111.31 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.429 40.3 pt -60.36 -35.58 63.53 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 C-N-CA 127.702 2.401 . . . . 0.0 108.16 171.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.355 8.8 ttpt -44.0 -72.74 0.05 Allowed 'General case' 0 N--CA 1.454 -0.272 1 C-N-CA 132.266 4.227 . . . . 0.0 115.951 -159.548 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 90.9 m -72.12 -21.87 61.41 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.111 0.964 . . . . 0.0 111.948 -165.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.473 ' HB1' HD12 ' A' ' 76' ' ' ILE . . . -76.71 -59.95 2.56 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 128.081 2.552 . . . . 0.0 107.872 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -43.77 -35.11 1.75 Allowed 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 127.77 2.428 . . . . 0.0 108.143 169.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . 0.304 17.2 tt0 -73.45 -41.23 63.46 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 122.42 2.373 . . . . 0.0 115.402 173.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -61.51 -19.7 62.37 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 121.564 1.984 . . . . 0.0 111.973 171.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 34' ' ' LEU . 8.1 tp -71.77 -34.64 69.62 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 123.503 1.621 . . . . 0.0 111.188 -173.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.57 -12.97 8.94 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-N 110.804 -2.907 . . . . 0.0 112.557 173.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.4 pt -70.79 154.54 7.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 O-C-N 120.383 -1.657 . . . . 0.0 110.403 -171.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 84.4 p -96.46 175.05 6.55 Favored 'General case' 0 N--CA 1.437 -1.106 0 O-C-N 118.265 -2.772 . . . . 0.0 113.473 -166.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -51.16 -40.85 59.51 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 113.437 -3.173 . . . . 0.0 113.95 161.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . 0.293 25.2 mp0 -61.16 -40.41 93.77 Favored 'General case' 0 N--CA 1.454 -0.268 0 O-C-N 127.822 3.201 . . . . 0.0 110.002 -175.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.9 mt-30 -72.75 -34.57 67.11 Favored 'General case' 0 N--CA 1.443 -0.802 0 O-C-N 119.706 -1.871 . . . . 0.0 113.586 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 63.1 tp -73.35 -27.68 61.64 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 122.682 1.229 . . . . 0.0 113.601 -176.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.77 -36.73 81.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 116.301 -1.809 . . . . 0.0 107.082 169.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . 0.277 87.8 mm-40 -73.29 -31.28 63.95 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 127.662 2.385 . . . . 0.0 111.266 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 30.7 tptt -67.3 -24.61 65.77 Favored 'General case' 0 N--CA 1.442 -0.864 0 O-C-N 117.227 -3.421 . . . . 0.0 111.736 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.9 mt -124.96 -3.14 7.67 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 128.02 2.528 . . . . 0.0 109.992 -165.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.258 27.2 mtpt 52.32 5.54 0.04 OUTLIER 'General case' 0 C--O 1.233 0.224 0 C-N-CA 130.486 3.514 . . . . 0.0 118.736 -171.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.8 m -88.51 -168.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 C-N-CA 128.386 2.674 . . . . 0.0 108.102 -173.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 90.9 p -100.1 158.87 15.53 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.911 1.284 . . . . 0.0 112.585 -173.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -52.33 -32.58 38.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 113.12 -1.855 . . . . 0.0 110.971 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -74.21 -31.12 62.5 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 175.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 67.7 mt -74.26 -34.63 37.87 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.494 0 O-C-N 118.459 -2.651 . . . . 0.0 112.196 174.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.41 11.2 m -64.22 -59.13 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 O-C-N 118.376 -2.703 . . . . 0.0 112.79 164.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -50.03 -18.91 0.61 Allowed 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 119.801 3.259 . . . . 0.0 119.801 175.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -58.95 -32.68 69.82 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 -171.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -93.91 -44.8 7.91 Favored 'General case' 0 CA--C 1.512 -0.5 0 O-C-N 126.148 2.155 . . . . 0.0 110.035 176.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -49.26 -30.82 7.76 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 127.606 2.362 . . . . 0.0 108.787 176.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.2 p -94.81 -28.09 15.43 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 117.443 -3.286 . . . . 0.0 114.253 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.58 9.52 56.44 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 118.556 -2.59 . . . . 0.0 113.776 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -88.76 45.1 1.26 Allowed 'General case' 0 N--CA 1.447 -0.606 1 C-N-CA 131.82 4.048 . . . . 0.0 113.222 -169.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.53 135.95 54.92 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 129.036 2.935 . . . . 0.0 112.844 -159.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.317 43.3 mtpt -109.78 76.19 0.91 Allowed Pre-proline 0 N--CA 1.445 -0.697 0 CA-C-O 114.656 -2.592 . . . . 0.0 115.612 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -84.06 157.91 13.36 Favored 'Trans proline' 0 C--N 1.329 -0.492 0 C-N-CA 124.861 3.707 . . . . 0.0 113.367 -158.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.669 ' H ' ' HB2' ' A' ' 66' ' ' GLN . 58.9 p -132.16 176.35 8.46 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 128.088 2.555 . . . . 0.0 112.943 168.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.413 HG12 ' H ' ' A' ' 64' ' ' ILE . 6.3 pt -48.02 -56.51 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 172.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.459 ' C ' HE21 ' A' ' 69' ' ' GLN . 90.8 p -47.34 -33.77 6.14 Favored 'General case' 0 C--N 1.342 0.244 0 O-C-N 117.468 -3.27 . . . . 0.0 115.916 166.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.669 ' HB2' ' H ' ' A' ' 63' ' ' THR . 62.4 mt-30 -75.01 -50.43 16.55 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 128.209 2.603 . . . . 0.0 112.28 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -42.62 -52.45 4.83 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 125.949 1.699 . . . . 0.0 111.458 162.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.9 mtm180 -63.82 -34.39 77.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 124.145 0.903 . . . . 0.0 111.824 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.459 HE21 ' C ' ' A' ' 65' ' ' SER . 35.5 mt-30 -80.36 -35.6 35.21 Favored 'General case' 0 CA--C 1.516 -0.351 0 O-C-N 119.695 -1.878 . . . . 0.0 112.634 -168.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.3 mt -73.69 -50.56 20.29 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 131.572 3.949 . . . . 0.0 115.264 -167.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -44.04 -34.92 1.9 Allowed 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.579 0.704 . . . . 0.0 112.215 158.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 46.2 mttp -98.35 10.31 41.04 Favored 'General case' 0 CA--C 1.513 -0.471 0 O-C-N 118.303 -2.748 . . . . 0.0 114.404 -165.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 20.7 pt -53.28 -50.85 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.149 0 CA-C-O 125.652 2.644 . . . . 0.0 112.912 -177.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 77.0 mt -106.43 0.67 25.01 Favored 'General case' 0 C--O 1.24 0.578 0 O-C-N 118.919 -2.363 . . . . 0.0 115.901 176.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.33 0.61 11.36 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 126.617 2.055 . . . . 0.0 115.245 175.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.473 HD12 ' HB1' ' A' ' 30' ' ' ALA . 21.7 pt -116.42 -174.49 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 O-C-N 116.979 -3.659 . . . . 0.0 116.605 -177.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -173.93 147.6 1.32 Allowed 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 113.501 -3.143 . . . . 0.0 109.432 -173.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 31.5 mt -132.08 157.12 45.01 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 125.931 2.019 . . . . 0.0 110.579 164.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.1 153.8 10.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 2 C-N-CA 133.848 4.859 . . . . 0.0 121.537 3.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 12.0 p -88.89 175.91 3.65 Favored Pre-proline 0 N--CA 1.446 -0.672 0 O-C-N 118.399 -2.688 . . . . 0.0 109.346 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -44.51 -17.55 0.15 Allowed 'Trans proline' 0 N--CA 1.45 -1.03 0 N-CA-C 118.189 2.342 . . . . 0.0 118.189 167.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 65.5 mt -55.2 -14.17 1.59 Allowed 'General case' 0 C--O 1.219 -0.53 0 O-C-N 125.917 2.011 . . . . 0.0 115.459 163.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . 0.361 5.6 tp10 -145.8 -39.3 0.23 Allowed 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 126.188 1.795 . . . . 0.0 110.404 174.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -145.86 154.3 41.82 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 123.524 1.63 . . . . 0.0 112.462 -175.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -131.95 132.51 43.59 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 118.669 -2.519 . . . . 0.0 112.9 -176.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -50.94 107.86 0.2 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 125.295 2.474 . . . . 0.0 114.003 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.294 39.9 tt0 -132.51 61.4 1.67 Allowed 'General case' 0 C--N 1.327 -0.41 0 O-C-N 119.393 -2.067 . . . . 0.0 113.198 -165.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 73.8 m -76.96 -13.05 60.01 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.974 1.71 . . . . 0.0 112.996 -162.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -55.19 -25.58 33.61 Favored 'General case' 0 CA--C 1.519 -0.241 0 O-C-N 118.674 -2.516 . . . . 0.0 117.406 172.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -72.75 -21.37 61.03 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 121.509 3.892 . . . . 0.0 121.509 165.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -118.64 -28.63 5.6 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 -175.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -109.49 148.9 30.4 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-O 126.43 3.014 . . . . 0.0 112.705 -175.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -69.56 -32.25 70.94 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 117.728 -3.107 . . . . 0.0 113.881 167.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -144.11 9.65 1.48 Allowed 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 116.458 2.021 . . . . 0.0 116.458 -171.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 89.0 m -107.32 137.16 45.9 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 128.307 2.643 . . . . 0.0 108.997 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.74 12.5 56.93 Favored Glycine 0 CA--C 1.535 1.326 0 O-C-N 124.12 0.887 . . . . 0.0 112.787 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.64 -19.06 19.29 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 115.301 -2.285 . . . . 0.0 110.359 -164.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.2 t -154.29 137.54 15.71 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 128.603 3.69 . . . . 0.0 114.103 166.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 26.4 tp -102.67 -29.08 11.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.143 -1.39 . . . . 0.0 113.18 161.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.58 6.06 83.79 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-O 116.843 -2.087 . . . . 0.0 109.258 176.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -74.67 109.59 8.27 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 126.503 1.943 . . . . 0.0 112.309 -176.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.419 ' HB ' ' HA ' ' A' ' 103' ' ' VAL 0.41 6.7 m -129.42 162.13 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.987 1 O-C-N 129.503 4.252 . . . . 0.0 117.229 177.433 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.419 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 20.0 t -57.09 127.01 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-N 123.802 3.001 . . . . 0.0 115.001 -4.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -90.35 119.83 30.97 Favored 'General case' 0 C--N 1.346 0.445 0 O-C-N 121.572 -0.705 . . . . 0.0 110.866 -167.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.479 ' C ' ' H ' ' A' ' 108' ' ' GLY . 20.8 pt -116.65 3.72 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 125.928 1.691 . . . . 0.0 110.316 -174.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -75.68 -10.44 59.44 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 118.899 -2.376 . . . . 0.0 112.6 147.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -67.91 -23.55 65.11 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 118.526 -1.27 . . . . 0.0 110.798 152.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.479 ' H ' ' C ' ' A' ' 105' ' ' ILE . . . 152.15 159.48 8.99 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 124.555 2.197 . . . . 0.0 117.241 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.3 tttt -83.19 43.94 0.91 Allowed 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 109.047 -3.577 . . . . 0.0 115.971 -171.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -78.88 -18.99 53.01 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 111.554 -2.566 . . . . 0.0 112.306 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 42.4 mt -101.63 150.17 23.38 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.998 2.119 . . . . 0.0 107.474 150.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.346 23.2 tt0 -164.35 -79.14 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 113.807 -2.997 . . . . 0.0 116.924 -148.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -91.31 8.54 35.55 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 118.376 2.732 . . . . 0.0 118.376 -175.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 . . . . . 0 C--O 1.256 1.406 0 C-N-CA 129.961 3.304 . . . . 0.0 111.462 -167.903 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 115.473 1.656 . . . . 0.0 115.473 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -98.15 153.58 18.35 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-O 116.943 -1.503 . . . . 0.0 112.05 -169.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.436 ' HA ' ' HB2' ' A' ' 18' ' ' GLU . . . -126.42 14.26 7.67 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-N 124.951 3.523 . . . . 0.0 113.067 -166.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -75.72 -32.83 60.2 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 126.791 3.186 . . . . 0.0 111.277 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.42 -9.81 53.69 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 118.613 2.819 . . . . 0.0 118.613 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.436 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 73.2 mm-40 -126.1 11.91 7.67 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 127.945 2.498 . . . . 0.0 110.487 -155.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 2.8 pp -115.89 176.01 2.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 130.354 3.462 . . . . 0.0 108.021 161.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.419 HG22 ' H ' ' A' ' 21' ' ' THR . 2.1 p -67.12 165.27 2.01 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 121.009 1.731 . . . . 0.0 115.351 -166.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.419 ' H ' HG22 ' A' ' 20' ' ' VAL . 43.8 p -69.97 -62.06 1.53 Allowed 'General case' 0 C--N 1.325 -0.489 1 O-C-N 129.735 4.397 . . . . 0.0 109.774 179.363 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.0 t70 174.46 73.42 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 100.335 -3.95 . . . . 0.0 100.335 -159.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.283 58.4 t80 -59.56 137.83 57.9 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 118.375 2.731 . . . . 0.0 118.375 -166.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -46.25 143.8 2.28 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 131.194 3.798 . . . . 0.0 118.182 -154.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -98.99 -32.87 11.07 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 117.768 2.507 . . . . 0.0 117.768 -176.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.2 pt -63.07 -33.4 60.58 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 C-N-CA 126.698 1.999 . . . . 0.0 107.59 -172.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.36 1.8 pt -60.11 -38.81 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 114.035 -1.439 . . . . 0.0 112.252 178.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.454 45.9 tttm -45.83 -74.6 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 118.841 2.904 . . . . 0.0 118.841 -162.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.5 m -53.47 -32.71 51.3 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 129.706 3.202 . . . . 0.0 113.706 -174.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.28 -55.86 9.27 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 114.544 -2.646 . . . . 0.0 110.775 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . 0.276 11.9 ptm180 -57.35 -40.96 79.15 Favored 'General case' 0 N--CA 1.447 -0.604 1 CA-C-N 126.302 4.137 . . . . 0.0 110.673 171.606 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -51.1 -35.78 36.9 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 114.87 -2.49 . . . . 0.0 115.448 176.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -51.54 -42.57 61.88 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 121.687 2.04 . . . . 0.0 109.736 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 50.3 mt -80.94 -25.68 37.23 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 131.538 3.935 . . . . 0.0 109.514 -176.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 55.97 5.39 0.96 Allowed Glycine 0 C--O 1.22 -0.75 0 CA-C-N 112.665 -2.061 . . . . 0.0 116.199 -170.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.5 pt -60.35 148.06 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 126.685 1.994 . . . . 0.0 108.392 -163.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 88.6 p -133.18 -177.29 4.45 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 122.728 2.513 . . . . 0.0 110.581 170.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . 0.254 65.0 mt-30 -21.61 -61.34 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 113.419 -3.181 . . . . 0.0 116.197 -163.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -58.99 -51.95 67.85 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 124.484 3.311 . . . . 0.0 109.365 -173.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -67.2 -29.38 69.03 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 117.435 -1.269 . . . . 0.0 110.864 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.8 tp -80.91 -23.89 38.62 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.935 1.694 . . . . 0.0 112.197 -167.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.74 -45.62 67.08 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 131.598 3.959 . . . . 0.0 111.163 153.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -77.94 -21.47 51.03 Favored 'General case' 0 CA--C 1.51 -0.561 0 O-C-N 126.773 2.546 . . . . 0.0 110.688 178.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -83.11 -12.06 57.4 Favored 'General case' 0 C--O 1.238 0.46 0 O-C-N 118.304 -2.748 . . . . 0.0 105.168 -169.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.432 HD12 ' HA ' ' A' ' 45' ' ' LEU . 21.8 tp -125.35 -9.58 6.95 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 -173.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 32.7 mtmt 57.31 52.89 8.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 131.196 3.798 . . . . 0.0 112.335 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.1 m -124.79 177.22 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 1 C-N-CA 134.019 4.928 . . . . 0.0 113.138 -177.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 62.1 p -82.06 159.61 23.4 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 116.81 2.152 . . . . 0.0 116.81 168.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -64.07 -14.54 55.32 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 169.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -80.97 -23.2 38.93 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 119.803 -1.811 . . . . 0.0 113.238 170.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.0 mt -69.45 -43.63 80.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 118.293 -0.86 . . . . 0.0 112.911 175.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.8 m -68.57 -25.96 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 118.44 2.755 . . . . 0.0 118.44 -178.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -42.32 -48.3 5.0 Favored 'General case' 0 N--CA 1.432 -1.374 0 C-N-CA 130.204 3.402 . . . . 0.0 116.706 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.6 mtt85 -61.72 -39.62 92.18 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 123.682 2.946 . . . . 0.0 111.13 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -82.36 -33.99 28.6 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -168.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -64.93 -49.11 71.67 Favored 'General case' 0 N--CA 1.441 -0.876 0 O-C-N 118.649 -2.532 . . . . 0.0 109.145 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.6 p -80.16 -28.66 38.76 Favored 'General case' 0 C--O 1.243 0.739 0 O-C-N 118.745 -2.472 . . . . 0.0 112.908 -167.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.2 5.48 62.17 Favored Glycine 0 CA--C 1.533 1.191 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -171.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -93.06 54.57 2.18 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 128.737 2.815 . . . . 0.0 112.433 -174.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . 0.252 62.7 tp -144.79 130.9 19.42 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 130.837 3.655 . . . . 0.0 107.241 -167.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.5 tttt -91.4 128.67 45.99 Favored Pre-proline 0 N--CA 1.45 -0.473 0 N-CA-C 119.156 3.021 . . . . 0.0 119.156 158.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -92.46 -172.03 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 1 C-N-CA 127.167 5.245 . . . . 0.0 107.722 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . 0.264 17.4 p -156.33 174.37 15.5 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 128.058 2.543 . . . . 0.0 111.278 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.7 pt -63.18 -44.18 99.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 126.736 2.015 . . . . 0.0 113.752 166.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.5 p -66.68 -38.38 86.68 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 121.085 1.766 . . . . 0.0 112.284 164.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 67.8 mm-40 -69.9 -27.78 65.07 Favored 'General case' 0 N--CA 1.45 -0.429 2 O-C-N 111.299 -7.125 . . . . 0.0 115.377 -171.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . 0.257 . . -55.93 -74.08 0.05 Allowed 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 123.321 2.782 . . . . 0.0 114.382 -164.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.0 mmp_? -51.02 -21.88 2.03 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 126.329 1.852 . . . . 0.0 109.867 -178.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.569 ' C ' ' H ' ' A' ' 72' ' ' LYS . 61.0 mt-30 -77.22 -36.09 55.04 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 124.615 1.197 . . . . 0.0 112.817 179.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 40.0 mt -79.18 -41.13 29.13 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 128.25 2.62 . . . . 0.0 104.483 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -53.84 -26.73 25.83 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 118.025 -2.922 . . . . 0.0 111.254 154.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.569 ' H ' ' C ' ' A' ' 69' ' ' GLN . 51.2 tttt -79.36 -24.88 42.39 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 125.388 3.722 . . . . 0.0 115.222 -173.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . 0.406 24.0 pt -54.52 -69.65 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 CA-C-N 125.603 3.82 . . . . 0.0 112.291 -165.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 82.6 mt -70.48 -20.92 62.82 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 130.276 3.431 . . . . 0.0 111.781 177.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.71 12.68 57.36 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 130.214 3.769 . . . . 0.0 118.775 174.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.5 pt -84.1 167.65 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.08 1 C-N-CA 132.385 4.274 . . . . 0.0 112.479 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.278 5.3 ptpt -175.94 144.84 0.63 Allowed 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 128.467 2.707 . . . . 0.0 114.413 175.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 31.4 mt -153.28 163.35 40.05 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 125.842 1.963 . . . . 0.0 109.153 163.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.7 m -113.92 148.5 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 1 C-N-CA 141.971 8.109 . . . . 0.0 114.935 14.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.409 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 6.7 p -92.82 -178.59 0.89 Allowed Pre-proline 0 N--CA 1.447 -0.582 0 C-N-CA 125.816 1.646 . . . . 0.0 112.987 -175.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.409 ' HD2' ' HB ' ' A' ' 80' ' ' THR . 76.6 Cg_exo -59.56 -3.4 1.92 Allowed 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 123.302 2.668 . . . . 0.0 114.849 178.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 60.3 mt -81.19 -0.36 40.11 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 120.436 1.471 . . . . 0.0 109.897 170.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.33 -43.2 0.25 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 128.917 2.887 . . . . 0.0 111.271 175.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -157.88 153.07 25.71 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 121.253 1.842 . . . . 0.0 111.471 -178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -135.64 131.07 35.31 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 118.394 -2.691 . . . . 0.0 115.073 -167.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -145.96 129.54 16.99 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 -170.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -135.1 142.79 46.31 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.996 2.118 . . . . 0.0 113.423 -168.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 86.8 p -86.57 -5.31 59.18 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 118.346 -2.721 . . . . 0.0 107.495 -170.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -55.55 -16.53 4.03 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 163.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -106.32 28.34 7.84 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 172.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -140.64 -28.55 0.7 Allowed 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.714 2.006 . . . . 0.0 111.085 -173.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -81.43 159.19 24.34 Favored 'General case' 0 N--CA 1.442 -0.851 0 O-C-N 118.095 -2.878 . . . . 0.0 105.7 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -98.97 -32.2 11.42 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 112.567 -2.106 . . . . 0.0 111.229 174.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -120.54 5.99 10.59 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 118.935 2.939 . . . . 0.0 118.935 -176.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.7 m -145.14 149.69 35.44 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 126.164 1.786 . . . . 0.0 111.991 -165.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.01 17.15 58.31 Favored Glycine 0 N--CA 1.438 -1.211 0 C-N-CA 126.316 1.912 . . . . 0.0 114.486 -168.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.2 mt -81.63 -12.67 58.62 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 -170.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.7 t -138.48 140.29 39.16 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 128.216 2.606 . . . . 0.0 112.741 175.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 26.8 tp -38.46 -36.48 0.24 Allowed 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 127.368 2.267 . . . . 0.0 114.638 159.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.62 2.08 87.55 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 126.893 2.187 . . . . 0.0 113.774 -166.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -66.77 100.3 0.69 Allowed 'General case' 0 N--CA 1.438 -1.036 1 O-C-N 115.421 -4.576 . . . . 0.0 112.84 174.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.502 ' HB ' ' HA ' ' A' ' 103' ' ' VAL . 0.9 OUTLIER -129.6 150.58 34.76 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 C-N-CA 126.494 1.918 . . . . 0.0 111.508 -162.528 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.502 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 69.0 t -76.86 133.92 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 1 O-C-N 113.898 -5.501 . . . . 0.0 108.279 10.449 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -83.54 108.93 16.99 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 116.806 -1.569 . . . . 0.0 108.978 -176.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.696 HD13 ' H ' ' A' ' 105' ' ' ILE . 0.2 OUTLIER -94.45 -3.98 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 O-C-N 124.621 1.201 . . . . 0.0 111.223 -174.824 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 16.6 ttpp -67.26 -42.91 83.1 Favored 'General case' 0 C--O 1.249 1.041 0 O-C-N 120.262 -1.524 . . . . 0.0 109.447 170.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -70.06 -12.3 61.51 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 127.854 2.461 . . . . 0.0 112.072 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 173.18 136.01 2.1 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-O 119.133 -0.815 . . . . 0.0 113.463 171.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -152.33 132.55 13.59 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 103.259 -2.867 . . . . 0.0 103.259 174.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 45.0 pttt 178.9 -17.46 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 119.351 -2.093 . . . . 0.0 106.75 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.6 mt -74.82 -171.75 1.39 Allowed 'General case' 0 CA--C 1.518 -0.285 0 O-C-N 118.273 -2.767 . . . . 0.0 106.121 168.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -155.07 -65.7 0.13 Allowed 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 112.912 -1.949 . . . . 0.0 114.587 -146.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -115.8 11.23 15.55 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 126.966 2.107 . . . . 0.0 110.137 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 31.1 p-80 . . . . . 0 C--O 1.257 1.466 0 C-N-CA 125.891 1.676 . . . . 0.0 113.632 -168.547 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 . . . . . 0 N--CA 1.474 0.762 0 CA-C-O 124.464 2.078 . . . . 0.0 106.031 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -82.36 135.42 35.18 Favored 'General case' 0 CA--C 1.517 -0.301 0 O-C-N 119.643 -1.911 . . . . 0.0 113.277 -163.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -96.85 -13.82 22.26 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -166.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -104.15 35.13 2.78 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 126.552 3.072 . . . . 0.0 117.078 -170.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.5 mt -94.91 -20.62 19.25 Favored 'General case' 0 CA--C 1.51 -0.564 0 O-C-N 117.076 -3.515 . . . . 0.0 112.927 -173.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -129.37 8.48 5.49 Favored 'General case' 0 C--O 1.226 -0.156 0 CA-C-N 123.956 3.071 . . . . 0.0 115.389 -168.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 30.4 pt -116.82 159.0 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 117.819 -3.051 . . . . 0.0 112.695 -164.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 14.4 p -79.88 151.39 4.76 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 O-C-N 120.13 -1.606 . . . . 0.0 108.522 -173.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 74.8 p -58.37 -33.0 69.11 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 119.725 -1.86 . . . . 0.0 111.197 -177.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -178.81 126.78 0.1 Allowed 'General case' 0 C--O 1.218 -0.592 0 C-N-CA 131.518 3.927 . . . . 0.0 106.132 170.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -55.77 162.3 1.81 Allowed 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 127.389 2.93 . . . . 0.0 113.805 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -91.28 157.5 17.11 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 112.118 -2.31 . . . . 0.0 114.276 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 37.5 mttt -110.93 -46.44 3.34 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 -141.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.0 pt -67.6 -30.8 49.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 113.176 -3.297 . . . . 0.0 109.47 -174.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.372 20.1 pt -54.93 -49.68 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 C-N-CA 128.157 2.583 . . . . 0.0 110.12 178.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.347 74.8 mttt -29.66 -81.19 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.448 2 C-N-CA 132.418 4.287 . . . . 0.0 121.963 -174.332 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.0 p -75.82 -21.86 56.89 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 118.56 2.8 . . . . 0.0 118.56 -159.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.57 -21.83 63.02 Favored 'General case' 0 N--CA 1.439 -1.009 1 C-N-CA 133.973 4.909 . . . . 0.0 115.625 173.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . 0.282 6.6 ptm180 -44.15 -50.05 8.8 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 115.883 -2.008 . . . . 0.0 114.914 175.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -48.92 -33.24 10.42 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 126.634 1.974 . . . . 0.0 115.742 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -58.89 -25.48 63.4 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 118.605 -2.559 . . . . 0.0 112.708 -176.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.416 ' HB3' HG12 ' A' ' 36' ' ' ILE . 10.1 mp -96.32 -30.27 13.52 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.92 3.78 2.79 Favored Glycine 0 C--N 1.342 0.888 0 C-N-CA 127.943 2.687 . . . . 0.0 112.844 173.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.416 HG12 ' HB3' ' A' ' 34' ' ' LEU . 13.5 pt -66.5 154.03 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 CA-C-N 120.344 2.072 . . . . 0.0 114.852 -173.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.0 p -71.79 161.85 30.34 Favored 'General case' 0 N--CA 1.443 -0.789 0 O-C-N 116.767 -3.708 . . . . 0.0 113.487 172.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -54.77 -46.44 74.4 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 114.604 -2.617 . . . . 0.0 108.489 173.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -61.74 -34.76 76.39 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 120.961 1.71 . . . . 0.0 111.068 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -80.43 -19.62 45.74 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 116.93 -1.908 . . . . 0.0 110.896 -175.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 66.8 tp -75.43 -46.51 32.23 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 125.856 2.741 . . . . 0.0 110.848 174.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.13 -39.31 66.36 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 118.551 -2.593 . . . . 0.0 110.953 173.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -63.86 -34.41 77.87 Favored 'General case' 0 C--O 1.223 -0.329 0 C-N-CA 126.258 1.823 . . . . 0.0 115.918 160.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -73.97 -16.11 61.09 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 122.123 2.238 . . . . 0.0 107.693 -170.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.8 mt -123.09 -4.29 8.49 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 127.837 2.455 . . . . 0.0 112.51 -173.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.272 1.6 mptp? 43.23 56.74 4.08 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 118.652 2.834 . . . . 0.0 118.652 -167.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 31.9 m -127.7 175.77 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 1 C-N-CA 132.196 4.198 . . . . 0.0 108.583 -175.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 62.1 p -78.76 159.07 28.09 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 167.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -74.38 -13.29 60.71 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 128.229 3.455 . . . . 0.0 111.117 169.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -53.33 -50.56 64.72 Favored 'General case' 0 N--CA 1.447 -0.577 1 O-C-N 115.887 -4.258 . . . . 0.0 111.055 161.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.3 mm -59.14 -45.25 92.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 1 O-C-N 115.62 -4.425 . . . . 0.0 111.507 -179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 5.4 m -66.22 -49.29 77.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 115.173 -2.346 . . . . 0.0 106.258 -174.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.4 mtmm -50.53 -40.09 50.69 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 127.194 2.198 . . . . 0.0 113.754 173.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -60.95 -29.6 69.74 Favored 'General case' 0 C--N 1.345 0.393 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 172.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -72.46 -50.87 23.06 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 171.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -53.86 -51.92 62.08 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.984 1.714 . . . . 0.0 114.342 -173.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.5 p -74.87 -9.18 58.3 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 120.162 3.393 . . . . 0.0 120.162 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.67 16.76 80.08 Favored Glycine 0 C--O 1.243 0.713 1 CA-C-O 110.19 -5.783 . . . . 0.0 111.573 -169.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -89.83 51.84 2.17 Favored 'General case' 0 C--O 1.24 0.581 1 CA-C-N 126.839 5.32 . . . . 0.0 111.274 -172.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.9 tp -131.97 147.52 52.46 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -164.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.277 61.0 tttt -112.43 71.91 1.21 Allowed Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 113.717 -3.04 . . . . 0.0 111.743 168.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -83.6 -164.45 0.26 Allowed 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 124.552 3.501 . . . . 0.0 103.234 -166.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.0 p -153.57 174.39 14.51 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 130.841 3.657 . . . . 0.0 108.962 -169.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 28.9 pt -75.45 -48.15 31.9 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 CA-C-O 113.721 -3.038 . . . . 0.0 111.392 -174.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.8 p -58.91 -31.7 68.87 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 124.549 3.34 . . . . 0.0 112.826 166.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -68.47 -43.4 77.05 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 115.62 -2.134 . . . . 0.0 111.912 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -52.78 -44.28 66.45 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 114.44 -2.695 . . . . 0.0 111.28 165.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.2 mmp_? -56.4 -32.33 64.72 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 125.246 3.657 . . . . 0.0 110.585 170.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -82.31 -26.91 32.63 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 127.272 2.857 . . . . 0.0 111.276 -177.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.8 mt -60.54 -54.01 50.6 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 131.647 3.979 . . . . 0.0 107.463 167.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -50.6 -54.59 21.53 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 127.362 2.265 . . . . 0.0 109.013 174.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.4 tttp -67.54 -42.75 82.2 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 117.56 2.43 . . . . 0.0 117.56 -170.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.418 HG13 ' H ' ' A' ' 74' ' ' LEU 0.258 9.5 pt -48.74 -63.96 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 O-C-N 116.962 -3.586 . . . . 0.0 113.852 -175.305 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.418 ' H ' HG13 ' A' ' 73' ' ' ILE . 21.2 mt -75.88 -14.65 60.27 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 122.851 1.31 . . . . 0.0 113.228 -176.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.39 -13.65 10.55 Favored Glycine 0 CA--C 1.532 1.117 0 O-C-N 119.061 -2.274 . . . . 0.0 114.677 176.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 9.8 pt -92.67 162.37 2.41 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.736 0 C-N-CA 130.253 3.421 . . . . 0.0 115.238 -174.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.0 pttt -173.04 150.41 1.98 Allowed 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 129.846 3.258 . . . . 0.0 108.29 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.429 ' HB3' ' HA ' ' A' ' 79' ' ' VAL . 26.4 mt -148.03 151.94 36.58 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 117.085 2.254 . . . . 0.0 117.085 165.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.429 ' HA ' ' HB3' ' A' ' 78' ' ' LEU . 7.7 m -111.51 177.83 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.894 1 O-C-N 115.162 -4.711 . . . . 0.0 116.616 26.673 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.412 ' HB ' ' HD2' ' A' ' 81' ' ' PRO . 82.6 p -96.56 164.49 18.09 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 126.858 2.063 . . . . 0.0 110.366 174.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.412 ' HD2' ' HB ' ' A' ' 80' ' ' THR . 53.1 Cg_exo -48.44 3.2 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.769 0 CA-C-O 115.927 -1.781 . . . . 0.0 115.632 164.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . 0.33 22.8 mt -70.04 -7.3 39.95 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 125.768 3.894 . . . . 0.0 114.969 158.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -150.45 -30.53 0.2 Allowed 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 128.831 2.852 . . . . 0.0 113.847 169.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -173.74 159.97 3.59 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 118.65 2.833 . . . . 0.0 118.65 -176.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -145.23 120.68 10.33 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 126.592 1.957 . . . . 0.0 111.886 176.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -44.18 135.0 4.61 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 119.239 3.051 . . . . 0.0 119.239 163.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -86.38 146.31 26.51 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 128.432 2.693 . . . . 0.0 115.37 -175.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.9 p -77.29 -36.89 53.82 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 112.147 -2.297 . . . . 0.0 110.62 -171.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -76.24 -4.65 43.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 120.804 1.638 . . . . 0.0 111.989 177.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.6 mmtm -98.86 -20.36 16.89 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 127.092 2.157 . . . . 0.0 114.552 163.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -51.99 -51.84 54.54 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 127.52 2.328 . . . . 0.0 110.74 172.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -176.35 172.8 2.21 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 126.633 1.973 . . . . 0.0 112.434 -171.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -86.64 -17.74 33.06 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 115.089 -2.386 . . . . 0.0 111.438 -165.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -106.03 11.57 31.4 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 130.08 3.352 . . . . 0.0 109.161 -178.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 26.0 m -122.6 159.3 28.1 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 125.655 1.847 . . . . 0.0 109.054 -167.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.54 -11.86 8.93 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 120.808 3.083 . . . . 0.0 120.808 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 44.4 mt -95.15 -23.54 17.25 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 118.52 2.785 . . . . 0.0 118.52 -158.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.1 t -151.81 142.28 22.58 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 126.843 2.057 . . . . 0.0 108.177 161.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 41.4 tp -94.4 -20.66 19.53 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 128.188 2.595 . . . . 0.0 117.814 163.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.04 16.19 63.5 Favored Glycine 0 C--O 1.227 -0.292 0 O-C-N 124.001 0.813 . . . . 0.0 113.603 176.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -93.89 77.15 4.19 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 127.483 2.313 . . . . 0.0 107.141 -168.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.483 ' HB ' ' HA ' ' A' ' 103' ' ' VAL . 11.1 m -138.65 178.84 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-O 113.875 -2.964 . . . . 0.0 115.89 -177.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.483 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 7.4 p -58.73 148.1 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 1 CA-C-N 128.287 5.039 . . . . 0.0 110.426 11.086 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.413 ' N ' HG22 ' A' ' 103' ' ' VAL . 21.8 t30 -72.04 102.27 2.94 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 117.317 -1.325 . . . . 0.0 110.546 -165.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 10.7 pt -77.85 -6.92 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-O 116.671 -1.633 . . . . 0.0 111.632 -175.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -80.32 -12.9 59.55 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 118.474 -1.29 . . . . 0.0 113.129 172.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -104.6 -14.59 15.58 Favored 'General case' 0 C--O 1.223 -0.304 1 C-N-CA 132.377 4.271 . . . . 0.0 109.424 171.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 120.2 166.11 13.08 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-O 118.241 -1.31 . . . . 0.0 115.37 155.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -118.87 143.67 46.84 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 118.805 1.302 . . . . 0.0 110.454 165.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 46.3 pttt -163.2 -21.02 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -153.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.256 1.0 OUTLIER -91.64 -178.54 5.1 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 129.204 3.002 . . . . 0.0 112.199 151.496 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.326 23.2 tt0 -159.91 -91.67 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 118.454 -2.654 . . . . 0.0 111.809 -162.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 32.1 p-80 -96.35 5.15 51.54 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 115.614 -2.136 . . . . 0.0 111.298 -165.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.19 0 C-N-CA 129.228 3.011 . . . . 0.0 110.413 166.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 . . . . . 0 N--CA 1.47 0.534 0 CA-C-O 123.566 1.65 . . . . 0.0 110.414 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -91.68 110.51 21.85 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 113.722 -1.581 . . . . 0.0 107.878 -178.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.33 -18.19 57.66 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 117.763 -3.086 . . . . 0.0 115.013 -165.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -51.54 -20.47 1.94 Allowed 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 131.038 3.735 . . . . 0.0 110.215 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . 0.36 12.2 mt -90.25 -7.58 53.12 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 130.439 3.495 . . . . 0.0 113.741 -173.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -136.39 -7.14 1.99 Allowed 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 122.666 1.222 . . . . 0.0 111.428 -163.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 8.0 pt -107.38 155.37 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 O-C-N 120.143 -1.598 . . . . 0.0 114.193 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.1 p -80.52 154.98 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 O-C-N 119.717 -1.864 . . . . 0.0 113.082 152.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.63 -83.29 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 130.604 3.562 . . . . 0.0 105.134 -173.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -85.89 80.07 9.03 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 119.493 1.042 . . . . 0.0 110.224 -161.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . 0.312 22.1 t80 -88.13 156.27 19.35 Favored 'General case' 0 N--CA 1.443 -0.775 0 O-C-N 117.476 -3.265 . . . . 0.0 116.229 -169.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -75.59 129.08 36.61 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 125.843 1.965 . . . . 0.0 111.827 179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -105.09 -21.21 13.31 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 127.831 2.452 . . . . 0.0 114.499 -175.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.8 pt -69.72 -38.1 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 1 O-C-N 115.923 -4.235 . . . . 0.0 113.794 -174.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.404 ' H ' HG12 ' A' ' 27' ' ' ILE 0.301 22.5 pt -67.84 -20.32 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 127.154 2.182 . . . . 0.0 115.184 179.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -67.09 -62.45 1.42 Allowed 'General case' 0 C--N 1.327 -0.38 1 N-CA-C 121.893 4.034 . . . . 0.0 121.893 -158.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . 0.471 76.0 p -67.1 -25.02 66.01 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-N 124.272 3.214 . . . . 0.0 117.154 -176.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.42 -29.3 61.41 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 117.714 2.487 . . . . 0.0 117.714 -171.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.7 ptt85 -50.59 -38.81 47.66 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 117.792 -3.068 . . . . 0.0 114.475 175.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -59.25 -29.02 67.24 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.076 1.75 . . . . 0.0 112.401 -176.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -55.98 -40.97 74.08 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 122.268 2.304 . . . . 0.0 112.663 -178.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 60.7 mt -75.45 -8.61 57.16 Favored 'General case' 0 CA--C 1.514 -0.409 0 O-C-N 127.448 2.968 . . . . 0.0 116.567 -158.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.41 -13.12 11.81 Favored Glycine 0 C--N 1.346 1.119 0 O-C-N 119.792 -1.817 . . . . 0.0 114.486 173.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.3 pt -88.24 163.42 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 115.894 1.813 . . . . 0.0 115.894 -164.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 96.1 p -84.18 177.62 8.14 Favored 'General case' 0 N--CA 1.436 -1.168 0 O-C-N 118.869 -2.395 . . . . 0.0 112.406 -175.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . 0.322 27.5 tt0 -54.92 -50.14 69.56 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 120.299 1.409 . . . . 0.0 112.71 172.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -61.95 -29.57 70.32 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 126.333 1.853 . . . . 0.0 115.854 -176.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -78.62 -40.18 35.1 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 175.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . 0.299 5.7 tp -46.9 -44.51 19.77 Favored 'General case' 0 C--O 1.239 0.55 1 O-C-N 129.747 4.404 . . . . 0.0 110.329 165.593 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.65 -55.46 34.51 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 128.099 2.56 . . . . 0.0 112.377 173.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -63.56 -34.88 78.77 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 120.175 1.352 . . . . 0.0 112.645 174.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -63.72 -36.68 84.67 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-O 126.191 2.901 . . . . 0.0 108.911 -172.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.1 mp -99.29 -5.1 30.36 Favored 'General case' 0 N--CA 1.438 -1.052 1 C-N-CA 135.199 5.4 . . . . 0.0 113.44 -170.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt 55.0 57.51 5.55 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.663 1.185 . . . . 0.0 113.389 -177.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.9 m -151.6 -176.25 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 130.076 3.351 . . . . 0.0 111.445 -171.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 65.7 p -93.85 163.02 13.68 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 118.482 -2.636 . . . . 0.0 115.218 167.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -70.4 -18.13 63.03 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 119.124 0.874 . . . . 0.0 111.517 171.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -68.02 -34.67 76.94 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 114.815 -2.754 . . . . 0.0 118.32 160.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 27.8 mt -73.77 -39.57 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 O-C-N 116.766 -3.709 . . . . 0.0 109.998 -179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.331 11.9 m -59.01 -49.86 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 O-C-N 119.441 -2.037 . . . . 0.0 111.02 178.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.7 mtmm -48.11 -43.51 31.07 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 129.868 3.267 . . . . 0.0 108.596 167.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -67.54 -32.43 73.2 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-N 123.184 2.72 . . . . 0.0 114.018 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -75.1 -39.49 60.61 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 129.797 3.239 . . . . 0.0 106.871 170.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 59.1 tt0 -60.1 -32.72 71.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 122.352 2.342 . . . . 0.0 108.595 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.6 p -112.15 -6.75 14.11 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -144.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.52 18.12 74.24 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-O 125.157 2.531 . . . . 0.0 114.402 -176.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -97.85 33.84 2.02 Favored 'General case' 0 N--CA 1.438 -1.025 1 O-C-N 115.423 -4.575 . . . . 0.0 113.704 -176.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.4 tp -130.65 129.73 43.02 Favored 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 130.492 3.517 . . . . 0.0 110.198 -178.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -101.65 102.7 23.73 Favored Pre-proline 0 N--CA 1.442 -0.853 0 CA-C-O 115.91 -1.995 . . . . 0.0 106.455 168.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -80.31 174.73 11.01 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 CA-C-N 120.372 1.169 . . . . 0.0 112.33 -171.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.453 ' H ' ' HB2' ' A' ' 66' ' ' GLN . 62.1 p -139.99 174.22 10.73 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 118.8 -2.437 . . . . 0.0 110.436 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.6 pp -62.89 -32.52 56.25 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 -171.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 77.3 p -56.83 -53.56 56.48 Favored 'General case' 0 CA--C 1.512 -0.498 2 O-C-N 112.643 -6.286 . . . . 0.0 112.906 158.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.453 ' HB2' ' H ' ' A' ' 63' ' ' THR . 57.6 mt-30 -67.14 -36.44 81.88 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 118.431 2.752 . . . . 0.0 118.431 -170.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -31.85 -73.74 0.03 OUTLIER 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 131.434 3.893 . . . . 0.0 116.451 163.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -56.04 -36.36 67.92 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.437 -1.71 . . . . 0.0 111.856 172.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -75.47 -25.87 57.74 Favored 'General case' 0 C--O 1.246 0.88 1 CA-C-O 111.509 -4.091 . . . . 0.0 111.735 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.5 mt -69.51 -41.53 75.92 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 126.617 2.448 . . . . 0.0 107.705 -176.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -55.14 -38.06 67.74 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 117.7 2.482 . . . . 0.0 117.7 165.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -87.97 -35.0 17.88 Favored 'General case' 0 C--O 1.225 -0.225 0 O-C-N 116.845 -3.659 . . . . 0.0 114.931 -168.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 2.9 pt -63.71 -44.11 98.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 122.466 2.394 . . . . 0.0 107.213 -175.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 24.4 tp -68.94 -24.43 64.27 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 126.073 1.749 . . . . 0.0 112.699 169.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 64.07 -20.07 0.09 OUTLIER Glycine 0 C--N 1.337 0.636 0 N-CA-C 117.218 1.647 . . . . 0.0 117.218 -174.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.1 pt -134.25 174.27 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 116.884 2.179 . . . . 0.0 116.884 -168.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -147.75 166.4 27.62 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-O 113.784 -3.008 . . . . 0.0 108.785 -170.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.9 mt -144.37 154.25 42.81 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 127.931 2.492 . . . . 0.0 112.556 160.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.408 ' CG2' ' HB3' ' A' ' 84' ' ' ASN . 25.9 m -106.1 175.91 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 130.962 3.705 . . . . 0.0 114.064 22.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 81.6 p -111.21 174.59 2.27 Favored Pre-proline 0 N--CA 1.449 -0.51 0 C-N-CA 128.743 2.817 . . . . 0.0 113.708 162.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -61.62 0.83 0.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.361 0 O-C-N 125.012 2.059 . . . . 0.0 112.265 177.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.1 mt -56.53 -23.23 38.46 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 115.767 1.766 . . . . 0.0 115.767 159.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -131.3 -49.09 1.0 Allowed 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 127.562 3.039 . . . . 0.0 112.133 169.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.408 ' HB3' ' CG2' ' A' ' 79' ' ' VAL . 28.4 t-20 -146.13 152.89 40.01 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 128.096 2.558 . . . . 0.0 116.502 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -110.75 108.12 17.88 Favored 'General case' 0 C--O 1.223 -0.3 0 O-C-N 119.987 -1.696 . . . . 0.0 108.947 173.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -112.91 129.24 56.54 Favored 'General case' 0 CA--C 1.515 -0.372 0 O-C-N 117.531 -3.231 . . . . 0.0 105.704 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.324 99.4 mt-10 -119.12 163.97 16.24 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 114.391 -2.719 . . . . 0.0 110.216 -171.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 83.9 p -42.89 -35.05 1.08 Allowed 'General case' 0 N--CA 1.449 -0.52 1 CA-C-N 126.889 4.404 . . . . 0.0 110.064 -170.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -67.49 -18.98 65.26 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 117.2 -3.437 . . . . 0.0 111.252 -175.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -111.08 -22.56 11.39 Favored 'General case' 0 N--CA 1.452 -0.367 1 O-C-N 116.234 -4.041 . . . . 0.0 115.747 164.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -83.52 -15.76 48.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 116.778 -1.582 . . . . 0.0 111.551 -175.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -144.1 108.91 4.93 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 121.955 2.161 . . . . 0.0 107.372 -171.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.49 -21.25 3.55 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 131.589 3.956 . . . . 0.0 113.257 -171.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -98.19 6.02 47.89 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.607 1.563 . . . . 0.0 113.279 -169.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.55 178.33 5.24 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 116.839 -1.553 . . . . 0.0 113.57 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.29 23.33 71.29 Favored Glycine 0 C--O 1.218 -0.864 0 O-C-N 126.752 2.532 . . . . 0.0 113.249 168.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.34 -10.94 14.58 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.115 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.7 t 169.33 162.25 0.05 Allowed 'General case' 0 N--CA 1.449 -0.49 1 C-N-CA 131.86 4.064 . . . . 0.0 114.579 -170.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 15.4 tp -84.51 6.72 22.5 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 120.224 -1.547 . . . . 0.0 111.355 165.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 33.76 52.0 0.63 Allowed Glycine 0 C--N 1.336 0.563 0 C-N-CA 129.94 3.638 . . . . 0.0 109.704 -159.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -74.83 93.95 2.7 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 117.494 -3.356 . . . . 0.0 116.353 -175.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.431 ' HB ' ' HA ' ' A' ' 103' ' ' VAL . 0.9 OUTLIER -119.12 155.83 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 O-C-N 127.442 2.964 . . . . 0.0 112.414 -165.83 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.431 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 12.1 p -59.22 135.54 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 2 O-C-N 112.728 -6.233 . . . . 0.0 113.195 17.584 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.44 HD21 ' HG3' ' A' ' 107' ' ' GLU . 5.9 p30 -49.03 126.75 13.08 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.011 164.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 44.7 pt -63.22 -15.86 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 117.823 2.527 . . . . 0.0 117.823 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 33.2 tptt -70.75 -35.81 72.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 122.318 2.326 . . . . 0.0 110.589 171.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.44 ' HG3' HD21 ' A' ' 104' ' ' ASN . 6.4 mm-40 -85.27 -8.38 58.55 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 117.763 2.505 . . . . 0.0 117.763 168.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 173.64 117.29 0.45 Allowed Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 119.209 2.444 . . . . 0.0 119.209 160.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -124.34 142.02 51.61 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 125.07 2.367 . . . . 0.0 108.122 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . 0.265 54.2 pttt -167.98 8.35 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.425 1 C-N-CA 132.281 4.232 . . . . 0.0 118.426 -172.006 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 mt -106.55 166.58 10.45 Favored 'General case' 0 N--CA 1.446 -0.671 1 C-N-CA 131.892 4.077 . . . . 0.0 113.085 153.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.358 15.0 tt0 -152.44 -100.29 0.05 Allowed 'General case' 0 CA--C 1.518 -0.286 1 O-C-N 115.809 -4.307 . . . . 0.0 113.27 -140.799 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.443 ' CD2' ' H ' ' A' ' 113' ' ' HIS . 25.2 p80 -78.02 -6.77 55.59 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.09 0.956 . . . . 0.0 112.692 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 . . . . . 0 C--O 1.247 0.934 0 C-N-CA 128.131 2.572 . . . . 0.0 114.56 -175.637 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 . . . . . 0 N--CA 1.472 0.626 0 CA-C-O 122.714 1.245 . . . . 0.0 108.278 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 173.44 117.27 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 111.641 -2.527 . . . . 0.0 114.893 -162.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.0 -33.8 18.27 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 116.171 -1.871 . . . . 0.0 112.983 -161.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -61.58 -23.59 66.1 Favored 'General case' 0 C--O 1.222 -0.395 0 N-CA-C 118.043 2.609 . . . . 0.0 118.043 171.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.5 tp -85.13 12.38 7.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 116.728 -1.606 . . . . 0.0 113.102 -171.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -152.39 12.45 0.55 Allowed 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 -169.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 18.6 pt -115.24 172.65 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 O-C-N 119.353 -2.092 . . . . 0.0 112.33 165.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.9 m -82.64 164.45 2.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 O-C-N 117.288 -3.383 . . . . 0.0 115.328 172.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 p -61.83 -47.76 83.65 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 119.265 -2.147 . . . . 0.0 110.825 174.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . 0.325 11.7 m-20 -82.34 37.62 0.51 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 119.699 1.136 . . . . 0.0 112.743 -172.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -75.52 142.15 42.89 Favored 'General case' 0 C--O 1.236 0.374 1 C-N-CA 131.744 4.018 . . . . 0.0 117.459 -175.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -58.65 141.74 51.6 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 118.362 -2.711 . . . . 0.0 115.541 174.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -113.08 -14.95 12.89 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 116.95 2.204 . . . . 0.0 116.95 -164.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.42 ' CD1' ' HG2' ' A' ' 71' ' ' GLU . 0.9 OUTLIER -60.14 -48.64 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 O-C-N 124.488 1.118 . . . . 0.0 111.35 -166.741 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.519 6.4 pt -72.77 -23.54 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 128.046 2.538 . . . . 0.0 117.003 173.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 51.1 tttm -56.54 -67.61 0.29 Allowed 'General case' 0 C--O 1.243 0.717 0 N-CA-C 118.079 2.622 . . . . 0.0 118.079 -162.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 57.8 p -68.64 -35.82 77.79 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 121.595 1.998 . . . . 0.0 106.574 -172.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.48 -37.43 87.29 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.748 2.019 . . . . 0.0 114.468 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 51.9 mtp180 -54.02 -49.98 67.68 Favored 'General case' 0 N--CA 1.44 -0.938 2 O-C-N 112.401 -6.437 . . . . 0.0 112.273 166.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -63.2 -33.37 75.33 Favored 'General case' 0 C--N 1.34 0.154 0 C-N-CA 129.354 3.062 . . . . 0.0 111.265 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -76.47 -25.99 54.9 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 122.703 2.501 . . . . 0.0 108.59 -176.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.414 HD11 HD11 ' A' ' 76' ' ' ILE . 97.1 mt -76.7 -23.42 53.13 Favored 'General case' 0 N--CA 1.452 -0.366 0 O-C-N 119.663 -1.898 . . . . 0.0 110.364 168.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.48 -14.89 6.28 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 122.327 2.33 . . . . 0.0 110.935 174.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.0 pt -71.14 155.92 7.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 O-C-N 118.392 -2.828 . . . . 0.0 113.9 -154.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . 0.309 78.8 p -74.18 175.84 7.16 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 127.84 3.213 . . . . 0.0 111.669 -177.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.77 -46.13 89.44 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 123.284 1.516 . . . . 0.0 110.292 161.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -59.07 -28.95 66.96 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 115.585 -2.15 . . . . 0.0 113.135 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -79.88 -29.17 39.92 Favored 'General case' 0 N--CA 1.446 -0.669 1 CA-C-O 111.461 -4.114 . . . . 0.0 111.47 174.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 15.5 tp -68.74 -34.97 76.49 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 125.205 3.638 . . . . 0.0 110.97 171.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.3 -41.53 80.03 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 121.382 1.901 . . . . 0.0 113.359 171.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -61.74 -42.42 98.95 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 127.192 2.808 . . . . 0.0 109.667 171.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -51.33 -32.35 25.03 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 127.089 3.328 . . . . 0.0 109.445 -172.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 81.5 mt -120.2 2.27 10.87 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 117.412 -3.305 . . . . 0.0 110.831 -153.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 77.2 mttt 47.17 -17.8 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.906 1 N-CA-C 123.725 4.713 . . . . 0.0 123.725 -159.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.3 m -94.91 156.42 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 130.15 3.38 . . . . 0.0 115.066 -172.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 84.5 p -72.39 168.09 19.15 Favored 'General case' 0 N--CA 1.441 -0.898 0 O-C-N 118.374 -2.704 . . . . 0.0 116.737 -177.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.443 ' HA ' HG22 ' A' ' 52' ' ' VAL . 21.5 pt-20 -65.91 -20.48 66.23 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 118.877 2.917 . . . . 0.0 118.877 -175.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -47.84 -34.19 8.41 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 118.234 2.679 . . . . 0.0 118.234 163.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.0 mm -80.78 -38.94 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 119.006 -1.078 . . . . 0.0 113.25 166.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.443 HG22 ' HA ' ' A' ' 49' ' ' GLU 0.261 11.0 m -66.05 -42.77 92.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-O 115.496 -2.193 . . . . 0.0 115.86 -170.001 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -58.18 -17.96 22.48 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 127.486 2.314 . . . . 0.0 113.621 177.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -72.55 -50.75 23.48 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 130.688 3.595 . . . . 0.0 110.52 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . 0.374 58.4 m-85 -73.13 -26.06 61.08 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 120.335 1.425 . . . . 0.0 109.173 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -69.0 -45.15 71.29 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 117.923 -2.986 . . . . 0.0 106.831 177.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.4 p -93.67 -34.93 13.07 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 -167.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.36 21.16 62.92 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-O 114.076 -3.624 . . . . 0.0 117.824 173.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -95.1 8.12 43.97 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 128.817 2.847 . . . . 0.0 114.189 -162.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.6 tp -134.38 144.0 47.96 Favored 'General case' 0 N--CA 1.447 -0.623 1 O-C-N 129.852 4.47 . . . . 0.0 114.043 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -102.09 91.8 2.71 Favored Pre-proline 0 N--CA 1.441 -0.878 0 O-C-N 118.678 -2.514 . . . . 0.0 108.749 166.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . 0.272 2.6 Cg_endo -74.9 176.65 9.59 Favored 'Trans proline' 0 N--CA 1.454 -0.81 1 C-N-CA 127.859 5.706 . . . . 0.0 107.789 -168.917 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.8 p -76.85 179.74 5.95 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 178.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.649 HD12 ' H ' ' A' ' 64' ' ' ILE . 2.3 mp -55.04 -62.24 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 C-N-CA 128.4 2.68 . . . . 0.0 107.669 -169.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.6 p -55.05 -30.62 59.99 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 115.237 -2.316 . . . . 0.0 113.896 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -84.15 -54.48 4.79 Favored 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 127.164 2.79 . . . . 0.0 106.661 -168.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -48.49 -33.32 9.24 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 128.683 2.793 . . . . 0.0 114.761 160.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.8 mtt-85 -75.64 -34.46 60.54 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 114.329 -2.748 . . . . 0.0 113.172 166.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -70.56 -32.67 70.18 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 122.932 2.605 . . . . 0.0 115.106 178.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.44 ' C ' ' H ' ' A' ' 72' ' ' LYS . 5.6 tt -41.64 -72.55 0.06 Allowed 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 130.118 3.367 . . . . 0.0 114.925 177.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.42 ' HG2' ' CD1' ' A' ' 26' ' ' ILE . 39.7 mt-10 -48.78 -19.43 0.37 Allowed 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 126.071 2.843 . . . . 0.0 110.26 173.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.44 ' H ' ' C ' ' A' ' 70' ' ' LEU . 28.1 mtpt -99.91 -8.33 24.14 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 117.524 -3.235 . . . . 0.0 115.996 -163.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 22.5 pt -61.43 -46.78 95.89 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 1 N-CA-C 122.004 4.075 . . . . 0.0 122.004 -171.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 49.3 mt -74.48 -18.23 60.65 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 126.002 1.721 . . . . 0.0 110.326 -172.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 69.47 -0.57 17.66 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 118.752 -1.69 . . . . 0.0 116.396 -158.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.414 HD11 HD11 ' A' ' 34' ' ' LEU . 30.8 pt -142.11 175.71 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 125.906 1.682 . . . . 0.0 109.238 179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . 0.357 11.5 pttt -176.95 149.06 0.69 Allowed 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 128.668 2.787 . . . . 0.0 108.526 -174.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 94.1 mt -133.81 145.07 49.4 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 176.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.2 m -113.03 152.84 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 1 C-N-CA 133.804 4.842 . . . . 0.0 114.188 21.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.482 ' HB ' ' HD2' ' A' ' 81' ' ' PRO 0.292 80.3 p -93.83 175.84 2.8 Favored Pre-proline 0 C--O 1.24 0.576 0 C-N-CA 127.2 2.2 . . . . 0.0 109.362 -169.113 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.482 ' HD2' ' HB ' ' A' ' 80' ' ' THR . 45.5 Cg_exo -54.53 -1.49 0.15 Allowed 'Trans proline' 0 N--CA 1.452 -0.946 1 C-N-CA 125.612 4.208 . . . . 0.0 111.363 179.607 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 65.9 mt -57.26 -31.9 66.04 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 122.709 2.504 . . . . 0.0 111.561 160.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -124.47 -39.18 2.34 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 127.778 2.431 . . . . 0.0 111.834 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -160.84 123.46 3.21 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 111.945 -2.389 . . . . 0.0 115.442 -160.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -101.18 163.7 12.15 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 126.546 2.404 . . . . 0.0 108.226 178.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . 0.285 1.3 tt0 -154.26 148.79 26.27 Favored 'General case' 0 N--CA 1.433 -1.324 0 C-N-CA 131.431 3.893 . . . . 0.0 110.438 170.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -69.45 129.74 40.58 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 125.281 1.613 . . . . 0.0 114.23 175.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.9 m -73.07 -13.77 61.27 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-O 116.564 -1.684 . . . . 0.0 114.286 -174.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -63.8 -19.61 65.15 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 119.908 1.231 . . . . 0.0 112.592 -175.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -56.28 -21.41 23.73 Favored 'General case' 0 N--CA 1.44 -0.972 0 O-C-N 116.362 -3.961 . . . . 0.0 110.208 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -82.99 -2.32 54.91 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -171.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -135.9 148.55 48.63 Favored 'General case' 0 CA--C 1.514 -0.428 0 O-C-N 116.463 -3.898 . . . . 0.0 107.878 174.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -152.03 -68.1 0.17 Allowed 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 103.801 -2.666 . . . . 0.0 103.801 -158.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -87.29 -10.83 51.32 Favored 'General case' 0 N--CA 1.447 -0.621 1 O-C-N 114.858 -4.901 . . . . 0.0 113.503 -169.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 44.3 p -120.63 174.04 6.82 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 108.729 -3.85 . . . . 0.0 110.316 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -119.59 125.9 6.52 Favored Glycine 0 C--N 1.335 0.507 1 C-N-CA 130.787 4.042 . . . . 0.0 109.42 164.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 15.0 tp -105.28 -16.71 14.68 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 118.41 -2.817 . . . . 0.0 115.968 -171.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 43.3 p -152.28 4.54 0.39 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 118.338 2.718 . . . . 0.0 118.338 -157.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.527 ' HG ' ' H ' ' A' ' 101' ' ' ASP . 22.5 tp -162.35 116.21 1.79 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 129.84 3.256 . . . . 0.0 115.079 173.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -61.93 -20.52 60.1 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-O 114.875 -3.18 . . . . 0.0 115.581 171.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.527 ' H ' ' HG ' ' A' ' 99' ' ' LEU 0.368 1.4 t70 -74.72 47.23 0.32 Allowed 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 128.607 2.763 . . . . 0.0 111.203 -168.662 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.447 ' HA ' ' C ' ' A' ' 103' ' ' VAL . 2.1 m -132.29 145.44 34.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 O-C-N 127.53 3.019 . . . . 0.0 111.889 -166.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.447 ' C ' ' HA ' ' A' ' 102' ' ' VAL . 33.9 m -73.97 146.16 10.5 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.509 0 O-C-N 117.837 -3.04 . . . . 0.0 104.615 25.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -62.19 98.69 0.11 Allowed 'General case' 0 C--O 1.239 0.54 0 CA-C-N 112.792 -2.004 . . . . 0.0 115.178 -178.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 88.8 mt -75.74 100.5 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 126.109 1.764 . . . . 0.0 106.938 -178.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.4 mmtt -69.99 -15.48 63.03 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 115.642 -2.123 . . . . 0.0 109.218 174.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -75.23 -6.87 52.0 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 127.977 2.511 . . . . 0.0 113.349 -176.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 144.54 155.13 6.34 Favored Glycine 0 C--O 1.22 -0.757 0 C-N-CA 127.086 2.279 . . . . 0.0 113.736 171.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -67.79 168.84 10.72 Favored 'General case' 0 N--CA 1.439 -1.002 0 O-C-N 124.864 0.979 . . . . 0.0 112.457 170.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 57.9 mtmt -51.73 101.95 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.528 1.531 . . . . 0.0 113.833 171.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.0 pp 174.77 179.66 0.12 Allowed 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 128.855 2.862 . . . . 0.0 110.461 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.433 ' C ' ' H ' ' A' ' 114' ' ' HIS . 21.7 tt0 -156.41 -110.39 0.03 OUTLIER 'General case' 0 C--O 1.222 -0.39 0 O-C-N 120.852 -1.155 . . . . 0.0 113.353 176.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -66.24 28.17 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 116.562 -3.836 . . . . 0.0 113.901 175.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . 0.433 ' H ' ' C ' ' A' ' 112' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.047 0 C-N-CA 128.698 2.799 . . . . 0.0 113.017 -175.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 . . . . . 0 C--O 1.217 -0.638 0 CA-C-O 123.408 1.575 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -154.97 98.51 2.04 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 116.994 2.22 . . . . 0.0 116.994 172.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.97 -7.26 15.91 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 118.913 2.931 . . . . 0.0 118.913 176.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -117.64 16.36 14.52 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 120.502 1.501 . . . . 0.0 111.728 175.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . 0.308 43.1 tp -61.02 -50.09 74.76 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 131.275 3.83 . . . . 0.0 110.009 -175.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -112.18 12.05 20.36 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 125.094 2.378 . . . . 0.0 113.357 -153.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 6.5 pt -107.45 155.11 8.27 Favored 'Isoleucine or valine' 0 C--N 1.34 0.171 1 O-C-N 115.579 -4.45 . . . . 0.0 109.128 174.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.7 m -74.36 167.15 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-N 121.542 1.974 . . . . 0.0 112.392 158.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 18.0 m -64.64 -43.51 93.46 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -76.31 10.88 1.77 Allowed 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 115.304 -2.284 . . . . 0.0 112.406 -172.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -65.91 154.13 40.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 129.986 3.314 . . . . 0.0 109.951 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . 0.506 0.0 OUTLIER -75.74 67.66 2.21 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 119.738 3.236 . . . . 0.0 119.738 179.348 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -60.08 -22.75 63.13 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 119.797 -1.814 . . . . 0.0 113.972 -169.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 36.1 pt -61.96 -29.34 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-O 114.815 -2.517 . . . . 0.0 112.851 173.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.316 12.2 mm -63.92 -57.11 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 CA-C-N 122.542 2.428 . . . . 0.0 105.836 174.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -51.02 -65.03 0.63 Allowed 'General case' 0 CA--C 1.532 0.266 1 C-N-CA 134.535 5.134 . . . . 0.0 109.874 -155.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 77.4 p -57.17 -31.68 65.65 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 126.253 2.221 . . . . 0.0 113.772 -164.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.87 -58.51 3.24 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.488 1.515 . . . . 0.0 108.183 174.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 56.5 ttt180 -51.15 -36.79 42.68 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 118.631 -2.543 . . . . 0.0 114.103 -176.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -68.32 -42.22 79.69 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 123.918 3.054 . . . . 0.0 113.467 172.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -54.19 -37.84 64.96 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-O 123.898 1.809 . . . . 0.0 113.206 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.256 62.9 mt -90.44 -11.1 41.4 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 111.266 -2.697 . . . . 0.0 112.371 -161.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.36 4.77 5.38 Favored Glycine 0 C--O 1.238 0.382 0 CA-C-O 125.329 2.627 . . . . 0.0 118.327 178.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.2 pt -69.02 153.06 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 O-C-N 119.668 -2.078 . . . . 0.0 112.161 -172.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.6 p -129.9 165.97 20.96 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 117.387 2.366 . . . . 0.0 117.387 -162.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -60.39 -37.28 80.3 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 116.978 -1.487 . . . . 0.0 112.833 -176.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -52.47 -34.65 50.08 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 115.322 -2.275 . . . . 0.0 113.458 166.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -77.51 -37.76 50.39 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 122.3 2.318 . . . . 0.0 111.632 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 52.3 tp -73.98 -31.93 63.2 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 115.364 -2.255 . . . . 0.0 108.602 -175.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.43 -47.02 76.64 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 166.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -60.6 -42.55 96.99 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 122.802 1.287 . . . . 0.0 112.825 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -70.43 -16.99 63.0 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 118.109 -2.869 . . . . 0.0 106.491 -173.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.8 tp -110.7 5.01 20.56 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 -169.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 44.2 tttp 45.56 52.67 9.09 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 131.158 3.783 . . . . 0.0 110.128 -177.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.8 m -142.45 -176.41 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 C-N-CA 130.036 3.335 . . . . 0.0 115.73 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 86.7 p -94.42 161.35 14.26 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 125.099 1.36 . . . . 0.0 112.544 167.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -73.17 -12.95 61.07 Favored 'General case' 0 N--CA 1.443 -0.819 0 O-C-N 117.122 -3.486 . . . . 0.0 110.378 -174.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -62.29 -37.4 85.37 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 119.027 -2.296 . . . . 0.0 111.961 170.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 36.0 mm -68.51 -28.94 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 125.936 1.694 . . . . 0.0 110.842 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . 0.378 3.2 m -66.29 -35.55 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 O-C-N 117.282 -3.386 . . . . 0.0 113.987 -175.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -50.18 -38.13 38.28 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 117.198 2.296 . . . . 0.0 117.198 -170.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.292 99.0 mtt180 -25.94 -87.03 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 127.927 2.491 . . . . 0.0 114.739 170.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -77.99 -25.03 47.84 Favored 'General case' 0 N--CA 1.452 -0.373 0 O-C-N 120.425 -1.422 . . . . 0.0 111.72 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -63.24 -13.04 33.36 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 120.28 1.4 . . . . 0.0 113.967 -177.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.8 p -65.04 -20.19 66.37 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 117.81 2.522 . . . . 0.0 117.81 170.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.79 19.46 75.09 Favored Glycine 0 N--CA 1.439 -1.161 0 C-N-CA 128.817 3.103 . . . . 0.0 114.408 174.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -92.65 12.3 23.72 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 128.385 3.05 . . . . 0.0 116.04 -174.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.5 mt -145.48 120.81 10.26 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 171.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.8 tttp -64.97 116.38 29.3 Favored Pre-proline 0 C--O 1.233 0.202 0 O-C-N 119.22 -2.175 . . . . 0.0 113.623 161.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -66.43 160.53 45.17 Favored 'Trans proline' 0 N--CA 1.448 -1.199 1 C-N-CA 128.479 6.119 . . . . 0.0 114.145 -176.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.519 ' H ' ' HB2' ' A' ' 66' ' ' GLN . 63.9 p -108.94 -165.93 1.07 Allowed 'General case' 0 C--O 1.239 0.514 0 C-N-CA 127.246 2.218 . . . . 0.0 114.472 172.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 34.2 mt -57.88 -59.43 3.42 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.158 0 O-C-N 118.772 -2.455 . . . . 0.0 114.126 -171.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.3 p -59.75 -40.7 89.01 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 115.686 1.735 . . . . 0.0 115.686 169.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.519 ' HB2' ' H ' ' A' ' 63' ' ' THR . 55.7 mt-30 -63.06 -55.21 27.49 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 116.361 1.985 . . . . 0.0 116.361 -178.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -39.71 -47.27 2.0 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 117.196 -1.383 . . . . 0.0 113.356 160.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 14.1 ttt85 -67.25 -39.57 86.14 Favored 'General case' 0 CA--C 1.515 -0.4 0 C-N-CA 127.234 2.213 . . . . 0.0 107.897 -172.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -67.84 -52.23 39.12 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 116.74 -1.6 . . . . 0.0 107.174 176.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 21.6 tp -59.88 -60.32 4.02 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 127.845 3.688 . . . . 0.0 111.049 -168.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 -52.63 -39.09 61.38 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 117.899 -3.001 . . . . 0.0 109.053 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -76.77 -34.73 58.0 Favored 'General case' 0 N--CA 1.446 -0.653 1 O-C-N 115.239 -4.663 . . . . 0.0 119.446 176.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 31.5 pt -67.84 -30.6 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 118.021 -1.471 . . . . 0.0 108.299 170.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.48 ' C ' ' H ' ' A' ' 76' ' ' ILE 0.311 95.8 mt -70.97 -41.97 70.33 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 117.024 -3.547 . . . . 0.0 117.102 174.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 62.15 -8.5 0.16 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 127.307 2.384 . . . . 0.0 110.961 -167.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.48 ' H ' ' C ' ' A' ' 74' ' ' LEU . 44.8 pt -116.91 146.62 21.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 117.803 2.52 . . . . 0.0 117.803 -177.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -176.2 153.68 1.29 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 114.604 -2.617 . . . . 0.0 112.572 176.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 78' ' ' LEU . 13.5 mt -144.33 123.03 12.57 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-O 126.485 3.04 . . . . 0.0 112.209 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 13.9 m -96.14 174.25 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.661 1 O-C-N 113.746 -5.596 . . . . 0.0 115.942 20.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 55.1 p -93.84 167.06 14.47 Favored Pre-proline 0 N--CA 1.462 0.163 0 O-C-N 120.723 -1.236 . . . . 0.0 108.849 -170.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -68.75 -8.94 24.77 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 O-C-N 115.178 -3.117 . . . . 0.0 109.451 -171.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 15.1 mt -75.55 -7.21 53.61 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 116.326 -1.797 . . . . 0.0 114.863 168.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -131.67 -4.63 3.67 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 114.336 -2.745 . . . . 0.0 111.163 172.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.0 154.21 48.42 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 124.782 3.446 . . . . 0.0 109.242 166.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -79.48 119.15 22.09 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 112.293 -2.23 . . . . 0.0 111.342 169.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.64 167.86 21.08 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 125.01 1.324 . . . . 0.0 109.777 168.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.506 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 27.8 tt0 -75.47 121.35 22.2 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.331 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -81.88 -17.51 47.03 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 120.134 1.334 . . . . 0.0 111.204 -160.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -55.87 -18.52 9.02 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 129.371 3.069 . . . . 0.0 111.342 169.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.506 ' HE3' ' HB3' ' A' ' 87' ' ' GLU . 93.3 mttt -63.78 -22.18 66.79 Favored 'General case' 0 CA--C 1.516 -0.353 0 O-C-N 117.338 -3.351 . . . . 0.0 110.319 179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -53.68 -37.07 62.86 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 124.177 3.171 . . . . 0.0 110.195 170.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -76.87 151.63 35.75 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 116.374 -3.954 . . . . 0.0 109.584 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -46.76 -65.35 0.57 Allowed 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.657 1.583 . . . . 0.0 114.732 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -118.3 -29.96 5.38 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 127.432 2.293 . . . . 0.0 116.795 -172.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . 0.257 12.7 t -173.59 153.94 2.41 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 127.702 3.126 . . . . 0.0 115.089 -173.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -60.48 117.92 13.1 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 127.657 2.551 . . . . 0.0 110.576 166.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.2 mt -94.55 153.89 17.66 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 116.145 -1.883 . . . . 0.0 113.102 178.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.4 m -105.94 132.95 51.42 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 126.235 2.209 . . . . 0.0 108.846 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 62.9 tp -83.92 -19.6 34.45 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 120.846 3.647 . . . . 0.0 120.846 169.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 57.09 53.33 45.43 Favored Glycine 0 N--CA 1.45 -0.421 0 O-C-N 124.023 0.827 . . . . 0.0 113.236 172.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.296 15.7 t70 -162.84 95.64 0.89 Allowed 'General case' 0 C--O 1.237 0.418 0 CA-C-O 115.33 -2.271 . . . . 0.0 112.854 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.615 ' HB ' ' HA ' ' A' ' 103' ' ' VAL . 4.2 m -133.02 163.03 39.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 O-C-N 127.27 2.856 . . . . 0.0 111.948 -173.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.615 ' HA ' ' HB ' ' A' ' 102' ' ' VAL . 56.1 t -67.93 136.18 27.04 Favored 'Isoleucine or valine' 0 C--N 1.345 0.404 1 O-C-N 113.835 -5.541 . . . . 0.0 117.37 -5.607 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -76.41 123.2 25.63 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 127.117 2.76 . . . . 0.0 110.646 166.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.411 HG13 ' H ' ' A' ' 108' ' ' GLY . 0.4 OUTLIER -109.55 151.12 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-N 122.764 2.529 . . . . 0.0 110.313 170.3 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -84.01 -23.7 30.85 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 120.56 1.527 . . . . 0.0 110.999 -167.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -82.8 -27.95 30.58 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 117.211 -1.376 . . . . 0.0 108.833 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.411 ' H ' HG13 ' A' ' 105' ' ' ILE . . . -115.56 163.37 12.29 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 122.086 2.221 . . . . 0.0 115.815 -165.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -138.17 35.61 2.32 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 128.904 2.882 . . . . 0.0 111.401 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 52.3 tttp 160.05 118.84 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.355 1 C-N-CA 136.093 5.757 . . . . 0.0 109.311 -166.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 58.1 mt -101.15 -176.26 3.11 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 156.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -153.95 -128.31 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 114.934 -2.46 . . . . 0.0 104.608 -176.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . 0.292 0.2 OUTLIER -72.1 19.51 0.07 Allowed 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 123.566 2.894 . . . . 0.0 115.993 -173.233 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . 0.254 72.4 m80 . . . . . 0 C--O 1.25 1.082 1 C-N-CA 133.702 4.801 . . . . 0.0 111.768 -179.403 . . . . . . . . 2 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.546 ' OE1' ' HA ' ' A' ' 13' ' ' GLU . 4.5 mm-40 . . . . . 0 CA--C 1.539 0.531 0 CA-C-O 118.415 -0.802 . . . . 0.0 111.595 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -137.11 55.39 1.82 Allowed 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 128.869 3.855 . . . . 0.0 117.243 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.4 -7.08 59.52 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 113.157 -1.838 . . . . 0.0 113.612 -160.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.403 0.3 OUTLIER -134.35 10.34 3.78 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 125.811 1.944 . . . . 0.0 115.164 -172.187 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . 0.29 5.8 mt 61.27 44.25 9.98 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 128.286 2.635 . . . . 0.0 111.247 177.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -157.3 135.4 11.03 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 112.789 -2.005 . . . . 0.0 115.246 -167.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 21.2 pt -105.13 -17.73 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-N 113.373 -1.739 . . . . 0.0 113.641 -173.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t -56.89 139.55 16.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 105.893 -1.892 . . . . 0.0 105.893 164.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -151.63 -45.31 0.11 Allowed 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 117.394 -1.289 . . . . 0.0 111.032 -175.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -76.15 63.5 1.85 Allowed 'General case' 0 CA--C 1.504 -0.81 0 C-N-CA 129.198 2.999 . . . . 0.0 113.713 174.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.577 ' HD1' ' H ' ' A' ' 60' ' ' LEU . 63.5 t80 -90.9 153.56 20.1 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 130.697 3.599 . . . . 0.0 108.599 -165.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -72.73 140.93 48.11 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 126.87 3.224 . . . . 0.0 111.332 -167.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.0 mttt -93.96 -45.9 7.4 Favored 'General case' 0 CA--C 1.503 -0.848 1 O-C-N 114.19 -5.319 . . . . 0.0 116.456 -155.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.7 tp -65.22 -37.54 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-O 115.614 -2.136 . . . . 0.0 113.414 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . 0.398 7.6 pt -55.05 -35.6 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 O-C-N 125.73 1.894 . . . . 0.0 109.302 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -67.54 -39.63 85.03 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 119.795 -1.816 . . . . 0.0 112.254 -174.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 62.9 p -62.17 -43.14 99.49 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 124.491 1.116 . . . . 0.0 108.705 -157.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.35 -74.8 0.13 Allowed 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 117.741 2.497 . . . . 0.0 117.741 -155.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -47.95 -46.36 32.13 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 -165.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -55.16 -58.6 7.01 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 124.374 3.261 . . . . 0.0 112.224 177.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -66.98 -23.1 65.91 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 123.519 2.872 . . . . 0.0 116.298 -172.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 99.3 mt -76.58 -1.8 29.29 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 177.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.54 -0.56 12.55 Favored Glycine 0 C--N 1.335 0.481 2 CA-C-N 107.327 -4.488 . . . . 0.0 117.064 172.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.2 pt -78.77 158.78 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 C-N-CA 130.077 3.351 . . . . 0.0 114.126 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 p -89.61 175.77 7.14 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 117.134 2.272 . . . . 0.0 117.134 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 -55.73 -50.98 68.9 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 116.59 -3.819 . . . . 0.0 110.299 161.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -60.07 -47.28 86.53 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 129.27 3.028 . . . . 0.0 113.319 -170.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -64.21 -33.44 75.8 Favored 'General case' 0 N--CA 1.449 -0.51 1 CA-C-O 111.62 -4.038 . . . . 0.0 114.4 174.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 23.0 tp -85.25 -27.14 26.23 Favored 'General case' 0 C--N 1.32 -0.709 0 O-C-N 127.822 3.202 . . . . 0.0 109.653 -177.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.56 -24.1 67.67 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 129.28 3.032 . . . . 0.0 113.483 167.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -66.12 -55.64 15.41 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 104.089 -2.56 . . . . 0.0 104.089 169.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -62.25 -14.99 44.27 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 128.32 2.648 . . . . 0.0 113.41 -159.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 40.8 mt -131.51 -8.47 3.68 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 128.297 3.903 . . . . 0.0 109.955 -163.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.312 88.1 mttt 56.4 -5.4 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 121.709 3.966 . . . . 0.0 121.709 -158.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.3 m -131.25 153.47 39.07 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 C-N-CA 127.87 2.468 . . . . 0.0 110.907 -168.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.921 ' C ' ' H ' ' A' ' 52' ' ' VAL . 91.3 p -128.57 -11.83 4.98 Favored 'General case' 0 N--CA 1.446 -0.653 1 N-CA-C 122.196 4.147 . . . . 0.0 122.196 -169.69 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -99.59 -30.46 12.12 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 117.354 -3.342 . . . . 0.0 111.397 -158.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . 0.253 64.6 t30 -103.15 -55.49 2.4 Favored 'General case' 0 C--O 1.217 -0.618 1 N-CA-C 122.431 4.234 . . . . 0.0 122.431 177.152 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . 0.325 0.7 OUTLIER 41.23 52.03 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.491 2 O-C-N 113.689 -5.632 . . . . 0.0 118.247 14.295 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.921 ' H ' ' C ' ' A' ' 48' ' ' SER . 15.7 t -105.33 -42.36 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 129.366 3.067 . . . . 0.0 107.929 23.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -69.95 -39.34 76.12 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 119.023 2.972 . . . . 0.0 119.023 -153.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 54' ' ' ARG . 34.8 ttm180 -83.05 -12.59 57.02 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 120.455 1.479 . . . . 0.0 114.391 -158.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 6.9 m-30 -79.7 -11.93 59.83 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -88.26 -5.95 58.06 Favored 'General case' 0 C--O 1.24 0.57 0 O-C-N 118.061 -2.899 . . . . 0.0 110.693 -175.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.6 p -92.1 -7.04 49.73 Favored 'General case' 0 N--CA 1.454 -0.268 1 N-CA-C 121.936 4.05 . . . . 0.0 121.936 -142.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.48 ' HA2' ' CD2' ' A' ' 23' ' ' TYR . . . 68.47 26.13 74.49 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-O 115.109 -3.05 . . . . 0.0 110.942 177.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -130.38 -1.32 4.46 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 119.068 2.988 . . . . 0.0 119.068 -160.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.577 ' H ' ' HD1' ' A' ' 23' ' ' TYR . 4.2 tp -135.31 158.87 43.27 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 -171.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -106.48 94.87 10.64 Favored Pre-proline 0 CA--C 1.513 -0.454 0 CA-C-O 115.646 -2.121 . . . . 0.0 113.259 147.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -76.08 151.28 34.62 Favored 'Trans proline' 0 N--CA 1.443 -1.467 0 C-N-CA 122.612 2.208 . . . . 0.0 110.61 172.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.5 p -80.17 171.72 14.72 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 127.213 2.821 . . . . 0.0 117.726 169.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . 0.315 2.1 tp -53.58 -61.17 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 130.548 3.539 . . . . 0.0 106.382 177.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 83.2 p -61.23 -23.6 65.75 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 116.308 -1.806 . . . . 0.0 112.887 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -80.77 -46.69 15.02 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 128.379 2.672 . . . . 0.0 109.233 173.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.04 93.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 130.173 3.389 . . . . 0.0 115.035 170.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -52.09 -22.41 4.12 Favored 'General case' 0 C--O 1.22 -0.476 0 C-N-CA 127.276 2.23 . . . . 0.0 113.959 175.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -66.68 -13.05 60.79 Favored 'General case' 0 N--CA 1.438 -1.025 0 C-N-CA 125.985 1.714 . . . . 0.0 111.339 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.6 tp -79.97 -49.6 11.62 Favored 'General case' 0 N--CA 1.436 -1.152 1 O-C-N 114.735 -4.978 . . . . 0.0 109.484 -175.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -50.56 -31.32 15.41 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 126.567 2.417 . . . . 0.0 108.022 172.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.1 tttp -69.17 -54.24 15.88 Favored 'General case' 0 C--O 1.24 0.579 1 C-N-CA 131.788 4.035 . . . . 0.0 106.786 -170.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 19.2 pt -79.53 -40.0 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 117.466 -3.271 . . . . 0.0 108.076 -168.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 25.4 mt -82.45 -13.46 56.7 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 128.189 2.596 . . . . 0.0 114.04 -175.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.517 ' O ' HG23 ' A' ' 76' ' ' ILE . . . 69.33 4.13 42.49 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-O 114.12 -3.6 . . . . 0.0 118.228 -167.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.517 HG23 ' O ' ' A' ' 75' ' ' GLY . 6.5 pt -171.94 135.31 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 127.854 2.462 . . . . 0.0 109.016 -161.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -65.73 131.0 45.25 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 114.173 -3.011 . . . . 0.0 115.629 170.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 12.5 mt -138.74 145.58 40.42 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 124.099 3.136 . . . . 0.0 111.185 -173.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . 0.401 1.4 m -81.62 159.03 4.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 1 O-C-N 115.708 -4.37 . . . . 0.0 116.659 -0.978 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 67.8 p -76.18 157.6 82.89 Favored Pre-proline 0 N--CA 1.451 -0.38 0 O-C-N 121.702 -0.624 . . . . 0.0 109.517 177.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -50.71 -10.41 0.28 Allowed 'Trans proline' 0 N--CA 1.445 -1.382 0 O-C-N 124.207 1.635 . . . . 0.0 115.204 170.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 32.5 tp -71.99 -41.12 68.01 Favored 'General case' 0 C--O 1.219 -0.544 0 O-C-N 118.9 -2.375 . . . . 0.0 111.423 172.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -109.35 6.07 24.08 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 118.367 2.728 . . . . 0.0 118.367 -175.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -58.59 124.45 19.69 Favored 'General case' 0 N--CA 1.449 -0.475 0 O-C-N 119.708 -1.87 . . . . 0.0 111.203 165.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -75.19 -15.37 60.56 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 122.618 2.463 . . . . 0.0 116.102 163.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -65.01 115.89 5.87 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 126.74 2.525 . . . . 0.0 108.62 173.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -78.33 -1.26 32.37 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 112.375 -3.678 . . . . 0.0 109.39 -177.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 67.4 p -105.81 15.4 26.78 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 125.587 3.812 . . . . 0.0 119.087 167.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -104.76 145.08 30.86 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 127.35 2.26 . . . . 0.0 111.56 164.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.2 pttt -161.47 169.73 21.31 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 125.12 2.39 . . . . 0.0 107.701 -175.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -72.37 138.75 47.45 Favored 'General case' 0 C--N 1.345 0.38 0 C-N-CA 127.149 2.18 . . . . 0.0 114.026 163.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -147.42 175.13 11.05 Favored 'General case' 0 CA--C 1.507 -0.673 0 C-N-CA 124.717 1.207 . . . . 0.0 108.173 -167.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.515 ' HB3' ' H ' ' A' ' 96' ' ' GLY . 5.1 t70 -157.61 159.35 36.96 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 114.498 -2.668 . . . . 0.0 111.739 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -50.17 -29.48 9.35 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 124.206 3.185 . . . . 0.0 114.692 156.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 53.6 m -70.0 -48.6 57.5 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 172.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.515 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -71.19 -13.45 73.23 Favored Glycine 0 CA--C 1.522 0.479 0 C-N-CA 117.184 -2.436 . . . . 0.0 114.498 175.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.4 tp -80.39 -28.15 37.98 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 121.02 3.711 . . . . 0.0 121.02 160.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 71.0 p -87.15 -10.71 52.04 Favored 'General case' 0 N--CA 1.447 -0.608 1 O-C-N 116.172 -4.08 . . . . 0.0 112.273 168.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 43.7 tp -75.08 -15.95 60.59 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 119.067 -2.27 . . . . 0.0 112.177 149.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 69.0 25.35 75.47 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-O 124.229 2.016 . . . . 0.0 114.338 -178.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -73.84 37.44 0.1 Allowed 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 117.953 2.575 . . . . 0.0 117.953 -177.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 9.9 p -128.81 152.46 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 1 C-N-CA 132.113 4.165 . . . . 0.0 111.597 -158.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . 0.283 0.3 OUTLIER 83.78 -21.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 O-C-N 118.657 -2.527 . . . . 0.0 116.032 149.246 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -66.25 -19.9 65.95 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 117.572 -1.204 . . . . 0.0 109.48 -167.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.66 -26.63 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.919 0 CA-C-N 122.413 2.37 . . . . 0.0 115.721 171.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -80.61 165.57 21.92 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 119.999 1.272 . . . . 0.0 108.84 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -96.07 146.59 24.52 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 69.0 -10.58 1.58 Allowed Glycine 0 C--N 1.337 0.632 0 N-CA-C 118.991 2.357 . . . . 0.0 118.991 -166.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -61.95 1.41 0.29 Allowed 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 120.13 1.965 . . . . 0.0 112.362 173.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -89.6 -26.84 20.58 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 118.544 -2.598 . . . . 0.0 114.257 -178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 23.1 tp -70.29 -31.13 68.34 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 126.372 2.987 . . . . 0.0 112.646 160.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . 0.379 17.0 tt0 -81.13 -74.35 0.33 Allowed 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 118.16 -2.837 . . . . 0.0 116.817 -177.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -77.21 6.9 5.8 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 119.875 3.287 . . . . 0.0 119.875 -176.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 . . . . . 0 C--O 1.25 1.126 0 O-C-N 118.488 -2.633 . . . . 0.0 113.787 -172.347 . . . . . . . . 0 0 . 1 stop_ save_